data_2mxn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mxn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.9 m . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.1 pt -61.07 -33.25 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 120.976 -1.077 . . . . 0.0 112.515 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -77.75 -22.65 49.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.587 1.555 . . . . 0.0 114.648 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 t -85.66 -28.71 24.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.049 2.14 . . . . 0.0 112.78 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -87.35 145.5 26.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.377 1.071 . . . . 0.0 111.004 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -84.12 -28.9 27.16 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.32 -0.863 . . . . 0.0 111.39 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.9 t -143.83 134.85 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.087 0.955 . . . . 0.0 112.255 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.3 t -133.01 138.32 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.893 1.277 . . . . 0.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 t -134.14 154.1 51.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.651 0.78 . . . . 0.0 111.473 170.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.57 147.58 50.28 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.487 0.661 . . . . 0.0 111.969 172.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.3 mt -137.01 159.8 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.331 -157.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -68.17 96.46 0.64 Allowed 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.345 -0.847 . . . . 0.0 108.971 156.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.49 -150.51 22.62 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 121.942 0.745 . . . . 0.0 114.383 -172.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.03 154.05 55.47 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.588 1.955 . . . . 0.0 110.029 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.63 -13.95 38.35 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.955 2.437 . . . . 0.0 114.59 -170.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -88.89 -19.92 25.23 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.716 1.206 . . . . 0.0 112.778 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.94 69.35 13.18 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.204 1.801 . . . . 0.0 111.021 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.39 148.97 74.72 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.66 2.24 . . . . 0.0 111.449 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.7 mmt -106.61 0.29 24.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.806 1.243 . . . . 0.0 113.781 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.7 t -141.84 147.0 36.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.499 1.52 . . . . 0.0 110.435 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.87 -47.01 86.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.831 0.852 . . . . 0.0 111.246 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -66.3 -33.35 75.53 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.998 -1.064 . . . . 0.0 111.548 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 m -62.26 -41.5 98.51 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.742 0.817 . . . . 0.0 113.111 170.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -62.82 -46.93 85.64 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.191 0.905 . . . . 0.0 111.466 171.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -56.97 -37.27 71.35 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.43 1.092 . . . . 0.0 111.993 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.5 tpp -59.34 -46.01 89.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.775 0.83 . . . . 0.0 112.923 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 mm -67.72 -33.13 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.981 1.264 . . . . 0.0 111.326 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.29 -32.83 73.26 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.911 0.884 . . . . 0.0 112.586 170.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.7 -37.25 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 125.628 1.571 . . . . 0.0 111.573 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.6 mt -63.77 -35.44 80.59 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.725 -1.234 . . . . 0.0 111.831 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -71.9 -31.23 66.2 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.816 -1.177 . . . . 0.0 111.998 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.26 -32.2 73.74 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.587 -1.321 . . . . 0.0 111.901 173.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.6 tp -86.07 -12.5 49.99 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.606 1.963 . . . . 0.0 112.716 171.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.82 4.23 13.49 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.854 1.693 . . . . 0.0 114.887 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.83 129.92 55.98 Favored 'General case' 0 C--N 1.335 -0.037 0 C-N-CA 124.599 1.16 . . . . 0.0 109.732 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -110.93 148.35 32.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.113 0.958 . . . . 0.0 110.645 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -120.65 172.64 7.72 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.236 1.815 . . . . 0.0 110.507 -169.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 93.0 m -86.71 122.52 30.72 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -163.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.5 p -113.27 144.63 42.4 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -159.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -137.09 147.87 46.36 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.505 1.122 . . . . 0.0 112.318 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.02 123.45 34.49 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.24 1.416 . . . . 0.0 110.464 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.6 m -67.78 -20.98 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -88.09 -24.19 23.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.938 1.295 . . . . 0.0 113.371 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.47 -35.34 17.08 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -139.11 120.07 9.78 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.357 0.663 . . . . 0.0 110.987 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.85 -13.15 36.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.853 2.369 . . . . 0.0 115.005 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.29 -36.0 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.603 0.761 . . . . 0.0 112.338 169.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.23 -51.45 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.887 0.875 . . . . 0.0 111.171 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.0 ptt-85 -69.32 -26.04 64.52 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.1 m -70.84 -49.31 47.54 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.069 0.948 . . . . 0.0 113.018 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -62.47 -48.55 79.12 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.736 -0.603 . . . . 0.0 111.377 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.1 p -61.0 -39.27 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 121.97 -0.456 . . . . 0.0 112.147 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -63.66 -44.77 92.82 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.226 1.41 . . . . 0.0 111.923 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -72.38 -36.51 68.74 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.276 3.0 t -87.27 -31.95 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.1 p -99.02 -5.66 29.99 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 64.48 -59.27 0.22 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.825 2.45 . . . . 0.0 114.635 -167.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -121.44 106.38 37.92 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.193 1.397 . . . . 0.0 109.908 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.32 136.1 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.305 2.67 . . . . 0.0 113.693 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.5 m -134.21 112.91 11.47 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.168 1.787 . . . . 0.0 109.235 171.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.6 pt -100.59 149.27 35.99 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.68 152.49 96.46 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 119.696 0.927 . . . . 0.0 112.785 2.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -141.41 146.57 36.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.335 0.654 . . . . 0.0 111.156 -166.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.11 140.52 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.876 1.27 . . . . 0.0 113.188 -164.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -133.24 140.68 47.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.987 2.115 . . . . 0.0 109.783 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.4 mt -130.31 132.42 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.155 0.982 . . . . 0.0 108.362 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . 0.292 26.8 mtpp 46.15 51.41 11.16 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.699 2.0 . . . . 0.0 114.47 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 56.98 24.12 9.11 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.492 2.317 . . . . 0.0 115.636 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -128.91 143.75 50.98 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.879 1.672 . . . . 0.0 110.861 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -79.26 124.29 28.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.0 t -101.96 -53.37 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.236 1.815 . . . . 0.0 112.51 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 165.68 169.96 29.98 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 117.973 1.949 . . . . 0.0 117.973 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.65 170.97 55.02 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.607 1.099 . . . . 0.0 112.397 162.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.2 tp -48.48 -41.68 30.52 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.491 1.116 . . . . 0.0 113.71 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.4 -31.71 69.51 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.996 0.816 . . . . 0.0 112.304 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.72 -47.3 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.695 1.598 . . . . 0.0 110.086 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.9 t -54.43 -38.04 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.188 1.395 . . . . 0.0 110.535 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 85.9 m -58.96 -46.56 87.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.63 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -62.88 -43.71 98.06 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 120.207 1.367 . . . . 0.0 110.656 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 59.5 mtt -65.24 -42.34 93.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.787 0.835 . . . . 0.0 112.039 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -44.24 71.52 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.213 1.805 . . . . 0.0 111.594 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.74 -15.53 63.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.729 1.611 . . . . 0.0 113.533 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.1 m -106.16 -6.32 18.65 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.36 3.9 54.9 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 120.216 1.371 . . . . 0.0 114.247 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -69.32 -34.2 74.29 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.348 -1.089 . . . . 0.0 111.702 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.37 -45.68 92.67 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.146 0.978 . . . . 0.0 110.138 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -31.09 69.07 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.096 1.758 . . . . 0.0 114.539 176.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -59.62 -46.94 87.47 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.791 1.178 . . . . 0.0 111.712 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -68.87 -43.41 75.42 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.66 -35.73 80.87 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.662 -0.648 . . . . 0.0 112.193 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -68.62 -35.18 76.97 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.234 -0.916 . . . . 0.0 112.338 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.5 -26.94 68.65 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.78 0.718 . . . . 0.0 112.225 171.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.77 4.34 25.63 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.853 1.661 . . . . 0.0 113.586 170.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.41 16.44 71.31 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.073 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.7 mt -101.86 145.15 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 118.808 1.304 . . . . 0.0 111.068 -171.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 97.4 m -103.28 123.21 46.35 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.916 1.286 . . . . 0.0 110.941 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.7 p -108.92 166.83 10.53 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.015 1.726 . . . . 0.0 112.572 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 153.275 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 78.9 m . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 pt -58.46 -36.12 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 120.111 1.323 . . . . 0.0 111.904 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -75.08 -39.9 60.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.069 1.348 . . . . 0.0 112.952 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.3 t -72.13 -34.57 68.65 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.858 1.263 . . . . 0.0 113.954 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -85.22 143.95 28.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.209 -0.932 . . . . 0.0 111.637 -174.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -84.1 -40.46 18.25 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.199 -0.938 . . . . 0.0 111.776 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.51 129.84 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.825 1.65 . . . . 0.0 110.211 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.5 t -134.02 133.45 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.436 1.094 . . . . 0.0 111.594 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.1 t -135.41 156.26 49.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.156 1.382 . . . . 0.0 111.113 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -135.0 137.89 43.45 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.828 0.851 . . . . 0.0 110.637 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.93 160.35 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.464 1.506 . . . . 0.0 109.703 -160.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -69.72 99.15 1.29 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.3 -0.875 . . . . 0.0 108.784 158.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.38 -144.1 21.35 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 118.236 0.471 . . . . 0.0 114.114 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -124.02 158.45 60.34 Favored Pre-proline 0 N--CA 1.473 0.704 0 C-N-CA 125.714 1.605 . . . . 0.0 112.258 -171.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.62 -16.44 53.62 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.179 2.586 . . . . 0.0 114.815 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -95.18 -19.17 20.29 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.601 1.56 . . . . 0.0 113.297 168.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.65 71.64 15.46 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.627 1.571 . . . . 0.0 113.393 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.27 156.51 29.45 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.07 3.18 . . . . 0.0 113.312 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 79.2 mtp -124.24 8.31 8.51 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.332 1.453 . . . . 0.0 114.138 -170.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 22.5 t -150.63 146.78 26.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.805 1.642 . . . . 0.0 110.673 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.56 95.1 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.87 -35.1 74.42 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.55 -0.719 . . . . 0.0 111.921 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.2 m -61.85 -44.78 96.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.931 0.892 . . . . 0.0 111.579 171.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 tmpt? -64.39 -40.82 96.55 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.028 0.931 . . . . 0.0 111.755 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -63.35 -35.91 81.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.5 ttp -58.51 -38.23 77.25 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.215 0.916 . . . . 0.0 111.933 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 mm -61.69 -36.26 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.506 0.594 . . . . 0.0 111.703 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -70.2 -33.81 72.16 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.727 1.611 . . . . 0.0 113.489 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.74 -39.19 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.589 0.756 . . . . 0.0 110.522 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.1 mt -66.34 -37.99 86.61 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -61.77 -29.16 69.95 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.792 1.237 . . . . 0.0 112.198 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.88 65.99 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.217 -0.927 . . . . 0.0 113.365 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.93 -12.67 20.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.987 1.315 . . . . 0.0 113.889 170.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.86 19.35 67.45 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.278 0.942 . . . . 0.0 114.121 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.7 mt -111.72 136.54 50.84 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.289 1.835 . . . . 0.0 111.518 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -117.22 145.52 43.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.874 1.321 . . . . 0.0 113.374 165.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -119.12 173.55 6.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.914 2.086 . . . . 0.0 111.211 -169.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.3 m -84.36 119.23 24.86 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.91 -1.119 . . . . 0.0 109.394 -160.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.4 m -125.05 130.66 52.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.103 -153.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -129.01 156.57 43.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.523 1.529 . . . . 0.0 113.007 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -95.11 104.14 16.01 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.107 1.363 . . . . 0.0 112.198 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.9 p -74.57 -11.11 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.6 tp -81.14 -28.53 35.05 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.027 -1.046 . . . . 0.0 110.718 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.75 -36.92 19.85 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -117.53 105.65 47.82 Favored Pre-proline 0 N--CA 1.476 0.871 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -167.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.86 -28.76 40.26 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.544 3.496 . . . . 0.0 115.256 168.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -56.51 -43.59 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.222 0.919 . . . . 0.0 112.283 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.27 -47.62 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -48.97 -54.85 13.85 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.188 0.995 . . . . 0.0 111.554 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.4 m -61.81 -44.74 96.26 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -170.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -70.5 -46.64 63.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.207 0.527 . . . . 0.0 110.545 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.37 -41.92 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.895 0.878 . . . . 0.0 112.22 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -67.63 -42.67 81.95 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -41.56 97.75 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.134 0.974 . . . . 0.0 113.157 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.34 -36.15 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 89.6 p -102.15 -4.92 25.07 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 62.89 -46.88 0.2 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 128.914 2.886 . . . . 0.0 115.73 -173.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -142.12 101.31 5.78 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 125.57 1.548 . . . . 0.0 111.055 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -86.52 148.37 8.7 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.924 2.416 . . . . 0.0 114.098 -171.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 87.5 m -100.13 149.91 23.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.379 1.872 . . . . 0.0 109.317 164.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 81.3 mt -119.54 113.86 34.71 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.727 0.811 . . . . 0.0 109.162 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -77.03 164.25 87.66 Favored 'Cis proline' 0 CA--C 1.544 1.013 0 CA-C-N 120.103 1.073 . . . . 0.0 114.241 -7.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -146.08 172.32 13.59 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.932 1.293 . . . . 0.0 111.815 166.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.34 142.05 49.18 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -165.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -122.72 142.41 50.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.626 1.97 . . . . 0.0 111.326 173.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 74.5 mt -134.18 134.89 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.273 1.429 . . . . 0.0 108.953 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp 49.9 42.85 24.83 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.359 1.464 . . . . 0.0 112.885 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.53 18.87 2.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.918 2.087 . . . . 0.0 116.213 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.07 148.61 38.69 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.491 1.516 . . . . 0.0 111.636 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -79.93 126.57 31.19 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.196 0.998 . . . . 0.0 112.032 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.0 -39.38 6.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.918 1.287 . . . . 0.0 111.357 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.98 -179.31 21.42 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 172.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.27 171.34 52.85 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.776 1.179 . . . . 0.0 113.107 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 pp -57.39 -29.46 64.1 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -70.26 -28.82 65.54 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.029 -1.044 . . . . 0.0 111.922 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.4 mm -74.33 -45.46 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.588 1.155 . . . . 0.0 109.596 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.7 t -57.17 -46.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.049 0.94 . . . . 0.0 110.79 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.6 m -60.31 -43.87 95.95 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.844 0.858 . . . . 0.0 110.825 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -61.25 -47.35 86.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.255 1.022 . . . . 0.0 112.509 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 22.1 mmt -65.63 -39.74 91.8 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.7 1.136 . . . . 0.0 111.818 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.61 -47.46 78.54 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.228 1.411 . . . . 0.0 111.197 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.39 -22.58 60.22 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.264 1.026 . . . . 0.0 112.664 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.0 t -81.09 -20.56 41.24 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.894 1.677 . . . . 0.0 113.419 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.16 -2.5 86.89 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 121.135 -0.978 . . . . 0.0 113.911 -171.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -70.72 -32.71 70.0 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.648 -0.913 . . . . 0.0 111.729 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -44.07 97.72 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.075 -1.016 . . . . 0.0 111.004 173.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -60.31 -33.67 72.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.954 1.302 . . . . 0.0 113.51 172.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -63.2 -47.3 83.15 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.66 0.664 . . . . 0.0 111.269 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.9 mtm -68.37 -43.97 76.22 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.5 pp -65.48 -35.46 80.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.746 0.703 . . . . 0.0 112.177 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -70.5 -30.22 66.95 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.473 -0.767 . . . . 0.0 112.717 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.91 -32.78 74.27 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.419 -0.8 . . . . 0.0 111.201 171.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -1.03 27.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.993 1.717 . . . . 0.0 113.283 169.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.81 2.23 84.45 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.038 2.256 . . . . 0.0 115.462 175.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.9 mt -81.54 144.21 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 119.132 1.466 . . . . 0.0 112.671 -158.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.3 m -83.47 123.15 29.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.135 1.374 . . . . 0.0 112.181 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 5.6 p -133.44 165.69 24.28 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.138 1.775 . . . . 0.0 112.882 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 . . . . . 0 N--CA 1.478 0.927 0 C-N-CA 125.848 1.659 . . . . 0.0 113.547 171.186 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 121.023 0.439 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -65.26 -30.47 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.781 1.232 . . . . 0.0 112.081 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -37.83 73.39 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.434 1.493 . . . . 0.0 112.895 170.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.4 t -73.33 -31.07 63.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.047 0.939 . . . . 0.0 113.13 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.15 146.49 25.01 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -76.76 -40.8 47.13 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.63 -1.294 . . . . 0.0 113.83 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.7 t -145.87 135.68 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.944 1.298 . . . . 0.0 110.076 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.16 132.23 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.876 0.871 . . . . 0.0 111.599 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -133.84 155.53 49.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.115 1.366 . . . . 0.0 111.317 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -129.7 137.31 50.53 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.876 0.87 . . . . 0.0 110.787 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.18 156.3 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.063 1.345 . . . . 0.0 110.408 -161.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -70.07 102.17 1.98 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 158.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.81 -147.28 27.7 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 118.748 0.704 . . . . 0.0 113.418 -172.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -126.75 157.45 71.3 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.344 1.857 . . . . 0.0 110.925 -172.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.21 -23.57 75.52 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.026 2.484 . . . . 0.0 114.388 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -76.67 -24.24 53.24 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 171.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -148.96 68.83 9.75 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 126.06 1.744 . . . . 0.0 111.887 -175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.0 142.23 42.02 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.504 2.136 . . . . 0.0 111.744 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.5 mtt -101.28 3.87 41.18 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.544 1.538 . . . . 0.0 113.434 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.8 t -145.32 146.08 31.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.282 1.433 . . . . 0.0 111.177 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.37 -44.77 88.98 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.523 0.729 . . . . 0.0 112.265 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -61.53 -36.89 81.84 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.34 -0.85 . . . . 0.0 111.909 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 m -66.57 -37.84 85.8 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.513 0.725 . . . . 0.0 112.646 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -66.46 -44.02 83.91 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.261 1.024 . . . . 0.0 112.881 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -60.94 -35.24 76.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.228 0.611 . . . . 0.0 112.225 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.1 tpp -55.67 -44.44 77.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.182 0.593 . . . . 0.0 112.265 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.72 -32.13 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 121.257 -0.902 . . . . 0.0 111.607 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -34.33 76.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.67 1.188 . . . . 0.0 112.712 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 t -69.23 -41.86 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.907 1.683 . . . . 0.0 111.767 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.8 mt -64.64 -36.32 83.87 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.432 -0.792 . . . . 0.0 112.59 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.74 -36.96 85.06 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.717 -1.239 . . . . 0.0 111.569 171.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.74 -26.34 65.19 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.2 tp -87.8 -14.07 40.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.956 0.903 . . . . 0.0 112.702 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.75 7.38 35.02 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.282 1.896 . . . . 0.0 114.876 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.1 mt -110.99 133.44 53.39 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.641 1.176 . . . . 0.0 111.218 172.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -112.61 159.6 18.7 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.592 1.187 . . . . 0.0 111.408 160.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -136.59 175.7 9.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.835 2.054 . . . . 0.0 110.506 -157.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.0 m -86.42 122.14 29.97 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.943 -1.098 . . . . 0.0 108.622 -175.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.2 p -119.79 147.61 44.43 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.089 1.355 . . . . 0.0 112.865 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -133.77 143.37 48.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.196 0.998 . . . . 0.0 113.064 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -85.67 102.22 13.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.035 1.334 . . . . 0.0 111.818 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.6 p -71.21 -17.15 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.787 1.235 . . . . 0.0 113.683 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -83.76 -29.39 27.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.661 0.784 . . . . 0.0 111.15 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.2 -32.05 13.86 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -128.04 117.49 20.58 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 119.582 1.083 . . . . 0.0 113.509 -165.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.25 -16.82 44.63 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.814 2.343 . . . . 0.0 114.364 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 p -53.31 -42.49 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.055 1.298 . . . . 0.0 111.756 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.62 -52.55 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.779 0.832 . . . . 0.0 110.343 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -52.06 -47.14 65.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.884 0.874 . . . . 0.0 111.442 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.6 m -66.12 -44.48 84.15 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.305 0.642 . . . . 0.0 112.558 -173.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -70.98 -40.46 71.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.369 0.667 . . . . 0.0 110.58 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 t -59.65 -36.35 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.246 1.018 . . . . 0.0 111.725 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -43.4 90.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.954 0.343 . . . . 0.0 111.418 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -65.34 -47.73 75.48 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.447 1.099 . . . . 0.0 112.467 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 52.7 t -82.26 -44.21 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -172.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m -100.53 -10.06 21.42 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 68.2 -54.32 0.52 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.807 2.043 . . . . 0.0 112.949 -168.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -137.67 147.04 55.63 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.276 1.43 . . . . 0.0 112.489 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -89.63 142.47 4.14 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.348 2.698 . . . . 0.0 115.025 -171.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 m -129.91 131.91 46.19 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.876 2.07 . . . . 0.0 107.402 156.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.5 pt -128.72 135.38 27.51 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.35 156.12 99.81 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 CA-C-N 119.438 0.835 . . . . 0.0 113.053 -5.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.24 158.16 39.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.302 1.441 . . . . 0.0 111.599 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.59 141.17 49.61 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -129.36 144.17 51.13 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.19 2.196 . . . . 0.0 109.887 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.0 mt -124.63 121.99 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.916 0.886 . . . . 0.0 108.667 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.0 tttp 44.3 51.79 7.43 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.27 1.828 . . . . 0.0 113.48 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.89 14.52 6.39 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.73 138.19 39.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.708 1.603 . . . . 0.0 110.197 168.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -83.45 123.85 30.11 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 121.351 -0.843 . . . . 0.0 112.886 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -105.37 -39.95 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.865 1.666 . . . . 0.0 112.993 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 144.75 175.31 17.79 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.644 1.418 . . . . 0.0 116.644 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.04 168.79 54.85 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.182 1.372 . . . . 0.0 113.365 166.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.2 tp -45.86 -41.39 11.16 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -71.0 -27.37 63.64 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.156 0.983 . . . . 0.0 112.212 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.9 mm -79.54 -45.38 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.049 1.34 . . . . 0.0 109.923 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.0 t -62.51 -44.8 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.433 1.093 . . . . 0.0 110.56 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 65.3 m -60.15 -48.25 82.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.791 0.836 . . . . 0.0 110.857 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -55.8 -50.21 71.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.455 1.502 . . . . 0.0 111.6 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.7 mmt -70.87 -33.03 70.2 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.364 1.065 . . . . 0.0 112.762 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.74 -46.56 65.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.845 1.658 . . . . 0.0 111.167 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.24 -26.0 67.16 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.393 1.077 . . . . 0.0 112.341 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.8 t -87.92 -15.81 35.6 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.638 1.975 . . . . 0.0 114.674 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.1 -11.02 59.09 Favored Glycine 0 CA--C 1.54 1.652 0 C-N-CA 124.541 1.067 . . . . 0.0 114.493 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.97 -29.35 69.72 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.574 1.55 . . . . 0.0 112.298 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.39 -46.58 89.58 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.722 -1.236 . . . . 0.0 111.106 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -59.6 -41.31 90.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.388 1.475 . . . . 0.0 111.502 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -58.93 -44.3 91.33 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.202 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 58.7 mtm -69.04 -46.59 67.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.048 0.84 . . . . 0.0 112.001 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -41.78 84.16 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -67.81 -34.52 76.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.94 0.896 . . . . 0.0 112.59 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -59.68 -26.18 65.35 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.244 1.017 . . . . 0.0 112.341 172.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -92.03 6.99 44.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.927 1.691 . . . . 0.0 114.312 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.67 9.37 75.09 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 124.411 1.005 . . . . 0.0 114.3 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.9 mt -94.48 142.56 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.87 0.868 . . . . 0.0 109.176 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 28.5 m -114.87 124.86 52.79 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.184 0.994 . . . . 0.0 112.369 -172.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -129.86 173.91 10.23 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.918 2.087 . . . . 0.0 112.946 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.185 0 O-C-N 120.654 -1.279 . . . . 0.0 111.939 160.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 118.383 -0.817 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.8 pt -62.02 -35.1 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.955 1.252 . . . . 0.0 111.811 172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -76.25 -24.62 54.53 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.853 1.261 . . . . 0.0 113.868 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 t -86.07 -38.24 18.03 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.302 1.441 . . . . 0.0 112.868 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -93.4 141.58 28.29 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.223 1.009 . . . . 0.0 111.937 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.64 -24.39 20.51 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.18 128.76 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.497 1.119 . . . . 0.0 110.294 168.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.01 132.8 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.058 0.943 . . . . 0.0 110.109 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 t -123.21 152.59 41.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.835 0.826 . . . . 0.0 109.903 165.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.06 143.1 49.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.791 0.805 . . . . 0.0 110.776 170.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 mt -132.92 160.09 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.837 -161.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -70.95 103.95 2.82 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 156.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.0 -143.12 23.87 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 119.246 0.93 . . . . 0.0 113.756 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.0 156.47 74.2 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.236 1.414 . . . . 0.0 111.738 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.36 -25.38 30.52 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.314 2.01 . . . . 0.0 113.937 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -90.24 -16.14 29.95 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.27 -0.894 . . . . 0.0 112.828 169.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.62 77.26 15.31 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.578 1.551 . . . . 0.0 111.628 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.95 151.9 35.88 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.262 2.641 . . . . 0.0 112.574 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 78.6 mmm -97.44 -5.22 36.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.318 1.447 . . . . 0.0 113.796 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 10.3 t -146.22 146.32 30.74 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.286 1.434 . . . . 0.0 111.334 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.6 -29.38 69.42 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -71.47 -36.84 71.32 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.633 -1.292 . . . . 0.0 111.66 169.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.3 m -63.98 -35.89 82.19 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -59.15 -47.97 83.34 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.521 1.128 . . . . 0.0 111.453 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -62.18 -28.91 69.99 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.8 tpt -52.38 -39.71 61.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.582 0.628 . . . . 0.0 111.4 171.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 mm -70.61 -35.17 60.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.66 1.184 . . . . 0.0 111.426 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -37.24 86.06 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.832 -1.167 . . . . 0.0 112.886 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 65.9 t -69.98 -37.51 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.167 0.987 . . . . 0.0 110.704 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.9 mt -65.72 -39.69 91.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.109 0.964 . . . . 0.0 113.488 170.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.55 -30.71 70.42 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.117 -0.99 . . . . 0.0 112.137 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.04 -29.47 66.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.569 0.748 . . . . 0.0 112.668 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.7 tp -81.78 -15.31 54.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.622 0.769 . . . . 0.0 112.39 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.87 11.96 58.93 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.496 1.046 . . . . 0.0 114.468 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 22.6 mt -110.58 129.4 55.81 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.551 1.176 . . . . 0.0 112.875 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -116.34 154.85 29.48 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.131 1.372 . . . . 0.0 113.519 168.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -139.59 170.27 16.21 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.576 2.35 . . . . 0.0 111.477 -161.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.0 m -88.09 131.15 34.79 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.047 -1.658 . . . . 0.0 109.655 -176.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -130.33 143.77 50.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.059 0.944 . . . . 0.0 113.528 -154.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -137.67 144.06 41.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.372 1.069 . . . . 0.0 113.315 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -83.59 120.08 25.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.774 1.23 . . . . 0.0 112.075 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.8 t -68.75 -29.82 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.25 1.02 . . . . 0.0 111.863 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.6 mt -74.98 -15.75 60.65 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.155 -0.966 . . . . 0.0 112.282 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.76 -32.57 21.77 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.421 -0.8 . . . . 0.0 112.975 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -129.67 106.48 17.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 119.451 1.023 . . . . 0.0 113.226 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -53.54 -26.94 38.69 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.085 3.19 . . . . 0.0 115.347 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.52 -35.53 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.249 -0.907 . . . . 0.0 112.54 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.79 -48.06 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.139 -0.976 . . . . 0.0 111.166 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -59.94 -28.16 67.39 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.151 0.887 . . . . 0.0 112.955 171.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.5 m -71.03 -53.92 13.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.373 0.533 . . . . 0.0 111.166 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -70.81 -34.76 72.06 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.157 -0.964 . . . . 0.0 111.915 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.15 -36.28 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 120.787 -1.196 . . . . 0.0 112.926 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -72.58 -49.37 32.79 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.484 1.038 . . . . 0.0 111.428 167.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -72.31 -30.53 64.87 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -164.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.53 -29.39 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.598 1.159 . . . . 0.0 111.396 171.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m -103.4 -5.77 22.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -169.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 62.35 -27.03 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 129.069 2.948 . . . . 0.0 116.168 -168.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -145.86 138.53 13.89 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.394 1.877 . . . . 0.0 109.521 165.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.3 149.0 11.75 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.048 2.498 . . . . 0.0 114.669 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.4 p -129.52 132.67 46.92 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.532 1.933 . . . . 0.0 108.807 160.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.0 mt -131.21 142.55 45.91 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.381 1.472 . . . . 0.0 108.383 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.58 161.18 79.14 Favored 'Cis proline' 0 C--N 1.35 0.643 0 CA-C-N 121.738 1.656 . . . . 0.0 111.924 -8.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -144.56 152.52 40.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.302 0.641 . . . . 0.0 112.287 -162.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.24 140.94 52.14 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.785 1.234 . . . . 0.0 112.362 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -130.25 140.41 50.7 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.894 2.078 . . . . 0.0 109.258 173.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 82.0 mt -129.29 133.29 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.3 1.04 . . . . 0.0 108.343 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.1 tttt 49.31 45.3 23.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.187 1.795 . . . . 0.0 113.428 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.65 12.33 5.47 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -115.85 144.2 44.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.381 1.472 . . . . 0.0 111.502 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.23 124.88 25.01 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.879 1.272 . . . . 0.0 111.976 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.49 -55.48 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.147 1.379 . . . . 0.0 110.95 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 165.67 167.21 25.93 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 117.109 1.604 . . . . 0.0 117.109 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.15 168.82 54.84 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.703 1.144 . . . . 0.0 112.499 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.7 tt -47.35 -45.72 24.98 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.058 1.343 . . . . 0.0 113.908 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.82 -35.44 78.62 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.339 -0.851 . . . . 0.0 111.407 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.67 -47.07 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.086 1.354 . . . . 0.0 110.513 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.5 -39.62 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.691 1.196 . . . . 0.0 109.992 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 41.2 m -61.5 -42.72 99.23 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.413 0.685 . . . . 0.0 112.29 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -55.2 -46.62 75.89 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.201 0.909 . . . . 0.0 110.41 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 61.1 mtt -72.92 -33.45 65.97 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.633 1.573 . . . . 0.0 113.342 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -70.52 -35.93 73.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.211 1.804 . . . . 0.0 112.629 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -80.06 -20.27 45.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.885 -1.135 . . . . 0.0 112.621 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.2 p -106.86 -16.0 14.58 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -162.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.7 82.63 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 124.756 1.17 . . . . 0.0 115.503 -170.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -70.03 -31.89 69.75 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.244 2.022 . . . . 0.0 112.55 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.86 -41.59 67.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.533 1.133 . . . . 0.0 110.596 176.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -55.84 -41.17 73.91 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.364 1.865 . . . . 0.0 110.769 173.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -56.63 -47.08 80.47 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.82 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 70.9 mtm -70.86 -46.03 63.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.461 1.028 . . . . 0.0 113.242 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -39.42 82.96 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -72.44 -32.88 66.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.597 1.159 . . . . 0.0 112.274 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.86 -27.2 64.94 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.513 0.597 . . . . 0.0 112.383 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -90.77 -4.43 56.67 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.56 22.37 47.33 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.803 1.192 . . . . 0.0 114.178 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 64.5 mt -94.51 147.84 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 119.038 1.419 . . . . 0.0 111.85 -172.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.6 m -101.11 130.89 47.24 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.323 1.449 . . . . 0.0 112.195 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 15.6 p -137.09 169.46 17.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.685 1.994 . . . . 0.0 111.502 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 174.704 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 pt -60.5 -36.87 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 118.498 0.59 . . . . 0.0 111.944 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.08 -21.98 58.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.006 1.722 . . . . 0.0 113.146 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.3 t -92.84 -38.76 11.57 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.523 1.929 . . . . 0.0 112.582 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.37 139.36 31.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.44 1.096 . . . . 0.0 111.514 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -70.62 -42.21 71.23 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.179 -0.951 . . . . 0.0 113.324 -171.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.7 t -139.92 128.14 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.516 1.126 . . . . 0.0 109.511 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.0 t -133.42 130.28 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.461 1.505 . . . . 0.0 111.134 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -130.79 157.12 43.71 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.849 1.26 . . . . 0.0 110.47 170.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.56 151.58 51.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.542 0.686 . . . . 0.0 112.007 170.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 mt -133.22 169.45 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.433 1.493 . . . . 0.0 109.444 -166.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.94 112.59 23.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.835 -0.541 . . . . 0.0 111.487 144.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.46 -171.98 31.21 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.132 1.825 . . . . 0.0 114.296 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.4 mt -88.87 150.57 45.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.555 1.542 . . . . 0.0 110.546 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.25 -27.78 78.5 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.64 2.227 . . . . 0.0 114.541 -173.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.8 -21.87 56.92 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.966 -1.084 . . . . 0.0 113.036 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.61 68.2 14.63 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 125.716 1.606 . . . . 0.0 112.345 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.78 157.31 39.54 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.316 2.677 . . . . 0.0 112.427 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 mmt -96.34 10.35 38.31 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.711 1.204 . . . . 0.0 114.094 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.8 t -147.87 145.5 28.71 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.904 -1.122 . . . . 0.0 111.593 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.28 96.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -67.37 -31.91 72.48 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.449 -1.407 . . . . 0.0 112.628 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.4 m -63.84 -36.37 83.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.75 167.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.39 -40.13 89.48 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.993 1.27 . . . . 0.0 112.892 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -60.0 -35.7 75.61 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 119.67 1.123 . . . . 0.0 112.878 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.9 tpt -58.31 -46.79 85.48 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.168 0.587 . . . . 0.0 111.468 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.7 mm -71.89 -33.3 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.373 0.669 . . . . 0.0 112.06 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.35 -42.17 73.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.103 0.961 . . . . 0.0 111.147 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.98 -44.55 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.543 1.137 . . . . 0.0 111.586 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.22 -36.74 85.11 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.865 . . . . 0.0 112.645 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -71.37 -30.88 66.67 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.805 -1.185 . . . . 0.0 113.196 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.76 -33.8 74.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.803 0.729 . . . . 0.0 112.135 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 tp -94.38 -10.71 31.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.487 1.115 . . . . 0.0 112.811 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.06 8.89 70.51 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.956 1.741 . . . . 0.0 115.195 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 132.49 54.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.083 0.953 . . . . 0.0 111.058 173.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -114.73 153.2 30.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.121 0.963 . . . . 0.0 112.686 173.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.52 173.75 9.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.526 1.93 . . . . 0.0 111.258 -166.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.5 m -88.6 129.36 35.51 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.846 -1.159 . . . . 0.0 109.824 -167.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.7 p -114.3 141.29 47.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.098 1.759 . . . . 0.0 113.592 -163.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -128.12 161.72 28.57 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.91 1.284 . . . . 0.0 111.784 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -131.22 118.05 19.88 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.287 1.435 . . . . 0.0 112.752 -170.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.15 -21.05 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 tp -80.96 -22.1 39.82 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.321 1.048 . . . . 0.0 111.817 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.16 -40.04 16.06 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.03 -1.044 . . . . 0.0 111.905 170.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -144.55 109.81 4.88 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.833 1.253 . . . . 0.0 112.319 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.95 -14.0 40.67 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.387 2.725 . . . . 0.0 114.994 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -46.9 -32.33 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 120.016 1.28 . . . . 0.0 113.032 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.0 t -58.01 -43.53 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.146 0.978 . . . . 0.0 111.688 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -68.83 -39.98 79.7 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.799 1.24 . . . . 0.0 111.528 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 m -65.76 -47.92 73.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -69.6 -39.69 77.11 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.162 -0.962 . . . . 0.0 112.04 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.91 -35.76 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 120.2 1.364 . . . . 0.0 112.21 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -66.3 -47.66 72.88 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.075 0.95 . . . . 0.0 111.734 172.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -42.29 80.94 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.61 -34.84 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.815 1.246 . . . . 0.0 113.128 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 m -97.99 5.83 48.35 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -170.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 62.48 -40.77 0.16 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 127.797 2.439 . . . . 0.0 114.445 -162.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -135.91 134.73 20.69 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.48 1.912 . . . . 0.0 110.613 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.23 138.15 27.22 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.653 2.235 . . . . 0.0 112.192 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.0 136.6 44.21 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.505 1.522 . . . . 0.0 109.908 165.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.3 mt -127.95 131.7 23.94 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.907 173.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.92 163.16 88.24 Favored 'Cis proline' 0 CA--C 1.541 0.857 0 CA-C-N 119.929 1.01 . . . . 0.0 110.813 -12.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -150.36 172.85 14.74 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.761 0.824 . . . . 0.0 111.514 171.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.07 140.03 52.19 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -174.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -120.66 142.49 49.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 112.779 -2.009 . . . . 0.0 110.51 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.4 mt -122.24 118.32 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 tptt 45.88 48.9 12.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.146 2.178 . . . . 0.0 114.567 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 58.51 13.24 2.43 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -172.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -94.36 131.68 39.76 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.856 -1.153 . . . . 0.0 108.702 164.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -76.34 124.76 28.02 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.608 -0.682 . . . . 0.0 111.278 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.4 t -101.92 -46.82 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.735 1.214 . . . . 0.0 111.186 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.58 170.44 31.48 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.69 174.65 54.7 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.359 1.457 . . . . 0.0 114.02 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -48.62 -43.82 36.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.539 1.936 . . . . 0.0 113.331 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.27 -44.65 95.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.316 0.647 . . . . 0.0 110.321 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.84 -45.72 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.093 1.357 . . . . 0.0 111.207 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.9 t -57.52 -37.06 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.633 1.573 . . . . 0.0 110.945 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.0 m -63.09 -44.09 96.69 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.233 0.613 . . . . 0.0 111.721 172.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -63.2 -41.59 99.18 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.504 1.047 . . . . 0.0 110.796 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 38.2 mtt -63.24 -39.23 94.03 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.011 0.925 . . . . 0.0 111.946 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.58 -40.32 80.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.064 1.346 . . . . 0.0 112.195 175.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.32 -33.49 55.56 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.0 t -85.2 -21.26 29.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.044 1.338 . . . . 0.0 113.489 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.49 0.17 67.49 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.526 1.06 . . . . 0.0 114.788 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.03 -29.95 66.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.515 1.157 . . . . 0.0 113.633 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.62 -44.04 96.78 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.842 -1.162 . . . . 0.0 110.021 174.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -36.74 84.0 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.915 1.286 . . . . 0.0 113.039 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -59.47 -48.49 81.44 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.43 1.014 . . . . 0.0 111.194 171.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.3 mtm -69.9 -45.82 66.77 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 pp -66.33 -36.71 83.61 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.735 0.698 . . . . 0.0 112.059 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -64.01 -41.8 97.34 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.663 0.785 . . . . 0.0 111.536 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.94 -20.58 64.21 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.16 1.43 31.99 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.369 1.468 . . . . 0.0 112.485 170.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.04 17.27 74.94 Favored Glycine 0 N--CA 1.469 0.869 0 O-C-N 120.984 -1.073 . . . . 0.0 114.229 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.4 mt -103.05 146.93 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.686 1.195 . . . . 0.0 109.364 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.3 m -112.36 137.1 50.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.257 1.023 . . . . 0.0 110.651 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.1 p -132.22 168.53 17.89 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.638 1.575 . . . . 0.0 113.075 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 123.631 0.772 . . . . 0.0 111.406 169.572 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.779 0.323 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.8 pt -62.0 -32.47 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.421 1.088 . . . . 0.0 112.914 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -79.15 -30.64 43.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.707 2.003 . . . . 0.0 113.825 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t -80.31 -28.0 38.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.067 1.747 . . . . 0.0 113.248 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -84.85 150.12 25.22 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.905 -1.122 . . . . 0.0 111.344 167.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -76.45 -45.79 29.8 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.632 -1.292 . . . . 0.0 111.691 169.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.9 t -145.33 131.38 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.561 1.144 . . . . 0.0 111.087 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.86 131.67 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.675 1.19 . . . . 0.0 111.663 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 t -134.31 154.96 51.02 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.894 1.277 . . . . 0.0 111.733 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -132.43 139.62 48.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.923 0.889 . . . . 0.0 111.472 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 mt -132.78 157.51 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.849 2.059 . . . . 0.0 108.853 -164.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -78.17 115.21 17.73 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 147.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.99 -152.9 25.07 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.185 0.897 . . . . 0.0 113.551 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.1 mt -104.96 152.59 39.64 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 124.932 1.293 . . . . 0.0 110.596 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.08 -31.72 54.42 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 121.758 1.639 . . . . 0.0 113.453 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -81.22 -13.28 58.71 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.406 -0.809 . . . . 0.0 112.95 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.55 67.66 52.2 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.97 1.708 . . . . 0.0 112.096 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.42 142.46 59.78 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.651 2.901 . . . . 0.0 112.964 -172.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 90.7 mtp -105.65 3.78 29.48 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 37.0 t -134.6 146.52 49.68 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.831 2.053 . . . . 0.0 111.06 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.07 -46.57 85.23 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.354 -0.842 . . . . 0.0 112.018 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -67.09 -25.47 66.24 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.018 -1.051 . . . . 0.0 112.056 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.4 p -71.45 -39.05 71.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 168.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -58.69 -45.32 89.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.75 1.159 . . . . 0.0 110.203 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -62.56 -39.78 94.74 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.292 1.037 . . . . 0.0 112.438 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.5 tpt -55.86 -49.61 72.85 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.791 1.178 . . . . 0.0 111.678 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.7 mm -70.38 -32.68 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.869 -0.519 . . . . 0.0 112.339 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -59.9 -36.27 76.62 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.003 -1.061 . . . . 0.0 112.927 171.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.23 -36.36 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.732 0.813 . . . . 0.0 110.596 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.89 -37.48 87.79 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.35 -0.844 . . . . 0.0 112.885 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -65.08 -33.89 77.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.757 -1.214 . . . . 0.0 111.41 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.35 -30.96 70.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.06 0.944 . . . . 0.0 112.314 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.2 tp -82.27 -16.98 47.53 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.695 0.68 . . . . 0.0 112.626 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.64 9.49 58.9 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.611 1.101 . . . . 0.0 115.166 -174.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.5 mt -114.81 133.97 55.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.53 1.532 . . . . 0.0 113.668 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -115.63 153.43 31.29 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.755 1.264 . . . . 0.0 113.044 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -137.19 175.01 10.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.616 1.967 . . . . 0.0 111.799 -156.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.8 m -85.79 117.36 24.61 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.548 -1.345 . . . . 0.0 108.943 -168.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.2 m -127.87 133.05 49.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.141 -153.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -129.63 149.83 51.22 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -172.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -99.45 98.16 9.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.697 1.599 . . . . 0.0 111.846 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.6 -21.94 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.018 0.927 . . . . 0.0 113.229 -175.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.3 tp -73.4 -28.62 62.1 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.626 -0.671 . . . . 0.0 111.565 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.14 -32.78 11.78 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -124.12 103.97 32.74 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.745 1.157 . . . . 0.0 113.661 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -57.27 -19.75 36.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.151 3.234 . . . . 0.0 115.371 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.14 -39.31 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 120.315 1.416 . . . . 0.0 112.452 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.95 -42.53 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.186 0.994 . . . . 0.0 111.119 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -69.99 -30.47 67.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.524 1.13 . . . . 0.0 112.148 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m -68.84 -48.98 62.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.831 0.852 . . . . 0.0 112.601 170.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -61.35 -46.67 89.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.427 0.558 . . . . 0.0 110.604 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.85 -32.83 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.483 -0.76 . . . . 0.0 112.873 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -70.25 -41.62 73.27 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.826 1.194 . . . . 0.0 112.929 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -61.63 -40.42 94.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.982 0.81 . . . . 0.0 112.723 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.0 t -83.8 -50.62 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 53.9 p -113.66 -0.62 14.25 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 65.08 -49.76 0.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.112 2.165 . . . . 0.0 116.138 -172.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -132.26 116.52 15.41 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 119.909 1.231 . . . . 0.0 112.337 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.94 144.86 21.88 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.339 2.693 . . . . 0.0 112.2 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.7 m -135.2 110.7 9.13 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.437 0.695 . . . . 0.0 109.335 161.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.3 pt -91.59 163.96 26.21 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -160.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.18 154.48 98.36 Favored 'Cis proline' 0 C--N 1.352 0.747 0 CA-C-N 119.195 0.748 . . . . 0.0 111.048 -21.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -136.54 153.12 51.08 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.816 1.246 . . . . 0.0 111.273 -170.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.31 140.63 51.35 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.931 1.292 . . . . 0.0 113.536 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -131.47 143.01 50.11 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.483 1.913 . . . . 0.0 109.718 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.0 mt -125.98 115.85 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.797 0.839 . . . . 0.0 108.903 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . 0.339 17.5 ttmm 40.9 57.65 2.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.076 2.15 . . . . 0.0 114.404 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 67.45 9.22 6.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.91 138.42 37.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.551 1.14 . . . . 0.0 110.306 168.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -79.82 123.71 27.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.607 1.194 . . . . 0.0 111.716 175.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.38 -48.72 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.767 1.227 . . . . 0.0 110.584 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.61 -179.68 27.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 168.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.24 173.66 53.88 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.55 1.072 . . . . 0.0 113.442 167.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -42.75 -46.56 5.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.339 1.856 . . . . 0.0 113.765 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -70.02 -26.52 64.09 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.628 -0.67 . . . . 0.0 112.304 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 mm -79.26 -46.51 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.834 1.254 . . . . 0.0 110.316 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.12 -38.56 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.11 0.964 . . . . 0.0 110.572 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 69.3 m -60.88 -46.21 91.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.08 0.952 . . . . 0.0 111.566 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -60.17 -43.86 95.49 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.091 0.956 . . . . 0.0 111.565 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.6 mtt -69.0 -35.25 76.48 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.412 -0.805 . . . . 0.0 112.953 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -69.56 -41.3 76.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.31 1.044 . . . . 0.0 111.506 172.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -65.07 -36.58 84.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.301 1.04 . . . . 0.0 113.183 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.3 t -88.79 -9.43 51.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.427 1.491 . . . . 0.0 114.032 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.84 4.46 82.36 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.247 -1.533 . . . . 0.0 114.201 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.2 -32.36 70.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.347 1.459 . . . . 0.0 112.936 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.16 -46.28 81.51 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.054 -1.029 . . . . 0.0 109.932 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -59.05 -41.1 87.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.745 1.618 . . . . 0.0 112.728 169.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -58.09 -42.66 86.08 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.954 0.902 . . . . 0.0 111.035 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 62.4 mtm -69.6 -50.32 45.67 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -69.08 -37.38 78.42 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -65.09 -34.24 77.94 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.04 0.936 . . . . 0.0 111.44 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.72 -29.65 69.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.238 1.415 . . . . 0.0 112.493 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -89.19 6.02 42.07 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.043 2.137 . . . . 0.0 114.306 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.48 19.43 60.29 Favored Glycine 0 N--CA 1.469 0.867 0 O-C-N 121.12 -0.987 . . . . 0.0 114.44 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.02 147.68 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.33 1.052 . . . . 0.0 110.792 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 95.8 m -102.69 126.2 49.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.749 1.22 . . . . 0.0 111.572 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.8 p -127.48 168.99 14.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.888 2.075 . . . . 0.0 111.156 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 19.1 mtp-105 . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 121.906 0.86 . . . . 0.0 112.99 173.304 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 118.952 -0.547 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 pt -63.81 -34.6 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.576 0.75 . . . . 0.0 112.925 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -78.95 -39.38 34.69 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.22 1.408 . . . . 0.0 112.964 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.2 t -85.02 -11.06 56.26 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.309 1.044 . . . . 0.0 113.446 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -89.52 148.67 23.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.362 1.865 . . . . 0.0 111.449 165.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -87.28 -42.84 12.62 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.783 -1.198 . . . . 0.0 113.205 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.27 130.49 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.062 1.345 . . . . 0.0 110.265 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.4 t -131.51 130.51 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.779 1.632 . . . . 0.0 111.278 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 t -133.5 156.18 48.23 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.084 1.354 . . . . 0.0 111.186 171.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -129.62 139.77 51.35 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.42 0.688 . . . . 0.0 111.872 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.83 156.57 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.26 1.424 . . . . 0.0 109.876 -163.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.9 102.86 1.66 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.852 -0.53 . . . . 0.0 109.665 155.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.74 -160.0 33.67 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 118.887 0.767 . . . . 0.0 114.783 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.51 153.68 48.26 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.951 2.1 . . . . 0.0 112.516 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -66.75 -15.59 47.79 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.311 2.674 . . . . 0.0 114.823 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -94.84 -20.43 19.46 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.45 69.26 21.21 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.416 1.486 . . . . 0.0 110.84 -171.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.54 144.01 48.71 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.058 2.505 . . . . 0.0 111.655 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 mmt -93.36 2.41 56.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.13 1.372 . . . . 0.0 113.741 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 53.6 t -142.12 145.64 34.48 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.804 1.642 . . . . 0.0 111.488 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.77 95.63 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.878 0.871 . . . . 0.0 112.731 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.08 -24.06 62.24 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.592 -1.317 . . . . 0.0 112.354 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 m -69.77 -36.44 75.77 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.427 -0.796 . . . . 0.0 112.362 166.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -62.29 -42.02 98.99 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.605 1.162 . . . . 0.0 112.021 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -55.84 -29.83 60.46 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.068 1.347 . . . . 0.0 113.526 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.2 tpt -69.24 -43.57 73.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.986 0.915 . . . . 0.0 111.756 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.4 mm -65.46 -36.44 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.752 0.821 . . . . 0.0 111.014 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.63 -40.44 79.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.213 1.005 . . . . 0.0 112.955 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.12 -42.93 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.921 1.289 . . . . 0.0 111.659 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.1 mt -65.39 -36.77 84.99 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.739 0.815 . . . . 0.0 112.548 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -67.07 -35.47 79.9 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.374 -1.454 . . . . 0.0 112.443 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.31 -21.66 65.67 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.57 -13.27 20.49 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.64 1.576 . . . . 0.0 114.124 170.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.74 71.3 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.433 1.492 . . . . 0.0 115.479 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.8 mp -112.09 144.89 40.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.26 1.424 . . . . 0.0 111.321 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -113.75 130.17 56.48 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.617 0.767 . . . . 0.0 110.649 166.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -104.82 170.6 7.78 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.023 1.729 . . . . 0.0 111.26 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -86.34 119.83 27.04 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.5 -1.375 . . . . 0.0 109.45 -157.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.2 m -113.23 129.71 56.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.339 -158.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -115.07 155.05 27.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.994 1.317 . . . . 0.0 111.059 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -111.21 94.95 5.24 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.845 1.258 . . . . 0.0 110.48 -168.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 p -70.02 -23.2 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.236 1.015 . . . . 0.0 112.953 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.9 tp -78.35 -30.75 48.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.081 0.952 . . . . 0.0 111.424 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.53 -35.28 19.63 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -131.32 98.93 17.94 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.825 0.85 . . . . 0.0 111.945 -170.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.97 -12.23 33.56 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.394 2.729 . . . . 0.0 114.761 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.0 p -49.1 -42.04 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.717 1.207 . . . . 0.0 112.489 170.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.75 -46.27 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.802 0.841 . . . . 0.0 111.704 -177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -71.33 -23.75 61.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -70.36 -51.43 29.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.116 0.567 . . . . 0.0 112.11 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -70.96 -37.99 72.8 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.641 -0.662 . . . . 0.0 112.429 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.39 -34.95 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.362 -0.836 . . . . 0.0 112.557 176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -66.72 -43.22 84.86 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.338 -0.851 . . . . 0.0 110.991 171.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.92 -42.69 80.44 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.678 0.791 . . . . 0.0 113.037 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -80.26 -45.28 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.618 1.167 . . . . 0.0 112.988 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.5 m -106.05 -5.93 19.09 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 62.65 -25.99 0.06 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 128.075 2.55 . . . . 0.0 115.973 -172.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -136.28 92.0 16.14 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 127.2 2.2 . . . . 0.0 112.045 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -72.31 147.64 47.73 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.624 2.883 . . . . 0.0 114.317 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.4 m -125.99 137.27 53.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.616 1.566 . . . . 0.0 107.842 160.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mp -108.04 133.26 20.57 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.45 159.1 73.35 Favored 'Cis proline' 0 CA--C 1.546 1.091 0 CA-C-N 120.706 1.288 . . . . 0.0 112.012 -12.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -137.92 164.28 29.39 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.953 1.701 . . . . 0.0 110.913 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.7 139.62 52.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 122.776 1.274 . . . . 0.0 114.209 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -125.43 140.31 52.9 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 112.741 -2.027 . . . . 0.0 110.247 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 57.3 mt -128.87 121.85 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.293 1.037 . . . . 0.0 109.138 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt 45.12 51.13 9.18 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.064 1.746 . . . . 0.0 113.008 -172.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.63 10.21 1.88 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 -175.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.58 143.63 28.77 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.193 1.36 . . . . 0.0 110.516 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -86.35 123.59 31.76 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.701 0.763 . . . . 0.0 112.909 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.8 -50.92 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.459 1.504 . . . . 0.0 111.964 -171.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 175.19 163.85 28.88 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 117.238 1.655 . . . . 0.0 117.238 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.72 168.94 53.98 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 125.575 1.56 . . . . 0.0 114.124 167.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.0 tp -44.19 -42.05 6.19 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.947 1.699 . . . . 0.0 115.01 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -67.9 -38.06 82.52 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.799 -0.563 . . . . 0.0 111.338 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.4 mm -74.97 -39.12 44.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 C-N-CA 125.131 1.373 . . . . 0.0 110.26 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.05 -42.42 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 120.971 -1.081 . . . . 0.0 110.696 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.9 m -65.33 -43.87 89.59 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.703 0.801 . . . . 0.0 111.427 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -56.8 -46.25 81.7 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.72 1.208 . . . . 0.0 111.74 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.9 mtt -67.05 -35.26 79.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.752 1.621 . . . . 0.0 112.7 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.84 -46.54 68.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.389 1.076 . . . . 0.0 111.109 173.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.96 -17.39 64.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.003 1.321 . . . . 0.0 112.906 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.2 m -101.03 -16.18 17.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.218 1.407 . . . . 0.0 114.788 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.26 -4.12 73.68 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 120.21 1.368 . . . . 0.0 114.446 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -65.14 -32.03 73.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.556 1.678 . . . . 0.0 112.922 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.71 -43.3 98.0 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.114 172.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -64.35 -38.71 91.99 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.518 1.527 . . . . 0.0 112.726 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -58.43 -48.82 79.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.722 1.146 . . . . 0.0 110.92 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.9 mtm -69.59 -44.92 69.8 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 pp -66.16 -40.83 90.82 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.011 0.369 . . . . 0.0 111.435 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -71.75 -32.28 67.54 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.426 -0.796 . . . . 0.0 112.963 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.18 -26.51 68.18 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.363 0.529 . . . . 0.0 112.407 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -76.23 4.44 8.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.592 1.557 . . . . 0.0 113.875 169.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.42 0.02 89.85 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.273 1.892 . . . . 0.0 113.671 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.3 mt -84.81 144.53 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 118.782 1.291 . . . . 0.0 109.862 -169.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.9 m -108.23 139.6 42.68 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.355 1.462 . . . . 0.0 111.094 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 21.8 p -137.17 170.04 16.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.924 1.689 . . . . 0.0 112.16 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 . . . . . 0 N--CA 1.479 1.018 0 O-C-N 121.536 -0.727 . . . . 0.0 112.512 167.009 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.6 0.714 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.4 mt -55.94 -36.4 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 127.685 2.394 . . . . 0.0 110.924 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -75.83 -30.17 58.89 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 126.535 1.934 . . . . 0.0 114.729 171.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.4 t -78.94 -39.93 33.32 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.509 0.724 . . . . 0.0 112.224 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -90.16 140.93 29.18 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -170.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -66.38 -39.6 89.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.37 0.668 . . . . 0.0 112.631 -171.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.1 t -140.77 133.72 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 109.759 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.44 134.14 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.778 1.231 . . . . 0.0 110.089 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.6 t -131.86 155.39 47.92 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.083 0.953 . . . . 0.0 111.237 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -133.31 135.88 45.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.426 0.632 . . . . 0.0 111.899 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.5 mt -133.95 153.69 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 109.015 -157.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -69.49 104.58 2.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 158.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.08 -134.16 12.75 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.829 1.204 . . . . 0.0 114.337 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.1 mt -126.33 157.72 69.31 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 126.342 1.857 . . . . 0.0 111.658 -168.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.25 -21.5 31.13 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.127 1.885 . . . . 0.0 113.833 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.23 -22.22 35.97 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.477 1.111 . . . . 0.0 113.108 167.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.22 74.02 11.87 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.4 1.48 . . . . 0.0 113.046 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.37 143.65 22.26 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.948 2.432 . . . . 0.0 111.262 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 51.0 ttm -110.14 7.18 23.31 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.256 1.822 . . . . 0.0 113.081 -163.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 54.1 t -150.63 149.01 29.32 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.647 1.979 . . . . 0.0 111.041 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.75 93.99 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.32 0.964 . . . . 0.0 112.702 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -66.93 -31.45 72.05 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.83 -1.169 . . . . 0.0 111.42 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.6 m -70.39 -37.96 74.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 118.265 -0.874 . . . . 0.0 112.933 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -55.94 -47.36 77.7 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 120.199 1.363 . . . . 0.0 110.703 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -61.81 -31.9 72.16 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.9 tpt -61.41 -44.35 97.29 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.668 0.667 . . . . 0.0 111.517 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.0 mm -68.28 -37.95 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.075 0.55 . . . . 0.0 111.146 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.4 -40.56 78.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.032 0.933 . . . . 0.0 112.58 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.77 -44.3 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.272 0.629 . . . . 0.0 111.506 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.6 mt -65.9 -36.98 84.91 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.813 0.845 . . . . 0.0 112.317 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -66.01 -32.99 74.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.562 1.145 . . . . 0.0 112.917 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.95 76.6 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.715 0.806 . . . . 0.0 111.978 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.65 -14.81 44.41 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.886 0.874 . . . . 0.0 113.092 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.57 14.17 62.05 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.619 1.104 . . . . 0.0 114.26 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 58.0 mt -112.07 128.44 56.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.209 1.004 . . . . 0.0 111.315 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -115.54 144.69 43.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.854 1.262 . . . . 0.0 111.17 172.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -125.12 169.95 11.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.384 1.874 . . . . 0.0 111.809 -166.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.1 m -85.07 126.29 33.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 122.495 1.141 . . . . 0.0 109.44 -166.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.1 m -123.72 138.93 54.43 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 113.681 -1.6 . . . . 0.0 112.095 -155.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.6 139.43 53.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -84.01 112.19 19.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.343 2.257 . . . . 0.0 111.495 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.4 m -70.35 -17.85 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.1 tp -87.36 -19.97 27.39 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.607 1.163 . . . . 0.0 111.957 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.24 -29.07 13.78 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.764 1.225 . . . . 0.0 113.366 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.32 96.9 38.23 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -53.11 -26.75 34.09 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.569 3.512 . . . . 0.0 115.501 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.27 -36.04 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.112 0.965 . . . . 0.0 113.595 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 63.1 t -69.75 -51.48 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.964 0.906 . . . . 0.0 110.819 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -63.98 -26.12 68.44 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.673 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.9 m -71.61 -48.05 50.65 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.439 ' CE2' HG22 ' A' ' 139' ' ' VAL . 48.7 t80 -61.02 -48.05 83.6 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 120.752 1.615 . . . . 0.0 109.807 176.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.64 -35.26 74.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 121.283 -0.886 . . . . 0.0 112.837 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -59.26 -46.61 88.05 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.19 1.396 . . . . 0.0 112.102 171.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.25 -46.64 40.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.301 1.04 . . . . 0.0 112.9 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.439 HG22 ' CE2' ' A' ' 135' ' ' TYR . 86.6 t -81.3 -36.19 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.629 1.572 . . . . 0.0 112.632 -164.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.4 m -104.97 4.22 31.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 58.19 -5.89 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.89 2.476 . . . . 0.0 117.358 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -146.27 121.43 5.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.638 1.975 . . . . 0.0 108.598 166.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.25 130.44 7.2 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.66 2.24 . . . . 0.0 111.801 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 68.5 p -128.45 136.85 51.41 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.968 1.307 . . . . 0.0 110.886 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.0 mt -130.03 140.56 39.01 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.259 1.424 . . . . 0.0 110.452 -172.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.17 156.42 78.76 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 120.939 1.371 . . . . 0.0 110.895 -8.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -138.25 160.01 40.56 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.69 135.61 52.31 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.536 1.134 . . . . 0.0 112.192 177.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -127.21 141.65 51.68 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.637 1.975 . . . . 0.0 109.155 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.6 mt -130.61 118.5 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.2 tptt 46.74 52.88 10.84 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 127.331 2.253 . . . . 0.0 115.647 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.81 28.64 18.38 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -127.89 137.29 52.26 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.093 -1.004 . . . . 0.0 110.508 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -70.35 130.39 41.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.408 0.623 . . . . 0.0 112.121 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.75 -47.58 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.063 0.945 . . . . 0.0 110.181 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.15 175.31 22.17 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.519 0.967 . . . . 0.0 115.519 171.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.64 169.99 54.65 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.258 0.933 . . . . 0.0 112.793 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.23 -43.4 10.28 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.109 1.364 . . . . 0.0 113.189 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.434 ' O ' ' HE3' ' A' ' 163' ' ' LYS . 19.7 t70 -60.24 -24.87 65.22 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.943 0.897 . . . . 0.0 113.283 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.4 mm -92.1 -47.01 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.675 1.59 . . . . 0.0 110.471 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.04 -36.55 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.361 1.864 . . . . 0.0 111.808 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -60.58 -50.92 71.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 159' ' ' ASP . 60.1 mttt -60.86 -38.62 86.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.625 0.37 . . . . 0.0 110.231 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.5 mtp -67.85 -35.5 78.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.748 0.819 . . . . 0.0 112.577 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.59 -46.24 69.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.602 1.161 . . . . 0.0 111.721 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -74.13 -16.29 61.01 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.8 m -100.78 -9.86 21.34 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.09 1.356 . . . . 0.0 114.353 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.17 -4.25 67.93 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-N 119.661 1.119 . . . . 0.0 114.453 -170.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.99 -34.12 74.3 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.866 -1.373 . . . . 0.0 113.532 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tt -61.67 -41.01 96.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.763 1.225 . . . . 0.0 111.029 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -67.31 -31.3 71.5 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.303 1.841 . . . . 0.0 113.239 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -57.02 -43.14 81.54 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.24 1.016 . . . . 0.0 111.837 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -73.6 -49.57 25.53 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 172.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.65 -39.02 90.94 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.844 -0.535 . . . . 0.0 112.128 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -69.49 -40.76 76.85 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.683 0.793 . . . . 0.0 111.393 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.82 -27.7 65.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.536 1.535 . . . . 0.0 113.455 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -75.06 -4.49 38.77 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.403 -0.81 . . . . 0.0 112.877 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.59 15.81 51.48 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 125.072 1.32 . . . . 0.0 114.498 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.0 mt -103.8 123.72 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.159 0.98 . . . . 0.0 109.976 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.3 m -85.27 133.58 34.16 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.36 0.6 . . . . 0.0 111.633 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -128.92 170.14 13.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.494 2.318 . . . . 0.0 111.957 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 . . . . . 0 N--CA 1.476 0.852 0 O-C-N 121.395 -0.815 . . . . 0.0 111.278 173.539 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.1 pt -61.2 -34.34 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.745 0.818 . . . . 0.0 111.83 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -80.85 -29.34 35.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.444 1.897 . . . . 0.0 114.486 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.1 t -74.25 -41.13 61.79 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.636 0.774 . . . . 0.0 111.209 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.82 138.29 32.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.26 1.024 . . . . 0.0 110.715 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.43 -31.89 24.39 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.252 -0.905 . . . . 0.0 112.538 -169.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.6 t -138.58 126.56 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.854 1.262 . . . . 0.0 109.546 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.0 t -130.53 131.21 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.406 1.482 . . . . 0.0 110.565 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.9 t -133.77 156.71 47.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.664 1.185 . . . . 0.0 110.457 172.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.67 142.74 49.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.146 169.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 mt -132.56 157.38 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.383 1.473 . . . . 0.0 109.403 -162.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.7 101.23 2.51 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 156.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.23 -154.82 27.93 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.174 0.897 . . . . 0.0 114.214 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.21 154.67 39.45 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 125.655 1.582 . . . . 0.0 111.969 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -65.67 -19.99 59.69 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.287 1.991 . . . . 0.0 113.605 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -93.9 -13.06 27.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.582 1.553 . . . . 0.0 113.986 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.54 73.34 11.68 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.544 1.537 . . . . 0.0 112.353 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.4 148.64 67.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.943 2.429 . . . . 0.0 111.874 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.4 mmt -104.42 -0.3 28.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.3 1.84 . . . . 0.0 113.631 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 17.1 t -146.46 144.83 29.94 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.969 1.307 . . . . 0.0 111.428 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.2 -38.66 80.45 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -72.23 -29.87 64.35 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.048 -1.033 . . . . 0.0 112.279 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 m -66.89 -34.45 77.81 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.346 167.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -67.27 -45.59 76.17 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.77 1.168 . . . . 0.0 112.781 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -57.27 -33.28 67.47 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.002 0.921 . . . . 0.0 112.915 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.0 tpt -56.07 -43.56 78.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.951 0.901 . . . . 0.0 111.865 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 mm -69.55 -33.34 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.337 1.055 . . . . 0.0 111.3 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.4 -34.91 79.41 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.36 -1.462 . . . . 0.0 112.771 172.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.81 -43.16 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.902 0.481 . . . . 0.0 110.728 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.9 mt -65.77 -37.92 87.64 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -66.65 -31.49 72.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.403 -1.436 . . . . 0.0 113.078 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.0 -25.49 68.41 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.613 -1.304 . . . . 0.0 113.374 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.04 -13.01 21.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.881 1.272 . . . . 0.0 114.154 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.6 13.0 67.92 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.568 1.08 . . . . 0.0 115.03 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.76 134.35 55.1 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.773 1.229 . . . . 0.0 112.905 174.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -113.68 157.93 21.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.772 1.229 . . . . 0.0 111.548 168.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -137.24 171.95 13.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.982 1.713 . . . . 0.0 111.418 -161.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.4 m -83.97 120.4 26.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.545 1.164 . . . . 0.0 108.842 -166.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.6 m -126.18 124.26 40.08 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.645 -155.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.25 157.98 18.3 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.305 1.042 . . . . 0.0 111.959 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -120.16 117.18 27.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.803 1.241 . . . . 0.0 111.292 -171.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.5 p -71.58 -27.7 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.3 -37.99 68.84 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.343 -0.848 . . . . 0.0 110.506 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.61 -31.62 22.51 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -141.4 107.38 6.09 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 119.466 1.03 . . . . 0.0 113.136 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -60.15 -15.49 34.48 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.648 2.898 . . . . 0.0 116.758 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 p -49.22 -32.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.552 1.524 . . . . 0.0 112.743 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.96 -44.46 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.94 0.896 . . . . 0.0 111.646 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -71.71 -27.52 63.07 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.916 0.78 . . . . 0.0 112.208 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m -67.05 -48.94 66.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.27 0.628 . . . . 0.0 112.259 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -38.86 71.23 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.489 1.04 . . . . 0.0 113.002 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.46 -32.46 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.508 1.049 . . . . 0.0 112.188 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -62.47 -41.99 99.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.883 0.873 . . . . 0.0 112.248 170.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.56 -47.29 55.92 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.537 -0.727 . . . . 0.0 111.771 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.6 t -82.82 -40.62 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -173.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.6 m -102.57 -12.86 17.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 64.84 -47.19 0.34 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 169.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -129.0 89.75 47.75 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.085 1.754 . . . . 0.0 106.784 164.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -89.6 158.23 5.28 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.935 2.424 . . . . 0.0 113.771 -166.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.0 p -122.98 151.57 41.72 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.874 1.669 . . . . 0.0 108.918 161.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 55.0 mt -125.07 127.26 25.1 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 124.007 0.923 . . . . 0.0 109.089 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.93 161.54 65.25 Favored 'Cis proline' 0 CA--C 1.542 0.9 0 CA-C-N 119.766 0.952 . . . . 0.0 113.948 7.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -135.26 158.74 43.6 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.358 1.863 . . . . 0.0 110.836 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.81 140.54 51.97 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.141 1.376 . . . . 0.0 113.234 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -133.79 143.0 48.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.886 2.074 . . . . 0.0 109.832 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.8 mt -129.66 117.48 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.591 0.756 . . . . 0.0 109.306 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.5 tptt 43.54 47.41 6.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.359 2.263 . . . . 0.0 113.745 -170.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.95 16.88 9.59 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.15 140.11 34.86 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.734 -1.229 . . . . 0.0 109.535 162.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -80.04 125.45 29.79 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.378 -0.826 . . . . 0.0 112.418 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.5 t -102.68 -47.14 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 124.656 1.182 . . . . 0.0 111.8 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.65 176.91 32.25 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.39 168.42 53.82 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.859 1.218 . . . . 0.0 113.341 165.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -45.59 -44.69 13.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.322 1.849 . . . . 0.0 113.817 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.78 -26.55 66.16 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.718 -0.614 . . . . 0.0 112.528 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.3 mm -79.22 -46.61 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.118 1.367 . . . . 0.0 110.389 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.1 t -57.73 -35.94 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.335 1.854 . . . . 0.0 111.337 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 86.7 m -64.06 -41.61 97.3 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.696 0.798 . . . . 0.0 112.527 173.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -65.95 -44.06 86.13 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.315 0.961 . . . . 0.0 110.198 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.7 mtt -61.51 -35.7 78.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.372 1.069 . . . . 0.0 112.317 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.81 -45.52 74.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.614 1.166 . . . . 0.0 111.984 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -69.78 -33.19 72.05 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.814 0.733 . . . . 0.0 112.479 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.6 t -86.23 -30.39 22.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.81 2.42 52.47 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 120.656 -1.278 . . . . 0.0 115.463 -171.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -68.17 -35.03 77.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.107 1.454 . . . . 0.0 112.086 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -45.5 85.14 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.34 -0.85 . . . . 0.0 110.158 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.86 -38.56 82.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.46 1.504 . . . . 0.0 113.136 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -60.6 -48.41 81.92 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.959 0.503 . . . . 0.0 111.66 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.1 mtm -70.85 -44.7 65.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.44 -37.84 88.93 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.503 -0.748 . . . . 0.0 111.176 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -72.57 -32.42 66.02 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.42 -28.35 69.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.278 1.031 . . . . 0.0 111.891 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 6.16 13.73 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.303 1.841 . . . . 0.0 113.771 171.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.14 -2.78 86.38 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.744 2.116 . . . . 0.0 113.7 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.4 mt -82.15 142.72 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.617 1.209 . . . . 0.0 110.459 -165.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 m -101.12 128.82 47.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.348 1.459 . . . . 0.0 110.273 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.8 p -132.04 170.69 14.59 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.81 1.644 . . . . 0.0 112.883 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 123.961 0.904 . . . . 0.0 109.755 166.69 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.6 m . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 pt -60.25 -34.47 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.412 1.005 . . . . 0.0 112.175 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -77.91 -30.15 50.5 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.326 1.851 . . . . 0.0 113.397 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 t -87.02 -34.01 19.37 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.796 1.638 . . . . 0.0 113.162 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.22 147.93 27.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.716 2.006 . . . . 0.0 110.503 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -70.11 -43.25 71.41 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 119.943 -1.723 . . . . 0.0 112.525 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -141.1 132.9 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.974 0.91 . . . . 0.0 112.17 -171.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.56 140.93 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.156 1.382 . . . . 0.0 112.266 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 t -133.02 158.98 41.36 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.925 1.29 . . . . 0.0 111.632 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -132.43 141.09 48.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.247 0.546 . . . . 0.0 112.045 171.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.6 mt -134.48 156.9 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.622 1.969 . . . . 0.0 109.336 -163.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -66.27 101.57 0.74 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 150.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 -140.39 20.15 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 121.126 -0.984 . . . . 0.0 114.277 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.8 mt -111.58 155.9 42.25 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 125.274 1.43 . . . . 0.0 112.581 -170.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.59 -12.61 31.6 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.727 2.284 . . . . 0.0 113.094 172.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -91.53 -26.93 18.53 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.827 1.651 . . . . 0.0 112.113 170.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.39 78.01 12.37 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.204 1.802 . . . . 0.0 111.872 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.05 143.21 17.78 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.106 2.537 . . . . 0.0 112.356 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 33.9 ttm -102.6 10.57 38.66 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.561 1.544 . . . . 0.0 113.352 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 51.4 t -145.09 145.18 31.32 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.917 -1.115 . . . . 0.0 111.843 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -36.79 83.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.493 1.117 . . . . 0.0 112.845 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -69.23 -24.45 64.01 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.066 -1.022 . . . . 0.0 112.544 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.55 -34.44 72.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.921 -1.112 . . . . 0.0 113.972 163.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -61.29 -39.6 91.06 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.453 1.479 . . . . 0.0 111.32 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -60.54 -38.6 84.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.713 0.805 . . . . 0.0 112.803 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.62 -47.58 78.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.652 1.181 . . . . 0.0 112.399 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.65 -32.17 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.408 -0.808 . . . . 0.0 111.369 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.73 -34.73 67.79 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.702 -1.249 . . . . 0.0 113.207 171.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.31 -41.85 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 122.673 0.389 . . . . 0.0 110.766 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -39.43 93.88 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.107 0.963 . . . . 0.0 112.229 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.27 -34.18 76.88 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.136 -0.978 . . . . 0.0 112.358 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.06 -23.58 63.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.436 1.095 . . . . 0.0 113.78 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.2 mt -95.9 -13.18 24.13 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.024 0.929 . . . . 0.0 113.244 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.07 18.64 67.11 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.277 0.941 . . . . 0.0 113.696 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 17.9 mt -113.12 130.71 56.1 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.581 1.552 . . . . 0.0 112.697 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -116.28 147.23 41.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.828 0.851 . . . . 0.0 112.941 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -129.35 172.45 11.49 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.027 2.531 . . . . 0.0 111.167 -163.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.3 m -86.4 133.9 33.75 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.365 -0.834 . . . . 0.0 110.405 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 t -131.12 146.9 52.52 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -164.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.01 152.71 39.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.167 1.787 . . . . 0.0 112.302 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -100.42 118.11 35.98 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.374 1.07 . . . . 0.0 111.426 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.6 p -66.4 -25.22 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.312 0.645 . . . . 0.0 112.624 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 tp -73.92 -22.21 59.77 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.028 0.931 . . . . 0.0 111.786 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.84 -29.88 11.19 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -125.08 106.44 28.47 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.88 -28.31 38.58 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.401 3.4 . . . . 0.0 115.663 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.67 -35.48 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.66 0.784 . . . . 0.0 112.111 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.81 -48.97 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.506 0.723 . . . . 0.0 110.871 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -70.75 -30.97 67.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.043 0.537 . . . . 0.0 112.056 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.8 m -69.38 -47.46 64.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.633 0.651 . . . . 0.0 112.301 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.5 -40.4 77.03 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.022 -1.049 . . . . 0.0 112.293 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.93 -35.81 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 120.651 -1.281 . . . . 0.0 112.539 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -65.87 -44.95 83.88 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.732 0.813 . . . . 0.0 111.64 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.6 -41.38 92.83 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.648 0.779 . . . . 0.0 112.956 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.35 -41.94 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.3 m -98.94 1.64 45.77 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.855 1.207 . . . . 0.0 113.91 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 67.29 -22.82 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.368 2.667 . . . . 0.0 116.448 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -145.94 132.23 9.67 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.788 1.635 . . . . 0.0 109.458 171.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.31 126.98 5.72 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.876 1.717 . . . . 0.0 113.188 -165.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.8 p -135.52 136.85 41.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.446 1.898 . . . . 0.0 111.275 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.9 mm -128.05 137.42 30.77 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 125.458 1.503 . . . . 0.0 110.745 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.64 160.57 76.48 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 121.341 1.515 . . . . 0.0 112.447 -4.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -134.88 159.63 40.81 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.968 1.307 . . . . 0.0 110.515 -172.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.33 139.46 53.28 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -124.11 140.8 52.62 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.796 2.038 . . . . 0.0 110.411 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.8 mt -130.2 123.32 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.456 1.102 . . . . 0.0 108.387 170.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm 45.54 49.92 10.63 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.886 2.075 . . . . 0.0 114.88 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.4 26.45 15.35 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -118.41 138.23 52.6 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.767 1.227 . . . . 0.0 108.689 164.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.49 125.49 30.03 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.459 -0.775 . . . . 0.0 111.093 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 t -80.55 -40.49 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.499 1.119 . . . . 0.0 110.261 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.81 175.64 34.92 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.373 1.463 . . . . 0.0 114.327 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.25 172.14 55.19 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.852 0.739 . . . . 0.0 113.885 165.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.3 tp -48.65 -42.67 35.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.069 1.347 . . . . 0.0 113.686 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -59.41 -25.32 64.22 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.832 1.253 . . . . 0.0 113.018 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 mm -91.23 -46.6 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.27 1.428 . . . . 0.0 110.122 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.73 -40.89 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.249 1.42 . . . . 0.0 111.583 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.6 p -64.78 -40.93 96.08 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -68.43 -40.87 81.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.274 0.63 . . . . 0.0 112.211 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.9 mtt -63.23 -36.09 82.49 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.329 1.052 . . . . 0.0 112.68 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.76 -42.3 77.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.468 1.107 . . . . 0.0 112.299 174.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -65.29 -39.32 92.4 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.16 0.584 . . . . 0.0 111.418 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 36.7 t -82.66 -28.08 30.89 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.262 1.825 . . . . 0.0 115.159 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.61 -2.19 67.02 Favored Glycine 0 N--CA 1.48 1.579 0 O-C-N 120.47 -1.394 . . . . 0.0 114.665 -170.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -64.07 -35.79 81.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.646 1.223 . . . . 0.0 112.263 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.66 -45.69 85.64 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.848 0.859 . . . . 0.0 110.881 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -59.33 -40.6 86.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.68 1.592 . . . . 0.0 112.748 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -65.76 -36.55 83.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 118.215 -0.897 . . . . 0.0 112.632 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 61.2 mtm -70.04 -50.44 41.29 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.73 1.15 . . . . 0.0 113.295 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -62.33 -35.02 77.8 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.259 -0.901 . . . . 0.0 111.91 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -64.35 -37.98 89.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.603 0.761 . . . . 0.0 112.846 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.18 -30.04 71.12 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.077 0.853 . . . . 0.0 111.977 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.03 5.11 17.43 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.176 1.79 . . . . 0.0 114.275 171.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.28 12.8 75.32 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.3 1.428 . . . . 0.0 114.573 173.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 60.3 mt -94.31 145.35 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 118.266 1.033 . . . . 0.0 111.276 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 29.0 m -105.13 131.29 52.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.106 1.362 . . . . 0.0 110.743 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.4 p -133.89 171.02 14.75 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.478 1.911 . . . . 0.0 112.81 -175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 . . . . . 0 N--CA 1.477 0.898 0 C-N-CA 124.158 0.983 . . . . 0.0 112.726 164.399 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.3 m . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 90.0 mt -55.56 -40.89 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.499 1.519 . . . . 0.0 110.733 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -77.62 -37.94 49.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.021 1.328 . . . . 0.0 113.255 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 t -95.57 -28.08 15.03 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.219 1.408 . . . . 0.0 114.382 -165.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -87.3 145.98 26.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.306 1.042 . . . . 0.0 111.505 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -66.67 -44.83 80.75 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.962 0.905 . . . . 0.0 112.109 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.9 t -141.7 134.45 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.771 1.229 . . . . 0.0 111.7 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.98 133.9 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.126 1.37 . . . . 0.0 111.816 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 t -133.7 156.33 48.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.619 1.568 . . . . 0.0 110.936 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -132.61 139.62 47.86 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.39 1.076 . . . . 0.0 110.399 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mt -137.1 158.39 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.851 1.66 . . . . 0.0 109.064 -165.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.91 106.51 9.81 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 154.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.44 -149.65 21.35 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.833 1.206 . . . . 0.0 113.096 -172.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.98 156.93 51.69 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.327 1.451 . . . . 0.0 111.114 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.97 -33.9 72.89 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 121.408 1.539 . . . . 0.0 113.378 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -82.79 -13.96 55.29 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.913 -1.117 . . . . 0.0 113.263 173.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.26 70.3 13.02 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.985 1.714 . . . . 0.0 112.839 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.11 151.93 21.14 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.24 2.627 . . . . 0.0 111.574 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 85.3 mtp -97.4 12.19 34.05 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.7 t -148.97 145.25 27.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.746 1.219 . . . . 0.0 111.245 176.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.12 -39.84 86.7 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.558 -0.714 . . . . 0.0 112.897 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -62.75 -34.56 77.48 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.086 -1.009 . . . . 0.0 111.858 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.9 m -68.45 -31.03 70.05 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.284 -0.885 . . . . 0.0 112.664 170.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -66.02 -38.56 88.73 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.083 1.31 . . . . 0.0 112.425 168.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -59.73 -31.39 69.58 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.201 1.0 . . . . 0.0 112.69 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.6 tpt -60.04 -47.15 87.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.993 0.917 . . . . 0.0 111.618 169.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mm -70.89 -33.99 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.25 -0.906 . . . . 0.0 112.81 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -58.06 -35.81 71.88 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.741 -1.225 . . . . 0.0 112.404 168.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.67 -38.7 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 122.264 -0.272 . . . . 0.0 111.281 176.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.77 -34.72 78.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.235 1.014 . . . . 0.0 113.323 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.1 -40.39 95.71 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.089 -1.007 . . . . 0.0 111.629 167.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.71 -21.7 64.39 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 tp -96.88 -15.86 21.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.929 1.292 . . . . 0.0 112.725 170.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.98 12.17 56.71 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.188 1.852 . . . . 0.0 114.932 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.5 133.06 54.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 111.76 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -111.76 150.98 29.5 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.254 1.025 . . . . 0.0 113.201 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.73 175.79 8.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.817 2.047 . . . . 0.0 112.284 -161.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.86 117.51 25.65 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.374 -0.829 . . . . 0.0 109.481 -167.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 m -126.74 129.5 48.51 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.882 0.873 . . . . 0.0 112.17 -154.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -128.29 143.01 50.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.4 77.67 9.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.91 3.284 . . . . 0.0 111.427 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.3 p -74.18 -9.74 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -167.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.07 -22.98 22.66 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.329 -0.857 . . . . 0.0 112.156 169.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.98 -32.85 21.31 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.819 0.736 . . . . 0.0 112.232 174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.53 107.06 10.92 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.129 0.972 . . . . 0.0 111.569 163.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.66 -16.2 41.83 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.717 2.278 . . . . 0.0 114.203 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.4 p -39.75 -43.38 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.616 1.966 . . . . 0.0 115.82 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 t -67.25 -43.55 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.048 -1.033 . . . . 0.0 111.248 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -64.1 -41.09 97.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.008 1.323 . . . . 0.0 111.162 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.5 m -59.02 -45.73 89.98 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.193 0.997 . . . . 0.0 111.681 -177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -75.33 -37.11 60.9 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -35.11 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 121.058 1.754 . . . . 0.0 112.091 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.53 -35.15 73.64 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.614 1.566 . . . . 0.0 112.28 170.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.88 -35.8 59.74 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.447 1.022 . . . . 0.0 113.349 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 81.1 t -80.38 -45.33 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.317 0.962 . . . . 0.0 113.214 -173.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.3 p -105.27 13.61 30.22 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.646 1.566 . . . . 0.0 115.078 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 68.57 -29.87 0.17 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 128.153 2.581 . . . . 0.0 117.143 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -149.65 130.02 6.84 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 120.632 1.56 . . . . 0.0 112.868 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -94.8 147.77 1.69 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.669 2.913 . . . . 0.0 114.413 -177.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.0 p -129.79 152.41 49.31 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.552 1.541 . . . . 0.0 110.182 162.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.1 124.24 23.77 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.994 0.918 . . . . 0.0 110.553 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.58 157.04 72.31 Favored 'Cis proline' 0 CA--C 1.543 0.944 0 CA-C-N 120.227 1.117 . . . . 0.0 113.312 -2.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -151.72 160.55 43.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.183 1.393 . . . . 0.0 111.269 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.94 141.97 51.67 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -128.7 142.48 51.0 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.1 2.16 . . . . 0.0 110.868 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.4 mt -136.88 130.59 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.123 1.369 . . . . 0.0 109.688 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt 48.19 43.87 19.01 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.867 1.667 . . . . 0.0 114.573 -172.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.21 13.25 5.71 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.061 1.744 . . . . 0.0 114.889 -172.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -112.77 141.9 46.03 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.76 1.624 . . . . 0.0 111.103 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -72.51 126.26 29.43 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.105 0.955 . . . . 0.0 112.556 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.3 t -104.49 -54.97 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.28 1.432 . . . . 0.0 112.356 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 167.09 163.29 20.68 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.48 169.0 54.16 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.991 1.758 . . . . 0.0 113.441 168.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.4 tp -46.84 -45.35 20.15 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.315 1.446 . . . . 0.0 113.803 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.2 -21.24 66.49 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.881 1.272 . . . . 0.0 112.748 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.3 mm -92.36 -44.42 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.599 1.96 . . . . 0.0 111.193 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.9 -36.0 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.046 1.738 . . . . 0.0 112.066 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -56.58 -49.81 73.77 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 170.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -61.74 -42.02 98.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.442 0.697 . . . . 0.0 110.362 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.8 mtt -66.55 -39.12 88.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.221 1.009 . . . . 0.0 112.981 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -68.36 -39.72 81.73 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.015 1.326 . . . . 0.0 112.156 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.88 -31.57 61.63 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 30.7 t -79.25 -26.97 42.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.811 1.245 . . . . 0.0 113.603 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.53 -0.64 80.74 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.082 0.849 . . . . 0.0 114.511 -168.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.04 -36.72 80.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.71 1.755 . . . . 0.0 111.781 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.1 -42.51 98.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.889 0.876 . . . . 0.0 110.906 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -69.06 -35.42 76.53 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 126.234 1.814 . . . . 0.0 112.973 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -58.05 -48.84 78.87 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.154 1.343 . . . . 0.0 110.946 171.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 70.3 mtm -67.89 -38.59 83.2 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.27 -43.64 77.35 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.341 0.973 . . . . 0.0 112.832 172.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -72.24 -26.35 61.98 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.309 -0.87 . . . . 0.0 113.305 -171.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.71 -30.12 63.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.321 1.048 . . . . 0.0 112.672 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -87.39 -2.5 58.66 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.51 16.36 55.3 Favored Glycine 0 N--CA 1.47 0.926 0 O-C-N 120.66 -1.275 . . . . 0.0 113.815 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.3 mt -86.19 147.67 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.323 1.049 . . . . 0.0 110.801 -171.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.6 m -105.04 124.44 49.54 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.091 1.356 . . . . 0.0 112.681 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 25.5 p -125.53 169.17 12.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.806 2.442 . . . . 0.0 111.441 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 N--CA 1.481 1.104 0 O-C-N 121.087 -1.008 . . . . 0.0 112.087 171.664 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.4 m . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -61.54 -33.53 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.743 -0.598 . . . . 0.0 112.455 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.81 -24.78 44.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.85 1.66 . . . . 0.0 113.759 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.5 t -92.52 -34.19 14.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.773 1.629 . . . . 0.0 113.667 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -87.76 147.86 24.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.325 1.05 . . . . 0.0 111.807 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -68.51 -47.63 66.49 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.942 -1.099 . . . . 0.0 113.779 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.9 t -140.39 129.93 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.773 1.229 . . . . 0.0 110.848 -173.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.55 137.64 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.648 1.179 . . . . 0.0 111.315 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -136.54 154.64 50.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.417 1.087 . . . . 0.0 111.758 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -134.5 143.61 47.57 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.753 0.787 . . . . 0.0 112.469 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 mt -136.79 157.45 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.495 1.518 . . . . 0.0 110.227 -155.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -76.19 106.52 7.85 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.973 153.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.26 -161.71 43.42 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.948 0.794 . . . . 0.0 114.257 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.82 156.09 41.06 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.724 1.209 . . . . 0.0 111.94 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -67.39 -21.04 47.72 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.28 1.987 . . . . 0.0 113.088 173.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.59 -24.53 21.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.136 1.374 . . . . 0.0 112.852 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.31 75.77 19.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.796 1.638 . . . . 0.0 111.334 -176.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.66 155.87 40.02 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.722 2.948 . . . . 0.0 112.362 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.3 mtt -109.62 4.04 21.67 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.316 1.446 . . . . 0.0 114.539 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 44.3 t -148.85 147.11 28.35 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.753 1.621 . . . . 0.0 110.523 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.15 94.71 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.698 -0.626 . . . . 0.0 111.548 176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -60.91 -34.66 75.02 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.278 -0.889 . . . . 0.0 112.203 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.8 m -63.48 -48.48 77.45 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 118.865 -0.588 . . . . 0.0 111.136 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -59.08 -48.97 79.67 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.025 0.83 . . . . 0.0 111.055 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -60.84 -28.64 68.98 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.417 1.087 . . . . 0.0 113.037 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 34.4 ttp -68.79 -42.62 77.11 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.6 mm -67.66 -34.57 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.227 -0.921 . . . . 0.0 110.73 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -39.53 72.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.915 1.286 . . . . 0.0 111.956 172.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.44 -42.35 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.557 1.143 . . . . 0.0 111.705 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.9 mt -66.48 -35.53 80.51 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -67.07 -33.62 75.88 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.972 -1.08 . . . . 0.0 112.495 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.79 -25.69 68.29 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.837 -1.164 . . . . 0.0 113.275 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.88 -14.48 20.66 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.426 1.09 . . . . 0.0 113.717 171.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.82 10.19 67.31 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.894 1.235 . . . . 0.0 115.355 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.32 131.38 55.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.184 0.993 . . . . 0.0 112.06 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -116.5 128.1 55.14 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.934 0.874 . . . . 0.0 113.018 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -106.36 171.98 7.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.818 2.447 . . . . 0.0 112.069 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.2 m -83.72 121.87 27.88 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.581 -1.324 . . . . 0.0 109.0 -161.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.9 m -122.79 128.03 49.91 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.243 -155.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -126.45 143.94 51.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.673 1.189 . . . . 0.0 113.386 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -92.7 113.91 26.32 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.679 1.192 . . . . 0.0 111.245 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 t -69.11 -18.44 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.757 -0.589 . . . . 0.0 112.061 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -77.7 -22.79 49.94 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.054 -1.029 . . . . 0.0 112.545 172.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.78 -37.37 17.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.893 0.769 . . . . 0.0 112.205 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -136.85 94.36 12.99 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -44.18 -20.93 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.586 1 C-N-CA 125.916 4.411 . . . . 0.0 116.891 165.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -48.62 -35.88 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 121.237 1.835 . . . . 0.0 112.867 171.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.35 -43.69 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 121.565 -0.709 . . . . 0.0 110.315 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.25 -32.94 73.7 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.845 1.258 . . . . 0.0 112.542 172.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.4 m -69.57 -37.9 77.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.911 1.684 . . . . 0.0 113.686 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -76.17 -47.19 25.13 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.54 -34.47 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 120.515 -1.365 . . . . 0.0 112.951 -174.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -62.13 -34.64 76.73 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -77.04 -43.53 34.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.664 1.986 . . . . 0.0 113.915 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.9 t -79.33 -38.59 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.108 1.363 . . . . 0.0 113.376 -166.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 m -100.39 10.98 40.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 62.11 -33.97 0.1 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 128.338 2.655 . . . . 0.0 115.376 -166.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -139.13 139.41 23.15 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.534 2.334 . . . . 0.0 108.833 169.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.99 128.37 9.11 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.075 1.85 . . . . 0.0 112.019 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.8 m -130.16 132.21 45.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.835 1.254 . . . . 0.0 110.987 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 57.0 mt -129.2 130.58 23.38 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.275 1.03 . . . . 0.0 110.52 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -80.78 152.66 82.2 Favored 'Cis proline' 0 CA--C 1.545 1.062 0 CA-C-N 120.021 1.043 . . . . 0.0 112.827 -5.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -147.81 158.56 44.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.352 1.061 . . . . 0.0 112.595 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.52 135.13 50.9 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.914 1.686 . . . . 0.0 111.987 -172.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -119.22 144.91 46.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.726 2.011 . . . . 0.0 110.128 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.6 mt -127.0 124.32 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 167.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.3 tttp 44.11 54.95 5.7 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.925 1.69 . . . . 0.0 114.328 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.69 27.83 17.55 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.08 145.86 51.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.109 1.364 . . . . 0.0 110.008 171.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -81.6 124.07 29.22 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.717 0.77 . . . . 0.0 111.332 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.9 t -99.94 -49.25 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.144 0.978 . . . . 0.0 110.104 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.05 158.75 23.88 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.674 1.429 . . . . 0.0 116.674 170.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.2 169.7 54.59 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.285 0.945 . . . . 0.0 112.157 164.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -52.12 -38.85 58.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.469 1.107 . . . . 0.0 113.969 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.49 -34.96 78.2 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.869 -1.144 . . . . 0.0 111.773 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.5 mm -72.54 -46.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.161 1.384 . . . . 0.0 110.668 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.98 -35.91 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.966 1.706 . . . . 0.0 111.032 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 90.6 m -62.04 -46.25 90.01 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.443 0.697 . . . . 0.0 111.807 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -59.57 -45.78 90.86 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.742 1.155 . . . . 0.0 110.28 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.3 mtt -61.36 -41.75 97.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.881 0.873 . . . . 0.0 111.365 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.87 -46.61 67.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.133 0.973 . . . . 0.0 111.335 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -72.64 -24.86 61.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.634 1.174 . . . . 0.0 112.597 -175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.9 t -100.44 -2.93 32.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.804 1.641 . . . . 0.0 114.041 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.44 -7.47 78.75 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 120.705 -1.247 . . . . 0.0 115.324 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -29.71 67.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.837 -1.39 . . . . 0.0 114.103 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.55 -46.42 86.03 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.077 0.853 . . . . 0.0 109.791 174.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -58.59 -42.2 87.54 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.122 0.969 . . . . 0.0 111.68 169.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.67 -37.35 86.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 117.0 -1.476 . . . . 0.0 111.825 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.8 mtm -69.82 -47.73 61.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.363 1.438 . . . . 0.0 112.88 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.27 -39.02 89.13 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.634 0.652 . . . . 0.0 112.251 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -69.36 -36.14 76.56 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.955 1.302 . . . . 0.0 111.912 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.0 -24.67 67.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.738 0.815 . . . . 0.0 112.546 168.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -92.12 6.44 46.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.929 1.292 . . . . 0.0 114.403 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.72 13.39 67.29 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.725 1.155 . . . . 0.0 114.431 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.2 mt -104.46 146.89 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.25 1.42 . . . . 0.0 108.959 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.0 m -116.02 136.13 53.32 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.861 -1.149 . . . . 0.0 112.777 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.4 p -131.34 167.98 18.33 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.18 1.792 . . . . 0.0 112.581 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 . . . . . 0 N--CA 1.476 0.842 0 O-C-N 121.439 -0.788 . . . . 0.0 110.096 171.009 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.71 -36.53 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 118.427 0.558 . . . . 0.0 111.991 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.4 -38.31 50.09 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.582 1.553 . . . . 0.0 112.896 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.7 t -81.84 -35.87 28.93 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.661 1.584 . . . . 0.0 113.122 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -83.04 142.36 31.37 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.888 -1.133 . . . . 0.0 109.968 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.417 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 34.9 m-20 -82.93 -46.0 13.48 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.879 -1.138 . . . . 0.0 112.345 -163.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 t -132.85 131.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.787 1.635 . . . . 0.0 109.764 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.2 t -132.49 132.88 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.529 1.532 . . . . 0.0 111.173 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.8 t -133.85 155.48 49.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.65 1.18 . . . . 0.0 110.839 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -131.39 142.44 50.05 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.31 0.644 . . . . 0.0 112.73 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.7 mt -136.42 159.69 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.351 1.861 . . . . 0.0 110.206 -158.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -73.06 104.03 4.01 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.509 -0.744 . . . . 0.0 109.505 158.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.24 -155.94 40.83 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.563 -0.71 . . . . 0.0 113.676 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -113.58 150.21 42.88 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.8 1.24 . . . . 0.0 112.209 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.02 -19.02 46.16 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.067 2.512 . . . . 0.0 114.711 -167.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.12 -27.34 60.82 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.606 1.162 . . . . 0.0 112.688 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.79 68.22 12.88 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.163 1.785 . . . . 0.0 111.549 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.1 143.8 73.17 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.422 2.082 . . . . 0.0 111.429 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.6 ttm -90.93 -7.51 51.91 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 41.3 t -140.8 146.28 37.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.282 1.433 . . . . 0.0 110.459 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.17 94.33 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.546 -0.721 . . . . 0.0 112.484 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -69.52 -34.1 73.78 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.436 -0.79 . . . . 0.0 111.593 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 m -62.75 -39.46 94.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.339 0.655 . . . . 0.0 112.477 168.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -67.23 -40.66 86.36 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.627 1.103 . . . . 0.0 112.828 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -64.42 -36.03 82.85 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.805 0.842 . . . . 0.0 112.509 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.8 tpt -55.94 -45.86 78.69 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.214 0.915 . . . . 0.0 112.289 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.3 mm -66.58 -34.14 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.303 0.641 . . . . 0.0 111.254 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -37.2 86.31 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.437 -0.79 . . . . 0.0 112.99 174.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.8 t -70.62 -36.11 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.897 0.879 . . . . 0.0 110.956 176.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.1 mt -66.1 -40.95 91.18 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.335 -0.853 . . . . 0.0 113.129 169.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -62.08 -31.29 71.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.09 -1.007 . . . . 0.0 111.863 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.15 -20.0 64.86 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -98.81 -9.17 24.75 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.459 1.504 . . . . 0.0 113.563 172.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.77 11.17 57.11 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.402 1.477 . . . . 0.0 114.954 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.11 132.62 55.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.333 1.066 . . . . 0.0 111.831 172.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -114.89 159.23 20.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.951 0.9 . . . . 0.0 113.356 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -133.19 172.82 12.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.856 2.062 . . . . 0.0 111.604 -161.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.4 m -87.9 119.6 28.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.469 -1.394 . . . . 0.0 108.354 -168.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.6 m -125.93 129.29 48.98 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.162 -151.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -125.88 143.72 50.96 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -91.87 122.59 34.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.395 1.478 . . . . 0.0 111.396 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.0 m -66.92 -22.22 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.0 mt -87.04 -11.3 50.74 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.211 1.404 . . . . 0.0 112.92 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.13 -36.79 15.51 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -146.29 135.27 11.2 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.95 0.9 . . . . 0.0 111.069 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.25 -31.63 93.25 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.393 2.728 . . . . 0.0 113.204 -174.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 p -44.02 -42.7 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.616 1.567 . . . . 0.0 113.789 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 t -71.11 -47.86 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.801 1.182 . . . . 0.0 111.419 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -72.42 -25.41 61.47 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 63.7 m -71.2 -48.07 53.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.316 1.046 . . . . 0.0 112.274 169.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -66.18 -44.22 84.62 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.96 -1.088 . . . . 0.0 112.623 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.82 -35.31 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.291 -0.88 . . . . 0.0 112.065 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -69.59 -36.53 76.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.274 1.03 . . . . 0.0 112.728 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -74.48 -44.21 52.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.464 1.106 . . . . 0.0 113.718 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.0 t -81.91 -41.27 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.24 1.416 . . . . 0.0 113.001 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.0 m -101.1 -9.33 21.47 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 64.13 -24.15 0.07 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 128.697 2.799 . . . . 0.0 117.439 172.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -127.3 110.6 21.3 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.189 1.795 . . . . 0.0 107.925 158.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.03 125.94 4.25 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 121.117 1.211 . . . . 0.0 111.875 -171.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.4 p -136.05 126.75 27.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.352 1.861 . . . . 0.0 109.453 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.62 146.13 57.43 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 119.226 0.921 . . . . 0.0 110.999 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.69 155.27 92.39 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 120.201 1.108 . . . . 0.0 114.292 8.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -150.01 157.29 42.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.472 1.909 . . . . 0.0 110.576 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.73 139.03 52.41 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.251 1.021 . . . . 0.0 113.665 -172.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -129.78 145.8 51.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.514 1.926 . . . . 0.0 111.101 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.6 mt -129.12 125.86 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.792 1.237 . . . . 0.0 108.685 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 90' ' ' ASP . 2.3 mmpt? 46.59 53.66 9.7 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.674 1.59 . . . . 0.0 114.422 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 58.05 24.45 11.18 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.399 1.88 . . . . 0.0 115.934 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -123.53 139.3 54.15 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.902 -1.124 . . . . 0.0 111.522 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -68.35 123.73 21.55 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.082 0.953 . . . . 0.0 111.023 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.77 -43.16 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.497 1.519 . . . . 0.0 111.807 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.62 173.67 26.33 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 117.165 1.626 . . . . 0.0 117.165 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.95 173.23 54.9 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.466 1.507 . . . . 0.0 113.769 171.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.95 -41.38 33.81 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.28 1.432 . . . . 0.0 112.895 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.86 -36.54 83.61 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.948 -1.095 . . . . 0.0 112.82 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 mm -74.27 -45.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.672 1.589 . . . . 0.0 109.62 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.5 t -58.65 -39.72 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.996 0.918 . . . . 0.0 110.835 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 30.7 m -63.52 -46.05 87.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.229 1.011 . . . . 0.0 111.369 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 29.7 tttp -60.88 -43.77 97.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.96 1.304 . . . . 0.0 111.585 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 51.9 mtt -70.6 -38.73 74.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.831 1.253 . . . . 0.0 112.698 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.09 -46.72 61.24 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.386 0.994 . . . . 0.0 112.294 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -63.55 -33.65 76.06 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.646 0.657 . . . . 0.0 111.713 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.7 m -85.14 -17.65 36.6 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.66 -4.65 85.77 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.945 1.248 . . . . 0.0 115.142 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -64.92 -28.49 69.56 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.426 1.613 . . . . 0.0 113.538 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tt -59.54 -46.55 88.56 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.915 -1.116 . . . . 0.0 109.922 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -61.9 -32.92 73.34 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.172 1.789 . . . . 0.0 112.823 172.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -64.45 -39.81 94.54 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.596 1.089 . . . . 0.0 112.101 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.1 mtm -66.16 -51.18 60.26 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.749 1.261 . . . . 0.0 111.562 172.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 53.7 tp -65.14 -42.83 93.44 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.706 2.002 . . . . 0.0 111.122 -165.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -68.65 -38.2 80.25 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.276 1.03 . . . . 0.0 112.337 171.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.89 -27.25 69.02 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.905 0.775 . . . . 0.0 112.666 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 -5.23 45.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.894 1.678 . . . . 0.0 113.714 175.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.46 16.42 64.25 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 125.203 1.383 . . . . 0.0 114.687 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.17 143.92 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.24 1.416 . . . . 0.0 110.15 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.5 m -114.15 134.34 54.96 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.244 -0.91 . . . . 0.0 113.403 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.2 p -125.73 174.07 8.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 129.007 2.923 . . . . 0.0 111.994 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 . . . . . 0 N--CA 1.476 0.85 0 C-N-CA 124.695 1.198 . . . . 0.0 113.172 167.4 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.6 pt -62.13 -35.3 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.747 1.158 . . . . 0.0 112.13 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -77.74 -37.75 48.49 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.044 1.738 . . . . 0.0 112.069 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 t -68.15 -31.55 71.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.853 2.461 . . . . 0.0 113.293 173.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -86.87 147.85 25.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.15 1.78 . . . . 0.0 111.727 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.87 -35.7 16.39 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.017 -1.052 . . . . 0.0 111.863 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.3 t -139.9 130.75 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.95 1.3 . . . . 0.0 112.261 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.9 t -132.83 133.32 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.059 1.344 . . . . 0.0 111.379 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 t -131.72 154.6 48.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.998 0.919 . . . . 0.0 110.596 167.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -134.2 146.23 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.404 0.621 . . . . 0.0 112.463 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.07 161.72 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.078 1.751 . . . . 0.0 109.174 -166.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.72 104.25 8.15 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.375 -0.828 . . . . 0.0 109.543 146.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.28 -162.41 18.03 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.265 0.936 . . . . 0.0 114.87 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -107.1 158.24 33.44 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.916 2.086 . . . . 0.0 110.833 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.29 -25.77 56.79 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.733 1.622 . . . . 0.0 113.666 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -76.07 -24.41 55.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.734 1.214 . . . . 0.0 113.684 169.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.12 69.05 14.14 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.07 1.348 . . . . 0.0 111.894 -174.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.99 143.71 23.24 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.856 2.37 . . . . 0.0 110.372 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 mmt -88.58 5.15 44.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 13.5 t -152.21 146.76 25.7 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.124 1.37 . . . . 0.0 110.961 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.33 77.85 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -65.3 -37.89 88.53 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.894 -1.129 . . . . 0.0 111.761 172.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 m -65.14 -39.26 92.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.872 0.869 . . . . 0.0 112.361 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.53 -45.77 92.79 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.269 1.027 . . . . 0.0 112.144 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -58.19 -35.86 72.24 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.69 1.596 . . . . 0.0 112.957 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.4 ttp -59.13 -42.45 90.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.622 0.369 . . . . 0.0 111.941 173.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 mm -71.73 -33.82 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.572 0.749 . . . . 0.0 111.848 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -58.35 -38.68 77.69 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.8 -1.188 . . . . 0.0 112.336 172.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.48 -39.38 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.173 0.989 . . . . 0.0 111.081 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.6 mt -65.89 -39.18 90.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.554 0.742 . . . . 0.0 112.532 173.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -67.0 -31.56 72.2 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.903 -1.123 . . . . 0.0 112.018 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.89 -19.91 64.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.848 1.259 . . . . 0.0 114.235 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.75 -9.55 28.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.889 1.276 . . . . 0.0 113.297 166.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.41 9.2 42.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.342 0.972 . . . . 0.0 113.721 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.0 mt -114.29 130.33 56.66 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 125.683 1.593 . . . . 0.0 111.72 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -115.02 133.67 55.85 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.017 0.913 . . . . 0.0 111.594 170.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -105.06 172.12 6.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.603 2.361 . . . . 0.0 110.773 -172.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.5 m -87.24 123.1 31.88 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.668 -1.27 . . . . 0.0 109.811 -161.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.5 p -108.36 134.14 51.59 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.406 1.482 . . . . 0.0 114.904 -158.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -126.71 146.78 50.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.503 1.121 . . . . 0.0 113.023 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.46 106.04 14.81 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.013 1.325 . . . . 0.0 111.328 -167.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.54 -36.04 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.586 1.555 . . . . 0.0 112.262 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 tp -80.48 -22.05 41.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.335 0.654 . . . . 0.0 111.666 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.11 -39.31 16.86 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.49 -0.757 . . . . 0.0 112.679 167.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -126.1 103.06 26.92 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 118.982 0.81 . . . . 0.0 112.52 -169.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.08 -28.77 25.92 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.713 2.942 . . . . 0.0 115.021 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -49.7 -36.86 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.792 1.237 . . . . 0.0 113.5 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.34 -52.2 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.553 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -64.48 -26.11 68.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.69 0.796 . . . . 0.0 112.955 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.6 m -71.46 -51.96 20.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.163 0.585 . . . . 0.0 111.763 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -73.43 -34.92 65.7 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.564 -1.335 . . . . 0.0 114.206 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.5 p -60.28 -34.34 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.715 1.143 . . . . 0.0 112.074 172.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 34.5 tttm -69.25 -35.21 75.88 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.139 0.881 . . . . 0.0 112.731 173.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.23 -37.74 86.52 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.221 1.373 . . . . 0.0 112.541 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.61 -45.26 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.1 m -106.08 -5.37 19.49 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 62.05 -48.09 0.16 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.517 2.327 . . . . 0.0 116.186 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -135.92 92.45 16.46 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.896 1.278 . . . . 0.0 111.546 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -101.47 156.7 0.37 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.838 3.692 . . . . 0.0 114.743 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 m -117.35 128.84 55.44 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.413 1.485 . . . . 0.0 110.393 161.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.22 140.69 25.79 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.879 1.272 . . . . 0.0 108.576 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -90.59 159.62 31.11 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-N 120.733 1.298 . . . . 0.0 113.693 1.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -160.2 171.65 18.83 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.464 1.106 . . . . 0.0 113.466 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.52 141.89 51.24 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.12 1.368 . . . . 0.0 113.455 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -128.29 141.71 51.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.61 1.964 . . . . 0.0 110.665 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 84.5 mt -129.65 135.63 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 125.049 1.339 . . . . 0.0 108.471 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 47.36 40.45 10.8 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.22 1.408 . . . . 0.0 113.509 -170.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.32 25.46 7.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.002 2.121 . . . . 0.0 115.526 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.87 142.47 46.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.513 1.525 . . . . 0.0 110.007 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -70.78 126.08 28.61 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.614 0.721 . . . . 0.0 112.088 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.7 t -101.57 -53.89 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.436 1.494 . . . . 0.0 111.078 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.82 160.6 26.41 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 116.058 1.183 . . . . 0.0 116.058 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 170.36 54.91 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.035 1.302 . . . . 0.0 112.769 165.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -49.31 -46.76 47.03 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.86 1.264 . . . . 0.0 114.337 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.9 -22.67 65.07 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.101 -0.999 . . . . 0.0 112.621 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.4 mm -82.23 -47.05 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.838 1.655 . . . . 0.0 110.664 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.67 -36.57 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.852 1.661 . . . . 0.0 111.024 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 55.1 m -59.69 -44.0 93.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.907 0.883 . . . . 0.0 111.881 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -66.41 -42.45 87.8 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.105 -0.997 . . . . 0.0 111.033 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.6 mtt -61.13 -43.83 98.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.597 0.759 . . . . 0.0 110.99 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.11 -48.85 72.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.078 0.951 . . . . 0.0 111.13 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.15 -16.26 61.98 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.165 1.386 . . . . 0.0 113.477 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m -91.32 -21.01 21.26 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 173.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.83 -2.35 88.25 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 121.718 -0.614 . . . . 0.0 113.927 -164.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.0 -33.55 74.84 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.688 1.244 . . . . 0.0 111.775 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.28 -45.63 92.41 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.363 -0.836 . . . . 0.0 110.689 172.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -63.48 -37.49 87.51 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.158 1.383 . . . . 0.0 113.105 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -61.38 -43.33 99.05 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 117.611 -1.185 . . . . 0.0 112.655 170.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 74.4 mtm -68.71 -48.02 64.89 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.939 1.245 . . . . 0.0 112.309 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 pp -64.04 -35.65 81.43 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.822 -0.549 . . . . 0.0 111.709 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -69.7 -35.76 75.35 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 121.496 -0.752 . . . . 0.0 112.952 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -65.2 -30.61 71.52 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.3 1.04 . . . . 0.0 111.876 171.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.99 5.28 6.81 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.014 1.726 . . . . 0.0 112.969 170.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.91 9.25 77.93 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.502 1.525 . . . . 0.0 114.796 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.4 mt -94.66 147.22 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.219 1.008 . . . . 0.0 110.854 -168.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.3 m -112.22 130.3 55.97 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.994 1.318 . . . . 0.0 111.101 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.5 p -138.36 169.51 17.66 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.977 1.711 . . . . 0.0 113.032 -169.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.0 ttt-85 . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 124.862 1.265 . . . . 0.0 110.813 164.938 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.618 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.3 pt -64.4 -36.63 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.138 0.575 . . . . 0.0 111.867 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -79.19 -34.26 43.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.323 1.449 . . . . 0.0 113.681 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -80.1 -29.65 39.06 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.853 0.861 . . . . 0.0 113.243 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -87.42 133.49 33.73 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.955 0.902 . . . . 0.0 112.047 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -67.67 -38.22 83.43 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.3 t -142.33 127.2 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.331 1.053 . . . . 0.0 111.514 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.77 130.17 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.467 1.507 . . . . 0.0 111.557 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 t -131.75 155.3 47.95 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.079 0.952 . . . . 0.0 111.532 168.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -131.62 127.9 38.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.591 1.156 . . . . 0.0 110.394 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.14 173.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.22 1.808 . . . . 0.0 111.773 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 102.15 4.52 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.333 1.053 . . . . 0.0 109.919 161.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.82 -162.12 37.11 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.41 1.005 . . . . 0.0 115.156 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.11 148.67 43.51 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.117 0.967 . . . . 0.0 110.549 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.21 -23.89 77.98 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.148 2.565 . . . . 0.0 113.996 -175.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -78.37 -26.47 46.62 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.799 1.24 . . . . 0.0 113.907 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.17 67.05 10.62 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.903 1.281 . . . . 0.0 111.881 -175.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.19 152.91 45.72 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.527 2.151 . . . . 0.0 112.841 -172.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -74.06 -8.13 55.02 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.196 -0.94 . . . . 0.0 113.34 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.7 m -152.66 146.73 25.4 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -158.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.1 64.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.247 1.419 . . . . 0.0 112.447 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -67.68 -26.66 66.3 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.315 0.962 . . . . 0.0 111.36 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.3 m -68.32 -38.38 81.51 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.274 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.31 -45.49 91.1 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.305 1.411 . . . . 0.0 111.768 167.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -56.61 -37.65 70.98 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.485 0.714 . . . . 0.0 112.342 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.8 tpt -60.79 -46.56 90.02 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.278 1.431 . . . . 0.0 112.355 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.3 mm -72.96 -33.21 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.426 -0.796 . . . . 0.0 112.459 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -57.58 -32.69 67.41 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.206 -1.558 . . . . 0.0 112.795 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.61 -44.07 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.177 0.991 . . . . 0.0 111.168 172.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.35 -36.28 83.53 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.031 1.332 . . . . 0.0 112.83 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -71.83 -31.23 66.32 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.358 -1.463 . . . . 0.0 113.137 172.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.91 -29.84 69.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.228 1.011 . . . . 0.0 112.642 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.35 -14.35 40.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.268 1.027 . . . . 0.0 113.412 169.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.83 11.11 57.2 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.083 1.325 . . . . 0.0 114.527 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.09 131.61 55.75 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.932 1.293 . . . . 0.0 111.326 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -113.0 145.37 40.96 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.715 1.143 . . . . 0.0 112.421 174.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -113.54 172.29 7.05 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.459 1.904 . . . . 0.0 111.721 -175.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.8 m -88.86 120.4 30.23 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -164.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.2 m -125.67 136.03 52.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.608 -148.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -124.02 159.55 29.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.827 1.251 . . . . 0.0 111.985 -173.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -112.99 118.27 34.35 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.088 1.355 . . . . 0.0 110.677 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.85 -21.78 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.427 0.691 . . . . 0.0 112.857 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.42 -9.92 53.4 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.517 1.127 . . . . 0.0 112.644 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.46 -34.35 11.53 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.332 0.969 . . . . 0.0 112.61 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -138.36 88.65 14.63 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.213 0.605 . . . . 0.0 111.005 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.86 -12.51 22.4 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.21 2.607 . . . . 0.0 114.961 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -45.91 -33.77 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.662 1.119 . . . . 0.0 112.902 167.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.43 -43.62 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.337 1.055 . . . . 0.0 111.824 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -65.68 -28.61 69.21 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.257 0.935 . . . . 0.0 111.98 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.4 m -74.48 -39.43 62.49 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -69.84 -39.99 76.1 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.695 1.134 . . . . 0.0 111.313 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.3 -32.11 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.808 -1.182 . . . . 0.0 112.233 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -61.49 -33.98 74.7 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.071 -1.018 . . . . 0.0 113.024 168.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -73.31 -47.85 39.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.182 0.993 . . . . 0.0 112.72 170.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.95 -34.43 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.0 m -100.61 -2.31 33.15 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 60.84 -38.74 0.1 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 130.221 3.408 . . . . 0.0 116.635 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -136.49 91.73 15.9 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.859 2.464 . . . . 0.0 109.572 173.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.41 136.58 8.82 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.117 2.545 . . . . 0.0 113.232 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.9 m -132.65 122.55 24.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.147 0.979 . . . . 0.0 109.85 165.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 12.6 pt -95.37 156.41 37.66 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.493 1.117 . . . . 0.0 113.683 -172.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.92 158.37 97.97 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 119.037 0.692 . . . . 0.0 112.978 -5.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -131.42 160.86 33.88 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.999 1.319 . . . . 0.0 111.433 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.84 139.95 53.06 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.278 1.431 . . . . 0.0 111.991 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -132.8 143.99 49.93 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.172 1.789 . . . . 0.0 110.28 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.1 mt -126.17 117.09 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 42.89 53.03 5.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 127.215 2.206 . . . . 0.0 114.324 -169.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 57.52 26.52 12.82 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -119.29 131.19 55.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.117 1.367 . . . . 0.0 109.224 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -74.33 125.03 27.59 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.86 -42.48 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.013 1.325 . . . . 0.0 111.662 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.35 177.88 30.88 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 169.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.98 169.31 54.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.831 1.205 . . . . 0.0 113.962 168.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -45.35 -44.48 11.79 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.147 1.779 . . . . 0.0 113.145 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.62 -45.04 93.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.356 0.662 . . . . 0.0 111.656 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 mm -68.45 -46.91 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.424 1.49 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.71 -36.21 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.946 1.699 . . . . 0.0 110.672 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 29.5 m -63.39 -46.04 88.29 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 118.8 -0.619 . . . . 0.0 111.701 173.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -63.61 -41.99 98.25 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.882 1.219 . . . . 0.0 110.82 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 54.6 mtt -64.17 -39.8 94.77 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.631 1.172 . . . . 0.0 112.399 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.09 -47.17 75.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.856 0.863 . . . . 0.0 110.874 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -70.93 -26.18 63.09 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.506 1.122 . . . . 0.0 113.283 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 75.2 m -105.18 0.88 27.75 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.24 -8.09 80.62 Favored Glycine 0 N--CA 1.478 1.442 0 CA-C-N 121.094 1.77 . . . . 0.0 115.419 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.55 -29.68 69.12 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.08 1.44 . . . . 0.0 112.885 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.34 -48.26 68.03 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.651 0.78 . . . . 0.0 110.782 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -60.62 -33.59 73.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.611 1.564 . . . . 0.0 112.889 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -59.02 -41.35 87.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.952 0.796 . . . . 0.0 112.821 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.8 mtm -67.32 -47.64 69.93 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.632 1.105 . . . . 0.0 112.143 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -37.97 87.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.251 0.62 . . . . 0.0 112.49 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -75.03 -33.98 61.84 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.412 -0.805 . . . . 0.0 112.989 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.78 -24.83 67.68 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.289 0.495 . . . . 0.0 111.955 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -80.31 -0.04 34.94 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.712 1.205 . . . . 0.0 113.825 171.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.32 22.02 57.53 Favored Glycine 0 CA--C 1.524 0.622 0 O-C-N 120.521 -1.362 . . . . 0.0 114.26 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 95.9 mt -99.4 145.04 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.666 1.233 . . . . 0.0 111.395 -173.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 99.2 m -91.42 126.89 36.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.685 1.194 . . . . 0.0 111.658 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 22.0 p -120.04 166.4 13.43 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.127 1.771 . . . . 0.0 112.193 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 125.954 1.701 . . . . 0.0 112.356 173.992 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 118.896 -0.573 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 pt -60.72 -33.35 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.356 0.98 . . . . 0.0 112.928 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -78.81 -23.55 45.08 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.907 1.683 . . . . 0.0 114.542 173.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.0 t -89.22 -32.82 17.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.361 1.865 . . . . 0.0 113.061 -174.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -88.86 143.18 27.06 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.767 1.227 . . . . 0.0 111.245 169.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.26 -33.13 61.25 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.38 -0.825 . . . . 0.0 111.105 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.3 t -142.82 131.46 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.65 1.18 . . . . 0.0 111.512 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -134.36 139.12 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.097 1.359 . . . . 0.0 111.773 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 t -134.24 156.54 48.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.086 1.355 . . . . 0.0 111.299 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.41 ' CE2' ' HB3' ' A' ' 147' ' ' GLN . 1.1 p90 -132.0 135.33 46.46 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.764 0.825 . . . . 0.0 110.839 173.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.65 167.64 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.585 1.954 . . . . 0.0 110.391 -168.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.11 112.55 15.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 152.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.43 -153.66 46.49 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 123.142 0.401 . . . . 0.0 113.811 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.18 160.07 65.73 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.838 1.655 . . . . 0.0 111.066 -166.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.75 -24.94 20.93 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 N-CA-C 116.515 1.698 . . . . 0.0 116.515 -156.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -98.89 -3.87 34.25 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.805 1.242 . . . . 0.0 113.402 168.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -141.62 71.97 25.19 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.531 1.532 . . . . 0.0 110.787 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.18 155.7 25.74 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.621 2.881 . . . . 0.0 112.818 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.99 7.06 18.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.36 1.464 . . . . 0.0 113.552 175.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 16.6 t -148.47 147.43 29.12 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.685 -1.26 . . . . 0.0 111.788 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.78 -41.07 77.03 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.598 -0.689 . . . . 0.0 112.011 170.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -66.66 -27.34 67.59 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.597 -0.689 . . . . 0.0 112.331 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.4 m -64.85 -47.49 77.71 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.318 -0.864 . . . . 0.0 110.936 169.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.31 -41.28 88.66 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.955 0.798 . . . . 0.0 111.298 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -61.22 -35.98 78.69 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.633 1.173 . . . . 0.0 114.06 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.7 tpt -62.13 -41.9 98.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.876 0.762 . . . . 0.0 111.246 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.6 mm -72.06 -36.91 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.26 -0.9 . . . . 0.0 112.259 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -58.23 -30.96 66.92 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.646 1.178 . . . . 0.0 112.496 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.06 -47.14 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.744 1.618 . . . . 0.0 112.141 170.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 44.9 mt -66.2 -35.49 80.59 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.144 -0.973 . . . . 0.0 113.08 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -62.4 -39.55 93.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.448 1.099 . . . . 0.0 112.011 168.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.73 -26.17 66.01 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.166 -0.959 . . . . 0.0 113.285 176.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.6 tp -86.79 -15.48 39.16 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.09 2.14 16.76 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 124.821 1.201 . . . . 0.0 115.146 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.51 135.35 54.18 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.876 1.671 . . . . 0.0 111.402 172.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -109.96 151.8 26.66 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.431 1.11 . . . . 0.0 113.286 171.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -130.2 168.9 16.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.897 2.079 . . . . 0.0 110.448 -172.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.1 m -90.33 133.73 34.78 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.868 -1.145 . . . . 0.0 111.192 -159.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.5 p -129.39 147.8 51.25 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -164.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.2 153.78 47.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.203 1.801 . . . . 0.0 111.677 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -89.96 113.96 25.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.122 0.969 . . . . 0.0 112.085 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.9 -16.78 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 121.227 -0.921 . . . . 0.0 113.265 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -73.19 -29.5 62.87 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.327 -0.858 . . . . 0.0 111.236 169.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.84 -33.78 21.23 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -130.2 102.35 17.29 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 118.744 0.702 . . . . 0.0 112.776 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -60.23 -21.66 67.38 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.221 2.614 . . . . 0.0 115.494 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 p -52.51 -31.14 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 120.05 1.296 . . . . 0.0 113.347 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.7 -47.65 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.349 -0.844 . . . . 0.0 110.592 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -67.79 -30.49 69.94 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.472 1.033 . . . . 0.0 112.831 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.5 m -58.58 -49.08 78.77 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.834 0.853 . . . . 0.0 111.993 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -74.1 -49.37 24.2 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 168.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.6 t -60.45 -41.65 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 121.083 -1.011 . . . . 0.0 113.286 -165.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -63.48 -34.87 78.72 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.233 0.54 . . . . 0.0 111.474 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.14 -50.6 11.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.271 1.829 . . . . 0.0 112.84 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.67 -30.38 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.124 0.969 . . . . 0.0 112.806 -175.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 84.4 p -90.05 -3.94 57.67 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 59.61 -34.56 0.06 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 129.839 3.256 . . . . 0.0 116.239 -171.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -145.65 110.69 4.52 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.604 1.561 . . . . 0.0 109.789 173.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -89.11 130.65 2.09 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 121.905 1.736 . . . . 0.0 114.16 -165.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 p -129.33 133.53 47.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.683 1.593 . . . . 0.0 109.97 166.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.3 pt -128.5 156.53 77.0 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 124.926 1.29 . . . . 0.0 113.678 -167.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -61.73 162.98 42.96 Favored 'Cis proline' 0 C--N 1.356 0.944 0 CA-C-N 119.967 1.024 . . . . 0.0 113.88 -5.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.41 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 18.9 tt0 -151.08 158.32 43.9 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.347 0.659 . . . . 0.0 111.729 -164.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.22 139.08 53.18 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.856 1.313 . . . . 0.0 113.724 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -120.46 140.89 50.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.787 -2.006 . . . . 0.0 109.43 169.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 53.7 mt -125.75 121.92 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 173.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.2 tptt 45.46 52.88 8.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.516 1.926 . . . . 0.0 114.073 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.72 27.46 16.72 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -121.55 136.48 54.95 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.344 1.457 . . . . 0.0 110.553 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -74.38 123.71 25.15 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.564 0.697 . . . . 0.0 111.114 174.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.6 t -103.93 -54.38 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 126.272 1.829 . . . . 0.0 111.565 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.93 166.7 23.24 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 116.967 1.547 . . . . 0.0 116.967 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.89 172.11 55.17 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.37 1.938 . . . . 0.0 113.609 170.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.2 tp -56.53 -35.82 68.53 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.472 1.109 . . . . 0.0 113.476 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.36 -33.48 75.62 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.994 0.816 . . . . 0.0 112.541 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.5 mm -77.66 -46.76 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.247 1.419 . . . . 0.0 110.475 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.69 -36.31 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.701 1.2 . . . . 0.0 110.777 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 94.6 m -59.25 -40.41 85.89 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.898 0.879 . . . . 0.0 112.108 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -65.08 -50.27 66.8 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.966 0.803 . . . . 0.0 110.157 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 47.6 mtt -61.49 -37.34 83.3 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.245 1.018 . . . . 0.0 112.333 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.36 -39.01 81.98 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.357 1.863 . . . . 0.0 112.369 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -76.95 -30.75 56.17 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 41.1 t -84.55 -26.45 28.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.024 1.33 . . . . 0.0 114.482 -172.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.31 -6.35 63.43 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-N 119.142 0.883 . . . . 0.0 114.554 -169.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.29 -32.49 72.67 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.77 1.785 . . . . 0.0 112.402 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.06 -46.15 88.83 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.203 -0.936 . . . . 0.0 110.147 174.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -62.02 -37.99 86.95 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.254 1.422 . . . . 0.0 113.199 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -67.41 -35.25 78.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.362 1.065 . . . . 0.0 112.596 175.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 60.5 mtm -70.07 -52.1 26.61 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.167 0.894 . . . . 0.0 113.143 169.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 pp -64.78 -35.88 82.51 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.251 -0.906 . . . . 0.0 112.368 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -71.8 -30.94 66.06 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.88 -36.8 82.33 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.58 0.627 . . . . 0.0 111.947 167.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.54 2.6 11.25 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.798 1.639 . . . . 0.0 113.964 175.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.54 12.57 81.61 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.121 1.343 . . . . 0.0 113.853 176.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.6 mt -93.91 149.63 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.027 1.331 . . . . 0.0 110.004 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.2 m -103.27 146.77 27.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.222 1.409 . . . . 0.0 110.947 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.7 p -141.75 167.67 21.6 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.81 1.644 . . . . 0.0 112.213 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 124.381 1.073 . . . . 0.0 112.372 168.532 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.6 pt -61.89 -35.55 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.17 0.588 . . . . 0.0 111.844 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -77.9 -32.96 52.1 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.505 1.922 . . . . 0.0 113.718 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.5 t -73.03 -15.99 61.51 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.845 1.258 . . . . 0.0 113.299 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -104.2 145.27 30.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.95 1.3 . . . . 0.0 113.969 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -83.46 -39.49 20.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.947 0.899 . . . . 0.0 111.366 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.57 137.87 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 126.731 2.012 . . . . 0.0 109.839 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.8 t -133.93 128.0 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.626 1.17 . . . . 0.0 110.566 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -136.66 156.95 47.86 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.943 1.297 . . . . 0.0 110.916 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -129.32 145.93 51.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.088 0.955 . . . . 0.0 111.282 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 mt -137.39 151.3 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.198 0.599 . . . . 0.0 111.406 -166.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.49 108.32 3.25 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 159.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.08 -136.36 15.59 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 118.582 0.628 . . . . 0.0 113.115 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.7 mt -123.16 158.4 58.07 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.728 2.011 . . . . 0.0 111.447 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.53 -23.47 37.12 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 121.976 1.784 . . . . 0.0 115.067 -173.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.7 -15.38 25.32 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.235 0.925 . . . . 0.0 113.221 169.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.95 68.68 70.93 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.213 1.405 . . . . 0.0 111.635 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.01 146.11 25.45 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.215 2.61 . . . . 0.0 111.414 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 96.4 mtp -97.69 4.79 49.93 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.488 1.515 . . . . 0.0 113.518 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.9 t -146.57 145.52 30.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.44 1.496 . . . . 0.0 111.078 -175.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.82 -44.12 97.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.215 0.606 . . . . 0.0 111.996 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -72.39 -24.7 61.29 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.935 -1.103 . . . . 0.0 112.567 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.0 m -68.42 -43.1 77.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.649 0.78 . . . . 0.0 111.6 167.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -61.4 -44.81 96.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.813 0.845 . . . . 0.0 111.861 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -57.8 -37.28 73.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.277 1.831 . . . . 0.0 113.036 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.9 ttp -63.58 -46.8 84.19 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.434 0.561 . . . . 0.0 111.624 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 mm -69.72 -33.01 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.346 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -57.98 -36.69 72.97 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.935 1.243 . . . . 0.0 113.026 170.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.13 -42.14 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.799 0.839 . . . . 0.0 111.1 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.35 -38.94 88.75 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.405 1.082 . . . . 0.0 112.678 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.05 -25.55 66.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.179 1.791 . . . . 0.0 112.723 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.27 73.45 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.06 -11.6 35.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.169 0.988 . . . . 0.0 113.327 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.73 20.3 70.13 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.477 1.037 . . . . 0.0 115.043 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.42 130.35 56.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.466 0.633 . . . . 0.0 109.462 156.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -115.78 131.31 56.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.472 0.709 . . . . 0.0 109.706 168.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -105.07 171.93 7.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.988 1.715 . . . . 0.0 113.021 -163.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.4 m -84.73 125.88 32.92 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.462 1.125 . . . . 0.0 108.861 -170.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.7 m -125.53 133.28 52.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.561 -154.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.04 141.98 46.24 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.097 0.951 . . . . 0.0 112.819 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -98.45 78.71 2.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.026 1.731 . . . . 0.0 112.164 -167.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.0 p -61.52 -28.3 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.263 1.425 . . . . 0.0 114.321 -172.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.0 tp -78.15 -22.69 48.39 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.664 -0.648 . . . . 0.0 111.533 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.87 -32.95 13.0 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 175.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -130.06 98.12 21.95 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.046 0.938 . . . . 0.0 112.055 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -62.19 -9.68 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.042 3.161 . . . . 0.0 116.247 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 p -48.78 -36.49 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.015 -1.053 . . . . 0.0 111.945 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.43 -47.9 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.232 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -67.57 -29.22 68.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.1 0.864 . . . . 0.0 112.243 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.2 m -70.5 -50.5 37.18 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -72.16 -39.43 68.74 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.956 0.798 . . . . 0.0 111.711 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.29 -35.36 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.109 0.868 . . . . 0.0 113.061 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.84 -46.34 78.91 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.979 0.809 . . . . 0.0 111.568 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -64.79 -34.58 78.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.156 0.982 . . . . 0.0 113.067 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.3 t -80.3 -41.56 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.1 t -97.47 -14.27 21.25 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -168.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 67.34 -40.66 0.4 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.874 2.07 . . . . 0.0 115.079 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -130.0 104.85 16.73 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.118 1.767 . . . . 0.0 110.529 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -88.14 128.43 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.563 2.176 . . . . 0.0 112.464 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 75.1 p -131.53 146.97 52.48 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.144 2.178 . . . . 0.0 108.58 169.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.1 tt -108.46 134.93 20.07 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 119.241 0.928 . . . . 0.0 111.9 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -79.99 162.75 83.91 Favored 'Cis proline' 0 CA--C 1.551 1.35 0 CA-C-N 119.835 0.977 . . . . 0.0 111.799 -16.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -134.18 161.58 34.51 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.893 1.677 . . . . 0.0 111.288 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.59 141.82 50.87 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -130.92 141.05 50.26 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.532 1.933 . . . . 0.0 110.073 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 60.3 mt -140.54 134.05 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.731 1.213 . . . . 0.0 109.556 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt 52.96 41.75 32.11 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.687 1.595 . . . . 0.0 114.162 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.04 14.2 5.19 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.95 2.1 . . . . 0.0 115.568 -172.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -111.42 140.89 45.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.625 1.57 . . . . 0.0 110.618 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -77.84 126.25 30.57 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.257 -0.902 . . . . 0.0 112.898 175.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.3 t -101.03 -48.05 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.555 1.542 . . . . 0.0 111.835 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 162.91 170.55 27.94 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.7 169.14 54.62 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.268 1.413 . . . . 0.0 113.685 166.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -46.69 -46.89 20.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.861 1.665 . . . . 0.0 114.746 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.56 -39.06 75.84 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.543 -0.723 . . . . 0.0 111.531 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.9 mm -72.62 -47.45 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.57 1.948 . . . . 0.0 111.56 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.35 -35.76 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.903 0.881 . . . . 0.0 110.503 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.1 m -62.06 -39.31 91.96 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.744 0.818 . . . . 0.0 112.153 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -64.29 -46.69 82.53 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.184 0.902 . . . . 0.0 110.633 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 47.5 mtt -61.65 -38.76 88.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.137 0.975 . . . . 0.0 111.812 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.61 -44.16 87.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.565 1.146 . . . . 0.0 111.781 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.25 -34.38 65.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 t -105.54 3.23 29.13 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -171.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.26 -0.41 75.12 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 116.259 1.263 . . . . 0.0 116.259 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -71.65 -31.85 67.28 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.561 1.181 . . . . 0.0 113.245 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.75 -43.77 83.24 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.483 -1.385 . . . . 0.0 109.951 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -58.22 -44.59 88.24 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.128 1.771 . . . . 0.0 112.307 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -57.28 -46.16 83.37 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.248 1.019 . . . . 0.0 110.932 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 65.1 mtm -69.59 -49.87 49.93 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.9 -37.73 86.87 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.613 -0.679 . . . . 0.0 112.638 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -71.66 -30.8 66.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.188 0.995 . . . . 0.0 111.99 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.77 -31.05 72.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.432 0.693 . . . . 0.0 112.199 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -76.05 -0.18 20.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.96 1.304 . . . . 0.0 113.51 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.4 24.87 60.12 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 124.153 0.882 . . . . 0.0 113.435 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 46.2 mt -105.42 140.4 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.012 0.906 . . . . 0.0 110.893 -174.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.0 m -94.2 125.33 38.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.859 1.264 . . . . 0.0 112.037 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.1 p -118.35 173.26 6.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.096 2.559 . . . . 0.0 111.691 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 . . . . . 0 N--CA 1.472 0.672 0 C-N-CA 123.359 0.664 . . . . 0.0 111.691 164.59 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.6 pt -62.04 -34.31 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.78 0.832 . . . . 0.0 112.054 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -78.5 -35.17 46.8 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.468 1.507 . . . . 0.0 113.534 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.5 t -72.63 -37.85 67.91 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.339 1.056 . . . . 0.0 113.015 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -87.13 133.51 33.62 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.157 0.889 . . . . 0.0 111.956 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.38 -38.31 77.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.731 -0.606 . . . . 0.0 111.717 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.5 t -143.92 131.66 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.216 1.806 . . . . 0.0 110.296 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -135.02 133.19 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.507 1.123 . . . . 0.0 112.118 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.0 t -131.41 155.13 47.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.954 1.302 . . . . 0.0 110.97 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -131.2 140.48 49.9 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.168 0.987 . . . . 0.0 111.79 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mt -140.54 155.65 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.031 1.332 . . . . 0.0 110.901 -158.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.1 102.22 1.6 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.124 0.569 . . . . 0.0 109.467 155.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.97 -143.97 23.55 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.302 -0.874 . . . . 0.0 114.7 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.1 mt -107.3 155.69 38.99 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 125.438 1.495 . . . . 0.0 111.929 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -63.9 -32.2 66.37 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.413 1.408 . . . . 0.0 112.356 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -75.2 -26.78 59.26 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.242 1.017 . . . . 0.0 113.124 172.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.81 76.51 15.48 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.31 1.444 . . . . 0.0 112.354 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.84 144.85 24.82 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.124 2.549 . . . . 0.0 111.772 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.84 10.87 28.54 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.134 1.773 . . . . 0.0 113.815 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.4 t -147.5 146.09 29.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.222 1.409 . . . . 0.0 110.233 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.52 -45.89 87.89 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.482 0.658 . . . . 0.0 111.846 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -70.73 -26.45 63.39 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.103 -0.998 . . . . 0.0 112.138 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -68.49 -38.3 80.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.255 -0.903 . . . . 0.0 112.681 166.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -65.49 -39.28 91.71 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.339 0.972 . . . . 0.0 112.285 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -59.58 -33.1 71.02 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.965 1.306 . . . . 0.0 112.873 174.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.7 tpt -61.51 -42.94 99.56 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.505 0.722 . . . . 0.0 111.74 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.12 -33.91 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.555 0.742 . . . . 0.0 111.654 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -39.79 74.58 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.741 1.216 . . . . 0.0 111.713 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.93 -43.41 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.475 1.51 . . . . 0.0 111.868 172.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.96 -37.96 89.33 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.696 -0.628 . . . . 0.0 112.102 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -69.36 -31.93 70.67 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.407 -0.808 . . . . 0.0 112.762 173.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.88 76.65 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.457 -0.777 . . . . 0.0 112.334 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.6 mt -87.01 -12.61 46.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.199 1.0 . . . . 0.0 113.298 171.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.5 15.01 63.24 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.884 1.707 . . . . 0.0 114.309 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.38 132.45 55.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.405 1.103 . . . . 0.0 113.449 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -110.82 157.36 19.9 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.249 1.02 . . . . 0.0 113.04 169.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -145.65 170.76 15.83 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.667 2.787 . . . . 0.0 110.531 -163.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.6 m -85.28 124.22 31.65 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.623 -1.298 . . . . 0.0 109.787 -168.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.9 m -130.43 132.09 45.55 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.041 1.336 . . . . 0.0 111.393 -156.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.5 143.18 48.69 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -87.65 121.1 29.66 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.693 1.197 . . . . 0.0 109.965 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.0 m -67.22 -21.2 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.049 0.94 . . . . 0.0 113.137 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.9 mt -88.34 -25.08 22.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.095 1.358 . . . . 0.0 114.446 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.11 -33.3 22.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -164.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -148.21 149.78 33.1 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.881 1.272 . . . . 0.0 110.087 -172.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.86 -6.9 19.85 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.862 2.375 . . . . 0.0 114.543 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.68 -40.37 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.704 -1.248 . . . . 0.0 113.318 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.35 -47.2 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.275 -0.891 . . . . 0.0 110.939 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -59.31 -30.19 68.16 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.27 0.941 . . . . 0.0 113.354 171.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.0 m -69.98 -44.75 68.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -77.66 -40.36 41.91 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.22 -43.87 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -159.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -69.46 -35.49 75.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.733 0.778 . . . . 0.0 110.32 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -67.39 -43.92 80.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.242 1.817 . . . . 0.0 113.343 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.54 -36.23 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.991 0.917 . . . . 0.0 113.297 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.6 p -102.37 1.13 35.09 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 -173.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 62.45 -30.84 0.08 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.589 2.355 . . . . 0.0 115.965 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -151.93 138.29 11.75 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.183 1.393 . . . . 0.0 111.349 167.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.75 128.38 19.83 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.206 1.937 . . . . 0.0 112.759 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.6 m -139.94 140.87 36.46 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.322 -1.486 . . . . 0.0 110.419 157.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.8 mt -122.83 135.62 25.96 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.443 1.097 . . . . 0.0 110.929 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -82.33 165.61 71.76 Favored 'Cis proline' 0 CA--C 1.543 0.973 0 CA-C-N 119.934 1.012 . . . . 0.0 111.837 -10.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -143.19 159.73 41.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.028 1.331 . . . . 0.0 111.96 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.1 140.15 51.69 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.515 1.126 . . . . 0.0 113.881 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -129.76 143.93 51.05 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.18 1.792 . . . . 0.0 110.514 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 55.2 mt -132.95 128.14 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.544 1.137 . . . . 0.0 108.341 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt 47.32 49.59 15.39 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.023 1.729 . . . . 0.0 115.544 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.87 19.11 9.39 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -122.59 147.1 46.81 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.502 1.921 . . . . 0.0 110.564 176.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -85.44 126.25 33.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.145 0.974 . . . . 0.0 112.88 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.1 t -100.26 -46.02 11.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 125.1 1.36 . . . . 0.0 110.602 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 158.73 179.0 33.26 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 117.261 1.665 . . . . 0.0 117.261 165.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.35 171.31 55.17 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.054 1.312 . . . . 0.0 113.751 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.6 tp -46.74 -46.31 20.27 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.793 1.237 . . . . 0.0 114.04 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -69.9 -17.87 63.36 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.8 mm -84.06 -45.64 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.967 1.307 . . . . 0.0 109.882 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.3 t -60.47 -44.19 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.752 1.621 . . . . 0.0 111.778 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.7 p -64.82 -37.96 89.37 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.679 0.672 . . . . 0.0 111.97 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -63.13 -44.1 96.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.319 1.048 . . . . 0.0 111.549 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.7 mtt -66.89 -35.97 81.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.6 1.16 . . . . 0.0 112.356 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.89 -45.96 66.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.9 1.28 . . . . 0.0 112.029 176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -68.54 -19.94 64.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.983 1.313 . . . . 0.0 113.151 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.6 m -105.16 -8.07 18.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.511 1.524 . . . . 0.0 114.721 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.03 -1.11 76.29 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 119.587 1.085 . . . . 0.0 115.08 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -67.21 -34.07 76.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.597 1.198 . . . . 0.0 112.069 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.06 -39.49 86.19 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.798 1.285 . . . . 0.0 110.913 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -66.04 -31.33 72.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.81 2.044 . . . . 0.0 113.493 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.61 -48.82 80.18 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.63 1.104 . . . . 0.0 111.134 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -70.6 -41.21 72.62 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 pp -65.18 -37.34 87.05 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.649 0.659 . . . . 0.0 111.351 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -71.91 -34.76 69.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.52 -30.02 70.99 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 167.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -77.13 -2.68 35.56 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.44 6.82 64.01 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.751 1.643 . . . . 0.0 114.85 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.05 147.05 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.183 1.393 . . . . 0.0 111.327 -170.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 36.4 m -105.24 126.1 51.72 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.118 0.967 . . . . 0.0 110.627 170.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 17.0 p -112.08 167.97 9.97 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.8 1.64 . . . . 0.0 111.822 172.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.767 0 C-N-CA 123.99 0.916 . . . . 0.0 111.238 171.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.0 m . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 119.526 -0.273 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.5 pt -59.98 -33.47 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 122.973 0.509 . . . . 0.0 111.826 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -78.2 -34.8 49.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.3 1.84 . . . . 0.0 113.542 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -68.78 -38.24 79.87 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.596 1.158 . . . . 0.0 111.719 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -86.03 133.27 33.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.494 0.718 . . . . 0.0 111.323 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.52 -26.3 45.78 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.987 -1.07 . . . . 0.0 112.507 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.5 t -142.37 131.24 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.482 1.113 . . . . 0.0 110.974 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.6 t -133.13 135.59 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.277 1.431 . . . . 0.0 111.468 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.0 t -135.45 155.2 50.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.978 1.311 . . . . 0.0 111.496 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -127.53 140.41 52.15 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.962 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.41 159.7 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.872 1.669 . . . . 0.0 110.273 -163.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -75.28 105.17 6.16 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.466 0.706 . . . . 0.0 109.299 157.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.27 -158.61 32.96 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 119.056 0.844 . . . . 0.0 113.949 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -94.35 158.73 35.29 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.428 1.491 . . . . 0.0 111.205 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.0 -31.86 76.47 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 121.897 1.731 . . . . 0.0 112.663 168.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.0 -14.53 53.84 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.027 1.331 . . . . 0.0 113.925 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.42 72.45 11.84 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.23 1.412 . . . . 0.0 112.5 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.27 141.97 18.67 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.243 1.962 . . . . 0.0 112.064 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.1 mmt -90.53 1.68 56.48 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.127 2.171 . . . . 0.0 113.645 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.4 t -152.06 146.22 25.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.096 1.358 . . . . 0.0 111.777 -171.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.4 -39.76 81.56 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.24 -0.912 . . . . 0.0 112.553 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -64.08 -29.91 71.02 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.969 -1.082 . . . . 0.0 111.746 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 m -68.27 -46.35 70.65 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.348 0.659 . . . . 0.0 112.268 169.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -58.53 -42.35 87.6 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 118.926 0.784 . . . . 0.0 112.512 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -57.35 -31.09 65.39 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.034 0.934 . . . . 0.0 113.278 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 49.9 ttm -70.38 -42.93 71.1 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.996 0.816 . . . . 0.0 112.34 171.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 mm -69.17 -30.91 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.92 -1.112 . . . . 0.0 111.359 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.43 -33.63 75.18 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.6 1.16 . . . . 0.0 112.649 167.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.36 -40.7 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.734 0.814 . . . . 0.0 111.468 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.8 mt -63.36 -34.86 78.63 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.897 0.879 . . . . 0.0 111.915 170.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -67.83 -34.84 77.51 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.723 -1.236 . . . . 0.0 113.014 170.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.79 79.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.991 0.814 . . . . 0.0 111.835 176.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -82.76 -14.49 54.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.01 7.68 44.95 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.463 1.03 . . . . 0.0 114.698 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.18 132.4 54.92 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.574 1.55 . . . . 0.0 111.02 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -115.91 149.85 38.05 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.292 0.951 . . . . 0.0 112.511 168.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -123.7 172.66 8.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.067 1.747 . . . . 0.0 112.676 -167.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.2 m -85.38 121.64 28.38 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.314 -0.866 . . . . 0.0 110.043 -161.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.2 m -124.76 132.14 53.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.996 -153.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -125.67 142.79 51.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.28 1.032 . . . . 0.0 112.674 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -96.04 118.54 32.84 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.788 1.235 . . . . 0.0 111.973 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.31 -22.73 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.323 1.049 . . . . 0.0 113.485 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.3 mt -87.93 -22.25 24.45 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.27 -35.09 11.37 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -124.25 108.71 29.51 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.077 0.853 . . . . 0.0 111.434 -174.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -54.19 -20.15 18.51 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.427 3.418 . . . . 0.0 116.46 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.4 p -54.32 -32.57 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.909 -1.119 . . . . 0.0 113.233 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.4 t -70.09 -53.79 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.515 -0.741 . . . . 0.0 111.7 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -64.59 -25.73 68.1 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.743 0.817 . . . . 0.0 112.21 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.4 m -70.37 -50.76 35.54 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.02 0.928 . . . . 0.0 113.103 169.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -70.38 -37.44 74.53 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.74 1.154 . . . . 0.0 112.003 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.89 -35.2 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 120.761 -1.212 . . . . 0.0 112.563 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -62.32 -38.38 89.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.241 1.016 . . . . 0.0 111.285 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -49.08 26.36 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 175.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 56.5 t -83.95 -42.93 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -169.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.8 m -100.27 -2.41 33.82 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 63.26 -32.52 0.11 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 128.765 2.826 . . . . 0.0 115.495 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -144.89 136.0 12.46 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.058 2.143 . . . . 0.0 109.961 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.3 126.78 3.76 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.852 1.701 . . . . 0.0 112.478 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.3 m -130.21 121.05 25.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.969 1.708 . . . . 0.0 107.249 166.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.4 140.4 25.8 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.849 0.86 . . . . 0.0 109.361 -172.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.53 158.21 97.35 Favored 'Cis proline' 0 CA--C 1.541 0.856 0 CA-C-N 119.383 0.815 . . . . 0.0 113.496 -10.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -128.82 152.94 47.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.774 1.63 . . . . 0.0 110.616 173.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.61 139.99 51.99 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.367 1.467 . . . . 0.0 113.108 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -131.85 142.89 49.83 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.711 2.005 . . . . 0.0 109.826 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 53.2 mt -123.91 122.57 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.3 tptt 44.09 54.36 6.0 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.852 2.061 . . . . 0.0 113.783 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.93 24.39 13.49 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -126.62 143.71 51.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.678 1.191 . . . . 0.0 110.151 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -82.81 125.62 31.51 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.586 1.184 . . . . 0.0 113.26 -169.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.17 -47.36 11.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 125.105 1.362 . . . . 0.0 110.962 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.14 176.92 28.82 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 116.62 1.408 . . . . 0.0 116.62 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.45 172.59 55.13 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.472 1.034 . . . . 0.0 113.97 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -44.85 -47.02 11.07 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.107 1.763 . . . . 0.0 113.695 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.83 -29.76 70.97 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 119.053 -0.498 . . . . 0.0 112.328 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.9 mm -82.32 -47.73 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.31 1.444 . . . . 0.0 111.177 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.6 t -62.1 -36.12 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.093 1.357 . . . . 0.0 111.089 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.1 m -59.79 -42.12 92.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.497 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -66.49 -43.91 84.07 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.801 1.182 . . . . 0.0 111.132 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 50.5 mtt -61.09 -36.73 80.44 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.142 0.577 . . . . 0.0 111.923 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.48 -47.0 58.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.159 0.984 . . . . 0.0 112.714 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.52 -21.49 64.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.001 0.921 . . . . 0.0 113.434 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 64.4 m -105.27 -21.5 13.23 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.975 1.71 . . . . 0.0 114.02 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.15 9.2 62.33 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.664 -1.273 . . . . 0.0 115.668 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.33 -32.14 73.63 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.627 1.713 . . . . 0.0 111.694 173.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.31 -45.18 95.51 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.83 173.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.54 -41.86 98.44 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.189 0.995 . . . . 0.0 111.815 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -56.02 -45.02 79.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.824 0.85 . . . . 0.0 110.504 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.54 -51.44 28.66 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.35 -36.62 84.72 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.316 0.507 . . . . 0.0 111.717 -175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -68.34 -38.02 81.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.898 1.279 . . . . 0.0 111.878 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.47 -29.23 69.31 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.986 0.812 . . . . 0.0 111.749 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -79.7 6.27 11.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.067 1.747 . . . . 0.0 114.306 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.8 10.91 75.01 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.194 1.378 . . . . 0.0 114.421 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.1 mt -99.13 147.42 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.887 1.275 . . . . 0.0 109.572 -171.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 5.7 m -112.93 120.22 40.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.255 1.022 . . . . 0.0 111.305 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.2 p -112.41 167.37 10.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.852 1.261 . . . . 0.0 111.779 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 124.102 0.961 . . . . 0.0 110.035 166.09 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.1 pt -62.97 -36.85 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.768 0.827 . . . . 0.0 112.174 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -76.54 -32.46 58.24 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.226 1.41 . . . . 0.0 111.592 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.6 t -92.39 -28.34 16.95 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -170.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -86.25 147.68 25.98 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.256 -0.903 . . . . 0.0 111.427 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -72.4 -47.62 47.8 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.007 -1.058 . . . . 0.0 113.531 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.5 t -144.1 130.08 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.625 1.57 . . . . 0.0 110.196 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.76 134.89 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.588 1.155 . . . . 0.0 112.075 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -130.75 155.11 47.21 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.525 1.53 . . . . 0.0 111.29 172.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.46 143.06 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.708 0.803 . . . . 0.0 111.243 170.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mt -130.9 157.36 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.392 1.477 . . . . 0.0 109.655 -165.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -72.12 97.93 2.02 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 152.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.12 -148.38 19.15 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.518 -0.739 . . . . 0.0 114.906 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.98 157.38 63.74 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 125.999 1.72 . . . . 0.0 110.812 -174.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.1 -33.28 50.86 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 121.434 1.422 . . . . 0.0 114.637 -169.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -94.37 -0.38 54.93 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.25 68.1 15.3 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 126.258 1.823 . . . . 0.0 112.018 174.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.05 143.76 11.62 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.274 2.65 . . . . 0.0 112.261 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.3 mmt -91.15 1.42 57.1 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.977 1.311 . . . . 0.0 113.674 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.21 146.15 28.56 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.163 -0.96 . . . . 0.0 111.709 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.85 96.28 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.112 0.965 . . . . 0.0 113.154 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -63.47 -36.86 85.16 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.505 -1.372 . . . . 0.0 112.019 171.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.7 m -64.87 -36.32 83.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.564 -0.732 . . . . 0.0 112.488 173.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -62.83 -46.2 89.02 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 120.153 1.342 . . . . 0.0 111.784 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -64.72 -29.81 70.81 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.677 1.191 . . . . 0.0 113.831 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.3 tpt -57.49 -46.69 83.44 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.345 1.058 . . . . 0.0 112.356 167.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 mm -70.84 -34.42 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.396 -0.815 . . . . 0.0 111.309 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.17 -34.95 68.97 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.571 -0.705 . . . . 0.0 111.835 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.9 -41.89 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.618 1.167 . . . . 0.0 111.684 174.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 69.2 mt -65.28 -36.59 84.56 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.697 0.799 . . . . 0.0 112.882 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.94 -29.64 65.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.989 -1.069 . . . . 0.0 112.739 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.22 77.38 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.254 -0.904 . . . . 0.0 112.042 175.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.76 -11.58 33.47 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.41 1.084 . . . . 0.0 113.474 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.76 9.28 82.86 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.356 1.931 . . . . 0.0 115.989 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.18 136.8 52.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.602 1.201 . . . . 0.0 113.045 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -114.27 159.21 20.44 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 171.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -142.18 174.01 11.0 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.294 2.238 . . . . 0.0 110.943 -162.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.0 m -86.11 130.57 34.49 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.906 -1.121 . . . . 0.0 110.157 -165.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.8 p -120.6 147.47 45.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.855 1.262 . . . . 0.0 113.881 -164.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -133.42 143.51 48.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.806 1.242 . . . . 0.0 112.27 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -94.25 119.93 33.76 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.87 1.268 . . . . 0.0 110.429 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.74 -22.51 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.607 1.163 . . . . 0.0 113.434 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -81.39 -23.36 37.68 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.461 -0.775 . . . . 0.0 112.774 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.04 -33.21 19.62 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -144.29 126.91 8.48 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.428 1.091 . . . . 0.0 111.179 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.05 -18.23 45.93 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.93 2.42 . . . . 0.0 114.483 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -46.77 -35.61 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.415 1.086 . . . . 0.0 113.298 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.31 -45.86 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.201 -0.937 . . . . 0.0 111.603 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -75.25 -23.34 57.48 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.841 0.746 . . . . 0.0 112.995 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.2 m -70.54 -53.83 14.54 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.396 0.544 . . . . 0.0 111.844 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -72.78 -35.42 67.41 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.24 -0.913 . . . . 0.0 112.427 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.15 -44.96 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.772 1.169 . . . . 0.0 112.043 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -71.81 -43.74 65.1 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.085 0.857 . . . . 0.0 112.396 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.25 -33.96 77.02 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.292 -0.88 . . . . 0.0 112.882 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.9 t -82.1 -46.95 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.371 0.987 . . . . 0.0 113.363 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -106.56 7.96 31.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -171.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 63.61 -26.31 0.07 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.88 2.472 . . . . 0.0 116.184 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -148.83 148.51 27.82 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.811 2.044 . . . . 0.0 112.779 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.02 150.83 16.06 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.646 2.897 . . . . 0.0 113.466 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.9 p -134.3 132.81 40.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.338 1.855 . . . . 0.0 108.706 156.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.7 mm -127.83 117.89 20.95 Favored Pre-proline 0 N--CA 1.478 0.96 0 CA-C-N 119.717 1.144 . . . . 0.0 111.754 -171.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -81.99 172.7 50.85 Favored 'Cis proline' 0 CA--C 1.543 0.943 0 CA-C-N 120.06 1.057 . . . . 0.0 112.842 -5.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -153.24 174.38 14.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.5 1.52 . . . . 0.0 112.605 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.0 140.93 47.03 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -174.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -120.48 144.17 48.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.682 1.993 . . . . 0.0 110.412 168.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.1 mt -131.53 121.49 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.522 1.129 . . . . 0.0 109.103 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 45.98 52.03 10.31 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.698 1.599 . . . . 0.0 114.211 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.258 . . 56.25 26.99 11.09 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -115.69 137.99 51.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.426 1.09 . . . . 0.0 110.111 165.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -75.91 125.53 29.27 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.218 1.009 . . . . 0.0 111.774 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -101.16 -46.42 11.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.195 1.398 . . . . 0.0 111.011 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.55 171.32 25.24 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 116.4 1.32 . . . . 0.0 116.4 169.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.02 170.29 54.74 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.014 0.816 . . . . 0.0 112.904 167.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -47.22 -37.92 11.25 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.658 1.183 . . . . 0.0 113.854 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -57.19 -43.78 82.99 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.76 0.709 . . . . 0.0 111.911 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.3 mm -76.42 -46.79 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.426 1.49 . . . . 0.0 109.931 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.18 -38.23 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.366 1.066 . . . . 0.0 110.829 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 60.7 m -64.01 -43.09 96.7 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.595 0.758 . . . . 0.0 111.655 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -67.16 -38.7 85.92 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.107 0.867 . . . . 0.0 112.125 176.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 34.7 mtt -65.65 -40.35 92.38 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.208 1.403 . . . . 0.0 112.153 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.22 -41.69 76.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.119 0.968 . . . . 0.0 111.605 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.94 -29.55 66.71 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 m -105.58 -0.8 25.42 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.09 -2.93 84.29 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.741 1.162 . . . . 0.0 115.721 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -67.38 -32.8 73.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.717 1.258 . . . . 0.0 112.07 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.81 -46.39 88.17 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.485 -0.759 . . . . 0.0 110.948 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -59.47 -42.12 91.31 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.588 1.155 . . . . 0.0 112.665 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -62.44 -39.07 92.16 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.137 0.575 . . . . 0.0 112.012 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 49.0 mtm -69.93 -53.43 17.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.609 0.763 . . . . 0.0 112.823 174.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 pp -65.64 -37.79 87.55 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.288 0.494 . . . . 0.0 111.932 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -66.8 -39.45 87.75 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.692 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -65.25 -30.54 71.43 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.744 0.702 . . . . 0.0 112.319 174.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -2.83 28.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.723 2.009 . . . . 0.0 114.183 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.23 57.4 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.418 1.009 . . . . 0.0 114.311 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.2 mt -104.17 145.57 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 118.369 1.084 . . . . 0.0 110.895 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 38.3 m -89.91 148.53 23.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.196 1.398 . . . . 0.0 111.612 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.4 p -145.86 169.27 18.9 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 120.653 -1.279 . . . . 0.0 112.903 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 124.151 0.981 . . . . 0.0 111.438 166.368 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.188 0.042 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.0 p -69.31 -39.26 78.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.5 m 54.52 27.15 8.0 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.179 1.791 . . . . 0.0 115.126 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.92 10.77 65.36 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.696 1.141 . . . . 0.0 114.969 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.6 pt -136.18 172.72 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.485 1.914 . . . . 0.0 111.642 -170.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.94 -177.91 39.02 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 122.466 1.037 . . . . 0.0 114.613 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.49 -112.78 1.24 Allowed Glycine 0 N--CA 1.464 0.504 0 C-N-CA 125.772 1.653 . . . . 0.0 109.723 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.02 106.93 0.56 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 153.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.8 t -81.65 130.45 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.641 0.776 . . . . 0.0 108.92 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -56.14 99.52 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.11 1.364 . . . . 0.0 111.483 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -77.91 118.54 20.32 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.869 0.867 . . . . 0.0 110.969 -165.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 pt -111.97 155.76 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.33 1.052 . . . . 0.0 110.998 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -142.08 139.18 32.18 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.065 0.946 . . . . 0.0 110.298 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -83.33 116.64 22.54 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.7 m -143.87 144.27 31.67 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.039 1.736 . . . . 0.0 108.579 167.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -68.79 142.66 93.95 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-O 119.044 -0.503 . . . . 0.0 112.221 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.72 145.28 50.11 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.523 2.815 . . . . 0.0 115.319 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -107.33 -7.59 16.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.654 1.582 . . . . 0.0 112.701 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -146.21 159.49 43.25 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.954 1.702 . . . . 0.0 112.205 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -67.5 151.76 96.86 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.685 1.594 . . . . 0.0 113.257 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -75.99 150.19 33.72 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.379 2.719 . . . . 0.0 110.253 158.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -95.66 126.72 41.13 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.766 1.226 . . . . 0.0 111.763 -167.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 tp 53.31 -3.94 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 128.433 2.693 . . . . 0.0 117.412 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.6 t -141.17 116.6 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.825 2.05 . . . . 0.0 108.321 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.0 p -80.75 156.36 26.26 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.393 0.677 . . . . 0.0 112.755 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.0 149.31 46.18 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.607 1.163 . . . . 0.0 110.992 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.85 -27.56 13.56 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.659 1.184 . . . . 0.0 112.698 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.84 140.91 38.13 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.161 1.784 . . . . 0.0 110.059 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -116.07 152.11 34.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 111.788 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.96 -37.66 85.59 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -169.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.77 -38.24 64.76 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.879 0.871 . . . . 0.0 110.983 172.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -70.47 -38.14 74.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.521 1.528 . . . . 0.0 112.811 -172.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.5 tp -82.66 2.44 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.244 1.018 . . . . 0.0 112.977 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.35 -29.01 7.37 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.623 1.169 . . . . 0.0 113.653 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 53.1 ttp -136.93 124.23 21.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.303 2.241 . . . . 0.0 110.585 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 p -69.88 150.57 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 118.357 0.526 . . . . 0.0 111.371 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -59.31 134.76 57.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.16 1.384 . . . . 0.0 110.128 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -63.23 -29.87 71.12 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -169.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.29 -39.08 91.79 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.61 1.164 . . . . 0.0 112.594 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 50.5 mm -75.6 -36.44 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.909 0.884 . . . . 0.0 110.847 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.33 -39.86 92.1 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.452 1.101 . . . . 0.0 111.397 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.89 -33.3 65.95 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.505 -0.747 . . . . 0.0 111.841 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.9 m -65.89 -47.31 75.26 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.17 0.988 . . . . 0.0 111.553 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.1 pt -61.07 -33.25 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 120.976 -1.077 . . . . 0.0 112.515 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -77.75 -22.65 49.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.587 1.555 . . . . 0.0 114.648 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 t -85.66 -28.71 24.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.049 2.14 . . . . 0.0 112.78 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -87.35 145.5 26.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.377 1.071 . . . . 0.0 111.004 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -84.12 -28.9 27.16 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.32 -0.863 . . . . 0.0 111.39 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.9 t -143.83 134.85 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.087 0.955 . . . . 0.0 112.255 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.3 t -133.01 138.32 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.893 1.277 . . . . 0.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 t -134.14 154.1 51.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.651 0.78 . . . . 0.0 111.473 170.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.57 147.58 50.28 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.487 0.661 . . . . 0.0 111.969 172.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.3 mt -137.01 159.8 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.331 -157.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -68.17 96.46 0.64 Allowed 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.345 -0.847 . . . . 0.0 108.971 156.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.49 -150.51 22.62 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 121.942 0.745 . . . . 0.0 114.383 -172.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.03 154.05 55.47 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.588 1.955 . . . . 0.0 110.029 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.63 -13.95 38.35 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.955 2.437 . . . . 0.0 114.59 -170.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -88.89 -19.92 25.23 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.716 1.206 . . . . 0.0 112.778 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.94 69.35 13.18 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.204 1.801 . . . . 0.0 111.021 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.39 148.97 74.72 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.66 2.24 . . . . 0.0 111.449 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.7 mmt -106.61 0.29 24.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.806 1.243 . . . . 0.0 113.781 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.7 t -141.84 147.0 36.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.499 1.52 . . . . 0.0 110.435 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.87 -47.01 86.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.831 0.852 . . . . 0.0 111.246 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -66.3 -33.35 75.53 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.998 -1.064 . . . . 0.0 111.548 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 m -62.26 -41.5 98.51 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.742 0.817 . . . . 0.0 113.111 170.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -62.82 -46.93 85.64 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.191 0.905 . . . . 0.0 111.466 171.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -56.97 -37.27 71.35 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.43 1.092 . . . . 0.0 111.993 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.5 tpp -59.34 -46.01 89.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.775 0.83 . . . . 0.0 112.923 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 mm -67.72 -33.13 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.981 1.264 . . . . 0.0 111.326 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.29 -32.83 73.26 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.911 0.884 . . . . 0.0 112.586 170.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.7 -37.25 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 125.628 1.571 . . . . 0.0 111.573 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.6 mt -63.77 -35.44 80.59 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.725 -1.234 . . . . 0.0 111.831 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -71.9 -31.23 66.2 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.816 -1.177 . . . . 0.0 111.998 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.26 -32.2 73.74 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.587 -1.321 . . . . 0.0 111.901 173.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.6 tp -86.07 -12.5 49.99 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.606 1.963 . . . . 0.0 112.716 171.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.82 4.23 13.49 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.854 1.693 . . . . 0.0 114.887 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.83 129.92 55.98 Favored 'General case' 0 C--N 1.335 -0.037 0 C-N-CA 124.599 1.16 . . . . 0.0 109.732 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -110.93 148.35 32.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.113 0.958 . . . . 0.0 110.645 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -120.65 172.64 7.72 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.236 1.815 . . . . 0.0 110.507 -169.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 93.0 m -86.71 122.52 30.72 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -163.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.5 p -113.27 144.63 42.4 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -159.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -137.09 147.87 46.36 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.505 1.122 . . . . 0.0 112.318 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.02 123.45 34.49 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.24 1.416 . . . . 0.0 110.464 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.6 m -67.78 -20.98 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -88.09 -24.19 23.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.938 1.295 . . . . 0.0 113.371 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.47 -35.34 17.08 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -139.11 120.07 9.78 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.357 0.663 . . . . 0.0 110.987 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.85 -13.15 36.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.853 2.369 . . . . 0.0 115.005 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.29 -36.0 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.603 0.761 . . . . 0.0 112.338 169.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.23 -51.45 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.887 0.875 . . . . 0.0 111.171 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.0 ptt-85 -69.32 -26.04 64.52 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.1 m -70.84 -49.31 47.54 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.069 0.948 . . . . 0.0 113.018 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -62.47 -48.55 79.12 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.736 -0.603 . . . . 0.0 111.377 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.1 p -61.0 -39.27 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 121.97 -0.456 . . . . 0.0 112.147 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -63.66 -44.77 92.82 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.226 1.41 . . . . 0.0 111.923 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -72.38 -36.51 68.74 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.276 3.0 t -87.27 -31.95 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.1 p -99.02 -5.66 29.99 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 64.48 -59.27 0.22 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.825 2.45 . . . . 0.0 114.635 -167.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -121.44 106.38 37.92 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.193 1.397 . . . . 0.0 109.908 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.32 136.1 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.305 2.67 . . . . 0.0 113.693 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.5 m -134.21 112.91 11.47 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.168 1.787 . . . . 0.0 109.235 171.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.6 pt -100.59 149.27 35.99 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.68 152.49 96.46 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 119.696 0.927 . . . . 0.0 112.785 2.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -141.41 146.57 36.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.335 0.654 . . . . 0.0 111.156 -166.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.11 140.52 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.876 1.27 . . . . 0.0 113.188 -164.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -133.24 140.68 47.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.987 2.115 . . . . 0.0 109.783 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.4 mt -130.31 132.42 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.155 0.982 . . . . 0.0 108.362 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . 0.292 26.8 mtpp 46.15 51.41 11.16 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.699 2.0 . . . . 0.0 114.47 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 56.98 24.12 9.11 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.492 2.317 . . . . 0.0 115.636 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -128.91 143.75 50.98 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.879 1.672 . . . . 0.0 110.861 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -79.26 124.29 28.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.0 t -101.96 -53.37 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.236 1.815 . . . . 0.0 112.51 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 165.68 169.96 29.98 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 117.973 1.949 . . . . 0.0 117.973 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.65 170.97 55.02 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.607 1.099 . . . . 0.0 112.397 162.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.2 tp -48.48 -41.68 30.52 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.491 1.116 . . . . 0.0 113.71 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.4 -31.71 69.51 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.996 0.816 . . . . 0.0 112.304 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.72 -47.3 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.695 1.598 . . . . 0.0 110.086 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.9 t -54.43 -38.04 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.188 1.395 . . . . 0.0 110.535 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 85.9 m -58.96 -46.56 87.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.63 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -62.88 -43.71 98.06 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 120.207 1.367 . . . . 0.0 110.656 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 59.5 mtt -65.24 -42.34 93.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.787 0.835 . . . . 0.0 112.039 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -44.24 71.52 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.213 1.805 . . . . 0.0 111.594 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.74 -15.53 63.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.729 1.611 . . . . 0.0 113.533 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.1 m -106.16 -6.32 18.65 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.36 3.9 54.9 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 120.216 1.371 . . . . 0.0 114.247 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -69.32 -34.2 74.29 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.348 -1.089 . . . . 0.0 111.702 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.37 -45.68 92.67 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.146 0.978 . . . . 0.0 110.138 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -31.09 69.07 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.096 1.758 . . . . 0.0 114.539 176.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -59.62 -46.94 87.47 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.791 1.178 . . . . 0.0 111.712 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -68.87 -43.41 75.42 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.66 -35.73 80.87 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.662 -0.648 . . . . 0.0 112.193 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -68.62 -35.18 76.97 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.234 -0.916 . . . . 0.0 112.338 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.5 -26.94 68.65 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.78 0.718 . . . . 0.0 112.225 171.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.77 4.34 25.63 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.853 1.661 . . . . 0.0 113.586 170.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.41 16.44 71.31 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.073 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.7 mt -101.86 145.15 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 118.808 1.304 . . . . 0.0 111.068 -171.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 97.4 m -103.28 123.21 46.35 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.916 1.286 . . . . 0.0 110.941 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.7 p -108.92 166.83 10.53 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.015 1.726 . . . . 0.0 112.572 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -65.31 133.77 52.13 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 153.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -126.46 141.92 51.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.928 0.891 . . . . 0.0 111.545 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.69 1.996 . . . . 0.0 110.157 -178.692 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 p . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.9 p -94.36 -3.4 50.4 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.948 1.699 . . . . 0.0 115.568 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.7 p -61.13 159.54 11.72 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.999 -1.063 . . . . 0.0 112.377 167.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.64 -9.95 3.21 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-O 118.671 -1.072 . . . . 0.0 115.482 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.77 121.34 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.289 1.544 . . . . 0.0 109.315 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.05 155.2 50.48 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -173.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.46 23.61 3.72 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.968 2.223 . . . . 0.0 113.346 -169.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -66.59 134.2 51.86 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.558 1.143 . . . . 0.0 113.694 -169.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.6 m -119.45 147.68 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.888 1.675 . . . . 0.0 110.256 168.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -135.39 164.21 28.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.926 1.29 . . . . 0.0 113.467 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.28 110.49 11.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.661 1.584 . . . . 0.0 110.851 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.5 pt -140.83 27.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 126.029 1.732 . . . . 0.0 112.491 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -83.82 139.71 32.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.391 1.876 . . . . 0.0 110.978 -171.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 pm0 -74.45 155.82 37.61 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.279 -0.888 . . . . 0.0 113.272 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.4 p -130.98 -16.73 3.19 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -172.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -75.05 138.01 72.59 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-N 120.637 1.562 . . . . 0.0 112.663 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.63 -179.68 4.75 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.603 3.535 . . . . 0.0 113.455 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -83.54 -14.44 52.23 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.773 -1.205 . . . . 0.0 113.164 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -85.01 136.72 33.47 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.436 1.495 . . . . 0.0 111.372 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -104.17 147.16 33.89 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -159.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.16 155.25 42.17 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.772 2.981 . . . . 0.0 111.844 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -73.16 125.74 28.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.932 1.293 . . . . 0.0 110.66 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 mt -147.64 156.63 42.98 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.237 1.415 . . . . 0.0 111.884 174.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.5 t -68.47 -57.38 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.993 0.917 . . . . 0.0 110.705 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.8 m -141.59 129.56 21.93 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.164 0.986 . . . . 0.0 110.954 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.05 162.28 35.61 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.402 1.081 . . . . 0.0 112.158 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -156.66 -19.79 0.1 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.1 tp -141.78 139.31 32.75 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.944 1.247 . . . . 0.0 113.642 -167.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.23 129.4 16.61 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.495 1.518 . . . . 0.0 112.087 -175.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -67.23 -25.53 66.14 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.988 1.715 . . . . 0.0 113.643 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -74.0 -45.31 50.67 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.0 -1.063 . . . . 0.0 111.924 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.24 -26.0 65.47 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 120.718 -1.238 . . . . 0.0 113.27 -177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.8 pt -84.93 -3.86 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 170.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.61 -22.84 12.36 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.233 1.413 . . . . 0.0 113.561 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.9 mtt -49.96 122.49 6.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.975 1.31 . . . . 0.0 110.671 168.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.9 131.08 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.478 1.111 . . . . 0.0 113.141 -175.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -111.32 128.74 56.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.631 1.972 . . . . 0.0 109.04 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -60.27 -29.12 68.6 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.7 0.8 . . . . 0.0 113.074 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -58.79 -27.84 65.4 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.0 mm -78.14 -43.61 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.427 -0.796 . . . . 0.0 111.029 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.68 -40.81 96.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.569 1.147 . . . . 0.0 111.614 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -61.45 -35.48 77.72 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.821 1.248 . . . . 0.0 112.623 170.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 78.9 m -73.54 -45.93 50.65 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.482 1.037 . . . . 0.0 111.91 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 pt -58.46 -36.12 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 120.111 1.323 . . . . 0.0 111.904 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -75.08 -39.9 60.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.069 1.348 . . . . 0.0 112.952 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.3 t -72.13 -34.57 68.65 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.858 1.263 . . . . 0.0 113.954 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -85.22 143.95 28.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.209 -0.932 . . . . 0.0 111.637 -174.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -84.1 -40.46 18.25 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.199 -0.938 . . . . 0.0 111.776 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.51 129.84 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.825 1.65 . . . . 0.0 110.211 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.5 t -134.02 133.45 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.436 1.094 . . . . 0.0 111.594 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.1 t -135.41 156.26 49.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.156 1.382 . . . . 0.0 111.113 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -135.0 137.89 43.45 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.828 0.851 . . . . 0.0 110.637 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.93 160.35 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.464 1.506 . . . . 0.0 109.703 -160.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -69.72 99.15 1.29 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.3 -0.875 . . . . 0.0 108.784 158.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.38 -144.1 21.35 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 118.236 0.471 . . . . 0.0 114.114 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -124.02 158.45 60.34 Favored Pre-proline 0 N--CA 1.473 0.704 0 C-N-CA 125.714 1.605 . . . . 0.0 112.258 -171.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.62 -16.44 53.62 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.179 2.586 . . . . 0.0 114.815 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -95.18 -19.17 20.29 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.601 1.56 . . . . 0.0 113.297 168.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.65 71.64 15.46 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.627 1.571 . . . . 0.0 113.393 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.27 156.51 29.45 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.07 3.18 . . . . 0.0 113.312 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 79.2 mtp -124.24 8.31 8.51 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.332 1.453 . . . . 0.0 114.138 -170.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 22.5 t -150.63 146.78 26.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.805 1.642 . . . . 0.0 110.673 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.56 95.1 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.87 -35.1 74.42 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.55 -0.719 . . . . 0.0 111.921 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.2 m -61.85 -44.78 96.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.931 0.892 . . . . 0.0 111.579 171.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 tmpt? -64.39 -40.82 96.55 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.028 0.931 . . . . 0.0 111.755 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -63.35 -35.91 81.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.5 ttp -58.51 -38.23 77.25 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.215 0.916 . . . . 0.0 111.933 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 mm -61.69 -36.26 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.506 0.594 . . . . 0.0 111.703 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -70.2 -33.81 72.16 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.727 1.611 . . . . 0.0 113.489 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.74 -39.19 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.589 0.756 . . . . 0.0 110.522 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.1 mt -66.34 -37.99 86.61 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -61.77 -29.16 69.95 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.792 1.237 . . . . 0.0 112.198 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.88 65.99 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.217 -0.927 . . . . 0.0 113.365 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.93 -12.67 20.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.987 1.315 . . . . 0.0 113.889 170.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.86 19.35 67.45 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.278 0.942 . . . . 0.0 114.121 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.7 mt -111.72 136.54 50.84 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.289 1.835 . . . . 0.0 111.518 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -117.22 145.52 43.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.874 1.321 . . . . 0.0 113.374 165.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -119.12 173.55 6.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.914 2.086 . . . . 0.0 111.211 -169.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.3 m -84.36 119.23 24.86 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.91 -1.119 . . . . 0.0 109.394 -160.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.4 m -125.05 130.66 52.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.103 -153.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -129.01 156.57 43.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.523 1.529 . . . . 0.0 113.007 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -95.11 104.14 16.01 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.107 1.363 . . . . 0.0 112.198 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.9 p -74.57 -11.11 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.6 tp -81.14 -28.53 35.05 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.027 -1.046 . . . . 0.0 110.718 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.75 -36.92 19.85 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -117.53 105.65 47.82 Favored Pre-proline 0 N--CA 1.476 0.871 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -167.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.86 -28.76 40.26 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.544 3.496 . . . . 0.0 115.256 168.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -56.51 -43.59 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.222 0.919 . . . . 0.0 112.283 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.27 -47.62 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -48.97 -54.85 13.85 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.188 0.995 . . . . 0.0 111.554 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.4 m -61.81 -44.74 96.26 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -170.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -70.5 -46.64 63.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.207 0.527 . . . . 0.0 110.545 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.37 -41.92 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.895 0.878 . . . . 0.0 112.22 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -67.63 -42.67 81.95 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -41.56 97.75 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.134 0.974 . . . . 0.0 113.157 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.34 -36.15 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 89.6 p -102.15 -4.92 25.07 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 62.89 -46.88 0.2 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 128.914 2.886 . . . . 0.0 115.73 -173.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -142.12 101.31 5.78 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 125.57 1.548 . . . . 0.0 111.055 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -86.52 148.37 8.7 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.924 2.416 . . . . 0.0 114.098 -171.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 87.5 m -100.13 149.91 23.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.379 1.872 . . . . 0.0 109.317 164.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 81.3 mt -119.54 113.86 34.71 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.727 0.811 . . . . 0.0 109.162 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -77.03 164.25 87.66 Favored 'Cis proline' 0 CA--C 1.544 1.013 0 CA-C-N 120.103 1.073 . . . . 0.0 114.241 -7.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -146.08 172.32 13.59 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.932 1.293 . . . . 0.0 111.815 166.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.34 142.05 49.18 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -165.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -122.72 142.41 50.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.626 1.97 . . . . 0.0 111.326 173.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 74.5 mt -134.18 134.89 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.273 1.429 . . . . 0.0 108.953 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp 49.9 42.85 24.83 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.359 1.464 . . . . 0.0 112.885 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.53 18.87 2.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.918 2.087 . . . . 0.0 116.213 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.07 148.61 38.69 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.491 1.516 . . . . 0.0 111.636 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -79.93 126.57 31.19 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.196 0.998 . . . . 0.0 112.032 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.0 -39.38 6.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.918 1.287 . . . . 0.0 111.357 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.98 -179.31 21.42 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 172.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.27 171.34 52.85 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.776 1.179 . . . . 0.0 113.107 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 pp -57.39 -29.46 64.1 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -70.26 -28.82 65.54 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.029 -1.044 . . . . 0.0 111.922 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.4 mm -74.33 -45.46 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.588 1.155 . . . . 0.0 109.596 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.7 t -57.17 -46.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.049 0.94 . . . . 0.0 110.79 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.6 m -60.31 -43.87 95.95 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.844 0.858 . . . . 0.0 110.825 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -61.25 -47.35 86.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.255 1.022 . . . . 0.0 112.509 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 22.1 mmt -65.63 -39.74 91.8 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.7 1.136 . . . . 0.0 111.818 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.61 -47.46 78.54 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.228 1.411 . . . . 0.0 111.197 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.39 -22.58 60.22 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.264 1.026 . . . . 0.0 112.664 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.0 t -81.09 -20.56 41.24 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.894 1.677 . . . . 0.0 113.419 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.16 -2.5 86.89 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 121.135 -0.978 . . . . 0.0 113.911 -171.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -70.72 -32.71 70.0 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.648 -0.913 . . . . 0.0 111.729 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -44.07 97.72 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.075 -1.016 . . . . 0.0 111.004 173.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -60.31 -33.67 72.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.954 1.302 . . . . 0.0 113.51 172.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -63.2 -47.3 83.15 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.66 0.664 . . . . 0.0 111.269 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.9 mtm -68.37 -43.97 76.22 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.5 pp -65.48 -35.46 80.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.746 0.703 . . . . 0.0 112.177 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -70.5 -30.22 66.95 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.473 -0.767 . . . . 0.0 112.717 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.91 -32.78 74.27 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.419 -0.8 . . . . 0.0 111.201 171.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -1.03 27.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.993 1.717 . . . . 0.0 113.283 169.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.81 2.23 84.45 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.038 2.256 . . . . 0.0 115.462 175.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.9 mt -81.54 144.21 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 119.132 1.466 . . . . 0.0 112.671 -158.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.3 m -83.47 123.15 29.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.135 1.374 . . . . 0.0 112.181 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 5.6 p -133.44 165.69 24.28 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.138 1.775 . . . . 0.0 112.882 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -73.21 159.12 33.96 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.848 1.659 . . . . 0.0 113.547 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -80.36 145.04 32.25 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.124 1.77 . . . . 0.0 113.494 170.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.252 1.219 0 C-N-CA 126.55 1.94 . . . . 0.0 113.269 178.712 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.7 m -65.39 -32.81 74.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.806 0.843 . . . . 0.0 112.776 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.5 p -118.89 5.4 11.43 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.61 1.964 . . . . 0.0 114.888 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.21 11.86 83.85 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.487 1.041 . . . . 0.0 115.598 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 pt -60.07 157.85 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.112 1.765 . . . . 0.0 113.152 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.14 151.42 50.02 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.414 -0.803 . . . . 0.0 113.523 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.78 -149.66 36.77 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 123.628 0.632 . . . . 0.0 113.729 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -145.55 144.83 30.74 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.875 1.67 . . . . 0.0 111.426 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.59 151.67 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.435 1.094 . . . . 0.0 112.717 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -65.64 158.25 27.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.047 2.539 . . . . 0.0 114.468 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -132.79 88.86 2.56 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.366 1.466 . . . . 0.0 111.414 167.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.16 143.38 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.683 1.193 . . . . 0.0 111.669 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -150.57 128.88 12.03 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.241 1.016 . . . . 0.0 110.087 168.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -128.82 131.17 47.72 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.954 2.102 . . . . 0.0 110.223 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.7 m -80.19 53.5 1.77 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.453 1.501 . . . . 0.0 111.578 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -79.41 156.75 75.79 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.707 1.603 . . . . 0.0 113.429 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.42 133.35 14.43 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.498 2.799 . . . . 0.0 111.627 166.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -100.02 -7.07 25.48 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -81.66 146.66 29.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.701 1.2 . . . . 0.0 113.338 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -76.07 145.45 77.16 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.864 1.266 . . . . 0.0 112.129 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -65.31 145.29 83.2 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.287 2.658 . . . . 0.0 111.095 167.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -124.84 143.09 51.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.495 1.518 . . . . 0.0 112.336 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp 64.51 -42.52 0.29 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 129.355 3.062 . . . . 0.0 115.957 -172.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 m -148.98 147.22 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.954 1.702 . . . . 0.0 111.82 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.6 p -70.83 159.48 34.51 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.552 1.541 . . . . 0.0 113.55 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.49 -171.6 3.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.092 1.357 . . . . 0.0 113.119 -171.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.74 166.76 12.48 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.986 -1.071 . . . . 0.0 111.984 166.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.12 151.83 30.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.89 146.99 37.3 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.294 1.438 . . . . 0.0 111.676 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -63.68 -33.14 74.98 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -173.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.58 -33.54 68.28 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.478 1.035 . . . . 0.0 111.721 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -74.7 -25.98 59.52 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.0 pt -106.68 -14.52 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.458 1.503 . . . . 0.0 114.868 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.62 13.59 8.34 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.352 1.461 . . . . 0.0 114.204 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 49.1 tpp -119.21 148.21 43.37 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.082 2.153 . . . . 0.0 111.625 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -137.47 106.99 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.923 1.289 . . . . 0.0 108.767 159.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -78.82 156.9 28.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -59.13 -34.12 71.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.217 1.807 . . . . 0.0 114.933 -164.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -69.27 -29.92 67.92 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.091 1.314 . . . . 0.0 113.023 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.6 mp -75.84 -50.74 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.794 0.837 . . . . 0.0 108.869 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.65 -39.56 73.91 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.403 1.481 . . . . 0.0 111.183 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.54 -30.74 64.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.0 m -72.54 -48.56 39.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.706 0.802 . . . . 0.0 110.312 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -65.26 -30.47 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.781 1.232 . . . . 0.0 112.081 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -37.83 73.39 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.434 1.493 . . . . 0.0 112.895 170.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.4 t -73.33 -31.07 63.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.047 0.939 . . . . 0.0 113.13 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.15 146.49 25.01 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -76.76 -40.8 47.13 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.63 -1.294 . . . . 0.0 113.83 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.7 t -145.87 135.68 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.944 1.298 . . . . 0.0 110.076 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.16 132.23 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.876 0.871 . . . . 0.0 111.599 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -133.84 155.53 49.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.115 1.366 . . . . 0.0 111.317 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -129.7 137.31 50.53 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.876 0.87 . . . . 0.0 110.787 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.18 156.3 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.063 1.345 . . . . 0.0 110.408 -161.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -70.07 102.17 1.98 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 158.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.81 -147.28 27.7 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 118.748 0.704 . . . . 0.0 113.418 -172.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -126.75 157.45 71.3 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.344 1.857 . . . . 0.0 110.925 -172.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.21 -23.57 75.52 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.026 2.484 . . . . 0.0 114.388 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -76.67 -24.24 53.24 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 171.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -148.96 68.83 9.75 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 126.06 1.744 . . . . 0.0 111.887 -175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.0 142.23 42.02 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.504 2.136 . . . . 0.0 111.744 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.5 mtt -101.28 3.87 41.18 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.544 1.538 . . . . 0.0 113.434 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.8 t -145.32 146.08 31.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.282 1.433 . . . . 0.0 111.177 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.37 -44.77 88.98 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.523 0.729 . . . . 0.0 112.265 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -61.53 -36.89 81.84 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.34 -0.85 . . . . 0.0 111.909 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 m -66.57 -37.84 85.8 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.513 0.725 . . . . 0.0 112.646 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -66.46 -44.02 83.91 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.261 1.024 . . . . 0.0 112.881 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -60.94 -35.24 76.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.228 0.611 . . . . 0.0 112.225 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.1 tpp -55.67 -44.44 77.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.182 0.593 . . . . 0.0 112.265 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.72 -32.13 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 121.257 -0.902 . . . . 0.0 111.607 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -34.33 76.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.67 1.188 . . . . 0.0 112.712 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 t -69.23 -41.86 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.907 1.683 . . . . 0.0 111.767 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.8 mt -64.64 -36.32 83.87 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.432 -0.792 . . . . 0.0 112.59 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.74 -36.96 85.06 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.717 -1.239 . . . . 0.0 111.569 171.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.74 -26.34 65.19 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.2 tp -87.8 -14.07 40.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.956 0.903 . . . . 0.0 112.702 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.75 7.38 35.02 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.282 1.896 . . . . 0.0 114.876 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.1 mt -110.99 133.44 53.39 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.641 1.176 . . . . 0.0 111.218 172.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -112.61 159.6 18.7 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.592 1.187 . . . . 0.0 111.408 160.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -136.59 175.7 9.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.835 2.054 . . . . 0.0 110.506 -157.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.0 m -86.42 122.14 29.97 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.943 -1.098 . . . . 0.0 108.622 -175.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.2 p -119.79 147.61 44.43 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.089 1.355 . . . . 0.0 112.865 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -133.77 143.37 48.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.196 0.998 . . . . 0.0 113.064 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -85.67 102.22 13.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.035 1.334 . . . . 0.0 111.818 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.6 p -71.21 -17.15 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.787 1.235 . . . . 0.0 113.683 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -83.76 -29.39 27.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.661 0.784 . . . . 0.0 111.15 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.2 -32.05 13.86 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -128.04 117.49 20.58 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 119.582 1.083 . . . . 0.0 113.509 -165.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.25 -16.82 44.63 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.814 2.343 . . . . 0.0 114.364 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 p -53.31 -42.49 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.055 1.298 . . . . 0.0 111.756 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.62 -52.55 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.779 0.832 . . . . 0.0 110.343 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -52.06 -47.14 65.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.884 0.874 . . . . 0.0 111.442 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.6 m -66.12 -44.48 84.15 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.305 0.642 . . . . 0.0 112.558 -173.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -70.98 -40.46 71.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.369 0.667 . . . . 0.0 110.58 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 t -59.65 -36.35 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.246 1.018 . . . . 0.0 111.725 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -43.4 90.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.954 0.343 . . . . 0.0 111.418 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -65.34 -47.73 75.48 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.447 1.099 . . . . 0.0 112.467 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 52.7 t -82.26 -44.21 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -172.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m -100.53 -10.06 21.42 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 68.2 -54.32 0.52 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.807 2.043 . . . . 0.0 112.949 -168.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -137.67 147.04 55.63 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.276 1.43 . . . . 0.0 112.489 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -89.63 142.47 4.14 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.348 2.698 . . . . 0.0 115.025 -171.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 m -129.91 131.91 46.19 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.876 2.07 . . . . 0.0 107.402 156.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.5 pt -128.72 135.38 27.51 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.35 156.12 99.81 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 CA-C-N 119.438 0.835 . . . . 0.0 113.053 -5.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.24 158.16 39.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.302 1.441 . . . . 0.0 111.599 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.59 141.17 49.61 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -129.36 144.17 51.13 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.19 2.196 . . . . 0.0 109.887 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.0 mt -124.63 121.99 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.916 0.886 . . . . 0.0 108.667 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.0 tttp 44.3 51.79 7.43 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.27 1.828 . . . . 0.0 113.48 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.89 14.52 6.39 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.73 138.19 39.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.708 1.603 . . . . 0.0 110.197 168.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -83.45 123.85 30.11 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 121.351 -0.843 . . . . 0.0 112.886 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -105.37 -39.95 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.865 1.666 . . . . 0.0 112.993 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 144.75 175.31 17.79 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.644 1.418 . . . . 0.0 116.644 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.04 168.79 54.85 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.182 1.372 . . . . 0.0 113.365 166.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.2 tp -45.86 -41.39 11.16 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -71.0 -27.37 63.64 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.156 0.983 . . . . 0.0 112.212 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.9 mm -79.54 -45.38 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.049 1.34 . . . . 0.0 109.923 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.0 t -62.51 -44.8 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.433 1.093 . . . . 0.0 110.56 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 65.3 m -60.15 -48.25 82.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.791 0.836 . . . . 0.0 110.857 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -55.8 -50.21 71.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.455 1.502 . . . . 0.0 111.6 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.7 mmt -70.87 -33.03 70.2 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.364 1.065 . . . . 0.0 112.762 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.74 -46.56 65.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.845 1.658 . . . . 0.0 111.167 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.24 -26.0 67.16 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.393 1.077 . . . . 0.0 112.341 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.8 t -87.92 -15.81 35.6 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.638 1.975 . . . . 0.0 114.674 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.1 -11.02 59.09 Favored Glycine 0 CA--C 1.54 1.652 0 C-N-CA 124.541 1.067 . . . . 0.0 114.493 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.97 -29.35 69.72 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.574 1.55 . . . . 0.0 112.298 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.39 -46.58 89.58 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.722 -1.236 . . . . 0.0 111.106 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -59.6 -41.31 90.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.388 1.475 . . . . 0.0 111.502 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -58.93 -44.3 91.33 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.202 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 58.7 mtm -69.04 -46.59 67.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.048 0.84 . . . . 0.0 112.001 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -41.78 84.16 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -67.81 -34.52 76.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.94 0.896 . . . . 0.0 112.59 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -59.68 -26.18 65.35 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.244 1.017 . . . . 0.0 112.341 172.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -92.03 6.99 44.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.927 1.691 . . . . 0.0 114.312 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.67 9.37 75.09 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 124.411 1.005 . . . . 0.0 114.3 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.9 mt -94.48 142.56 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.87 0.868 . . . . 0.0 109.176 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 28.5 m -114.87 124.86 52.79 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.184 0.994 . . . . 0.0 112.369 -172.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -129.86 173.91 10.23 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.918 2.087 . . . . 0.0 112.946 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.91 158.4 1.41 Allowed 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.654 -1.279 . . . . 0.0 111.939 160.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.25 145.79 29.83 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.25 0.62 . . . . 0.0 110.258 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 74.4 mt . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.691 1.197 . . . . 0.0 111.781 -174.451 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 p -89.1 -13.46 38.49 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 95.0 p -126.78 -12.77 5.94 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.63 -6.8 36.71 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.362 0.982 . . . . 0.0 114.431 -168.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.06 137.66 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.162 1.385 . . . . 0.0 108.883 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.92 125.73 7.46 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 121.586 -0.696 . . . . 0.0 111.658 171.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.73 -30.8 61.23 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 117.616 0.708 . . . . 0.0 112.318 170.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.93 157.68 46.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.858 1.663 . . . . 0.0 112.381 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.58 138.25 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.691 1.597 . . . . 0.0 109.504 171.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -75.91 119.54 20.02 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.535 1.134 . . . . 0.0 111.895 -174.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -144.38 88.87 1.96 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.675 1.59 . . . . 0.0 108.745 166.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.4 tt -136.44 101.04 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.137 1.375 . . . . 0.0 109.079 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -137.45 140.64 41.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.093 0.957 . . . . 0.0 111.73 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.52 156.87 45.18 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.623 1.169 . . . . 0.0 113.1 -172.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.8 m -140.48 -28.57 0.71 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -146.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -84.75 163.82 44.91 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.108 1.363 . . . . 0.0 113.433 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.7 179.09 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.634 3.556 . . . . 0.0 114.142 161.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -79.03 -5.3 53.62 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -168.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -137.16 131.49 32.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.319 1.448 . . . . 0.0 112.914 -169.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -105.82 151.78 40.04 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 126.076 1.75 . . . . 0.0 111.048 167.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.65 153.61 34.26 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 124.017 3.145 . . . . 0.0 116.398 -165.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -89.04 145.21 25.62 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.117 2.967 . . . . 0.0 112.801 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.1 tp 61.86 -22.54 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 129.343 3.057 . . . . 0.0 118.108 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.8 128.59 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.796 1.238 . . . . 0.0 110.428 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.9 p -141.95 155.58 45.47 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.129 0.972 . . . . 0.0 113.126 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.3 -22.56 10.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.084 1.354 . . . . 0.0 113.643 -175.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -144.56 161.53 38.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.483 1.513 . . . . 0.0 111.336 -174.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.69 111.9 23.01 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 160.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.92 141.47 58.76 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -164.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -52.34 -35.07 50.03 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.059 0.943 . . . . 0.0 112.984 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.57 -33.23 64.57 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.417 1.487 . . . . 0.0 113.309 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -73.59 -28.17 61.69 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.163 -0.96 . . . . 0.0 112.306 170.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.4 mm -80.49 -32.04 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.43 0.692 . . . . 0.0 112.014 173.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.35 -34.79 28.32 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.404 1.002 . . . . 0.0 112.756 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 39.0 tpp -74.18 143.67 45.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.663 0.665 . . . . 0.0 112.09 -174.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.2 m -125.2 141.85 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.574 1.15 . . . . 0.0 112.129 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -66.01 109.35 2.52 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 164.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -52.75 -44.9 66.79 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.274 1.43 . . . . 0.0 112.107 -171.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.44 -28.49 59.35 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.6 mm -76.54 -42.06 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.356 -0.84 . . . . 0.0 110.112 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.51 -39.22 90.19 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.483 1.113 . . . . 0.0 111.461 169.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.2 -29.38 69.03 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 120.755 -1.215 . . . . 0.0 112.094 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.5 m -73.06 -41.96 63.58 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.216 -0.927 . . . . 0.0 111.709 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.8 pt -62.02 -35.1 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.955 1.252 . . . . 0.0 111.811 172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -76.25 -24.62 54.53 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.853 1.261 . . . . 0.0 113.868 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 t -86.07 -38.24 18.03 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.302 1.441 . . . . 0.0 112.868 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -93.4 141.58 28.29 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.223 1.009 . . . . 0.0 111.937 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.64 -24.39 20.51 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.18 128.76 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.497 1.119 . . . . 0.0 110.294 168.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.01 132.8 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.058 0.943 . . . . 0.0 110.109 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 t -123.21 152.59 41.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.835 0.826 . . . . 0.0 109.903 165.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.06 143.1 49.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.791 0.805 . . . . 0.0 110.776 170.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 mt -132.92 160.09 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.837 -161.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -70.95 103.95 2.82 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 156.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.0 -143.12 23.87 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 119.246 0.93 . . . . 0.0 113.756 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.0 156.47 74.2 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.236 1.414 . . . . 0.0 111.738 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.36 -25.38 30.52 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.314 2.01 . . . . 0.0 113.937 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -90.24 -16.14 29.95 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.27 -0.894 . . . . 0.0 112.828 169.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.62 77.26 15.31 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.578 1.551 . . . . 0.0 111.628 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.95 151.9 35.88 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.262 2.641 . . . . 0.0 112.574 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 78.6 mmm -97.44 -5.22 36.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.318 1.447 . . . . 0.0 113.796 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 10.3 t -146.22 146.32 30.74 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.286 1.434 . . . . 0.0 111.334 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.6 -29.38 69.42 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -71.47 -36.84 71.32 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.633 -1.292 . . . . 0.0 111.66 169.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.3 m -63.98 -35.89 82.19 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -59.15 -47.97 83.34 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.521 1.128 . . . . 0.0 111.453 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -62.18 -28.91 69.99 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.8 tpt -52.38 -39.71 61.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.582 0.628 . . . . 0.0 111.4 171.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 mm -70.61 -35.17 60.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.66 1.184 . . . . 0.0 111.426 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -37.24 86.06 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.832 -1.167 . . . . 0.0 112.886 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 65.9 t -69.98 -37.51 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.167 0.987 . . . . 0.0 110.704 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.9 mt -65.72 -39.69 91.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.109 0.964 . . . . 0.0 113.488 170.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.55 -30.71 70.42 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.117 -0.99 . . . . 0.0 112.137 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.04 -29.47 66.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.569 0.748 . . . . 0.0 112.668 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.7 tp -81.78 -15.31 54.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.622 0.769 . . . . 0.0 112.39 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.87 11.96 58.93 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.496 1.046 . . . . 0.0 114.468 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 22.6 mt -110.58 129.4 55.81 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.551 1.176 . . . . 0.0 112.875 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -116.34 154.85 29.48 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.131 1.372 . . . . 0.0 113.519 168.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -139.59 170.27 16.21 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.576 2.35 . . . . 0.0 111.477 -161.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.0 m -88.09 131.15 34.79 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.047 -1.658 . . . . 0.0 109.655 -176.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -130.33 143.77 50.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.059 0.944 . . . . 0.0 113.528 -154.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -137.67 144.06 41.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.372 1.069 . . . . 0.0 113.315 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -83.59 120.08 25.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.774 1.23 . . . . 0.0 112.075 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.8 t -68.75 -29.82 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.25 1.02 . . . . 0.0 111.863 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.6 mt -74.98 -15.75 60.65 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.155 -0.966 . . . . 0.0 112.282 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.76 -32.57 21.77 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.421 -0.8 . . . . 0.0 112.975 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -129.67 106.48 17.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 119.451 1.023 . . . . 0.0 113.226 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -53.54 -26.94 38.69 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.085 3.19 . . . . 0.0 115.347 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.52 -35.53 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.249 -0.907 . . . . 0.0 112.54 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.79 -48.06 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.139 -0.976 . . . . 0.0 111.166 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -59.94 -28.16 67.39 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.151 0.887 . . . . 0.0 112.955 171.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.5 m -71.03 -53.92 13.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.373 0.533 . . . . 0.0 111.166 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -70.81 -34.76 72.06 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.157 -0.964 . . . . 0.0 111.915 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.15 -36.28 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 120.787 -1.196 . . . . 0.0 112.926 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -72.58 -49.37 32.79 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.484 1.038 . . . . 0.0 111.428 167.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -72.31 -30.53 64.87 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -164.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.53 -29.39 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.598 1.159 . . . . 0.0 111.396 171.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m -103.4 -5.77 22.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -169.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 62.35 -27.03 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 129.069 2.948 . . . . 0.0 116.168 -168.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -145.86 138.53 13.89 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.394 1.877 . . . . 0.0 109.521 165.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.3 149.0 11.75 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.048 2.498 . . . . 0.0 114.669 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.4 p -129.52 132.67 46.92 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.532 1.933 . . . . 0.0 108.807 160.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.0 mt -131.21 142.55 45.91 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.381 1.472 . . . . 0.0 108.383 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.58 161.18 79.14 Favored 'Cis proline' 0 C--N 1.35 0.643 0 CA-C-N 121.738 1.656 . . . . 0.0 111.924 -8.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -144.56 152.52 40.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.302 0.641 . . . . 0.0 112.287 -162.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.24 140.94 52.14 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.785 1.234 . . . . 0.0 112.362 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -130.25 140.41 50.7 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.894 2.078 . . . . 0.0 109.258 173.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 82.0 mt -129.29 133.29 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.3 1.04 . . . . 0.0 108.343 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.1 tttt 49.31 45.3 23.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.187 1.795 . . . . 0.0 113.428 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.65 12.33 5.47 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -115.85 144.2 44.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.381 1.472 . . . . 0.0 111.502 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.23 124.88 25.01 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.879 1.272 . . . . 0.0 111.976 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.49 -55.48 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.147 1.379 . . . . 0.0 110.95 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 165.67 167.21 25.93 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 117.109 1.604 . . . . 0.0 117.109 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.15 168.82 54.84 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.703 1.144 . . . . 0.0 112.499 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.7 tt -47.35 -45.72 24.98 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.058 1.343 . . . . 0.0 113.908 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.82 -35.44 78.62 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.339 -0.851 . . . . 0.0 111.407 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.67 -47.07 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.086 1.354 . . . . 0.0 110.513 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.5 -39.62 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.691 1.196 . . . . 0.0 109.992 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 41.2 m -61.5 -42.72 99.23 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.413 0.685 . . . . 0.0 112.29 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -55.2 -46.62 75.89 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.201 0.909 . . . . 0.0 110.41 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 61.1 mtt -72.92 -33.45 65.97 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.633 1.573 . . . . 0.0 113.342 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -70.52 -35.93 73.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.211 1.804 . . . . 0.0 112.629 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -80.06 -20.27 45.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.885 -1.135 . . . . 0.0 112.621 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.2 p -106.86 -16.0 14.58 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -162.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.7 82.63 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 124.756 1.17 . . . . 0.0 115.503 -170.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -70.03 -31.89 69.75 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.244 2.022 . . . . 0.0 112.55 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.86 -41.59 67.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.533 1.133 . . . . 0.0 110.596 176.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -55.84 -41.17 73.91 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.364 1.865 . . . . 0.0 110.769 173.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -56.63 -47.08 80.47 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.82 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 70.9 mtm -70.86 -46.03 63.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.461 1.028 . . . . 0.0 113.242 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -39.42 82.96 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -72.44 -32.88 66.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.597 1.159 . . . . 0.0 112.274 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.86 -27.2 64.94 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.513 0.597 . . . . 0.0 112.383 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -90.77 -4.43 56.67 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.56 22.37 47.33 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.803 1.192 . . . . 0.0 114.178 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 64.5 mt -94.51 147.84 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 119.038 1.419 . . . . 0.0 111.85 -172.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.6 m -101.11 130.89 47.24 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.323 1.449 . . . . 0.0 112.195 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 15.6 p -137.09 169.46 17.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.685 1.994 . . . . 0.0 111.502 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -74.2 158.42 34.16 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -135.99 129.69 32.46 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.717 1.607 . . . . 0.0 113.343 165.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.413 1.485 . . . . 0.0 111.881 176.688 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.6 -0.148 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.7 p -78.35 -31.87 48.78 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -166.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -105.59 0.85 26.87 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.054 1.341 . . . . 0.0 114.121 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.8 7.43 74.74 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.58 1.562 . . . . 0.0 116.019 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.8 mt -91.19 141.67 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.77 2.028 . . . . 0.0 109.26 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.64 136.66 4.71 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.037 0.835 . . . . 0.0 114.684 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.62 -31.7 0.86 Allowed Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.983 1.754 . . . . 0.0 116.605 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -148.66 152.57 36.92 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.248 1.819 . . . . 0.0 110.599 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.11 152.79 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.247 1.019 . . . . 0.0 111.785 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.73 167.36 18.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.912 1.285 . . . . 0.0 111.148 173.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -149.95 166.96 28.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.832 0.853 . . . . 0.0 111.456 166.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.0 mt -85.34 116.33 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.322 1.049 . . . . 0.0 108.464 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -138.79 147.92 43.17 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.664 1.185 . . . . 0.0 112.619 -174.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.7 116.47 13.22 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.468 1.507 . . . . 0.0 109.252 158.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.7 p -138.97 -11.58 1.28 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -71.96 153.68 92.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 119.438 1.017 . . . . 0.0 112.392 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -72.29 175.1 10.45 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.01 3.14 . . . . 0.0 112.453 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -77.64 -9.84 59.19 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.746 -1.221 . . . . 0.0 113.291 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -140.38 117.0 10.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.521 1.528 . . . . 0.0 109.382 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -96.03 147.38 32.89 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.26 139.93 39.64 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.321 2.68 . . . . 0.0 111.047 167.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.9 mtm-85 -92.86 129.41 38.79 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.554 -0.716 . . . . 0.0 111.562 -171.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.0 tp -155.45 -44.09 0.08 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.167 0.987 . . . . 0.0 112.179 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.2 t -144.6 110.66 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.068 1.347 . . . . 0.0 110.414 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.4 t -82.9 75.36 9.8 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.127 -0.983 . . . . 0.0 110.672 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.69 133.17 53.3 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.819 1.248 . . . . 0.0 111.773 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.3 t0 51.94 178.91 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.033 1.733 . . . . 0.0 112.905 -163.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.9 tp -104.44 132.4 50.73 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.849 -1.157 . . . . 0.0 108.949 165.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.54 152.75 29.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -169.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -51.03 -42.46 60.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.737 1.215 . . . . 0.0 112.881 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.57 -31.5 63.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.016 1.726 . . . . 0.0 114.12 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -75.52 -41.69 54.5 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.162 1.385 . . . . 0.0 113.161 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.1 tp -82.64 -20.17 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.25 0.49 28.43 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.324 1.05 . . . . 0.0 113.518 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.4 ttt -61.69 126.92 29.07 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.129 -0.982 . . . . 0.0 112.212 -171.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.15 148.36 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.311 1.044 . . . . 0.0 112.283 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -120.42 126.86 51.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.474 1.51 . . . . 0.0 110.326 164.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -57.44 -43.55 83.97 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.62 1.168 . . . . 0.0 113.363 -163.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -72.79 -28.82 62.82 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.6 mm -72.12 -48.89 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.035 0.934 . . . . 0.0 109.618 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.53 -38.38 77.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.189 1.396 . . . . 0.0 112.304 170.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.5 -30.79 66.35 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.279 -0.888 . . . . 0.0 113.163 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 67.3 m -66.43 -47.89 71.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.193 0.997 . . . . 0.0 111.061 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 pt -60.5 -36.87 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 118.498 0.59 . . . . 0.0 111.944 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.08 -21.98 58.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.006 1.722 . . . . 0.0 113.146 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.3 t -92.84 -38.76 11.57 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.523 1.929 . . . . 0.0 112.582 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.37 139.36 31.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.44 1.096 . . . . 0.0 111.514 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -70.62 -42.21 71.23 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.179 -0.951 . . . . 0.0 113.324 -171.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.7 t -139.92 128.14 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.516 1.126 . . . . 0.0 109.511 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.0 t -133.42 130.28 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.461 1.505 . . . . 0.0 111.134 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -130.79 157.12 43.71 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.849 1.26 . . . . 0.0 110.47 170.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.56 151.58 51.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.542 0.686 . . . . 0.0 112.007 170.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 mt -133.22 169.45 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.433 1.493 . . . . 0.0 109.444 -166.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.94 112.59 23.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.835 -0.541 . . . . 0.0 111.487 144.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.46 -171.98 31.21 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.132 1.825 . . . . 0.0 114.296 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.4 mt -88.87 150.57 45.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.555 1.542 . . . . 0.0 110.546 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.25 -27.78 78.5 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.64 2.227 . . . . 0.0 114.541 -173.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.8 -21.87 56.92 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.966 -1.084 . . . . 0.0 113.036 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.61 68.2 14.63 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 125.716 1.606 . . . . 0.0 112.345 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.78 157.31 39.54 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.316 2.677 . . . . 0.0 112.427 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 mmt -96.34 10.35 38.31 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.711 1.204 . . . . 0.0 114.094 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.8 t -147.87 145.5 28.71 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.904 -1.122 . . . . 0.0 111.593 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.28 96.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -67.37 -31.91 72.48 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.449 -1.407 . . . . 0.0 112.628 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.4 m -63.84 -36.37 83.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.75 167.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.39 -40.13 89.48 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.993 1.27 . . . . 0.0 112.892 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -60.0 -35.7 75.61 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 119.67 1.123 . . . . 0.0 112.878 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.9 tpt -58.31 -46.79 85.48 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.168 0.587 . . . . 0.0 111.468 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.7 mm -71.89 -33.3 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.373 0.669 . . . . 0.0 112.06 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.35 -42.17 73.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.103 0.961 . . . . 0.0 111.147 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.8 t -62.98 -44.55 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.543 1.137 . . . . 0.0 111.586 176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.22 -36.74 85.11 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.865 . . . . 0.0 112.645 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -71.37 -30.88 66.67 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.805 -1.185 . . . . 0.0 113.196 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.76 -33.8 74.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.803 0.729 . . . . 0.0 112.135 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 tp -94.38 -10.71 31.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.487 1.115 . . . . 0.0 112.811 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.06 8.89 70.51 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.956 1.741 . . . . 0.0 115.195 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 132.49 54.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.083 0.953 . . . . 0.0 111.058 173.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -114.73 153.2 30.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.121 0.963 . . . . 0.0 112.686 173.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.52 173.75 9.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.526 1.93 . . . . 0.0 111.258 -166.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.5 m -88.6 129.36 35.51 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.846 -1.159 . . . . 0.0 109.824 -167.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.7 p -114.3 141.29 47.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.098 1.759 . . . . 0.0 113.592 -163.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -128.12 161.72 28.57 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.91 1.284 . . . . 0.0 111.784 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -131.22 118.05 19.88 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.287 1.435 . . . . 0.0 112.752 -170.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.15 -21.05 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 tp -80.96 -22.1 39.82 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.321 1.048 . . . . 0.0 111.817 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.16 -40.04 16.06 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.03 -1.044 . . . . 0.0 111.905 170.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -144.55 109.81 4.88 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.833 1.253 . . . . 0.0 112.319 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.95 -14.0 40.67 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.387 2.725 . . . . 0.0 114.994 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -46.9 -32.33 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 120.016 1.28 . . . . 0.0 113.032 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.0 t -58.01 -43.53 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.146 0.978 . . . . 0.0 111.688 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -68.83 -39.98 79.7 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.799 1.24 . . . . 0.0 111.528 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 m -65.76 -47.92 73.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -69.6 -39.69 77.11 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.162 -0.962 . . . . 0.0 112.04 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.91 -35.76 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 120.2 1.364 . . . . 0.0 112.21 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -66.3 -47.66 72.88 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.075 0.95 . . . . 0.0 111.734 172.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -42.29 80.94 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.61 -34.84 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.815 1.246 . . . . 0.0 113.128 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 m -97.99 5.83 48.35 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -170.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 62.48 -40.77 0.16 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 127.797 2.439 . . . . 0.0 114.445 -162.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -135.91 134.73 20.69 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.48 1.912 . . . . 0.0 110.613 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.23 138.15 27.22 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.653 2.235 . . . . 0.0 112.192 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.0 136.6 44.21 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.505 1.522 . . . . 0.0 109.908 165.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.3 mt -127.95 131.7 23.94 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.907 173.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.92 163.16 88.24 Favored 'Cis proline' 0 CA--C 1.541 0.857 0 CA-C-N 119.929 1.01 . . . . 0.0 110.813 -12.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -150.36 172.85 14.74 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.761 0.824 . . . . 0.0 111.514 171.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.07 140.03 52.19 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -174.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -120.66 142.49 49.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 112.779 -2.009 . . . . 0.0 110.51 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.4 mt -122.24 118.32 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 tptt 45.88 48.9 12.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.146 2.178 . . . . 0.0 114.567 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 58.51 13.24 2.43 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -172.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -94.36 131.68 39.76 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.856 -1.153 . . . . 0.0 108.702 164.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -76.34 124.76 28.02 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.608 -0.682 . . . . 0.0 111.278 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.4 t -101.92 -46.82 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.735 1.214 . . . . 0.0 111.186 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.58 170.44 31.48 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.69 174.65 54.7 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.359 1.457 . . . . 0.0 114.02 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -48.62 -43.82 36.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.539 1.936 . . . . 0.0 113.331 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.27 -44.65 95.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.316 0.647 . . . . 0.0 110.321 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.84 -45.72 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.093 1.357 . . . . 0.0 111.207 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.9 t -57.52 -37.06 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.633 1.573 . . . . 0.0 110.945 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.0 m -63.09 -44.09 96.69 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.233 0.613 . . . . 0.0 111.721 172.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -63.2 -41.59 99.18 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.504 1.047 . . . . 0.0 110.796 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 38.2 mtt -63.24 -39.23 94.03 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.011 0.925 . . . . 0.0 111.946 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.58 -40.32 80.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.064 1.346 . . . . 0.0 112.195 175.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.32 -33.49 55.56 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.0 t -85.2 -21.26 29.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.044 1.338 . . . . 0.0 113.489 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.49 0.17 67.49 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.526 1.06 . . . . 0.0 114.788 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.03 -29.95 66.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.515 1.157 . . . . 0.0 113.633 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.62 -44.04 96.78 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.842 -1.162 . . . . 0.0 110.021 174.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -36.74 84.0 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.915 1.286 . . . . 0.0 113.039 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -59.47 -48.49 81.44 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.43 1.014 . . . . 0.0 111.194 171.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.3 mtm -69.9 -45.82 66.77 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 pp -66.33 -36.71 83.61 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.735 0.698 . . . . 0.0 112.059 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -64.01 -41.8 97.34 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.663 0.785 . . . . 0.0 111.536 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.94 -20.58 64.21 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.16 1.43 31.99 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.369 1.468 . . . . 0.0 112.485 170.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.04 17.27 74.94 Favored Glycine 0 N--CA 1.469 0.869 0 O-C-N 120.984 -1.073 . . . . 0.0 114.229 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.4 mt -103.05 146.93 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.686 1.195 . . . . 0.0 109.364 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.3 m -112.36 137.1 50.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.257 1.023 . . . . 0.0 110.651 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.1 p -132.22 168.53 17.89 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.638 1.575 . . . . 0.0 113.075 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -67.09 157.3 33.94 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.631 0.772 . . . . 0.0 111.406 169.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -90.23 105.0 17.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.469 1.107 . . . . 0.0 111.931 -170.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 58.1 tp . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.77 2.028 . . . . 0.0 112.607 -177.334 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.3 m -80.28 -32.75 38.12 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.02 0.928 . . . . 0.0 112.065 171.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.4 m 58.56 162.06 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.784 1.634 . . . . 0.0 113.367 -155.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.0 15.45 81.37 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.717 1.151 . . . . 0.0 115.197 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mt -86.22 140.72 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.243 1.417 . . . . 0.0 110.39 -172.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.37 126.76 28.51 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.292 0.949 . . . . 0.0 114.966 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.32 -147.1 43.59 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.443 1.021 . . . . 0.0 113.848 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -148.69 155.18 40.67 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.419 -1.047 . . . . 0.0 111.395 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.53 139.77 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 121.201 -0.937 . . . . 0.0 111.864 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -88.69 139.98 29.92 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.011 0.924 . . . . 0.0 111.515 171.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -87.6 151.18 23.18 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.274 1.03 . . . . 0.0 111.724 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.0 mt -112.56 144.06 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.293 1.837 . . . . 0.0 108.665 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.08 122.01 21.11 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.204 -0.935 . . . . 0.0 110.246 173.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -63.11 125.83 25.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.07 0.948 . . . . 0.0 111.916 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.0 p -131.69 137.84 48.44 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.564 1.546 . . . . 0.0 109.136 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -94.06 145.76 30.39 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -164.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.37 151.18 86.16 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.856 3.038 . . . . 0.0 113.205 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -96.21 -4.3 42.73 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -129.73 117.45 20.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.542 1.137 . . . . 0.0 111.464 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -107.23 143.19 26.65 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.543 1.937 . . . . 0.0 111.508 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -67.55 151.67 79.35 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.164 2.576 . . . . 0.0 111.649 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -68.31 128.76 37.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.147 0.979 . . . . 0.0 112.109 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -149.86 149.58 30.67 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.445 1.498 . . . . 0.0 110.565 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.1 t -111.45 -33.64 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.744 1.218 . . . . 0.0 111.487 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.0 m -68.78 167.73 14.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.584 1.153 . . . . 0.0 111.289 159.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.68 130.5 35.95 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.642 0.734 . . . . 0.0 112.147 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -151.0 150.03 30.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.116 2.166 . . . . 0.0 107.209 160.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 tp -134.75 152.44 51.76 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.606 1.094 . . . . 0.0 111.895 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.83 146.92 35.44 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.563 1.145 . . . . 0.0 113.119 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -54.25 -44.54 71.89 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.968 1.307 . . . . 0.0 113.554 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -71.51 -31.37 67.01 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.325 0.511 . . . . 0.0 112.169 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.92 -28.56 63.57 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.279 -0.888 . . . . 0.0 111.963 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.9 mt -72.77 -27.78 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.978 1.311 . . . . 0.0 111.321 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.9 8.74 7.61 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.907 1.283 . . . . 0.0 114.059 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 7.4 mmt -115.43 116.48 28.29 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.931 1.693 . . . . 0.0 110.481 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.4 147.88 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.186 0.995 . . . . 0.0 112.618 -172.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -92.85 128.88 38.87 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.533 1.133 . . . . 0.0 111.422 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -60.97 -29.16 69.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.872 0.869 . . . . 0.0 112.288 167.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.38 -37.68 75.75 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.056 0.942 . . . . 0.0 112.861 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 97.5 mt -75.99 -44.9 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.661 1.184 . . . . 0.0 110.119 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.41 -38.4 71.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.856 1.263 . . . . 0.0 112.15 171.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.4 -28.5 64.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.898 0.879 . . . . 0.0 113.107 172.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.7 m -70.16 -47.2 62.65 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 120.335 1.425 . . . . 0.0 110.948 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.8 pt -62.0 -32.47 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.421 1.088 . . . . 0.0 112.914 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -79.15 -30.64 43.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.707 2.003 . . . . 0.0 113.825 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t -80.31 -28.0 38.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.067 1.747 . . . . 0.0 113.248 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -84.85 150.12 25.22 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.905 -1.122 . . . . 0.0 111.344 167.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -76.45 -45.79 29.8 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.632 -1.292 . . . . 0.0 111.691 169.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.9 t -145.33 131.38 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.561 1.144 . . . . 0.0 111.087 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.86 131.67 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.675 1.19 . . . . 0.0 111.663 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 t -134.31 154.96 51.02 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.894 1.277 . . . . 0.0 111.733 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -132.43 139.62 48.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.923 0.889 . . . . 0.0 111.472 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 mt -132.78 157.51 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.849 2.059 . . . . 0.0 108.853 -164.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -78.17 115.21 17.73 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 147.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.99 -152.9 25.07 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.185 0.897 . . . . 0.0 113.551 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.1 mt -104.96 152.59 39.64 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 124.932 1.293 . . . . 0.0 110.596 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.08 -31.72 54.42 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 121.758 1.639 . . . . 0.0 113.453 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -81.22 -13.28 58.71 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.406 -0.809 . . . . 0.0 112.95 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.55 67.66 52.2 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.97 1.708 . . . . 0.0 112.096 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.42 142.46 59.78 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.651 2.901 . . . . 0.0 112.964 -172.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 90.7 mtp -105.65 3.78 29.48 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 37.0 t -134.6 146.52 49.68 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.831 2.053 . . . . 0.0 111.06 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.07 -46.57 85.23 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.354 -0.842 . . . . 0.0 112.018 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -67.09 -25.47 66.24 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.018 -1.051 . . . . 0.0 112.056 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.4 p -71.45 -39.05 71.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 168.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -58.69 -45.32 89.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.75 1.159 . . . . 0.0 110.203 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -62.56 -39.78 94.74 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.292 1.037 . . . . 0.0 112.438 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.5 tpt -55.86 -49.61 72.85 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.791 1.178 . . . . 0.0 111.678 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.7 mm -70.38 -32.68 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.869 -0.519 . . . . 0.0 112.339 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -59.9 -36.27 76.62 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.003 -1.061 . . . . 0.0 112.927 171.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.23 -36.36 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.732 0.813 . . . . 0.0 110.596 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.89 -37.48 87.79 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.35 -0.844 . . . . 0.0 112.885 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -65.08 -33.89 77.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.757 -1.214 . . . . 0.0 111.41 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.35 -30.96 70.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.06 0.944 . . . . 0.0 112.314 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.2 tp -82.27 -16.98 47.53 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.695 0.68 . . . . 0.0 112.626 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.64 9.49 58.9 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.611 1.101 . . . . 0.0 115.166 -174.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.5 mt -114.81 133.97 55.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.53 1.532 . . . . 0.0 113.668 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -115.63 153.43 31.29 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.755 1.264 . . . . 0.0 113.044 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -137.19 175.01 10.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.616 1.967 . . . . 0.0 111.799 -156.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.8 m -85.79 117.36 24.61 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.548 -1.345 . . . . 0.0 108.943 -168.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.2 m -127.87 133.05 49.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.141 -153.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -129.63 149.83 51.22 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -172.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -99.45 98.16 9.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.697 1.599 . . . . 0.0 111.846 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.6 -21.94 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.018 0.927 . . . . 0.0 113.229 -175.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.3 tp -73.4 -28.62 62.1 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.626 -0.671 . . . . 0.0 111.565 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.14 -32.78 11.78 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -124.12 103.97 32.74 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.745 1.157 . . . . 0.0 113.661 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -57.27 -19.75 36.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.151 3.234 . . . . 0.0 115.371 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.14 -39.31 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 120.315 1.416 . . . . 0.0 112.452 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.95 -42.53 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.186 0.994 . . . . 0.0 111.119 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -69.99 -30.47 67.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.524 1.13 . . . . 0.0 112.148 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m -68.84 -48.98 62.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.831 0.852 . . . . 0.0 112.601 170.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -61.35 -46.67 89.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.427 0.558 . . . . 0.0 110.604 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.85 -32.83 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.483 -0.76 . . . . 0.0 112.873 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -70.25 -41.62 73.27 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.826 1.194 . . . . 0.0 112.929 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -61.63 -40.42 94.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.982 0.81 . . . . 0.0 112.723 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.0 t -83.8 -50.62 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 53.9 p -113.66 -0.62 14.25 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 65.08 -49.76 0.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.112 2.165 . . . . 0.0 116.138 -172.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -132.26 116.52 15.41 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 119.909 1.231 . . . . 0.0 112.337 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.94 144.86 21.88 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.339 2.693 . . . . 0.0 112.2 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.7 m -135.2 110.7 9.13 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.437 0.695 . . . . 0.0 109.335 161.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.3 pt -91.59 163.96 26.21 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -160.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.18 154.48 98.36 Favored 'Cis proline' 0 C--N 1.352 0.747 0 CA-C-N 119.195 0.748 . . . . 0.0 111.048 -21.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -136.54 153.12 51.08 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.816 1.246 . . . . 0.0 111.273 -170.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.31 140.63 51.35 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.931 1.292 . . . . 0.0 113.536 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -131.47 143.01 50.11 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.483 1.913 . . . . 0.0 109.718 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.0 mt -125.98 115.85 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.797 0.839 . . . . 0.0 108.903 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . 0.339 17.5 ttmm 40.9 57.65 2.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.076 2.15 . . . . 0.0 114.404 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 67.45 9.22 6.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.91 138.42 37.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.551 1.14 . . . . 0.0 110.306 168.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -79.82 123.71 27.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.607 1.194 . . . . 0.0 111.716 175.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.38 -48.72 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.767 1.227 . . . . 0.0 110.584 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.61 -179.68 27.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 168.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.24 173.66 53.88 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.55 1.072 . . . . 0.0 113.442 167.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -42.75 -46.56 5.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.339 1.856 . . . . 0.0 113.765 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -70.02 -26.52 64.09 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.628 -0.67 . . . . 0.0 112.304 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 mm -79.26 -46.51 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.834 1.254 . . . . 0.0 110.316 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.12 -38.56 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.11 0.964 . . . . 0.0 110.572 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 69.3 m -60.88 -46.21 91.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.08 0.952 . . . . 0.0 111.566 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -60.17 -43.86 95.49 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.091 0.956 . . . . 0.0 111.565 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.6 mtt -69.0 -35.25 76.48 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.412 -0.805 . . . . 0.0 112.953 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -69.56 -41.3 76.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.31 1.044 . . . . 0.0 111.506 172.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -65.07 -36.58 84.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.301 1.04 . . . . 0.0 113.183 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.3 t -88.79 -9.43 51.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.427 1.491 . . . . 0.0 114.032 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.84 4.46 82.36 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.247 -1.533 . . . . 0.0 114.201 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.2 -32.36 70.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.347 1.459 . . . . 0.0 112.936 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.16 -46.28 81.51 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.054 -1.029 . . . . 0.0 109.932 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -59.05 -41.1 87.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.745 1.618 . . . . 0.0 112.728 169.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -58.09 -42.66 86.08 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.954 0.902 . . . . 0.0 111.035 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 62.4 mtm -69.6 -50.32 45.67 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -69.08 -37.38 78.42 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -65.09 -34.24 77.94 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.04 0.936 . . . . 0.0 111.44 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.72 -29.65 69.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.238 1.415 . . . . 0.0 112.493 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -89.19 6.02 42.07 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.043 2.137 . . . . 0.0 114.306 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.48 19.43 60.29 Favored Glycine 0 N--CA 1.469 0.867 0 O-C-N 121.12 -0.987 . . . . 0.0 114.44 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.02 147.68 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.33 1.052 . . . . 0.0 110.792 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 95.8 m -102.69 126.2 49.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.749 1.22 . . . . 0.0 111.572 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.8 p -127.48 168.99 14.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.888 2.075 . . . . 0.0 111.156 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 19.1 mtp-105 -68.33 155.59 39.46 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.906 0.86 . . . . 0.0 112.99 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -98.14 134.46 41.18 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.657 1.983 . . . . 0.0 109.463 158.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.1 tp . . . . . 0 C--O 1.253 1.255 0 C-N-CA 127.607 2.363 . . . . 0.0 115.141 -176.773 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.3 m -90.21 -9.14 49.21 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.864 0.866 . . . . 0.0 112.691 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.1 m -57.2 126.19 26.13 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.636 -1.29 . . . . 0.0 111.718 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.94 3.63 87.71 Favored Glycine 0 CA--C 1.54 1.64 0 N-CA-C 117.045 1.578 . . . . 0.0 117.045 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.7 mt -84.49 95.15 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.316 2.058 . . . . 0.0 110.06 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.62 158.76 20.21 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.318 1.437 . . . . 0.0 112.634 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.9 163.23 54.6 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 116.463 1.345 . . . . 0.0 116.463 -169.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -67.77 139.04 56.63 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.437 -1.037 . . . . 0.0 112.89 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -93.57 137.32 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.894 1.278 . . . . 0.0 109.809 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -129.69 153.12 48.46 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.309 1.044 . . . . 0.0 112.973 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -78.77 84.66 4.82 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.173 0.589 . . . . 0.0 111.352 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.3 tp -134.93 21.18 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.183 1.393 . . . . 0.0 113.92 -166.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -140.53 150.64 43.96 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.574 1.55 . . . . 0.0 111.696 167.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -109.86 147.17 33.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.377 1.871 . . . . 0.0 110.487 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.3 p -134.49 164.88 26.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.821 1.248 . . . . 0.0 112.017 170.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.33 159.23 51.37 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.887 1.275 . . . . 0.0 112.475 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.33 155.46 36.9 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.494 2.13 . . . . 0.0 115.282 -154.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.58 -9.5 59.63 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.201 1.8 . . . . 0.0 113.529 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -144.84 139.92 28.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.336 1.854 . . . . 0.0 109.99 -174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -93.46 153.13 41.4 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -165.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.4 155.4 62.48 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.685 3.59 . . . . 0.0 113.543 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -122.68 110.24 15.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.124 1.77 . . . . 0.0 111.338 -176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 tp 60.46 -30.24 0.05 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 130.834 3.654 . . . . 0.0 117.631 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 m -130.29 155.45 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.41 1.884 . . . . 0.0 111.194 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.6 p -140.39 164.27 30.55 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -174.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.74 153.79 42.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.788 1.235 . . . . 0.0 113.004 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.62 -49.94 64.64 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.327 1.051 . . . . 0.0 111.582 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.47 132.83 55.4 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.0 1.32 . . . . 0.0 110.422 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.54 162.17 18.67 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.435 1.494 . . . . 0.0 113.66 -175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -52.56 -44.78 66.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.281 1.432 . . . . 0.0 113.543 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -75.31 -37.95 60.53 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.465 1.506 . . . . 0.0 112.369 174.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.7 -29.5 67.95 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.486 1.514 . . . . 0.0 112.356 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.5 tp -89.66 -12.25 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.402 1.481 . . . . 0.0 113.159 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.14 -25.82 15.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.733 1.213 . . . . 0.0 113.617 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.7 ttp -75.12 133.46 41.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.216 1.806 . . . . 0.0 111.008 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.7 84.29 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.34 0.656 . . . . 0.0 110.29 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -72.4 114.69 10.79 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.104 0.962 . . . . 0.0 112.437 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -57.8 -25.36 60.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.655 1.182 . . . . 0.0 113.433 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.18 -28.26 64.6 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.693 1.133 . . . . 0.0 113.037 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.2 mm -70.04 -49.09 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 120.794 1.634 . . . . 0.0 110.701 171.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.82 -39.21 93.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.372 1.469 . . . . 0.0 112.244 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.85 -29.68 61.11 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.346 -0.846 . . . . 0.0 112.559 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.1 m -66.31 -46.14 77.94 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.987 1.267 . . . . 0.0 110.933 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 pt -63.81 -34.6 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.576 0.75 . . . . 0.0 112.925 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -78.95 -39.38 34.69 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.22 1.408 . . . . 0.0 112.964 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.2 t -85.02 -11.06 56.26 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.309 1.044 . . . . 0.0 113.446 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -89.52 148.67 23.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.362 1.865 . . . . 0.0 111.449 165.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -87.28 -42.84 12.62 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.783 -1.198 . . . . 0.0 113.205 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.27 130.49 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.062 1.345 . . . . 0.0 110.265 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.4 t -131.51 130.51 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.779 1.632 . . . . 0.0 111.278 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 t -133.5 156.18 48.23 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.084 1.354 . . . . 0.0 111.186 171.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -129.62 139.77 51.35 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.42 0.688 . . . . 0.0 111.872 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.83 156.57 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.26 1.424 . . . . 0.0 109.876 -163.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.9 102.86 1.66 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.852 -0.53 . . . . 0.0 109.665 155.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.74 -160.0 33.67 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 118.887 0.767 . . . . 0.0 114.783 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.51 153.68 48.26 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.951 2.1 . . . . 0.0 112.516 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -66.75 -15.59 47.79 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.311 2.674 . . . . 0.0 114.823 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -94.84 -20.43 19.46 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.45 69.26 21.21 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.416 1.486 . . . . 0.0 110.84 -171.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.54 144.01 48.71 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.058 2.505 . . . . 0.0 111.655 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 mmt -93.36 2.41 56.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.13 1.372 . . . . 0.0 113.741 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 53.6 t -142.12 145.64 34.48 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.804 1.642 . . . . 0.0 111.488 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.77 95.63 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.878 0.871 . . . . 0.0 112.731 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.08 -24.06 62.24 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.592 -1.317 . . . . 0.0 112.354 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 m -69.77 -36.44 75.77 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.427 -0.796 . . . . 0.0 112.362 166.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -62.29 -42.02 98.99 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.605 1.162 . . . . 0.0 112.021 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -55.84 -29.83 60.46 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.068 1.347 . . . . 0.0 113.526 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.2 tpt -69.24 -43.57 73.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.986 0.915 . . . . 0.0 111.756 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.4 mm -65.46 -36.44 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.752 0.821 . . . . 0.0 111.014 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.63 -40.44 79.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.213 1.005 . . . . 0.0 112.955 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.12 -42.93 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.921 1.289 . . . . 0.0 111.659 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.1 mt -65.39 -36.77 84.99 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.739 0.815 . . . . 0.0 112.548 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -67.07 -35.47 79.9 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.374 -1.454 . . . . 0.0 112.443 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.31 -21.66 65.67 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.57 -13.27 20.49 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.64 1.576 . . . . 0.0 114.124 170.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.74 71.3 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.433 1.492 . . . . 0.0 115.479 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.8 mp -112.09 144.89 40.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.26 1.424 . . . . 0.0 111.321 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -113.75 130.17 56.48 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.617 0.767 . . . . 0.0 110.649 166.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -104.82 170.6 7.78 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.023 1.729 . . . . 0.0 111.26 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -86.34 119.83 27.04 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.5 -1.375 . . . . 0.0 109.45 -157.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.2 m -113.23 129.71 56.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.339 -158.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -115.07 155.05 27.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.994 1.317 . . . . 0.0 111.059 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -111.21 94.95 5.24 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.845 1.258 . . . . 0.0 110.48 -168.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 p -70.02 -23.2 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.236 1.015 . . . . 0.0 112.953 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.9 tp -78.35 -30.75 48.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.081 0.952 . . . . 0.0 111.424 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.53 -35.28 19.63 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -131.32 98.93 17.94 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.825 0.85 . . . . 0.0 111.945 -170.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.97 -12.23 33.56 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.394 2.729 . . . . 0.0 114.761 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.0 p -49.1 -42.04 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.717 1.207 . . . . 0.0 112.489 170.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.75 -46.27 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.802 0.841 . . . . 0.0 111.704 -177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -71.33 -23.75 61.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -70.36 -51.43 29.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.116 0.567 . . . . 0.0 112.11 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -70.96 -37.99 72.8 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.641 -0.662 . . . . 0.0 112.429 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.39 -34.95 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.362 -0.836 . . . . 0.0 112.557 176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -66.72 -43.22 84.86 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.338 -0.851 . . . . 0.0 110.991 171.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.92 -42.69 80.44 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.678 0.791 . . . . 0.0 113.037 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -80.26 -45.28 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.618 1.167 . . . . 0.0 112.988 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.5 m -106.05 -5.93 19.09 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 62.65 -25.99 0.06 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 128.075 2.55 . . . . 0.0 115.973 -172.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -136.28 92.0 16.14 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 127.2 2.2 . . . . 0.0 112.045 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -72.31 147.64 47.73 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.624 2.883 . . . . 0.0 114.317 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.4 m -125.99 137.27 53.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.616 1.566 . . . . 0.0 107.842 160.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mp -108.04 133.26 20.57 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.45 159.1 73.35 Favored 'Cis proline' 0 CA--C 1.546 1.091 0 CA-C-N 120.706 1.288 . . . . 0.0 112.012 -12.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -137.92 164.28 29.39 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.953 1.701 . . . . 0.0 110.913 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.7 139.62 52.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 122.776 1.274 . . . . 0.0 114.209 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -125.43 140.31 52.9 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 112.741 -2.027 . . . . 0.0 110.247 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 57.3 mt -128.87 121.85 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.293 1.037 . . . . 0.0 109.138 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt 45.12 51.13 9.18 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.064 1.746 . . . . 0.0 113.008 -172.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.63 10.21 1.88 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 -175.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.58 143.63 28.77 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.193 1.36 . . . . 0.0 110.516 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -86.35 123.59 31.76 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.701 0.763 . . . . 0.0 112.909 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.8 -50.92 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.459 1.504 . . . . 0.0 111.964 -171.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 175.19 163.85 28.88 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 117.238 1.655 . . . . 0.0 117.238 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.72 168.94 53.98 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 125.575 1.56 . . . . 0.0 114.124 167.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.0 tp -44.19 -42.05 6.19 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.947 1.699 . . . . 0.0 115.01 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -67.9 -38.06 82.52 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.799 -0.563 . . . . 0.0 111.338 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.4 mm -74.97 -39.12 44.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 C-N-CA 125.131 1.373 . . . . 0.0 110.26 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.05 -42.42 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 120.971 -1.081 . . . . 0.0 110.696 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.9 m -65.33 -43.87 89.59 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.703 0.801 . . . . 0.0 111.427 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -56.8 -46.25 81.7 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.72 1.208 . . . . 0.0 111.74 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.9 mtt -67.05 -35.26 79.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.752 1.621 . . . . 0.0 112.7 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.84 -46.54 68.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.389 1.076 . . . . 0.0 111.109 173.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.96 -17.39 64.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.003 1.321 . . . . 0.0 112.906 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.2 m -101.03 -16.18 17.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.218 1.407 . . . . 0.0 114.788 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.26 -4.12 73.68 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 120.21 1.368 . . . . 0.0 114.446 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -65.14 -32.03 73.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.556 1.678 . . . . 0.0 112.922 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.71 -43.3 98.0 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.114 172.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -64.35 -38.71 91.99 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.518 1.527 . . . . 0.0 112.726 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -58.43 -48.82 79.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.722 1.146 . . . . 0.0 110.92 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.9 mtm -69.59 -44.92 69.8 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 pp -66.16 -40.83 90.82 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.011 0.369 . . . . 0.0 111.435 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -71.75 -32.28 67.54 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.426 -0.796 . . . . 0.0 112.963 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.18 -26.51 68.18 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.363 0.529 . . . . 0.0 112.407 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -76.23 4.44 8.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.592 1.557 . . . . 0.0 113.875 169.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.42 0.02 89.85 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.273 1.892 . . . . 0.0 113.671 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.3 mt -84.81 144.53 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 118.782 1.291 . . . . 0.0 109.862 -169.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.9 m -108.23 139.6 42.68 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.355 1.462 . . . . 0.0 111.094 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 21.8 p -137.17 170.04 16.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.924 1.689 . . . . 0.0 112.16 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -47.26 155.1 0.34 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 121.536 -0.727 . . . . 0.0 112.512 167.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -118.05 130.43 56.15 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.151 0.981 . . . . 0.0 108.861 154.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.9 tp . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.866 1.666 . . . . 0.0 112.025 -165.058 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 m -70.37 -7.45 42.94 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.7 m -53.14 120.38 5.85 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.911 -1.118 . . . . 0.0 111.888 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.84 -6.19 42.47 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 126.576 2.036 . . . . 0.0 117.085 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.1 mt -80.46 126.76 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.478 2.139 . . . . 0.0 112.68 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.69 167.11 39.42 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 125.538 1.542 . . . . 0.0 114.59 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.66 167.94 34.71 Favored Glycine 0 CA--C 1.536 1.382 0 O-C-N 121.635 -0.921 . . . . 0.0 115.115 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -137.44 160.9 37.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.458 1.503 . . . . 0.0 114.037 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -135.27 149.79 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.854 2.062 . . . . 0.0 111.469 -167.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.34 152.93 18.84 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 126.358 1.863 . . . . 0.0 113.466 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -117.13 151.33 37.07 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.216 1.406 . . . . 0.0 114.716 -168.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.0 mt -112.51 132.28 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 126.033 1.733 . . . . 0.0 111.088 -171.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -73.32 125.09 27.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.812 0.845 . . . . 0.0 113.089 177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.91 132.99 35.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.772 1.229 . . . . 0.0 109.792 169.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.6 m -136.61 -17.84 1.46 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.61 1.964 . . . . 0.0 111.593 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -59.87 148.51 76.22 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 126.106 1.762 . . . . 0.0 112.981 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -63.13 -179.33 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.275 3.317 . . . . 0.0 116.924 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.99 0.14 25.53 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.164 2.186 . . . . 0.0 114.477 -176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -133.23 123.91 26.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.761 1.224 . . . . 0.0 111.264 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -73.28 145.07 85.12 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 122.891 0.476 . . . . 0.0 111.364 -175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -59.87 154.12 52.3 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.652 2.235 . . . . 0.0 112.707 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -106.5 140.58 39.17 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.308 1.443 . . . . 0.0 109.695 171.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.9 tp -163.53 148.61 11.02 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.201 1.4 . . . . 0.0 111.822 -176.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 t -67.17 -49.46 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.912 0.885 . . . . 0.0 111.938 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.7 m -74.77 153.52 38.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.054 0.942 . . . . 0.0 111.867 173.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.39 106.79 5.35 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.796 0.838 . . . . 0.0 112.261 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -156.6 153.77 29.13 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.212 1.405 . . . . 0.0 110.109 169.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.6 mt -135.95 167.31 21.45 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.119 1.767 . . . . 0.0 110.987 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.24 176.13 2.36 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.941 1.296 . . . . 0.0 113.637 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -62.33 -26.35 68.39 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.372 -0.83 . . . . 0.0 112.044 170.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.252 0.4 OUTLIER -66.02 -25.55 67.12 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 120.339 -1.475 . . . . 0.0 114.021 -176.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -59.1 -22.83 61.45 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.746 1.618 . . . . 0.0 112.967 166.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.9 mt -85.17 -26.94 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.209 1.404 . . . . 0.0 110.505 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.23 14.66 13.73 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.236 1.814 . . . . 0.0 113.744 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.0 ttt -59.15 149.99 26.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.96 1.304 . . . . 0.0 113.113 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.7 m -45.18 148.65 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.898 1.679 . . . . 0.0 113.913 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -85.3 153.4 22.6 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.029 1.332 . . . . 0.0 111.646 -166.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -58.15 -28.51 64.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.177 1.391 . . . . 0.0 114.326 -170.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -58.01 -31.35 66.88 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.473 1.509 . . . . 0.0 113.599 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 40.0 mm -75.17 -48.28 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.682 1.193 . . . . 0.0 110.179 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.54 -37.97 82.97 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.55 1.14 . . . . 0.0 111.89 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.88 -30.34 71.45 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.957 1.703 . . . . 0.0 112.68 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.6 m -76.89 -48.35 18.54 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.216 1.406 . . . . 0.0 110.334 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.4 mt -55.94 -36.4 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 127.685 2.394 . . . . 0.0 110.924 175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -75.83 -30.17 58.89 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 126.535 1.934 . . . . 0.0 114.729 171.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.4 t -78.94 -39.93 33.32 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.509 0.724 . . . . 0.0 112.224 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -90.16 140.93 29.18 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -170.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -66.38 -39.6 89.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.37 0.668 . . . . 0.0 112.631 -171.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.1 t -140.77 133.72 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 109.759 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.44 134.14 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.778 1.231 . . . . 0.0 110.089 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.6 t -131.86 155.39 47.92 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.083 0.953 . . . . 0.0 111.237 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -133.31 135.88 45.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.426 0.632 . . . . 0.0 111.899 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.5 mt -133.95 153.69 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 109.015 -157.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -69.49 104.58 2.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 158.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.08 -134.16 12.75 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.829 1.204 . . . . 0.0 114.337 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.1 mt -126.33 157.72 69.31 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 126.342 1.857 . . . . 0.0 111.658 -168.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.25 -21.5 31.13 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.127 1.885 . . . . 0.0 113.833 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.23 -22.22 35.97 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.477 1.111 . . . . 0.0 113.108 167.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.22 74.02 11.87 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.4 1.48 . . . . 0.0 113.046 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.37 143.65 22.26 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.948 2.432 . . . . 0.0 111.262 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 51.0 ttm -110.14 7.18 23.31 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.256 1.822 . . . . 0.0 113.081 -163.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 54.1 t -150.63 149.01 29.32 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.647 1.979 . . . . 0.0 111.041 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.75 93.99 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.32 0.964 . . . . 0.0 112.702 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -66.93 -31.45 72.05 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.83 -1.169 . . . . 0.0 111.42 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.6 m -70.39 -37.96 74.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 118.265 -0.874 . . . . 0.0 112.933 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -55.94 -47.36 77.7 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 120.199 1.363 . . . . 0.0 110.703 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -61.81 -31.9 72.16 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.9 tpt -61.41 -44.35 97.29 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.668 0.667 . . . . 0.0 111.517 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.0 mm -68.28 -37.95 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.075 0.55 . . . . 0.0 111.146 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.4 -40.56 78.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.032 0.933 . . . . 0.0 112.58 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.77 -44.3 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.272 0.629 . . . . 0.0 111.506 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.6 mt -65.9 -36.98 84.91 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.813 0.845 . . . . 0.0 112.317 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -66.01 -32.99 74.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.562 1.145 . . . . 0.0 112.917 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.95 76.6 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.715 0.806 . . . . 0.0 111.978 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.65 -14.81 44.41 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.886 0.874 . . . . 0.0 113.092 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.57 14.17 62.05 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.619 1.104 . . . . 0.0 114.26 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 58.0 mt -112.07 128.44 56.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.209 1.004 . . . . 0.0 111.315 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -115.54 144.69 43.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.854 1.262 . . . . 0.0 111.17 172.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -125.12 169.95 11.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.384 1.874 . . . . 0.0 111.809 -166.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.1 m -85.07 126.29 33.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 122.495 1.141 . . . . 0.0 109.44 -166.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.1 m -123.72 138.93 54.43 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 113.681 -1.6 . . . . 0.0 112.095 -155.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.6 139.43 53.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -84.01 112.19 19.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.343 2.257 . . . . 0.0 111.495 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.4 m -70.35 -17.85 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.1 tp -87.36 -19.97 27.39 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.607 1.163 . . . . 0.0 111.957 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.24 -29.07 13.78 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.764 1.225 . . . . 0.0 113.366 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.32 96.9 38.23 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -53.11 -26.75 34.09 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.569 3.512 . . . . 0.0 115.501 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.27 -36.04 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.112 0.965 . . . . 0.0 113.595 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 63.1 t -69.75 -51.48 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.964 0.906 . . . . 0.0 110.819 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -63.98 -26.12 68.44 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.673 175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.9 m -71.61 -48.05 50.65 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.439 ' CE2' HG22 ' A' ' 139' ' ' VAL . 48.7 t80 -61.02 -48.05 83.6 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 120.752 1.615 . . . . 0.0 109.807 176.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.64 -35.26 74.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 121.283 -0.886 . . . . 0.0 112.837 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -59.26 -46.61 88.05 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.19 1.396 . . . . 0.0 112.102 171.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.25 -46.64 40.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.301 1.04 . . . . 0.0 112.9 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.439 HG22 ' CE2' ' A' ' 135' ' ' TYR . 86.6 t -81.3 -36.19 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.629 1.572 . . . . 0.0 112.632 -164.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.4 m -104.97 4.22 31.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 58.19 -5.89 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.89 2.476 . . . . 0.0 117.358 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -146.27 121.43 5.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.638 1.975 . . . . 0.0 108.598 166.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.25 130.44 7.2 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.66 2.24 . . . . 0.0 111.801 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 68.5 p -128.45 136.85 51.41 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.968 1.307 . . . . 0.0 110.886 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.0 mt -130.03 140.56 39.01 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.259 1.424 . . . . 0.0 110.452 -172.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.17 156.42 78.76 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 120.939 1.371 . . . . 0.0 110.895 -8.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -138.25 160.01 40.56 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.69 135.61 52.31 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.536 1.134 . . . . 0.0 112.192 177.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -127.21 141.65 51.68 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.637 1.975 . . . . 0.0 109.155 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.6 mt -130.61 118.5 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.2 tptt 46.74 52.88 10.84 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 127.331 2.253 . . . . 0.0 115.647 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.81 28.64 18.38 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -127.89 137.29 52.26 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.093 -1.004 . . . . 0.0 110.508 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -70.35 130.39 41.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.408 0.623 . . . . 0.0 112.121 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.75 -47.58 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.063 0.945 . . . . 0.0 110.181 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.15 175.31 22.17 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.519 0.967 . . . . 0.0 115.519 171.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.64 169.99 54.65 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.258 0.933 . . . . 0.0 112.793 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.23 -43.4 10.28 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.109 1.364 . . . . 0.0 113.189 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.434 ' O ' ' HE3' ' A' ' 163' ' ' LYS . 19.7 t70 -60.24 -24.87 65.22 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.943 0.897 . . . . 0.0 113.283 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.4 mm -92.1 -47.01 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.675 1.59 . . . . 0.0 110.471 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.04 -36.55 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.361 1.864 . . . . 0.0 111.808 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -60.58 -50.92 71.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 159' ' ' ASP . 60.1 mttt -60.86 -38.62 86.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.625 0.37 . . . . 0.0 110.231 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.5 mtp -67.85 -35.5 78.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.748 0.819 . . . . 0.0 112.577 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.59 -46.24 69.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.602 1.161 . . . . 0.0 111.721 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -74.13 -16.29 61.01 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.8 m -100.78 -9.86 21.34 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.09 1.356 . . . . 0.0 114.353 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.17 -4.25 67.93 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-N 119.661 1.119 . . . . 0.0 114.453 -170.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.99 -34.12 74.3 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.866 -1.373 . . . . 0.0 113.532 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tt -61.67 -41.01 96.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.763 1.225 . . . . 0.0 111.029 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -67.31 -31.3 71.5 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.303 1.841 . . . . 0.0 113.239 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -57.02 -43.14 81.54 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.24 1.016 . . . . 0.0 111.837 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -73.6 -49.57 25.53 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 172.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.65 -39.02 90.94 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.844 -0.535 . . . . 0.0 112.128 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -69.49 -40.76 76.85 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.683 0.793 . . . . 0.0 111.393 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.82 -27.7 65.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.536 1.535 . . . . 0.0 113.455 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -75.06 -4.49 38.77 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.403 -0.81 . . . . 0.0 112.877 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.59 15.81 51.48 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 125.072 1.32 . . . . 0.0 114.498 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.0 mt -103.8 123.72 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.159 0.98 . . . . 0.0 109.976 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.3 m -85.27 133.58 34.16 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.36 0.6 . . . . 0.0 111.633 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -128.92 170.14 13.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.494 2.318 . . . . 0.0 111.957 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -81.38 154.02 26.67 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.395 -0.815 . . . . 0.0 111.278 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -81.19 139.5 35.51 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.255 1.385 0 C-N-CA 126.814 2.046 . . . . 0.0 113.119 -178.194 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.1 m -65.24 -24.05 67.22 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.299 1.408 . . . . 0.0 113.672 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.5 m -83.21 -7.57 59.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.84 22.72 78.29 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.419 1.009 . . . . 0.0 115.265 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.0 pt -100.25 153.86 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.578 1.551 . . . . 0.0 112.842 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.44 164.06 35.97 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.708 0.671 . . . . 0.0 114.44 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.46 -131.4 7.13 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.365 1.936 . . . . 0.0 113.488 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -109.17 106.75 16.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.112 2.165 . . . . 0.0 109.814 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.9 p -148.03 142.49 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.051 1.34 . . . . 0.0 111.011 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -142.62 150.98 41.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.153 1.381 . . . . 0.0 112.559 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -127.11 141.03 51.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.455 1.902 . . . . 0.0 110.368 173.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.0 mm -80.42 124.48 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.439 -0.788 . . . . 0.0 111.953 -175.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -155.72 127.02 7.16 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.14 1.776 . . . . 0.0 110.067 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -145.29 154.43 42.35 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.12 2.568 . . . . 0.0 111.077 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.7 p -73.5 134.46 43.87 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -93.57 146.69 32.26 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.348 1.059 . . . . 0.0 110.784 164.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.45 158.71 36.44 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.139 2.559 . . . . 0.0 111.602 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -92.18 -4.55 54.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.226 1.011 . . . . 0.0 113.328 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -142.24 153.56 44.06 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.707 1.603 . . . . 0.0 111.69 -174.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -105.98 154.16 39.68 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 126.09 1.756 . . . . 0.0 111.777 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.73 155.29 63.01 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.887 3.058 . . . . 0.0 116.162 -168.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -119.93 123.96 44.83 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.43 2.292 . . . . 0.0 110.387 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt 52.96 31.91 11.77 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.823 2.049 . . . . 0.0 114.072 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.8 t -145.21 144.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 127.122 2.169 . . . . 0.0 109.399 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.2 t -63.23 143.29 57.92 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.72 -11.52 58.55 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 49.49 -119.85 1.33 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.783 2.033 . . . . 0.0 112.001 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.0 tp -138.02 146.41 43.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.595 2.358 . . . . 0.0 109.329 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.1 137.34 41.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.463 0.705 . . . . 0.0 112.516 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.31 -36.58 78.24 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.345 1.058 . . . . 0.0 111.71 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -65.52 -34.39 78.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.756 2.023 . . . . 0.0 113.806 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -73.21 -48.38 35.54 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.964 0.906 . . . . 0.0 112.728 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.8 tp -73.69 -13.13 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.136 0.974 . . . . 0.0 113.507 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.6 -22.86 50.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.602 0.761 . . . . 0.0 112.72 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 49.3 ttm -110.27 120.6 42.96 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.467 1.107 . . . . 0.0 111.21 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.6 m -81.91 141.56 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 158.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -94.87 111.52 23.3 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -170.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -62.79 -30.51 71.52 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -156.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.76 -32.73 72.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.272 1.396 . . . . 0.0 112.572 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.81 -44.37 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.375 1.07 . . . . 0.0 109.738 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -58.0 -36.86 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.04 1.336 . . . . 0.0 112.311 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.17 -37.14 86.41 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.762 -1.211 . . . . 0.0 112.33 170.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.2 m -75.89 -50.9 13.74 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.162 0.985 . . . . 0.0 111.694 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.1 pt -61.2 -34.34 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.745 0.818 . . . . 0.0 111.83 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -80.85 -29.34 35.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.444 1.897 . . . . 0.0 114.486 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.1 t -74.25 -41.13 61.79 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.636 0.774 . . . . 0.0 111.209 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.82 138.29 32.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.26 1.024 . . . . 0.0 110.715 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.43 -31.89 24.39 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.252 -0.905 . . . . 0.0 112.538 -169.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.6 t -138.58 126.56 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.854 1.262 . . . . 0.0 109.546 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.0 t -130.53 131.21 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.406 1.482 . . . . 0.0 110.565 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.9 t -133.77 156.71 47.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.664 1.185 . . . . 0.0 110.457 172.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.67 142.74 49.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.146 169.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 mt -132.56 157.38 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.383 1.473 . . . . 0.0 109.403 -162.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.7 101.23 2.51 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 156.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.23 -154.82 27.93 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.174 0.897 . . . . 0.0 114.214 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.21 154.67 39.45 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 125.655 1.582 . . . . 0.0 111.969 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -65.67 -19.99 59.69 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.287 1.991 . . . . 0.0 113.605 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -93.9 -13.06 27.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.582 1.553 . . . . 0.0 113.986 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.54 73.34 11.68 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.544 1.537 . . . . 0.0 112.353 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.4 148.64 67.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.943 2.429 . . . . 0.0 111.874 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.4 mmt -104.42 -0.3 28.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.3 1.84 . . . . 0.0 113.631 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 17.1 t -146.46 144.83 29.94 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.969 1.307 . . . . 0.0 111.428 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.2 -38.66 80.45 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -72.23 -29.87 64.35 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.048 -1.033 . . . . 0.0 112.279 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 m -66.89 -34.45 77.81 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.346 167.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -67.27 -45.59 76.17 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.77 1.168 . . . . 0.0 112.781 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -57.27 -33.28 67.47 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.002 0.921 . . . . 0.0 112.915 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.0 tpt -56.07 -43.56 78.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.951 0.901 . . . . 0.0 111.865 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 mm -69.55 -33.34 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.337 1.055 . . . . 0.0 111.3 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.4 -34.91 79.41 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.36 -1.462 . . . . 0.0 112.771 172.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.81 -43.16 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.902 0.481 . . . . 0.0 110.728 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.9 mt -65.77 -37.92 87.64 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -66.65 -31.49 72.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.403 -1.436 . . . . 0.0 113.078 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.0 -25.49 68.41 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.613 -1.304 . . . . 0.0 113.374 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.04 -13.01 21.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.881 1.272 . . . . 0.0 114.154 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.6 13.0 67.92 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.568 1.08 . . . . 0.0 115.03 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.76 134.35 55.1 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.773 1.229 . . . . 0.0 112.905 174.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -113.68 157.93 21.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.772 1.229 . . . . 0.0 111.548 168.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -137.24 171.95 13.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.982 1.713 . . . . 0.0 111.418 -161.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.4 m -83.97 120.4 26.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.545 1.164 . . . . 0.0 108.842 -166.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.6 m -126.18 124.26 40.08 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.645 -155.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.25 157.98 18.3 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.305 1.042 . . . . 0.0 111.959 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -120.16 117.18 27.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.803 1.241 . . . . 0.0 111.292 -171.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.5 p -71.58 -27.7 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.3 -37.99 68.84 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.343 -0.848 . . . . 0.0 110.506 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.61 -31.62 22.51 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -141.4 107.38 6.09 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 119.466 1.03 . . . . 0.0 113.136 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -60.15 -15.49 34.48 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.648 2.898 . . . . 0.0 116.758 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 p -49.22 -32.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.552 1.524 . . . . 0.0 112.743 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.96 -44.46 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.94 0.896 . . . . 0.0 111.646 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 ptm85 -71.71 -27.52 63.07 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.916 0.78 . . . . 0.0 112.208 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m -67.05 -48.94 66.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.27 0.628 . . . . 0.0 112.259 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -38.86 71.23 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.489 1.04 . . . . 0.0 113.002 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.46 -32.46 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.508 1.049 . . . . 0.0 112.188 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -62.47 -41.99 99.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.883 0.873 . . . . 0.0 112.248 170.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.56 -47.29 55.92 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.537 -0.727 . . . . 0.0 111.771 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.6 t -82.82 -40.62 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -173.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.6 m -102.57 -12.86 17.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 64.84 -47.19 0.34 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 169.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -129.0 89.75 47.75 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.085 1.754 . . . . 0.0 106.784 164.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -89.6 158.23 5.28 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.935 2.424 . . . . 0.0 113.771 -166.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.0 p -122.98 151.57 41.72 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.874 1.669 . . . . 0.0 108.918 161.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 55.0 mt -125.07 127.26 25.1 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 124.007 0.923 . . . . 0.0 109.089 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.93 161.54 65.25 Favored 'Cis proline' 0 CA--C 1.542 0.9 0 CA-C-N 119.766 0.952 . . . . 0.0 113.948 7.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -135.26 158.74 43.6 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.358 1.863 . . . . 0.0 110.836 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.81 140.54 51.97 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.141 1.376 . . . . 0.0 113.234 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -133.79 143.0 48.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.886 2.074 . . . . 0.0 109.832 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.8 mt -129.66 117.48 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.591 0.756 . . . . 0.0 109.306 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.5 tptt 43.54 47.41 6.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.359 2.263 . . . . 0.0 113.745 -170.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.95 16.88 9.59 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.15 140.11 34.86 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.734 -1.229 . . . . 0.0 109.535 162.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -80.04 125.45 29.79 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.378 -0.826 . . . . 0.0 112.418 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.5 t -102.68 -47.14 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 124.656 1.182 . . . . 0.0 111.8 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.65 176.91 32.25 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.39 168.42 53.82 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.859 1.218 . . . . 0.0 113.341 165.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -45.59 -44.69 13.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.322 1.849 . . . . 0.0 113.817 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.78 -26.55 66.16 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.718 -0.614 . . . . 0.0 112.528 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.3 mm -79.22 -46.61 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.118 1.367 . . . . 0.0 110.389 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.1 t -57.73 -35.94 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.335 1.854 . . . . 0.0 111.337 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 86.7 m -64.06 -41.61 97.3 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.696 0.798 . . . . 0.0 112.527 173.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -65.95 -44.06 86.13 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.315 0.961 . . . . 0.0 110.198 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.7 mtt -61.51 -35.7 78.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.372 1.069 . . . . 0.0 112.317 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.81 -45.52 74.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.614 1.166 . . . . 0.0 111.984 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -69.78 -33.19 72.05 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.814 0.733 . . . . 0.0 112.479 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.6 t -86.23 -30.39 22.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.81 2.42 52.47 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 120.656 -1.278 . . . . 0.0 115.463 -171.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -68.17 -35.03 77.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.107 1.454 . . . . 0.0 112.086 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -45.5 85.14 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.34 -0.85 . . . . 0.0 110.158 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.86 -38.56 82.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.46 1.504 . . . . 0.0 113.136 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -60.6 -48.41 81.92 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.959 0.503 . . . . 0.0 111.66 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.1 mtm -70.85 -44.7 65.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.44 -37.84 88.93 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.503 -0.748 . . . . 0.0 111.176 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -72.57 -32.42 66.02 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.42 -28.35 69.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.278 1.031 . . . . 0.0 111.891 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 6.16 13.73 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.303 1.841 . . . . 0.0 113.771 171.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.14 -2.78 86.38 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.744 2.116 . . . . 0.0 113.7 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.4 mt -82.15 142.72 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.617 1.209 . . . . 0.0 110.459 -165.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 m -101.12 128.82 47.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.348 1.459 . . . . 0.0 110.273 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.8 p -132.04 170.69 14.59 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.81 1.644 . . . . 0.0 112.883 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -65.15 129.47 39.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.961 0.904 . . . . 0.0 109.755 166.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -137.69 145.0 42.05 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--O 1.253 1.242 0 C-N-CA 126.651 1.98 . . . . 0.0 113.44 -179.308 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.9 m -82.08 -34.83 29.2 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.122 1.769 . . . . 0.0 111.879 171.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.0 m -71.89 132.69 44.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.093 0.957 . . . . 0.0 112.565 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.22 25.97 67.33 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 115.811 1.084 . . . . 0.0 115.811 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.4 tt -135.71 132.91 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.195 1.398 . . . . 0.0 110.523 170.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.32 160.54 49.0 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.473 1.035 . . . . 0.0 114.272 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.34 103.76 1.49 Allowed Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.866 1.698 . . . . 0.0 112.949 -175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -107.25 148.3 29.13 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.37 1.468 . . . . 0.0 112.598 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -99.53 151.29 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.371 1.068 . . . . 0.0 113.285 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -108.39 161.62 14.86 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.415 1.886 . . . . 0.0 112.926 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -114.28 148.27 37.75 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.966 1.306 . . . . 0.0 114.17 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.1 tt -152.43 145.72 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.655 1.582 . . . . 0.0 112.194 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -120.66 126.2 49.62 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 0.0 111.176 174.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.59 159.63 43.24 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.387 1.475 . . . . 0.0 113.429 -166.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.7 m -155.92 103.46 2.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.043 1.337 . . . . 0.0 109.763 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -74.83 141.53 75.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.13 162.69 25.79 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.052 3.168 . . . . 0.0 111.971 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -77.8 -7.21 56.29 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -67.5 122.13 17.32 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.158 0.983 . . . . 0.0 110.651 176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -73.91 144.33 82.37 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 122.936 0.495 . . . . 0.0 111.461 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.55 149.92 89.78 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.939 2.426 . . . . 0.0 112.658 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -65.34 122.91 18.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.426 1.09 . . . . 0.0 111.823 -169.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.22 157.58 25.45 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.158 0.983 . . . . 0.0 111.544 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t 63.78 -25.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 127.835 2.454 . . . . 0.0 115.134 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 t -80.7 149.32 29.78 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.53 1.132 . . . . 0.0 113.157 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.88 58.98 5.12 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.417 1.087 . . . . 0.0 109.847 159.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.49 142.22 48.55 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.861 0.865 . . . . 0.0 111.849 -172.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tt -135.48 132.93 37.97 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.118 -0.989 . . . . 0.0 111.827 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.15 149.66 38.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.691 1.197 . . . . 0.0 112.657 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.69 -31.97 73.27 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -60.56 -28.8 68.72 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.923 -1.11 . . . . 0.0 113.044 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -56.4 -21.39 24.73 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.342 1.457 . . . . 0.0 113.596 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 97.7 mt -67.71 -26.53 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.144 0.978 . . . . 0.0 110.855 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.08 0.39 14.97 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.053 1.341 . . . . 0.0 114.459 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.3 mtt -73.26 112.89 9.74 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -146.85 133.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.713 0.805 . . . . 0.0 111.672 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -113.15 98.09 6.92 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.913 0.885 . . . . 0.0 108.669 169.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -59.63 -40.59 88.13 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.542 1.537 . . . . 0.0 113.862 -160.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -76.13 -29.59 57.89 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.9 mt -78.57 -40.81 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.855 0.862 . . . . 0.0 110.504 174.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -58.94 -39.44 81.62 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.934 0.894 . . . . 0.0 111.738 168.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.4 -33.11 74.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.431 1.093 . . . . 0.0 112.586 169.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.6 m -63.67 -49.94 71.2 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.185 0.902 . . . . 0.0 111.079 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 pt -60.25 -34.47 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.412 1.005 . . . . 0.0 112.175 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -77.91 -30.15 50.5 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.326 1.851 . . . . 0.0 113.397 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 t -87.02 -34.01 19.37 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.796 1.638 . . . . 0.0 113.162 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.22 147.93 27.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.716 2.006 . . . . 0.0 110.503 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -70.11 -43.25 71.41 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 119.943 -1.723 . . . . 0.0 112.525 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -141.1 132.9 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.974 0.91 . . . . 0.0 112.17 -171.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.56 140.93 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.156 1.382 . . . . 0.0 112.266 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 t -133.02 158.98 41.36 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.925 1.29 . . . . 0.0 111.632 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -132.43 141.09 48.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.247 0.546 . . . . 0.0 112.045 171.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.6 mt -134.48 156.9 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.622 1.969 . . . . 0.0 109.336 -163.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -66.27 101.57 0.74 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 150.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 -140.39 20.15 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 121.126 -0.984 . . . . 0.0 114.277 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.8 mt -111.58 155.9 42.25 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 125.274 1.43 . . . . 0.0 112.581 -170.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.59 -12.61 31.6 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.727 2.284 . . . . 0.0 113.094 172.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -91.53 -26.93 18.53 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.827 1.651 . . . . 0.0 112.113 170.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.39 78.01 12.37 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.204 1.802 . . . . 0.0 111.872 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.05 143.21 17.78 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.106 2.537 . . . . 0.0 112.356 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 33.9 ttm -102.6 10.57 38.66 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.561 1.544 . . . . 0.0 113.352 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 51.4 t -145.09 145.18 31.32 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.917 -1.115 . . . . 0.0 111.843 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -36.79 83.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.493 1.117 . . . . 0.0 112.845 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -69.23 -24.45 64.01 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.066 -1.022 . . . . 0.0 112.544 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.55 -34.44 72.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.921 -1.112 . . . . 0.0 113.972 163.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -61.29 -39.6 91.06 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.453 1.479 . . . . 0.0 111.32 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -60.54 -38.6 84.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.713 0.805 . . . . 0.0 112.803 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.62 -47.58 78.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.652 1.181 . . . . 0.0 112.399 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.65 -32.17 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.408 -0.808 . . . . 0.0 111.369 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.73 -34.73 67.79 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.702 -1.249 . . . . 0.0 113.207 171.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.31 -41.85 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 122.673 0.389 . . . . 0.0 110.766 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -39.43 93.88 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.107 0.963 . . . . 0.0 112.229 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.27 -34.18 76.88 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.136 -0.978 . . . . 0.0 112.358 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.06 -23.58 63.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.436 1.095 . . . . 0.0 113.78 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.2 mt -95.9 -13.18 24.13 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.024 0.929 . . . . 0.0 113.244 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.07 18.64 67.11 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.277 0.941 . . . . 0.0 113.696 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 17.9 mt -113.12 130.71 56.1 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.581 1.552 . . . . 0.0 112.697 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -116.28 147.23 41.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.828 0.851 . . . . 0.0 112.941 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -129.35 172.45 11.49 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.027 2.531 . . . . 0.0 111.167 -163.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.3 m -86.4 133.9 33.75 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.365 -0.834 . . . . 0.0 110.405 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 t -131.12 146.9 52.52 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -164.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.01 152.71 39.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.167 1.787 . . . . 0.0 112.302 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -100.42 118.11 35.98 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.374 1.07 . . . . 0.0 111.426 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.6 p -66.4 -25.22 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.312 0.645 . . . . 0.0 112.624 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 tp -73.92 -22.21 59.77 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.028 0.931 . . . . 0.0 111.786 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.84 -29.88 11.19 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -125.08 106.44 28.47 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.88 -28.31 38.58 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.401 3.4 . . . . 0.0 115.663 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.67 -35.48 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.66 0.784 . . . . 0.0 112.111 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.81 -48.97 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.506 0.723 . . . . 0.0 110.871 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -70.75 -30.97 67.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.043 0.537 . . . . 0.0 112.056 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.8 m -69.38 -47.46 64.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.633 0.651 . . . . 0.0 112.301 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.5 -40.4 77.03 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.022 -1.049 . . . . 0.0 112.293 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.93 -35.81 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 120.651 -1.281 . . . . 0.0 112.539 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -65.87 -44.95 83.88 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.732 0.813 . . . . 0.0 111.64 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.6 -41.38 92.83 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.648 0.779 . . . . 0.0 112.956 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.35 -41.94 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.3 m -98.94 1.64 45.77 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.855 1.207 . . . . 0.0 113.91 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 67.29 -22.82 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.368 2.667 . . . . 0.0 116.448 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -145.94 132.23 9.67 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.788 1.635 . . . . 0.0 109.458 171.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.31 126.98 5.72 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.876 1.717 . . . . 0.0 113.188 -165.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.8 p -135.52 136.85 41.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.446 1.898 . . . . 0.0 111.275 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.9 mm -128.05 137.42 30.77 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 125.458 1.503 . . . . 0.0 110.745 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.64 160.57 76.48 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 121.341 1.515 . . . . 0.0 112.447 -4.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -134.88 159.63 40.81 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.968 1.307 . . . . 0.0 110.515 -172.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.33 139.46 53.28 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -124.11 140.8 52.62 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.796 2.038 . . . . 0.0 110.411 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.8 mt -130.2 123.32 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.456 1.102 . . . . 0.0 108.387 170.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm 45.54 49.92 10.63 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.886 2.075 . . . . 0.0 114.88 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.4 26.45 15.35 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -118.41 138.23 52.6 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.767 1.227 . . . . 0.0 108.689 164.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.49 125.49 30.03 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.459 -0.775 . . . . 0.0 111.093 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 t -80.55 -40.49 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.499 1.119 . . . . 0.0 110.261 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.81 175.64 34.92 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.373 1.463 . . . . 0.0 114.327 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.25 172.14 55.19 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.852 0.739 . . . . 0.0 113.885 165.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.3 tp -48.65 -42.67 35.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.069 1.347 . . . . 0.0 113.686 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -59.41 -25.32 64.22 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.832 1.253 . . . . 0.0 113.018 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 mm -91.23 -46.6 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.27 1.428 . . . . 0.0 110.122 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.73 -40.89 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.249 1.42 . . . . 0.0 111.583 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.6 p -64.78 -40.93 96.08 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -68.43 -40.87 81.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.274 0.63 . . . . 0.0 112.211 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.9 mtt -63.23 -36.09 82.49 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.329 1.052 . . . . 0.0 112.68 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.76 -42.3 77.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.468 1.107 . . . . 0.0 112.299 174.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -65.29 -39.32 92.4 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.16 0.584 . . . . 0.0 111.418 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 36.7 t -82.66 -28.08 30.89 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.262 1.825 . . . . 0.0 115.159 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.61 -2.19 67.02 Favored Glycine 0 N--CA 1.48 1.579 0 O-C-N 120.47 -1.394 . . . . 0.0 114.665 -170.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -64.07 -35.79 81.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.646 1.223 . . . . 0.0 112.263 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.66 -45.69 85.64 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.848 0.859 . . . . 0.0 110.881 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -59.33 -40.6 86.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.68 1.592 . . . . 0.0 112.748 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -65.76 -36.55 83.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 118.215 -0.897 . . . . 0.0 112.632 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 61.2 mtm -70.04 -50.44 41.29 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.73 1.15 . . . . 0.0 113.295 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -62.33 -35.02 77.8 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.259 -0.901 . . . . 0.0 111.91 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -64.35 -37.98 89.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.603 0.761 . . . . 0.0 112.846 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.18 -30.04 71.12 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.077 0.853 . . . . 0.0 111.977 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.03 5.11 17.43 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.176 1.79 . . . . 0.0 114.275 171.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.28 12.8 75.32 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.3 1.428 . . . . 0.0 114.573 173.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 60.3 mt -94.31 145.35 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 118.266 1.033 . . . . 0.0 111.276 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 29.0 m -105.13 131.29 52.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.106 1.362 . . . . 0.0 110.743 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.4 p -133.89 171.02 14.75 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.478 1.911 . . . . 0.0 112.81 -175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -56.98 138.41 54.29 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.158 0.983 . . . . 0.0 112.726 164.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -137.09 147.28 45.99 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.009 1.324 . . . . 0.0 112.431 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.5 mt . . . . . 0 C--O 1.255 1.363 0 C-N-CA 128.111 2.564 . . . . 0.0 116.272 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m -67.08 -36.83 82.85 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -165.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.2 t 57.46 157.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.249 1.42 . . . . 0.0 113.149 -157.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.28 27.26 66.33 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 120.797 -1.189 . . . . 0.0 113.008 -170.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.1 pt -69.19 162.63 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.221 1.009 . . . . 0.0 113.112 -171.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.81 171.53 34.39 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.561 1.077 . . . . 0.0 114.697 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 144.68 -45.83 0.83 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.427 1.965 . . . . 0.0 111.911 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -91.53 152.56 20.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.017 0.927 . . . . 0.0 111.477 159.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 m -68.87 147.52 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.058 0.543 . . . . 0.0 111.558 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -106.41 92.45 4.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.296 1.439 . . . . 0.0 110.541 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -159.34 133.81 7.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.412 1.485 . . . . 0.0 108.851 169.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.9 tp -140.66 105.9 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 122.262 1.029 . . . . 0.0 111.64 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -151.48 147.77 27.25 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.079 2.152 . . . . 0.0 109.934 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -127.6 141.52 51.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.248 1.419 . . . . 0.0 109.343 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.7 m -103.57 137.04 42.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.514 1.526 . . . . 0.0 110.379 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -82.3 148.12 58.58 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.06 156.29 55.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.362 2.708 . . . . 0.0 113.033 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -106.96 5.38 28.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.856 1.662 . . . . 0.0 113.087 -173.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -76.78 155.51 33.07 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.499 1.92 . . . . 0.0 114.256 -160.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -68.21 143.13 95.56 Favored Pre-proline 0 CA--C 1.551 1.016 0 O-C-N 121.221 -0.924 . . . . 0.0 112.104 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.14 154.02 75.7 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.042 3.162 . . . . 0.0 114.954 -169.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -85.19 140.57 30.8 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.542 1.137 . . . . 0.0 112.908 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -77.57 -36.51 51.97 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.501 1.52 . . . . 0.0 112.118 171.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.5 m -67.84 149.39 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.698 0.799 . . . . 0.0 109.942 164.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -68.06 116.23 8.45 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.506 -0.746 . . . . 0.0 111.821 -174.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.16 143.5 50.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.917 1.687 . . . . 0.0 109.95 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -157.93 35.15 0.25 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -166.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.5 tt -121.53 152.85 38.73 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.901 0.88 . . . . 0.0 111.69 -175.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.91 119.1 23.78 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.616 1.566 . . . . 0.0 110.976 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -57.09 -41.73 79.41 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.596 1.958 . . . . 0.0 114.225 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.91 -36.29 76.68 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.083 1.753 . . . . 0.0 113.468 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -71.98 -24.78 61.64 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.5 mt -103.85 -28.08 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.937 1.295 . . . . 0.0 111.917 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.29 -16.44 56.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.827 1.251 . . . . 0.0 112.661 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 19.1 ttt -132.2 112.1 11.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.519 1.528 . . . . 0.0 109.18 161.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.5 t -82.98 132.05 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.426 -0.796 . . . . 0.0 111.682 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -77.67 109.54 11.74 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.635 1.174 . . . . 0.0 110.283 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -63.77 -28.17 69.69 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.538 1.135 . . . . 0.0 113.507 -166.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -59.23 -37.62 77.95 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.96 0.904 . . . . 0.0 112.83 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mp -78.21 -42.15 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.805 0.842 . . . . 0.0 110.219 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -58.83 -39.82 82.38 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.66 0.784 . . . . 0.0 112.602 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -72.41 -27.65 62.49 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.626 1.17 . . . . 0.0 112.822 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.3 m -72.04 -44.42 63.39 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.805 1.184 . . . . 0.0 109.063 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 90.0 mt -55.56 -40.89 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.499 1.519 . . . . 0.0 110.733 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -77.62 -37.94 49.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.021 1.328 . . . . 0.0 113.255 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 t -95.57 -28.08 15.03 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.219 1.408 . . . . 0.0 114.382 -165.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -87.3 145.98 26.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.306 1.042 . . . . 0.0 111.505 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -66.67 -44.83 80.75 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.962 0.905 . . . . 0.0 112.109 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.9 t -141.7 134.45 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.771 1.229 . . . . 0.0 111.7 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.98 133.9 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.126 1.37 . . . . 0.0 111.816 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 t -133.7 156.33 48.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.619 1.568 . . . . 0.0 110.936 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -132.61 139.62 47.86 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.39 1.076 . . . . 0.0 110.399 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mt -137.1 158.39 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.851 1.66 . . . . 0.0 109.064 -165.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.91 106.51 9.81 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 154.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.44 -149.65 21.35 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.833 1.206 . . . . 0.0 113.096 -172.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.98 156.93 51.69 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.327 1.451 . . . . 0.0 111.114 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.97 -33.9 72.89 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 121.408 1.539 . . . . 0.0 113.378 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -82.79 -13.96 55.29 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.913 -1.117 . . . . 0.0 113.263 173.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.26 70.3 13.02 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.985 1.714 . . . . 0.0 112.839 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.11 151.93 21.14 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.24 2.627 . . . . 0.0 111.574 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 85.3 mtp -97.4 12.19 34.05 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.7 t -148.97 145.25 27.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.746 1.219 . . . . 0.0 111.245 176.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.12 -39.84 86.7 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.558 -0.714 . . . . 0.0 112.897 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -62.75 -34.56 77.48 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.086 -1.009 . . . . 0.0 111.858 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.9 m -68.45 -31.03 70.05 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.284 -0.885 . . . . 0.0 112.664 170.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -66.02 -38.56 88.73 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.083 1.31 . . . . 0.0 112.425 168.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -59.73 -31.39 69.58 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.201 1.0 . . . . 0.0 112.69 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.6 tpt -60.04 -47.15 87.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.993 0.917 . . . . 0.0 111.618 169.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mm -70.89 -33.99 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.25 -0.906 . . . . 0.0 112.81 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -58.06 -35.81 71.88 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.741 -1.225 . . . . 0.0 112.404 168.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.67 -38.7 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 122.264 -0.272 . . . . 0.0 111.281 176.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.77 -34.72 78.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.235 1.014 . . . . 0.0 113.323 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.1 -40.39 95.71 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.089 -1.007 . . . . 0.0 111.629 167.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.71 -21.7 64.39 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 tp -96.88 -15.86 21.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.929 1.292 . . . . 0.0 112.725 170.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.98 12.17 56.71 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.188 1.852 . . . . 0.0 114.932 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.5 133.06 54.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 111.76 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -111.76 150.98 29.5 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.254 1.025 . . . . 0.0 113.201 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.73 175.79 8.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.817 2.047 . . . . 0.0 112.284 -161.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.86 117.51 25.65 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.374 -0.829 . . . . 0.0 109.481 -167.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 m -126.74 129.5 48.51 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.882 0.873 . . . . 0.0 112.17 -154.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -128.29 143.01 50.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.4 77.67 9.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.91 3.284 . . . . 0.0 111.427 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.3 p -74.18 -9.74 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -167.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.07 -22.98 22.66 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.329 -0.857 . . . . 0.0 112.156 169.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.98 -32.85 21.31 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.819 0.736 . . . . 0.0 112.232 174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.53 107.06 10.92 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.129 0.972 . . . . 0.0 111.569 163.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.66 -16.2 41.83 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.717 2.278 . . . . 0.0 114.203 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.4 p -39.75 -43.38 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.616 1.966 . . . . 0.0 115.82 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 t -67.25 -43.55 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.048 -1.033 . . . . 0.0 111.248 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -64.1 -41.09 97.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.008 1.323 . . . . 0.0 111.162 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.5 m -59.02 -45.73 89.98 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.193 0.997 . . . . 0.0 111.681 -177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -75.33 -37.11 60.9 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -35.11 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 121.058 1.754 . . . . 0.0 112.091 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.53 -35.15 73.64 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.614 1.566 . . . . 0.0 112.28 170.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.88 -35.8 59.74 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.447 1.022 . . . . 0.0 113.349 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 81.1 t -80.38 -45.33 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.317 0.962 . . . . 0.0 113.214 -173.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.3 p -105.27 13.61 30.22 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.646 1.566 . . . . 0.0 115.078 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 68.57 -29.87 0.17 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 128.153 2.581 . . . . 0.0 117.143 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -149.65 130.02 6.84 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 120.632 1.56 . . . . 0.0 112.868 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -94.8 147.77 1.69 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.669 2.913 . . . . 0.0 114.413 -177.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.0 p -129.79 152.41 49.31 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.552 1.541 . . . . 0.0 110.182 162.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.1 124.24 23.77 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.994 0.918 . . . . 0.0 110.553 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.58 157.04 72.31 Favored 'Cis proline' 0 CA--C 1.543 0.944 0 CA-C-N 120.227 1.117 . . . . 0.0 113.312 -2.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -151.72 160.55 43.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.183 1.393 . . . . 0.0 111.269 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.94 141.97 51.67 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -128.7 142.48 51.0 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.1 2.16 . . . . 0.0 110.868 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.4 mt -136.88 130.59 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.123 1.369 . . . . 0.0 109.688 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt 48.19 43.87 19.01 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.867 1.667 . . . . 0.0 114.573 -172.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.21 13.25 5.71 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.061 1.744 . . . . 0.0 114.889 -172.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -112.77 141.9 46.03 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.76 1.624 . . . . 0.0 111.103 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -72.51 126.26 29.43 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.105 0.955 . . . . 0.0 112.556 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.3 t -104.49 -54.97 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.28 1.432 . . . . 0.0 112.356 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 167.09 163.29 20.68 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.48 169.0 54.16 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.991 1.758 . . . . 0.0 113.441 168.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.4 tp -46.84 -45.35 20.15 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.315 1.446 . . . . 0.0 113.803 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.2 -21.24 66.49 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.881 1.272 . . . . 0.0 112.748 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.3 mm -92.36 -44.42 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.599 1.96 . . . . 0.0 111.193 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.9 -36.0 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.046 1.738 . . . . 0.0 112.066 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -56.58 -49.81 73.77 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 170.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -61.74 -42.02 98.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.442 0.697 . . . . 0.0 110.362 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.8 mtt -66.55 -39.12 88.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.221 1.009 . . . . 0.0 112.981 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -68.36 -39.72 81.73 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.015 1.326 . . . . 0.0 112.156 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.88 -31.57 61.63 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 30.7 t -79.25 -26.97 42.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.811 1.245 . . . . 0.0 113.603 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.53 -0.64 80.74 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.082 0.849 . . . . 0.0 114.511 -168.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.04 -36.72 80.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.71 1.755 . . . . 0.0 111.781 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.1 -42.51 98.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.889 0.876 . . . . 0.0 110.906 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -69.06 -35.42 76.53 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 126.234 1.814 . . . . 0.0 112.973 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -58.05 -48.84 78.87 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.154 1.343 . . . . 0.0 110.946 171.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 70.3 mtm -67.89 -38.59 83.2 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.27 -43.64 77.35 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.341 0.973 . . . . 0.0 112.832 172.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -72.24 -26.35 61.98 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.309 -0.87 . . . . 0.0 113.305 -171.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.71 -30.12 63.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.321 1.048 . . . . 0.0 112.672 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -87.39 -2.5 58.66 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.51 16.36 55.3 Favored Glycine 0 N--CA 1.47 0.926 0 O-C-N 120.66 -1.275 . . . . 0.0 113.815 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.3 mt -86.19 147.67 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.323 1.049 . . . . 0.0 110.801 -171.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.6 m -105.04 124.44 49.54 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.091 1.356 . . . . 0.0 112.681 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 25.5 p -125.53 169.17 12.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.806 2.442 . . . . 0.0 111.441 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -57.31 149.24 20.73 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.087 -1.008 . . . . 0.0 112.087 171.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.85 144.92 47.41 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.749 0.82 . . . . 0.0 112.319 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.072 1.749 . . . . 0.0 111.095 -171.421 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.4 p . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.0 p -103.15 -18.71 14.81 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -165.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.5 p -101.42 18.54 19.84 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.722 1.146 . . . . 0.0 113.931 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.88 -22.74 2.78 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.847 1.689 . . . . 0.0 115.368 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.1 tt -139.07 164.81 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 127.384 2.273 . . . . 0.0 109.971 170.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.56 -173.68 45.81 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 120.959 -1.088 . . . . 0.0 114.39 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.6 -155.63 28.41 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.265 1.888 . . . . 0.0 112.349 168.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -63.89 127.88 33.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.072 0.949 . . . . 0.0 111.287 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.84 133.1 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.705 1.202 . . . . 0.0 111.308 -169.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 mtm105 -90.32 81.49 6.05 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.119 1.368 . . . . 0.0 110.847 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -143.37 157.77 44.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.215 1.406 . . . . 0.0 111.412 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mt 56.77 38.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.835 1.254 . . . . 0.0 112.174 -173.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.25 138.83 54.27 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.824 -1.172 . . . . 0.0 113.577 -164.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -74.88 138.14 42.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.552 1.541 . . . . 0.0 111.518 -174.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 m -88.73 69.45 8.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.919 1.288 . . . . 0.0 110.642 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -59.38 155.92 33.73 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.803 -168.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.34 152.06 69.67 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.271 1.981 . . . . 0.0 111.386 165.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -98.9 3.24 47.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.604 1.161 . . . . 0.0 113.277 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -61.41 155.42 21.68 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.888 1.275 . . . . 0.0 112.552 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -73.94 147.67 86.37 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 123.451 0.7 . . . . 0.0 110.037 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -63.08 139.38 72.7 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.637 2.225 . . . . 0.0 111.982 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -127.35 135.86 51.11 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.628 1.571 . . . . 0.0 111.757 -175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -129.74 -46.42 1.16 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.836 1.254 . . . . 0.0 111.966 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.5 t -80.23 -28.99 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.435 1.094 . . . . 0.0 112.201 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.1 m -88.83 126.27 35.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.283 1.033 . . . . 0.0 109.892 162.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.0 125.9 30.09 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.328 -0.858 . . . . 0.0 113.309 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -152.45 160.45 43.26 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.346 1.859 . . . . 0.0 111.606 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.8 tp -148.3 138.08 22.32 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.317 1.447 . . . . 0.0 111.404 169.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.74 136.34 42.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.318 1.447 . . . . 0.0 112.234 171.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -60.23 -29.84 69.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.894 1.278 . . . . 0.0 111.876 172.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.08 -28.94 70.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.173 1.789 . . . . 0.0 112.638 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -70.74 -26.69 63.49 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.211 -0.93 . . . . 0.0 112.65 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.4 mm -76.97 -16.18 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.518 1.127 . . . . 0.0 112.071 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.5 2.88 20.44 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.6 mtm -115.89 144.46 44.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.479 1.511 . . . . 0.0 111.808 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.7 m -138.96 153.74 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.67 1.188 . . . . 0.0 113.137 -168.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -119.27 110.56 17.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.959 1.704 . . . . 0.0 110.416 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -63.09 -31.9 73.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.194 0.998 . . . . 0.0 113.648 -176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -64.44 -42.71 95.83 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.6 tp -77.54 -39.14 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.699 -0.626 . . . . 0.0 111.569 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.15 -44.81 92.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.242 1.017 . . . . 0.0 112.213 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.94 -34.28 75.1 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.764 -0.585 . . . . 0.0 112.326 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.4 m -66.26 -48.85 69.12 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.849 0.86 . . . . 0.0 111.817 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -61.54 -33.53 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.743 -0.598 . . . . 0.0 112.455 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.81 -24.78 44.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.85 1.66 . . . . 0.0 113.759 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.5 t -92.52 -34.19 14.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.773 1.629 . . . . 0.0 113.667 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -87.76 147.86 24.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.325 1.05 . . . . 0.0 111.807 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -68.51 -47.63 66.49 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.942 -1.099 . . . . 0.0 113.779 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.9 t -140.39 129.93 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.773 1.229 . . . . 0.0 110.848 -173.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.55 137.64 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.648 1.179 . . . . 0.0 111.315 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -136.54 154.64 50.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.417 1.087 . . . . 0.0 111.758 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -134.5 143.61 47.57 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.753 0.787 . . . . 0.0 112.469 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 mt -136.79 157.45 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.495 1.518 . . . . 0.0 110.227 -155.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -76.19 106.52 7.85 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.973 153.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.26 -161.71 43.42 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.948 0.794 . . . . 0.0 114.257 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.82 156.09 41.06 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.724 1.209 . . . . 0.0 111.94 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -67.39 -21.04 47.72 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.28 1.987 . . . . 0.0 113.088 173.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.59 -24.53 21.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.136 1.374 . . . . 0.0 112.852 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.31 75.77 19.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.796 1.638 . . . . 0.0 111.334 -176.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.66 155.87 40.02 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.722 2.948 . . . . 0.0 112.362 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.3 mtt -109.62 4.04 21.67 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.316 1.446 . . . . 0.0 114.539 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 44.3 t -148.85 147.11 28.35 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.753 1.621 . . . . 0.0 110.523 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.15 94.71 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.698 -0.626 . . . . 0.0 111.548 176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -60.91 -34.66 75.02 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.278 -0.889 . . . . 0.0 112.203 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.8 m -63.48 -48.48 77.45 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 118.865 -0.588 . . . . 0.0 111.136 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -59.08 -48.97 79.67 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.025 0.83 . . . . 0.0 111.055 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -60.84 -28.64 68.98 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.417 1.087 . . . . 0.0 113.037 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 34.4 ttp -68.79 -42.62 77.11 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.6 mm -67.66 -34.57 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.227 -0.921 . . . . 0.0 110.73 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -39.53 72.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.915 1.286 . . . . 0.0 111.956 172.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.44 -42.35 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.557 1.143 . . . . 0.0 111.705 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.9 mt -66.48 -35.53 80.51 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -67.07 -33.62 75.88 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.972 -1.08 . . . . 0.0 112.495 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.79 -25.69 68.29 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.837 -1.164 . . . . 0.0 113.275 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.88 -14.48 20.66 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.426 1.09 . . . . 0.0 113.717 171.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.82 10.19 67.31 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.894 1.235 . . . . 0.0 115.355 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.32 131.38 55.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.184 0.993 . . . . 0.0 112.06 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -116.5 128.1 55.14 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.934 0.874 . . . . 0.0 113.018 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -106.36 171.98 7.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.818 2.447 . . . . 0.0 112.069 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.2 m -83.72 121.87 27.88 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.581 -1.324 . . . . 0.0 109.0 -161.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.9 m -122.79 128.03 49.91 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.243 -155.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -126.45 143.94 51.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.673 1.189 . . . . 0.0 113.386 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -92.7 113.91 26.32 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.679 1.192 . . . . 0.0 111.245 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 t -69.11 -18.44 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.757 -0.589 . . . . 0.0 112.061 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -77.7 -22.79 49.94 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.054 -1.029 . . . . 0.0 112.545 172.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.78 -37.37 17.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.893 0.769 . . . . 0.0 112.205 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -136.85 94.36 12.99 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -44.18 -20.93 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.586 1 C-N-CA 125.916 4.411 . . . . 0.0 116.891 165.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -48.62 -35.88 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 121.237 1.835 . . . . 0.0 112.867 171.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.35 -43.69 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 121.565 -0.709 . . . . 0.0 110.315 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.25 -32.94 73.7 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.845 1.258 . . . . 0.0 112.542 172.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.4 m -69.57 -37.9 77.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.911 1.684 . . . . 0.0 113.686 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -76.17 -47.19 25.13 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.54 -34.47 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 120.515 -1.365 . . . . 0.0 112.951 -174.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -62.13 -34.64 76.73 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -77.04 -43.53 34.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.664 1.986 . . . . 0.0 113.915 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.9 t -79.33 -38.59 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.108 1.363 . . . . 0.0 113.376 -166.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 m -100.39 10.98 40.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 62.11 -33.97 0.1 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 128.338 2.655 . . . . 0.0 115.376 -166.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -139.13 139.41 23.15 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.534 2.334 . . . . 0.0 108.833 169.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.99 128.37 9.11 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.075 1.85 . . . . 0.0 112.019 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.8 m -130.16 132.21 45.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.835 1.254 . . . . 0.0 110.987 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 57.0 mt -129.2 130.58 23.38 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.275 1.03 . . . . 0.0 110.52 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -80.78 152.66 82.2 Favored 'Cis proline' 0 CA--C 1.545 1.062 0 CA-C-N 120.021 1.043 . . . . 0.0 112.827 -5.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -147.81 158.56 44.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.352 1.061 . . . . 0.0 112.595 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.52 135.13 50.9 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.914 1.686 . . . . 0.0 111.987 -172.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -119.22 144.91 46.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.726 2.011 . . . . 0.0 110.128 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.6 mt -127.0 124.32 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 167.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.3 tttp 44.11 54.95 5.7 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.925 1.69 . . . . 0.0 114.328 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.69 27.83 17.55 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.08 145.86 51.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.109 1.364 . . . . 0.0 110.008 171.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -81.6 124.07 29.22 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.717 0.77 . . . . 0.0 111.332 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.9 t -99.94 -49.25 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.144 0.978 . . . . 0.0 110.104 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.05 158.75 23.88 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.674 1.429 . . . . 0.0 116.674 170.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.2 169.7 54.59 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.285 0.945 . . . . 0.0 112.157 164.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -52.12 -38.85 58.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.469 1.107 . . . . 0.0 113.969 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.49 -34.96 78.2 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.869 -1.144 . . . . 0.0 111.773 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.5 mm -72.54 -46.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.161 1.384 . . . . 0.0 110.668 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.98 -35.91 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.966 1.706 . . . . 0.0 111.032 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 90.6 m -62.04 -46.25 90.01 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.443 0.697 . . . . 0.0 111.807 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -59.57 -45.78 90.86 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.742 1.155 . . . . 0.0 110.28 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.3 mtt -61.36 -41.75 97.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.881 0.873 . . . . 0.0 111.365 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.87 -46.61 67.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.133 0.973 . . . . 0.0 111.335 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -72.64 -24.86 61.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.634 1.174 . . . . 0.0 112.597 -175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.9 t -100.44 -2.93 32.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.804 1.641 . . . . 0.0 114.041 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.44 -7.47 78.75 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 120.705 -1.247 . . . . 0.0 115.324 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -29.71 67.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.837 -1.39 . . . . 0.0 114.103 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.55 -46.42 86.03 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.077 0.853 . . . . 0.0 109.791 174.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -58.59 -42.2 87.54 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.122 0.969 . . . . 0.0 111.68 169.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.67 -37.35 86.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 117.0 -1.476 . . . . 0.0 111.825 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.8 mtm -69.82 -47.73 61.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.363 1.438 . . . . 0.0 112.88 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.27 -39.02 89.13 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.634 0.652 . . . . 0.0 112.251 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -69.36 -36.14 76.56 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.955 1.302 . . . . 0.0 111.912 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.0 -24.67 67.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.738 0.815 . . . . 0.0 112.546 168.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -92.12 6.44 46.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.929 1.292 . . . . 0.0 114.403 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.72 13.39 67.29 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.725 1.155 . . . . 0.0 114.431 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.2 mt -104.46 146.89 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.25 1.42 . . . . 0.0 108.959 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.0 m -116.02 136.13 53.32 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.861 -1.149 . . . . 0.0 112.777 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.4 p -131.34 167.98 18.33 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.18 1.792 . . . . 0.0 112.581 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 -64.53 121.93 15.58 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.439 -0.788 . . . . 0.0 110.096 171.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -135.14 139.67 44.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.286 1.434 . . . . 0.0 112.404 -167.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.701 2.001 . . . . 0.0 112.217 -170.815 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.8 p -68.57 -22.19 64.48 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.231 2.212 . . . . 0.0 115.546 -170.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.9 p -97.56 -12.23 22.79 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.19 -0.34 59.45 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.635 1.112 . . . . 0.0 114.399 -171.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.5 mm -75.98 126.05 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 118.619 1.209 . . . . 0.0 109.969 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.53 159.64 25.04 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.024 1.297 . . . . 0.0 112.785 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.4 -151.64 14.0 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.283 0.944 . . . . 0.0 112.892 -174.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -150.72 144.33 25.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.777 0.831 . . . . 0.0 112.027 168.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.03 126.83 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.266 1.826 . . . . 0.0 110.182 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.33 133.29 19.16 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.98 1.312 . . . . 0.0 112.803 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -155.06 156.14 35.36 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.192 1.797 . . . . 0.0 109.635 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.3 mt 54.37 80.99 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.204 1.802 . . . . 0.0 111.27 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -104.3 157.04 17.41 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.775 2.03 . . . . 0.0 112.691 -175.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -93.34 134.06 35.94 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.385 -0.822 . . . . 0.0 111.623 164.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.2 p -142.1 25.85 1.89 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -152.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -70.92 136.49 85.14 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 120.109 -1.62 . . . . 0.0 112.588 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.93 -25.35 19.88 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.902 2.401 . . . . 0.0 115.151 -165.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.85 11.35 39.76 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -173.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -53.72 131.12 38.72 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.567 1.147 . . . . 0.0 111.275 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -67.28 149.61 98.33 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.018 1.327 . . . . 0.0 111.696 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -57.74 149.19 70.13 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.764 2.31 . . . . 0.0 111.606 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -85.84 109.63 18.82 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.779 1.232 . . . . 0.0 108.578 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.1 mt -134.44 165.77 24.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.124 1.37 . . . . 0.0 112.22 -165.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.83 -57.97 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.841 0.857 . . . . 0.0 111.556 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 m -84.17 69.41 10.4 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.151 0.977 . . . . 0.0 110.545 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.12 172.35 15.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.75 1.62 . . . . 0.0 111.502 -172.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -94.39 175.85 6.53 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.754 1.222 . . . . 0.0 112.317 170.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.22 175.32 3.95 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.185 0.994 . . . . 0.0 112.641 157.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -149.3 166.29 29.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.883 1.273 . . . . 0.0 112.003 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.38 -40.51 68.24 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.649 1.18 . . . . 0.0 113.967 -171.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.41 -28.5 59.42 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -70.44 -35.0 73.1 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.96 -1.088 . . . . 0.0 111.955 173.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 pt -83.21 -28.25 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.44 -23.36 40.32 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.648 0.779 . . . . 0.0 112.845 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 8.3 ttt -62.89 134.42 56.19 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.816 1.247 . . . . 0.0 110.791 167.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.4 t -124.34 109.2 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.011 0.924 . . . . 0.0 110.409 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -83.43 120.64 26.15 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.854 0.862 . . . . 0.0 109.909 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -64.64 -32.04 73.53 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -161.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.92 -28.16 64.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 64.5 mt -74.48 -47.42 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.857 0.863 . . . . 0.0 109.786 173.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.97 -38.29 75.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.405 1.082 . . . . 0.0 111.968 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.34 -35.5 79.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.402 1.081 . . . . 0.0 112.969 171.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.0 m -66.2 -47.0 75.3 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.511 1.05 . . . . 0.0 111.111 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.71 -36.53 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 118.427 0.558 . . . . 0.0 111.991 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.4 -38.31 50.09 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.582 1.553 . . . . 0.0 112.896 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.7 t -81.84 -35.87 28.93 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.661 1.584 . . . . 0.0 113.122 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -83.04 142.36 31.37 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.888 -1.133 . . . . 0.0 109.968 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.417 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 34.9 m-20 -82.93 -46.0 13.48 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.879 -1.138 . . . . 0.0 112.345 -163.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 t -132.85 131.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.787 1.635 . . . . 0.0 109.764 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.2 t -132.49 132.88 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.529 1.532 . . . . 0.0 111.173 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.8 t -133.85 155.48 49.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.65 1.18 . . . . 0.0 110.839 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -131.39 142.44 50.05 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.31 0.644 . . . . 0.0 112.73 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.7 mt -136.42 159.69 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.351 1.861 . . . . 0.0 110.206 -158.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -73.06 104.03 4.01 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.509 -0.744 . . . . 0.0 109.505 158.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.24 -155.94 40.83 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.563 -0.71 . . . . 0.0 113.676 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -113.58 150.21 42.88 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.8 1.24 . . . . 0.0 112.209 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.02 -19.02 46.16 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.067 2.512 . . . . 0.0 114.711 -167.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.12 -27.34 60.82 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.606 1.162 . . . . 0.0 112.688 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.79 68.22 12.88 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.163 1.785 . . . . 0.0 111.549 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.1 143.8 73.17 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.422 2.082 . . . . 0.0 111.429 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.6 ttm -90.93 -7.51 51.91 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 41.3 t -140.8 146.28 37.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.282 1.433 . . . . 0.0 110.459 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.17 94.33 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.546 -0.721 . . . . 0.0 112.484 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -69.52 -34.1 73.78 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.436 -0.79 . . . . 0.0 111.593 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 m -62.75 -39.46 94.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.339 0.655 . . . . 0.0 112.477 168.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -67.23 -40.66 86.36 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.627 1.103 . . . . 0.0 112.828 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -64.42 -36.03 82.85 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.805 0.842 . . . . 0.0 112.509 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.8 tpt -55.94 -45.86 78.69 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.214 0.915 . . . . 0.0 112.289 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.3 mm -66.58 -34.14 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.303 0.641 . . . . 0.0 111.254 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -37.2 86.31 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.437 -0.79 . . . . 0.0 112.99 174.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.8 t -70.62 -36.11 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.897 0.879 . . . . 0.0 110.956 176.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.1 mt -66.1 -40.95 91.18 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.335 -0.853 . . . . 0.0 113.129 169.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -62.08 -31.29 71.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.09 -1.007 . . . . 0.0 111.863 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.15 -20.0 64.86 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -98.81 -9.17 24.75 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.459 1.504 . . . . 0.0 113.563 172.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.77 11.17 57.11 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.402 1.477 . . . . 0.0 114.954 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.11 132.62 55.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.333 1.066 . . . . 0.0 111.831 172.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -114.89 159.23 20.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.951 0.9 . . . . 0.0 113.356 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -133.19 172.82 12.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.856 2.062 . . . . 0.0 111.604 -161.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.4 m -87.9 119.6 28.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.469 -1.394 . . . . 0.0 108.354 -168.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.6 m -125.93 129.29 48.98 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.162 -151.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -125.88 143.72 50.96 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -91.87 122.59 34.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.395 1.478 . . . . 0.0 111.396 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.0 m -66.92 -22.22 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.0 mt -87.04 -11.3 50.74 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.211 1.404 . . . . 0.0 112.92 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.13 -36.79 15.51 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -146.29 135.27 11.2 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.95 0.9 . . . . 0.0 111.069 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.25 -31.63 93.25 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.393 2.728 . . . . 0.0 113.204 -174.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 p -44.02 -42.7 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.616 1.567 . . . . 0.0 113.789 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 t -71.11 -47.86 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.801 1.182 . . . . 0.0 111.419 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -72.42 -25.41 61.47 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 63.7 m -71.2 -48.07 53.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.316 1.046 . . . . 0.0 112.274 169.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -66.18 -44.22 84.62 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.96 -1.088 . . . . 0.0 112.623 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.82 -35.31 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.291 -0.88 . . . . 0.0 112.065 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -69.59 -36.53 76.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.274 1.03 . . . . 0.0 112.728 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -74.48 -44.21 52.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.464 1.106 . . . . 0.0 113.718 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.0 t -81.91 -41.27 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.24 1.416 . . . . 0.0 113.001 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.0 m -101.1 -9.33 21.47 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 64.13 -24.15 0.07 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 128.697 2.799 . . . . 0.0 117.439 172.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -127.3 110.6 21.3 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.189 1.795 . . . . 0.0 107.925 158.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.03 125.94 4.25 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 121.117 1.211 . . . . 0.0 111.875 -171.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.4 p -136.05 126.75 27.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.352 1.861 . . . . 0.0 109.453 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.62 146.13 57.43 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 119.226 0.921 . . . . 0.0 110.999 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.69 155.27 92.39 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 120.201 1.108 . . . . 0.0 114.292 8.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -150.01 157.29 42.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.472 1.909 . . . . 0.0 110.576 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.73 139.03 52.41 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.251 1.021 . . . . 0.0 113.665 -172.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -129.78 145.8 51.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.514 1.926 . . . . 0.0 111.101 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.6 mt -129.12 125.86 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.792 1.237 . . . . 0.0 108.685 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 90' ' ' ASP . 2.3 mmpt? 46.59 53.66 9.7 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.674 1.59 . . . . 0.0 114.422 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 58.05 24.45 11.18 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.399 1.88 . . . . 0.0 115.934 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -123.53 139.3 54.15 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.902 -1.124 . . . . 0.0 111.522 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -68.35 123.73 21.55 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.082 0.953 . . . . 0.0 111.023 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.77 -43.16 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.497 1.519 . . . . 0.0 111.807 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.62 173.67 26.33 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 117.165 1.626 . . . . 0.0 117.165 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.95 173.23 54.9 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.466 1.507 . . . . 0.0 113.769 171.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.95 -41.38 33.81 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.28 1.432 . . . . 0.0 112.895 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.86 -36.54 83.61 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.948 -1.095 . . . . 0.0 112.82 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 mm -74.27 -45.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.672 1.589 . . . . 0.0 109.62 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.5 t -58.65 -39.72 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.996 0.918 . . . . 0.0 110.835 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 30.7 m -63.52 -46.05 87.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.229 1.011 . . . . 0.0 111.369 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 29.7 tttp -60.88 -43.77 97.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.96 1.304 . . . . 0.0 111.585 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 51.9 mtt -70.6 -38.73 74.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.831 1.253 . . . . 0.0 112.698 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.09 -46.72 61.24 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.386 0.994 . . . . 0.0 112.294 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -63.55 -33.65 76.06 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.646 0.657 . . . . 0.0 111.713 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.7 m -85.14 -17.65 36.6 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.66 -4.65 85.77 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.945 1.248 . . . . 0.0 115.142 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -64.92 -28.49 69.56 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.426 1.613 . . . . 0.0 113.538 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tt -59.54 -46.55 88.56 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.915 -1.116 . . . . 0.0 109.922 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -61.9 -32.92 73.34 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.172 1.789 . . . . 0.0 112.823 172.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -64.45 -39.81 94.54 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.596 1.089 . . . . 0.0 112.101 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.1 mtm -66.16 -51.18 60.26 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.749 1.261 . . . . 0.0 111.562 172.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 53.7 tp -65.14 -42.83 93.44 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.706 2.002 . . . . 0.0 111.122 -165.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -68.65 -38.2 80.25 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.276 1.03 . . . . 0.0 112.337 171.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.89 -27.25 69.02 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.905 0.775 . . . . 0.0 112.666 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 -5.23 45.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.894 1.678 . . . . 0.0 113.714 175.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.46 16.42 64.25 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 125.203 1.383 . . . . 0.0 114.687 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.17 143.92 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.24 1.416 . . . . 0.0 110.15 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.5 m -114.15 134.34 54.96 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.244 -0.91 . . . . 0.0 113.403 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.2 p -125.73 174.07 8.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 129.007 2.923 . . . . 0.0 111.994 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -40.18 138.95 0.78 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.695 1.198 . . . . 0.0 113.172 167.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -64.4 146.36 54.6 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.663 1.185 . . . . 0.0 112.482 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.9 tp . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.38 1.472 . . . . 0.0 111.019 175.148 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -67.16 -39.95 86.57 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.3 p -124.52 -160.52 0.94 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.047 0.939 . . . . 0.0 112.872 -161.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.16 11.64 81.75 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.067 0.842 . . . . 0.0 113.99 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mm -60.23 138.98 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.24 1.416 . . . . 0.0 110.162 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.51 148.54 19.24 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.955 1.264 . . . . 0.0 112.787 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.99 -152.31 10.7 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.045 1.307 . . . . 0.0 113.653 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.0 147.51 53.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.403 1.881 . . . . 0.0 111.746 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.33 131.32 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.138 0.975 . . . . 0.0 112.305 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -68.52 136.72 53.58 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.201 -0.937 . . . . 0.0 110.572 168.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -136.0 144.47 45.35 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.157 1.383 . . . . 0.0 110.568 -168.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.8 mt -113.45 130.15 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.017 0.927 . . . . 0.0 110.381 -174.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.86 142.63 58.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.038 1.335 . . . . 0.0 112.314 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.87 143.32 57.95 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.505 -0.747 . . . . 0.0 111.837 168.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.6 p -75.84 14.87 0.59 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.247 1.819 . . . . 0.0 115.727 -171.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -71.17 153.36 94.39 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.821 1.248 . . . . 0.0 113.743 -171.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.13 173.77 13.88 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.708 3.605 . . . . 0.0 112.879 171.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -82.32 5.43 20.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -175.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -63.01 150.15 43.15 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.985 -1.072 . . . . 0.0 113.216 -170.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -70.74 153.93 94.6 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.389 1.476 . . . . 0.0 112.282 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -58.23 154.89 37.64 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.115 3.21 . . . . 0.0 113.036 173.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -125.0 143.33 50.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.987 1.315 . . . . 0.0 112.126 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.81 173.4 6.77 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.051 1.74 . . . . 0.0 111.258 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 t 68.75 -34.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 128.57 2.748 . . . . 0.0 115.322 174.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.0 p -65.82 173.15 3.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.092 2.157 . . . . 0.0 114.311 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.81 55.61 0.82 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.783 1.633 . . . . 0.0 111.141 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -142.38 168.02 20.71 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.936 1.694 . . . . 0.0 112.649 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.3 168.28 10.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.624 1.57 . . . . 0.0 113.002 166.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.35 162.16 19.18 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.606 1.162 . . . . 0.0 112.501 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -64.57 -37.95 89.32 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 120.777 -1.202 . . . . 0.0 113.361 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.57 -33.35 69.84 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.978 -1.076 . . . . 0.0 112.443 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.12 -25.43 60.85 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.641 1.177 . . . . 0.0 112.93 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.6 tp -103.75 -28.1 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.897 1.279 . . . . 0.0 114.219 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.63 -9.71 59.48 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -166.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -67.33 147.49 52.89 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.449 -0.782 . . . . 0.0 112.007 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -128.6 88.9 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.895 1.678 . . . . 0.0 107.642 172.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -70.79 103.0 2.47 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -63.96 -37.97 89.37 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -163.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -74.08 -26.11 60.19 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.006 0.821 . . . . 0.0 112.813 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.96 -42.78 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.955 1.302 . . . . 0.0 110.085 173.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -58.65 -38.29 77.79 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.652 1.181 . . . . 0.0 111.631 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.21 -29.12 64.76 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.915 0.886 . . . . 0.0 112.406 169.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.1 m -63.95 -45.41 89.27 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 120.217 -1.552 . . . . 0.0 111.311 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.6 pt -62.13 -35.3 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.747 1.158 . . . . 0.0 112.13 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -77.74 -37.75 48.49 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.044 1.738 . . . . 0.0 112.069 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 t -68.15 -31.55 71.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.853 2.461 . . . . 0.0 113.293 173.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -86.87 147.85 25.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.15 1.78 . . . . 0.0 111.727 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.87 -35.7 16.39 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.017 -1.052 . . . . 0.0 111.863 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.3 t -139.9 130.75 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.95 1.3 . . . . 0.0 112.261 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.9 t -132.83 133.32 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.059 1.344 . . . . 0.0 111.379 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 t -131.72 154.6 48.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.998 0.919 . . . . 0.0 110.596 167.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -134.2 146.23 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.404 0.621 . . . . 0.0 112.463 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.07 161.72 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.078 1.751 . . . . 0.0 109.174 -166.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.72 104.25 8.15 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.375 -0.828 . . . . 0.0 109.543 146.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.28 -162.41 18.03 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.265 0.936 . . . . 0.0 114.87 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -107.1 158.24 33.44 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.916 2.086 . . . . 0.0 110.833 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.29 -25.77 56.79 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.733 1.622 . . . . 0.0 113.666 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -76.07 -24.41 55.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.734 1.214 . . . . 0.0 113.684 169.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.12 69.05 14.14 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.07 1.348 . . . . 0.0 111.894 -174.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.99 143.71 23.24 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.856 2.37 . . . . 0.0 110.372 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 mmt -88.58 5.15 44.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 13.5 t -152.21 146.76 25.7 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.124 1.37 . . . . 0.0 110.961 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.33 77.85 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -65.3 -37.89 88.53 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.894 -1.129 . . . . 0.0 111.761 172.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 m -65.14 -39.26 92.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.872 0.869 . . . . 0.0 112.361 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.53 -45.77 92.79 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.269 1.027 . . . . 0.0 112.144 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -58.19 -35.86 72.24 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.69 1.596 . . . . 0.0 112.957 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.4 ttp -59.13 -42.45 90.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.622 0.369 . . . . 0.0 111.941 173.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 mm -71.73 -33.82 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.572 0.749 . . . . 0.0 111.848 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -58.35 -38.68 77.69 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.8 -1.188 . . . . 0.0 112.336 172.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.48 -39.38 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.173 0.989 . . . . 0.0 111.081 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.6 mt -65.89 -39.18 90.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.554 0.742 . . . . 0.0 112.532 173.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -67.0 -31.56 72.2 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.903 -1.123 . . . . 0.0 112.018 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.89 -19.91 64.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.848 1.259 . . . . 0.0 114.235 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.75 -9.55 28.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.889 1.276 . . . . 0.0 113.297 166.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.41 9.2 42.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.342 0.972 . . . . 0.0 113.721 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.0 mt -114.29 130.33 56.66 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 125.683 1.593 . . . . 0.0 111.72 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -115.02 133.67 55.85 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.017 0.913 . . . . 0.0 111.594 170.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -105.06 172.12 6.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.603 2.361 . . . . 0.0 110.773 -172.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.5 m -87.24 123.1 31.88 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.668 -1.27 . . . . 0.0 109.811 -161.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.5 p -108.36 134.14 51.59 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.406 1.482 . . . . 0.0 114.904 -158.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -126.71 146.78 50.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.503 1.121 . . . . 0.0 113.023 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.46 106.04 14.81 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.013 1.325 . . . . 0.0 111.328 -167.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.54 -36.04 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.586 1.555 . . . . 0.0 112.262 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 tp -80.48 -22.05 41.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.335 0.654 . . . . 0.0 111.666 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.11 -39.31 16.86 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.49 -0.757 . . . . 0.0 112.679 167.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -126.1 103.06 26.92 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 118.982 0.81 . . . . 0.0 112.52 -169.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.08 -28.77 25.92 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.713 2.942 . . . . 0.0 115.021 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -49.7 -36.86 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.792 1.237 . . . . 0.0 113.5 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.34 -52.2 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.553 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -64.48 -26.11 68.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.69 0.796 . . . . 0.0 112.955 173.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.6 m -71.46 -51.96 20.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.163 0.585 . . . . 0.0 111.763 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -73.43 -34.92 65.7 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.564 -1.335 . . . . 0.0 114.206 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.5 p -60.28 -34.34 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.715 1.143 . . . . 0.0 112.074 172.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 34.5 tttm -69.25 -35.21 75.88 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.139 0.881 . . . . 0.0 112.731 173.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.23 -37.74 86.52 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.221 1.373 . . . . 0.0 112.541 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.61 -45.26 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.1 m -106.08 -5.37 19.49 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 62.05 -48.09 0.16 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.517 2.327 . . . . 0.0 116.186 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -135.92 92.45 16.46 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.896 1.278 . . . . 0.0 111.546 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -101.47 156.7 0.37 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.838 3.692 . . . . 0.0 114.743 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 m -117.35 128.84 55.44 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.413 1.485 . . . . 0.0 110.393 161.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.22 140.69 25.79 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.879 1.272 . . . . 0.0 108.576 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -90.59 159.62 31.11 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-N 120.733 1.298 . . . . 0.0 113.693 1.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -160.2 171.65 18.83 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.464 1.106 . . . . 0.0 113.466 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.52 141.89 51.24 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.12 1.368 . . . . 0.0 113.455 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -128.29 141.71 51.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.61 1.964 . . . . 0.0 110.665 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 84.5 mt -129.65 135.63 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 125.049 1.339 . . . . 0.0 108.471 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 47.36 40.45 10.8 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.22 1.408 . . . . 0.0 113.509 -170.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.32 25.46 7.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.002 2.121 . . . . 0.0 115.526 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.87 142.47 46.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.513 1.525 . . . . 0.0 110.007 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -70.78 126.08 28.61 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.614 0.721 . . . . 0.0 112.088 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.7 t -101.57 -53.89 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.436 1.494 . . . . 0.0 111.078 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.82 160.6 26.41 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 116.058 1.183 . . . . 0.0 116.058 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 170.36 54.91 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.035 1.302 . . . . 0.0 112.769 165.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -49.31 -46.76 47.03 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.86 1.264 . . . . 0.0 114.337 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.9 -22.67 65.07 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.101 -0.999 . . . . 0.0 112.621 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.4 mm -82.23 -47.05 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.838 1.655 . . . . 0.0 110.664 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.67 -36.57 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.852 1.661 . . . . 0.0 111.024 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 55.1 m -59.69 -44.0 93.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.907 0.883 . . . . 0.0 111.881 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -66.41 -42.45 87.8 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.105 -0.997 . . . . 0.0 111.033 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.6 mtt -61.13 -43.83 98.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.597 0.759 . . . . 0.0 110.99 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -65.11 -48.85 72.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.078 0.951 . . . . 0.0 111.13 177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.15 -16.26 61.98 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.165 1.386 . . . . 0.0 113.477 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m -91.32 -21.01 21.26 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 173.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.83 -2.35 88.25 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 121.718 -0.614 . . . . 0.0 113.927 -164.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.0 -33.55 74.84 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.688 1.244 . . . . 0.0 111.775 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.28 -45.63 92.41 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.363 -0.836 . . . . 0.0 110.689 172.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -63.48 -37.49 87.51 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.158 1.383 . . . . 0.0 113.105 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -61.38 -43.33 99.05 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 117.611 -1.185 . . . . 0.0 112.655 170.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 74.4 mtm -68.71 -48.02 64.89 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.939 1.245 . . . . 0.0 112.309 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 pp -64.04 -35.65 81.43 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.822 -0.549 . . . . 0.0 111.709 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -69.7 -35.76 75.35 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 121.496 -0.752 . . . . 0.0 112.952 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -65.2 -30.61 71.52 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.3 1.04 . . . . 0.0 111.876 171.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.99 5.28 6.81 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.014 1.726 . . . . 0.0 112.969 170.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.91 9.25 77.93 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.502 1.525 . . . . 0.0 114.796 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.4 mt -94.66 147.22 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.219 1.008 . . . . 0.0 110.854 -168.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.3 m -112.22 130.3 55.97 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.994 1.318 . . . . 0.0 111.101 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.5 p -138.36 169.51 17.66 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.977 1.711 . . . . 0.0 113.032 -169.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.0 ttt-85 -62.03 146.28 50.68 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.862 1.265 . . . . 0.0 110.813 164.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -123.2 133.62 54.21 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.621 1.169 . . . . 0.0 111.014 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.9 tp . . . . . 0 C--O 1.253 1.255 0 C-N-CA 128.002 2.521 . . . . 0.0 114.062 -169.966 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 119.811 -0.137 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.3 p -93.68 -21.87 19.09 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.7 m -78.96 166.7 22.08 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.175 -0.953 . . . . 0.0 112.774 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.6 13.55 82.35 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.654 -1.081 . . . . 0.0 114.948 172.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.7 mt -77.74 94.65 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.333 1.567 . . . . 0.0 109.934 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -174.97 159.15 27.43 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.657 2.075 . . . . 0.0 112.155 -176.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.61 -146.39 4.96 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 121.7 -0.883 . . . . 0.0 113.348 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -96.74 145.9 25.38 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.162 1.385 . . . . 0.0 110.287 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 p -148.01 157.81 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.735 1.214 . . . . 0.0 111.634 -171.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -87.69 122.28 31.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.883 0.873 . . . . 0.0 110.096 164.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.89 143.09 48.06 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.407 1.083 . . . . 0.0 112.798 -174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.8 tt -100.92 148.21 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.569 1.148 . . . . 0.0 113.673 -170.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -118.06 147.31 43.38 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.788 1.635 . . . . 0.0 111.029 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -136.55 143.11 43.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.736 1.214 . . . . 0.0 111.52 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 p -147.59 128.33 14.29 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.215 1.806 . . . . 0.0 109.665 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -87.32 141.37 32.56 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -172.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -60.62 164.48 13.36 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.535 3.49 . . . . 0.0 114.483 174.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -80.31 14.16 2.08 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -130.04 156.68 44.09 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.078 1.351 . . . . 0.0 111.199 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -72.07 152.22 92.69 Favored Pre-proline 0 CA--C 1.549 0.923 0 O-C-N 121.918 -0.489 . . . . 0.0 112.259 168.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.76 134.77 13.77 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.761 2.974 . . . . 0.0 112.165 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -119.75 104.3 10.12 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.699 1.6 . . . . 0.0 111.608 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.9 tt -162.22 -42.04 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.222 1.809 . . . . 0.0 110.699 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 p -153.91 152.7 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.648 1.579 . . . . 0.0 111.858 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -71.97 117.12 13.18 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.367 -0.833 . . . . 0.0 111.221 169.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.72 149.88 27.95 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.526 1.53 . . . . 0.0 111.119 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -69.1 -50.18 50.46 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.701 0.8 . . . . 0.0 113.052 -170.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.72 159.08 18.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.741 1.216 . . . . 0.0 113.063 -176.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.68 162.18 19.44 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.403 1.881 . . . . 0.0 110.611 166.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.83 -32.71 74.31 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -168.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.49 -34.97 60.9 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.825 1.193 . . . . 0.0 112.971 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.6 -36.4 70.81 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.04 -1.037 . . . . 0.0 112.525 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.8 tt -73.08 -18.06 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 O-C-N 120.794 -1.191 . . . . 0.0 112.316 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.37 -11.51 59.92 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.375 1.07 . . . . 0.0 113.237 168.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.1 tpt -78.44 122.61 26.05 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.152 -0.968 . . . . 0.0 109.506 161.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.2 t -135.87 122.33 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.083 1.353 . . . . 0.0 107.85 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -68.65 113.89 6.54 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.696 0.399 . . . . 0.0 110.157 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.4 -36.16 77.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.112 0.965 . . . . 0.0 112.988 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.15 -26.37 68.28 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 50.9 mm -77.42 -45.45 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.999 1.272 . . . . 0.0 110.857 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.32 -42.25 81.48 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.615 0.766 . . . . 0.0 111.487 170.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -68.27 -34.21 75.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.512 0.725 . . . . 0.0 112.329 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -66.88 -48.55 68.42 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.999 -1.063 . . . . 0.0 111.618 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.3 pt -64.4 -36.63 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.138 0.575 . . . . 0.0 111.867 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -79.19 -34.26 43.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.323 1.449 . . . . 0.0 113.681 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -80.1 -29.65 39.06 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.853 0.861 . . . . 0.0 113.243 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -87.42 133.49 33.73 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.955 0.902 . . . . 0.0 112.047 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -67.67 -38.22 83.43 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.3 t -142.33 127.2 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.331 1.053 . . . . 0.0 111.514 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.77 130.17 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.467 1.507 . . . . 0.0 111.557 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 t -131.75 155.3 47.95 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.079 0.952 . . . . 0.0 111.532 168.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -131.62 127.9 38.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.591 1.156 . . . . 0.0 110.394 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.14 173.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.22 1.808 . . . . 0.0 111.773 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 102.15 4.52 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.333 1.053 . . . . 0.0 109.919 161.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.82 -162.12 37.11 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.41 1.005 . . . . 0.0 115.156 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.11 148.67 43.51 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.117 0.967 . . . . 0.0 110.549 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.21 -23.89 77.98 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.148 2.565 . . . . 0.0 113.996 -175.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -78.37 -26.47 46.62 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.799 1.24 . . . . 0.0 113.907 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.17 67.05 10.62 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.903 1.281 . . . . 0.0 111.881 -175.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.19 152.91 45.72 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.527 2.151 . . . . 0.0 112.841 -172.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -74.06 -8.13 55.02 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.196 -0.94 . . . . 0.0 113.34 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.7 m -152.66 146.73 25.4 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -158.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.1 64.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.247 1.419 . . . . 0.0 112.447 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -67.68 -26.66 66.3 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.315 0.962 . . . . 0.0 111.36 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.3 m -68.32 -38.38 81.51 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.274 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.31 -45.49 91.1 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.305 1.411 . . . . 0.0 111.768 167.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -56.61 -37.65 70.98 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.485 0.714 . . . . 0.0 112.342 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.8 tpt -60.79 -46.56 90.02 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.278 1.431 . . . . 0.0 112.355 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.3 mm -72.96 -33.21 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.426 -0.796 . . . . 0.0 112.459 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -57.58 -32.69 67.41 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.206 -1.558 . . . . 0.0 112.795 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 t -62.61 -44.07 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.177 0.991 . . . . 0.0 111.168 172.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.35 -36.28 83.53 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.031 1.332 . . . . 0.0 112.83 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -71.83 -31.23 66.32 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.358 -1.463 . . . . 0.0 113.137 172.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.91 -29.84 69.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.228 1.011 . . . . 0.0 112.642 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.35 -14.35 40.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.268 1.027 . . . . 0.0 113.412 169.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.83 11.11 57.2 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.083 1.325 . . . . 0.0 114.527 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.09 131.61 55.75 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.932 1.293 . . . . 0.0 111.326 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -113.0 145.37 40.96 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.715 1.143 . . . . 0.0 112.421 174.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -113.54 172.29 7.05 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.459 1.904 . . . . 0.0 111.721 -175.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.8 m -88.86 120.4 30.23 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -164.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.2 m -125.67 136.03 52.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.608 -148.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -124.02 159.55 29.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.827 1.251 . . . . 0.0 111.985 -173.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -112.99 118.27 34.35 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.088 1.355 . . . . 0.0 110.677 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.85 -21.78 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.427 0.691 . . . . 0.0 112.857 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.42 -9.92 53.4 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.517 1.127 . . . . 0.0 112.644 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.46 -34.35 11.53 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.332 0.969 . . . . 0.0 112.61 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -138.36 88.65 14.63 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.213 0.605 . . . . 0.0 111.005 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.86 -12.51 22.4 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.21 2.607 . . . . 0.0 114.961 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -45.91 -33.77 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.662 1.119 . . . . 0.0 112.902 167.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.43 -43.62 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.337 1.055 . . . . 0.0 111.824 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -65.68 -28.61 69.21 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.257 0.935 . . . . 0.0 111.98 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.4 m -74.48 -39.43 62.49 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -69.84 -39.99 76.1 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.695 1.134 . . . . 0.0 111.313 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.3 -32.11 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.808 -1.182 . . . . 0.0 112.233 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -61.49 -33.98 74.7 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.071 -1.018 . . . . 0.0 113.024 168.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -73.31 -47.85 39.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.182 0.993 . . . . 0.0 112.72 170.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.95 -34.43 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.0 m -100.61 -2.31 33.15 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 60.84 -38.74 0.1 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 130.221 3.408 . . . . 0.0 116.635 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -136.49 91.73 15.9 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.859 2.464 . . . . 0.0 109.572 173.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.41 136.58 8.82 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.117 2.545 . . . . 0.0 113.232 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.9 m -132.65 122.55 24.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.147 0.979 . . . . 0.0 109.85 165.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 12.6 pt -95.37 156.41 37.66 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.493 1.117 . . . . 0.0 113.683 -172.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.92 158.37 97.97 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 119.037 0.692 . . . . 0.0 112.978 -5.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -131.42 160.86 33.88 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.999 1.319 . . . . 0.0 111.433 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.84 139.95 53.06 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.278 1.431 . . . . 0.0 111.991 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -132.8 143.99 49.93 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.172 1.789 . . . . 0.0 110.28 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.1 mt -126.17 117.09 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 42.89 53.03 5.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 127.215 2.206 . . . . 0.0 114.324 -169.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 57.52 26.52 12.82 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -119.29 131.19 55.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.117 1.367 . . . . 0.0 109.224 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -74.33 125.03 27.59 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.86 -42.48 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.013 1.325 . . . . 0.0 111.662 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.35 177.88 30.88 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 169.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.98 169.31 54.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.831 1.205 . . . . 0.0 113.962 168.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -45.35 -44.48 11.79 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.147 1.779 . . . . 0.0 113.145 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.62 -45.04 93.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.356 0.662 . . . . 0.0 111.656 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 mm -68.45 -46.91 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.424 1.49 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.71 -36.21 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.946 1.699 . . . . 0.0 110.672 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 29.5 m -63.39 -46.04 88.29 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 118.8 -0.619 . . . . 0.0 111.701 173.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -63.61 -41.99 98.25 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.882 1.219 . . . . 0.0 110.82 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 54.6 mtt -64.17 -39.8 94.77 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.631 1.172 . . . . 0.0 112.399 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.09 -47.17 75.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.856 0.863 . . . . 0.0 110.874 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -70.93 -26.18 63.09 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.506 1.122 . . . . 0.0 113.283 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 75.2 m -105.18 0.88 27.75 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.24 -8.09 80.62 Favored Glycine 0 N--CA 1.478 1.442 0 CA-C-N 121.094 1.77 . . . . 0.0 115.419 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.55 -29.68 69.12 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.08 1.44 . . . . 0.0 112.885 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.34 -48.26 68.03 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.651 0.78 . . . . 0.0 110.782 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -60.62 -33.59 73.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.611 1.564 . . . . 0.0 112.889 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -59.02 -41.35 87.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.952 0.796 . . . . 0.0 112.821 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.8 mtm -67.32 -47.64 69.93 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.632 1.105 . . . . 0.0 112.143 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -37.97 87.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.251 0.62 . . . . 0.0 112.49 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -75.03 -33.98 61.84 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.412 -0.805 . . . . 0.0 112.989 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.78 -24.83 67.68 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.289 0.495 . . . . 0.0 111.955 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -80.31 -0.04 34.94 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.712 1.205 . . . . 0.0 113.825 171.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.32 22.02 57.53 Favored Glycine 0 CA--C 1.524 0.622 0 O-C-N 120.521 -1.362 . . . . 0.0 114.26 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 95.9 mt -99.4 145.04 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.666 1.233 . . . . 0.0 111.395 -173.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 99.2 m -91.42 126.89 36.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.685 1.194 . . . . 0.0 111.658 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 22.0 p -120.04 166.4 13.43 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.127 1.771 . . . . 0.0 112.193 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -61.47 155.12 22.64 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.954 1.701 . . . . 0.0 112.356 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -109.49 139.42 44.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.197 0.999 . . . . 0.0 111.917 167.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 70.9 mt . . . . . 0 C--O 1.254 1.339 0 C-N-CA 125.701 1.601 . . . . 0.0 113.168 176.822 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.3 p . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.7 p -78.47 -6.7 56.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.1 p -86.07 168.95 13.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.27 1.428 . . . . 0.0 113.156 176.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.23 83.85 Favored Glycine 0 CA--C 1.535 1.337 0 N-CA-C 115.366 0.907 . . . . 0.0 115.366 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mm -63.1 137.18 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.479 1.139 . . . . 0.0 109.937 174.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.34 174.38 22.61 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.234 0.921 . . . . 0.0 114.945 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.19 152.15 29.67 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.636 1.112 . . . . 0.0 114.833 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -85.2 139.48 31.63 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -161.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.4 t -115.16 138.16 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.194 1.398 . . . . 0.0 110.482 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -58.8 151.57 21.06 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -174.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -112.79 154.93 25.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.699 2.0 . . . . 0.0 112.381 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.93 23.28 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.916 1.686 . . . . 0.0 112.993 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -108.17 136.47 47.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.365 1.466 . . . . 0.0 111.436 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -82.37 150.92 26.9 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.566 -0.709 . . . . 0.0 112.01 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.3 p -125.31 100.74 6.65 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.503 1.521 . . . . 0.0 112.261 -173.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -72.6 147.63 89.64 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.519 1.128 . . . . 0.0 112.661 173.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.86 151.02 31.01 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.36 2.706 . . . . 0.0 109.938 161.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -88.36 -5.32 58.38 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -168.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -75.06 136.85 41.16 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.17 -0.956 . . . . 0.0 110.874 169.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -107.09 151.12 40.61 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.427 1.091 . . . . 0.0 112.198 -175.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.75 154.58 43.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.452 2.768 . . . . 0.0 113.391 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -81.52 134.49 35.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.015 2.126 . . . . 0.0 111.212 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.9 mt 51.86 -174.88 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.839 1.656 . . . . 0.0 113.523 -172.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.5 133.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 120.3 -1.5 . . . . 0.0 110.372 173.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.2 m -97.48 152.03 19.4 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -172.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.59 6.83 11.03 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.823 1.649 . . . . 0.0 113.568 168.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -74.45 149.17 40.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.823 1.649 . . . . 0.0 111.815 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 36.9 tp -110.03 129.04 55.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.916 0.886 . . . . 0.0 110.693 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -148.75 173.97 12.68 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.917 1.287 . . . . 0.0 113.047 -163.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.38 -42.14 92.99 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -159.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.28 -33.63 74.7 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 120.342 1.428 . . . . 0.0 111.757 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.09 -40.29 95.91 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.032 0.933 . . . . 0.0 111.348 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.0 pt -85.1 -23.07 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.119 0.968 . . . . 0.0 113.493 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.76 -28.09 50.52 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.33 0.968 . . . . 0.0 112.399 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 78.8 mtm -80.59 115.45 20.11 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.759 0.708 . . . . 0.0 110.767 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.46 85.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.847 1.308 . . . . 0.0 108.961 171.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -78.97 103.7 9.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.468 1.507 . . . . 0.0 110.251 -169.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -65.61 -28.85 69.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.253 1.421 . . . . 0.0 113.665 -170.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.81 -32.27 73.71 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.63 0.772 . . . . 0.0 113.037 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.0 mp -76.25 -44.04 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.089 0.956 . . . . 0.0 109.661 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.32 -39.52 87.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.087 0.955 . . . . 0.0 111.83 173.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.63 -38.88 92.53 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.865 -1.147 . . . . 0.0 112.188 170.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.2 m -66.41 -43.25 86.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.74 0.816 . . . . 0.0 112.331 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 pt -60.72 -33.35 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.356 0.98 . . . . 0.0 112.928 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -78.81 -23.55 45.08 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.907 1.683 . . . . 0.0 114.542 173.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.0 t -89.22 -32.82 17.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.361 1.865 . . . . 0.0 113.061 -174.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -88.86 143.18 27.06 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.767 1.227 . . . . 0.0 111.245 169.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.26 -33.13 61.25 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.38 -0.825 . . . . 0.0 111.105 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.3 t -142.82 131.46 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.65 1.18 . . . . 0.0 111.512 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -134.36 139.12 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.097 1.359 . . . . 0.0 111.773 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 t -134.24 156.54 48.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.086 1.355 . . . . 0.0 111.299 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.41 ' CE2' ' HB3' ' A' ' 147' ' ' GLN . 1.1 p90 -132.0 135.33 46.46 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.764 0.825 . . . . 0.0 110.839 173.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.65 167.64 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.585 1.954 . . . . 0.0 110.391 -168.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.11 112.55 15.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 152.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.43 -153.66 46.49 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 123.142 0.401 . . . . 0.0 113.811 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.18 160.07 65.73 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.838 1.655 . . . . 0.0 111.066 -166.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.75 -24.94 20.93 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 N-CA-C 116.515 1.698 . . . . 0.0 116.515 -156.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -98.89 -3.87 34.25 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.805 1.242 . . . . 0.0 113.402 168.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -141.62 71.97 25.19 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.531 1.532 . . . . 0.0 110.787 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.18 155.7 25.74 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.621 2.881 . . . . 0.0 112.818 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.99 7.06 18.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.36 1.464 . . . . 0.0 113.552 175.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 16.6 t -148.47 147.43 29.12 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.685 -1.26 . . . . 0.0 111.788 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.78 -41.07 77.03 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.598 -0.689 . . . . 0.0 112.011 170.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -66.66 -27.34 67.59 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.597 -0.689 . . . . 0.0 112.331 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.4 m -64.85 -47.49 77.71 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.318 -0.864 . . . . 0.0 110.936 169.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.31 -41.28 88.66 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.955 0.798 . . . . 0.0 111.298 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -61.22 -35.98 78.69 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.633 1.173 . . . . 0.0 114.06 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.7 tpt -62.13 -41.9 98.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.876 0.762 . . . . 0.0 111.246 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.6 mm -72.06 -36.91 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.26 -0.9 . . . . 0.0 112.259 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -58.23 -30.96 66.92 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.646 1.178 . . . . 0.0 112.496 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.06 -47.14 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.744 1.618 . . . . 0.0 112.141 170.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 44.9 mt -66.2 -35.49 80.59 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.144 -0.973 . . . . 0.0 113.08 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -62.4 -39.55 93.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.448 1.099 . . . . 0.0 112.011 168.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.73 -26.17 66.01 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.166 -0.959 . . . . 0.0 113.285 176.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.6 tp -86.79 -15.48 39.16 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.09 2.14 16.76 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 124.821 1.201 . . . . 0.0 115.146 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.51 135.35 54.18 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.876 1.671 . . . . 0.0 111.402 172.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -109.96 151.8 26.66 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.431 1.11 . . . . 0.0 113.286 171.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -130.2 168.9 16.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.897 2.079 . . . . 0.0 110.448 -172.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.1 m -90.33 133.73 34.78 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.868 -1.145 . . . . 0.0 111.192 -159.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.5 p -129.39 147.8 51.25 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -164.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.2 153.78 47.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.203 1.801 . . . . 0.0 111.677 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -89.96 113.96 25.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.122 0.969 . . . . 0.0 112.085 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.9 -16.78 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 121.227 -0.921 . . . . 0.0 113.265 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -73.19 -29.5 62.87 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.327 -0.858 . . . . 0.0 111.236 169.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.84 -33.78 21.23 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -130.2 102.35 17.29 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 118.744 0.702 . . . . 0.0 112.776 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -60.23 -21.66 67.38 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.221 2.614 . . . . 0.0 115.494 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 p -52.51 -31.14 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 120.05 1.296 . . . . 0.0 113.347 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.7 -47.65 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.349 -0.844 . . . . 0.0 110.592 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -67.79 -30.49 69.94 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.472 1.033 . . . . 0.0 112.831 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.5 m -58.58 -49.08 78.77 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.834 0.853 . . . . 0.0 111.993 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -74.1 -49.37 24.2 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 168.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.6 t -60.45 -41.65 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 121.083 -1.011 . . . . 0.0 113.286 -165.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -63.48 -34.87 78.72 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.233 0.54 . . . . 0.0 111.474 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.14 -50.6 11.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.271 1.829 . . . . 0.0 112.84 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.67 -30.38 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.124 0.969 . . . . 0.0 112.806 -175.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 84.4 p -90.05 -3.94 57.67 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 59.61 -34.56 0.06 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 129.839 3.256 . . . . 0.0 116.239 -171.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -145.65 110.69 4.52 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.604 1.561 . . . . 0.0 109.789 173.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -89.11 130.65 2.09 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 121.905 1.736 . . . . 0.0 114.16 -165.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 p -129.33 133.53 47.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.683 1.593 . . . . 0.0 109.97 166.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.3 pt -128.5 156.53 77.0 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 124.926 1.29 . . . . 0.0 113.678 -167.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -61.73 162.98 42.96 Favored 'Cis proline' 0 C--N 1.356 0.944 0 CA-C-N 119.967 1.024 . . . . 0.0 113.88 -5.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.41 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 18.9 tt0 -151.08 158.32 43.9 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.347 0.659 . . . . 0.0 111.729 -164.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.22 139.08 53.18 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.856 1.313 . . . . 0.0 113.724 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -120.46 140.89 50.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.787 -2.006 . . . . 0.0 109.43 169.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 53.7 mt -125.75 121.92 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 173.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.2 tptt 45.46 52.88 8.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.516 1.926 . . . . 0.0 114.073 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.72 27.46 16.72 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -121.55 136.48 54.95 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.344 1.457 . . . . 0.0 110.553 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -74.38 123.71 25.15 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.564 0.697 . . . . 0.0 111.114 174.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.6 t -103.93 -54.38 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 126.272 1.829 . . . . 0.0 111.565 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.93 166.7 23.24 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 116.967 1.547 . . . . 0.0 116.967 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.89 172.11 55.17 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.37 1.938 . . . . 0.0 113.609 170.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.2 tp -56.53 -35.82 68.53 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.472 1.109 . . . . 0.0 113.476 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.36 -33.48 75.62 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.994 0.816 . . . . 0.0 112.541 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.5 mm -77.66 -46.76 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.247 1.419 . . . . 0.0 110.475 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.69 -36.31 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.701 1.2 . . . . 0.0 110.777 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 94.6 m -59.25 -40.41 85.89 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.898 0.879 . . . . 0.0 112.108 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -65.08 -50.27 66.8 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.966 0.803 . . . . 0.0 110.157 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 47.6 mtt -61.49 -37.34 83.3 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.245 1.018 . . . . 0.0 112.333 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.36 -39.01 81.98 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.357 1.863 . . . . 0.0 112.369 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -76.95 -30.75 56.17 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 41.1 t -84.55 -26.45 28.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.024 1.33 . . . . 0.0 114.482 -172.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.31 -6.35 63.43 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-N 119.142 0.883 . . . . 0.0 114.554 -169.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.29 -32.49 72.67 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.77 1.785 . . . . 0.0 112.402 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.06 -46.15 88.83 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.203 -0.936 . . . . 0.0 110.147 174.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -62.02 -37.99 86.95 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.254 1.422 . . . . 0.0 113.199 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -67.41 -35.25 78.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.362 1.065 . . . . 0.0 112.596 175.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 60.5 mtm -70.07 -52.1 26.61 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.167 0.894 . . . . 0.0 113.143 169.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 pp -64.78 -35.88 82.51 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.251 -0.906 . . . . 0.0 112.368 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -71.8 -30.94 66.06 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.88 -36.8 82.33 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.58 0.627 . . . . 0.0 111.947 167.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.54 2.6 11.25 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.798 1.639 . . . . 0.0 113.964 175.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.54 12.57 81.61 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.121 1.343 . . . . 0.0 113.853 176.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.6 mt -93.91 149.63 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.027 1.331 . . . . 0.0 110.004 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.2 m -103.27 146.77 27.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.222 1.409 . . . . 0.0 110.947 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.7 p -141.75 167.67 21.6 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.81 1.644 . . . . 0.0 112.213 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -70.06 159.33 34.05 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.381 1.073 . . . . 0.0 112.372 168.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.0 147.9 23.22 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.79 1.236 . . . . 0.0 112.759 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 21.8 tp . . . . . 0 C--O 1.252 1.231 0 C-N-CA 129.501 3.12 . . . . 0.0 116.206 178.982 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.861 0.362 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.2 m -71.19 -19.36 62.41 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -161.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 m -124.87 20.67 8.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.014 1.326 . . . . 0.0 112.412 170.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.9 -22.3 0.92 Allowed Glycine 0 CA--C 1.54 1.636 0 C-N-CA 126.295 1.902 . . . . 0.0 116.187 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 tp -136.29 155.53 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.983 2.113 . . . . 0.0 109.521 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.46 147.04 24.25 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.841 1.21 . . . . 0.0 115.47 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.42 175.32 25.65 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.62 1.581 . . . . 0.0 115.542 -170.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -123.68 131.85 53.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.948 2.099 . . . . 0.0 109.946 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.5 p -88.54 137.58 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.537 0.735 . . . . 0.0 111.953 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -134.67 170.83 15.22 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.589 1.556 . . . . 0.0 113.424 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -154.91 153.05 30.48 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.471 1.908 . . . . 0.0 112.121 172.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.3 mt -127.78 72.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.171 1.388 . . . . 0.0 108.5 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -140.13 144.68 36.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.229 1.014 . . . . 0.0 113.003 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -91.77 133.42 35.64 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 126.371 1.868 . . . . 0.0 110.976 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.5 p -140.11 53.25 1.66 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.031 0.932 . . . . 0.0 112.599 -157.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.2 156.23 36.08 Favored Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 120.769 -1.207 . . . . 0.0 112.848 158.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.11 -179.35 3.44 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.624 2.883 . . . . 0.0 112.197 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.48 15.12 0.5 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.963 1.705 . . . . 0.0 111.634 169.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -122.5 135.21 54.6 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.059 2.144 . . . . 0.0 111.206 -168.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -109.96 140.58 22.44 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.653 0.781 . . . . 0.0 110.509 156.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.98 160.6 43.57 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.008 2.472 . . . . 0.0 110.117 159.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -64.66 135.23 55.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.928 -1.108 . . . . 0.0 111.691 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.76 147.08 36.41 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.968 1.707 . . . . 0.0 112.024 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.06 -30.4 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.773 1.629 . . . . 0.0 111.418 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 m -142.25 133.87 26.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.74 1.616 . . . . 0.0 110.749 165.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.19 146.68 53.96 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -167.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -157.78 173.6 16.56 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.349 1.06 . . . . 0.0 112.824 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.6 mt -84.4 155.79 22.12 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.606 1.162 . . . . 0.0 111.861 168.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.9 133.51 34.29 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.937 -0.477 . . . . 0.0 110.447 159.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -58.71 -34.37 71.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.903 1.281 . . . . 0.0 112.008 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.39 -28.23 62.87 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.115 1.366 . . . . 0.0 112.951 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.64 -42.35 58.7 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 119.869 -1.77 . . . . 0.0 113.024 175.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.4 tp -75.56 -17.73 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.3 -3.65 55.1 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 169.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -99.01 137.7 37.16 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.193 1.797 . . . . 0.0 111.188 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 p -94.4 130.45 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 122.041 0.924 . . . . 0.0 111.305 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -86.24 136.29 33.23 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -53.71 -43.35 68.95 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.492 0.717 . . . . 0.0 112.583 -167.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -61.95 -27.74 69.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.49 1.116 . . . . 0.0 113.726 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.89 -54.66 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 118.808 0.731 . . . . 0.0 109.483 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.66 -37.71 88.38 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.772 0.829 . . . . 0.0 111.454 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -68.96 -43.91 74.04 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.8 m -73.73 -40.19 63.73 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.394 -1.441 . . . . 0.0 112.043 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.6 pt -61.89 -35.55 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.17 0.588 . . . . 0.0 111.844 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -77.9 -32.96 52.1 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.505 1.922 . . . . 0.0 113.718 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.5 t -73.03 -15.99 61.51 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.845 1.258 . . . . 0.0 113.299 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -104.2 145.27 30.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.95 1.3 . . . . 0.0 113.969 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -83.46 -39.49 20.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.947 0.899 . . . . 0.0 111.366 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.57 137.87 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 126.731 2.012 . . . . 0.0 109.839 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.8 t -133.93 128.0 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.626 1.17 . . . . 0.0 110.566 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -136.66 156.95 47.86 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.943 1.297 . . . . 0.0 110.916 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -129.32 145.93 51.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.088 0.955 . . . . 0.0 111.282 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 mt -137.39 151.3 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.198 0.599 . . . . 0.0 111.406 -166.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.49 108.32 3.25 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 159.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.08 -136.36 15.59 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 118.582 0.628 . . . . 0.0 113.115 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.7 mt -123.16 158.4 58.07 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.728 2.011 . . . . 0.0 111.447 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.53 -23.47 37.12 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 121.976 1.784 . . . . 0.0 115.067 -173.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.7 -15.38 25.32 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.235 0.925 . . . . 0.0 113.221 169.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.95 68.68 70.93 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.213 1.405 . . . . 0.0 111.635 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.01 146.11 25.45 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.215 2.61 . . . . 0.0 111.414 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 96.4 mtp -97.69 4.79 49.93 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.488 1.515 . . . . 0.0 113.518 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.9 t -146.57 145.52 30.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.44 1.496 . . . . 0.0 111.078 -175.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.82 -44.12 97.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.215 0.606 . . . . 0.0 111.996 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -72.39 -24.7 61.29 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.935 -1.103 . . . . 0.0 112.567 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.0 m -68.42 -43.1 77.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.649 0.78 . . . . 0.0 111.6 167.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -61.4 -44.81 96.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.813 0.845 . . . . 0.0 111.861 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -57.8 -37.28 73.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.277 1.831 . . . . 0.0 113.036 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.9 ttp -63.58 -46.8 84.19 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.434 0.561 . . . . 0.0 111.624 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 mm -69.72 -33.01 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.346 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -57.98 -36.69 72.97 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.935 1.243 . . . . 0.0 113.026 170.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.13 -42.14 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.799 0.839 . . . . 0.0 111.1 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.35 -38.94 88.75 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.405 1.082 . . . . 0.0 112.678 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.05 -25.55 66.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.179 1.791 . . . . 0.0 112.723 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.27 73.45 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.06 -11.6 35.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.169 0.988 . . . . 0.0 113.327 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.73 20.3 70.13 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.477 1.037 . . . . 0.0 115.043 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.42 130.35 56.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.466 0.633 . . . . 0.0 109.462 156.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -115.78 131.31 56.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.472 0.709 . . . . 0.0 109.706 168.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -105.07 171.93 7.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.988 1.715 . . . . 0.0 113.021 -163.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.4 m -84.73 125.88 32.92 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.462 1.125 . . . . 0.0 108.861 -170.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.7 m -125.53 133.28 52.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.561 -154.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.04 141.98 46.24 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.097 0.951 . . . . 0.0 112.819 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -98.45 78.71 2.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.026 1.731 . . . . 0.0 112.164 -167.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.0 p -61.52 -28.3 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.263 1.425 . . . . 0.0 114.321 -172.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.0 tp -78.15 -22.69 48.39 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.664 -0.648 . . . . 0.0 111.533 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.87 -32.95 13.0 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 175.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -130.06 98.12 21.95 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.046 0.938 . . . . 0.0 112.055 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -62.19 -9.68 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.042 3.161 . . . . 0.0 116.247 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 p -48.78 -36.49 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.015 -1.053 . . . . 0.0 111.945 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.43 -47.9 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.232 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -67.57 -29.22 68.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.1 0.864 . . . . 0.0 112.243 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.2 m -70.5 -50.5 37.18 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -72.16 -39.43 68.74 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.956 0.798 . . . . 0.0 111.711 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.29 -35.36 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.109 0.868 . . . . 0.0 113.061 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.84 -46.34 78.91 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.979 0.809 . . . . 0.0 111.568 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -64.79 -34.58 78.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.156 0.982 . . . . 0.0 113.067 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.3 t -80.3 -41.56 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.1 t -97.47 -14.27 21.25 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -168.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 67.34 -40.66 0.4 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.874 2.07 . . . . 0.0 115.079 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -130.0 104.85 16.73 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.118 1.767 . . . . 0.0 110.529 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -88.14 128.43 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.563 2.176 . . . . 0.0 112.464 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 75.1 p -131.53 146.97 52.48 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.144 2.178 . . . . 0.0 108.58 169.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.1 tt -108.46 134.93 20.07 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 119.241 0.928 . . . . 0.0 111.9 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -79.99 162.75 83.91 Favored 'Cis proline' 0 CA--C 1.551 1.35 0 CA-C-N 119.835 0.977 . . . . 0.0 111.799 -16.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -134.18 161.58 34.51 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.893 1.677 . . . . 0.0 111.288 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.59 141.82 50.87 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -130.92 141.05 50.26 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.532 1.933 . . . . 0.0 110.073 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 60.3 mt -140.54 134.05 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.731 1.213 . . . . 0.0 109.556 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt 52.96 41.75 32.11 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.687 1.595 . . . . 0.0 114.162 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.04 14.2 5.19 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.95 2.1 . . . . 0.0 115.568 -172.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -111.42 140.89 45.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.625 1.57 . . . . 0.0 110.618 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -77.84 126.25 30.57 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.257 -0.902 . . . . 0.0 112.898 175.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.3 t -101.03 -48.05 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.555 1.542 . . . . 0.0 111.835 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 162.91 170.55 27.94 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.7 169.14 54.62 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.268 1.413 . . . . 0.0 113.685 166.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -46.69 -46.89 20.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.861 1.665 . . . . 0.0 114.746 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.56 -39.06 75.84 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.543 -0.723 . . . . 0.0 111.531 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.9 mm -72.62 -47.45 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.57 1.948 . . . . 0.0 111.56 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.35 -35.76 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.903 0.881 . . . . 0.0 110.503 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.1 m -62.06 -39.31 91.96 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.744 0.818 . . . . 0.0 112.153 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -64.29 -46.69 82.53 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.184 0.902 . . . . 0.0 110.633 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 47.5 mtt -61.65 -38.76 88.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.137 0.975 . . . . 0.0 111.812 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.61 -44.16 87.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.565 1.146 . . . . 0.0 111.781 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.25 -34.38 65.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 t -105.54 3.23 29.13 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -171.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.26 -0.41 75.12 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 116.259 1.263 . . . . 0.0 116.259 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -71.65 -31.85 67.28 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.561 1.181 . . . . 0.0 113.245 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.75 -43.77 83.24 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.483 -1.385 . . . . 0.0 109.951 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -58.22 -44.59 88.24 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.128 1.771 . . . . 0.0 112.307 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -57.28 -46.16 83.37 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.248 1.019 . . . . 0.0 110.932 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 65.1 mtm -69.59 -49.87 49.93 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.9 -37.73 86.87 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.613 -0.679 . . . . 0.0 112.638 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -71.66 -30.8 66.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.188 0.995 . . . . 0.0 111.99 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.77 -31.05 72.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.432 0.693 . . . . 0.0 112.199 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -76.05 -0.18 20.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.96 1.304 . . . . 0.0 113.51 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.4 24.87 60.12 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 124.153 0.882 . . . . 0.0 113.435 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 46.2 mt -105.42 140.4 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.012 0.906 . . . . 0.0 110.893 -174.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.0 m -94.2 125.33 38.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.859 1.264 . . . . 0.0 112.037 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.1 p -118.35 173.26 6.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.096 2.559 . . . . 0.0 111.691 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -55.18 120.72 7.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.359 0.664 . . . . 0.0 111.691 164.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -112.85 121.74 45.6 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.58 1.552 . . . . 0.0 108.71 170.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 49.9 tp . . . . . 0 C--O 1.253 1.254 0 C-N-CA 124.374 1.07 . . . . 0.0 112.351 -167.705 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 119.603 -0.237 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 p -66.16 -18.23 65.22 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.375 1.47 . . . . 0.0 114.781 -174.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.7 m -128.72 146.83 50.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.363 1.465 . . . . 0.0 111.914 165.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.62 -5.87 70.3 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 117.382 1.713 . . . . 0.0 117.382 163.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.3 tt -139.27 156.99 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.367 1.583 . . . . 0.0 111.055 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.41 166.54 54.59 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 123.973 0.797 . . . . 0.0 114.673 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.08 148.21 40.77 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.448 1.023 . . . . 0.0 114.871 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -136.87 137.32 39.54 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.659 1.183 . . . . 0.0 111.454 -171.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.05 126.0 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.628 1.171 . . . . 0.0 113.402 -168.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -70.97 151.81 44.26 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -88.03 141.46 28.56 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.386 1.474 . . . . 0.0 113.219 -166.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.1 tp -59.6 135.02 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.205 1.402 . . . . 0.0 112.455 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -91.3 117.12 29.39 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.191 0.996 . . . . 0.0 110.961 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -144.17 162.41 36.39 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.798 2.039 . . . . 0.0 110.65 -171.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 m -128.44 138.09 52.15 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.976 1.31 . . . . 0.0 110.477 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -94.04 136.1 24.01 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.759 0.823 . . . . 0.0 112.162 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.8 162.07 29.96 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.925 2.417 . . . . 0.0 112.232 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.53 -9.8 59.61 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.462 1.105 . . . . 0.0 112.986 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -126.43 111.19 14.16 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.32 1.448 . . . . 0.0 108.214 170.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -106.55 153.2 40.74 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 127.116 2.167 . . . . 0.0 111.183 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.45 153.15 23.7 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.271 2.647 . . . . 0.0 114.62 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.7 ttm105 -108.92 140.49 42.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.706 2.402 . . . . 0.0 110.549 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.1 tp -145.43 -72.12 0.25 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.547 0.739 . . . . 0.0 111.904 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.4 t -106.95 -43.61 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.186 0.994 . . . . 0.0 109.681 166.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.1 m -112.54 168.61 9.51 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.486 1.514 . . . . 0.0 111.516 162.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.08 167.45 10.66 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.032 1.733 . . . . 0.0 112.024 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 52.66 61.96 2.93 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.203 1.801 . . . . 0.0 115.653 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.6 tp -139.35 139.21 37.17 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.519 1.128 . . . . 0.0 111.448 168.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.58 161.0 38.99 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.691 1.196 . . . . 0.0 113.522 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -56.01 -28.77 58.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.594 1.558 . . . . 0.0 113.432 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -59.31 -38.84 81.27 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.905 1.682 . . . . 0.0 112.789 175.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -79.06 -41.23 29.28 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 165.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.22 -30.3 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 120.501 -1.374 . . . . 0.0 112.22 -168.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.12 0.18 56.93 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 80.0 mmm -120.79 127.97 52.45 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.837 1.255 . . . . 0.0 112.364 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -85.81 146.69 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.342 0.657 . . . . 0.0 110.796 163.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -93.82 123.18 36.99 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.075 1.35 . . . . 0.0 111.153 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -61.51 -32.48 72.52 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -169.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.78 -38.88 80.34 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.155 1.343 . . . . 0.0 112.058 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.4 mt -70.45 -50.57 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.094 0.958 . . . . 0.0 109.458 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.05 -39.68 94.61 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.059 1.344 . . . . 0.0 112.526 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.23 -32.57 72.86 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.626 -0.671 . . . . 0.0 112.617 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.9 m -71.06 -48.03 55.06 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.566 1.075 . . . . 0.0 111.584 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.6 pt -62.04 -34.31 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.78 0.832 . . . . 0.0 112.054 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -78.5 -35.17 46.8 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.468 1.507 . . . . 0.0 113.534 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.5 t -72.63 -37.85 67.91 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.339 1.056 . . . . 0.0 113.015 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -87.13 133.51 33.62 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.157 0.889 . . . . 0.0 111.956 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.38 -38.31 77.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.731 -0.606 . . . . 0.0 111.717 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.5 t -143.92 131.66 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.216 1.806 . . . . 0.0 110.296 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -135.02 133.19 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.507 1.123 . . . . 0.0 112.118 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.0 t -131.41 155.13 47.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.954 1.302 . . . . 0.0 110.97 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -131.2 140.48 49.9 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.168 0.987 . . . . 0.0 111.79 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mt -140.54 155.65 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.031 1.332 . . . . 0.0 110.901 -158.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.1 102.22 1.6 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.124 0.569 . . . . 0.0 109.467 155.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.97 -143.97 23.55 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.302 -0.874 . . . . 0.0 114.7 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.1 mt -107.3 155.69 38.99 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 125.438 1.495 . . . . 0.0 111.929 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -63.9 -32.2 66.37 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.413 1.408 . . . . 0.0 112.356 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -75.2 -26.78 59.26 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.242 1.017 . . . . 0.0 113.124 172.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.81 76.51 15.48 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.31 1.444 . . . . 0.0 112.354 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.84 144.85 24.82 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.124 2.549 . . . . 0.0 111.772 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.84 10.87 28.54 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.134 1.773 . . . . 0.0 113.815 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.4 t -147.5 146.09 29.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.222 1.409 . . . . 0.0 110.233 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.52 -45.89 87.89 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.482 0.658 . . . . 0.0 111.846 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -70.73 -26.45 63.39 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.103 -0.998 . . . . 0.0 112.138 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -68.49 -38.3 80.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.255 -0.903 . . . . 0.0 112.681 166.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -65.49 -39.28 91.71 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.339 0.972 . . . . 0.0 112.285 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -59.58 -33.1 71.02 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.965 1.306 . . . . 0.0 112.873 174.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.7 tpt -61.51 -42.94 99.56 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.505 0.722 . . . . 0.0 111.74 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.12 -33.91 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.555 0.742 . . . . 0.0 111.654 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -39.79 74.58 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.741 1.216 . . . . 0.0 111.713 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.93 -43.41 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.475 1.51 . . . . 0.0 111.868 172.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.96 -37.96 89.33 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.696 -0.628 . . . . 0.0 112.102 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -69.36 -31.93 70.67 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.407 -0.808 . . . . 0.0 112.762 173.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.88 76.65 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.457 -0.777 . . . . 0.0 112.334 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.6 mt -87.01 -12.61 46.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.199 1.0 . . . . 0.0 113.298 171.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.5 15.01 63.24 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.884 1.707 . . . . 0.0 114.309 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.38 132.45 55.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.405 1.103 . . . . 0.0 113.449 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -110.82 157.36 19.9 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.249 1.02 . . . . 0.0 113.04 169.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -145.65 170.76 15.83 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.667 2.787 . . . . 0.0 110.531 -163.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.6 m -85.28 124.22 31.65 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.623 -1.298 . . . . 0.0 109.787 -168.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.9 m -130.43 132.09 45.55 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.041 1.336 . . . . 0.0 111.393 -156.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.5 143.18 48.69 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -87.65 121.1 29.66 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.693 1.197 . . . . 0.0 109.965 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.0 m -67.22 -21.2 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.049 0.94 . . . . 0.0 113.137 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.9 mt -88.34 -25.08 22.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.095 1.358 . . . . 0.0 114.446 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.11 -33.3 22.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -164.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -148.21 149.78 33.1 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.881 1.272 . . . . 0.0 110.087 -172.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.86 -6.9 19.85 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.862 2.375 . . . . 0.0 114.543 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.68 -40.37 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.704 -1.248 . . . . 0.0 113.318 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.35 -47.2 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.275 -0.891 . . . . 0.0 110.939 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -59.31 -30.19 68.16 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.27 0.941 . . . . 0.0 113.354 171.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.0 m -69.98 -44.75 68.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -77.66 -40.36 41.91 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.22 -43.87 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -159.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -69.46 -35.49 75.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.733 0.778 . . . . 0.0 110.32 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -67.39 -43.92 80.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.242 1.817 . . . . 0.0 113.343 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.54 -36.23 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.991 0.917 . . . . 0.0 113.297 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.6 p -102.37 1.13 35.09 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 -173.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 62.45 -30.84 0.08 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.589 2.355 . . . . 0.0 115.965 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -151.93 138.29 11.75 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.183 1.393 . . . . 0.0 111.349 167.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.75 128.38 19.83 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.206 1.937 . . . . 0.0 112.759 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.6 m -139.94 140.87 36.46 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.322 -1.486 . . . . 0.0 110.419 157.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.8 mt -122.83 135.62 25.96 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.443 1.097 . . . . 0.0 110.929 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -82.33 165.61 71.76 Favored 'Cis proline' 0 CA--C 1.543 0.973 0 CA-C-N 119.934 1.012 . . . . 0.0 111.837 -10.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -143.19 159.73 41.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.028 1.331 . . . . 0.0 111.96 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.1 140.15 51.69 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.515 1.126 . . . . 0.0 113.881 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -129.76 143.93 51.05 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.18 1.792 . . . . 0.0 110.514 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 55.2 mt -132.95 128.14 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.544 1.137 . . . . 0.0 108.341 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt 47.32 49.59 15.39 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.023 1.729 . . . . 0.0 115.544 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.87 19.11 9.39 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -122.59 147.1 46.81 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.502 1.921 . . . . 0.0 110.564 176.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -85.44 126.25 33.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.145 0.974 . . . . 0.0 112.88 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.1 t -100.26 -46.02 11.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 125.1 1.36 . . . . 0.0 110.602 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 158.73 179.0 33.26 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 117.261 1.665 . . . . 0.0 117.261 165.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.35 171.31 55.17 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.054 1.312 . . . . 0.0 113.751 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.6 tp -46.74 -46.31 20.27 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.793 1.237 . . . . 0.0 114.04 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -69.9 -17.87 63.36 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.8 mm -84.06 -45.64 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.967 1.307 . . . . 0.0 109.882 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.3 t -60.47 -44.19 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.752 1.621 . . . . 0.0 111.778 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.7 p -64.82 -37.96 89.37 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.679 0.672 . . . . 0.0 111.97 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -63.13 -44.1 96.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.319 1.048 . . . . 0.0 111.549 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.7 mtt -66.89 -35.97 81.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.6 1.16 . . . . 0.0 112.356 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.89 -45.96 66.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.9 1.28 . . . . 0.0 112.029 176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -68.54 -19.94 64.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.983 1.313 . . . . 0.0 113.151 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.6 m -105.16 -8.07 18.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.511 1.524 . . . . 0.0 114.721 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.03 -1.11 76.29 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 119.587 1.085 . . . . 0.0 115.08 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -67.21 -34.07 76.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.597 1.198 . . . . 0.0 112.069 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.06 -39.49 86.19 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.798 1.285 . . . . 0.0 110.913 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -66.04 -31.33 72.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.81 2.044 . . . . 0.0 113.493 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.61 -48.82 80.18 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.63 1.104 . . . . 0.0 111.134 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -70.6 -41.21 72.62 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 pp -65.18 -37.34 87.05 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.649 0.659 . . . . 0.0 111.351 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -71.91 -34.76 69.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.52 -30.02 70.99 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 167.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -77.13 -2.68 35.56 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.44 6.82 64.01 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.751 1.643 . . . . 0.0 114.85 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.05 147.05 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.183 1.393 . . . . 0.0 111.327 -170.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 36.4 m -105.24 126.1 51.72 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.118 0.967 . . . . 0.0 110.627 170.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 17.0 p -112.08 167.97 9.97 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.8 1.64 . . . . 0.0 111.822 172.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.56 161.28 28.26 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.99 0.916 . . . . 0.0 111.238 171.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -76.08 146.35 39.43 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.288 0.566 . . . . 0.0 110.69 170.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.253 1.278 0 C-N-CA 125.186 1.394 . . . . 0.0 112.209 -174.682 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.6 p -65.51 -16.2 63.43 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -174.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 97.5 p -119.67 10.85 11.82 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.912 1.685 . . . . 0.0 113.558 171.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.92 -11.31 48.55 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.063 1.316 . . . . 0.0 115.853 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mt -125.17 125.38 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.914 1.357 . . . . 0.0 109.623 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.86 -178.66 31.15 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.193 1.377 . . . . 0.0 114.066 -175.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.65 147.53 48.05 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.11 1.338 . . . . 0.0 115.893 -167.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.12 141.5 57.4 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.159 1.384 . . . . 0.0 112.897 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.77 140.47 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.713 0.805 . . . . 0.0 112.198 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -122.08 165.57 15.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.04 1.736 . . . . 0.0 112.175 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.43 145.1 30.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.088 0.955 . . . . 0.0 112.491 166.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.5 mt -117.25 142.41 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.713 1.605 . . . . 0.0 108.536 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -116.93 151.69 36.12 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -76.53 152.65 35.95 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.542 1.537 . . . . 0.0 109.578 163.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 p -50.0 -27.67 5.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.587 2.355 . . . . 0.0 115.834 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.09 158.44 81.31 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.532 1.533 . . . . 0.0 114.108 -166.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -66.52 172.8 8.67 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.736 2.29 . . . . 0.0 110.927 160.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -104.56 -2.46 25.14 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 167.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -79.9 119.54 22.9 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.028 -1.045 . . . . 0.0 109.854 162.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -83.6 141.69 42.06 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.18 152.89 31.43 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 124.271 3.314 . . . . 0.0 114.983 -174.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.2 mtp85 -76.29 130.53 38.27 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.629 1.572 . . . . 0.0 111.515 161.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.9 mt -140.96 152.89 45.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.222 1.809 . . . . 0.0 111.076 -176.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.58 -35.79 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.362 1.065 . . . . 0.0 110.816 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.9 m -113.81 123.37 49.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.664 1.986 . . . . 0.0 109.656 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.16 103.62 15.58 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -169.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.01 155.5 18.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.701 1.2 . . . . 0.0 111.536 167.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.9 mt -71.52 141.59 50.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.139 0.975 . . . . 0.0 109.14 164.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.19 162.52 26.53 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.554 -0.716 . . . . 0.0 111.286 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -54.35 -43.45 71.3 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.291 -0.881 . . . . 0.0 111.938 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.34 -30.48 71.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.414 1.086 . . . . 0.0 113.547 175.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.52 -41.48 55.04 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 172.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.2 tt -92.78 -26.77 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -170.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.73 -5.89 54.42 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.176 -0.952 . . . . 0.0 113.008 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.2 ttt -120.09 144.27 47.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.531 1.932 . . . . 0.0 111.975 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -89.11 151.45 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.447 1.099 . . . . 0.0 113.283 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.2 106.27 16.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.324 1.449 . . . . 0.0 110.899 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -54.16 -40.24 67.29 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.033 1.333 . . . . 0.0 113.062 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.31 -36.51 74.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.649 0.779 . . . . 0.0 112.38 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.56 -46.01 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.237 1.415 . . . . 0.0 110.378 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.54 -40.63 79.28 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.574 1.15 . . . . 0.0 111.691 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.09 -29.06 65.93 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.952 0.901 . . . . 0.0 113.116 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.0 m -71.31 -48.09 52.75 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.83 1.195 . . . . 0.0 111.6 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.5 pt -59.98 -33.47 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 122.973 0.509 . . . . 0.0 111.826 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -78.2 -34.8 49.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.3 1.84 . . . . 0.0 113.542 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -68.78 -38.24 79.87 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.596 1.158 . . . . 0.0 111.719 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -86.03 133.27 33.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.494 0.718 . . . . 0.0 111.323 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.52 -26.3 45.78 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.987 -1.07 . . . . 0.0 112.507 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.5 t -142.37 131.24 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.482 1.113 . . . . 0.0 110.974 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.6 t -133.13 135.59 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.277 1.431 . . . . 0.0 111.468 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.0 t -135.45 155.2 50.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.978 1.311 . . . . 0.0 111.496 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -127.53 140.41 52.15 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.962 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.41 159.7 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.872 1.669 . . . . 0.0 110.273 -163.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -75.28 105.17 6.16 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.466 0.706 . . . . 0.0 109.299 157.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.27 -158.61 32.96 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 119.056 0.844 . . . . 0.0 113.949 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -94.35 158.73 35.29 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.428 1.491 . . . . 0.0 111.205 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.0 -31.86 76.47 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 121.897 1.731 . . . . 0.0 112.663 168.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.0 -14.53 53.84 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.027 1.331 . . . . 0.0 113.925 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.42 72.45 11.84 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.23 1.412 . . . . 0.0 112.5 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.27 141.97 18.67 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.243 1.962 . . . . 0.0 112.064 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.1 mmt -90.53 1.68 56.48 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.127 2.171 . . . . 0.0 113.645 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.4 t -152.06 146.22 25.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.096 1.358 . . . . 0.0 111.777 -171.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.4 -39.76 81.56 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.24 -0.912 . . . . 0.0 112.553 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -64.08 -29.91 71.02 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.969 -1.082 . . . . 0.0 111.746 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 m -68.27 -46.35 70.65 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.348 0.659 . . . . 0.0 112.268 169.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -58.53 -42.35 87.6 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 118.926 0.784 . . . . 0.0 112.512 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -57.35 -31.09 65.39 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.034 0.934 . . . . 0.0 113.278 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 49.9 ttm -70.38 -42.93 71.1 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.996 0.816 . . . . 0.0 112.34 171.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 mm -69.17 -30.91 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.92 -1.112 . . . . 0.0 111.359 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.43 -33.63 75.18 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.6 1.16 . . . . 0.0 112.649 167.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.36 -40.7 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.734 0.814 . . . . 0.0 111.468 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.8 mt -63.36 -34.86 78.63 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.897 0.879 . . . . 0.0 111.915 170.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -67.83 -34.84 77.51 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.723 -1.236 . . . . 0.0 113.014 170.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.79 79.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.991 0.814 . . . . 0.0 111.835 176.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -82.76 -14.49 54.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.01 7.68 44.95 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.463 1.03 . . . . 0.0 114.698 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.18 132.4 54.92 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.574 1.55 . . . . 0.0 111.02 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -115.91 149.85 38.05 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.292 0.951 . . . . 0.0 112.511 168.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -123.7 172.66 8.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.067 1.747 . . . . 0.0 112.676 -167.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.2 m -85.38 121.64 28.38 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.314 -0.866 . . . . 0.0 110.043 -161.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.2 m -124.76 132.14 53.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.996 -153.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -125.67 142.79 51.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.28 1.032 . . . . 0.0 112.674 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -96.04 118.54 32.84 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.788 1.235 . . . . 0.0 111.973 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.31 -22.73 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.323 1.049 . . . . 0.0 113.485 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.3 mt -87.93 -22.25 24.45 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.27 -35.09 11.37 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -124.25 108.71 29.51 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.077 0.853 . . . . 0.0 111.434 -174.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -54.19 -20.15 18.51 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.427 3.418 . . . . 0.0 116.46 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.4 p -54.32 -32.57 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.909 -1.119 . . . . 0.0 113.233 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.4 t -70.09 -53.79 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.515 -0.741 . . . . 0.0 111.7 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -64.59 -25.73 68.1 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.743 0.817 . . . . 0.0 112.21 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.4 m -70.37 -50.76 35.54 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.02 0.928 . . . . 0.0 113.103 169.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -70.38 -37.44 74.53 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.74 1.154 . . . . 0.0 112.003 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.89 -35.2 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 120.761 -1.212 . . . . 0.0 112.563 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -62.32 -38.38 89.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.241 1.016 . . . . 0.0 111.285 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -49.08 26.36 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 175.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 56.5 t -83.95 -42.93 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -169.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.8 m -100.27 -2.41 33.82 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 63.26 -32.52 0.11 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 128.765 2.826 . . . . 0.0 115.495 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -144.89 136.0 12.46 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.058 2.143 . . . . 0.0 109.961 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.3 126.78 3.76 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.852 1.701 . . . . 0.0 112.478 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.3 m -130.21 121.05 25.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.969 1.708 . . . . 0.0 107.249 166.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.4 140.4 25.8 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.849 0.86 . . . . 0.0 109.361 -172.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.53 158.21 97.35 Favored 'Cis proline' 0 CA--C 1.541 0.856 0 CA-C-N 119.383 0.815 . . . . 0.0 113.496 -10.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -128.82 152.94 47.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.774 1.63 . . . . 0.0 110.616 173.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.61 139.99 51.99 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.367 1.467 . . . . 0.0 113.108 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -131.85 142.89 49.83 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.711 2.005 . . . . 0.0 109.826 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 53.2 mt -123.91 122.57 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.3 tptt 44.09 54.36 6.0 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.852 2.061 . . . . 0.0 113.783 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.93 24.39 13.49 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -126.62 143.71 51.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.678 1.191 . . . . 0.0 110.151 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -82.81 125.62 31.51 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.586 1.184 . . . . 0.0 113.26 -169.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.17 -47.36 11.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 125.105 1.362 . . . . 0.0 110.962 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.14 176.92 28.82 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 116.62 1.408 . . . . 0.0 116.62 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.45 172.59 55.13 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.472 1.034 . . . . 0.0 113.97 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -44.85 -47.02 11.07 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.107 1.763 . . . . 0.0 113.695 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.83 -29.76 70.97 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 119.053 -0.498 . . . . 0.0 112.328 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.9 mm -82.32 -47.73 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.31 1.444 . . . . 0.0 111.177 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.6 t -62.1 -36.12 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.093 1.357 . . . . 0.0 111.089 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.1 m -59.79 -42.12 92.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.497 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -66.49 -43.91 84.07 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.801 1.182 . . . . 0.0 111.132 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 50.5 mtt -61.09 -36.73 80.44 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.142 0.577 . . . . 0.0 111.923 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.48 -47.0 58.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.159 0.984 . . . . 0.0 112.714 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.52 -21.49 64.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.001 0.921 . . . . 0.0 113.434 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 64.4 m -105.27 -21.5 13.23 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.975 1.71 . . . . 0.0 114.02 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.15 9.2 62.33 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.664 -1.273 . . . . 0.0 115.668 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.33 -32.14 73.63 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.627 1.713 . . . . 0.0 111.694 173.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.31 -45.18 95.51 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.83 173.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.54 -41.86 98.44 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.189 0.995 . . . . 0.0 111.815 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -56.02 -45.02 79.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.824 0.85 . . . . 0.0 110.504 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.54 -51.44 28.66 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.35 -36.62 84.72 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.316 0.507 . . . . 0.0 111.717 -175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -68.34 -38.02 81.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.898 1.279 . . . . 0.0 111.878 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.47 -29.23 69.31 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.986 0.812 . . . . 0.0 111.749 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -79.7 6.27 11.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.067 1.747 . . . . 0.0 114.306 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.8 10.91 75.01 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.194 1.378 . . . . 0.0 114.421 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.1 mt -99.13 147.42 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.887 1.275 . . . . 0.0 109.572 -171.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 5.7 m -112.93 120.22 40.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.255 1.022 . . . . 0.0 111.305 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.2 p -112.41 167.37 10.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.852 1.261 . . . . 0.0 111.779 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -56.75 144.09 34.11 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.102 0.961 . . . . 0.0 110.035 166.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -93.58 132.15 38.17 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.04 0.936 . . . . 0.0 112.107 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--O 1.251 1.15 0 C-N-CA 126.706 2.002 . . . . 0.0 111.726 175.352 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -71.21 -24.41 62.21 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -173.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.1 t -161.1 -46.16 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 167.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.02 7.65 62.9 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 116.285 1.274 . . . . 0.0 116.285 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 tt -86.84 147.14 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.882 1.341 . . . . 0.0 112.991 -167.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -171.34 177.36 44.27 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.063 0.839 . . . . 0.0 113.752 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.31 -26.47 28.06 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.02 1.295 . . . . 0.0 114.117 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.78 137.16 51.66 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.421 1.111 . . . . 0.0 110.713 165.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -141.59 165.04 18.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 125.51 1.524 . . . . 0.0 110.152 -162.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ptm85 -57.38 115.34 2.66 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.351 1.06 . . . . 0.0 111.076 168.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -161.87 127.65 3.6 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.601 1.56 . . . . 0.0 111.358 -171.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.4 tp -142.37 145.93 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.462 0.705 . . . . 0.0 112.888 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -136.97 144.08 43.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.116 1.366 . . . . 0.0 112.727 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -97.08 118.69 34.06 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.075 1.75 . . . . 0.0 109.87 164.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.5 p -80.63 42.86 0.63 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.621 1.569 . . . . 0.0 114.838 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -83.19 141.7 43.3 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.394 1.477 . . . . 0.0 112.353 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.29 166.56 12.69 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.174 2.582 . . . . 0.0 112.463 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -79.67 16.74 1.03 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -172.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -92.11 149.5 21.46 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.733 167.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -72.24 143.98 86.51 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 121.167 -0.958 . . . . 0.0 110.868 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -74.08 144.88 34.5 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.185 2.59 . . . . 0.0 112.908 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.28 111.27 16.24 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.277 1.431 . . . . 0.0 109.154 170.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.9 mt -120.08 -5.65 10.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.663 1.185 . . . . 0.0 113.995 -166.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.55 -32.31 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.742 1.155 . . . . 0.0 111.708 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.2 m -131.08 119.67 22.31 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.959 1.703 . . . . 0.0 109.866 167.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.28 152.32 29.1 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.79 -36.55 8.64 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.292 1.837 . . . . 0.0 111.526 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.2 tp -149.05 162.13 40.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.976 1.31 . . . . 0.0 111.882 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.26 123.57 30.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.195 0.998 . . . . 0.0 112.036 168.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -57.42 -35.42 70.04 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.275 1.43 . . . . 0.0 112.923 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.59 -29.99 59.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.553 1.141 . . . . 0.0 113.142 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -70.37 -34.36 72.51 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.972 -1.08 . . . . 0.0 111.784 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.89 2.85 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.642 1.177 . . . . 0.0 113.845 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.89 -10.48 13.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.152 1.381 . . . . 0.0 114.704 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -117.9 133.79 55.58 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.876 1.27 . . . . 0.0 111.472 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 m -133.2 131.91 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.544 1.137 . . . . 0.0 111.019 169.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -68.42 127.11 31.79 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.894 1.278 . . . . 0.0 109.854 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -61.63 -33.41 73.89 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -165.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.59 -34.29 77.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.257 1.023 . . . . 0.0 112.374 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.4 mm -77.54 -44.65 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.282 1.033 . . . . 0.0 110.129 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.24 -38.42 71.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.993 1.317 . . . . 0.0 111.775 172.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.69 -36.61 67.91 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.366 -0.834 . . . . 0.0 112.885 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.0 m -65.77 -44.84 84.65 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.051 -1.031 . . . . 0.0 111.31 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.1 pt -62.97 -36.85 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.768 0.827 . . . . 0.0 112.174 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -76.54 -32.46 58.24 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.226 1.41 . . . . 0.0 111.592 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.6 t -92.39 -28.34 16.95 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -170.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -86.25 147.68 25.98 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.256 -0.903 . . . . 0.0 111.427 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -72.4 -47.62 47.8 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.007 -1.058 . . . . 0.0 113.531 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.5 t -144.1 130.08 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.625 1.57 . . . . 0.0 110.196 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.76 134.89 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.588 1.155 . . . . 0.0 112.075 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -130.75 155.11 47.21 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.525 1.53 . . . . 0.0 111.29 172.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.46 143.06 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.708 0.803 . . . . 0.0 111.243 170.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mt -130.9 157.36 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.392 1.477 . . . . 0.0 109.655 -165.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -72.12 97.93 2.02 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 152.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.12 -148.38 19.15 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.518 -0.739 . . . . 0.0 114.906 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.98 157.38 63.74 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 125.999 1.72 . . . . 0.0 110.812 -174.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.1 -33.28 50.86 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 121.434 1.422 . . . . 0.0 114.637 -169.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -94.37 -0.38 54.93 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.25 68.1 15.3 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 126.258 1.823 . . . . 0.0 112.018 174.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.05 143.76 11.62 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.274 2.65 . . . . 0.0 112.261 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.3 mmt -91.15 1.42 57.1 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.977 1.311 . . . . 0.0 113.674 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.21 146.15 28.56 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.163 -0.96 . . . . 0.0 111.709 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.85 96.28 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.112 0.965 . . . . 0.0 113.154 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -63.47 -36.86 85.16 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.505 -1.372 . . . . 0.0 112.019 171.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.7 m -64.87 -36.32 83.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.564 -0.732 . . . . 0.0 112.488 173.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -62.83 -46.2 89.02 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 120.153 1.342 . . . . 0.0 111.784 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -64.72 -29.81 70.81 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.677 1.191 . . . . 0.0 113.831 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.3 tpt -57.49 -46.69 83.44 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.345 1.058 . . . . 0.0 112.356 167.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 mm -70.84 -34.42 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.396 -0.815 . . . . 0.0 111.309 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.17 -34.95 68.97 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.571 -0.705 . . . . 0.0 111.835 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.9 -41.89 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.618 1.167 . . . . 0.0 111.684 174.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 69.2 mt -65.28 -36.59 84.56 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.697 0.799 . . . . 0.0 112.882 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.94 -29.64 65.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.989 -1.069 . . . . 0.0 112.739 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.22 77.38 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.254 -0.904 . . . . 0.0 112.042 175.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.76 -11.58 33.47 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.41 1.084 . . . . 0.0 113.474 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.76 9.28 82.86 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.356 1.931 . . . . 0.0 115.989 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.18 136.8 52.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.602 1.201 . . . . 0.0 113.045 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -114.27 159.21 20.44 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 171.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -142.18 174.01 11.0 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.294 2.238 . . . . 0.0 110.943 -162.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.0 m -86.11 130.57 34.49 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.906 -1.121 . . . . 0.0 110.157 -165.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.8 p -120.6 147.47 45.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.855 1.262 . . . . 0.0 113.881 -164.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -133.42 143.51 48.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.806 1.242 . . . . 0.0 112.27 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -94.25 119.93 33.76 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.87 1.268 . . . . 0.0 110.429 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.74 -22.51 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.607 1.163 . . . . 0.0 113.434 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -81.39 -23.36 37.68 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.461 -0.775 . . . . 0.0 112.774 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.04 -33.21 19.62 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -144.29 126.91 8.48 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.428 1.091 . . . . 0.0 111.179 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.05 -18.23 45.93 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.93 2.42 . . . . 0.0 114.483 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -46.77 -35.61 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.415 1.086 . . . . 0.0 113.298 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.31 -45.86 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.201 -0.937 . . . . 0.0 111.603 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -75.25 -23.34 57.48 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.841 0.746 . . . . 0.0 112.995 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.2 m -70.54 -53.83 14.54 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.396 0.544 . . . . 0.0 111.844 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -72.78 -35.42 67.41 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.24 -0.913 . . . . 0.0 112.427 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.15 -44.96 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.772 1.169 . . . . 0.0 112.043 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -71.81 -43.74 65.1 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.085 0.857 . . . . 0.0 112.396 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.25 -33.96 77.02 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.292 -0.88 . . . . 0.0 112.882 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.9 t -82.1 -46.95 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.371 0.987 . . . . 0.0 113.363 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -106.56 7.96 31.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -171.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 63.61 -26.31 0.07 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.88 2.472 . . . . 0.0 116.184 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -148.83 148.51 27.82 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.811 2.044 . . . . 0.0 112.779 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.02 150.83 16.06 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.646 2.897 . . . . 0.0 113.466 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.9 p -134.3 132.81 40.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.338 1.855 . . . . 0.0 108.706 156.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.7 mm -127.83 117.89 20.95 Favored Pre-proline 0 N--CA 1.478 0.96 0 CA-C-N 119.717 1.144 . . . . 0.0 111.754 -171.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -81.99 172.7 50.85 Favored 'Cis proline' 0 CA--C 1.543 0.943 0 CA-C-N 120.06 1.057 . . . . 0.0 112.842 -5.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -153.24 174.38 14.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.5 1.52 . . . . 0.0 112.605 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.0 140.93 47.03 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -174.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -120.48 144.17 48.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.682 1.993 . . . . 0.0 110.412 168.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.1 mt -131.53 121.49 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.522 1.129 . . . . 0.0 109.103 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 45.98 52.03 10.31 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.698 1.599 . . . . 0.0 114.211 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.258 . . 56.25 26.99 11.09 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -115.69 137.99 51.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.426 1.09 . . . . 0.0 110.111 165.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -75.91 125.53 29.27 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.218 1.009 . . . . 0.0 111.774 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -101.16 -46.42 11.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.195 1.398 . . . . 0.0 111.011 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.55 171.32 25.24 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 116.4 1.32 . . . . 0.0 116.4 169.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.02 170.29 54.74 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.014 0.816 . . . . 0.0 112.904 167.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -47.22 -37.92 11.25 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.658 1.183 . . . . 0.0 113.854 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -57.19 -43.78 82.99 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.76 0.709 . . . . 0.0 111.911 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.3 mm -76.42 -46.79 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.426 1.49 . . . . 0.0 109.931 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.18 -38.23 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.366 1.066 . . . . 0.0 110.829 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 60.7 m -64.01 -43.09 96.7 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.595 0.758 . . . . 0.0 111.655 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -67.16 -38.7 85.92 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.107 0.867 . . . . 0.0 112.125 176.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 34.7 mtt -65.65 -40.35 92.38 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.208 1.403 . . . . 0.0 112.153 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.22 -41.69 76.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.119 0.968 . . . . 0.0 111.605 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.94 -29.55 66.71 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 m -105.58 -0.8 25.42 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.09 -2.93 84.29 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.741 1.162 . . . . 0.0 115.721 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -67.38 -32.8 73.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.717 1.258 . . . . 0.0 112.07 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.81 -46.39 88.17 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.485 -0.759 . . . . 0.0 110.948 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -59.47 -42.12 91.31 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.588 1.155 . . . . 0.0 112.665 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -62.44 -39.07 92.16 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.137 0.575 . . . . 0.0 112.012 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 49.0 mtm -69.93 -53.43 17.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.609 0.763 . . . . 0.0 112.823 174.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 pp -65.64 -37.79 87.55 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.288 0.494 . . . . 0.0 111.932 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -66.8 -39.45 87.75 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.692 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -65.25 -30.54 71.43 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.744 0.702 . . . . 0.0 112.319 174.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -2.83 28.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.723 2.009 . . . . 0.0 114.183 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.23 57.4 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.418 1.009 . . . . 0.0 114.311 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.2 mt -104.17 145.57 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 118.369 1.084 . . . . 0.0 110.895 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 38.3 m -89.91 148.53 23.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.196 1.398 . . . . 0.0 111.612 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.4 p -145.86 169.27 18.9 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 120.653 -1.279 . . . . 0.0 112.903 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -76.04 156.79 33.66 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.151 0.981 . . . . 0.0 111.438 166.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -91.33 108.07 19.63 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.293 0.637 . . . . 0.0 112.446 -169.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.706 1.603 . . . . 0.0 112.575 -172.832 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.9 m . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.1 pt -61.07 -33.25 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 120.976 -1.077 . . . . 0.0 112.515 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -77.75 -22.65 49.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.587 1.555 . . . . 0.0 114.648 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 t -85.66 -28.71 24.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.049 2.14 . . . . 0.0 112.78 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -87.35 145.5 26.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.377 1.071 . . . . 0.0 111.004 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -84.12 -28.9 27.16 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.32 -0.863 . . . . 0.0 111.39 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.9 t -143.83 134.85 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.087 0.955 . . . . 0.0 112.255 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.3 t -133.01 138.32 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.893 1.277 . . . . 0.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 t -134.14 154.1 51.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.651 0.78 . . . . 0.0 111.473 170.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.57 147.58 50.28 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.487 0.661 . . . . 0.0 111.969 172.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.3 mt -137.01 159.8 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.331 -157.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -68.17 96.46 0.64 Allowed 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.345 -0.847 . . . . 0.0 108.971 156.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.49 -150.51 22.62 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 121.942 0.745 . . . . 0.0 114.383 -172.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.03 154.05 55.47 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.588 1.955 . . . . 0.0 110.029 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.63 -13.95 38.35 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.955 2.437 . . . . 0.0 114.59 -170.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -88.89 -19.92 25.23 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.716 1.206 . . . . 0.0 112.778 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.94 69.35 13.18 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.204 1.801 . . . . 0.0 111.021 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.39 148.97 74.72 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.66 2.24 . . . . 0.0 111.449 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.7 mmt -106.61 0.29 24.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.806 1.243 . . . . 0.0 113.781 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.7 t -141.84 147.0 36.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.499 1.52 . . . . 0.0 110.435 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.87 -47.01 86.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.831 0.852 . . . . 0.0 111.246 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -66.3 -33.35 75.53 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.998 -1.064 . . . . 0.0 111.548 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 m -62.26 -41.5 98.51 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.742 0.817 . . . . 0.0 113.111 170.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -62.82 -46.93 85.64 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.191 0.905 . . . . 0.0 111.466 171.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -56.97 -37.27 71.35 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.43 1.092 . . . . 0.0 111.993 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.5 tpp -59.34 -46.01 89.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.775 0.83 . . . . 0.0 112.923 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 mm -67.72 -33.13 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.981 1.264 . . . . 0.0 111.326 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.29 -32.83 73.26 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.911 0.884 . . . . 0.0 112.586 170.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.7 -37.25 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 125.628 1.571 . . . . 0.0 111.573 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.6 mt -63.77 -35.44 80.59 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.725 -1.234 . . . . 0.0 111.831 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -71.9 -31.23 66.2 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.816 -1.177 . . . . 0.0 111.998 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.26 -32.2 73.74 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.587 -1.321 . . . . 0.0 111.901 173.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.6 tp -86.07 -12.5 49.99 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.606 1.963 . . . . 0.0 112.716 171.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.82 4.23 13.49 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.854 1.693 . . . . 0.0 114.887 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.83 129.92 55.98 Favored 'General case' 0 C--N 1.335 -0.037 0 C-N-CA 124.599 1.16 . . . . 0.0 109.732 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -110.93 148.35 32.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.113 0.958 . . . . 0.0 110.645 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -120.65 172.64 7.72 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.236 1.815 . . . . 0.0 110.507 -169.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 93.0 m -86.71 122.52 30.72 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -163.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.5 p -113.27 144.63 42.4 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -159.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -137.09 147.87 46.36 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.505 1.122 . . . . 0.0 112.318 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.02 123.45 34.49 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.24 1.416 . . . . 0.0 110.464 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.6 m -67.78 -20.98 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -88.09 -24.19 23.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.938 1.295 . . . . 0.0 113.371 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.47 -35.34 17.08 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -139.11 120.07 9.78 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.357 0.663 . . . . 0.0 110.987 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.85 -13.15 36.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.853 2.369 . . . . 0.0 115.005 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.29 -36.0 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.603 0.761 . . . . 0.0 112.338 169.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.23 -51.45 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.887 0.875 . . . . 0.0 111.171 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.0 ptt-85 -69.32 -26.04 64.52 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.1 m -70.84 -49.31 47.54 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.069 0.948 . . . . 0.0 113.018 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.489 ' CE1' HG21 ' A' ' 139' ' ' VAL . 83.8 t80 -62.47 -48.55 79.12 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.736 -0.603 . . . . 0.0 111.377 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.1 p -61.0 -39.27 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 121.97 -0.456 . . . . 0.0 112.147 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -63.66 -44.77 92.82 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.226 1.41 . . . . 0.0 111.923 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -72.38 -36.51 68.74 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.489 HG21 ' CE1' ' A' ' 135' ' ' TYR 0.276 3.0 t -87.27 -31.95 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.1 p -99.02 -5.66 29.99 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 64.48 -59.27 0.22 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.825 2.45 . . . . 0.0 114.635 -167.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -121.44 106.38 37.92 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.193 1.397 . . . . 0.0 109.908 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.32 136.1 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.305 2.67 . . . . 0.0 113.693 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.5 m -134.21 112.91 11.47 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.168 1.787 . . . . 0.0 109.235 171.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.6 pt -100.59 149.27 35.99 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.68 152.49 96.46 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 119.696 0.927 . . . . 0.0 112.785 2.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -141.41 146.57 36.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.335 0.654 . . . . 0.0 111.156 -166.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.11 140.52 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.876 1.27 . . . . 0.0 113.188 -164.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -133.24 140.68 47.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.987 2.115 . . . . 0.0 109.783 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.4 mt -130.31 132.42 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.155 0.982 . . . . 0.0 108.362 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . 0.292 26.8 mtpp 46.15 51.41 11.16 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.699 2.0 . . . . 0.0 114.47 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 56.98 24.12 9.11 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.492 2.317 . . . . 0.0 115.636 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -128.91 143.75 50.98 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.879 1.672 . . . . 0.0 110.861 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -79.26 124.29 28.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.0 t -101.96 -53.37 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.236 1.815 . . . . 0.0 112.51 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 165.68 169.96 29.98 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 117.973 1.949 . . . . 0.0 117.973 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.65 170.97 55.02 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.607 1.099 . . . . 0.0 112.397 162.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.2 tp -48.48 -41.68 30.52 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.491 1.116 . . . . 0.0 113.71 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.4 -31.71 69.51 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.996 0.816 . . . . 0.0 112.304 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.72 -47.3 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.695 1.598 . . . . 0.0 110.086 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.9 t -54.43 -38.04 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.188 1.395 . . . . 0.0 110.535 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 85.9 m -58.96 -46.56 87.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.63 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -62.88 -43.71 98.06 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 120.207 1.367 . . . . 0.0 110.656 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 59.5 mtt -65.24 -42.34 93.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.787 0.835 . . . . 0.0 112.039 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -44.24 71.52 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.213 1.805 . . . . 0.0 111.594 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.74 -15.53 63.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.729 1.611 . . . . 0.0 113.533 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.1 m -106.16 -6.32 18.65 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.36 3.9 54.9 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 120.216 1.371 . . . . 0.0 114.247 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -69.32 -34.2 74.29 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.348 -1.089 . . . . 0.0 111.702 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.37 -45.68 92.67 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.146 0.978 . . . . 0.0 110.138 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -31.09 69.07 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.096 1.758 . . . . 0.0 114.539 176.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -59.62 -46.94 87.47 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.791 1.178 . . . . 0.0 111.712 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -68.87 -43.41 75.42 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.66 -35.73 80.87 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.662 -0.648 . . . . 0.0 112.193 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -68.62 -35.18 76.97 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.234 -0.916 . . . . 0.0 112.338 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.5 -26.94 68.65 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.78 0.718 . . . . 0.0 112.225 171.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.41 ' HA ' ' HE3' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -82.77 4.34 25.63 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.853 1.661 . . . . 0.0 113.586 170.374 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.41 16.44 71.31 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.073 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.7 mt -101.86 145.15 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 118.808 1.304 . . . . 0.0 111.068 -171.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 97.4 m -103.28 123.21 46.35 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.916 1.286 . . . . 0.0 110.941 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.7 p -108.92 166.83 10.53 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.015 1.726 . . . . 0.0 112.572 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 153.275 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 78.9 m . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 pt -58.46 -36.12 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 120.111 1.323 . . . . 0.0 111.904 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -75.08 -39.9 60.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.069 1.348 . . . . 0.0 112.952 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.3 t -72.13 -34.57 68.65 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.858 1.263 . . . . 0.0 113.954 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -85.22 143.95 28.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.209 -0.932 . . . . 0.0 111.637 -174.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -84.1 -40.46 18.25 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.199 -0.938 . . . . 0.0 111.776 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.51 129.84 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.825 1.65 . . . . 0.0 110.211 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.5 t -134.02 133.45 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.436 1.094 . . . . 0.0 111.594 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.1 t -135.41 156.26 49.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.156 1.382 . . . . 0.0 111.113 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -135.0 137.89 43.45 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.828 0.851 . . . . 0.0 110.637 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.93 160.35 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.464 1.506 . . . . 0.0 109.703 -160.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -69.72 99.15 1.29 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.3 -0.875 . . . . 0.0 108.784 158.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.38 -144.1 21.35 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 118.236 0.471 . . . . 0.0 114.114 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -124.02 158.45 60.34 Favored Pre-proline 0 N--CA 1.473 0.704 0 C-N-CA 125.714 1.605 . . . . 0.0 112.258 -171.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.62 -16.44 53.62 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.179 2.586 . . . . 0.0 114.815 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -95.18 -19.17 20.29 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.601 1.56 . . . . 0.0 113.297 168.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.65 71.64 15.46 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.627 1.571 . . . . 0.0 113.393 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.27 156.51 29.45 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.07 3.18 . . . . 0.0 113.312 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 79.2 mtp -124.24 8.31 8.51 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.332 1.453 . . . . 0.0 114.138 -170.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 22.5 t -150.63 146.78 26.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.805 1.642 . . . . 0.0 110.673 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.56 95.1 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.87 -35.1 74.42 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.55 -0.719 . . . . 0.0 111.921 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.2 m -61.85 -44.78 96.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.931 0.892 . . . . 0.0 111.579 171.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 tmpt? -64.39 -40.82 96.55 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.028 0.931 . . . . 0.0 111.755 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -63.35 -35.91 81.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.5 ttp -58.51 -38.23 77.25 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.215 0.916 . . . . 0.0 111.933 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 mm -61.69 -36.26 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.506 0.594 . . . . 0.0 111.703 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -70.2 -33.81 72.16 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.727 1.611 . . . . 0.0 113.489 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.74 -39.19 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.589 0.756 . . . . 0.0 110.522 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.1 mt -66.34 -37.99 86.61 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -61.77 -29.16 69.95 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.792 1.237 . . . . 0.0 112.198 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.88 65.99 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.217 -0.927 . . . . 0.0 113.365 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.93 -12.67 20.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.987 1.315 . . . . 0.0 113.889 170.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.86 19.35 67.45 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.278 0.942 . . . . 0.0 114.121 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.7 mt -111.72 136.54 50.84 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.289 1.835 . . . . 0.0 111.518 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -117.22 145.52 43.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.874 1.321 . . . . 0.0 113.374 165.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -119.12 173.55 6.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.914 2.086 . . . . 0.0 111.211 -169.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.3 m -84.36 119.23 24.86 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.91 -1.119 . . . . 0.0 109.394 -160.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.4 m -125.05 130.66 52.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.103 -153.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -129.01 156.57 43.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.523 1.529 . . . . 0.0 113.007 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -95.11 104.14 16.01 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.107 1.363 . . . . 0.0 112.198 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.9 p -74.57 -11.11 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.6 tp -81.14 -28.53 35.05 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.027 -1.046 . . . . 0.0 110.718 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.75 -36.92 19.85 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -117.53 105.65 47.82 Favored Pre-proline 0 N--CA 1.476 0.871 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -167.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.86 -28.76 40.26 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.544 3.496 . . . . 0.0 115.256 168.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -56.51 -43.59 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.222 0.919 . . . . 0.0 112.283 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.27 -47.62 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -48.97 -54.85 13.85 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.188 0.995 . . . . 0.0 111.554 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.4 m -61.81 -44.74 96.26 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -170.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -70.5 -46.64 63.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.207 0.527 . . . . 0.0 110.545 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.37 -41.92 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.895 0.878 . . . . 0.0 112.22 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -67.63 -42.67 81.95 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -41.56 97.75 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.134 0.974 . . . . 0.0 113.157 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.34 -36.15 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 89.6 p -102.15 -4.92 25.07 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 62.89 -46.88 0.2 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 128.914 2.886 . . . . 0.0 115.73 -173.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -142.12 101.31 5.78 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 125.57 1.548 . . . . 0.0 111.055 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -86.52 148.37 8.7 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.924 2.416 . . . . 0.0 114.098 -171.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 87.5 m -100.13 149.91 23.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.379 1.872 . . . . 0.0 109.317 164.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 81.3 mt -119.54 113.86 34.71 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.727 0.811 . . . . 0.0 109.162 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -77.03 164.25 87.66 Favored 'Cis proline' 0 CA--C 1.544 1.013 0 CA-C-N 120.103 1.073 . . . . 0.0 114.241 -7.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -146.08 172.32 13.59 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.932 1.293 . . . . 0.0 111.815 166.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.34 142.05 49.18 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -165.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -122.72 142.41 50.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.626 1.97 . . . . 0.0 111.326 173.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 74.5 mt -134.18 134.89 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.273 1.429 . . . . 0.0 108.953 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp 49.9 42.85 24.83 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.359 1.464 . . . . 0.0 112.885 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.53 18.87 2.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.918 2.087 . . . . 0.0 116.213 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.07 148.61 38.69 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.491 1.516 . . . . 0.0 111.636 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -79.93 126.57 31.19 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.196 0.998 . . . . 0.0 112.032 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.0 -39.38 6.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.918 1.287 . . . . 0.0 111.357 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.98 -179.31 21.42 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 172.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.27 171.34 52.85 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.776 1.179 . . . . 0.0 113.107 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 pp -57.39 -29.46 64.1 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -70.26 -28.82 65.54 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.029 -1.044 . . . . 0.0 111.922 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.4 mm -74.33 -45.46 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.588 1.155 . . . . 0.0 109.596 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.7 t -57.17 -46.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.049 0.94 . . . . 0.0 110.79 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.6 m -60.31 -43.87 95.95 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.844 0.858 . . . . 0.0 110.825 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -61.25 -47.35 86.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.255 1.022 . . . . 0.0 112.509 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 22.1 mmt -65.63 -39.74 91.8 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.7 1.136 . . . . 0.0 111.818 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.61 -47.46 78.54 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.228 1.411 . . . . 0.0 111.197 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.39 -22.58 60.22 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.264 1.026 . . . . 0.0 112.664 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.0 t -81.09 -20.56 41.24 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.894 1.677 . . . . 0.0 113.419 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.16 -2.5 86.89 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 121.135 -0.978 . . . . 0.0 113.911 -171.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -70.72 -32.71 70.0 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.648 -0.913 . . . . 0.0 111.729 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -44.07 97.72 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.075 -1.016 . . . . 0.0 111.004 173.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -60.31 -33.67 72.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.954 1.302 . . . . 0.0 113.51 172.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -63.2 -47.3 83.15 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.66 0.664 . . . . 0.0 111.269 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.9 mtm -68.37 -43.97 76.22 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.5 pp -65.48 -35.46 80.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.746 0.703 . . . . 0.0 112.177 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -70.5 -30.22 66.95 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.473 -0.767 . . . . 0.0 112.717 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.91 -32.78 74.27 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.419 -0.8 . . . . 0.0 111.201 171.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -1.03 27.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.993 1.717 . . . . 0.0 113.283 169.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.81 2.23 84.45 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.038 2.256 . . . . 0.0 115.462 175.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.9 mt -81.54 144.21 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 119.132 1.466 . . . . 0.0 112.671 -158.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.3 m -83.47 123.15 29.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.135 1.374 . . . . 0.0 112.181 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 5.6 p -133.44 165.69 24.28 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.138 1.775 . . . . 0.0 112.882 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 . . . . . 0 N--CA 1.478 0.927 0 C-N-CA 125.848 1.659 . . . . 0.0 113.547 171.186 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 121.023 0.439 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -65.26 -30.47 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.781 1.232 . . . . 0.0 112.081 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -37.83 73.39 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.434 1.493 . . . . 0.0 112.895 170.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.4 t -73.33 -31.07 63.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.047 0.939 . . . . 0.0 113.13 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.15 146.49 25.01 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -76.76 -40.8 47.13 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.63 -1.294 . . . . 0.0 113.83 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.7 t -145.87 135.68 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.944 1.298 . . . . 0.0 110.076 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.16 132.23 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.876 0.871 . . . . 0.0 111.599 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -133.84 155.53 49.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.115 1.366 . . . . 0.0 111.317 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -129.7 137.31 50.53 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.876 0.87 . . . . 0.0 110.787 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.18 156.3 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.063 1.345 . . . . 0.0 110.408 -161.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -70.07 102.17 1.98 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 158.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.81 -147.28 27.7 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 118.748 0.704 . . . . 0.0 113.418 -172.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -126.75 157.45 71.3 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.344 1.857 . . . . 0.0 110.925 -172.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.21 -23.57 75.52 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.026 2.484 . . . . 0.0 114.388 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -76.67 -24.24 53.24 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 171.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -148.96 68.83 9.75 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 126.06 1.744 . . . . 0.0 111.887 -175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.0 142.23 42.02 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.504 2.136 . . . . 0.0 111.744 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.5 mtt -101.28 3.87 41.18 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.544 1.538 . . . . 0.0 113.434 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.8 t -145.32 146.08 31.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.282 1.433 . . . . 0.0 111.177 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.37 -44.77 88.98 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.523 0.729 . . . . 0.0 112.265 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -61.53 -36.89 81.84 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.34 -0.85 . . . . 0.0 111.909 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 m -66.57 -37.84 85.8 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.513 0.725 . . . . 0.0 112.646 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -66.46 -44.02 83.91 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.261 1.024 . . . . 0.0 112.881 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -60.94 -35.24 76.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.228 0.611 . . . . 0.0 112.225 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.1 tpp -55.67 -44.44 77.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.182 0.593 . . . . 0.0 112.265 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.72 -32.13 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 121.257 -0.902 . . . . 0.0 111.607 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -34.33 76.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.67 1.188 . . . . 0.0 112.712 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 t -69.23 -41.86 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.907 1.683 . . . . 0.0 111.767 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.8 mt -64.64 -36.32 83.87 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.432 -0.792 . . . . 0.0 112.59 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.74 -36.96 85.06 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.717 -1.239 . . . . 0.0 111.569 171.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.74 -26.34 65.19 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.2 tp -87.8 -14.07 40.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.956 0.903 . . . . 0.0 112.702 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.75 7.38 35.02 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.282 1.896 . . . . 0.0 114.876 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.1 mt -110.99 133.44 53.39 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.641 1.176 . . . . 0.0 111.218 172.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -112.61 159.6 18.7 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.592 1.187 . . . . 0.0 111.408 160.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -136.59 175.7 9.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.835 2.054 . . . . 0.0 110.506 -157.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.0 m -86.42 122.14 29.97 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.943 -1.098 . . . . 0.0 108.622 -175.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.2 p -119.79 147.61 44.43 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.089 1.355 . . . . 0.0 112.865 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -133.77 143.37 48.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.196 0.998 . . . . 0.0 113.064 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -85.67 102.22 13.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.035 1.334 . . . . 0.0 111.818 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.6 p -71.21 -17.15 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.787 1.235 . . . . 0.0 113.683 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -83.76 -29.39 27.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.661 0.784 . . . . 0.0 111.15 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.2 -32.05 13.86 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -128.04 117.49 20.58 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 119.582 1.083 . . . . 0.0 113.509 -165.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.25 -16.82 44.63 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.814 2.343 . . . . 0.0 114.364 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 p -53.31 -42.49 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.055 1.298 . . . . 0.0 111.756 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.62 -52.55 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.779 0.832 . . . . 0.0 110.343 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -52.06 -47.14 65.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.884 0.874 . . . . 0.0 111.442 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.6 m -66.12 -44.48 84.15 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.305 0.642 . . . . 0.0 112.558 -173.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -70.98 -40.46 71.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.369 0.667 . . . . 0.0 110.58 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 t -59.65 -36.35 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.246 1.018 . . . . 0.0 111.725 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -43.4 90.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.954 0.343 . . . . 0.0 111.418 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -65.34 -47.73 75.48 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.447 1.099 . . . . 0.0 112.467 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 52.7 t -82.26 -44.21 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -172.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m -100.53 -10.06 21.42 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 68.2 -54.32 0.52 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.807 2.043 . . . . 0.0 112.949 -168.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -137.67 147.04 55.63 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.276 1.43 . . . . 0.0 112.489 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -89.63 142.47 4.14 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.348 2.698 . . . . 0.0 115.025 -171.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 m -129.91 131.91 46.19 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.876 2.07 . . . . 0.0 107.402 156.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.5 pt -128.72 135.38 27.51 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.35 156.12 99.81 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 CA-C-N 119.438 0.835 . . . . 0.0 113.053 -5.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.24 158.16 39.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.302 1.441 . . . . 0.0 111.599 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.59 141.17 49.61 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -129.36 144.17 51.13 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.19 2.196 . . . . 0.0 109.887 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.0 mt -124.63 121.99 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.916 0.886 . . . . 0.0 108.667 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.0 tttp 44.3 51.79 7.43 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.27 1.828 . . . . 0.0 113.48 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.89 14.52 6.39 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.73 138.19 39.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.708 1.603 . . . . 0.0 110.197 168.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -83.45 123.85 30.11 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 121.351 -0.843 . . . . 0.0 112.886 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -105.37 -39.95 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.865 1.666 . . . . 0.0 112.993 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 144.75 175.31 17.79 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.644 1.418 . . . . 0.0 116.644 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.04 168.79 54.85 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.182 1.372 . . . . 0.0 113.365 166.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.2 tp -45.86 -41.39 11.16 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -71.0 -27.37 63.64 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.156 0.983 . . . . 0.0 112.212 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.9 mm -79.54 -45.38 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.049 1.34 . . . . 0.0 109.923 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.0 t -62.51 -44.8 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.433 1.093 . . . . 0.0 110.56 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 65.3 m -60.15 -48.25 82.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.791 0.836 . . . . 0.0 110.857 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -55.8 -50.21 71.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.455 1.502 . . . . 0.0 111.6 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.7 mmt -70.87 -33.03 70.2 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.364 1.065 . . . . 0.0 112.762 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.74 -46.56 65.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.845 1.658 . . . . 0.0 111.167 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.24 -26.0 67.16 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.393 1.077 . . . . 0.0 112.341 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.8 t -87.92 -15.81 35.6 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.638 1.975 . . . . 0.0 114.674 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.1 -11.02 59.09 Favored Glycine 0 CA--C 1.54 1.652 0 C-N-CA 124.541 1.067 . . . . 0.0 114.493 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.97 -29.35 69.72 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.574 1.55 . . . . 0.0 112.298 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.39 -46.58 89.58 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.722 -1.236 . . . . 0.0 111.106 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -59.6 -41.31 90.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.388 1.475 . . . . 0.0 111.502 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -58.93 -44.3 91.33 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.202 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 58.7 mtm -69.04 -46.59 67.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.048 0.84 . . . . 0.0 112.001 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -41.78 84.16 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -67.81 -34.52 76.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.94 0.896 . . . . 0.0 112.59 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -59.68 -26.18 65.35 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.244 1.017 . . . . 0.0 112.341 172.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -92.03 6.99 44.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.927 1.691 . . . . 0.0 114.312 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.67 9.37 75.09 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 124.411 1.005 . . . . 0.0 114.3 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.9 mt -94.48 142.56 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.87 0.868 . . . . 0.0 109.176 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 28.5 m -114.87 124.86 52.79 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.184 0.994 . . . . 0.0 112.369 -172.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -129.86 173.91 10.23 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.918 2.087 . . . . 0.0 112.946 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.185 0 O-C-N 120.654 -1.279 . . . . 0.0 111.939 160.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 118.383 -0.817 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.8 pt -62.02 -35.1 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.955 1.252 . . . . 0.0 111.811 172.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -76.25 -24.62 54.53 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.853 1.261 . . . . 0.0 113.868 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 t -86.07 -38.24 18.03 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.302 1.441 . . . . 0.0 112.868 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -93.4 141.58 28.29 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.223 1.009 . . . . 0.0 111.937 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.64 -24.39 20.51 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.18 128.76 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.497 1.119 . . . . 0.0 110.294 168.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.01 132.8 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.058 0.943 . . . . 0.0 110.109 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 t -123.21 152.59 41.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.835 0.826 . . . . 0.0 109.903 165.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.06 143.1 49.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.791 0.805 . . . . 0.0 110.776 170.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 mt -132.92 160.09 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.837 -161.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -70.95 103.95 2.82 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 156.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.0 -143.12 23.87 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 119.246 0.93 . . . . 0.0 113.756 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.0 156.47 74.2 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.236 1.414 . . . . 0.0 111.738 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.36 -25.38 30.52 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.314 2.01 . . . . 0.0 113.937 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -90.24 -16.14 29.95 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.27 -0.894 . . . . 0.0 112.828 169.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.62 77.26 15.31 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.578 1.551 . . . . 0.0 111.628 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.95 151.9 35.88 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.262 2.641 . . . . 0.0 112.574 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 78.6 mmm -97.44 -5.22 36.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.318 1.447 . . . . 0.0 113.796 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 10.3 t -146.22 146.32 30.74 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.286 1.434 . . . . 0.0 111.334 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.6 -29.38 69.42 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -71.47 -36.84 71.32 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.633 -1.292 . . . . 0.0 111.66 169.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.3 m -63.98 -35.89 82.19 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -59.15 -47.97 83.34 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.521 1.128 . . . . 0.0 111.453 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -62.18 -28.91 69.99 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.8 tpt -52.38 -39.71 61.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.582 0.628 . . . . 0.0 111.4 171.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 mm -70.61 -35.17 60.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.66 1.184 . . . . 0.0 111.426 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -37.24 86.06 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.832 -1.167 . . . . 0.0 112.886 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 65.9 t -69.98 -37.51 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.167 0.987 . . . . 0.0 110.704 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.9 mt -65.72 -39.69 91.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.109 0.964 . . . . 0.0 113.488 170.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.55 -30.71 70.42 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.117 -0.99 . . . . 0.0 112.137 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.04 -29.47 66.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.569 0.748 . . . . 0.0 112.668 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.7 tp -81.78 -15.31 54.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.622 0.769 . . . . 0.0 112.39 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.87 11.96 58.93 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.496 1.046 . . . . 0.0 114.468 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 22.6 mt -110.58 129.4 55.81 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.551 1.176 . . . . 0.0 112.875 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -116.34 154.85 29.48 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.131 1.372 . . . . 0.0 113.519 168.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -139.59 170.27 16.21 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.576 2.35 . . . . 0.0 111.477 -161.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.0 m -88.09 131.15 34.79 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.047 -1.658 . . . . 0.0 109.655 -176.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -130.33 143.77 50.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.059 0.944 . . . . 0.0 113.528 -154.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -137.67 144.06 41.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.372 1.069 . . . . 0.0 113.315 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -83.59 120.08 25.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.774 1.23 . . . . 0.0 112.075 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.8 t -68.75 -29.82 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.25 1.02 . . . . 0.0 111.863 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.6 mt -74.98 -15.75 60.65 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.155 -0.966 . . . . 0.0 112.282 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.76 -32.57 21.77 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.421 -0.8 . . . . 0.0 112.975 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -129.67 106.48 17.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 119.451 1.023 . . . . 0.0 113.226 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -53.54 -26.94 38.69 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.085 3.19 . . . . 0.0 115.347 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.52 -35.53 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.249 -0.907 . . . . 0.0 112.54 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.79 -48.06 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.139 -0.976 . . . . 0.0 111.166 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -59.94 -28.16 67.39 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.151 0.887 . . . . 0.0 112.955 171.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.5 m -71.03 -53.92 13.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.373 0.533 . . . . 0.0 111.166 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -70.81 -34.76 72.06 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.157 -0.964 . . . . 0.0 111.915 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.15 -36.28 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 120.787 -1.196 . . . . 0.0 112.926 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -72.58 -49.37 32.79 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.484 1.038 . . . . 0.0 111.428 167.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -72.31 -30.53 64.87 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -164.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.53 -29.39 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.598 1.159 . . . . 0.0 111.396 171.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m -103.4 -5.77 22.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -169.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 62.35 -27.03 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 129.069 2.948 . . . . 0.0 116.168 -168.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -145.86 138.53 13.89 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.394 1.877 . . . . 0.0 109.521 165.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.3 149.0 11.75 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.048 2.498 . . . . 0.0 114.669 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.4 p -129.52 132.67 46.92 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.532 1.933 . . . . 0.0 108.807 160.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.0 mt -131.21 142.55 45.91 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.381 1.472 . . . . 0.0 108.383 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.58 161.18 79.14 Favored 'Cis proline' 0 C--N 1.35 0.643 0 CA-C-N 121.738 1.656 . . . . 0.0 111.924 -8.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -144.56 152.52 40.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.302 0.641 . . . . 0.0 112.287 -162.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.24 140.94 52.14 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.785 1.234 . . . . 0.0 112.362 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -130.25 140.41 50.7 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.894 2.078 . . . . 0.0 109.258 173.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 82.0 mt -129.29 133.29 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.3 1.04 . . . . 0.0 108.343 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.1 tttt 49.31 45.3 23.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.187 1.795 . . . . 0.0 113.428 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.65 12.33 5.47 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -115.85 144.2 44.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.381 1.472 . . . . 0.0 111.502 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.23 124.88 25.01 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.879 1.272 . . . . 0.0 111.976 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.49 -55.48 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.147 1.379 . . . . 0.0 110.95 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 165.67 167.21 25.93 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 117.109 1.604 . . . . 0.0 117.109 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.15 168.82 54.84 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.703 1.144 . . . . 0.0 112.499 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.7 tt -47.35 -45.72 24.98 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.058 1.343 . . . . 0.0 113.908 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.82 -35.44 78.62 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.339 -0.851 . . . . 0.0 111.407 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.67 -47.07 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.086 1.354 . . . . 0.0 110.513 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.5 -39.62 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.691 1.196 . . . . 0.0 109.992 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 41.2 m -61.5 -42.72 99.23 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.413 0.685 . . . . 0.0 112.29 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -55.2 -46.62 75.89 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.201 0.909 . . . . 0.0 110.41 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 61.1 mtt -72.92 -33.45 65.97 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.633 1.573 . . . . 0.0 113.342 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -70.52 -35.93 73.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.211 1.804 . . . . 0.0 112.629 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -80.06 -20.27 45.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.885 -1.135 . . . . 0.0 112.621 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.2 p -106.86 -16.0 14.58 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -162.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.7 82.63 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 124.756 1.17 . . . . 0.0 115.503 -170.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -70.03 -31.89 69.75 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.244 2.022 . . . . 0.0 112.55 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.86 -41.59 67.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.533 1.133 . . . . 0.0 110.596 176.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -55.84 -41.17 73.91 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.364 1.865 . . . . 0.0 110.769 173.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -56.63 -47.08 80.47 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.82 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 70.9 mtm -70.86 -46.03 63.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.461 1.028 . . . . 0.0 113.242 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -39.42 82.96 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -72.44 -32.88 66.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.597 1.159 . . . . 0.0 112.274 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.86 -27.2 64.94 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.513 0.597 . . . . 0.0 112.383 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -90.77 -4.43 56.67 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.56 22.37 47.33 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.803 1.192 . . . . 0.0 114.178 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 64.5 mt -94.51 147.84 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 119.038 1.419 . . . . 0.0 111.85 -172.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.6 m -101.11 130.89 47.24 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.323 1.449 . . . . 0.0 112.195 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 15.6 p -137.09 169.46 17.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.685 1.994 . . . . 0.0 111.502 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 174.704 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 pt -60.5 -36.87 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 118.498 0.59 . . . . 0.0 111.944 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.08 -21.98 58.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.006 1.722 . . . . 0.0 113.146 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.3 t -92.84 -38.76 11.57 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.523 1.929 . . . . 0.0 112.582 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.37 139.36 31.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.44 1.096 . . . . 0.0 111.514 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -70.62 -42.21 71.23 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.179 -0.951 . . . . 0.0 113.324 -171.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.7 t -139.92 128.14 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.516 1.126 . . . . 0.0 109.511 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.0 t -133.42 130.28 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.461 1.505 . . . . 0.0 111.134 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -130.79 157.12 43.71 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.849 1.26 . . . . 0.0 110.47 170.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.56 151.58 51.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.542 0.686 . . . . 0.0 112.007 170.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 mt -133.22 169.45 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.433 1.493 . . . . 0.0 109.444 -166.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.94 112.59 23.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.835 -0.541 . . . . 0.0 111.487 144.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.46 -171.98 31.21 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.132 1.825 . . . . 0.0 114.296 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.4 mt -88.87 150.57 45.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.555 1.542 . . . . 0.0 110.546 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.25 -27.78 78.5 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.64 2.227 . . . . 0.0 114.541 -173.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.8 -21.87 56.92 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.966 -1.084 . . . . 0.0 113.036 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.61 68.2 14.63 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 125.716 1.606 . . . . 0.0 112.345 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.78 157.31 39.54 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.316 2.677 . . . . 0.0 112.427 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 mmt -96.34 10.35 38.31 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.711 1.204 . . . . 0.0 114.094 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.8 t -147.87 145.5 28.71 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.904 -1.122 . . . . 0.0 111.593 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.28 96.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -67.37 -31.91 72.48 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.449 -1.407 . . . . 0.0 112.628 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.4 m -63.84 -36.37 83.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.75 167.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.39 -40.13 89.48 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.993 1.27 . . . . 0.0 112.892 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -60.0 -35.7 75.61 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 119.67 1.123 . . . . 0.0 112.878 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.9 tpt -58.31 -46.79 85.48 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.168 0.587 . . . . 0.0 111.468 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.7 mm -71.89 -33.3 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.373 0.669 . . . . 0.0 112.06 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.35 -42.17 73.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.103 0.961 . . . . 0.0 111.147 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.425 HG13 ' HG ' ' A' ' 165' ' ' LEU . 3.8 t -62.98 -44.55 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.543 1.137 . . . . 0.0 111.586 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.22 -36.74 85.11 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.865 . . . . 0.0 112.645 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -71.37 -30.88 66.67 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.805 -1.185 . . . . 0.0 113.196 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.76 -33.8 74.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.803 0.729 . . . . 0.0 112.135 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 tp -94.38 -10.71 31.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.487 1.115 . . . . 0.0 112.811 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.06 8.89 70.51 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.956 1.741 . . . . 0.0 115.195 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 132.49 54.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.083 0.953 . . . . 0.0 111.058 173.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -114.73 153.2 30.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.121 0.963 . . . . 0.0 112.686 173.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.52 173.75 9.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.526 1.93 . . . . 0.0 111.258 -166.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.5 m -88.6 129.36 35.51 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.846 -1.159 . . . . 0.0 109.824 -167.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.7 p -114.3 141.29 47.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.098 1.759 . . . . 0.0 113.592 -163.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -128.12 161.72 28.57 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.91 1.284 . . . . 0.0 111.784 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -131.22 118.05 19.88 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.287 1.435 . . . . 0.0 112.752 -170.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.15 -21.05 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 tp -80.96 -22.1 39.82 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.321 1.048 . . . . 0.0 111.817 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.16 -40.04 16.06 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.03 -1.044 . . . . 0.0 111.905 170.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.408 ' HB3' HG12 ' A' ' 131' ' ' VAL . 59.6 m-70 -144.55 109.81 4.88 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.833 1.253 . . . . 0.0 112.319 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.95 -14.0 40.67 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.387 2.725 . . . . 0.0 114.994 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.408 HG12 ' HB3' ' A' ' 129' ' ' HIS . 7.8 p -46.9 -32.33 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 120.016 1.28 . . . . 0.0 113.032 169.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.0 t -58.01 -43.53 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.146 0.978 . . . . 0.0 111.688 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.449 ' HA ' HG12 ' A' ' 136' ' ' VAL . 23.8 ttp180 -68.83 -39.98 79.7 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.799 1.24 . . . . 0.0 111.528 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 m -65.76 -47.92 73.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -69.6 -39.69 77.11 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.162 -0.962 . . . . 0.0 112.04 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 133' ' ' ARG . 9.8 p -62.91 -35.76 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 120.2 1.364 . . . . 0.0 112.21 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -66.3 -47.66 72.88 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.075 0.95 . . . . 0.0 111.734 172.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -42.29 80.94 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.61 -34.84 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.815 1.246 . . . . 0.0 113.128 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 m -97.99 5.83 48.35 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -170.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 62.48 -40.77 0.16 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 127.797 2.439 . . . . 0.0 114.445 -162.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -135.91 134.73 20.69 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.48 1.912 . . . . 0.0 110.613 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.23 138.15 27.22 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.653 2.235 . . . . 0.0 112.192 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.0 136.6 44.21 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.505 1.522 . . . . 0.0 109.908 165.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.3 mt -127.95 131.7 23.94 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.907 173.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.92 163.16 88.24 Favored 'Cis proline' 0 CA--C 1.541 0.857 0 CA-C-N 119.929 1.01 . . . . 0.0 110.813 -12.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -150.36 172.85 14.74 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.761 0.824 . . . . 0.0 111.514 171.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.07 140.03 52.19 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -174.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -120.66 142.49 49.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 112.779 -2.009 . . . . 0.0 110.51 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.4 mt -122.24 118.32 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 tptt 45.88 48.9 12.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.146 2.178 . . . . 0.0 114.567 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 58.51 13.24 2.43 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -172.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -94.36 131.68 39.76 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.856 -1.153 . . . . 0.0 108.702 164.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -76.34 124.76 28.02 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.608 -0.682 . . . . 0.0 111.278 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.4 t -101.92 -46.82 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.735 1.214 . . . . 0.0 111.186 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.58 170.44 31.48 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.69 174.65 54.7 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.359 1.457 . . . . 0.0 114.02 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -48.62 -43.82 36.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.539 1.936 . . . . 0.0 113.331 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.27 -44.65 95.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.316 0.647 . . . . 0.0 110.321 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.84 -45.72 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.093 1.357 . . . . 0.0 111.207 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.9 t -57.52 -37.06 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.633 1.573 . . . . 0.0 110.945 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.0 m -63.09 -44.09 96.69 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.233 0.613 . . . . 0.0 111.721 172.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -63.2 -41.59 99.18 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.504 1.047 . . . . 0.0 110.796 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 38.2 mtt -63.24 -39.23 94.03 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.011 0.925 . . . . 0.0 111.946 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.425 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.2 tm? -68.58 -40.32 80.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.064 1.346 . . . . 0.0 112.195 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.32 -33.49 55.56 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.0 t -85.2 -21.26 29.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.044 1.338 . . . . 0.0 113.489 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.49 0.17 67.49 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.526 1.06 . . . . 0.0 114.788 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.03 -29.95 66.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.515 1.157 . . . . 0.0 113.633 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.62 -44.04 96.78 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.842 -1.162 . . . . 0.0 110.021 174.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -36.74 84.0 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.915 1.286 . . . . 0.0 113.039 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -59.47 -48.49 81.44 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.43 1.014 . . . . 0.0 111.194 171.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.3 mtm -69.9 -45.82 66.77 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 pp -66.33 -36.71 83.61 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.735 0.698 . . . . 0.0 112.059 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -64.01 -41.8 97.34 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.663 0.785 . . . . 0.0 111.536 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.94 -20.58 64.21 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.16 1.43 31.99 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.369 1.468 . . . . 0.0 112.485 170.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.04 17.27 74.94 Favored Glycine 0 N--CA 1.469 0.869 0 O-C-N 120.984 -1.073 . . . . 0.0 114.229 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.4 mt -103.05 146.93 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.686 1.195 . . . . 0.0 109.364 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.3 m -112.36 137.1 50.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.257 1.023 . . . . 0.0 110.651 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.1 p -132.22 168.53 17.89 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.638 1.575 . . . . 0.0 113.075 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 123.631 0.772 . . . . 0.0 111.406 169.572 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.779 0.323 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.8 pt -62.0 -32.47 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.421 1.088 . . . . 0.0 112.914 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -79.15 -30.64 43.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.707 2.003 . . . . 0.0 113.825 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t -80.31 -28.0 38.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.067 1.747 . . . . 0.0 113.248 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -84.85 150.12 25.22 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.905 -1.122 . . . . 0.0 111.344 167.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -76.45 -45.79 29.8 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.632 -1.292 . . . . 0.0 111.691 169.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.9 t -145.33 131.38 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.561 1.144 . . . . 0.0 111.087 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.86 131.67 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.675 1.19 . . . . 0.0 111.663 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 t -134.31 154.96 51.02 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.894 1.277 . . . . 0.0 111.733 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -132.43 139.62 48.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.923 0.889 . . . . 0.0 111.472 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 mt -132.78 157.51 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.849 2.059 . . . . 0.0 108.853 -164.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -78.17 115.21 17.73 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 147.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.99 -152.9 25.07 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.185 0.897 . . . . 0.0 113.551 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.1 mt -104.96 152.59 39.64 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 124.932 1.293 . . . . 0.0 110.596 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.08 -31.72 54.42 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 121.758 1.639 . . . . 0.0 113.453 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -81.22 -13.28 58.71 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.406 -0.809 . . . . 0.0 112.95 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.55 67.66 52.2 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.97 1.708 . . . . 0.0 112.096 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.42 142.46 59.78 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.651 2.901 . . . . 0.0 112.964 -172.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 90.7 mtp -105.65 3.78 29.48 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 37.0 t -134.6 146.52 49.68 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.831 2.053 . . . . 0.0 111.06 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.07 -46.57 85.23 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.354 -0.842 . . . . 0.0 112.018 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -67.09 -25.47 66.24 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.018 -1.051 . . . . 0.0 112.056 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.4 p -71.45 -39.05 71.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 168.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -58.69 -45.32 89.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.75 1.159 . . . . 0.0 110.203 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -62.56 -39.78 94.74 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.292 1.037 . . . . 0.0 112.438 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.5 tpt -55.86 -49.61 72.85 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.791 1.178 . . . . 0.0 111.678 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.7 mm -70.38 -32.68 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.869 -0.519 . . . . 0.0 112.339 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -59.9 -36.27 76.62 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.003 -1.061 . . . . 0.0 112.927 171.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.23 -36.36 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.732 0.813 . . . . 0.0 110.596 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.89 -37.48 87.79 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.35 -0.844 . . . . 0.0 112.885 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -65.08 -33.89 77.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.757 -1.214 . . . . 0.0 111.41 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.35 -30.96 70.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.06 0.944 . . . . 0.0 112.314 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.2 tp -82.27 -16.98 47.53 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.695 0.68 . . . . 0.0 112.626 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.64 9.49 58.9 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.611 1.101 . . . . 0.0 115.166 -174.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.5 mt -114.81 133.97 55.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.53 1.532 . . . . 0.0 113.668 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -115.63 153.43 31.29 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.755 1.264 . . . . 0.0 113.044 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -137.19 175.01 10.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.616 1.967 . . . . 0.0 111.799 -156.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.8 m -85.79 117.36 24.61 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.548 -1.345 . . . . 0.0 108.943 -168.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.2 m -127.87 133.05 49.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.141 -153.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -129.63 149.83 51.22 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -172.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -99.45 98.16 9.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.697 1.599 . . . . 0.0 111.846 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.6 -21.94 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.018 0.927 . . . . 0.0 113.229 -175.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.3 tp -73.4 -28.62 62.1 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.626 -0.671 . . . . 0.0 111.565 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.14 -32.78 11.78 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -124.12 103.97 32.74 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.745 1.157 . . . . 0.0 113.661 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -57.27 -19.75 36.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.151 3.234 . . . . 0.0 115.371 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.14 -39.31 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 120.315 1.416 . . . . 0.0 112.452 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.95 -42.53 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.186 0.994 . . . . 0.0 111.119 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 136' ' ' VAL . 2.4 ptm180 -69.99 -30.47 67.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.524 1.13 . . . . 0.0 112.148 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m -68.84 -48.98 62.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.831 0.852 . . . . 0.0 112.601 170.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -61.35 -46.67 89.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.427 0.558 . . . . 0.0 110.604 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 133' ' ' ARG . 8.0 p -66.85 -32.83 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.483 -0.76 . . . . 0.0 112.873 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -70.25 -41.62 73.27 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.826 1.194 . . . . 0.0 112.929 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -61.63 -40.42 94.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.982 0.81 . . . . 0.0 112.723 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.0 t -83.8 -50.62 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 53.9 p -113.66 -0.62 14.25 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 65.08 -49.76 0.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.112 2.165 . . . . 0.0 116.138 -172.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -132.26 116.52 15.41 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 119.909 1.231 . . . . 0.0 112.337 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.94 144.86 21.88 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.339 2.693 . . . . 0.0 112.2 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.7 m -135.2 110.7 9.13 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.437 0.695 . . . . 0.0 109.335 161.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.3 pt -91.59 163.96 26.21 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -160.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.18 154.48 98.36 Favored 'Cis proline' 0 C--N 1.352 0.747 0 CA-C-N 119.195 0.748 . . . . 0.0 111.048 -21.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -136.54 153.12 51.08 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.816 1.246 . . . . 0.0 111.273 -170.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.31 140.63 51.35 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.931 1.292 . . . . 0.0 113.536 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -131.47 143.01 50.11 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.483 1.913 . . . . 0.0 109.718 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.0 mt -125.98 115.85 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.797 0.839 . . . . 0.0 108.903 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . 0.339 17.5 ttmm 40.9 57.65 2.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.076 2.15 . . . . 0.0 114.404 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 67.45 9.22 6.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.91 138.42 37.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.551 1.14 . . . . 0.0 110.306 168.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -79.82 123.71 27.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.607 1.194 . . . . 0.0 111.716 175.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.38 -48.72 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.767 1.227 . . . . 0.0 110.584 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.61 -179.68 27.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 168.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.24 173.66 53.88 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.55 1.072 . . . . 0.0 113.442 167.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -42.75 -46.56 5.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.339 1.856 . . . . 0.0 113.765 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -70.02 -26.52 64.09 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.628 -0.67 . . . . 0.0 112.304 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 mm -79.26 -46.51 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.834 1.254 . . . . 0.0 110.316 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.12 -38.56 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.11 0.964 . . . . 0.0 110.572 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 69.3 m -60.88 -46.21 91.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.08 0.952 . . . . 0.0 111.566 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -60.17 -43.86 95.49 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.091 0.956 . . . . 0.0 111.565 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.6 mtt -69.0 -35.25 76.48 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.412 -0.805 . . . . 0.0 112.953 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -69.56 -41.3 76.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.31 1.044 . . . . 0.0 111.506 172.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -65.07 -36.58 84.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.301 1.04 . . . . 0.0 113.183 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.3 t -88.79 -9.43 51.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.427 1.491 . . . . 0.0 114.032 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.84 4.46 82.36 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.247 -1.533 . . . . 0.0 114.201 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.2 -32.36 70.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.347 1.459 . . . . 0.0 112.936 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.16 -46.28 81.51 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.054 -1.029 . . . . 0.0 109.932 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -59.05 -41.1 87.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.745 1.618 . . . . 0.0 112.728 169.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -58.09 -42.66 86.08 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.954 0.902 . . . . 0.0 111.035 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 62.4 mtm -69.6 -50.32 45.67 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -69.08 -37.38 78.42 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -65.09 -34.24 77.94 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.04 0.936 . . . . 0.0 111.44 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.72 -29.65 69.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.238 1.415 . . . . 0.0 112.493 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -89.19 6.02 42.07 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.043 2.137 . . . . 0.0 114.306 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.48 19.43 60.29 Favored Glycine 0 N--CA 1.469 0.867 0 O-C-N 121.12 -0.987 . . . . 0.0 114.44 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.02 147.68 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.33 1.052 . . . . 0.0 110.792 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 95.8 m -102.69 126.2 49.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.749 1.22 . . . . 0.0 111.572 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.8 p -127.48 168.99 14.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.888 2.075 . . . . 0.0 111.156 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 19.1 mtp-105 . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 121.906 0.86 . . . . 0.0 112.99 173.304 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 118.952 -0.547 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 pt -63.81 -34.6 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.576 0.75 . . . . 0.0 112.925 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -78.95 -39.38 34.69 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.22 1.408 . . . . 0.0 112.964 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.2 t -85.02 -11.06 56.26 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.309 1.044 . . . . 0.0 113.446 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -89.52 148.67 23.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.362 1.865 . . . . 0.0 111.449 165.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -87.28 -42.84 12.62 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.783 -1.198 . . . . 0.0 113.205 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.27 130.49 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.062 1.345 . . . . 0.0 110.265 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.4 t -131.51 130.51 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.779 1.632 . . . . 0.0 111.278 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 t -133.5 156.18 48.23 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.084 1.354 . . . . 0.0 111.186 171.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -129.62 139.77 51.35 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.42 0.688 . . . . 0.0 111.872 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.83 156.57 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.26 1.424 . . . . 0.0 109.876 -163.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.9 102.86 1.66 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.852 -0.53 . . . . 0.0 109.665 155.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.74 -160.0 33.67 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 118.887 0.767 . . . . 0.0 114.783 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.51 153.68 48.26 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.951 2.1 . . . . 0.0 112.516 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -66.75 -15.59 47.79 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.311 2.674 . . . . 0.0 114.823 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -94.84 -20.43 19.46 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.45 69.26 21.21 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.416 1.486 . . . . 0.0 110.84 -171.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.54 144.01 48.71 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.058 2.505 . . . . 0.0 111.655 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 mmt -93.36 2.41 56.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.13 1.372 . . . . 0.0 113.741 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 53.6 t -142.12 145.64 34.48 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.804 1.642 . . . . 0.0 111.488 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.77 95.63 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.878 0.871 . . . . 0.0 112.731 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.08 -24.06 62.24 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.592 -1.317 . . . . 0.0 112.354 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 m -69.77 -36.44 75.77 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.427 -0.796 . . . . 0.0 112.362 166.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -62.29 -42.02 98.99 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.605 1.162 . . . . 0.0 112.021 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -55.84 -29.83 60.46 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.068 1.347 . . . . 0.0 113.526 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.2 tpt -69.24 -43.57 73.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.986 0.915 . . . . 0.0 111.756 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.4 mm -65.46 -36.44 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.752 0.821 . . . . 0.0 111.014 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.63 -40.44 79.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.213 1.005 . . . . 0.0 112.955 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.12 -42.93 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.921 1.289 . . . . 0.0 111.659 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.1 mt -65.39 -36.77 84.99 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.739 0.815 . . . . 0.0 112.548 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -67.07 -35.47 79.9 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.374 -1.454 . . . . 0.0 112.443 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.31 -21.66 65.67 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.57 -13.27 20.49 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.64 1.576 . . . . 0.0 114.124 170.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.74 71.3 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.433 1.492 . . . . 0.0 115.479 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.8 mp -112.09 144.89 40.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.26 1.424 . . . . 0.0 111.321 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -113.75 130.17 56.48 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.617 0.767 . . . . 0.0 110.649 166.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -104.82 170.6 7.78 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.023 1.729 . . . . 0.0 111.26 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -86.34 119.83 27.04 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.5 -1.375 . . . . 0.0 109.45 -157.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.2 m -113.23 129.71 56.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.339 -158.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -115.07 155.05 27.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.994 1.317 . . . . 0.0 111.059 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -111.21 94.95 5.24 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.845 1.258 . . . . 0.0 110.48 -168.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 p -70.02 -23.2 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.236 1.015 . . . . 0.0 112.953 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.9 tp -78.35 -30.75 48.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.081 0.952 . . . . 0.0 111.424 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.53 -35.28 19.63 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -131.32 98.93 17.94 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.825 0.85 . . . . 0.0 111.945 -170.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.97 -12.23 33.56 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.394 2.729 . . . . 0.0 114.761 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.0 p -49.1 -42.04 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.717 1.207 . . . . 0.0 112.489 170.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.75 -46.27 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.802 0.841 . . . . 0.0 111.704 -177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.455 ' HA ' HG12 ' A' ' 136' ' ' VAL . 50.8 ptt85 -71.33 -23.75 61.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -70.36 -51.43 29.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.116 0.567 . . . . 0.0 112.11 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -70.96 -37.99 72.8 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.641 -0.662 . . . . 0.0 112.429 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 133' ' ' ARG . 8.9 p -65.39 -34.95 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.362 -0.836 . . . . 0.0 112.557 176.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -66.72 -43.22 84.86 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.338 -0.851 . . . . 0.0 110.991 171.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.92 -42.69 80.44 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.678 0.791 . . . . 0.0 113.037 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -80.26 -45.28 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.618 1.167 . . . . 0.0 112.988 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.5 m -106.05 -5.93 19.09 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 62.65 -25.99 0.06 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 128.075 2.55 . . . . 0.0 115.973 -172.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -136.28 92.0 16.14 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 127.2 2.2 . . . . 0.0 112.045 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -72.31 147.64 47.73 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.624 2.883 . . . . 0.0 114.317 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.4 m -125.99 137.27 53.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.616 1.566 . . . . 0.0 107.842 160.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mp -108.04 133.26 20.57 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.45 159.1 73.35 Favored 'Cis proline' 0 CA--C 1.546 1.091 0 CA-C-N 120.706 1.288 . . . . 0.0 112.012 -12.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -137.92 164.28 29.39 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.953 1.701 . . . . 0.0 110.913 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.7 139.62 52.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 122.776 1.274 . . . . 0.0 114.209 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -125.43 140.31 52.9 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 112.741 -2.027 . . . . 0.0 110.247 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 57.3 mt -128.87 121.85 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.293 1.037 . . . . 0.0 109.138 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt 45.12 51.13 9.18 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.064 1.746 . . . . 0.0 113.008 -172.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.63 10.21 1.88 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 -175.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.58 143.63 28.77 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.193 1.36 . . . . 0.0 110.516 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -86.35 123.59 31.76 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.701 0.763 . . . . 0.0 112.909 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.8 -50.92 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.459 1.504 . . . . 0.0 111.964 -171.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 175.19 163.85 28.88 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 117.238 1.655 . . . . 0.0 117.238 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.72 168.94 53.98 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 125.575 1.56 . . . . 0.0 114.124 167.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.0 tp -44.19 -42.05 6.19 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.947 1.699 . . . . 0.0 115.01 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -67.9 -38.06 82.52 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.799 -0.563 . . . . 0.0 111.338 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.4 mm -74.97 -39.12 44.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 C-N-CA 125.131 1.373 . . . . 0.0 110.26 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.05 -42.42 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 120.971 -1.081 . . . . 0.0 110.696 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.9 m -65.33 -43.87 89.59 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.703 0.801 . . . . 0.0 111.427 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -56.8 -46.25 81.7 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.72 1.208 . . . . 0.0 111.74 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.9 mtt -67.05 -35.26 79.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.752 1.621 . . . . 0.0 112.7 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.84 -46.54 68.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.389 1.076 . . . . 0.0 111.109 173.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.96 -17.39 64.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.003 1.321 . . . . 0.0 112.906 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.2 m -101.03 -16.18 17.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.218 1.407 . . . . 0.0 114.788 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.26 -4.12 73.68 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 120.21 1.368 . . . . 0.0 114.446 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -65.14 -32.03 73.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.556 1.678 . . . . 0.0 112.922 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.71 -43.3 98.0 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.114 172.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -64.35 -38.71 91.99 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.518 1.527 . . . . 0.0 112.726 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -58.43 -48.82 79.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.722 1.146 . . . . 0.0 110.92 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.9 mtm -69.59 -44.92 69.8 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 pp -66.16 -40.83 90.82 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.011 0.369 . . . . 0.0 111.435 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -71.75 -32.28 67.54 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.426 -0.796 . . . . 0.0 112.963 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.18 -26.51 68.18 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.363 0.529 . . . . 0.0 112.407 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -76.23 4.44 8.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.592 1.557 . . . . 0.0 113.875 169.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.42 0.02 89.85 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.273 1.892 . . . . 0.0 113.671 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.3 mt -84.81 144.53 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 118.782 1.291 . . . . 0.0 109.862 -169.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.9 m -108.23 139.6 42.68 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.355 1.462 . . . . 0.0 111.094 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 21.8 p -137.17 170.04 16.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.924 1.689 . . . . 0.0 112.16 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 . . . . . 0 N--CA 1.479 1.018 0 O-C-N 121.536 -0.727 . . . . 0.0 112.512 167.009 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.6 0.714 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.432 HD13 ' CE2' ' A' ' 135' ' ' TYR . 29.4 mt -55.94 -36.4 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 127.685 2.394 . . . . 0.0 110.924 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -75.83 -30.17 58.89 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 126.535 1.934 . . . . 0.0 114.729 171.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.4 t -78.94 -39.93 33.32 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.509 0.724 . . . . 0.0 112.224 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -90.16 140.93 29.18 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -170.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -66.38 -39.6 89.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.37 0.668 . . . . 0.0 112.631 -171.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.1 t -140.77 133.72 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 109.759 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.44 134.14 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.778 1.231 . . . . 0.0 110.089 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.6 t -131.86 155.39 47.92 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.083 0.953 . . . . 0.0 111.237 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -133.31 135.88 45.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.426 0.632 . . . . 0.0 111.899 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.5 mt -133.95 153.69 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 109.015 -157.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -69.49 104.58 2.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 158.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.08 -134.16 12.75 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.829 1.204 . . . . 0.0 114.337 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.1 mt -126.33 157.72 69.31 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 126.342 1.857 . . . . 0.0 111.658 -168.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.25 -21.5 31.13 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.127 1.885 . . . . 0.0 113.833 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.23 -22.22 35.97 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.477 1.111 . . . . 0.0 113.108 167.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.22 74.02 11.87 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.4 1.48 . . . . 0.0 113.046 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.37 143.65 22.26 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.948 2.432 . . . . 0.0 111.262 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 51.0 ttm -110.14 7.18 23.31 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.256 1.822 . . . . 0.0 113.081 -163.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 54.1 t -150.63 149.01 29.32 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.647 1.979 . . . . 0.0 111.041 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.75 93.99 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.32 0.964 . . . . 0.0 112.702 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -66.93 -31.45 72.05 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.83 -1.169 . . . . 0.0 111.42 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.6 m -70.39 -37.96 74.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 118.265 -0.874 . . . . 0.0 112.933 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -55.94 -47.36 77.7 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 120.199 1.363 . . . . 0.0 110.703 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -61.81 -31.9 72.16 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.9 tpt -61.41 -44.35 97.29 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.668 0.667 . . . . 0.0 111.517 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.0 mm -68.28 -37.95 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.075 0.55 . . . . 0.0 111.146 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.4 -40.56 78.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.032 0.933 . . . . 0.0 112.58 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.77 -44.3 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.272 0.629 . . . . 0.0 111.506 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.6 mt -65.9 -36.98 84.91 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.813 0.845 . . . . 0.0 112.317 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -66.01 -32.99 74.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.562 1.145 . . . . 0.0 112.917 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.95 76.6 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.715 0.806 . . . . 0.0 111.978 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.65 -14.81 44.41 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.886 0.874 . . . . 0.0 113.092 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.57 14.17 62.05 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.619 1.104 . . . . 0.0 114.26 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 58.0 mt -112.07 128.44 56.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.209 1.004 . . . . 0.0 111.315 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -115.54 144.69 43.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.854 1.262 . . . . 0.0 111.17 172.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -125.12 169.95 11.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.384 1.874 . . . . 0.0 111.809 -166.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.1 m -85.07 126.29 33.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 122.495 1.141 . . . . 0.0 109.44 -166.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.1 m -123.72 138.93 54.43 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 113.681 -1.6 . . . . 0.0 112.095 -155.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.6 139.43 53.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -84.01 112.19 19.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.343 2.257 . . . . 0.0 111.495 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.4 m -70.35 -17.85 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.1 tp -87.36 -19.97 27.39 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.607 1.163 . . . . 0.0 111.957 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.24 -29.07 13.78 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.764 1.225 . . . . 0.0 113.366 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.32 96.9 38.23 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -53.11 -26.75 34.09 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.569 3.512 . . . . 0.0 115.501 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.27 -36.04 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.112 0.965 . . . . 0.0 113.595 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 63.1 t -69.75 -51.48 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.964 0.906 . . . . 0.0 110.819 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.461 ' HA ' HG12 ' A' ' 136' ' ' VAL . 8.1 ptm180 -63.98 -26.12 68.44 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.673 175.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.9 m -71.61 -48.05 50.65 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.49 ' CZ ' HG21 ' A' ' 139' ' ' VAL . 48.7 t80 -61.02 -48.05 83.6 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 120.752 1.615 . . . . 0.0 109.807 176.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 133' ' ' ARG . 9.1 p -66.64 -35.26 74.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 121.283 -0.886 . . . . 0.0 112.837 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -59.26 -46.61 88.05 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.19 1.396 . . . . 0.0 112.102 171.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.25 -46.64 40.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.301 1.04 . . . . 0.0 112.9 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.49 HG21 ' CZ ' ' A' ' 135' ' ' TYR . 86.6 t -81.3 -36.19 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.629 1.572 . . . . 0.0 112.632 -164.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.4 m -104.97 4.22 31.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 58.19 -5.89 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.89 2.476 . . . . 0.0 117.358 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -146.27 121.43 5.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.638 1.975 . . . . 0.0 108.598 166.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.25 130.44 7.2 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.66 2.24 . . . . 0.0 111.801 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 68.5 p -128.45 136.85 51.41 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.968 1.307 . . . . 0.0 110.886 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.0 mt -130.03 140.56 39.01 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.259 1.424 . . . . 0.0 110.452 -172.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.17 156.42 78.76 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 120.939 1.371 . . . . 0.0 110.895 -8.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -138.25 160.01 40.56 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.69 135.61 52.31 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.536 1.134 . . . . 0.0 112.192 177.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -127.21 141.65 51.68 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.637 1.975 . . . . 0.0 109.155 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.6 mt -130.61 118.5 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.2 tptt 46.74 52.88 10.84 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 127.331 2.253 . . . . 0.0 115.647 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.81 28.64 18.38 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -127.89 137.29 52.26 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.093 -1.004 . . . . 0.0 110.508 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -70.35 130.39 41.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.408 0.623 . . . . 0.0 112.121 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.75 -47.58 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.063 0.945 . . . . 0.0 110.181 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.15 175.31 22.17 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.519 0.967 . . . . 0.0 115.519 171.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.64 169.99 54.65 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.258 0.933 . . . . 0.0 112.793 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.23 -43.4 10.28 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.109 1.364 . . . . 0.0 113.189 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.45 ' O ' ' HE3' ' A' ' 163' ' ' LYS . 19.7 t70 -60.24 -24.87 65.22 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.943 0.897 . . . . 0.0 113.283 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.4 mm -92.1 -47.01 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.675 1.59 . . . . 0.0 110.471 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.04 -36.55 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.361 1.864 . . . . 0.0 111.808 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -60.58 -50.92 71.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 159' ' ' ASP . 60.1 mttt -60.86 -38.62 86.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.625 0.37 . . . . 0.0 110.231 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.5 mtp -67.85 -35.5 78.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.748 0.819 . . . . 0.0 112.577 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.59 -46.24 69.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.602 1.161 . . . . 0.0 111.721 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -74.13 -16.29 61.01 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.8 m -100.78 -9.86 21.34 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.09 1.356 . . . . 0.0 114.353 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.17 -4.25 67.93 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-N 119.661 1.119 . . . . 0.0 114.453 -170.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.99 -34.12 74.3 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.866 -1.373 . . . . 0.0 113.532 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tt -61.67 -41.01 96.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.763 1.225 . . . . 0.0 111.029 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -67.31 -31.3 71.5 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.303 1.841 . . . . 0.0 113.239 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -57.02 -43.14 81.54 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.24 1.016 . . . . 0.0 111.837 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -73.6 -49.57 25.53 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 172.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.65 -39.02 90.94 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.844 -0.535 . . . . 0.0 112.128 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -69.49 -40.76 76.85 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.683 0.793 . . . . 0.0 111.393 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.82 -27.7 65.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.536 1.535 . . . . 0.0 113.455 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -75.06 -4.49 38.77 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.403 -0.81 . . . . 0.0 112.877 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.59 15.81 51.48 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 125.072 1.32 . . . . 0.0 114.498 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.0 mt -103.8 123.72 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.159 0.98 . . . . 0.0 109.976 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.3 m -85.27 133.58 34.16 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.36 0.6 . . . . 0.0 111.633 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -128.92 170.14 13.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.494 2.318 . . . . 0.0 111.957 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 . . . . . 0 N--CA 1.476 0.852 0 O-C-N 121.395 -0.815 . . . . 0.0 111.278 173.539 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.1 pt -61.2 -34.34 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.745 0.818 . . . . 0.0 111.83 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -80.85 -29.34 35.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.444 1.897 . . . . 0.0 114.486 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.1 t -74.25 -41.13 61.79 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.636 0.774 . . . . 0.0 111.209 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.82 138.29 32.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.26 1.024 . . . . 0.0 110.715 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.43 -31.89 24.39 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.252 -0.905 . . . . 0.0 112.538 -169.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.6 t -138.58 126.56 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.854 1.262 . . . . 0.0 109.546 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.0 t -130.53 131.21 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.406 1.482 . . . . 0.0 110.565 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.9 t -133.77 156.71 47.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.664 1.185 . . . . 0.0 110.457 172.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.67 142.74 49.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.146 169.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 mt -132.56 157.38 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.383 1.473 . . . . 0.0 109.403 -162.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.7 101.23 2.51 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 156.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.23 -154.82 27.93 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.174 0.897 . . . . 0.0 114.214 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.21 154.67 39.45 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 125.655 1.582 . . . . 0.0 111.969 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -65.67 -19.99 59.69 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.287 1.991 . . . . 0.0 113.605 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -93.9 -13.06 27.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.582 1.553 . . . . 0.0 113.986 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.54 73.34 11.68 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.544 1.537 . . . . 0.0 112.353 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.4 148.64 67.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.943 2.429 . . . . 0.0 111.874 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.4 mmt -104.42 -0.3 28.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.3 1.84 . . . . 0.0 113.631 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 17.1 t -146.46 144.83 29.94 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.969 1.307 . . . . 0.0 111.428 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.2 -38.66 80.45 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -72.23 -29.87 64.35 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.048 -1.033 . . . . 0.0 112.279 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 m -66.89 -34.45 77.81 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.346 167.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -67.27 -45.59 76.17 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.77 1.168 . . . . 0.0 112.781 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -57.27 -33.28 67.47 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.002 0.921 . . . . 0.0 112.915 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.0 tpt -56.07 -43.56 78.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.951 0.901 . . . . 0.0 111.865 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 mm -69.55 -33.34 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.337 1.055 . . . . 0.0 111.3 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.4 -34.91 79.41 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.36 -1.462 . . . . 0.0 112.771 172.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.81 -43.16 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.902 0.481 . . . . 0.0 110.728 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.9 mt -65.77 -37.92 87.64 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -66.65 -31.49 72.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.403 -1.436 . . . . 0.0 113.078 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.0 -25.49 68.41 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.613 -1.304 . . . . 0.0 113.374 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.04 -13.01 21.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.881 1.272 . . . . 0.0 114.154 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.6 13.0 67.92 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.568 1.08 . . . . 0.0 115.03 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.76 134.35 55.1 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.773 1.229 . . . . 0.0 112.905 174.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -113.68 157.93 21.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.772 1.229 . . . . 0.0 111.548 168.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -137.24 171.95 13.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.982 1.713 . . . . 0.0 111.418 -161.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.4 m -83.97 120.4 26.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.545 1.164 . . . . 0.0 108.842 -166.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.6 m -126.18 124.26 40.08 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.645 -155.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.25 157.98 18.3 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.305 1.042 . . . . 0.0 111.959 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -120.16 117.18 27.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.803 1.241 . . . . 0.0 111.292 -171.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.5 p -71.58 -27.7 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.3 -37.99 68.84 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.343 -0.848 . . . . 0.0 110.506 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.61 -31.62 22.51 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -141.4 107.38 6.09 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 119.466 1.03 . . . . 0.0 113.136 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -60.15 -15.49 34.48 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.648 2.898 . . . . 0.0 116.758 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 p -49.22 -32.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.552 1.524 . . . . 0.0 112.743 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.96 -44.46 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.94 0.896 . . . . 0.0 111.646 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.565 ' HA ' HG12 ' A' ' 136' ' ' VAL . 9.3 ptm85 -71.71 -27.52 63.07 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.916 0.78 . . . . 0.0 112.208 175.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m -67.05 -48.94 66.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.27 0.628 . . . . 0.0 112.259 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -38.86 71.23 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.489 1.04 . . . . 0.0 113.002 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 133' ' ' ARG . 1.9 p -66.46 -32.46 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.508 1.049 . . . . 0.0 112.188 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -62.47 -41.99 99.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.883 0.873 . . . . 0.0 112.248 170.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.56 -47.29 55.92 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.537 -0.727 . . . . 0.0 111.771 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.6 t -82.82 -40.62 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -173.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.6 m -102.57 -12.86 17.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 64.84 -47.19 0.34 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 169.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -129.0 89.75 47.75 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.085 1.754 . . . . 0.0 106.784 164.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -89.6 158.23 5.28 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.935 2.424 . . . . 0.0 113.771 -166.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.0 p -122.98 151.57 41.72 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.874 1.669 . . . . 0.0 108.918 161.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 55.0 mt -125.07 127.26 25.1 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 124.007 0.923 . . . . 0.0 109.089 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.93 161.54 65.25 Favored 'Cis proline' 0 CA--C 1.542 0.9 0 CA-C-N 119.766 0.952 . . . . 0.0 113.948 7.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -135.26 158.74 43.6 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.358 1.863 . . . . 0.0 110.836 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.81 140.54 51.97 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.141 1.376 . . . . 0.0 113.234 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -133.79 143.0 48.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.886 2.074 . . . . 0.0 109.832 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.8 mt -129.66 117.48 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.591 0.756 . . . . 0.0 109.306 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.5 tptt 43.54 47.41 6.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.359 2.263 . . . . 0.0 113.745 -170.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.95 16.88 9.59 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.15 140.11 34.86 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.734 -1.229 . . . . 0.0 109.535 162.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -80.04 125.45 29.79 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.378 -0.826 . . . . 0.0 112.418 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.5 t -102.68 -47.14 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 124.656 1.182 . . . . 0.0 111.8 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.65 176.91 32.25 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.39 168.42 53.82 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.859 1.218 . . . . 0.0 113.341 165.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -45.59 -44.69 13.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.322 1.849 . . . . 0.0 113.817 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.78 -26.55 66.16 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.718 -0.614 . . . . 0.0 112.528 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.3 mm -79.22 -46.61 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.118 1.367 . . . . 0.0 110.389 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.1 t -57.73 -35.94 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.335 1.854 . . . . 0.0 111.337 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 86.7 m -64.06 -41.61 97.3 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.696 0.798 . . . . 0.0 112.527 173.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -65.95 -44.06 86.13 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.315 0.961 . . . . 0.0 110.198 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.7 mtt -61.51 -35.7 78.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.372 1.069 . . . . 0.0 112.317 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.81 -45.52 74.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.614 1.166 . . . . 0.0 111.984 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -69.78 -33.19 72.05 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.814 0.733 . . . . 0.0 112.479 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.6 t -86.23 -30.39 22.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.81 2.42 52.47 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 120.656 -1.278 . . . . 0.0 115.463 -171.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -68.17 -35.03 77.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.107 1.454 . . . . 0.0 112.086 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -45.5 85.14 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.34 -0.85 . . . . 0.0 110.158 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.86 -38.56 82.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.46 1.504 . . . . 0.0 113.136 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -60.6 -48.41 81.92 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.959 0.503 . . . . 0.0 111.66 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.1 mtm -70.85 -44.7 65.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.44 -37.84 88.93 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.503 -0.748 . . . . 0.0 111.176 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -72.57 -32.42 66.02 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.42 -28.35 69.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.278 1.031 . . . . 0.0 111.891 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 6.16 13.73 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.303 1.841 . . . . 0.0 113.771 171.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.14 -2.78 86.38 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.744 2.116 . . . . 0.0 113.7 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.4 mt -82.15 142.72 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.617 1.209 . . . . 0.0 110.459 -165.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 m -101.12 128.82 47.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.348 1.459 . . . . 0.0 110.273 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.8 p -132.04 170.69 14.59 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.81 1.644 . . . . 0.0 112.883 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 123.961 0.904 . . . . 0.0 109.755 166.69 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.6 m . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 pt -60.25 -34.47 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.412 1.005 . . . . 0.0 112.175 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -77.91 -30.15 50.5 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.326 1.851 . . . . 0.0 113.397 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 t -87.02 -34.01 19.37 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.796 1.638 . . . . 0.0 113.162 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.22 147.93 27.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.716 2.006 . . . . 0.0 110.503 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -70.11 -43.25 71.41 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 119.943 -1.723 . . . . 0.0 112.525 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -141.1 132.9 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.974 0.91 . . . . 0.0 112.17 -171.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.56 140.93 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.156 1.382 . . . . 0.0 112.266 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 t -133.02 158.98 41.36 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.925 1.29 . . . . 0.0 111.632 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -132.43 141.09 48.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.247 0.546 . . . . 0.0 112.045 171.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 107' ' ' SER . 9.6 mt -134.48 156.9 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.622 1.969 . . . . 0.0 109.336 -163.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -66.27 101.57 0.74 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 150.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 -140.39 20.15 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 121.126 -0.984 . . . . 0.0 114.277 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.8 mt -111.58 155.9 42.25 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 125.274 1.43 . . . . 0.0 112.581 -170.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.59 -12.61 31.6 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.727 2.284 . . . . 0.0 113.094 172.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -91.53 -26.93 18.53 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.827 1.651 . . . . 0.0 112.113 170.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.39 78.01 12.37 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.204 1.802 . . . . 0.0 111.872 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.05 143.21 17.78 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.106 2.537 . . . . 0.0 112.356 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 33.9 ttm -102.6 10.57 38.66 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.561 1.544 . . . . 0.0 113.352 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 51.4 t -145.09 145.18 31.32 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.917 -1.115 . . . . 0.0 111.843 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -36.79 83.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.493 1.117 . . . . 0.0 112.845 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -69.23 -24.45 64.01 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.066 -1.022 . . . . 0.0 112.544 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.488 ' HB3' HG23 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -70.55 -34.44 72.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.921 -1.112 . . . . 0.0 113.972 163.338 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -61.29 -39.6 91.06 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.453 1.479 . . . . 0.0 111.32 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -60.54 -38.6 84.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.713 0.805 . . . . 0.0 112.803 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.62 -47.58 78.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.652 1.181 . . . . 0.0 112.399 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.65 -32.17 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.408 -0.808 . . . . 0.0 111.369 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.73 -34.73 67.79 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.702 -1.249 . . . . 0.0 113.207 171.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.31 -41.85 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 122.673 0.389 . . . . 0.0 110.766 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -39.43 93.88 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.107 0.963 . . . . 0.0 112.229 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.27 -34.18 76.88 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.136 -0.978 . . . . 0.0 112.358 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.06 -23.58 63.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.436 1.095 . . . . 0.0 113.78 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.2 mt -95.9 -13.18 24.13 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.024 0.929 . . . . 0.0 113.244 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.07 18.64 67.11 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.277 0.941 . . . . 0.0 113.696 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 17.9 mt -113.12 130.71 56.1 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.581 1.552 . . . . 0.0 112.697 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -116.28 147.23 41.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.828 0.851 . . . . 0.0 112.941 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -129.35 172.45 11.49 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.027 2.531 . . . . 0.0 111.167 -163.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.3 m -86.4 133.9 33.75 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.365 -0.834 . . . . 0.0 110.405 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 t -131.12 146.9 52.52 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -164.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.01 152.71 39.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.167 1.787 . . . . 0.0 112.302 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -100.42 118.11 35.98 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.374 1.07 . . . . 0.0 111.426 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.6 p -66.4 -25.22 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.312 0.645 . . . . 0.0 112.624 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 tp -73.92 -22.21 59.77 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.028 0.931 . . . . 0.0 111.786 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.84 -29.88 11.19 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -125.08 106.44 28.47 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.88 -28.31 38.58 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.401 3.4 . . . . 0.0 115.663 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.67 -35.48 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.66 0.784 . . . . 0.0 112.111 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.81 -48.97 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.506 0.723 . . . . 0.0 110.871 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.428 ' HA ' HG12 ' A' ' 136' ' ' VAL . 9.7 ptp180 -70.75 -30.97 67.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.043 0.537 . . . . 0.0 112.056 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.8 m -69.38 -47.46 64.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.633 0.651 . . . . 0.0 112.301 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.5 -40.4 77.03 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.022 -1.049 . . . . 0.0 112.293 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 133' ' ' ARG . 12.3 p -63.93 -35.81 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 120.651 -1.281 . . . . 0.0 112.539 176.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -65.87 -44.95 83.88 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.732 0.813 . . . . 0.0 111.64 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.6 -41.38 92.83 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.648 0.779 . . . . 0.0 112.956 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.35 -41.94 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.3 m -98.94 1.64 45.77 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.855 1.207 . . . . 0.0 113.91 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 67.29 -22.82 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.368 2.667 . . . . 0.0 116.448 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -145.94 132.23 9.67 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.788 1.635 . . . . 0.0 109.458 171.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.31 126.98 5.72 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.876 1.717 . . . . 0.0 113.188 -165.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.8 p -135.52 136.85 41.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.446 1.898 . . . . 0.0 111.275 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.9 mm -128.05 137.42 30.77 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 125.458 1.503 . . . . 0.0 110.745 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.64 160.57 76.48 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 121.341 1.515 . . . . 0.0 112.447 -4.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -134.88 159.63 40.81 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.968 1.307 . . . . 0.0 110.515 -172.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.33 139.46 53.28 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -124.11 140.8 52.62 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.796 2.038 . . . . 0.0 110.411 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.8 mt -130.2 123.32 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.456 1.102 . . . . 0.0 108.387 170.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm 45.54 49.92 10.63 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.886 2.075 . . . . 0.0 114.88 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.4 26.45 15.35 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -118.41 138.23 52.6 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.767 1.227 . . . . 0.0 108.689 164.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.49 125.49 30.03 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.459 -0.775 . . . . 0.0 111.093 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 t -80.55 -40.49 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.499 1.119 . . . . 0.0 110.261 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.81 175.64 34.92 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.373 1.463 . . . . 0.0 114.327 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.25 172.14 55.19 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.852 0.739 . . . . 0.0 113.885 165.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.3 tp -48.65 -42.67 35.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.069 1.347 . . . . 0.0 113.686 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -59.41 -25.32 64.22 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.832 1.253 . . . . 0.0 113.018 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 mm -91.23 -46.6 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.27 1.428 . . . . 0.0 110.122 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.73 -40.89 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.249 1.42 . . . . 0.0 111.583 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.6 p -64.78 -40.93 96.08 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -68.43 -40.87 81.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.274 0.63 . . . . 0.0 112.211 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.9 mtt -63.23 -36.09 82.49 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.329 1.052 . . . . 0.0 112.68 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.76 -42.3 77.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.468 1.107 . . . . 0.0 112.299 174.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -65.29 -39.32 92.4 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.16 0.584 . . . . 0.0 111.418 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 36.7 t -82.66 -28.08 30.89 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.262 1.825 . . . . 0.0 115.159 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.61 -2.19 67.02 Favored Glycine 0 N--CA 1.48 1.579 0 O-C-N 120.47 -1.394 . . . . 0.0 114.665 -170.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -64.07 -35.79 81.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.646 1.223 . . . . 0.0 112.263 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.66 -45.69 85.64 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.848 0.859 . . . . 0.0 110.881 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -59.33 -40.6 86.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.68 1.592 . . . . 0.0 112.748 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -65.76 -36.55 83.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 118.215 -0.897 . . . . 0.0 112.632 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 61.2 mtm -70.04 -50.44 41.29 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.73 1.15 . . . . 0.0 113.295 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -62.33 -35.02 77.8 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.259 -0.901 . . . . 0.0 111.91 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -64.35 -37.98 89.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.603 0.761 . . . . 0.0 112.846 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.18 -30.04 71.12 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.077 0.853 . . . . 0.0 111.977 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.03 5.11 17.43 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.176 1.79 . . . . 0.0 114.275 171.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.28 12.8 75.32 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.3 1.428 . . . . 0.0 114.573 173.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 60.3 mt -94.31 145.35 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 118.266 1.033 . . . . 0.0 111.276 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 29.0 m -105.13 131.29 52.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.106 1.362 . . . . 0.0 110.743 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.4 p -133.89 171.02 14.75 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.478 1.911 . . . . 0.0 112.81 -175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 . . . . . 0 N--CA 1.477 0.898 0 C-N-CA 124.158 0.983 . . . . 0.0 112.726 164.399 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.3 m . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 90.0 mt -55.56 -40.89 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.499 1.519 . . . . 0.0 110.733 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -77.62 -37.94 49.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.021 1.328 . . . . 0.0 113.255 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 t -95.57 -28.08 15.03 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.219 1.408 . . . . 0.0 114.382 -165.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -87.3 145.98 26.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.306 1.042 . . . . 0.0 111.505 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -66.67 -44.83 80.75 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.962 0.905 . . . . 0.0 112.109 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.9 t -141.7 134.45 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.771 1.229 . . . . 0.0 111.7 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.98 133.9 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.126 1.37 . . . . 0.0 111.816 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 t -133.7 156.33 48.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.619 1.568 . . . . 0.0 110.936 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -132.61 139.62 47.86 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.39 1.076 . . . . 0.0 110.399 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mt -137.1 158.39 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.851 1.66 . . . . 0.0 109.064 -165.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -77.91 106.51 9.81 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 154.186 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.44 -149.65 21.35 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.833 1.206 . . . . 0.0 113.096 -172.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.98 156.93 51.69 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.327 1.451 . . . . 0.0 111.114 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.97 -33.9 72.89 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 121.408 1.539 . . . . 0.0 113.378 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -82.79 -13.96 55.29 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.913 -1.117 . . . . 0.0 113.263 173.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.26 70.3 13.02 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.985 1.714 . . . . 0.0 112.839 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.11 151.93 21.14 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.24 2.627 . . . . 0.0 111.574 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 85.3 mtp -97.4 12.19 34.05 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.7 t -148.97 145.25 27.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.746 1.219 . . . . 0.0 111.245 176.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.12 -39.84 86.7 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.558 -0.714 . . . . 0.0 112.897 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -62.75 -34.56 77.48 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.086 -1.009 . . . . 0.0 111.858 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.9 m -68.45 -31.03 70.05 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.284 -0.885 . . . . 0.0 112.664 170.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -66.02 -38.56 88.73 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.083 1.31 . . . . 0.0 112.425 168.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -59.73 -31.39 69.58 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.201 1.0 . . . . 0.0 112.69 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.6 tpt -60.04 -47.15 87.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.993 0.917 . . . . 0.0 111.618 169.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mm -70.89 -33.99 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.25 -0.906 . . . . 0.0 112.81 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -58.06 -35.81 71.88 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.741 -1.225 . . . . 0.0 112.404 168.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.67 -38.7 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 122.264 -0.272 . . . . 0.0 111.281 176.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.77 -34.72 78.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.235 1.014 . . . . 0.0 113.323 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.1 -40.39 95.71 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.089 -1.007 . . . . 0.0 111.629 167.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.71 -21.7 64.39 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 tp -96.88 -15.86 21.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.929 1.292 . . . . 0.0 112.725 170.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.98 12.17 56.71 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.188 1.852 . . . . 0.0 114.932 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.5 133.06 54.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 111.76 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -111.76 150.98 29.5 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.254 1.025 . . . . 0.0 113.201 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.73 175.79 8.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.817 2.047 . . . . 0.0 112.284 -161.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.86 117.51 25.65 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.374 -0.829 . . . . 0.0 109.481 -167.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 m -126.74 129.5 48.51 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.882 0.873 . . . . 0.0 112.17 -154.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -128.29 143.01 50.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.4 77.67 9.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.91 3.284 . . . . 0.0 111.427 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.3 p -74.18 -9.74 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -167.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.07 -22.98 22.66 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.329 -0.857 . . . . 0.0 112.156 169.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.98 -32.85 21.31 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.819 0.736 . . . . 0.0 112.232 174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -134.53 107.06 10.92 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.129 0.972 . . . . 0.0 111.569 163.627 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 129' ' ' HIS . 37.1 Cg_endo -60.66 -16.2 41.83 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.717 2.278 . . . . 0.0 114.203 173.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.4 p -39.75 -43.38 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.616 1.966 . . . . 0.0 115.82 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 t -67.25 -43.55 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.048 -1.033 . . . . 0.0 111.248 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -64.1 -41.09 97.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.008 1.323 . . . . 0.0 111.162 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.5 m -59.02 -45.73 89.98 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.193 0.997 . . . . 0.0 111.681 -177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -75.33 -37.11 60.9 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -35.11 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 121.058 1.754 . . . . 0.0 112.091 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.53 -35.15 73.64 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.614 1.566 . . . . 0.0 112.28 170.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.88 -35.8 59.74 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.447 1.022 . . . . 0.0 113.349 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 81.1 t -80.38 -45.33 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.317 0.962 . . . . 0.0 113.214 -173.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.3 p -105.27 13.61 30.22 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.646 1.566 . . . . 0.0 115.078 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 68.57 -29.87 0.17 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 128.153 2.581 . . . . 0.0 117.143 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -149.65 130.02 6.84 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 120.632 1.56 . . . . 0.0 112.868 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -94.8 147.77 1.69 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.669 2.913 . . . . 0.0 114.413 -177.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.0 p -129.79 152.41 49.31 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.552 1.541 . . . . 0.0 110.182 162.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.1 124.24 23.77 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.994 0.918 . . . . 0.0 110.553 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.58 157.04 72.31 Favored 'Cis proline' 0 CA--C 1.543 0.944 0 CA-C-N 120.227 1.117 . . . . 0.0 113.312 -2.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -151.72 160.55 43.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.183 1.393 . . . . 0.0 111.269 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.94 141.97 51.67 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -128.7 142.48 51.0 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.1 2.16 . . . . 0.0 110.868 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.4 mt -136.88 130.59 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.123 1.369 . . . . 0.0 109.688 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt 48.19 43.87 19.01 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.867 1.667 . . . . 0.0 114.573 -172.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.21 13.25 5.71 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.061 1.744 . . . . 0.0 114.889 -172.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -112.77 141.9 46.03 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.76 1.624 . . . . 0.0 111.103 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -72.51 126.26 29.43 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.105 0.955 . . . . 0.0 112.556 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.3 t -104.49 -54.97 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.28 1.432 . . . . 0.0 112.356 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 167.09 163.29 20.68 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.48 169.0 54.16 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.991 1.758 . . . . 0.0 113.441 168.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.4 tp -46.84 -45.35 20.15 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.315 1.446 . . . . 0.0 113.803 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.2 -21.24 66.49 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.881 1.272 . . . . 0.0 112.748 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.3 mm -92.36 -44.42 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.599 1.96 . . . . 0.0 111.193 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.9 -36.0 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.046 1.738 . . . . 0.0 112.066 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -56.58 -49.81 73.77 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 170.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -61.74 -42.02 98.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.442 0.697 . . . . 0.0 110.362 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.8 mtt -66.55 -39.12 88.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.221 1.009 . . . . 0.0 112.981 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -68.36 -39.72 81.73 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.015 1.326 . . . . 0.0 112.156 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.88 -31.57 61.63 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 30.7 t -79.25 -26.97 42.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.811 1.245 . . . . 0.0 113.603 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.53 -0.64 80.74 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.082 0.849 . . . . 0.0 114.511 -168.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.04 -36.72 80.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.71 1.755 . . . . 0.0 111.781 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.1 -42.51 98.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.889 0.876 . . . . 0.0 110.906 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -69.06 -35.42 76.53 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 126.234 1.814 . . . . 0.0 112.973 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -58.05 -48.84 78.87 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.154 1.343 . . . . 0.0 110.946 171.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 70.3 mtm -67.89 -38.59 83.2 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.27 -43.64 77.35 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.341 0.973 . . . . 0.0 112.832 172.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -72.24 -26.35 61.98 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.309 -0.87 . . . . 0.0 113.305 -171.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.71 -30.12 63.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.321 1.048 . . . . 0.0 112.672 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -87.39 -2.5 58.66 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.51 16.36 55.3 Favored Glycine 0 N--CA 1.47 0.926 0 O-C-N 120.66 -1.275 . . . . 0.0 113.815 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.3 mt -86.19 147.67 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.323 1.049 . . . . 0.0 110.801 -171.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.6 m -105.04 124.44 49.54 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.091 1.356 . . . . 0.0 112.681 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 25.5 p -125.53 169.17 12.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.806 2.442 . . . . 0.0 111.441 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 N--CA 1.481 1.104 0 O-C-N 121.087 -1.008 . . . . 0.0 112.087 171.664 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.4 m . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -61.54 -33.53 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.743 -0.598 . . . . 0.0 112.455 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.81 -24.78 44.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.85 1.66 . . . . 0.0 113.759 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.5 t -92.52 -34.19 14.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.773 1.629 . . . . 0.0 113.667 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -87.76 147.86 24.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.325 1.05 . . . . 0.0 111.807 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -68.51 -47.63 66.49 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.942 -1.099 . . . . 0.0 113.779 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.9 t -140.39 129.93 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.773 1.229 . . . . 0.0 110.848 -173.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.55 137.64 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.648 1.179 . . . . 0.0 111.315 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -136.54 154.64 50.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.417 1.087 . . . . 0.0 111.758 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -134.5 143.61 47.57 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.753 0.787 . . . . 0.0 112.469 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 mt -136.79 157.45 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.495 1.518 . . . . 0.0 110.227 -155.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -76.19 106.52 7.85 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.973 153.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.26 -161.71 43.42 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.948 0.794 . . . . 0.0 114.257 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.82 156.09 41.06 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.724 1.209 . . . . 0.0 111.94 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -67.39 -21.04 47.72 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.28 1.987 . . . . 0.0 113.088 173.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.59 -24.53 21.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.136 1.374 . . . . 0.0 112.852 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.31 75.77 19.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.796 1.638 . . . . 0.0 111.334 -176.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.66 155.87 40.02 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.722 2.948 . . . . 0.0 112.362 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.3 mtt -109.62 4.04 21.67 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.316 1.446 . . . . 0.0 114.539 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 44.3 t -148.85 147.11 28.35 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.753 1.621 . . . . 0.0 110.523 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.15 94.71 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.698 -0.626 . . . . 0.0 111.548 176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -60.91 -34.66 75.02 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.278 -0.889 . . . . 0.0 112.203 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.8 m -63.48 -48.48 77.45 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 118.865 -0.588 . . . . 0.0 111.136 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -59.08 -48.97 79.67 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.025 0.83 . . . . 0.0 111.055 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -60.84 -28.64 68.98 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.417 1.087 . . . . 0.0 113.037 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 34.4 ttp -68.79 -42.62 77.11 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.6 mm -67.66 -34.57 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.227 -0.921 . . . . 0.0 110.73 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -39.53 72.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.915 1.286 . . . . 0.0 111.956 172.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.44 -42.35 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.557 1.143 . . . . 0.0 111.705 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.9 mt -66.48 -35.53 80.51 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -67.07 -33.62 75.88 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.972 -1.08 . . . . 0.0 112.495 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.79 -25.69 68.29 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.837 -1.164 . . . . 0.0 113.275 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.88 -14.48 20.66 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.426 1.09 . . . . 0.0 113.717 171.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.82 10.19 67.31 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.894 1.235 . . . . 0.0 115.355 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.32 131.38 55.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.184 0.993 . . . . 0.0 112.06 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -116.5 128.1 55.14 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.934 0.874 . . . . 0.0 113.018 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -106.36 171.98 7.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.818 2.447 . . . . 0.0 112.069 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.2 m -83.72 121.87 27.88 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.581 -1.324 . . . . 0.0 109.0 -161.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.9 m -122.79 128.03 49.91 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.243 -155.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -126.45 143.94 51.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.673 1.189 . . . . 0.0 113.386 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -92.7 113.91 26.32 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.679 1.192 . . . . 0.0 111.245 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 t -69.11 -18.44 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.757 -0.589 . . . . 0.0 112.061 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -77.7 -22.79 49.94 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.054 -1.029 . . . . 0.0 112.545 172.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.78 -37.37 17.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.893 0.769 . . . . 0.0 112.205 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -136.85 94.36 12.99 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -44.18 -20.93 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.586 1 C-N-CA 125.916 4.411 . . . . 0.0 116.891 165.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -48.62 -35.88 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 121.237 1.835 . . . . 0.0 112.867 171.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.35 -43.69 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 121.565 -0.709 . . . . 0.0 110.315 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.526 ' HA ' HG12 ' A' ' 136' ' ' VAL . 0.7 OUTLIER -62.25 -32.94 73.7 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.845 1.258 . . . . 0.0 112.542 172.63 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.421 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 40.4 m -69.57 -37.9 77.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.911 1.684 . . . . 0.0 113.686 173.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -76.17 -47.19 25.13 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 133' ' ' ARG . 8.0 p -60.54 -34.47 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 120.515 -1.365 . . . . 0.0 112.951 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 134' ' ' SER . 17.7 ptpt -62.13 -34.64 76.73 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -77.04 -43.53 34.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.664 1.986 . . . . 0.0 113.915 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.9 t -79.33 -38.59 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.108 1.363 . . . . 0.0 113.376 -166.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 m -100.39 10.98 40.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 62.11 -33.97 0.1 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 128.338 2.655 . . . . 0.0 115.376 -166.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -139.13 139.41 23.15 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.534 2.334 . . . . 0.0 108.833 169.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.99 128.37 9.11 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.075 1.85 . . . . 0.0 112.019 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.8 m -130.16 132.21 45.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.835 1.254 . . . . 0.0 110.987 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 57.0 mt -129.2 130.58 23.38 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.275 1.03 . . . . 0.0 110.52 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -80.78 152.66 82.2 Favored 'Cis proline' 0 CA--C 1.545 1.062 0 CA-C-N 120.021 1.043 . . . . 0.0 112.827 -5.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -147.81 158.56 44.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.352 1.061 . . . . 0.0 112.595 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.52 135.13 50.9 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.914 1.686 . . . . 0.0 111.987 -172.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -119.22 144.91 46.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.726 2.011 . . . . 0.0 110.128 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.6 mt -127.0 124.32 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 167.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.3 tttp 44.11 54.95 5.7 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.925 1.69 . . . . 0.0 114.328 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.69 27.83 17.55 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.08 145.86 51.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.109 1.364 . . . . 0.0 110.008 171.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -81.6 124.07 29.22 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.717 0.77 . . . . 0.0 111.332 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.9 t -99.94 -49.25 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.144 0.978 . . . . 0.0 110.104 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.05 158.75 23.88 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.674 1.429 . . . . 0.0 116.674 170.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.2 169.7 54.59 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.285 0.945 . . . . 0.0 112.157 164.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -52.12 -38.85 58.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.469 1.107 . . . . 0.0 113.969 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.49 -34.96 78.2 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.869 -1.144 . . . . 0.0 111.773 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.5 mm -72.54 -46.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.161 1.384 . . . . 0.0 110.668 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.98 -35.91 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.966 1.706 . . . . 0.0 111.032 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 90.6 m -62.04 -46.25 90.01 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.443 0.697 . . . . 0.0 111.807 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -59.57 -45.78 90.86 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.742 1.155 . . . . 0.0 110.28 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.3 mtt -61.36 -41.75 97.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.881 0.873 . . . . 0.0 111.365 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.87 -46.61 67.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.133 0.973 . . . . 0.0 111.335 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -72.64 -24.86 61.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.634 1.174 . . . . 0.0 112.597 -175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.9 t -100.44 -2.93 32.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.804 1.641 . . . . 0.0 114.041 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.44 -7.47 78.75 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 120.705 -1.247 . . . . 0.0 115.324 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -29.71 67.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.837 -1.39 . . . . 0.0 114.103 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.55 -46.42 86.03 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.077 0.853 . . . . 0.0 109.791 174.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -58.59 -42.2 87.54 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.122 0.969 . . . . 0.0 111.68 169.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.67 -37.35 86.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 117.0 -1.476 . . . . 0.0 111.825 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.8 mtm -69.82 -47.73 61.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.363 1.438 . . . . 0.0 112.88 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.27 -39.02 89.13 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.634 0.652 . . . . 0.0 112.251 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -69.36 -36.14 76.56 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.955 1.302 . . . . 0.0 111.912 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.0 -24.67 67.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.738 0.815 . . . . 0.0 112.546 168.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -92.12 6.44 46.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.929 1.292 . . . . 0.0 114.403 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.72 13.39 67.29 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.725 1.155 . . . . 0.0 114.431 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.2 mt -104.46 146.89 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.25 1.42 . . . . 0.0 108.959 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.0 m -116.02 136.13 53.32 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.861 -1.149 . . . . 0.0 112.777 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.4 p -131.34 167.98 18.33 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.18 1.792 . . . . 0.0 112.581 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 . . . . . 0 N--CA 1.476 0.842 0 O-C-N 121.439 -0.788 . . . . 0.0 110.096 171.009 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.71 -36.53 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 118.427 0.558 . . . . 0.0 111.991 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.4 -38.31 50.09 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.582 1.553 . . . . 0.0 112.896 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.7 t -81.84 -35.87 28.93 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.661 1.584 . . . . 0.0 113.122 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -83.04 142.36 31.37 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.888 -1.133 . . . . 0.0 109.968 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.416 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 34.9 m-20 -82.93 -46.0 13.48 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.879 -1.138 . . . . 0.0 112.345 -163.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 t -132.85 131.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.787 1.635 . . . . 0.0 109.764 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.2 t -132.49 132.88 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.529 1.532 . . . . 0.0 111.173 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.8 t -133.85 155.48 49.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.65 1.18 . . . . 0.0 110.839 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -131.39 142.44 50.05 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.31 0.644 . . . . 0.0 112.73 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.7 mt -136.42 159.69 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.351 1.861 . . . . 0.0 110.206 -158.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -73.06 104.03 4.01 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.509 -0.744 . . . . 0.0 109.505 158.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.24 -155.94 40.83 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.563 -0.71 . . . . 0.0 113.676 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -113.58 150.21 42.88 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.8 1.24 . . . . 0.0 112.209 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.02 -19.02 46.16 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.067 2.512 . . . . 0.0 114.711 -167.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.12 -27.34 60.82 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.606 1.162 . . . . 0.0 112.688 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.79 68.22 12.88 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.163 1.785 . . . . 0.0 111.549 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.1 143.8 73.17 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.422 2.082 . . . . 0.0 111.429 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.6 ttm -90.93 -7.51 51.91 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 41.3 t -140.8 146.28 37.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.282 1.433 . . . . 0.0 110.459 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.17 94.33 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.546 -0.721 . . . . 0.0 112.484 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -69.52 -34.1 73.78 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.436 -0.79 . . . . 0.0 111.593 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 m -62.75 -39.46 94.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.339 0.655 . . . . 0.0 112.477 168.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -67.23 -40.66 86.36 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.627 1.103 . . . . 0.0 112.828 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -64.42 -36.03 82.85 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.805 0.842 . . . . 0.0 112.509 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.8 tpt -55.94 -45.86 78.69 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.214 0.915 . . . . 0.0 112.289 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.3 mm -66.58 -34.14 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.303 0.641 . . . . 0.0 111.254 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -37.2 86.31 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.437 -0.79 . . . . 0.0 112.99 174.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.8 t -70.62 -36.11 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.897 0.879 . . . . 0.0 110.956 176.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.1 mt -66.1 -40.95 91.18 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.335 -0.853 . . . . 0.0 113.129 169.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -62.08 -31.29 71.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.09 -1.007 . . . . 0.0 111.863 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.15 -20.0 64.86 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -98.81 -9.17 24.75 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.459 1.504 . . . . 0.0 113.563 172.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.77 11.17 57.11 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.402 1.477 . . . . 0.0 114.954 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.11 132.62 55.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.333 1.066 . . . . 0.0 111.831 172.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -114.89 159.23 20.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.951 0.9 . . . . 0.0 113.356 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -133.19 172.82 12.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.856 2.062 . . . . 0.0 111.604 -161.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.4 m -87.9 119.6 28.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.469 -1.394 . . . . 0.0 108.354 -168.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.6 m -125.93 129.29 48.98 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.162 -151.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -125.88 143.72 50.96 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -91.87 122.59 34.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.395 1.478 . . . . 0.0 111.396 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.0 m -66.92 -22.22 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.0 mt -87.04 -11.3 50.74 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.211 1.404 . . . . 0.0 112.92 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.13 -36.79 15.51 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -146.29 135.27 11.2 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.95 0.9 . . . . 0.0 111.069 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.25 -31.63 93.25 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.393 2.728 . . . . 0.0 113.204 -174.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 p -44.02 -42.7 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.616 1.567 . . . . 0.0 113.789 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 t -71.11 -47.86 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.801 1.182 . . . . 0.0 111.419 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -72.42 -25.41 61.47 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 63.7 m -71.2 -48.07 53.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.316 1.046 . . . . 0.0 112.274 169.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -66.18 -44.22 84.62 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.96 -1.088 . . . . 0.0 112.623 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.82 -35.31 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.291 -0.88 . . . . 0.0 112.065 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -69.59 -36.53 76.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.274 1.03 . . . . 0.0 112.728 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -74.48 -44.21 52.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.464 1.106 . . . . 0.0 113.718 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.0 t -81.91 -41.27 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.24 1.416 . . . . 0.0 113.001 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.0 m -101.1 -9.33 21.47 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 64.13 -24.15 0.07 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 128.697 2.799 . . . . 0.0 117.439 172.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -127.3 110.6 21.3 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.189 1.795 . . . . 0.0 107.925 158.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.03 125.94 4.25 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 121.117 1.211 . . . . 0.0 111.875 -171.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.4 p -136.05 126.75 27.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.352 1.861 . . . . 0.0 109.453 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.62 146.13 57.43 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 119.226 0.921 . . . . 0.0 110.999 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.69 155.27 92.39 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 120.201 1.108 . . . . 0.0 114.292 8.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -150.01 157.29 42.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.472 1.909 . . . . 0.0 110.576 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.73 139.03 52.41 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.251 1.021 . . . . 0.0 113.665 -172.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -129.78 145.8 51.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.514 1.926 . . . . 0.0 111.101 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.6 mt -129.12 125.86 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.792 1.237 . . . . 0.0 108.685 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 90' ' ' ASP . 2.3 mmpt? 46.59 53.66 9.7 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.674 1.59 . . . . 0.0 114.422 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 58.05 24.45 11.18 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.399 1.88 . . . . 0.0 115.934 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -123.53 139.3 54.15 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.902 -1.124 . . . . 0.0 111.522 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -68.35 123.73 21.55 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.082 0.953 . . . . 0.0 111.023 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.77 -43.16 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.497 1.519 . . . . 0.0 111.807 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.62 173.67 26.33 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 117.165 1.626 . . . . 0.0 117.165 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.95 173.23 54.9 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.466 1.507 . . . . 0.0 113.769 171.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.95 -41.38 33.81 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.28 1.432 . . . . 0.0 112.895 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.86 -36.54 83.61 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.948 -1.095 . . . . 0.0 112.82 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 mm -74.27 -45.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.672 1.589 . . . . 0.0 109.62 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.5 t -58.65 -39.72 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.996 0.918 . . . . 0.0 110.835 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 30.7 m -63.52 -46.05 87.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.229 1.011 . . . . 0.0 111.369 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 29.7 tttp -60.88 -43.77 97.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.96 1.304 . . . . 0.0 111.585 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 51.9 mtt -70.6 -38.73 74.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.831 1.253 . . . . 0.0 112.698 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.09 -46.72 61.24 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.386 0.994 . . . . 0.0 112.294 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -63.55 -33.65 76.06 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.646 0.657 . . . . 0.0 111.713 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.7 m -85.14 -17.65 36.6 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.66 -4.65 85.77 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.945 1.248 . . . . 0.0 115.142 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -64.92 -28.49 69.56 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.426 1.613 . . . . 0.0 113.538 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tt -59.54 -46.55 88.56 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.915 -1.116 . . . . 0.0 109.922 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -61.9 -32.92 73.34 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.172 1.789 . . . . 0.0 112.823 172.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -64.45 -39.81 94.54 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.596 1.089 . . . . 0.0 112.101 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.1 mtm -66.16 -51.18 60.26 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.749 1.261 . . . . 0.0 111.562 172.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 53.7 tp -65.14 -42.83 93.44 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.706 2.002 . . . . 0.0 111.122 -165.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -68.65 -38.2 80.25 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.276 1.03 . . . . 0.0 112.337 171.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.89 -27.25 69.02 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.905 0.775 . . . . 0.0 112.666 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 -5.23 45.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.894 1.678 . . . . 0.0 113.714 175.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.46 16.42 64.25 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 125.203 1.383 . . . . 0.0 114.687 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.17 143.92 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.24 1.416 . . . . 0.0 110.15 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.5 m -114.15 134.34 54.96 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.244 -0.91 . . . . 0.0 113.403 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.2 p -125.73 174.07 8.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 129.007 2.923 . . . . 0.0 111.994 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 . . . . . 0 N--CA 1.476 0.85 0 C-N-CA 124.695 1.198 . . . . 0.0 113.172 167.4 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.6 pt -62.13 -35.3 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.747 1.158 . . . . 0.0 112.13 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -77.74 -37.75 48.49 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.044 1.738 . . . . 0.0 112.069 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 t -68.15 -31.55 71.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.853 2.461 . . . . 0.0 113.293 173.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -86.87 147.85 25.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.15 1.78 . . . . 0.0 111.727 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.87 -35.7 16.39 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.017 -1.052 . . . . 0.0 111.863 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.3 t -139.9 130.75 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.95 1.3 . . . . 0.0 112.261 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.9 t -132.83 133.32 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.059 1.344 . . . . 0.0 111.379 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 t -131.72 154.6 48.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.998 0.919 . . . . 0.0 110.596 167.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -134.2 146.23 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.404 0.621 . . . . 0.0 112.463 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.07 161.72 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.078 1.751 . . . . 0.0 109.174 -166.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.72 104.25 8.15 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.375 -0.828 . . . . 0.0 109.543 146.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.28 -162.41 18.03 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.265 0.936 . . . . 0.0 114.87 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -107.1 158.24 33.44 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.916 2.086 . . . . 0.0 110.833 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.29 -25.77 56.79 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.733 1.622 . . . . 0.0 113.666 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -76.07 -24.41 55.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.734 1.214 . . . . 0.0 113.684 169.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.12 69.05 14.14 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.07 1.348 . . . . 0.0 111.894 -174.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.99 143.71 23.24 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.856 2.37 . . . . 0.0 110.372 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 mmt -88.58 5.15 44.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 13.5 t -152.21 146.76 25.7 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.124 1.37 . . . . 0.0 110.961 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.33 77.85 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -65.3 -37.89 88.53 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.894 -1.129 . . . . 0.0 111.761 172.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 m -65.14 -39.26 92.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.872 0.869 . . . . 0.0 112.361 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.53 -45.77 92.79 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.269 1.027 . . . . 0.0 112.144 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -58.19 -35.86 72.24 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.69 1.596 . . . . 0.0 112.957 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.4 ttp -59.13 -42.45 90.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.622 0.369 . . . . 0.0 111.941 173.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 mm -71.73 -33.82 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.572 0.749 . . . . 0.0 111.848 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -58.35 -38.68 77.69 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.8 -1.188 . . . . 0.0 112.336 172.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.425 HG13 ' HG ' ' A' ' 165' ' ' LEU . 2.2 t -63.48 -39.38 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.173 0.989 . . . . 0.0 111.081 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.6 mt -65.89 -39.18 90.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.554 0.742 . . . . 0.0 112.532 173.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -67.0 -31.56 72.2 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.903 -1.123 . . . . 0.0 112.018 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.89 -19.91 64.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.848 1.259 . . . . 0.0 114.235 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.75 -9.55 28.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.889 1.276 . . . . 0.0 113.297 166.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.41 9.2 42.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.342 0.972 . . . . 0.0 113.721 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.0 mt -114.29 130.33 56.66 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 125.683 1.593 . . . . 0.0 111.72 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -115.02 133.67 55.85 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.017 0.913 . . . . 0.0 111.594 170.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -105.06 172.12 6.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.603 2.361 . . . . 0.0 110.773 -172.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.5 m -87.24 123.1 31.88 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.668 -1.27 . . . . 0.0 109.811 -161.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.5 p -108.36 134.14 51.59 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.406 1.482 . . . . 0.0 114.904 -158.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -126.71 146.78 50.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.503 1.121 . . . . 0.0 113.023 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.46 106.04 14.81 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.013 1.325 . . . . 0.0 111.328 -167.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.54 -36.04 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.586 1.555 . . . . 0.0 112.262 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 tp -80.48 -22.05 41.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.335 0.654 . . . . 0.0 111.666 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.11 -39.31 16.86 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.49 -0.757 . . . . 0.0 112.679 167.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -126.1 103.06 26.92 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 118.982 0.81 . . . . 0.0 112.52 -169.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.08 -28.77 25.92 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.713 2.942 . . . . 0.0 115.021 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -49.7 -36.86 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.792 1.237 . . . . 0.0 113.5 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.34 -52.2 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.553 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.434 ' HA ' HG12 ' A' ' 136' ' ' VAL . 16.1 ptm180 -64.48 -26.11 68.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.69 0.796 . . . . 0.0 112.955 173.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.6 m -71.46 -51.96 20.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.163 0.585 . . . . 0.0 111.763 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -73.43 -34.92 65.7 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.564 -1.335 . . . . 0.0 114.206 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 133' ' ' ARG . 11.5 p -60.28 -34.34 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.715 1.143 . . . . 0.0 112.074 172.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 34.5 tttm -69.25 -35.21 75.88 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.139 0.881 . . . . 0.0 112.731 173.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.23 -37.74 86.52 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.221 1.373 . . . . 0.0 112.541 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.61 -45.26 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.1 m -106.08 -5.37 19.49 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 62.05 -48.09 0.16 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.517 2.327 . . . . 0.0 116.186 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -135.92 92.45 16.46 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.896 1.278 . . . . 0.0 111.546 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -101.47 156.7 0.37 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.838 3.692 . . . . 0.0 114.743 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 m -117.35 128.84 55.44 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.413 1.485 . . . . 0.0 110.393 161.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.22 140.69 25.79 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.879 1.272 . . . . 0.0 108.576 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -90.59 159.62 31.11 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-N 120.733 1.298 . . . . 0.0 113.693 1.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -160.2 171.65 18.83 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.464 1.106 . . . . 0.0 113.466 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.52 141.89 51.24 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.12 1.368 . . . . 0.0 113.455 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -128.29 141.71 51.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.61 1.964 . . . . 0.0 110.665 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 84.5 mt -129.65 135.63 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 125.049 1.339 . . . . 0.0 108.471 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 47.36 40.45 10.8 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.22 1.408 . . . . 0.0 113.509 -170.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.32 25.46 7.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.002 2.121 . . . . 0.0 115.526 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.87 142.47 46.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.513 1.525 . . . . 0.0 110.007 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -70.78 126.08 28.61 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.614 0.721 . . . . 0.0 112.088 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.7 t -101.57 -53.89 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.436 1.494 . . . . 0.0 111.078 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.82 160.6 26.41 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 116.058 1.183 . . . . 0.0 116.058 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 170.36 54.91 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.035 1.302 . . . . 0.0 112.769 165.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -49.31 -46.76 47.03 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.86 1.264 . . . . 0.0 114.337 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.9 -22.67 65.07 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.101 -0.999 . . . . 0.0 112.621 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.4 mm -82.23 -47.05 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.838 1.655 . . . . 0.0 110.664 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.67 -36.57 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.852 1.661 . . . . 0.0 111.024 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 55.1 m -59.69 -44.0 93.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.907 0.883 . . . . 0.0 111.881 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -66.41 -42.45 87.8 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.105 -0.997 . . . . 0.0 111.033 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.6 mtt -61.13 -43.83 98.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.597 0.759 . . . . 0.0 110.99 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.425 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.0 tm? -65.11 -48.85 72.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.078 0.951 . . . . 0.0 111.13 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.15 -16.26 61.98 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.165 1.386 . . . . 0.0 113.477 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m -91.32 -21.01 21.26 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 173.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.83 -2.35 88.25 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 121.718 -0.614 . . . . 0.0 113.927 -164.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.0 -33.55 74.84 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.688 1.244 . . . . 0.0 111.775 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.28 -45.63 92.41 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.363 -0.836 . . . . 0.0 110.689 172.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -63.48 -37.49 87.51 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.158 1.383 . . . . 0.0 113.105 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -61.38 -43.33 99.05 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 117.611 -1.185 . . . . 0.0 112.655 170.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 74.4 mtm -68.71 -48.02 64.89 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.939 1.245 . . . . 0.0 112.309 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 pp -64.04 -35.65 81.43 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.822 -0.549 . . . . 0.0 111.709 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -69.7 -35.76 75.35 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 121.496 -0.752 . . . . 0.0 112.952 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -65.2 -30.61 71.52 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.3 1.04 . . . . 0.0 111.876 171.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.99 5.28 6.81 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.014 1.726 . . . . 0.0 112.969 170.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.91 9.25 77.93 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.502 1.525 . . . . 0.0 114.796 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.4 mt -94.66 147.22 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.219 1.008 . . . . 0.0 110.854 -168.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.3 m -112.22 130.3 55.97 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.994 1.318 . . . . 0.0 111.101 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.5 p -138.36 169.51 17.66 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.977 1.711 . . . . 0.0 113.032 -169.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.0 ttt-85 . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 124.862 1.265 . . . . 0.0 110.813 164.938 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.618 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.3 pt -64.4 -36.63 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.138 0.575 . . . . 0.0 111.867 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -79.19 -34.26 43.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.323 1.449 . . . . 0.0 113.681 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -80.1 -29.65 39.06 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.853 0.861 . . . . 0.0 113.243 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -87.42 133.49 33.73 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.955 0.902 . . . . 0.0 112.047 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -67.67 -38.22 83.43 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.3 t -142.33 127.2 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.331 1.053 . . . . 0.0 111.514 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.77 130.17 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.467 1.507 . . . . 0.0 111.557 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 t -131.75 155.3 47.95 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.079 0.952 . . . . 0.0 111.532 168.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -131.62 127.9 38.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.591 1.156 . . . . 0.0 110.394 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.14 173.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.22 1.808 . . . . 0.0 111.773 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 102.15 4.52 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.333 1.053 . . . . 0.0 109.919 161.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.82 -162.12 37.11 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.41 1.005 . . . . 0.0 115.156 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.11 148.67 43.51 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.117 0.967 . . . . 0.0 110.549 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.21 -23.89 77.98 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.148 2.565 . . . . 0.0 113.996 -175.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -78.37 -26.47 46.62 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.799 1.24 . . . . 0.0 113.907 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.17 67.05 10.62 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.903 1.281 . . . . 0.0 111.881 -175.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.19 152.91 45.72 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.527 2.151 . . . . 0.0 112.841 -172.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -74.06 -8.13 55.02 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.196 -0.94 . . . . 0.0 113.34 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.7 m -152.66 146.73 25.4 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -158.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.1 64.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.247 1.419 . . . . 0.0 112.447 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -67.68 -26.66 66.3 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.315 0.962 . . . . 0.0 111.36 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.3 m -68.32 -38.38 81.51 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.274 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.31 -45.49 91.1 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.305 1.411 . . . . 0.0 111.768 167.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -56.61 -37.65 70.98 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.485 0.714 . . . . 0.0 112.342 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.8 tpt -60.79 -46.56 90.02 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.278 1.431 . . . . 0.0 112.355 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.3 mm -72.96 -33.21 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.426 -0.796 . . . . 0.0 112.459 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -57.58 -32.69 67.41 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.206 -1.558 . . . . 0.0 112.795 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.419 HG13 ' HG ' ' A' ' 165' ' ' LEU . 4.0 t -62.61 -44.07 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.177 0.991 . . . . 0.0 111.168 172.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.35 -36.28 83.53 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.031 1.332 . . . . 0.0 112.83 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -71.83 -31.23 66.32 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.358 -1.463 . . . . 0.0 113.137 172.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.91 -29.84 69.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.228 1.011 . . . . 0.0 112.642 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.35 -14.35 40.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.268 1.027 . . . . 0.0 113.412 169.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.83 11.11 57.2 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.083 1.325 . . . . 0.0 114.527 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.09 131.61 55.75 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.932 1.293 . . . . 0.0 111.326 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -113.0 145.37 40.96 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.715 1.143 . . . . 0.0 112.421 174.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -113.54 172.29 7.05 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.459 1.904 . . . . 0.0 111.721 -175.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.8 m -88.86 120.4 30.23 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -164.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.2 m -125.67 136.03 52.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.608 -148.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -124.02 159.55 29.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.827 1.251 . . . . 0.0 111.985 -173.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -112.99 118.27 34.35 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.088 1.355 . . . . 0.0 110.677 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.85 -21.78 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.427 0.691 . . . . 0.0 112.857 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.42 -9.92 53.4 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.517 1.127 . . . . 0.0 112.644 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.46 -34.35 11.53 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.332 0.969 . . . . 0.0 112.61 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -138.36 88.65 14.63 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.213 0.605 . . . . 0.0 111.005 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.86 -12.51 22.4 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.21 2.607 . . . . 0.0 114.961 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -45.91 -33.77 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.662 1.119 . . . . 0.0 112.902 167.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.43 -43.62 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.337 1.055 . . . . 0.0 111.824 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.469 ' HA ' HG12 ' A' ' 136' ' ' VAL . 11.4 ptm180 -65.68 -28.61 69.21 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.257 0.935 . . . . 0.0 111.98 177.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.4 m -74.48 -39.43 62.49 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -69.84 -39.99 76.1 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.695 1.134 . . . . 0.0 111.313 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 133' ' ' ARG . 9.9 p -67.3 -32.11 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.808 -1.182 . . . . 0.0 112.233 175.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -61.49 -33.98 74.7 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.071 -1.018 . . . . 0.0 113.024 168.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -73.31 -47.85 39.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.182 0.993 . . . . 0.0 112.72 170.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.95 -34.43 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.0 m -100.61 -2.31 33.15 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 60.84 -38.74 0.1 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 130.221 3.408 . . . . 0.0 116.635 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -136.49 91.73 15.9 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.859 2.464 . . . . 0.0 109.572 173.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.41 136.58 8.82 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.117 2.545 . . . . 0.0 113.232 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.9 m -132.65 122.55 24.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.147 0.979 . . . . 0.0 109.85 165.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 12.6 pt -95.37 156.41 37.66 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.493 1.117 . . . . 0.0 113.683 -172.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.92 158.37 97.97 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 119.037 0.692 . . . . 0.0 112.978 -5.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -131.42 160.86 33.88 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.999 1.319 . . . . 0.0 111.433 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.84 139.95 53.06 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.278 1.431 . . . . 0.0 111.991 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -132.8 143.99 49.93 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.172 1.789 . . . . 0.0 110.28 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.1 mt -126.17 117.09 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 42.89 53.03 5.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 127.215 2.206 . . . . 0.0 114.324 -169.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 57.52 26.52 12.82 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -119.29 131.19 55.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.117 1.367 . . . . 0.0 109.224 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -74.33 125.03 27.59 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.86 -42.48 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.013 1.325 . . . . 0.0 111.662 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.35 177.88 30.88 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 169.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.98 169.31 54.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.831 1.205 . . . . 0.0 113.962 168.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -45.35 -44.48 11.79 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.147 1.779 . . . . 0.0 113.145 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.62 -45.04 93.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.356 0.662 . . . . 0.0 111.656 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 mm -68.45 -46.91 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.424 1.49 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.71 -36.21 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.946 1.699 . . . . 0.0 110.672 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 29.5 m -63.39 -46.04 88.29 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 118.8 -0.619 . . . . 0.0 111.701 173.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -63.61 -41.99 98.25 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.882 1.219 . . . . 0.0 110.82 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 54.6 mtt -64.17 -39.8 94.77 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.631 1.172 . . . . 0.0 112.399 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.419 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.1 tm? -66.09 -47.17 75.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.856 0.863 . . . . 0.0 110.874 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -70.93 -26.18 63.09 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.506 1.122 . . . . 0.0 113.283 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 75.2 m -105.18 0.88 27.75 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.24 -8.09 80.62 Favored Glycine 0 N--CA 1.478 1.442 0 CA-C-N 121.094 1.77 . . . . 0.0 115.419 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.55 -29.68 69.12 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.08 1.44 . . . . 0.0 112.885 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.34 -48.26 68.03 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.651 0.78 . . . . 0.0 110.782 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -60.62 -33.59 73.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.611 1.564 . . . . 0.0 112.889 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -59.02 -41.35 87.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.952 0.796 . . . . 0.0 112.821 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.8 mtm -67.32 -47.64 69.93 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.632 1.105 . . . . 0.0 112.143 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -37.97 87.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.251 0.62 . . . . 0.0 112.49 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -75.03 -33.98 61.84 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.412 -0.805 . . . . 0.0 112.989 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.78 -24.83 67.68 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.289 0.495 . . . . 0.0 111.955 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -80.31 -0.04 34.94 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.712 1.205 . . . . 0.0 113.825 171.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.32 22.02 57.53 Favored Glycine 0 CA--C 1.524 0.622 0 O-C-N 120.521 -1.362 . . . . 0.0 114.26 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 95.9 mt -99.4 145.04 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.666 1.233 . . . . 0.0 111.395 -173.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 99.2 m -91.42 126.89 36.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.685 1.194 . . . . 0.0 111.658 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 22.0 p -120.04 166.4 13.43 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.127 1.771 . . . . 0.0 112.193 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 125.954 1.701 . . . . 0.0 112.356 173.992 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 118.896 -0.573 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 pt -60.72 -33.35 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.356 0.98 . . . . 0.0 112.928 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -78.81 -23.55 45.08 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.907 1.683 . . . . 0.0 114.542 173.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.0 t -89.22 -32.82 17.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.361 1.865 . . . . 0.0 113.061 -174.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -88.86 143.18 27.06 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.767 1.227 . . . . 0.0 111.245 169.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.26 -33.13 61.25 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.38 -0.825 . . . . 0.0 111.105 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.3 t -142.82 131.46 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.65 1.18 . . . . 0.0 111.512 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -134.36 139.12 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.097 1.359 . . . . 0.0 111.773 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 t -134.24 156.54 48.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.086 1.355 . . . . 0.0 111.299 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 147' ' ' GLN . 1.1 p90 -132.0 135.33 46.46 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.764 0.825 . . . . 0.0 110.839 173.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.65 167.64 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.585 1.954 . . . . 0.0 110.391 -168.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.11 112.55 15.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 152.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.43 -153.66 46.49 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 123.142 0.401 . . . . 0.0 113.811 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.18 160.07 65.73 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.838 1.655 . . . . 0.0 111.066 -166.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.75 -24.94 20.93 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 N-CA-C 116.515 1.698 . . . . 0.0 116.515 -156.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -98.89 -3.87 34.25 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.805 1.242 . . . . 0.0 113.402 168.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -141.62 71.97 25.19 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.531 1.532 . . . . 0.0 110.787 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.18 155.7 25.74 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.621 2.881 . . . . 0.0 112.818 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.99 7.06 18.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.36 1.464 . . . . 0.0 113.552 175.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 16.6 t -148.47 147.43 29.12 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.685 -1.26 . . . . 0.0 111.788 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.78 -41.07 77.03 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.598 -0.689 . . . . 0.0 112.011 170.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -66.66 -27.34 67.59 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.597 -0.689 . . . . 0.0 112.331 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.4 m -64.85 -47.49 77.71 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.318 -0.864 . . . . 0.0 110.936 169.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.31 -41.28 88.66 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.955 0.798 . . . . 0.0 111.298 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -61.22 -35.98 78.69 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.633 1.173 . . . . 0.0 114.06 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.7 tpt -62.13 -41.9 98.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.876 0.762 . . . . 0.0 111.246 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.6 mm -72.06 -36.91 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.26 -0.9 . . . . 0.0 112.259 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -58.23 -30.96 66.92 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.646 1.178 . . . . 0.0 112.496 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.06 -47.14 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.744 1.618 . . . . 0.0 112.141 170.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 44.9 mt -66.2 -35.49 80.59 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.144 -0.973 . . . . 0.0 113.08 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -62.4 -39.55 93.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.448 1.099 . . . . 0.0 112.011 168.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.73 -26.17 66.01 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.166 -0.959 . . . . 0.0 113.285 176.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.6 tp -86.79 -15.48 39.16 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.09 2.14 16.76 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 124.821 1.201 . . . . 0.0 115.146 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.51 135.35 54.18 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.876 1.671 . . . . 0.0 111.402 172.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -109.96 151.8 26.66 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.431 1.11 . . . . 0.0 113.286 171.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -130.2 168.9 16.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.897 2.079 . . . . 0.0 110.448 -172.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.1 m -90.33 133.73 34.78 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.868 -1.145 . . . . 0.0 111.192 -159.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.5 p -129.39 147.8 51.25 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -164.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.2 153.78 47.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.203 1.801 . . . . 0.0 111.677 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -89.96 113.96 25.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.122 0.969 . . . . 0.0 112.085 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.9 -16.78 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 121.227 -0.921 . . . . 0.0 113.265 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -73.19 -29.5 62.87 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.327 -0.858 . . . . 0.0 111.236 169.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.84 -33.78 21.23 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -130.2 102.35 17.29 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 118.744 0.702 . . . . 0.0 112.776 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -60.23 -21.66 67.38 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.221 2.614 . . . . 0.0 115.494 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 p -52.51 -31.14 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 120.05 1.296 . . . . 0.0 113.347 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.7 -47.65 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.349 -0.844 . . . . 0.0 110.592 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -67.79 -30.49 69.94 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.472 1.033 . . . . 0.0 112.831 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.5 m -58.58 -49.08 78.77 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.834 0.853 . . . . 0.0 111.993 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -74.1 -49.37 24.2 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 168.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.6 t -60.45 -41.65 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 121.083 -1.011 . . . . 0.0 113.286 -165.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -63.48 -34.87 78.72 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.233 0.54 . . . . 0.0 111.474 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.14 -50.6 11.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.271 1.829 . . . . 0.0 112.84 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.67 -30.38 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.124 0.969 . . . . 0.0 112.806 -175.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 84.4 p -90.05 -3.94 57.67 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 59.61 -34.56 0.06 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 129.839 3.256 . . . . 0.0 116.239 -171.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -145.65 110.69 4.52 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.604 1.561 . . . . 0.0 109.789 173.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -89.11 130.65 2.09 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 121.905 1.736 . . . . 0.0 114.16 -165.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 p -129.33 133.53 47.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.683 1.593 . . . . 0.0 109.97 166.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.3 pt -128.5 156.53 77.0 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 124.926 1.29 . . . . 0.0 113.678 -167.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -61.73 162.98 42.96 Favored 'Cis proline' 0 C--N 1.356 0.944 0 CA-C-N 119.967 1.024 . . . . 0.0 113.88 -5.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.426 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 18.9 tt0 -151.08 158.32 43.9 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.347 0.659 . . . . 0.0 111.729 -164.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.22 139.08 53.18 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.856 1.313 . . . . 0.0 113.724 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -120.46 140.89 50.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.787 -2.006 . . . . 0.0 109.43 169.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 53.7 mt -125.75 121.92 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 173.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.2 tptt 45.46 52.88 8.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.516 1.926 . . . . 0.0 114.073 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.72 27.46 16.72 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -121.55 136.48 54.95 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.344 1.457 . . . . 0.0 110.553 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -74.38 123.71 25.15 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.564 0.697 . . . . 0.0 111.114 174.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.6 t -103.93 -54.38 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 126.272 1.829 . . . . 0.0 111.565 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.93 166.7 23.24 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 116.967 1.547 . . . . 0.0 116.967 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.89 172.11 55.17 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.37 1.938 . . . . 0.0 113.609 170.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.2 tp -56.53 -35.82 68.53 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.472 1.109 . . . . 0.0 113.476 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.36 -33.48 75.62 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.994 0.816 . . . . 0.0 112.541 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.5 mm -77.66 -46.76 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.247 1.419 . . . . 0.0 110.475 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.69 -36.31 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.701 1.2 . . . . 0.0 110.777 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 94.6 m -59.25 -40.41 85.89 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.898 0.879 . . . . 0.0 112.108 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -65.08 -50.27 66.8 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.966 0.803 . . . . 0.0 110.157 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 47.6 mtt -61.49 -37.34 83.3 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.245 1.018 . . . . 0.0 112.333 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.36 -39.01 81.98 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.357 1.863 . . . . 0.0 112.369 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -76.95 -30.75 56.17 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 41.1 t -84.55 -26.45 28.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.024 1.33 . . . . 0.0 114.482 -172.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.31 -6.35 63.43 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-N 119.142 0.883 . . . . 0.0 114.554 -169.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.29 -32.49 72.67 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.77 1.785 . . . . 0.0 112.402 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.06 -46.15 88.83 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.203 -0.936 . . . . 0.0 110.147 174.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -62.02 -37.99 86.95 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.254 1.422 . . . . 0.0 113.199 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -67.41 -35.25 78.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.362 1.065 . . . . 0.0 112.596 175.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 60.5 mtm -70.07 -52.1 26.61 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.167 0.894 . . . . 0.0 113.143 169.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 pp -64.78 -35.88 82.51 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.251 -0.906 . . . . 0.0 112.368 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -71.8 -30.94 66.06 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.88 -36.8 82.33 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.58 0.627 . . . . 0.0 111.947 167.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.54 2.6 11.25 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.798 1.639 . . . . 0.0 113.964 175.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.54 12.57 81.61 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.121 1.343 . . . . 0.0 113.853 176.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.6 mt -93.91 149.63 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.027 1.331 . . . . 0.0 110.004 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.2 m -103.27 146.77 27.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.222 1.409 . . . . 0.0 110.947 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.7 p -141.75 167.67 21.6 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.81 1.644 . . . . 0.0 112.213 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 124.381 1.073 . . . . 0.0 112.372 168.532 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.6 pt -61.89 -35.55 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.17 0.588 . . . . 0.0 111.844 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -77.9 -32.96 52.1 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.505 1.922 . . . . 0.0 113.718 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.5 t -73.03 -15.99 61.51 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.845 1.258 . . . . 0.0 113.299 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -104.2 145.27 30.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.95 1.3 . . . . 0.0 113.969 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -83.46 -39.49 20.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.947 0.899 . . . . 0.0 111.366 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.57 137.87 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 126.731 2.012 . . . . 0.0 109.839 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.8 t -133.93 128.0 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.626 1.17 . . . . 0.0 110.566 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -136.66 156.95 47.86 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.943 1.297 . . . . 0.0 110.916 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.406 ' CE1' HG21 ' A' ' 136' ' ' VAL . 52.7 p90 -129.32 145.93 51.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.088 0.955 . . . . 0.0 111.282 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 mt -137.39 151.3 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.198 0.599 . . . . 0.0 111.406 -166.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.49 108.32 3.25 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 159.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.08 -136.36 15.59 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 118.582 0.628 . . . . 0.0 113.115 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.7 mt -123.16 158.4 58.07 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.728 2.011 . . . . 0.0 111.447 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.53 -23.47 37.12 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 121.976 1.784 . . . . 0.0 115.067 -173.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.7 -15.38 25.32 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.235 0.925 . . . . 0.0 113.221 169.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.95 68.68 70.93 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.213 1.405 . . . . 0.0 111.635 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.01 146.11 25.45 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.215 2.61 . . . . 0.0 111.414 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 96.4 mtp -97.69 4.79 49.93 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.488 1.515 . . . . 0.0 113.518 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.9 t -146.57 145.52 30.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.44 1.496 . . . . 0.0 111.078 -175.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.82 -44.12 97.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.215 0.606 . . . . 0.0 111.996 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -72.39 -24.7 61.29 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.935 -1.103 . . . . 0.0 112.567 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.0 m -68.42 -43.1 77.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.649 0.78 . . . . 0.0 111.6 167.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -61.4 -44.81 96.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.813 0.845 . . . . 0.0 111.861 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -57.8 -37.28 73.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.277 1.831 . . . . 0.0 113.036 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.9 ttp -63.58 -46.8 84.19 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.434 0.561 . . . . 0.0 111.624 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 mm -69.72 -33.01 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.346 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -57.98 -36.69 72.97 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.935 1.243 . . . . 0.0 113.026 170.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.13 -42.14 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.799 0.839 . . . . 0.0 111.1 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.35 -38.94 88.75 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.405 1.082 . . . . 0.0 112.678 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.05 -25.55 66.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.179 1.791 . . . . 0.0 112.723 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.27 73.45 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.06 -11.6 35.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.169 0.988 . . . . 0.0 113.327 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.73 20.3 70.13 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.477 1.037 . . . . 0.0 115.043 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.42 130.35 56.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.466 0.633 . . . . 0.0 109.462 156.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -115.78 131.31 56.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.472 0.709 . . . . 0.0 109.706 168.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -105.07 171.93 7.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.988 1.715 . . . . 0.0 113.021 -163.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.4 m -84.73 125.88 32.92 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.462 1.125 . . . . 0.0 108.861 -170.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.7 m -125.53 133.28 52.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.561 -154.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.04 141.98 46.24 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.097 0.951 . . . . 0.0 112.819 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -98.45 78.71 2.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.026 1.731 . . . . 0.0 112.164 -167.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.0 p -61.52 -28.3 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.263 1.425 . . . . 0.0 114.321 -172.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.0 tp -78.15 -22.69 48.39 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.664 -0.648 . . . . 0.0 111.533 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.87 -32.95 13.0 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 175.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -130.06 98.12 21.95 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.046 0.938 . . . . 0.0 112.055 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -62.19 -9.68 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.042 3.161 . . . . 0.0 116.247 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 p -48.78 -36.49 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.015 -1.053 . . . . 0.0 111.945 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.43 -47.9 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.232 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -67.57 -29.22 68.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.1 0.864 . . . . 0.0 112.243 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.2 m -70.5 -50.5 37.18 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -72.16 -39.43 68.74 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.956 0.798 . . . . 0.0 111.711 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.406 HG21 ' CE1' ' A' ' 94' ' ' PHE . 9.0 p -61.29 -35.36 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.109 0.868 . . . . 0.0 113.061 -175.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.84 -46.34 78.91 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.979 0.809 . . . . 0.0 111.568 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -64.79 -34.58 78.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.156 0.982 . . . . 0.0 113.067 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.3 t -80.3 -41.56 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.1 t -97.47 -14.27 21.25 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -168.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 67.34 -40.66 0.4 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.874 2.07 . . . . 0.0 115.079 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -130.0 104.85 16.73 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.118 1.767 . . . . 0.0 110.529 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -88.14 128.43 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.563 2.176 . . . . 0.0 112.464 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 75.1 p -131.53 146.97 52.48 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.144 2.178 . . . . 0.0 108.58 169.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.1 tt -108.46 134.93 20.07 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 119.241 0.928 . . . . 0.0 111.9 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -79.99 162.75 83.91 Favored 'Cis proline' 0 CA--C 1.551 1.35 0 CA-C-N 119.835 0.977 . . . . 0.0 111.799 -16.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -134.18 161.58 34.51 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.893 1.677 . . . . 0.0 111.288 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.59 141.82 50.87 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -130.92 141.05 50.26 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.532 1.933 . . . . 0.0 110.073 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 60.3 mt -140.54 134.05 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.731 1.213 . . . . 0.0 109.556 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt 52.96 41.75 32.11 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.687 1.595 . . . . 0.0 114.162 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.04 14.2 5.19 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.95 2.1 . . . . 0.0 115.568 -172.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -111.42 140.89 45.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.625 1.57 . . . . 0.0 110.618 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -77.84 126.25 30.57 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.257 -0.902 . . . . 0.0 112.898 175.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.3 t -101.03 -48.05 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.555 1.542 . . . . 0.0 111.835 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 162.91 170.55 27.94 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.7 169.14 54.62 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.268 1.413 . . . . 0.0 113.685 166.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -46.69 -46.89 20.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.861 1.665 . . . . 0.0 114.746 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.56 -39.06 75.84 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.543 -0.723 . . . . 0.0 111.531 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.9 mm -72.62 -47.45 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.57 1.948 . . . . 0.0 111.56 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.35 -35.76 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.903 0.881 . . . . 0.0 110.503 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.1 m -62.06 -39.31 91.96 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.744 0.818 . . . . 0.0 112.153 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -64.29 -46.69 82.53 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.184 0.902 . . . . 0.0 110.633 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 47.5 mtt -61.65 -38.76 88.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.137 0.975 . . . . 0.0 111.812 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.61 -44.16 87.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.565 1.146 . . . . 0.0 111.781 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.25 -34.38 65.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 t -105.54 3.23 29.13 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -171.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.26 -0.41 75.12 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 116.259 1.263 . . . . 0.0 116.259 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -71.65 -31.85 67.28 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.561 1.181 . . . . 0.0 113.245 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.75 -43.77 83.24 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.483 -1.385 . . . . 0.0 109.951 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -58.22 -44.59 88.24 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.128 1.771 . . . . 0.0 112.307 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -57.28 -46.16 83.37 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.248 1.019 . . . . 0.0 110.932 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 65.1 mtm -69.59 -49.87 49.93 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.9 -37.73 86.87 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.613 -0.679 . . . . 0.0 112.638 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -71.66 -30.8 66.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.188 0.995 . . . . 0.0 111.99 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.77 -31.05 72.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.432 0.693 . . . . 0.0 112.199 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -76.05 -0.18 20.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.96 1.304 . . . . 0.0 113.51 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.4 24.87 60.12 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 124.153 0.882 . . . . 0.0 113.435 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 46.2 mt -105.42 140.4 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.012 0.906 . . . . 0.0 110.893 -174.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.0 m -94.2 125.33 38.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.859 1.264 . . . . 0.0 112.037 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.1 p -118.35 173.26 6.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.096 2.559 . . . . 0.0 111.691 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 . . . . . 0 N--CA 1.472 0.672 0 C-N-CA 123.359 0.664 . . . . 0.0 111.691 164.59 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.6 pt -62.04 -34.31 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.78 0.832 . . . . 0.0 112.054 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -78.5 -35.17 46.8 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.468 1.507 . . . . 0.0 113.534 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.5 t -72.63 -37.85 67.91 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.339 1.056 . . . . 0.0 113.015 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -87.13 133.51 33.62 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.157 0.889 . . . . 0.0 111.956 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.38 -38.31 77.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.731 -0.606 . . . . 0.0 111.717 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.5 t -143.92 131.66 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.216 1.806 . . . . 0.0 110.296 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -135.02 133.19 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.507 1.123 . . . . 0.0 112.118 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.0 t -131.41 155.13 47.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.954 1.302 . . . . 0.0 110.97 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -131.2 140.48 49.9 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.168 0.987 . . . . 0.0 111.79 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mt -140.54 155.65 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.031 1.332 . . . . 0.0 110.901 -158.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.1 102.22 1.6 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.124 0.569 . . . . 0.0 109.467 155.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.97 -143.97 23.55 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.302 -0.874 . . . . 0.0 114.7 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.1 mt -107.3 155.69 38.99 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 125.438 1.495 . . . . 0.0 111.929 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -63.9 -32.2 66.37 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.413 1.408 . . . . 0.0 112.356 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -75.2 -26.78 59.26 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.242 1.017 . . . . 0.0 113.124 172.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.81 76.51 15.48 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.31 1.444 . . . . 0.0 112.354 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.84 144.85 24.82 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.124 2.549 . . . . 0.0 111.772 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.84 10.87 28.54 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.134 1.773 . . . . 0.0 113.815 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.4 t -147.5 146.09 29.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.222 1.409 . . . . 0.0 110.233 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.52 -45.89 87.89 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.482 0.658 . . . . 0.0 111.846 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -70.73 -26.45 63.39 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.103 -0.998 . . . . 0.0 112.138 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -68.49 -38.3 80.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.255 -0.903 . . . . 0.0 112.681 166.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -65.49 -39.28 91.71 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.339 0.972 . . . . 0.0 112.285 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -59.58 -33.1 71.02 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.965 1.306 . . . . 0.0 112.873 174.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.7 tpt -61.51 -42.94 99.56 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.505 0.722 . . . . 0.0 111.74 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.12 -33.91 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.555 0.742 . . . . 0.0 111.654 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -39.79 74.58 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.741 1.216 . . . . 0.0 111.713 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.93 -43.41 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.475 1.51 . . . . 0.0 111.868 172.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.96 -37.96 89.33 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.696 -0.628 . . . . 0.0 112.102 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -69.36 -31.93 70.67 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.407 -0.808 . . . . 0.0 112.762 173.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.88 76.65 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.457 -0.777 . . . . 0.0 112.334 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.6 mt -87.01 -12.61 46.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.199 1.0 . . . . 0.0 113.298 171.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.5 15.01 63.24 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.884 1.707 . . . . 0.0 114.309 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.38 132.45 55.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.405 1.103 . . . . 0.0 113.449 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -110.82 157.36 19.9 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.249 1.02 . . . . 0.0 113.04 169.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -145.65 170.76 15.83 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.667 2.787 . . . . 0.0 110.531 -163.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.6 m -85.28 124.22 31.65 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.623 -1.298 . . . . 0.0 109.787 -168.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.9 m -130.43 132.09 45.55 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.041 1.336 . . . . 0.0 111.393 -156.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.5 143.18 48.69 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -87.65 121.1 29.66 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.693 1.197 . . . . 0.0 109.965 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.0 m -67.22 -21.2 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.049 0.94 . . . . 0.0 113.137 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.9 mt -88.34 -25.08 22.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.095 1.358 . . . . 0.0 114.446 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.11 -33.3 22.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -164.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -148.21 149.78 33.1 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.881 1.272 . . . . 0.0 110.087 -172.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.86 -6.9 19.85 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.862 2.375 . . . . 0.0 114.543 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.68 -40.37 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.704 -1.248 . . . . 0.0 113.318 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.35 -47.2 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.275 -0.891 . . . . 0.0 110.939 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -59.31 -30.19 68.16 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.27 0.941 . . . . 0.0 113.354 171.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.0 m -69.98 -44.75 68.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -77.66 -40.36 41.91 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.22 -43.87 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -159.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -69.46 -35.49 75.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.733 0.778 . . . . 0.0 110.32 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -67.39 -43.92 80.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.242 1.817 . . . . 0.0 113.343 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.54 -36.23 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.991 0.917 . . . . 0.0 113.297 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.6 p -102.37 1.13 35.09 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 -173.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 62.45 -30.84 0.08 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.589 2.355 . . . . 0.0 115.965 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -151.93 138.29 11.75 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.183 1.393 . . . . 0.0 111.349 167.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.75 128.38 19.83 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.206 1.937 . . . . 0.0 112.759 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.6 m -139.94 140.87 36.46 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.322 -1.486 . . . . 0.0 110.419 157.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.8 mt -122.83 135.62 25.96 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.443 1.097 . . . . 0.0 110.929 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -82.33 165.61 71.76 Favored 'Cis proline' 0 CA--C 1.543 0.973 0 CA-C-N 119.934 1.012 . . . . 0.0 111.837 -10.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -143.19 159.73 41.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.028 1.331 . . . . 0.0 111.96 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.1 140.15 51.69 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.515 1.126 . . . . 0.0 113.881 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -129.76 143.93 51.05 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.18 1.792 . . . . 0.0 110.514 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 55.2 mt -132.95 128.14 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.544 1.137 . . . . 0.0 108.341 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt 47.32 49.59 15.39 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.023 1.729 . . . . 0.0 115.544 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.87 19.11 9.39 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -122.59 147.1 46.81 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.502 1.921 . . . . 0.0 110.564 176.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -85.44 126.25 33.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.145 0.974 . . . . 0.0 112.88 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.1 t -100.26 -46.02 11.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 125.1 1.36 . . . . 0.0 110.602 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 158.73 179.0 33.26 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 117.261 1.665 . . . . 0.0 117.261 165.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.35 171.31 55.17 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.054 1.312 . . . . 0.0 113.751 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.6 tp -46.74 -46.31 20.27 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.793 1.237 . . . . 0.0 114.04 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -69.9 -17.87 63.36 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.8 mm -84.06 -45.64 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.967 1.307 . . . . 0.0 109.882 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.3 t -60.47 -44.19 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.752 1.621 . . . . 0.0 111.778 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.7 p -64.82 -37.96 89.37 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.679 0.672 . . . . 0.0 111.97 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -63.13 -44.1 96.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.319 1.048 . . . . 0.0 111.549 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.7 mtt -66.89 -35.97 81.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.6 1.16 . . . . 0.0 112.356 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.89 -45.96 66.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.9 1.28 . . . . 0.0 112.029 176.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -68.54 -19.94 64.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.983 1.313 . . . . 0.0 113.151 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.6 m -105.16 -8.07 18.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.511 1.524 . . . . 0.0 114.721 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.03 -1.11 76.29 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 119.587 1.085 . . . . 0.0 115.08 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -67.21 -34.07 76.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.597 1.198 . . . . 0.0 112.069 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.06 -39.49 86.19 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.798 1.285 . . . . 0.0 110.913 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -66.04 -31.33 72.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.81 2.044 . . . . 0.0 113.493 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.61 -48.82 80.18 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.63 1.104 . . . . 0.0 111.134 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -70.6 -41.21 72.62 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 pp -65.18 -37.34 87.05 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.649 0.659 . . . . 0.0 111.351 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -71.91 -34.76 69.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.52 -30.02 70.99 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 167.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -77.13 -2.68 35.56 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.44 6.82 64.01 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.751 1.643 . . . . 0.0 114.85 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.05 147.05 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.183 1.393 . . . . 0.0 111.327 -170.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 36.4 m -105.24 126.1 51.72 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.118 0.967 . . . . 0.0 110.627 170.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 17.0 p -112.08 167.97 9.97 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.8 1.64 . . . . 0.0 111.822 172.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.767 0 C-N-CA 123.99 0.916 . . . . 0.0 111.238 171.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.0 m . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 119.526 -0.273 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.5 pt -59.98 -33.47 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 122.973 0.509 . . . . 0.0 111.826 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -78.2 -34.8 49.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.3 1.84 . . . . 0.0 113.542 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -68.78 -38.24 79.87 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.596 1.158 . . . . 0.0 111.719 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -86.03 133.27 33.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.494 0.718 . . . . 0.0 111.323 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.52 -26.3 45.78 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.987 -1.07 . . . . 0.0 112.507 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.5 t -142.37 131.24 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.482 1.113 . . . . 0.0 110.974 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.6 t -133.13 135.59 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.277 1.431 . . . . 0.0 111.468 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.0 t -135.45 155.2 50.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.978 1.311 . . . . 0.0 111.496 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -127.53 140.41 52.15 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.962 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.41 159.7 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.872 1.669 . . . . 0.0 110.273 -163.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -75.28 105.17 6.16 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.466 0.706 . . . . 0.0 109.299 157.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.27 -158.61 32.96 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 119.056 0.844 . . . . 0.0 113.949 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -94.35 158.73 35.29 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.428 1.491 . . . . 0.0 111.205 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.0 -31.86 76.47 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 121.897 1.731 . . . . 0.0 112.663 168.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.0 -14.53 53.84 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.027 1.331 . . . . 0.0 113.925 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.42 72.45 11.84 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.23 1.412 . . . . 0.0 112.5 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.27 141.97 18.67 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.243 1.962 . . . . 0.0 112.064 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.1 mmt -90.53 1.68 56.48 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.127 2.171 . . . . 0.0 113.645 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.4 t -152.06 146.22 25.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.096 1.358 . . . . 0.0 111.777 -171.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.4 -39.76 81.56 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.24 -0.912 . . . . 0.0 112.553 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -64.08 -29.91 71.02 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.969 -1.082 . . . . 0.0 111.746 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 m -68.27 -46.35 70.65 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.348 0.659 . . . . 0.0 112.268 169.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -58.53 -42.35 87.6 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 118.926 0.784 . . . . 0.0 112.512 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -57.35 -31.09 65.39 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.034 0.934 . . . . 0.0 113.278 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 49.9 ttm -70.38 -42.93 71.1 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.996 0.816 . . . . 0.0 112.34 171.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 mm -69.17 -30.91 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.92 -1.112 . . . . 0.0 111.359 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.43 -33.63 75.18 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.6 1.16 . . . . 0.0 112.649 167.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.415 HG13 ' HG ' ' A' ' 165' ' ' LEU . 1.4 t -73.36 -40.7 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.734 0.814 . . . . 0.0 111.468 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.8 mt -63.36 -34.86 78.63 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.897 0.879 . . . . 0.0 111.915 170.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -67.83 -34.84 77.51 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.723 -1.236 . . . . 0.0 113.014 170.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.79 79.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.991 0.814 . . . . 0.0 111.835 176.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -82.76 -14.49 54.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.01 7.68 44.95 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.463 1.03 . . . . 0.0 114.698 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.18 132.4 54.92 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.574 1.55 . . . . 0.0 111.02 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -115.91 149.85 38.05 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.292 0.951 . . . . 0.0 112.511 168.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -123.7 172.66 8.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.067 1.747 . . . . 0.0 112.676 -167.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.2 m -85.38 121.64 28.38 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.314 -0.866 . . . . 0.0 110.043 -161.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.2 m -124.76 132.14 53.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.996 -153.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -125.67 142.79 51.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.28 1.032 . . . . 0.0 112.674 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -96.04 118.54 32.84 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.788 1.235 . . . . 0.0 111.973 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.31 -22.73 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.323 1.049 . . . . 0.0 113.485 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.3 mt -87.93 -22.25 24.45 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.27 -35.09 11.37 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -124.25 108.71 29.51 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.077 0.853 . . . . 0.0 111.434 -174.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -54.19 -20.15 18.51 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.427 3.418 . . . . 0.0 116.46 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.4 p -54.32 -32.57 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.909 -1.119 . . . . 0.0 113.233 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.4 t -70.09 -53.79 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.515 -0.741 . . . . 0.0 111.7 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HA ' HG12 ' A' ' 136' ' ' VAL . 6.9 ptm180 -64.59 -25.73 68.1 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.743 0.817 . . . . 0.0 112.21 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.4 m -70.37 -50.76 35.54 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.02 0.928 . . . . 0.0 113.103 169.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -70.38 -37.44 74.53 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.74 1.154 . . . . 0.0 112.003 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 133' ' ' ARG . 7.4 p -65.89 -35.2 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 120.761 -1.212 . . . . 0.0 112.563 175.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -62.32 -38.38 89.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.241 1.016 . . . . 0.0 111.285 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -49.08 26.36 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 175.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 56.5 t -83.95 -42.93 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -169.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.8 m -100.27 -2.41 33.82 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 63.26 -32.52 0.11 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 128.765 2.826 . . . . 0.0 115.495 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -144.89 136.0 12.46 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.058 2.143 . . . . 0.0 109.961 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.3 126.78 3.76 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.852 1.701 . . . . 0.0 112.478 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.3 m -130.21 121.05 25.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.969 1.708 . . . . 0.0 107.249 166.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.4 140.4 25.8 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.849 0.86 . . . . 0.0 109.361 -172.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.53 158.21 97.35 Favored 'Cis proline' 0 CA--C 1.541 0.856 0 CA-C-N 119.383 0.815 . . . . 0.0 113.496 -10.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -128.82 152.94 47.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.774 1.63 . . . . 0.0 110.616 173.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.61 139.99 51.99 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.367 1.467 . . . . 0.0 113.108 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -131.85 142.89 49.83 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.711 2.005 . . . . 0.0 109.826 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 53.2 mt -123.91 122.57 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.3 tptt 44.09 54.36 6.0 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.852 2.061 . . . . 0.0 113.783 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.93 24.39 13.49 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -126.62 143.71 51.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.678 1.191 . . . . 0.0 110.151 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -82.81 125.62 31.51 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.586 1.184 . . . . 0.0 113.26 -169.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.17 -47.36 11.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 125.105 1.362 . . . . 0.0 110.962 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.14 176.92 28.82 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 116.62 1.408 . . . . 0.0 116.62 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.45 172.59 55.13 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.472 1.034 . . . . 0.0 113.97 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -44.85 -47.02 11.07 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.107 1.763 . . . . 0.0 113.695 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.83 -29.76 70.97 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 119.053 -0.498 . . . . 0.0 112.328 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.9 mm -82.32 -47.73 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.31 1.444 . . . . 0.0 111.177 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.6 t -62.1 -36.12 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.093 1.357 . . . . 0.0 111.089 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.1 m -59.79 -42.12 92.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.497 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -66.49 -43.91 84.07 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.801 1.182 . . . . 0.0 111.132 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 50.5 mtt -61.09 -36.73 80.44 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.142 0.577 . . . . 0.0 111.923 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.415 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.2 tm? -71.48 -47.0 58.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.159 0.984 . . . . 0.0 112.714 170.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.52 -21.49 64.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.001 0.921 . . . . 0.0 113.434 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 64.4 m -105.27 -21.5 13.23 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.975 1.71 . . . . 0.0 114.02 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.15 9.2 62.33 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.664 -1.273 . . . . 0.0 115.668 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.33 -32.14 73.63 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.627 1.713 . . . . 0.0 111.694 173.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.31 -45.18 95.51 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.83 173.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.54 -41.86 98.44 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.189 0.995 . . . . 0.0 111.815 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -56.02 -45.02 79.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.824 0.85 . . . . 0.0 110.504 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.54 -51.44 28.66 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.35 -36.62 84.72 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.316 0.507 . . . . 0.0 111.717 -175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -68.34 -38.02 81.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.898 1.279 . . . . 0.0 111.878 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.47 -29.23 69.31 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.986 0.812 . . . . 0.0 111.749 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -79.7 6.27 11.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.067 1.747 . . . . 0.0 114.306 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.8 10.91 75.01 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.194 1.378 . . . . 0.0 114.421 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.1 mt -99.13 147.42 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.887 1.275 . . . . 0.0 109.572 -171.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 5.7 m -112.93 120.22 40.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.255 1.022 . . . . 0.0 111.305 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.2 p -112.41 167.37 10.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.852 1.261 . . . . 0.0 111.779 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 124.102 0.961 . . . . 0.0 110.035 166.09 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.1 pt -62.97 -36.85 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.768 0.827 . . . . 0.0 112.174 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -76.54 -32.46 58.24 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.226 1.41 . . . . 0.0 111.592 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.6 t -92.39 -28.34 16.95 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -170.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -86.25 147.68 25.98 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.256 -0.903 . . . . 0.0 111.427 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -72.4 -47.62 47.8 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.007 -1.058 . . . . 0.0 113.531 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.5 t -144.1 130.08 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.625 1.57 . . . . 0.0 110.196 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.76 134.89 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.588 1.155 . . . . 0.0 112.075 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -130.75 155.11 47.21 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.525 1.53 . . . . 0.0 111.29 172.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.46 143.06 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.708 0.803 . . . . 0.0 111.243 170.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mt -130.9 157.36 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.392 1.477 . . . . 0.0 109.655 -165.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -72.12 97.93 2.02 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 152.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.12 -148.38 19.15 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.518 -0.739 . . . . 0.0 114.906 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.98 157.38 63.74 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 125.999 1.72 . . . . 0.0 110.812 -174.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.1 -33.28 50.86 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 121.434 1.422 . . . . 0.0 114.637 -169.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -94.37 -0.38 54.93 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.25 68.1 15.3 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 126.258 1.823 . . . . 0.0 112.018 174.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.05 143.76 11.62 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.274 2.65 . . . . 0.0 112.261 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.3 mmt -91.15 1.42 57.1 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.977 1.311 . . . . 0.0 113.674 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.21 146.15 28.56 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.163 -0.96 . . . . 0.0 111.709 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.85 96.28 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.112 0.965 . . . . 0.0 113.154 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -63.47 -36.86 85.16 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.505 -1.372 . . . . 0.0 112.019 171.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.7 m -64.87 -36.32 83.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.564 -0.732 . . . . 0.0 112.488 173.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -62.83 -46.2 89.02 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 120.153 1.342 . . . . 0.0 111.784 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -64.72 -29.81 70.81 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.677 1.191 . . . . 0.0 113.831 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.3 tpt -57.49 -46.69 83.44 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.345 1.058 . . . . 0.0 112.356 167.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 mm -70.84 -34.42 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.396 -0.815 . . . . 0.0 111.309 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.17 -34.95 68.97 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.571 -0.705 . . . . 0.0 111.835 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.9 -41.89 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.618 1.167 . . . . 0.0 111.684 174.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 69.2 mt -65.28 -36.59 84.56 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.697 0.799 . . . . 0.0 112.882 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.94 -29.64 65.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.989 -1.069 . . . . 0.0 112.739 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.22 77.38 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.254 -0.904 . . . . 0.0 112.042 175.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.76 -11.58 33.47 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.41 1.084 . . . . 0.0 113.474 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.76 9.28 82.86 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.356 1.931 . . . . 0.0 115.989 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.18 136.8 52.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.602 1.201 . . . . 0.0 113.045 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -114.27 159.21 20.44 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 171.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -142.18 174.01 11.0 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.294 2.238 . . . . 0.0 110.943 -162.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.0 m -86.11 130.57 34.49 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.906 -1.121 . . . . 0.0 110.157 -165.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.8 p -120.6 147.47 45.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.855 1.262 . . . . 0.0 113.881 -164.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -133.42 143.51 48.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.806 1.242 . . . . 0.0 112.27 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -94.25 119.93 33.76 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.87 1.268 . . . . 0.0 110.429 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.74 -22.51 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.607 1.163 . . . . 0.0 113.434 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -81.39 -23.36 37.68 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.461 -0.775 . . . . 0.0 112.774 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.04 -33.21 19.62 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -144.29 126.91 8.48 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.428 1.091 . . . . 0.0 111.179 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.05 -18.23 45.93 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.93 2.42 . . . . 0.0 114.483 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -46.77 -35.61 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.415 1.086 . . . . 0.0 113.298 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.31 -45.86 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.201 -0.937 . . . . 0.0 111.603 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.402 ' HA ' HG12 ' A' ' 136' ' ' VAL . 23.2 ptt180 -75.25 -23.34 57.48 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.841 0.746 . . . . 0.0 112.995 177.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.2 m -70.54 -53.83 14.54 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.396 0.544 . . . . 0.0 111.844 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -72.78 -35.42 67.41 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.24 -0.913 . . . . 0.0 112.427 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 133' ' ' ARG . 11.6 p -59.15 -44.96 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.772 1.169 . . . . 0.0 112.043 174.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -71.81 -43.74 65.1 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.085 0.857 . . . . 0.0 112.396 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.25 -33.96 77.02 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.292 -0.88 . . . . 0.0 112.882 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.9 t -82.1 -46.95 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.371 0.987 . . . . 0.0 113.363 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -106.56 7.96 31.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -171.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 63.61 -26.31 0.07 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.88 2.472 . . . . 0.0 116.184 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -148.83 148.51 27.82 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.811 2.044 . . . . 0.0 112.779 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.02 150.83 16.06 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.646 2.897 . . . . 0.0 113.466 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.9 p -134.3 132.81 40.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.338 1.855 . . . . 0.0 108.706 156.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.7 mm -127.83 117.89 20.95 Favored Pre-proline 0 N--CA 1.478 0.96 0 CA-C-N 119.717 1.144 . . . . 0.0 111.754 -171.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -81.99 172.7 50.85 Favored 'Cis proline' 0 CA--C 1.543 0.943 0 CA-C-N 120.06 1.057 . . . . 0.0 112.842 -5.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -153.24 174.38 14.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.5 1.52 . . . . 0.0 112.605 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.0 140.93 47.03 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -174.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -120.48 144.17 48.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.682 1.993 . . . . 0.0 110.412 168.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.1 mt -131.53 121.49 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.522 1.129 . . . . 0.0 109.103 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 45.98 52.03 10.31 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.698 1.599 . . . . 0.0 114.211 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.258 . . 56.25 26.99 11.09 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -115.69 137.99 51.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.426 1.09 . . . . 0.0 110.111 165.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -75.91 125.53 29.27 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.218 1.009 . . . . 0.0 111.774 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -101.16 -46.42 11.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.195 1.398 . . . . 0.0 111.011 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.55 171.32 25.24 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 116.4 1.32 . . . . 0.0 116.4 169.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.02 170.29 54.74 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.014 0.816 . . . . 0.0 112.904 167.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -47.22 -37.92 11.25 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.658 1.183 . . . . 0.0 113.854 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -57.19 -43.78 82.99 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.76 0.709 . . . . 0.0 111.911 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.3 mm -76.42 -46.79 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.426 1.49 . . . . 0.0 109.931 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.18 -38.23 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.366 1.066 . . . . 0.0 110.829 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 60.7 m -64.01 -43.09 96.7 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.595 0.758 . . . . 0.0 111.655 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -67.16 -38.7 85.92 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.107 0.867 . . . . 0.0 112.125 176.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 34.7 mtt -65.65 -40.35 92.38 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.208 1.403 . . . . 0.0 112.153 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.22 -41.69 76.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.119 0.968 . . . . 0.0 111.605 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.94 -29.55 66.71 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 m -105.58 -0.8 25.42 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.09 -2.93 84.29 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.741 1.162 . . . . 0.0 115.721 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -67.38 -32.8 73.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.717 1.258 . . . . 0.0 112.07 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.81 -46.39 88.17 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.485 -0.759 . . . . 0.0 110.948 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -59.47 -42.12 91.31 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.588 1.155 . . . . 0.0 112.665 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -62.44 -39.07 92.16 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.137 0.575 . . . . 0.0 112.012 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 49.0 mtm -69.93 -53.43 17.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.609 0.763 . . . . 0.0 112.823 174.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 pp -65.64 -37.79 87.55 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.288 0.494 . . . . 0.0 111.932 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -66.8 -39.45 87.75 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.692 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -65.25 -30.54 71.43 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.744 0.702 . . . . 0.0 112.319 174.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -2.83 28.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.723 2.009 . . . . 0.0 114.183 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.23 57.4 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.418 1.009 . . . . 0.0 114.311 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.2 mt -104.17 145.57 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 118.369 1.084 . . . . 0.0 110.895 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 38.3 m -89.91 148.53 23.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.196 1.398 . . . . 0.0 111.612 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.4 p -145.86 169.27 18.9 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 120.653 -1.279 . . . . 0.0 112.903 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 124.151 0.981 . . . . 0.0 111.438 166.368 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.188 0.042 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.0 p -69.31 -39.26 78.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.5 m 54.52 27.15 8.0 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.179 1.791 . . . . 0.0 115.126 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.92 10.77 65.36 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.696 1.141 . . . . 0.0 114.969 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.6 pt -136.18 172.72 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.485 1.914 . . . . 0.0 111.642 -170.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.94 -177.91 39.02 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 122.466 1.037 . . . . 0.0 114.613 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.49 -112.78 1.24 Allowed Glycine 0 N--CA 1.464 0.504 0 C-N-CA 125.772 1.653 . . . . 0.0 109.723 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.02 106.93 0.56 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 153.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.8 t -81.65 130.45 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.641 0.776 . . . . 0.0 108.92 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -56.14 99.52 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.11 1.364 . . . . 0.0 111.483 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -77.91 118.54 20.32 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.869 0.867 . . . . 0.0 110.969 -165.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 pt -111.97 155.76 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.33 1.052 . . . . 0.0 110.998 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -142.08 139.18 32.18 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.065 0.946 . . . . 0.0 110.298 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -83.33 116.64 22.54 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.7 m -143.87 144.27 31.67 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.039 1.736 . . . . 0.0 108.579 167.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -68.79 142.66 93.95 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-O 119.044 -0.503 . . . . 0.0 112.221 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.72 145.28 50.11 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.523 2.815 . . . . 0.0 115.319 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -107.33 -7.59 16.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.654 1.582 . . . . 0.0 112.701 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -146.21 159.49 43.25 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.954 1.702 . . . . 0.0 112.205 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -67.5 151.76 96.86 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.685 1.594 . . . . 0.0 113.257 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -75.99 150.19 33.72 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.379 2.719 . . . . 0.0 110.253 158.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -95.66 126.72 41.13 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.766 1.226 . . . . 0.0 111.763 -167.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 tp 53.31 -3.94 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 128.433 2.693 . . . . 0.0 117.412 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.6 t -141.17 116.6 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.825 2.05 . . . . 0.0 108.321 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.0 p -80.75 156.36 26.26 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.393 0.677 . . . . 0.0 112.755 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.0 149.31 46.18 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.607 1.163 . . . . 0.0 110.992 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.85 -27.56 13.56 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.659 1.184 . . . . 0.0 112.698 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.84 140.91 38.13 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.161 1.784 . . . . 0.0 110.059 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -116.07 152.11 34.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 111.788 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.96 -37.66 85.59 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -169.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.77 -38.24 64.76 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.879 0.871 . . . . 0.0 110.983 172.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -70.47 -38.14 74.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.521 1.528 . . . . 0.0 112.811 -172.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.5 tp -82.66 2.44 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.244 1.018 . . . . 0.0 112.977 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.35 -29.01 7.37 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.623 1.169 . . . . 0.0 113.653 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 53.1 ttp -136.93 124.23 21.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.303 2.241 . . . . 0.0 110.585 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 p -69.88 150.57 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 118.357 0.526 . . . . 0.0 111.371 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -59.31 134.76 57.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.16 1.384 . . . . 0.0 110.128 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -63.23 -29.87 71.12 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -169.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.29 -39.08 91.79 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.61 1.164 . . . . 0.0 112.594 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 50.5 mm -75.6 -36.44 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.909 0.884 . . . . 0.0 110.847 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.33 -39.86 92.1 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.452 1.101 . . . . 0.0 111.397 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.89 -33.3 65.95 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.505 -0.747 . . . . 0.0 111.841 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.9 m -65.89 -47.31 75.26 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.17 0.988 . . . . 0.0 111.553 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.1 pt -61.07 -33.25 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 120.976 -1.077 . . . . 0.0 112.515 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -77.75 -22.65 49.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.587 1.555 . . . . 0.0 114.648 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 t -85.66 -28.71 24.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.049 2.14 . . . . 0.0 112.78 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -87.35 145.5 26.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.377 1.071 . . . . 0.0 111.004 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -84.12 -28.9 27.16 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.32 -0.863 . . . . 0.0 111.39 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.9 t -143.83 134.85 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.087 0.955 . . . . 0.0 112.255 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.3 t -133.01 138.32 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.893 1.277 . . . . 0.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 t -134.14 154.1 51.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.651 0.78 . . . . 0.0 111.473 170.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.57 147.58 50.28 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.487 0.661 . . . . 0.0 111.969 172.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.3 mt -137.01 159.8 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.331 -157.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -68.17 96.46 0.64 Allowed 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.345 -0.847 . . . . 0.0 108.971 156.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.49 -150.51 22.62 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 121.942 0.745 . . . . 0.0 114.383 -172.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.03 154.05 55.47 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.588 1.955 . . . . 0.0 110.029 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.63 -13.95 38.35 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.955 2.437 . . . . 0.0 114.59 -170.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -88.89 -19.92 25.23 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.716 1.206 . . . . 0.0 112.778 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.94 69.35 13.18 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.204 1.801 . . . . 0.0 111.021 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.39 148.97 74.72 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.66 2.24 . . . . 0.0 111.449 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.7 mmt -106.61 0.29 24.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.806 1.243 . . . . 0.0 113.781 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.7 t -141.84 147.0 36.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.499 1.52 . . . . 0.0 110.435 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.87 -47.01 86.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.831 0.852 . . . . 0.0 111.246 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -66.3 -33.35 75.53 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.998 -1.064 . . . . 0.0 111.548 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 m -62.26 -41.5 98.51 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.742 0.817 . . . . 0.0 113.111 170.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -62.82 -46.93 85.64 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.191 0.905 . . . . 0.0 111.466 171.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -56.97 -37.27 71.35 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.43 1.092 . . . . 0.0 111.993 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.5 tpp -59.34 -46.01 89.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.775 0.83 . . . . 0.0 112.923 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 mm -67.72 -33.13 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.981 1.264 . . . . 0.0 111.326 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.29 -32.83 73.26 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.911 0.884 . . . . 0.0 112.586 170.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.7 -37.25 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 125.628 1.571 . . . . 0.0 111.573 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.6 mt -63.77 -35.44 80.59 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.725 -1.234 . . . . 0.0 111.831 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -71.9 -31.23 66.2 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.816 -1.177 . . . . 0.0 111.998 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.26 -32.2 73.74 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.587 -1.321 . . . . 0.0 111.901 173.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.6 tp -86.07 -12.5 49.99 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.606 1.963 . . . . 0.0 112.716 171.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.82 4.23 13.49 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.854 1.693 . . . . 0.0 114.887 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.83 129.92 55.98 Favored 'General case' 0 C--N 1.335 -0.037 0 C-N-CA 124.599 1.16 . . . . 0.0 109.732 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -110.93 148.35 32.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.113 0.958 . . . . 0.0 110.645 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -120.65 172.64 7.72 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.236 1.815 . . . . 0.0 110.507 -169.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 93.0 m -86.71 122.52 30.72 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -163.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.5 p -113.27 144.63 42.4 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -159.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -137.09 147.87 46.36 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.505 1.122 . . . . 0.0 112.318 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.02 123.45 34.49 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.24 1.416 . . . . 0.0 110.464 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.6 m -67.78 -20.98 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -88.09 -24.19 23.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.938 1.295 . . . . 0.0 113.371 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.47 -35.34 17.08 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -139.11 120.07 9.78 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.357 0.663 . . . . 0.0 110.987 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.85 -13.15 36.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.853 2.369 . . . . 0.0 115.005 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.29 -36.0 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.603 0.761 . . . . 0.0 112.338 169.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.23 -51.45 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.887 0.875 . . . . 0.0 111.171 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.0 ptt-85 -69.32 -26.04 64.52 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.1 m -70.84 -49.31 47.54 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.069 0.948 . . . . 0.0 113.018 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.489 ' CE1' HG21 ' A' ' 139' ' ' VAL . 83.8 t80 -62.47 -48.55 79.12 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.736 -0.603 . . . . 0.0 111.377 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.1 p -61.0 -39.27 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 121.97 -0.456 . . . . 0.0 112.147 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -63.66 -44.77 92.82 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.226 1.41 . . . . 0.0 111.923 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -72.38 -36.51 68.74 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.489 HG21 ' CE1' ' A' ' 135' ' ' TYR 0.276 3.0 t -87.27 -31.95 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.1 p -99.02 -5.66 29.99 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 64.48 -59.27 0.22 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.825 2.45 . . . . 0.0 114.635 -167.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -121.44 106.38 37.92 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.193 1.397 . . . . 0.0 109.908 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.32 136.1 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.305 2.67 . . . . 0.0 113.693 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.5 m -134.21 112.91 11.47 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.168 1.787 . . . . 0.0 109.235 171.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.6 pt -100.59 149.27 35.99 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.68 152.49 96.46 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 119.696 0.927 . . . . 0.0 112.785 2.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -141.41 146.57 36.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.335 0.654 . . . . 0.0 111.156 -166.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.11 140.52 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.876 1.27 . . . . 0.0 113.188 -164.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -133.24 140.68 47.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.987 2.115 . . . . 0.0 109.783 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.4 mt -130.31 132.42 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.155 0.982 . . . . 0.0 108.362 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . 0.292 26.8 mtpp 46.15 51.41 11.16 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.699 2.0 . . . . 0.0 114.47 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 56.98 24.12 9.11 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.492 2.317 . . . . 0.0 115.636 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -128.91 143.75 50.98 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.879 1.672 . . . . 0.0 110.861 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -79.26 124.29 28.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.0 t -101.96 -53.37 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.236 1.815 . . . . 0.0 112.51 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 165.68 169.96 29.98 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 117.973 1.949 . . . . 0.0 117.973 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.65 170.97 55.02 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.607 1.099 . . . . 0.0 112.397 162.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.2 tp -48.48 -41.68 30.52 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.491 1.116 . . . . 0.0 113.71 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.4 -31.71 69.51 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.996 0.816 . . . . 0.0 112.304 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.72 -47.3 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.695 1.598 . . . . 0.0 110.086 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.9 t -54.43 -38.04 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.188 1.395 . . . . 0.0 110.535 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 85.9 m -58.96 -46.56 87.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.63 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -62.88 -43.71 98.06 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 120.207 1.367 . . . . 0.0 110.656 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 59.5 mtt -65.24 -42.34 93.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.787 0.835 . . . . 0.0 112.039 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -44.24 71.52 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.213 1.805 . . . . 0.0 111.594 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.74 -15.53 63.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.729 1.611 . . . . 0.0 113.533 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.1 m -106.16 -6.32 18.65 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.36 3.9 54.9 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 120.216 1.371 . . . . 0.0 114.247 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -69.32 -34.2 74.29 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.348 -1.089 . . . . 0.0 111.702 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.37 -45.68 92.67 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.146 0.978 . . . . 0.0 110.138 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -31.09 69.07 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.096 1.758 . . . . 0.0 114.539 176.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -59.62 -46.94 87.47 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.791 1.178 . . . . 0.0 111.712 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -68.87 -43.41 75.42 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.66 -35.73 80.87 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.662 -0.648 . . . . 0.0 112.193 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -68.62 -35.18 76.97 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.234 -0.916 . . . . 0.0 112.338 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.5 -26.94 68.65 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.78 0.718 . . . . 0.0 112.225 171.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.41 ' HA ' ' HE3' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -82.77 4.34 25.63 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.853 1.661 . . . . 0.0 113.586 170.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.41 16.44 71.31 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.073 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.7 mt -101.86 145.15 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 118.808 1.304 . . . . 0.0 111.068 -171.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 97.4 m -103.28 123.21 46.35 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.916 1.286 . . . . 0.0 110.941 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.7 p -108.92 166.83 10.53 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.015 1.726 . . . . 0.0 112.572 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -65.31 133.77 52.13 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 153.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -126.46 141.92 51.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.928 0.891 . . . . 0.0 111.545 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.69 1.996 . . . . 0.0 110.157 -178.692 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 p . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.9 p -94.36 -3.4 50.4 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.948 1.699 . . . . 0.0 115.568 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.7 p -61.13 159.54 11.72 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.999 -1.063 . . . . 0.0 112.377 167.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.64 -9.95 3.21 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-O 118.671 -1.072 . . . . 0.0 115.482 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.77 121.34 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.289 1.544 . . . . 0.0 109.315 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.05 155.2 50.48 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -173.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.46 23.61 3.72 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.968 2.223 . . . . 0.0 113.346 -169.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -66.59 134.2 51.86 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.558 1.143 . . . . 0.0 113.694 -169.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.6 m -119.45 147.68 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.888 1.675 . . . . 0.0 110.256 168.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -135.39 164.21 28.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.926 1.29 . . . . 0.0 113.467 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.28 110.49 11.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.661 1.584 . . . . 0.0 110.851 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.5 pt -140.83 27.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 126.029 1.732 . . . . 0.0 112.491 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -83.82 139.71 32.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.391 1.876 . . . . 0.0 110.978 -171.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 pm0 -74.45 155.82 37.61 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.279 -0.888 . . . . 0.0 113.272 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.4 p -130.98 -16.73 3.19 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -172.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -75.05 138.01 72.59 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-N 120.637 1.562 . . . . 0.0 112.663 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.63 -179.68 4.75 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.603 3.535 . . . . 0.0 113.455 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -83.54 -14.44 52.23 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.773 -1.205 . . . . 0.0 113.164 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -85.01 136.72 33.47 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.436 1.495 . . . . 0.0 111.372 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -104.17 147.16 33.89 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -159.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.16 155.25 42.17 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.772 2.981 . . . . 0.0 111.844 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -73.16 125.74 28.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.932 1.293 . . . . 0.0 110.66 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 mt -147.64 156.63 42.98 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.237 1.415 . . . . 0.0 111.884 174.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.5 t -68.47 -57.38 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.993 0.917 . . . . 0.0 110.705 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.8 m -141.59 129.56 21.93 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.164 0.986 . . . . 0.0 110.954 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.05 162.28 35.61 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.402 1.081 . . . . 0.0 112.158 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -156.66 -19.79 0.1 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.1 tp -141.78 139.31 32.75 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.944 1.247 . . . . 0.0 113.642 -167.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.23 129.4 16.61 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.495 1.518 . . . . 0.0 112.087 -175.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -67.23 -25.53 66.14 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.988 1.715 . . . . 0.0 113.643 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -74.0 -45.31 50.67 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.0 -1.063 . . . . 0.0 111.924 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.24 -26.0 65.47 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 120.718 -1.238 . . . . 0.0 113.27 -177.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.8 pt -84.93 -3.86 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 170.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.61 -22.84 12.36 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.233 1.413 . . . . 0.0 113.561 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.9 mtt -49.96 122.49 6.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.975 1.31 . . . . 0.0 110.671 168.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.9 131.08 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.478 1.111 . . . . 0.0 113.141 -175.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -111.32 128.74 56.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.631 1.972 . . . . 0.0 109.04 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -60.27 -29.12 68.6 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.7 0.8 . . . . 0.0 113.074 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -58.79 -27.84 65.4 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.0 mm -78.14 -43.61 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.427 -0.796 . . . . 0.0 111.029 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.68 -40.81 96.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.569 1.147 . . . . 0.0 111.614 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -61.45 -35.48 77.72 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.821 1.248 . . . . 0.0 112.623 170.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 78.9 m -73.54 -45.93 50.65 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.482 1.037 . . . . 0.0 111.91 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 pt -58.46 -36.12 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 120.111 1.323 . . . . 0.0 111.904 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -75.08 -39.9 60.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.069 1.348 . . . . 0.0 112.952 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.3 t -72.13 -34.57 68.65 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.858 1.263 . . . . 0.0 113.954 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -85.22 143.95 28.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.209 -0.932 . . . . 0.0 111.637 -174.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -84.1 -40.46 18.25 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.199 -0.938 . . . . 0.0 111.776 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.51 129.84 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.825 1.65 . . . . 0.0 110.211 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.5 t -134.02 133.45 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.436 1.094 . . . . 0.0 111.594 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.1 t -135.41 156.26 49.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.156 1.382 . . . . 0.0 111.113 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -135.0 137.89 43.45 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.828 0.851 . . . . 0.0 110.637 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.93 160.35 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.464 1.506 . . . . 0.0 109.703 -160.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -69.72 99.15 1.29 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.3 -0.875 . . . . 0.0 108.784 158.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.38 -144.1 21.35 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 118.236 0.471 . . . . 0.0 114.114 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -124.02 158.45 60.34 Favored Pre-proline 0 N--CA 1.473 0.704 0 C-N-CA 125.714 1.605 . . . . 0.0 112.258 -171.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.62 -16.44 53.62 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.179 2.586 . . . . 0.0 114.815 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -95.18 -19.17 20.29 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.601 1.56 . . . . 0.0 113.297 168.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.65 71.64 15.46 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.627 1.571 . . . . 0.0 113.393 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.27 156.51 29.45 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.07 3.18 . . . . 0.0 113.312 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 79.2 mtp -124.24 8.31 8.51 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.332 1.453 . . . . 0.0 114.138 -170.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 22.5 t -150.63 146.78 26.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.805 1.642 . . . . 0.0 110.673 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.56 95.1 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.87 -35.1 74.42 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.55 -0.719 . . . . 0.0 111.921 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.2 m -61.85 -44.78 96.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.931 0.892 . . . . 0.0 111.579 171.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 tmpt? -64.39 -40.82 96.55 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.028 0.931 . . . . 0.0 111.755 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -63.35 -35.91 81.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.5 ttp -58.51 -38.23 77.25 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.215 0.916 . . . . 0.0 111.933 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 mm -61.69 -36.26 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.506 0.594 . . . . 0.0 111.703 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -70.2 -33.81 72.16 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.727 1.611 . . . . 0.0 113.489 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.74 -39.19 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.589 0.756 . . . . 0.0 110.522 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.1 mt -66.34 -37.99 86.61 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -61.77 -29.16 69.95 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.792 1.237 . . . . 0.0 112.198 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.88 65.99 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.217 -0.927 . . . . 0.0 113.365 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.93 -12.67 20.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.987 1.315 . . . . 0.0 113.889 170.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.86 19.35 67.45 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.278 0.942 . . . . 0.0 114.121 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.7 mt -111.72 136.54 50.84 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.289 1.835 . . . . 0.0 111.518 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -117.22 145.52 43.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.874 1.321 . . . . 0.0 113.374 165.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -119.12 173.55 6.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.914 2.086 . . . . 0.0 111.211 -169.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.3 m -84.36 119.23 24.86 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.91 -1.119 . . . . 0.0 109.394 -160.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.4 m -125.05 130.66 52.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.103 -153.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -129.01 156.57 43.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.523 1.529 . . . . 0.0 113.007 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -95.11 104.14 16.01 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.107 1.363 . . . . 0.0 112.198 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.9 p -74.57 -11.11 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.6 tp -81.14 -28.53 35.05 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.027 -1.046 . . . . 0.0 110.718 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.75 -36.92 19.85 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -117.53 105.65 47.82 Favored Pre-proline 0 N--CA 1.476 0.871 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -167.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.86 -28.76 40.26 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.544 3.496 . . . . 0.0 115.256 168.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -56.51 -43.59 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.222 0.919 . . . . 0.0 112.283 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.27 -47.62 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -48.97 -54.85 13.85 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.188 0.995 . . . . 0.0 111.554 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.4 m -61.81 -44.74 96.26 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -170.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -70.5 -46.64 63.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.207 0.527 . . . . 0.0 110.545 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.37 -41.92 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.895 0.878 . . . . 0.0 112.22 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -67.63 -42.67 81.95 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -41.56 97.75 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.134 0.974 . . . . 0.0 113.157 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.34 -36.15 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 89.6 p -102.15 -4.92 25.07 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 62.89 -46.88 0.2 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 128.914 2.886 . . . . 0.0 115.73 -173.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -142.12 101.31 5.78 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 125.57 1.548 . . . . 0.0 111.055 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -86.52 148.37 8.7 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.924 2.416 . . . . 0.0 114.098 -171.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 87.5 m -100.13 149.91 23.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.379 1.872 . . . . 0.0 109.317 164.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 81.3 mt -119.54 113.86 34.71 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.727 0.811 . . . . 0.0 109.162 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -77.03 164.25 87.66 Favored 'Cis proline' 0 CA--C 1.544 1.013 0 CA-C-N 120.103 1.073 . . . . 0.0 114.241 -7.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -146.08 172.32 13.59 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.932 1.293 . . . . 0.0 111.815 166.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.34 142.05 49.18 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -165.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -122.72 142.41 50.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.626 1.97 . . . . 0.0 111.326 173.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 74.5 mt -134.18 134.89 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.273 1.429 . . . . 0.0 108.953 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp 49.9 42.85 24.83 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.359 1.464 . . . . 0.0 112.885 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.53 18.87 2.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.918 2.087 . . . . 0.0 116.213 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.07 148.61 38.69 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.491 1.516 . . . . 0.0 111.636 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -79.93 126.57 31.19 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.196 0.998 . . . . 0.0 112.032 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.0 -39.38 6.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.918 1.287 . . . . 0.0 111.357 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.98 -179.31 21.42 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 172.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.27 171.34 52.85 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.776 1.179 . . . . 0.0 113.107 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 pp -57.39 -29.46 64.1 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -70.26 -28.82 65.54 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.029 -1.044 . . . . 0.0 111.922 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.4 mm -74.33 -45.46 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.588 1.155 . . . . 0.0 109.596 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.7 t -57.17 -46.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.049 0.94 . . . . 0.0 110.79 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.6 m -60.31 -43.87 95.95 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.844 0.858 . . . . 0.0 110.825 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -61.25 -47.35 86.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.255 1.022 . . . . 0.0 112.509 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 22.1 mmt -65.63 -39.74 91.8 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.7 1.136 . . . . 0.0 111.818 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.61 -47.46 78.54 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.228 1.411 . . . . 0.0 111.197 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.39 -22.58 60.22 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.264 1.026 . . . . 0.0 112.664 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.0 t -81.09 -20.56 41.24 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.894 1.677 . . . . 0.0 113.419 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.16 -2.5 86.89 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 121.135 -0.978 . . . . 0.0 113.911 -171.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -70.72 -32.71 70.0 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.648 -0.913 . . . . 0.0 111.729 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -44.07 97.72 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.075 -1.016 . . . . 0.0 111.004 173.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -60.31 -33.67 72.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.954 1.302 . . . . 0.0 113.51 172.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -63.2 -47.3 83.15 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.66 0.664 . . . . 0.0 111.269 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.9 mtm -68.37 -43.97 76.22 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.5 pp -65.48 -35.46 80.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.746 0.703 . . . . 0.0 112.177 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -70.5 -30.22 66.95 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.473 -0.767 . . . . 0.0 112.717 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.91 -32.78 74.27 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.419 -0.8 . . . . 0.0 111.201 171.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -1.03 27.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.993 1.717 . . . . 0.0 113.283 169.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.81 2.23 84.45 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.038 2.256 . . . . 0.0 115.462 175.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.9 mt -81.54 144.21 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 119.132 1.466 . . . . 0.0 112.671 -158.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.3 m -83.47 123.15 29.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.135 1.374 . . . . 0.0 112.181 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 5.6 p -133.44 165.69 24.28 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.138 1.775 . . . . 0.0 112.882 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -73.21 159.12 33.96 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.848 1.659 . . . . 0.0 113.547 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -80.36 145.04 32.25 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.124 1.77 . . . . 0.0 113.494 170.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.252 1.219 0 C-N-CA 126.55 1.94 . . . . 0.0 113.269 178.712 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.7 m -65.39 -32.81 74.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.806 0.843 . . . . 0.0 112.776 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.5 p -118.89 5.4 11.43 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.61 1.964 . . . . 0.0 114.888 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.21 11.86 83.85 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.487 1.041 . . . . 0.0 115.598 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 pt -60.07 157.85 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.112 1.765 . . . . 0.0 113.152 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.14 151.42 50.02 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.414 -0.803 . . . . 0.0 113.523 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.78 -149.66 36.77 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 123.628 0.632 . . . . 0.0 113.729 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -145.55 144.83 30.74 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.875 1.67 . . . . 0.0 111.426 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.59 151.67 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.435 1.094 . . . . 0.0 112.717 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -65.64 158.25 27.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.047 2.539 . . . . 0.0 114.468 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -132.79 88.86 2.56 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.366 1.466 . . . . 0.0 111.414 167.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.16 143.38 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.683 1.193 . . . . 0.0 111.669 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -150.57 128.88 12.03 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.241 1.016 . . . . 0.0 110.087 168.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -128.82 131.17 47.72 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.954 2.102 . . . . 0.0 110.223 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.7 m -80.19 53.5 1.77 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.453 1.501 . . . . 0.0 111.578 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -79.41 156.75 75.79 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.707 1.603 . . . . 0.0 113.429 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.42 133.35 14.43 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.498 2.799 . . . . 0.0 111.627 166.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -100.02 -7.07 25.48 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -81.66 146.66 29.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.701 1.2 . . . . 0.0 113.338 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -76.07 145.45 77.16 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.864 1.266 . . . . 0.0 112.129 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -65.31 145.29 83.2 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.287 2.658 . . . . 0.0 111.095 167.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -124.84 143.09 51.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.495 1.518 . . . . 0.0 112.336 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp 64.51 -42.52 0.29 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 129.355 3.062 . . . . 0.0 115.957 -172.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 m -148.98 147.22 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.954 1.702 . . . . 0.0 111.82 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.6 p -70.83 159.48 34.51 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.552 1.541 . . . . 0.0 113.55 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.49 -171.6 3.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.092 1.357 . . . . 0.0 113.119 -171.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.74 166.76 12.48 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.986 -1.071 . . . . 0.0 111.984 166.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.12 151.83 30.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.89 146.99 37.3 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.294 1.438 . . . . 0.0 111.676 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -63.68 -33.14 74.98 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -173.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.58 -33.54 68.28 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.478 1.035 . . . . 0.0 111.721 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -74.7 -25.98 59.52 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.0 pt -106.68 -14.52 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.458 1.503 . . . . 0.0 114.868 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.62 13.59 8.34 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.352 1.461 . . . . 0.0 114.204 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 49.1 tpp -119.21 148.21 43.37 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.082 2.153 . . . . 0.0 111.625 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -137.47 106.99 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.923 1.289 . . . . 0.0 108.767 159.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -78.82 156.9 28.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -59.13 -34.12 71.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.217 1.807 . . . . 0.0 114.933 -164.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -69.27 -29.92 67.92 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.091 1.314 . . . . 0.0 113.023 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 82' ' ' ILE . 4.6 mp -75.84 -50.74 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.794 0.837 . . . . 0.0 108.869 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.65 -39.56 73.91 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.403 1.481 . . . . 0.0 111.183 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.54 -30.74 64.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.0 m -72.54 -48.56 39.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.706 0.802 . . . . 0.0 110.312 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -65.26 -30.47 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.781 1.232 . . . . 0.0 112.081 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -37.83 73.39 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.434 1.493 . . . . 0.0 112.895 170.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.4 t -73.33 -31.07 63.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.047 0.939 . . . . 0.0 113.13 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.15 146.49 25.01 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -76.76 -40.8 47.13 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.63 -1.294 . . . . 0.0 113.83 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.7 t -145.87 135.68 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.944 1.298 . . . . 0.0 110.076 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.16 132.23 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.876 0.871 . . . . 0.0 111.599 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -133.84 155.53 49.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.115 1.366 . . . . 0.0 111.317 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -129.7 137.31 50.53 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.876 0.87 . . . . 0.0 110.787 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.18 156.3 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.063 1.345 . . . . 0.0 110.408 -161.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -70.07 102.17 1.98 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 158.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.81 -147.28 27.7 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 118.748 0.704 . . . . 0.0 113.418 -172.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -126.75 157.45 71.3 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.344 1.857 . . . . 0.0 110.925 -172.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.21 -23.57 75.52 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.026 2.484 . . . . 0.0 114.388 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -76.67 -24.24 53.24 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 171.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -148.96 68.83 9.75 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 126.06 1.744 . . . . 0.0 111.887 -175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.0 142.23 42.02 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.504 2.136 . . . . 0.0 111.744 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.5 mtt -101.28 3.87 41.18 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.544 1.538 . . . . 0.0 113.434 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.8 t -145.32 146.08 31.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.282 1.433 . . . . 0.0 111.177 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.37 -44.77 88.98 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.523 0.729 . . . . 0.0 112.265 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -61.53 -36.89 81.84 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.34 -0.85 . . . . 0.0 111.909 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 m -66.57 -37.84 85.8 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.513 0.725 . . . . 0.0 112.646 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -66.46 -44.02 83.91 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.261 1.024 . . . . 0.0 112.881 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -60.94 -35.24 76.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.228 0.611 . . . . 0.0 112.225 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.1 tpp -55.67 -44.44 77.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.182 0.593 . . . . 0.0 112.265 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.72 -32.13 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 121.257 -0.902 . . . . 0.0 111.607 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -34.33 76.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.67 1.188 . . . . 0.0 112.712 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 t -69.23 -41.86 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.907 1.683 . . . . 0.0 111.767 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.8 mt -64.64 -36.32 83.87 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.432 -0.792 . . . . 0.0 112.59 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.74 -36.96 85.06 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.717 -1.239 . . . . 0.0 111.569 171.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.74 -26.34 65.19 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.2 tp -87.8 -14.07 40.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.956 0.903 . . . . 0.0 112.702 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.75 7.38 35.02 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.282 1.896 . . . . 0.0 114.876 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.1 mt -110.99 133.44 53.39 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.641 1.176 . . . . 0.0 111.218 172.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -112.61 159.6 18.7 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.592 1.187 . . . . 0.0 111.408 160.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -136.59 175.7 9.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.835 2.054 . . . . 0.0 110.506 -157.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.0 m -86.42 122.14 29.97 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.943 -1.098 . . . . 0.0 108.622 -175.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.2 p -119.79 147.61 44.43 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.089 1.355 . . . . 0.0 112.865 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -133.77 143.37 48.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.196 0.998 . . . . 0.0 113.064 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -85.67 102.22 13.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.035 1.334 . . . . 0.0 111.818 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.6 p -71.21 -17.15 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.787 1.235 . . . . 0.0 113.683 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -83.76 -29.39 27.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.661 0.784 . . . . 0.0 111.15 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.2 -32.05 13.86 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -128.04 117.49 20.58 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 119.582 1.083 . . . . 0.0 113.509 -165.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.25 -16.82 44.63 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.814 2.343 . . . . 0.0 114.364 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 p -53.31 -42.49 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.055 1.298 . . . . 0.0 111.756 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.62 -52.55 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.779 0.832 . . . . 0.0 110.343 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -52.06 -47.14 65.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.884 0.874 . . . . 0.0 111.442 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.6 m -66.12 -44.48 84.15 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.305 0.642 . . . . 0.0 112.558 -173.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -70.98 -40.46 71.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.369 0.667 . . . . 0.0 110.58 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 t -59.65 -36.35 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.246 1.018 . . . . 0.0 111.725 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -43.4 90.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.954 0.343 . . . . 0.0 111.418 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -65.34 -47.73 75.48 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.447 1.099 . . . . 0.0 112.467 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 52.7 t -82.26 -44.21 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -172.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m -100.53 -10.06 21.42 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 68.2 -54.32 0.52 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.807 2.043 . . . . 0.0 112.949 -168.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -137.67 147.04 55.63 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.276 1.43 . . . . 0.0 112.489 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -89.63 142.47 4.14 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.348 2.698 . . . . 0.0 115.025 -171.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 m -129.91 131.91 46.19 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.876 2.07 . . . . 0.0 107.402 156.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.5 pt -128.72 135.38 27.51 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.35 156.12 99.81 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 CA-C-N 119.438 0.835 . . . . 0.0 113.053 -5.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.24 158.16 39.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.302 1.441 . . . . 0.0 111.599 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.59 141.17 49.61 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -129.36 144.17 51.13 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.19 2.196 . . . . 0.0 109.887 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.0 mt -124.63 121.99 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.916 0.886 . . . . 0.0 108.667 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.0 tttp 44.3 51.79 7.43 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.27 1.828 . . . . 0.0 113.48 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.89 14.52 6.39 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.73 138.19 39.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.708 1.603 . . . . 0.0 110.197 168.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -83.45 123.85 30.11 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 121.351 -0.843 . . . . 0.0 112.886 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -105.37 -39.95 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.865 1.666 . . . . 0.0 112.993 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 144.75 175.31 17.79 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.644 1.418 . . . . 0.0 116.644 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.04 168.79 54.85 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.182 1.372 . . . . 0.0 113.365 166.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.2 tp -45.86 -41.39 11.16 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -71.0 -27.37 63.64 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.156 0.983 . . . . 0.0 112.212 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.9 mm -79.54 -45.38 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.049 1.34 . . . . 0.0 109.923 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.0 t -62.51 -44.8 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.433 1.093 . . . . 0.0 110.56 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 65.3 m -60.15 -48.25 82.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.791 0.836 . . . . 0.0 110.857 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -55.8 -50.21 71.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.455 1.502 . . . . 0.0 111.6 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.7 mmt -70.87 -33.03 70.2 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.364 1.065 . . . . 0.0 112.762 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.74 -46.56 65.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.845 1.658 . . . . 0.0 111.167 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.24 -26.0 67.16 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.393 1.077 . . . . 0.0 112.341 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.8 t -87.92 -15.81 35.6 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.638 1.975 . . . . 0.0 114.674 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.1 -11.02 59.09 Favored Glycine 0 CA--C 1.54 1.652 0 C-N-CA 124.541 1.067 . . . . 0.0 114.493 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.97 -29.35 69.72 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.574 1.55 . . . . 0.0 112.298 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.39 -46.58 89.58 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.722 -1.236 . . . . 0.0 111.106 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -59.6 -41.31 90.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.388 1.475 . . . . 0.0 111.502 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -58.93 -44.3 91.33 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.202 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 58.7 mtm -69.04 -46.59 67.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.048 0.84 . . . . 0.0 112.001 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -41.78 84.16 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -67.81 -34.52 76.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.94 0.896 . . . . 0.0 112.59 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -59.68 -26.18 65.35 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.244 1.017 . . . . 0.0 112.341 172.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -92.03 6.99 44.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.927 1.691 . . . . 0.0 114.312 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.67 9.37 75.09 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 124.411 1.005 . . . . 0.0 114.3 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.9 mt -94.48 142.56 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.87 0.868 . . . . 0.0 109.176 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 28.5 m -114.87 124.86 52.79 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.184 0.994 . . . . 0.0 112.369 -172.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -129.86 173.91 10.23 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.918 2.087 . . . . 0.0 112.946 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.91 158.4 1.41 Allowed 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.654 -1.279 . . . . 0.0 111.939 160.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.25 145.79 29.83 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.25 0.62 . . . . 0.0 110.258 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 74.4 mt . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.691 1.197 . . . . 0.0 111.781 -174.451 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 p -89.1 -13.46 38.49 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 95.0 p -126.78 -12.77 5.94 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.63 -6.8 36.71 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.362 0.982 . . . . 0.0 114.431 -168.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.06 137.66 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.162 1.385 . . . . 0.0 108.883 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.92 125.73 7.46 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 121.586 -0.696 . . . . 0.0 111.658 171.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.73 -30.8 61.23 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 117.616 0.708 . . . . 0.0 112.318 170.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.93 157.68 46.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.858 1.663 . . . . 0.0 112.381 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.58 138.25 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.691 1.597 . . . . 0.0 109.504 171.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -75.91 119.54 20.02 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.535 1.134 . . . . 0.0 111.895 -174.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -144.38 88.87 1.96 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.675 1.59 . . . . 0.0 108.745 166.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.4 tt -136.44 101.04 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.137 1.375 . . . . 0.0 109.079 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -137.45 140.64 41.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.093 0.957 . . . . 0.0 111.73 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.52 156.87 45.18 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.623 1.169 . . . . 0.0 113.1 -172.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.8 m -140.48 -28.57 0.71 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -146.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -84.75 163.82 44.91 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.108 1.363 . . . . 0.0 113.433 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.7 179.09 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.634 3.556 . . . . 0.0 114.142 161.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -79.03 -5.3 53.62 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -168.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -137.16 131.49 32.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.319 1.448 . . . . 0.0 112.914 -169.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -105.82 151.78 40.04 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 126.076 1.75 . . . . 0.0 111.048 167.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.65 153.61 34.26 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 124.017 3.145 . . . . 0.0 116.398 -165.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -89.04 145.21 25.62 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.117 2.967 . . . . 0.0 112.801 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.1 tp 61.86 -22.54 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 129.343 3.057 . . . . 0.0 118.108 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.8 128.59 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.796 1.238 . . . . 0.0 110.428 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.9 p -141.95 155.58 45.47 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.129 0.972 . . . . 0.0 113.126 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.3 -22.56 10.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.084 1.354 . . . . 0.0 113.643 -175.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -144.56 161.53 38.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.483 1.513 . . . . 0.0 111.336 -174.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.69 111.9 23.01 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 160.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.92 141.47 58.76 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -164.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -52.34 -35.07 50.03 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.059 0.943 . . . . 0.0 112.984 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.57 -33.23 64.57 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.417 1.487 . . . . 0.0 113.309 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -73.59 -28.17 61.69 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.163 -0.96 . . . . 0.0 112.306 170.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.4 mm -80.49 -32.04 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.43 0.692 . . . . 0.0 112.014 173.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.35 -34.79 28.32 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.404 1.002 . . . . 0.0 112.756 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 39.0 tpp -74.18 143.67 45.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.663 0.665 . . . . 0.0 112.09 -174.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.2 m -125.2 141.85 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.574 1.15 . . . . 0.0 112.129 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -66.01 109.35 2.52 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 164.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -52.75 -44.9 66.79 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.274 1.43 . . . . 0.0 112.107 -171.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.44 -28.49 59.35 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.6 mm -76.54 -42.06 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.356 -0.84 . . . . 0.0 110.112 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.51 -39.22 90.19 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.483 1.113 . . . . 0.0 111.461 169.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.2 -29.38 69.03 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 120.755 -1.215 . . . . 0.0 112.094 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.5 m -73.06 -41.96 63.58 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.216 -0.927 . . . . 0.0 111.709 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.8 pt -62.02 -35.1 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.955 1.252 . . . . 0.0 111.811 172.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -76.25 -24.62 54.53 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.853 1.261 . . . . 0.0 113.868 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 t -86.07 -38.24 18.03 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.302 1.441 . . . . 0.0 112.868 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -93.4 141.58 28.29 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.223 1.009 . . . . 0.0 111.937 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.64 -24.39 20.51 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.18 128.76 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.497 1.119 . . . . 0.0 110.294 168.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.01 132.8 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.058 0.943 . . . . 0.0 110.109 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 t -123.21 152.59 41.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.835 0.826 . . . . 0.0 109.903 165.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.06 143.1 49.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.791 0.805 . . . . 0.0 110.776 170.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 mt -132.92 160.09 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.837 -161.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -70.95 103.95 2.82 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 156.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.0 -143.12 23.87 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 119.246 0.93 . . . . 0.0 113.756 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.0 156.47 74.2 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.236 1.414 . . . . 0.0 111.738 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.36 -25.38 30.52 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.314 2.01 . . . . 0.0 113.937 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -90.24 -16.14 29.95 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.27 -0.894 . . . . 0.0 112.828 169.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.62 77.26 15.31 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.578 1.551 . . . . 0.0 111.628 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.95 151.9 35.88 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.262 2.641 . . . . 0.0 112.574 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 78.6 mmm -97.44 -5.22 36.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.318 1.447 . . . . 0.0 113.796 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 10.3 t -146.22 146.32 30.74 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.286 1.434 . . . . 0.0 111.334 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.6 -29.38 69.42 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -71.47 -36.84 71.32 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.633 -1.292 . . . . 0.0 111.66 169.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.3 m -63.98 -35.89 82.19 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -59.15 -47.97 83.34 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.521 1.128 . . . . 0.0 111.453 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -62.18 -28.91 69.99 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.8 tpt -52.38 -39.71 61.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.582 0.628 . . . . 0.0 111.4 171.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 mm -70.61 -35.17 60.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.66 1.184 . . . . 0.0 111.426 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -37.24 86.06 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.832 -1.167 . . . . 0.0 112.886 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 65.9 t -69.98 -37.51 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.167 0.987 . . . . 0.0 110.704 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.9 mt -65.72 -39.69 91.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.109 0.964 . . . . 0.0 113.488 170.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.55 -30.71 70.42 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.117 -0.99 . . . . 0.0 112.137 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.04 -29.47 66.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.569 0.748 . . . . 0.0 112.668 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.7 tp -81.78 -15.31 54.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.622 0.769 . . . . 0.0 112.39 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.87 11.96 58.93 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.496 1.046 . . . . 0.0 114.468 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 22.6 mt -110.58 129.4 55.81 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.551 1.176 . . . . 0.0 112.875 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -116.34 154.85 29.48 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.131 1.372 . . . . 0.0 113.519 168.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -139.59 170.27 16.21 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.576 2.35 . . . . 0.0 111.477 -161.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.0 m -88.09 131.15 34.79 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.047 -1.658 . . . . 0.0 109.655 -176.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -130.33 143.77 50.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.059 0.944 . . . . 0.0 113.528 -154.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -137.67 144.06 41.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.372 1.069 . . . . 0.0 113.315 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -83.59 120.08 25.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.774 1.23 . . . . 0.0 112.075 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.8 t -68.75 -29.82 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.25 1.02 . . . . 0.0 111.863 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.6 mt -74.98 -15.75 60.65 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.155 -0.966 . . . . 0.0 112.282 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.76 -32.57 21.77 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.421 -0.8 . . . . 0.0 112.975 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -129.67 106.48 17.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 119.451 1.023 . . . . 0.0 113.226 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -53.54 -26.94 38.69 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.085 3.19 . . . . 0.0 115.347 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.52 -35.53 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.249 -0.907 . . . . 0.0 112.54 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.79 -48.06 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.139 -0.976 . . . . 0.0 111.166 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -59.94 -28.16 67.39 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.151 0.887 . . . . 0.0 112.955 171.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.5 m -71.03 -53.92 13.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.373 0.533 . . . . 0.0 111.166 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -70.81 -34.76 72.06 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.157 -0.964 . . . . 0.0 111.915 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.15 -36.28 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 120.787 -1.196 . . . . 0.0 112.926 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -72.58 -49.37 32.79 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.484 1.038 . . . . 0.0 111.428 167.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -72.31 -30.53 64.87 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -164.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.53 -29.39 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.598 1.159 . . . . 0.0 111.396 171.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m -103.4 -5.77 22.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -169.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 62.35 -27.03 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 129.069 2.948 . . . . 0.0 116.168 -168.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -145.86 138.53 13.89 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.394 1.877 . . . . 0.0 109.521 165.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.3 149.0 11.75 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.048 2.498 . . . . 0.0 114.669 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.4 p -129.52 132.67 46.92 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.532 1.933 . . . . 0.0 108.807 160.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.0 mt -131.21 142.55 45.91 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.381 1.472 . . . . 0.0 108.383 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.58 161.18 79.14 Favored 'Cis proline' 0 C--N 1.35 0.643 0 CA-C-N 121.738 1.656 . . . . 0.0 111.924 -8.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -144.56 152.52 40.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.302 0.641 . . . . 0.0 112.287 -162.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.24 140.94 52.14 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.785 1.234 . . . . 0.0 112.362 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -130.25 140.41 50.7 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.894 2.078 . . . . 0.0 109.258 173.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 82.0 mt -129.29 133.29 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.3 1.04 . . . . 0.0 108.343 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.1 tttt 49.31 45.3 23.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.187 1.795 . . . . 0.0 113.428 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.65 12.33 5.47 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -115.85 144.2 44.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.381 1.472 . . . . 0.0 111.502 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.23 124.88 25.01 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.879 1.272 . . . . 0.0 111.976 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.49 -55.48 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.147 1.379 . . . . 0.0 110.95 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 165.67 167.21 25.93 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 117.109 1.604 . . . . 0.0 117.109 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.15 168.82 54.84 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.703 1.144 . . . . 0.0 112.499 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.7 tt -47.35 -45.72 24.98 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.058 1.343 . . . . 0.0 113.908 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.82 -35.44 78.62 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.339 -0.851 . . . . 0.0 111.407 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.67 -47.07 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.086 1.354 . . . . 0.0 110.513 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.5 -39.62 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.691 1.196 . . . . 0.0 109.992 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 41.2 m -61.5 -42.72 99.23 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.413 0.685 . . . . 0.0 112.29 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -55.2 -46.62 75.89 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.201 0.909 . . . . 0.0 110.41 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 61.1 mtt -72.92 -33.45 65.97 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.633 1.573 . . . . 0.0 113.342 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -70.52 -35.93 73.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.211 1.804 . . . . 0.0 112.629 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -80.06 -20.27 45.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.885 -1.135 . . . . 0.0 112.621 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.2 p -106.86 -16.0 14.58 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -162.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.7 82.63 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 124.756 1.17 . . . . 0.0 115.503 -170.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -70.03 -31.89 69.75 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.244 2.022 . . . . 0.0 112.55 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.86 -41.59 67.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.533 1.133 . . . . 0.0 110.596 176.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -55.84 -41.17 73.91 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.364 1.865 . . . . 0.0 110.769 173.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -56.63 -47.08 80.47 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.82 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 70.9 mtm -70.86 -46.03 63.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.461 1.028 . . . . 0.0 113.242 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -39.42 82.96 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -72.44 -32.88 66.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.597 1.159 . . . . 0.0 112.274 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.86 -27.2 64.94 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.513 0.597 . . . . 0.0 112.383 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -90.77 -4.43 56.67 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.56 22.37 47.33 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.803 1.192 . . . . 0.0 114.178 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 64.5 mt -94.51 147.84 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 119.038 1.419 . . . . 0.0 111.85 -172.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.6 m -101.11 130.89 47.24 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.323 1.449 . . . . 0.0 112.195 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 15.6 p -137.09 169.46 17.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.685 1.994 . . . . 0.0 111.502 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -74.2 158.42 34.16 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -135.99 129.69 32.46 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.717 1.607 . . . . 0.0 113.343 165.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.413 1.485 . . . . 0.0 111.881 176.688 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.6 -0.148 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.7 p -78.35 -31.87 48.78 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -166.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -105.59 0.85 26.87 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.054 1.341 . . . . 0.0 114.121 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.8 7.43 74.74 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.58 1.562 . . . . 0.0 116.019 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.8 mt -91.19 141.67 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.77 2.028 . . . . 0.0 109.26 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.64 136.66 4.71 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.037 0.835 . . . . 0.0 114.684 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.62 -31.7 0.86 Allowed Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.983 1.754 . . . . 0.0 116.605 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -148.66 152.57 36.92 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.248 1.819 . . . . 0.0 110.599 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.11 152.79 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.247 1.019 . . . . 0.0 111.785 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.73 167.36 18.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.912 1.285 . . . . 0.0 111.148 173.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -149.95 166.96 28.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.832 0.853 . . . . 0.0 111.456 166.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.0 mt -85.34 116.33 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.322 1.049 . . . . 0.0 108.464 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -138.79 147.92 43.17 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.664 1.185 . . . . 0.0 112.619 -174.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.7 116.47 13.22 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.468 1.507 . . . . 0.0 109.252 158.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.7 p -138.97 -11.58 1.28 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -71.96 153.68 92.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 119.438 1.017 . . . . 0.0 112.392 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -72.29 175.1 10.45 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.01 3.14 . . . . 0.0 112.453 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -77.64 -9.84 59.19 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.746 -1.221 . . . . 0.0 113.291 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -140.38 117.0 10.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.521 1.528 . . . . 0.0 109.382 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -96.03 147.38 32.89 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.26 139.93 39.64 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.321 2.68 . . . . 0.0 111.047 167.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.9 mtm-85 -92.86 129.41 38.79 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.554 -0.716 . . . . 0.0 111.562 -171.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.0 tp -155.45 -44.09 0.08 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.167 0.987 . . . . 0.0 112.179 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.2 t -144.6 110.66 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.068 1.347 . . . . 0.0 110.414 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.4 t -82.9 75.36 9.8 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.127 -0.983 . . . . 0.0 110.672 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.69 133.17 53.3 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.819 1.248 . . . . 0.0 111.773 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.3 t0 51.94 178.91 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.033 1.733 . . . . 0.0 112.905 -163.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.9 tp -104.44 132.4 50.73 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.849 -1.157 . . . . 0.0 108.949 165.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.54 152.75 29.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -169.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -51.03 -42.46 60.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.737 1.215 . . . . 0.0 112.881 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.57 -31.5 63.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.016 1.726 . . . . 0.0 114.12 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -75.52 -41.69 54.5 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.162 1.385 . . . . 0.0 113.161 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.1 tp -82.64 -20.17 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.25 0.49 28.43 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.324 1.05 . . . . 0.0 113.518 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.4 ttt -61.69 126.92 29.07 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.129 -0.982 . . . . 0.0 112.212 -171.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.15 148.36 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.311 1.044 . . . . 0.0 112.283 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -120.42 126.86 51.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.474 1.51 . . . . 0.0 110.326 164.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -57.44 -43.55 83.97 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.62 1.168 . . . . 0.0 113.363 -163.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -72.79 -28.82 62.82 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.6 mm -72.12 -48.89 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.035 0.934 . . . . 0.0 109.618 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.53 -38.38 77.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.189 1.396 . . . . 0.0 112.304 170.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.5 -30.79 66.35 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.279 -0.888 . . . . 0.0 113.163 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 67.3 m -66.43 -47.89 71.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.193 0.997 . . . . 0.0 111.061 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 pt -60.5 -36.87 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 118.498 0.59 . . . . 0.0 111.944 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.08 -21.98 58.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.006 1.722 . . . . 0.0 113.146 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.3 t -92.84 -38.76 11.57 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.523 1.929 . . . . 0.0 112.582 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.37 139.36 31.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.44 1.096 . . . . 0.0 111.514 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -70.62 -42.21 71.23 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.179 -0.951 . . . . 0.0 113.324 -171.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.7 t -139.92 128.14 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.516 1.126 . . . . 0.0 109.511 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.0 t -133.42 130.28 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.461 1.505 . . . . 0.0 111.134 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -130.79 157.12 43.71 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.849 1.26 . . . . 0.0 110.47 170.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.56 151.58 51.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.542 0.686 . . . . 0.0 112.007 170.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 mt -133.22 169.45 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.433 1.493 . . . . 0.0 109.444 -166.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.94 112.59 23.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.835 -0.541 . . . . 0.0 111.487 144.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.46 -171.98 31.21 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.132 1.825 . . . . 0.0 114.296 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.4 mt -88.87 150.57 45.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.555 1.542 . . . . 0.0 110.546 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.25 -27.78 78.5 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.64 2.227 . . . . 0.0 114.541 -173.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.8 -21.87 56.92 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.966 -1.084 . . . . 0.0 113.036 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.61 68.2 14.63 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 125.716 1.606 . . . . 0.0 112.345 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.78 157.31 39.54 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.316 2.677 . . . . 0.0 112.427 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 mmt -96.34 10.35 38.31 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.711 1.204 . . . . 0.0 114.094 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.8 t -147.87 145.5 28.71 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.904 -1.122 . . . . 0.0 111.593 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.28 96.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -67.37 -31.91 72.48 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.449 -1.407 . . . . 0.0 112.628 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.4 m -63.84 -36.37 83.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.75 167.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.39 -40.13 89.48 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.993 1.27 . . . . 0.0 112.892 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -60.0 -35.7 75.61 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 119.67 1.123 . . . . 0.0 112.878 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.9 tpt -58.31 -46.79 85.48 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.168 0.587 . . . . 0.0 111.468 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.7 mm -71.89 -33.3 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.373 0.669 . . . . 0.0 112.06 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.35 -42.17 73.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.103 0.961 . . . . 0.0 111.147 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.425 HG13 ' HG ' ' A' ' 165' ' ' LEU . 3.8 t -62.98 -44.55 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.543 1.137 . . . . 0.0 111.586 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.22 -36.74 85.11 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.865 . . . . 0.0 112.645 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -71.37 -30.88 66.67 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.805 -1.185 . . . . 0.0 113.196 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.76 -33.8 74.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.803 0.729 . . . . 0.0 112.135 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 tp -94.38 -10.71 31.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.487 1.115 . . . . 0.0 112.811 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.06 8.89 70.51 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.956 1.741 . . . . 0.0 115.195 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 132.49 54.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.083 0.953 . . . . 0.0 111.058 173.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -114.73 153.2 30.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.121 0.963 . . . . 0.0 112.686 173.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.52 173.75 9.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.526 1.93 . . . . 0.0 111.258 -166.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.5 m -88.6 129.36 35.51 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.846 -1.159 . . . . 0.0 109.824 -167.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.7 p -114.3 141.29 47.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.098 1.759 . . . . 0.0 113.592 -163.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -128.12 161.72 28.57 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.91 1.284 . . . . 0.0 111.784 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -131.22 118.05 19.88 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.287 1.435 . . . . 0.0 112.752 -170.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.15 -21.05 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 tp -80.96 -22.1 39.82 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.321 1.048 . . . . 0.0 111.817 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.16 -40.04 16.06 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.03 -1.044 . . . . 0.0 111.905 170.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.408 ' HB3' HG12 ' A' ' 131' ' ' VAL . 59.6 m-70 -144.55 109.81 4.88 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.833 1.253 . . . . 0.0 112.319 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.95 -14.0 40.67 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.387 2.725 . . . . 0.0 114.994 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.408 HG12 ' HB3' ' A' ' 129' ' ' HIS . 7.8 p -46.9 -32.33 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 120.016 1.28 . . . . 0.0 113.032 169.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.0 t -58.01 -43.53 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.146 0.978 . . . . 0.0 111.688 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.449 ' HA ' HG12 ' A' ' 136' ' ' VAL . 23.8 ttp180 -68.83 -39.98 79.7 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.799 1.24 . . . . 0.0 111.528 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 m -65.76 -47.92 73.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -69.6 -39.69 77.11 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.162 -0.962 . . . . 0.0 112.04 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 133' ' ' ARG . 9.8 p -62.91 -35.76 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 120.2 1.364 . . . . 0.0 112.21 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -66.3 -47.66 72.88 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.075 0.95 . . . . 0.0 111.734 172.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -42.29 80.94 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.61 -34.84 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.815 1.246 . . . . 0.0 113.128 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 m -97.99 5.83 48.35 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -170.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 62.48 -40.77 0.16 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 127.797 2.439 . . . . 0.0 114.445 -162.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -135.91 134.73 20.69 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.48 1.912 . . . . 0.0 110.613 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.23 138.15 27.22 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.653 2.235 . . . . 0.0 112.192 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.0 136.6 44.21 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.505 1.522 . . . . 0.0 109.908 165.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.3 mt -127.95 131.7 23.94 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.907 173.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.92 163.16 88.24 Favored 'Cis proline' 0 CA--C 1.541 0.857 0 CA-C-N 119.929 1.01 . . . . 0.0 110.813 -12.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -150.36 172.85 14.74 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.761 0.824 . . . . 0.0 111.514 171.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.07 140.03 52.19 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -174.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -120.66 142.49 49.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 112.779 -2.009 . . . . 0.0 110.51 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.4 mt -122.24 118.32 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 tptt 45.88 48.9 12.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.146 2.178 . . . . 0.0 114.567 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 58.51 13.24 2.43 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -172.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -94.36 131.68 39.76 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.856 -1.153 . . . . 0.0 108.702 164.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -76.34 124.76 28.02 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.608 -0.682 . . . . 0.0 111.278 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.4 t -101.92 -46.82 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.735 1.214 . . . . 0.0 111.186 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.58 170.44 31.48 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.69 174.65 54.7 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.359 1.457 . . . . 0.0 114.02 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -48.62 -43.82 36.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.539 1.936 . . . . 0.0 113.331 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.27 -44.65 95.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.316 0.647 . . . . 0.0 110.321 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.84 -45.72 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.093 1.357 . . . . 0.0 111.207 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.9 t -57.52 -37.06 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.633 1.573 . . . . 0.0 110.945 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.0 m -63.09 -44.09 96.69 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.233 0.613 . . . . 0.0 111.721 172.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -63.2 -41.59 99.18 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.504 1.047 . . . . 0.0 110.796 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 38.2 mtt -63.24 -39.23 94.03 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.011 0.925 . . . . 0.0 111.946 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.425 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.2 tm? -68.58 -40.32 80.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.064 1.346 . . . . 0.0 112.195 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.32 -33.49 55.56 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.0 t -85.2 -21.26 29.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.044 1.338 . . . . 0.0 113.489 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.49 0.17 67.49 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.526 1.06 . . . . 0.0 114.788 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.03 -29.95 66.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.515 1.157 . . . . 0.0 113.633 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.62 -44.04 96.78 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.842 -1.162 . . . . 0.0 110.021 174.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -36.74 84.0 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.915 1.286 . . . . 0.0 113.039 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -59.47 -48.49 81.44 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.43 1.014 . . . . 0.0 111.194 171.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.3 mtm -69.9 -45.82 66.77 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 pp -66.33 -36.71 83.61 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.735 0.698 . . . . 0.0 112.059 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -64.01 -41.8 97.34 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.663 0.785 . . . . 0.0 111.536 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.94 -20.58 64.21 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.16 1.43 31.99 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.369 1.468 . . . . 0.0 112.485 170.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.04 17.27 74.94 Favored Glycine 0 N--CA 1.469 0.869 0 O-C-N 120.984 -1.073 . . . . 0.0 114.229 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.4 mt -103.05 146.93 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.686 1.195 . . . . 0.0 109.364 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.3 m -112.36 137.1 50.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.257 1.023 . . . . 0.0 110.651 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.1 p -132.22 168.53 17.89 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.638 1.575 . . . . 0.0 113.075 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -67.09 157.3 33.94 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.631 0.772 . . . . 0.0 111.406 169.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -90.23 105.0 17.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.469 1.107 . . . . 0.0 111.931 -170.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 58.1 tp . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.77 2.028 . . . . 0.0 112.607 -177.334 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.3 m -80.28 -32.75 38.12 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.02 0.928 . . . . 0.0 112.065 171.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.4 m 58.56 162.06 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.784 1.634 . . . . 0.0 113.367 -155.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.0 15.45 81.37 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.717 1.151 . . . . 0.0 115.197 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mt -86.22 140.72 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.243 1.417 . . . . 0.0 110.39 -172.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.37 126.76 28.51 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.292 0.949 . . . . 0.0 114.966 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.32 -147.1 43.59 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.443 1.021 . . . . 0.0 113.848 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -148.69 155.18 40.67 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.419 -1.047 . . . . 0.0 111.395 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.53 139.77 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 121.201 -0.937 . . . . 0.0 111.864 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -88.69 139.98 29.92 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.011 0.924 . . . . 0.0 111.515 171.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -87.6 151.18 23.18 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.274 1.03 . . . . 0.0 111.724 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.0 mt -112.56 144.06 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.293 1.837 . . . . 0.0 108.665 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.08 122.01 21.11 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.204 -0.935 . . . . 0.0 110.246 173.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -63.11 125.83 25.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.07 0.948 . . . . 0.0 111.916 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.0 p -131.69 137.84 48.44 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.564 1.546 . . . . 0.0 109.136 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 18.3 p80 -94.06 145.76 30.39 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -164.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 58' ' ' HIS . 32.2 Cg_exo -63.37 151.18 86.16 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.856 3.038 . . . . 0.0 113.205 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -96.21 -4.3 42.73 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -129.73 117.45 20.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.542 1.137 . . . . 0.0 111.464 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -107.23 143.19 26.65 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.543 1.937 . . . . 0.0 111.508 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -67.55 151.67 79.35 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.164 2.576 . . . . 0.0 111.649 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -68.31 128.76 37.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.147 0.979 . . . . 0.0 112.109 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -149.86 149.58 30.67 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.445 1.498 . . . . 0.0 110.565 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.1 t -111.45 -33.64 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.744 1.218 . . . . 0.0 111.487 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.0 m -68.78 167.73 14.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.584 1.153 . . . . 0.0 111.289 159.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.68 130.5 35.95 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.642 0.734 . . . . 0.0 112.147 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -151.0 150.03 30.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.116 2.166 . . . . 0.0 107.209 160.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 tp -134.75 152.44 51.76 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.606 1.094 . . . . 0.0 111.895 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.83 146.92 35.44 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.563 1.145 . . . . 0.0 113.119 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -54.25 -44.54 71.89 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.968 1.307 . . . . 0.0 113.554 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -71.51 -31.37 67.01 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.325 0.511 . . . . 0.0 112.169 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.92 -28.56 63.57 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.279 -0.888 . . . . 0.0 111.963 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.9 mt -72.77 -27.78 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.978 1.311 . . . . 0.0 111.321 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.9 8.74 7.61 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.907 1.283 . . . . 0.0 114.059 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 7.4 mmt -115.43 116.48 28.29 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.931 1.693 . . . . 0.0 110.481 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.4 147.88 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.186 0.995 . . . . 0.0 112.618 -172.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -92.85 128.88 38.87 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.533 1.133 . . . . 0.0 111.422 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -60.97 -29.16 69.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.872 0.869 . . . . 0.0 112.288 167.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.38 -37.68 75.75 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.056 0.942 . . . . 0.0 112.861 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 97.5 mt -75.99 -44.9 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.661 1.184 . . . . 0.0 110.119 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.41 -38.4 71.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.856 1.263 . . . . 0.0 112.15 171.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.4 -28.5 64.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.898 0.879 . . . . 0.0 113.107 172.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.7 m -70.16 -47.2 62.65 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 120.335 1.425 . . . . 0.0 110.948 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.8 pt -62.0 -32.47 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.421 1.088 . . . . 0.0 112.914 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -79.15 -30.64 43.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.707 2.003 . . . . 0.0 113.825 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t -80.31 -28.0 38.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.067 1.747 . . . . 0.0 113.248 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -84.85 150.12 25.22 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.905 -1.122 . . . . 0.0 111.344 167.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -76.45 -45.79 29.8 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.632 -1.292 . . . . 0.0 111.691 169.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.9 t -145.33 131.38 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.561 1.144 . . . . 0.0 111.087 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.86 131.67 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.675 1.19 . . . . 0.0 111.663 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 t -134.31 154.96 51.02 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.894 1.277 . . . . 0.0 111.733 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -132.43 139.62 48.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.923 0.889 . . . . 0.0 111.472 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 mt -132.78 157.51 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.849 2.059 . . . . 0.0 108.853 -164.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -78.17 115.21 17.73 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 147.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.99 -152.9 25.07 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.185 0.897 . . . . 0.0 113.551 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.1 mt -104.96 152.59 39.64 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 124.932 1.293 . . . . 0.0 110.596 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.08 -31.72 54.42 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 121.758 1.639 . . . . 0.0 113.453 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -81.22 -13.28 58.71 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.406 -0.809 . . . . 0.0 112.95 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.55 67.66 52.2 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.97 1.708 . . . . 0.0 112.096 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.42 142.46 59.78 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.651 2.901 . . . . 0.0 112.964 -172.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 90.7 mtp -105.65 3.78 29.48 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 37.0 t -134.6 146.52 49.68 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.831 2.053 . . . . 0.0 111.06 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.07 -46.57 85.23 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.354 -0.842 . . . . 0.0 112.018 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -67.09 -25.47 66.24 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.018 -1.051 . . . . 0.0 112.056 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.4 p -71.45 -39.05 71.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 168.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -58.69 -45.32 89.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.75 1.159 . . . . 0.0 110.203 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -62.56 -39.78 94.74 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.292 1.037 . . . . 0.0 112.438 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.5 tpt -55.86 -49.61 72.85 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.791 1.178 . . . . 0.0 111.678 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.7 mm -70.38 -32.68 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.869 -0.519 . . . . 0.0 112.339 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -59.9 -36.27 76.62 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.003 -1.061 . . . . 0.0 112.927 171.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.23 -36.36 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.732 0.813 . . . . 0.0 110.596 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.89 -37.48 87.79 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.35 -0.844 . . . . 0.0 112.885 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -65.08 -33.89 77.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.757 -1.214 . . . . 0.0 111.41 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.35 -30.96 70.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.06 0.944 . . . . 0.0 112.314 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.2 tp -82.27 -16.98 47.53 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.695 0.68 . . . . 0.0 112.626 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.64 9.49 58.9 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.611 1.101 . . . . 0.0 115.166 -174.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.5 mt -114.81 133.97 55.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.53 1.532 . . . . 0.0 113.668 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -115.63 153.43 31.29 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.755 1.264 . . . . 0.0 113.044 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -137.19 175.01 10.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.616 1.967 . . . . 0.0 111.799 -156.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.8 m -85.79 117.36 24.61 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.548 -1.345 . . . . 0.0 108.943 -168.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.2 m -127.87 133.05 49.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.141 -153.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -129.63 149.83 51.22 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -172.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -99.45 98.16 9.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.697 1.599 . . . . 0.0 111.846 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.6 -21.94 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.018 0.927 . . . . 0.0 113.229 -175.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.3 tp -73.4 -28.62 62.1 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.626 -0.671 . . . . 0.0 111.565 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.14 -32.78 11.78 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -124.12 103.97 32.74 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.745 1.157 . . . . 0.0 113.661 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -57.27 -19.75 36.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.151 3.234 . . . . 0.0 115.371 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.14 -39.31 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 120.315 1.416 . . . . 0.0 112.452 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.95 -42.53 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.186 0.994 . . . . 0.0 111.119 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 136' ' ' VAL . 2.4 ptm180 -69.99 -30.47 67.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.524 1.13 . . . . 0.0 112.148 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m -68.84 -48.98 62.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.831 0.852 . . . . 0.0 112.601 170.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -61.35 -46.67 89.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.427 0.558 . . . . 0.0 110.604 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 133' ' ' ARG . 8.0 p -66.85 -32.83 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.483 -0.76 . . . . 0.0 112.873 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -70.25 -41.62 73.27 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.826 1.194 . . . . 0.0 112.929 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -61.63 -40.42 94.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.982 0.81 . . . . 0.0 112.723 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.0 t -83.8 -50.62 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 53.9 p -113.66 -0.62 14.25 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 65.08 -49.76 0.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.112 2.165 . . . . 0.0 116.138 -172.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -132.26 116.52 15.41 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 119.909 1.231 . . . . 0.0 112.337 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.94 144.86 21.88 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.339 2.693 . . . . 0.0 112.2 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.7 m -135.2 110.7 9.13 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.437 0.695 . . . . 0.0 109.335 161.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.3 pt -91.59 163.96 26.21 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -160.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.18 154.48 98.36 Favored 'Cis proline' 0 C--N 1.352 0.747 0 CA-C-N 119.195 0.748 . . . . 0.0 111.048 -21.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -136.54 153.12 51.08 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.816 1.246 . . . . 0.0 111.273 -170.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.31 140.63 51.35 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.931 1.292 . . . . 0.0 113.536 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -131.47 143.01 50.11 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.483 1.913 . . . . 0.0 109.718 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.0 mt -125.98 115.85 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.797 0.839 . . . . 0.0 108.903 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . 0.339 17.5 ttmm 40.9 57.65 2.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.076 2.15 . . . . 0.0 114.404 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 67.45 9.22 6.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.91 138.42 37.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.551 1.14 . . . . 0.0 110.306 168.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -79.82 123.71 27.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.607 1.194 . . . . 0.0 111.716 175.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.38 -48.72 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.767 1.227 . . . . 0.0 110.584 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.61 -179.68 27.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 168.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.24 173.66 53.88 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.55 1.072 . . . . 0.0 113.442 167.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -42.75 -46.56 5.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.339 1.856 . . . . 0.0 113.765 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -70.02 -26.52 64.09 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.628 -0.67 . . . . 0.0 112.304 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 mm -79.26 -46.51 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.834 1.254 . . . . 0.0 110.316 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.12 -38.56 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.11 0.964 . . . . 0.0 110.572 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 69.3 m -60.88 -46.21 91.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.08 0.952 . . . . 0.0 111.566 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -60.17 -43.86 95.49 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.091 0.956 . . . . 0.0 111.565 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.6 mtt -69.0 -35.25 76.48 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.412 -0.805 . . . . 0.0 112.953 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -69.56 -41.3 76.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.31 1.044 . . . . 0.0 111.506 172.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -65.07 -36.58 84.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.301 1.04 . . . . 0.0 113.183 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.3 t -88.79 -9.43 51.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.427 1.491 . . . . 0.0 114.032 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.84 4.46 82.36 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.247 -1.533 . . . . 0.0 114.201 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.2 -32.36 70.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.347 1.459 . . . . 0.0 112.936 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.16 -46.28 81.51 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.054 -1.029 . . . . 0.0 109.932 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -59.05 -41.1 87.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.745 1.618 . . . . 0.0 112.728 169.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -58.09 -42.66 86.08 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.954 0.902 . . . . 0.0 111.035 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 62.4 mtm -69.6 -50.32 45.67 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -69.08 -37.38 78.42 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -65.09 -34.24 77.94 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.04 0.936 . . . . 0.0 111.44 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.72 -29.65 69.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.238 1.415 . . . . 0.0 112.493 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -89.19 6.02 42.07 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.043 2.137 . . . . 0.0 114.306 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.48 19.43 60.29 Favored Glycine 0 N--CA 1.469 0.867 0 O-C-N 121.12 -0.987 . . . . 0.0 114.44 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.02 147.68 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.33 1.052 . . . . 0.0 110.792 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 95.8 m -102.69 126.2 49.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.749 1.22 . . . . 0.0 111.572 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.8 p -127.48 168.99 14.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.888 2.075 . . . . 0.0 111.156 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 19.1 mtp-105 -68.33 155.59 39.46 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.906 0.86 . . . . 0.0 112.99 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -98.14 134.46 41.18 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.657 1.983 . . . . 0.0 109.463 158.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.1 tp . . . . . 0 C--O 1.253 1.255 0 C-N-CA 127.607 2.363 . . . . 0.0 115.141 -176.773 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.3 m -90.21 -9.14 49.21 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.864 0.866 . . . . 0.0 112.691 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.1 m -57.2 126.19 26.13 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.636 -1.29 . . . . 0.0 111.718 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.94 3.63 87.71 Favored Glycine 0 CA--C 1.54 1.64 0 N-CA-C 117.045 1.578 . . . . 0.0 117.045 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.7 mt -84.49 95.15 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.316 2.058 . . . . 0.0 110.06 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.62 158.76 20.21 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.318 1.437 . . . . 0.0 112.634 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.9 163.23 54.6 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 116.463 1.345 . . . . 0.0 116.463 -169.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -67.77 139.04 56.63 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.437 -1.037 . . . . 0.0 112.89 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -93.57 137.32 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.894 1.278 . . . . 0.0 109.809 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -129.69 153.12 48.46 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.309 1.044 . . . . 0.0 112.973 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -78.77 84.66 4.82 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.173 0.589 . . . . 0.0 111.352 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.3 tp -134.93 21.18 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.183 1.393 . . . . 0.0 113.92 -166.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -140.53 150.64 43.96 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.574 1.55 . . . . 0.0 111.696 167.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -109.86 147.17 33.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.377 1.871 . . . . 0.0 110.487 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.3 p -134.49 164.88 26.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.821 1.248 . . . . 0.0 112.017 170.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.33 159.23 51.37 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.887 1.275 . . . . 0.0 112.475 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.33 155.46 36.9 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.494 2.13 . . . . 0.0 115.282 -154.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.58 -9.5 59.63 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.201 1.8 . . . . 0.0 113.529 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -144.84 139.92 28.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.336 1.854 . . . . 0.0 109.99 -174.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -93.46 153.13 41.4 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -165.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.4 155.4 62.48 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.685 3.59 . . . . 0.0 113.543 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -122.68 110.24 15.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.124 1.77 . . . . 0.0 111.338 -176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 tp 60.46 -30.24 0.05 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 130.834 3.654 . . . . 0.0 117.631 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 m -130.29 155.45 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.41 1.884 . . . . 0.0 111.194 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.6 p -140.39 164.27 30.55 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -174.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.74 153.79 42.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.788 1.235 . . . . 0.0 113.004 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.62 -49.94 64.64 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.327 1.051 . . . . 0.0 111.582 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.47 132.83 55.4 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.0 1.32 . . . . 0.0 110.422 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.54 162.17 18.67 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.435 1.494 . . . . 0.0 113.66 -175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -52.56 -44.78 66.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.281 1.432 . . . . 0.0 113.543 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -75.31 -37.95 60.53 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.465 1.506 . . . . 0.0 112.369 174.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.7 -29.5 67.95 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.486 1.514 . . . . 0.0 112.356 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.5 tp -89.66 -12.25 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.402 1.481 . . . . 0.0 113.159 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.14 -25.82 15.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.733 1.213 . . . . 0.0 113.617 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.7 ttp -75.12 133.46 41.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.216 1.806 . . . . 0.0 111.008 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.7 84.29 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.34 0.656 . . . . 0.0 110.29 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -72.4 114.69 10.79 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.104 0.962 . . . . 0.0 112.437 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -57.8 -25.36 60.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.655 1.182 . . . . 0.0 113.433 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.18 -28.26 64.6 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.693 1.133 . . . . 0.0 113.037 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.2 mm -70.04 -49.09 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 120.794 1.634 . . . . 0.0 110.701 171.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.82 -39.21 93.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.372 1.469 . . . . 0.0 112.244 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.85 -29.68 61.11 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.346 -0.846 . . . . 0.0 112.559 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.1 m -66.31 -46.14 77.94 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.987 1.267 . . . . 0.0 110.933 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 pt -63.81 -34.6 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.576 0.75 . . . . 0.0 112.925 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -78.95 -39.38 34.69 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.22 1.408 . . . . 0.0 112.964 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.2 t -85.02 -11.06 56.26 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.309 1.044 . . . . 0.0 113.446 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -89.52 148.67 23.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.362 1.865 . . . . 0.0 111.449 165.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -87.28 -42.84 12.62 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.783 -1.198 . . . . 0.0 113.205 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.27 130.49 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.062 1.345 . . . . 0.0 110.265 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.4 t -131.51 130.51 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.779 1.632 . . . . 0.0 111.278 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 t -133.5 156.18 48.23 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.084 1.354 . . . . 0.0 111.186 171.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -129.62 139.77 51.35 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.42 0.688 . . . . 0.0 111.872 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.83 156.57 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.26 1.424 . . . . 0.0 109.876 -163.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.9 102.86 1.66 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.852 -0.53 . . . . 0.0 109.665 155.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.74 -160.0 33.67 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 118.887 0.767 . . . . 0.0 114.783 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.51 153.68 48.26 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.951 2.1 . . . . 0.0 112.516 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -66.75 -15.59 47.79 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.311 2.674 . . . . 0.0 114.823 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -94.84 -20.43 19.46 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.45 69.26 21.21 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.416 1.486 . . . . 0.0 110.84 -171.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.54 144.01 48.71 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.058 2.505 . . . . 0.0 111.655 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 mmt -93.36 2.41 56.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.13 1.372 . . . . 0.0 113.741 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 53.6 t -142.12 145.64 34.48 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.804 1.642 . . . . 0.0 111.488 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.77 95.63 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.878 0.871 . . . . 0.0 112.731 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.08 -24.06 62.24 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.592 -1.317 . . . . 0.0 112.354 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 m -69.77 -36.44 75.77 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.427 -0.796 . . . . 0.0 112.362 166.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -62.29 -42.02 98.99 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.605 1.162 . . . . 0.0 112.021 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -55.84 -29.83 60.46 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.068 1.347 . . . . 0.0 113.526 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.2 tpt -69.24 -43.57 73.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.986 0.915 . . . . 0.0 111.756 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.4 mm -65.46 -36.44 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.752 0.821 . . . . 0.0 111.014 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.63 -40.44 79.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.213 1.005 . . . . 0.0 112.955 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.12 -42.93 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.921 1.289 . . . . 0.0 111.659 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.1 mt -65.39 -36.77 84.99 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.739 0.815 . . . . 0.0 112.548 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -67.07 -35.47 79.9 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.374 -1.454 . . . . 0.0 112.443 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.31 -21.66 65.67 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.57 -13.27 20.49 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.64 1.576 . . . . 0.0 114.124 170.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.74 71.3 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.433 1.492 . . . . 0.0 115.479 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.8 mp -112.09 144.89 40.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.26 1.424 . . . . 0.0 111.321 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -113.75 130.17 56.48 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.617 0.767 . . . . 0.0 110.649 166.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -104.82 170.6 7.78 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.023 1.729 . . . . 0.0 111.26 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -86.34 119.83 27.04 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.5 -1.375 . . . . 0.0 109.45 -157.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.2 m -113.23 129.71 56.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.339 -158.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -115.07 155.05 27.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.994 1.317 . . . . 0.0 111.059 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -111.21 94.95 5.24 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.845 1.258 . . . . 0.0 110.48 -168.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 p -70.02 -23.2 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.236 1.015 . . . . 0.0 112.953 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.9 tp -78.35 -30.75 48.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.081 0.952 . . . . 0.0 111.424 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.53 -35.28 19.63 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -131.32 98.93 17.94 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.825 0.85 . . . . 0.0 111.945 -170.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.97 -12.23 33.56 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.394 2.729 . . . . 0.0 114.761 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.0 p -49.1 -42.04 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.717 1.207 . . . . 0.0 112.489 170.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.75 -46.27 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.802 0.841 . . . . 0.0 111.704 -177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.455 ' HA ' HG12 ' A' ' 136' ' ' VAL . 50.8 ptt85 -71.33 -23.75 61.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -70.36 -51.43 29.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.116 0.567 . . . . 0.0 112.11 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -70.96 -37.99 72.8 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.641 -0.662 . . . . 0.0 112.429 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 133' ' ' ARG . 8.9 p -65.39 -34.95 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.362 -0.836 . . . . 0.0 112.557 176.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -66.72 -43.22 84.86 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.338 -0.851 . . . . 0.0 110.991 171.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.92 -42.69 80.44 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.678 0.791 . . . . 0.0 113.037 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -80.26 -45.28 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.618 1.167 . . . . 0.0 112.988 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.5 m -106.05 -5.93 19.09 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 62.65 -25.99 0.06 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 128.075 2.55 . . . . 0.0 115.973 -172.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -136.28 92.0 16.14 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 127.2 2.2 . . . . 0.0 112.045 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -72.31 147.64 47.73 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.624 2.883 . . . . 0.0 114.317 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.4 m -125.99 137.27 53.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.616 1.566 . . . . 0.0 107.842 160.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mp -108.04 133.26 20.57 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.45 159.1 73.35 Favored 'Cis proline' 0 CA--C 1.546 1.091 0 CA-C-N 120.706 1.288 . . . . 0.0 112.012 -12.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -137.92 164.28 29.39 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.953 1.701 . . . . 0.0 110.913 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.7 139.62 52.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 122.776 1.274 . . . . 0.0 114.209 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -125.43 140.31 52.9 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 112.741 -2.027 . . . . 0.0 110.247 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 57.3 mt -128.87 121.85 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.293 1.037 . . . . 0.0 109.138 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt 45.12 51.13 9.18 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.064 1.746 . . . . 0.0 113.008 -172.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.63 10.21 1.88 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 -175.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.58 143.63 28.77 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.193 1.36 . . . . 0.0 110.516 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -86.35 123.59 31.76 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.701 0.763 . . . . 0.0 112.909 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.8 -50.92 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.459 1.504 . . . . 0.0 111.964 -171.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 175.19 163.85 28.88 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 117.238 1.655 . . . . 0.0 117.238 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.72 168.94 53.98 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 125.575 1.56 . . . . 0.0 114.124 167.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.0 tp -44.19 -42.05 6.19 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.947 1.699 . . . . 0.0 115.01 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -67.9 -38.06 82.52 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.799 -0.563 . . . . 0.0 111.338 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.4 mm -74.97 -39.12 44.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 C-N-CA 125.131 1.373 . . . . 0.0 110.26 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.05 -42.42 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 120.971 -1.081 . . . . 0.0 110.696 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.9 m -65.33 -43.87 89.59 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.703 0.801 . . . . 0.0 111.427 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -56.8 -46.25 81.7 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.72 1.208 . . . . 0.0 111.74 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.9 mtt -67.05 -35.26 79.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.752 1.621 . . . . 0.0 112.7 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.84 -46.54 68.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.389 1.076 . . . . 0.0 111.109 173.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.96 -17.39 64.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.003 1.321 . . . . 0.0 112.906 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.2 m -101.03 -16.18 17.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.218 1.407 . . . . 0.0 114.788 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.26 -4.12 73.68 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 120.21 1.368 . . . . 0.0 114.446 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -65.14 -32.03 73.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.556 1.678 . . . . 0.0 112.922 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.71 -43.3 98.0 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.114 172.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -64.35 -38.71 91.99 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.518 1.527 . . . . 0.0 112.726 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -58.43 -48.82 79.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.722 1.146 . . . . 0.0 110.92 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.9 mtm -69.59 -44.92 69.8 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 pp -66.16 -40.83 90.82 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.011 0.369 . . . . 0.0 111.435 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -71.75 -32.28 67.54 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.426 -0.796 . . . . 0.0 112.963 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.18 -26.51 68.18 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.363 0.529 . . . . 0.0 112.407 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -76.23 4.44 8.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.592 1.557 . . . . 0.0 113.875 169.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.42 0.02 89.85 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.273 1.892 . . . . 0.0 113.671 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.3 mt -84.81 144.53 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 118.782 1.291 . . . . 0.0 109.862 -169.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.9 m -108.23 139.6 42.68 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.355 1.462 . . . . 0.0 111.094 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 21.8 p -137.17 170.04 16.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.924 1.689 . . . . 0.0 112.16 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -47.26 155.1 0.34 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 121.536 -0.727 . . . . 0.0 112.512 167.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -118.05 130.43 56.15 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.151 0.981 . . . . 0.0 108.861 154.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.9 tp . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.866 1.666 . . . . 0.0 112.025 -165.058 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 m -70.37 -7.45 42.94 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.7 m -53.14 120.38 5.85 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.911 -1.118 . . . . 0.0 111.888 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.84 -6.19 42.47 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 126.576 2.036 . . . . 0.0 117.085 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.1 mt -80.46 126.76 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.478 2.139 . . . . 0.0 112.68 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.69 167.11 39.42 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 125.538 1.542 . . . . 0.0 114.59 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.66 167.94 34.71 Favored Glycine 0 CA--C 1.536 1.382 0 O-C-N 121.635 -0.921 . . . . 0.0 115.115 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -137.44 160.9 37.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.458 1.503 . . . . 0.0 114.037 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -135.27 149.79 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.854 2.062 . . . . 0.0 111.469 -167.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.34 152.93 18.84 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 126.358 1.863 . . . . 0.0 113.466 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -117.13 151.33 37.07 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.216 1.406 . . . . 0.0 114.716 -168.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.0 mt -112.51 132.28 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 126.033 1.733 . . . . 0.0 111.088 -171.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -73.32 125.09 27.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.812 0.845 . . . . 0.0 113.089 177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.91 132.99 35.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.772 1.229 . . . . 0.0 109.792 169.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.6 m -136.61 -17.84 1.46 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.61 1.964 . . . . 0.0 111.593 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 53.0 t-80 -59.87 148.51 76.22 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 126.106 1.762 . . . . 0.0 112.981 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 58' ' ' HIS . 82.6 Cg_exo -63.13 -179.33 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.275 3.317 . . . . 0.0 116.924 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.99 0.14 25.53 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.164 2.186 . . . . 0.0 114.477 -176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -133.23 123.91 26.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.761 1.224 . . . . 0.0 111.264 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -73.28 145.07 85.12 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 122.891 0.476 . . . . 0.0 111.364 -175.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -59.87 154.12 52.3 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.652 2.235 . . . . 0.0 112.707 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -106.5 140.58 39.17 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.308 1.443 . . . . 0.0 109.695 171.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.9 tp -163.53 148.61 11.02 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.201 1.4 . . . . 0.0 111.822 -176.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 t -67.17 -49.46 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.912 0.885 . . . . 0.0 111.938 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.7 m -74.77 153.52 38.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.054 0.942 . . . . 0.0 111.867 173.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.39 106.79 5.35 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.796 0.838 . . . . 0.0 112.261 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -156.6 153.77 29.13 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.212 1.405 . . . . 0.0 110.109 169.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.6 mt -135.95 167.31 21.45 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.119 1.767 . . . . 0.0 110.987 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.24 176.13 2.36 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.941 1.296 . . . . 0.0 113.637 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -62.33 -26.35 68.39 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.372 -0.83 . . . . 0.0 112.044 170.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.252 0.4 OUTLIER -66.02 -25.55 67.12 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 120.339 -1.475 . . . . 0.0 114.021 -176.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -59.1 -22.83 61.45 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.746 1.618 . . . . 0.0 112.967 166.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.9 mt -85.17 -26.94 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.209 1.404 . . . . 0.0 110.505 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.23 14.66 13.73 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.236 1.814 . . . . 0.0 113.744 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.0 ttt -59.15 149.99 26.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.96 1.304 . . . . 0.0 113.113 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.7 m -45.18 148.65 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.898 1.679 . . . . 0.0 113.913 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -85.3 153.4 22.6 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.029 1.332 . . . . 0.0 111.646 -166.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -58.15 -28.51 64.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.177 1.391 . . . . 0.0 114.326 -170.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -58.01 -31.35 66.88 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.473 1.509 . . . . 0.0 113.599 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 40.0 mm -75.17 -48.28 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.682 1.193 . . . . 0.0 110.179 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.54 -37.97 82.97 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.55 1.14 . . . . 0.0 111.89 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.88 -30.34 71.45 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.957 1.703 . . . . 0.0 112.68 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.6 m -76.89 -48.35 18.54 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.216 1.406 . . . . 0.0 110.334 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.432 HD13 ' CE2' ' A' ' 135' ' ' TYR . 29.4 mt -55.94 -36.4 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 127.685 2.394 . . . . 0.0 110.924 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -75.83 -30.17 58.89 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 126.535 1.934 . . . . 0.0 114.729 171.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.4 t -78.94 -39.93 33.32 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.509 0.724 . . . . 0.0 112.224 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -90.16 140.93 29.18 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -170.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -66.38 -39.6 89.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.37 0.668 . . . . 0.0 112.631 -171.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.1 t -140.77 133.72 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 109.759 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.44 134.14 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.778 1.231 . . . . 0.0 110.089 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.6 t -131.86 155.39 47.92 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.083 0.953 . . . . 0.0 111.237 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -133.31 135.88 45.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.426 0.632 . . . . 0.0 111.899 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.5 mt -133.95 153.69 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 109.015 -157.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -69.49 104.58 2.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 158.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.08 -134.16 12.75 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.829 1.204 . . . . 0.0 114.337 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.1 mt -126.33 157.72 69.31 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 126.342 1.857 . . . . 0.0 111.658 -168.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.25 -21.5 31.13 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.127 1.885 . . . . 0.0 113.833 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.23 -22.22 35.97 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.477 1.111 . . . . 0.0 113.108 167.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.22 74.02 11.87 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.4 1.48 . . . . 0.0 113.046 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.37 143.65 22.26 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.948 2.432 . . . . 0.0 111.262 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 51.0 ttm -110.14 7.18 23.31 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.256 1.822 . . . . 0.0 113.081 -163.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 54.1 t -150.63 149.01 29.32 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.647 1.979 . . . . 0.0 111.041 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.75 93.99 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.32 0.964 . . . . 0.0 112.702 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -66.93 -31.45 72.05 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.83 -1.169 . . . . 0.0 111.42 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.6 m -70.39 -37.96 74.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 118.265 -0.874 . . . . 0.0 112.933 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -55.94 -47.36 77.7 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 120.199 1.363 . . . . 0.0 110.703 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -61.81 -31.9 72.16 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.9 tpt -61.41 -44.35 97.29 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.668 0.667 . . . . 0.0 111.517 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.0 mm -68.28 -37.95 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.075 0.55 . . . . 0.0 111.146 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.4 -40.56 78.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.032 0.933 . . . . 0.0 112.58 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.77 -44.3 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.272 0.629 . . . . 0.0 111.506 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.6 mt -65.9 -36.98 84.91 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.813 0.845 . . . . 0.0 112.317 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -66.01 -32.99 74.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.562 1.145 . . . . 0.0 112.917 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.95 76.6 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.715 0.806 . . . . 0.0 111.978 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.65 -14.81 44.41 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.886 0.874 . . . . 0.0 113.092 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.57 14.17 62.05 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.619 1.104 . . . . 0.0 114.26 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 58.0 mt -112.07 128.44 56.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.209 1.004 . . . . 0.0 111.315 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -115.54 144.69 43.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.854 1.262 . . . . 0.0 111.17 172.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -125.12 169.95 11.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.384 1.874 . . . . 0.0 111.809 -166.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.1 m -85.07 126.29 33.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 122.495 1.141 . . . . 0.0 109.44 -166.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.1 m -123.72 138.93 54.43 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 113.681 -1.6 . . . . 0.0 112.095 -155.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.6 139.43 53.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -84.01 112.19 19.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.343 2.257 . . . . 0.0 111.495 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.4 m -70.35 -17.85 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.1 tp -87.36 -19.97 27.39 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.607 1.163 . . . . 0.0 111.957 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.24 -29.07 13.78 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.764 1.225 . . . . 0.0 113.366 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.32 96.9 38.23 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -53.11 -26.75 34.09 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.569 3.512 . . . . 0.0 115.501 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.27 -36.04 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.112 0.965 . . . . 0.0 113.595 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 63.1 t -69.75 -51.48 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.964 0.906 . . . . 0.0 110.819 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.461 ' HA ' HG12 ' A' ' 136' ' ' VAL . 8.1 ptm180 -63.98 -26.12 68.44 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.673 175.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.9 m -71.61 -48.05 50.65 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.49 ' CZ ' HG21 ' A' ' 139' ' ' VAL . 48.7 t80 -61.02 -48.05 83.6 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 120.752 1.615 . . . . 0.0 109.807 176.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 133' ' ' ARG . 9.1 p -66.64 -35.26 74.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 121.283 -0.886 . . . . 0.0 112.837 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -59.26 -46.61 88.05 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.19 1.396 . . . . 0.0 112.102 171.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.25 -46.64 40.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.301 1.04 . . . . 0.0 112.9 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.49 HG21 ' CZ ' ' A' ' 135' ' ' TYR . 86.6 t -81.3 -36.19 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.629 1.572 . . . . 0.0 112.632 -164.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.4 m -104.97 4.22 31.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 58.19 -5.89 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.89 2.476 . . . . 0.0 117.358 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -146.27 121.43 5.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.638 1.975 . . . . 0.0 108.598 166.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.25 130.44 7.2 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.66 2.24 . . . . 0.0 111.801 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 68.5 p -128.45 136.85 51.41 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.968 1.307 . . . . 0.0 110.886 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.0 mt -130.03 140.56 39.01 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.259 1.424 . . . . 0.0 110.452 -172.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.17 156.42 78.76 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 120.939 1.371 . . . . 0.0 110.895 -8.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -138.25 160.01 40.56 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.69 135.61 52.31 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.536 1.134 . . . . 0.0 112.192 177.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -127.21 141.65 51.68 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.637 1.975 . . . . 0.0 109.155 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.6 mt -130.61 118.5 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.2 tptt 46.74 52.88 10.84 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 127.331 2.253 . . . . 0.0 115.647 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.81 28.64 18.38 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -127.89 137.29 52.26 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.093 -1.004 . . . . 0.0 110.508 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -70.35 130.39 41.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.408 0.623 . . . . 0.0 112.121 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.75 -47.58 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.063 0.945 . . . . 0.0 110.181 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.15 175.31 22.17 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.519 0.967 . . . . 0.0 115.519 171.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.64 169.99 54.65 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.258 0.933 . . . . 0.0 112.793 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.23 -43.4 10.28 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.109 1.364 . . . . 0.0 113.189 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.45 ' O ' ' HE3' ' A' ' 163' ' ' LYS . 19.7 t70 -60.24 -24.87 65.22 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.943 0.897 . . . . 0.0 113.283 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.4 mm -92.1 -47.01 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.675 1.59 . . . . 0.0 110.471 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.04 -36.55 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.361 1.864 . . . . 0.0 111.808 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -60.58 -50.92 71.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 159' ' ' ASP . 60.1 mttt -60.86 -38.62 86.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.625 0.37 . . . . 0.0 110.231 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.5 mtp -67.85 -35.5 78.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.748 0.819 . . . . 0.0 112.577 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.59 -46.24 69.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.602 1.161 . . . . 0.0 111.721 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -74.13 -16.29 61.01 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.8 m -100.78 -9.86 21.34 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.09 1.356 . . . . 0.0 114.353 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.17 -4.25 67.93 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-N 119.661 1.119 . . . . 0.0 114.453 -170.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.99 -34.12 74.3 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.866 -1.373 . . . . 0.0 113.532 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tt -61.67 -41.01 96.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.763 1.225 . . . . 0.0 111.029 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -67.31 -31.3 71.5 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.303 1.841 . . . . 0.0 113.239 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -57.02 -43.14 81.54 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.24 1.016 . . . . 0.0 111.837 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -73.6 -49.57 25.53 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 172.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.65 -39.02 90.94 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.844 -0.535 . . . . 0.0 112.128 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -69.49 -40.76 76.85 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.683 0.793 . . . . 0.0 111.393 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.82 -27.7 65.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.536 1.535 . . . . 0.0 113.455 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -75.06 -4.49 38.77 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.403 -0.81 . . . . 0.0 112.877 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.59 15.81 51.48 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 125.072 1.32 . . . . 0.0 114.498 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.0 mt -103.8 123.72 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.159 0.98 . . . . 0.0 109.976 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.3 m -85.27 133.58 34.16 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.36 0.6 . . . . 0.0 111.633 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -128.92 170.14 13.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.494 2.318 . . . . 0.0 111.957 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -81.38 154.02 26.67 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.395 -0.815 . . . . 0.0 111.278 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -81.19 139.5 35.51 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.255 1.385 0 C-N-CA 126.814 2.046 . . . . 0.0 113.119 -178.194 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.1 m -65.24 -24.05 67.22 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.299 1.408 . . . . 0.0 113.672 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.5 m -83.21 -7.57 59.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.84 22.72 78.29 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.419 1.009 . . . . 0.0 115.265 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.0 pt -100.25 153.86 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.578 1.551 . . . . 0.0 112.842 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.44 164.06 35.97 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.708 0.671 . . . . 0.0 114.44 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.46 -131.4 7.13 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.365 1.936 . . . . 0.0 113.488 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -109.17 106.75 16.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.112 2.165 . . . . 0.0 109.814 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.9 p -148.03 142.49 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.051 1.34 . . . . 0.0 111.011 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -142.62 150.98 41.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.153 1.381 . . . . 0.0 112.559 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -127.11 141.03 51.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.455 1.902 . . . . 0.0 110.368 173.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.0 mm -80.42 124.48 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.439 -0.788 . . . . 0.0 111.953 -175.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -155.72 127.02 7.16 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.14 1.776 . . . . 0.0 110.067 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -145.29 154.43 42.35 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.12 2.568 . . . . 0.0 111.077 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.7 p -73.5 134.46 43.87 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -93.57 146.69 32.26 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.348 1.059 . . . . 0.0 110.784 164.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.45 158.71 36.44 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.139 2.559 . . . . 0.0 111.602 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -92.18 -4.55 54.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.226 1.011 . . . . 0.0 113.328 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -142.24 153.56 44.06 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.707 1.603 . . . . 0.0 111.69 -174.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -105.98 154.16 39.68 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 126.09 1.756 . . . . 0.0 111.777 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.73 155.29 63.01 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.887 3.058 . . . . 0.0 116.162 -168.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -119.93 123.96 44.83 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.43 2.292 . . . . 0.0 110.387 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt 52.96 31.91 11.77 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.823 2.049 . . . . 0.0 114.072 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.8 t -145.21 144.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 127.122 2.169 . . . . 0.0 109.399 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.2 t -63.23 143.29 57.92 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.72 -11.52 58.55 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 49.49 -119.85 1.33 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.783 2.033 . . . . 0.0 112.001 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.0 tp -138.02 146.41 43.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.595 2.358 . . . . 0.0 109.329 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.1 137.34 41.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.463 0.705 . . . . 0.0 112.516 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.31 -36.58 78.24 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.345 1.058 . . . . 0.0 111.71 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -65.52 -34.39 78.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.756 2.023 . . . . 0.0 113.806 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -73.21 -48.38 35.54 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.964 0.906 . . . . 0.0 112.728 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.8 tp -73.69 -13.13 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.136 0.974 . . . . 0.0 113.507 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.6 -22.86 50.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.602 0.761 . . . . 0.0 112.72 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 49.3 ttm -110.27 120.6 42.96 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.467 1.107 . . . . 0.0 111.21 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.6 m -81.91 141.56 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 158.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -94.87 111.52 23.3 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -170.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -62.79 -30.51 71.52 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -156.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.76 -32.73 72.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.272 1.396 . . . . 0.0 112.572 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.81 -44.37 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.375 1.07 . . . . 0.0 109.738 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -58.0 -36.86 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.04 1.336 . . . . 0.0 112.311 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.17 -37.14 86.41 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.762 -1.211 . . . . 0.0 112.33 170.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.2 m -75.89 -50.9 13.74 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.162 0.985 . . . . 0.0 111.694 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.1 pt -61.2 -34.34 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.745 0.818 . . . . 0.0 111.83 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -80.85 -29.34 35.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.444 1.897 . . . . 0.0 114.486 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.1 t -74.25 -41.13 61.79 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.636 0.774 . . . . 0.0 111.209 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.82 138.29 32.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.26 1.024 . . . . 0.0 110.715 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.43 -31.89 24.39 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.252 -0.905 . . . . 0.0 112.538 -169.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.6 t -138.58 126.56 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.854 1.262 . . . . 0.0 109.546 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.0 t -130.53 131.21 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.406 1.482 . . . . 0.0 110.565 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.9 t -133.77 156.71 47.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.664 1.185 . . . . 0.0 110.457 172.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.67 142.74 49.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.146 169.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 mt -132.56 157.38 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.383 1.473 . . . . 0.0 109.403 -162.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.7 101.23 2.51 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 156.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.23 -154.82 27.93 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.174 0.897 . . . . 0.0 114.214 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.21 154.67 39.45 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 125.655 1.582 . . . . 0.0 111.969 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -65.67 -19.99 59.69 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.287 1.991 . . . . 0.0 113.605 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -93.9 -13.06 27.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.582 1.553 . . . . 0.0 113.986 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.54 73.34 11.68 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.544 1.537 . . . . 0.0 112.353 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.4 148.64 67.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.943 2.429 . . . . 0.0 111.874 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.4 mmt -104.42 -0.3 28.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.3 1.84 . . . . 0.0 113.631 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 17.1 t -146.46 144.83 29.94 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.969 1.307 . . . . 0.0 111.428 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.2 -38.66 80.45 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -72.23 -29.87 64.35 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.048 -1.033 . . . . 0.0 112.279 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 m -66.89 -34.45 77.81 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.346 167.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -67.27 -45.59 76.17 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.77 1.168 . . . . 0.0 112.781 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -57.27 -33.28 67.47 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.002 0.921 . . . . 0.0 112.915 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.0 tpt -56.07 -43.56 78.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.951 0.901 . . . . 0.0 111.865 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 mm -69.55 -33.34 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.337 1.055 . . . . 0.0 111.3 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.4 -34.91 79.41 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.36 -1.462 . . . . 0.0 112.771 172.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.81 -43.16 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.902 0.481 . . . . 0.0 110.728 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.9 mt -65.77 -37.92 87.64 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -66.65 -31.49 72.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.403 -1.436 . . . . 0.0 113.078 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.0 -25.49 68.41 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.613 -1.304 . . . . 0.0 113.374 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.04 -13.01 21.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.881 1.272 . . . . 0.0 114.154 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.6 13.0 67.92 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.568 1.08 . . . . 0.0 115.03 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.76 134.35 55.1 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.773 1.229 . . . . 0.0 112.905 174.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -113.68 157.93 21.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.772 1.229 . . . . 0.0 111.548 168.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -137.24 171.95 13.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.982 1.713 . . . . 0.0 111.418 -161.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.4 m -83.97 120.4 26.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.545 1.164 . . . . 0.0 108.842 -166.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.6 m -126.18 124.26 40.08 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.645 -155.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.25 157.98 18.3 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.305 1.042 . . . . 0.0 111.959 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -120.16 117.18 27.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.803 1.241 . . . . 0.0 111.292 -171.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.5 p -71.58 -27.7 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.3 -37.99 68.84 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.343 -0.848 . . . . 0.0 110.506 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.61 -31.62 22.51 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -141.4 107.38 6.09 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 119.466 1.03 . . . . 0.0 113.136 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -60.15 -15.49 34.48 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.648 2.898 . . . . 0.0 116.758 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 p -49.22 -32.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.552 1.524 . . . . 0.0 112.743 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.96 -44.46 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.94 0.896 . . . . 0.0 111.646 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.565 ' HA ' HG12 ' A' ' 136' ' ' VAL . 9.3 ptm85 -71.71 -27.52 63.07 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.916 0.78 . . . . 0.0 112.208 175.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m -67.05 -48.94 66.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.27 0.628 . . . . 0.0 112.259 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -38.86 71.23 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.489 1.04 . . . . 0.0 113.002 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 133' ' ' ARG . 1.9 p -66.46 -32.46 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.508 1.049 . . . . 0.0 112.188 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -62.47 -41.99 99.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.883 0.873 . . . . 0.0 112.248 170.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.56 -47.29 55.92 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.537 -0.727 . . . . 0.0 111.771 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.6 t -82.82 -40.62 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -173.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.6 m -102.57 -12.86 17.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 64.84 -47.19 0.34 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 169.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -129.0 89.75 47.75 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.085 1.754 . . . . 0.0 106.784 164.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -89.6 158.23 5.28 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.935 2.424 . . . . 0.0 113.771 -166.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.0 p -122.98 151.57 41.72 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.874 1.669 . . . . 0.0 108.918 161.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 55.0 mt -125.07 127.26 25.1 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 124.007 0.923 . . . . 0.0 109.089 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.93 161.54 65.25 Favored 'Cis proline' 0 CA--C 1.542 0.9 0 CA-C-N 119.766 0.952 . . . . 0.0 113.948 7.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -135.26 158.74 43.6 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.358 1.863 . . . . 0.0 110.836 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.81 140.54 51.97 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.141 1.376 . . . . 0.0 113.234 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -133.79 143.0 48.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.886 2.074 . . . . 0.0 109.832 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.8 mt -129.66 117.48 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.591 0.756 . . . . 0.0 109.306 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.5 tptt 43.54 47.41 6.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.359 2.263 . . . . 0.0 113.745 -170.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.95 16.88 9.59 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.15 140.11 34.86 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.734 -1.229 . . . . 0.0 109.535 162.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -80.04 125.45 29.79 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.378 -0.826 . . . . 0.0 112.418 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.5 t -102.68 -47.14 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 124.656 1.182 . . . . 0.0 111.8 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.65 176.91 32.25 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.39 168.42 53.82 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.859 1.218 . . . . 0.0 113.341 165.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -45.59 -44.69 13.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.322 1.849 . . . . 0.0 113.817 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.78 -26.55 66.16 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.718 -0.614 . . . . 0.0 112.528 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.3 mm -79.22 -46.61 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.118 1.367 . . . . 0.0 110.389 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.1 t -57.73 -35.94 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.335 1.854 . . . . 0.0 111.337 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 86.7 m -64.06 -41.61 97.3 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.696 0.798 . . . . 0.0 112.527 173.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -65.95 -44.06 86.13 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.315 0.961 . . . . 0.0 110.198 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.7 mtt -61.51 -35.7 78.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.372 1.069 . . . . 0.0 112.317 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.81 -45.52 74.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.614 1.166 . . . . 0.0 111.984 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -69.78 -33.19 72.05 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.814 0.733 . . . . 0.0 112.479 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.6 t -86.23 -30.39 22.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.81 2.42 52.47 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 120.656 -1.278 . . . . 0.0 115.463 -171.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -68.17 -35.03 77.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.107 1.454 . . . . 0.0 112.086 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -45.5 85.14 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.34 -0.85 . . . . 0.0 110.158 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.86 -38.56 82.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.46 1.504 . . . . 0.0 113.136 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -60.6 -48.41 81.92 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.959 0.503 . . . . 0.0 111.66 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.1 mtm -70.85 -44.7 65.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.44 -37.84 88.93 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.503 -0.748 . . . . 0.0 111.176 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -72.57 -32.42 66.02 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.42 -28.35 69.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.278 1.031 . . . . 0.0 111.891 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 6.16 13.73 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.303 1.841 . . . . 0.0 113.771 171.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.14 -2.78 86.38 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.744 2.116 . . . . 0.0 113.7 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.4 mt -82.15 142.72 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.617 1.209 . . . . 0.0 110.459 -165.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 m -101.12 128.82 47.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.348 1.459 . . . . 0.0 110.273 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.8 p -132.04 170.69 14.59 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.81 1.644 . . . . 0.0 112.883 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -65.15 129.47 39.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.961 0.904 . . . . 0.0 109.755 166.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -137.69 145.0 42.05 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--O 1.253 1.242 0 C-N-CA 126.651 1.98 . . . . 0.0 113.44 -179.308 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.9 m -82.08 -34.83 29.2 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.122 1.769 . . . . 0.0 111.879 171.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.0 m -71.89 132.69 44.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.093 0.957 . . . . 0.0 112.565 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.22 25.97 67.33 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 115.811 1.084 . . . . 0.0 115.811 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.4 tt -135.71 132.91 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.195 1.398 . . . . 0.0 110.523 170.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.32 160.54 49.0 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.473 1.035 . . . . 0.0 114.272 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.34 103.76 1.49 Allowed Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.866 1.698 . . . . 0.0 112.949 -175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -107.25 148.3 29.13 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.37 1.468 . . . . 0.0 112.598 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -99.53 151.29 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.371 1.068 . . . . 0.0 113.285 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -108.39 161.62 14.86 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.415 1.886 . . . . 0.0 112.926 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -114.28 148.27 37.75 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.966 1.306 . . . . 0.0 114.17 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.1 tt -152.43 145.72 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.655 1.582 . . . . 0.0 112.194 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -120.66 126.2 49.62 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 0.0 111.176 174.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.59 159.63 43.24 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.387 1.475 . . . . 0.0 113.429 -166.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.7 m -155.92 103.46 2.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.043 1.337 . . . . 0.0 109.763 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -74.83 141.53 75.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.13 162.69 25.79 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.052 3.168 . . . . 0.0 111.971 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -77.8 -7.21 56.29 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -67.5 122.13 17.32 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.158 0.983 . . . . 0.0 110.651 176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -73.91 144.33 82.37 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 122.936 0.495 . . . . 0.0 111.461 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.55 149.92 89.78 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.939 2.426 . . . . 0.0 112.658 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -65.34 122.91 18.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.426 1.09 . . . . 0.0 111.823 -169.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.22 157.58 25.45 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.158 0.983 . . . . 0.0 111.544 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t 63.78 -25.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 127.835 2.454 . . . . 0.0 115.134 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 t -80.7 149.32 29.78 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.53 1.132 . . . . 0.0 113.157 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.88 58.98 5.12 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.417 1.087 . . . . 0.0 109.847 159.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.49 142.22 48.55 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.861 0.865 . . . . 0.0 111.849 -172.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tt -135.48 132.93 37.97 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.118 -0.989 . . . . 0.0 111.827 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.15 149.66 38.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.691 1.197 . . . . 0.0 112.657 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.69 -31.97 73.27 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -60.56 -28.8 68.72 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.923 -1.11 . . . . 0.0 113.044 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -56.4 -21.39 24.73 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.342 1.457 . . . . 0.0 113.596 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 97.7 mt -67.71 -26.53 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.144 0.978 . . . . 0.0 110.855 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.08 0.39 14.97 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.053 1.341 . . . . 0.0 114.459 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.3 mtt -73.26 112.89 9.74 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -146.85 133.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.713 0.805 . . . . 0.0 111.672 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -113.15 98.09 6.92 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.913 0.885 . . . . 0.0 108.669 169.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -59.63 -40.59 88.13 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.542 1.537 . . . . 0.0 113.862 -160.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -76.13 -29.59 57.89 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.9 mt -78.57 -40.81 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.855 0.862 . . . . 0.0 110.504 174.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -58.94 -39.44 81.62 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.934 0.894 . . . . 0.0 111.738 168.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.4 -33.11 74.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.431 1.093 . . . . 0.0 112.586 169.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.6 m -63.67 -49.94 71.2 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.185 0.902 . . . . 0.0 111.079 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 pt -60.25 -34.47 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.412 1.005 . . . . 0.0 112.175 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -77.91 -30.15 50.5 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.326 1.851 . . . . 0.0 113.397 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 t -87.02 -34.01 19.37 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.796 1.638 . . . . 0.0 113.162 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.22 147.93 27.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.716 2.006 . . . . 0.0 110.503 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -70.11 -43.25 71.41 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 119.943 -1.723 . . . . 0.0 112.525 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -141.1 132.9 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.974 0.91 . . . . 0.0 112.17 -171.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.56 140.93 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.156 1.382 . . . . 0.0 112.266 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 t -133.02 158.98 41.36 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.925 1.29 . . . . 0.0 111.632 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -132.43 141.09 48.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.247 0.546 . . . . 0.0 112.045 171.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 107' ' ' SER . 9.6 mt -134.48 156.9 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.622 1.969 . . . . 0.0 109.336 -163.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -66.27 101.57 0.74 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 150.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 -140.39 20.15 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 121.126 -0.984 . . . . 0.0 114.277 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.8 mt -111.58 155.9 42.25 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 125.274 1.43 . . . . 0.0 112.581 -170.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.59 -12.61 31.6 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.727 2.284 . . . . 0.0 113.094 172.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -91.53 -26.93 18.53 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.827 1.651 . . . . 0.0 112.113 170.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.39 78.01 12.37 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.204 1.802 . . . . 0.0 111.872 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.05 143.21 17.78 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.106 2.537 . . . . 0.0 112.356 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 33.9 ttm -102.6 10.57 38.66 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.561 1.544 . . . . 0.0 113.352 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 51.4 t -145.09 145.18 31.32 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.917 -1.115 . . . . 0.0 111.843 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -36.79 83.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.493 1.117 . . . . 0.0 112.845 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -69.23 -24.45 64.01 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.066 -1.022 . . . . 0.0 112.544 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.488 ' HB3' HG23 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -70.55 -34.44 72.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.921 -1.112 . . . . 0.0 113.972 163.338 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -61.29 -39.6 91.06 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.453 1.479 . . . . 0.0 111.32 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -60.54 -38.6 84.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.713 0.805 . . . . 0.0 112.803 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.62 -47.58 78.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.652 1.181 . . . . 0.0 112.399 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.65 -32.17 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.408 -0.808 . . . . 0.0 111.369 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.73 -34.73 67.79 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.702 -1.249 . . . . 0.0 113.207 171.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.31 -41.85 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 122.673 0.389 . . . . 0.0 110.766 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -39.43 93.88 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.107 0.963 . . . . 0.0 112.229 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.27 -34.18 76.88 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.136 -0.978 . . . . 0.0 112.358 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.06 -23.58 63.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.436 1.095 . . . . 0.0 113.78 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.2 mt -95.9 -13.18 24.13 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.024 0.929 . . . . 0.0 113.244 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.07 18.64 67.11 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.277 0.941 . . . . 0.0 113.696 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 17.9 mt -113.12 130.71 56.1 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.581 1.552 . . . . 0.0 112.697 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -116.28 147.23 41.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.828 0.851 . . . . 0.0 112.941 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -129.35 172.45 11.49 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.027 2.531 . . . . 0.0 111.167 -163.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.3 m -86.4 133.9 33.75 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.365 -0.834 . . . . 0.0 110.405 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 t -131.12 146.9 52.52 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -164.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.01 152.71 39.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.167 1.787 . . . . 0.0 112.302 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -100.42 118.11 35.98 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.374 1.07 . . . . 0.0 111.426 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.6 p -66.4 -25.22 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.312 0.645 . . . . 0.0 112.624 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 tp -73.92 -22.21 59.77 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.028 0.931 . . . . 0.0 111.786 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.84 -29.88 11.19 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -125.08 106.44 28.47 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.88 -28.31 38.58 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.401 3.4 . . . . 0.0 115.663 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.67 -35.48 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.66 0.784 . . . . 0.0 112.111 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.81 -48.97 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.506 0.723 . . . . 0.0 110.871 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.428 ' HA ' HG12 ' A' ' 136' ' ' VAL . 9.7 ptp180 -70.75 -30.97 67.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.043 0.537 . . . . 0.0 112.056 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.8 m -69.38 -47.46 64.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.633 0.651 . . . . 0.0 112.301 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.5 -40.4 77.03 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.022 -1.049 . . . . 0.0 112.293 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 133' ' ' ARG . 12.3 p -63.93 -35.81 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 120.651 -1.281 . . . . 0.0 112.539 176.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -65.87 -44.95 83.88 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.732 0.813 . . . . 0.0 111.64 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.6 -41.38 92.83 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.648 0.779 . . . . 0.0 112.956 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.35 -41.94 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.3 m -98.94 1.64 45.77 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.855 1.207 . . . . 0.0 113.91 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 67.29 -22.82 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.368 2.667 . . . . 0.0 116.448 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -145.94 132.23 9.67 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.788 1.635 . . . . 0.0 109.458 171.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.31 126.98 5.72 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.876 1.717 . . . . 0.0 113.188 -165.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.8 p -135.52 136.85 41.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.446 1.898 . . . . 0.0 111.275 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.9 mm -128.05 137.42 30.77 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 125.458 1.503 . . . . 0.0 110.745 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.64 160.57 76.48 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 121.341 1.515 . . . . 0.0 112.447 -4.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -134.88 159.63 40.81 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.968 1.307 . . . . 0.0 110.515 -172.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.33 139.46 53.28 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -124.11 140.8 52.62 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.796 2.038 . . . . 0.0 110.411 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.8 mt -130.2 123.32 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.456 1.102 . . . . 0.0 108.387 170.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm 45.54 49.92 10.63 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.886 2.075 . . . . 0.0 114.88 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.4 26.45 15.35 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -118.41 138.23 52.6 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.767 1.227 . . . . 0.0 108.689 164.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.49 125.49 30.03 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.459 -0.775 . . . . 0.0 111.093 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 t -80.55 -40.49 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.499 1.119 . . . . 0.0 110.261 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.81 175.64 34.92 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.373 1.463 . . . . 0.0 114.327 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.25 172.14 55.19 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.852 0.739 . . . . 0.0 113.885 165.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.3 tp -48.65 -42.67 35.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.069 1.347 . . . . 0.0 113.686 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -59.41 -25.32 64.22 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.832 1.253 . . . . 0.0 113.018 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 mm -91.23 -46.6 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.27 1.428 . . . . 0.0 110.122 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.73 -40.89 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.249 1.42 . . . . 0.0 111.583 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.6 p -64.78 -40.93 96.08 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -68.43 -40.87 81.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.274 0.63 . . . . 0.0 112.211 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.9 mtt -63.23 -36.09 82.49 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.329 1.052 . . . . 0.0 112.68 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.76 -42.3 77.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.468 1.107 . . . . 0.0 112.299 174.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -65.29 -39.32 92.4 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.16 0.584 . . . . 0.0 111.418 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 36.7 t -82.66 -28.08 30.89 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.262 1.825 . . . . 0.0 115.159 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.61 -2.19 67.02 Favored Glycine 0 N--CA 1.48 1.579 0 O-C-N 120.47 -1.394 . . . . 0.0 114.665 -170.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -64.07 -35.79 81.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.646 1.223 . . . . 0.0 112.263 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.66 -45.69 85.64 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.848 0.859 . . . . 0.0 110.881 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -59.33 -40.6 86.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.68 1.592 . . . . 0.0 112.748 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -65.76 -36.55 83.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 118.215 -0.897 . . . . 0.0 112.632 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 61.2 mtm -70.04 -50.44 41.29 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.73 1.15 . . . . 0.0 113.295 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -62.33 -35.02 77.8 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.259 -0.901 . . . . 0.0 111.91 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -64.35 -37.98 89.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.603 0.761 . . . . 0.0 112.846 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.18 -30.04 71.12 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.077 0.853 . . . . 0.0 111.977 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.03 5.11 17.43 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.176 1.79 . . . . 0.0 114.275 171.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.28 12.8 75.32 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.3 1.428 . . . . 0.0 114.573 173.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 60.3 mt -94.31 145.35 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 118.266 1.033 . . . . 0.0 111.276 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 29.0 m -105.13 131.29 52.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.106 1.362 . . . . 0.0 110.743 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.4 p -133.89 171.02 14.75 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.478 1.911 . . . . 0.0 112.81 -175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -56.98 138.41 54.29 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.158 0.983 . . . . 0.0 112.726 164.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -137.09 147.28 45.99 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.009 1.324 . . . . 0.0 112.431 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.5 mt . . . . . 0 C--O 1.255 1.363 0 C-N-CA 128.111 2.564 . . . . 0.0 116.272 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m -67.08 -36.83 82.85 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -165.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.2 t 57.46 157.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.249 1.42 . . . . 0.0 113.149 -157.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.28 27.26 66.33 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 120.797 -1.189 . . . . 0.0 113.008 -170.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.1 pt -69.19 162.63 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.221 1.009 . . . . 0.0 113.112 -171.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.81 171.53 34.39 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.561 1.077 . . . . 0.0 114.697 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 144.68 -45.83 0.83 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.427 1.965 . . . . 0.0 111.911 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -91.53 152.56 20.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.017 0.927 . . . . 0.0 111.477 159.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 m -68.87 147.52 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.058 0.543 . . . . 0.0 111.558 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -106.41 92.45 4.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.296 1.439 . . . . 0.0 110.541 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -159.34 133.81 7.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.412 1.485 . . . . 0.0 108.851 169.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.9 tp -140.66 105.9 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 122.262 1.029 . . . . 0.0 111.64 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -151.48 147.77 27.25 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.079 2.152 . . . . 0.0 109.934 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -127.6 141.52 51.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.248 1.419 . . . . 0.0 109.343 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.7 m -103.57 137.04 42.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.514 1.526 . . . . 0.0 110.379 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -82.3 148.12 58.58 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.06 156.29 55.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.362 2.708 . . . . 0.0 113.033 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -106.96 5.38 28.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.856 1.662 . . . . 0.0 113.087 -173.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -76.78 155.51 33.07 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.499 1.92 . . . . 0.0 114.256 -160.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -68.21 143.13 95.56 Favored Pre-proline 0 CA--C 1.551 1.016 0 O-C-N 121.221 -0.924 . . . . 0.0 112.104 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.14 154.02 75.7 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.042 3.162 . . . . 0.0 114.954 -169.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -85.19 140.57 30.8 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.542 1.137 . . . . 0.0 112.908 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -77.57 -36.51 51.97 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.501 1.52 . . . . 0.0 112.118 171.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.5 m -67.84 149.39 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.698 0.799 . . . . 0.0 109.942 164.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -68.06 116.23 8.45 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.506 -0.746 . . . . 0.0 111.821 -174.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.16 143.5 50.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.917 1.687 . . . . 0.0 109.95 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -157.93 35.15 0.25 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -166.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.5 tt -121.53 152.85 38.73 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.901 0.88 . . . . 0.0 111.69 -175.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.91 119.1 23.78 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.616 1.566 . . . . 0.0 110.976 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -57.09 -41.73 79.41 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.596 1.958 . . . . 0.0 114.225 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.91 -36.29 76.68 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.083 1.753 . . . . 0.0 113.468 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -71.98 -24.78 61.64 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.5 mt -103.85 -28.08 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.937 1.295 . . . . 0.0 111.917 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.29 -16.44 56.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.827 1.251 . . . . 0.0 112.661 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 19.1 ttt -132.2 112.1 11.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.519 1.528 . . . . 0.0 109.18 161.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.5 t -82.98 132.05 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.426 -0.796 . . . . 0.0 111.682 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -77.67 109.54 11.74 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.635 1.174 . . . . 0.0 110.283 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -63.77 -28.17 69.69 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.538 1.135 . . . . 0.0 113.507 -166.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -59.23 -37.62 77.95 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.96 0.904 . . . . 0.0 112.83 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mp -78.21 -42.15 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.805 0.842 . . . . 0.0 110.219 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -58.83 -39.82 82.38 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.66 0.784 . . . . 0.0 112.602 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -72.41 -27.65 62.49 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.626 1.17 . . . . 0.0 112.822 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.3 m -72.04 -44.42 63.39 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.805 1.184 . . . . 0.0 109.063 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 90.0 mt -55.56 -40.89 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.499 1.519 . . . . 0.0 110.733 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -77.62 -37.94 49.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.021 1.328 . . . . 0.0 113.255 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 t -95.57 -28.08 15.03 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.219 1.408 . . . . 0.0 114.382 -165.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -87.3 145.98 26.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.306 1.042 . . . . 0.0 111.505 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -66.67 -44.83 80.75 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.962 0.905 . . . . 0.0 112.109 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.9 t -141.7 134.45 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.771 1.229 . . . . 0.0 111.7 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.98 133.9 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.126 1.37 . . . . 0.0 111.816 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 t -133.7 156.33 48.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.619 1.568 . . . . 0.0 110.936 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -132.61 139.62 47.86 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.39 1.076 . . . . 0.0 110.399 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mt -137.1 158.39 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.851 1.66 . . . . 0.0 109.064 -165.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -77.91 106.51 9.81 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 154.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.44 -149.65 21.35 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.833 1.206 . . . . 0.0 113.096 -172.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.98 156.93 51.69 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.327 1.451 . . . . 0.0 111.114 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.97 -33.9 72.89 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 121.408 1.539 . . . . 0.0 113.378 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -82.79 -13.96 55.29 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.913 -1.117 . . . . 0.0 113.263 173.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.26 70.3 13.02 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.985 1.714 . . . . 0.0 112.839 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.11 151.93 21.14 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.24 2.627 . . . . 0.0 111.574 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 85.3 mtp -97.4 12.19 34.05 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.7 t -148.97 145.25 27.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.746 1.219 . . . . 0.0 111.245 176.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.12 -39.84 86.7 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.558 -0.714 . . . . 0.0 112.897 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -62.75 -34.56 77.48 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.086 -1.009 . . . . 0.0 111.858 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.9 m -68.45 -31.03 70.05 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.284 -0.885 . . . . 0.0 112.664 170.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -66.02 -38.56 88.73 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.083 1.31 . . . . 0.0 112.425 168.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -59.73 -31.39 69.58 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.201 1.0 . . . . 0.0 112.69 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.6 tpt -60.04 -47.15 87.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.993 0.917 . . . . 0.0 111.618 169.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mm -70.89 -33.99 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.25 -0.906 . . . . 0.0 112.81 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -58.06 -35.81 71.88 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.741 -1.225 . . . . 0.0 112.404 168.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.67 -38.7 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 122.264 -0.272 . . . . 0.0 111.281 176.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.77 -34.72 78.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.235 1.014 . . . . 0.0 113.323 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.1 -40.39 95.71 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.089 -1.007 . . . . 0.0 111.629 167.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.71 -21.7 64.39 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 tp -96.88 -15.86 21.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.929 1.292 . . . . 0.0 112.725 170.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.98 12.17 56.71 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.188 1.852 . . . . 0.0 114.932 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.5 133.06 54.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 111.76 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -111.76 150.98 29.5 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.254 1.025 . . . . 0.0 113.201 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.73 175.79 8.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.817 2.047 . . . . 0.0 112.284 -161.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.86 117.51 25.65 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.374 -0.829 . . . . 0.0 109.481 -167.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 m -126.74 129.5 48.51 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.882 0.873 . . . . 0.0 112.17 -154.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -128.29 143.01 50.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.4 77.67 9.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.91 3.284 . . . . 0.0 111.427 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.3 p -74.18 -9.74 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -167.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.07 -22.98 22.66 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.329 -0.857 . . . . 0.0 112.156 169.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.98 -32.85 21.31 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.819 0.736 . . . . 0.0 112.232 174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -134.53 107.06 10.92 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.129 0.972 . . . . 0.0 111.569 163.627 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 129' ' ' HIS . 37.1 Cg_endo -60.66 -16.2 41.83 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.717 2.278 . . . . 0.0 114.203 173.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.4 p -39.75 -43.38 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.616 1.966 . . . . 0.0 115.82 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 t -67.25 -43.55 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.048 -1.033 . . . . 0.0 111.248 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -64.1 -41.09 97.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.008 1.323 . . . . 0.0 111.162 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.5 m -59.02 -45.73 89.98 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.193 0.997 . . . . 0.0 111.681 -177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -75.33 -37.11 60.9 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -35.11 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 121.058 1.754 . . . . 0.0 112.091 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.53 -35.15 73.64 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.614 1.566 . . . . 0.0 112.28 170.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.88 -35.8 59.74 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.447 1.022 . . . . 0.0 113.349 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 81.1 t -80.38 -45.33 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.317 0.962 . . . . 0.0 113.214 -173.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.3 p -105.27 13.61 30.22 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.646 1.566 . . . . 0.0 115.078 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 68.57 -29.87 0.17 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 128.153 2.581 . . . . 0.0 117.143 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -149.65 130.02 6.84 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 120.632 1.56 . . . . 0.0 112.868 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -94.8 147.77 1.69 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.669 2.913 . . . . 0.0 114.413 -177.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.0 p -129.79 152.41 49.31 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.552 1.541 . . . . 0.0 110.182 162.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.1 124.24 23.77 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.994 0.918 . . . . 0.0 110.553 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.58 157.04 72.31 Favored 'Cis proline' 0 CA--C 1.543 0.944 0 CA-C-N 120.227 1.117 . . . . 0.0 113.312 -2.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -151.72 160.55 43.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.183 1.393 . . . . 0.0 111.269 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.94 141.97 51.67 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -128.7 142.48 51.0 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.1 2.16 . . . . 0.0 110.868 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.4 mt -136.88 130.59 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.123 1.369 . . . . 0.0 109.688 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt 48.19 43.87 19.01 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.867 1.667 . . . . 0.0 114.573 -172.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.21 13.25 5.71 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.061 1.744 . . . . 0.0 114.889 -172.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -112.77 141.9 46.03 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.76 1.624 . . . . 0.0 111.103 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -72.51 126.26 29.43 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.105 0.955 . . . . 0.0 112.556 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.3 t -104.49 -54.97 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.28 1.432 . . . . 0.0 112.356 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 167.09 163.29 20.68 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.48 169.0 54.16 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.991 1.758 . . . . 0.0 113.441 168.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.4 tp -46.84 -45.35 20.15 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.315 1.446 . . . . 0.0 113.803 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.2 -21.24 66.49 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.881 1.272 . . . . 0.0 112.748 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.3 mm -92.36 -44.42 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.599 1.96 . . . . 0.0 111.193 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.9 -36.0 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.046 1.738 . . . . 0.0 112.066 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -56.58 -49.81 73.77 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 170.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -61.74 -42.02 98.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.442 0.697 . . . . 0.0 110.362 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.8 mtt -66.55 -39.12 88.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.221 1.009 . . . . 0.0 112.981 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -68.36 -39.72 81.73 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.015 1.326 . . . . 0.0 112.156 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.88 -31.57 61.63 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 30.7 t -79.25 -26.97 42.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.811 1.245 . . . . 0.0 113.603 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.53 -0.64 80.74 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.082 0.849 . . . . 0.0 114.511 -168.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.04 -36.72 80.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.71 1.755 . . . . 0.0 111.781 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.1 -42.51 98.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.889 0.876 . . . . 0.0 110.906 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -69.06 -35.42 76.53 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 126.234 1.814 . . . . 0.0 112.973 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -58.05 -48.84 78.87 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.154 1.343 . . . . 0.0 110.946 171.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 70.3 mtm -67.89 -38.59 83.2 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.27 -43.64 77.35 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.341 0.973 . . . . 0.0 112.832 172.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -72.24 -26.35 61.98 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.309 -0.87 . . . . 0.0 113.305 -171.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.71 -30.12 63.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.321 1.048 . . . . 0.0 112.672 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -87.39 -2.5 58.66 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.51 16.36 55.3 Favored Glycine 0 N--CA 1.47 0.926 0 O-C-N 120.66 -1.275 . . . . 0.0 113.815 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.3 mt -86.19 147.67 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.323 1.049 . . . . 0.0 110.801 -171.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.6 m -105.04 124.44 49.54 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.091 1.356 . . . . 0.0 112.681 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 25.5 p -125.53 169.17 12.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.806 2.442 . . . . 0.0 111.441 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -57.31 149.24 20.73 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.087 -1.008 . . . . 0.0 112.087 171.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.85 144.92 47.41 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.749 0.82 . . . . 0.0 112.319 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.072 1.749 . . . . 0.0 111.095 -171.421 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.4 p . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.0 p -103.15 -18.71 14.81 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -165.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.5 p -101.42 18.54 19.84 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.722 1.146 . . . . 0.0 113.931 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.88 -22.74 2.78 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.847 1.689 . . . . 0.0 115.368 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.1 tt -139.07 164.81 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 127.384 2.273 . . . . 0.0 109.971 170.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.56 -173.68 45.81 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 120.959 -1.088 . . . . 0.0 114.39 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.6 -155.63 28.41 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.265 1.888 . . . . 0.0 112.349 168.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -63.89 127.88 33.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.072 0.949 . . . . 0.0 111.287 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.84 133.1 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.705 1.202 . . . . 0.0 111.308 -169.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 mtm105 -90.32 81.49 6.05 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.119 1.368 . . . . 0.0 110.847 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -143.37 157.77 44.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.215 1.406 . . . . 0.0 111.412 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mt 56.77 38.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.835 1.254 . . . . 0.0 112.174 -173.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.25 138.83 54.27 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.824 -1.172 . . . . 0.0 113.577 -164.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -74.88 138.14 42.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.552 1.541 . . . . 0.0 111.518 -174.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 m -88.73 69.45 8.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.919 1.288 . . . . 0.0 110.642 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -59.38 155.92 33.73 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.803 -168.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.34 152.06 69.67 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.271 1.981 . . . . 0.0 111.386 165.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -98.9 3.24 47.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.604 1.161 . . . . 0.0 113.277 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -61.41 155.42 21.68 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.888 1.275 . . . . 0.0 112.552 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -73.94 147.67 86.37 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 123.451 0.7 . . . . 0.0 110.037 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -63.08 139.38 72.7 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.637 2.225 . . . . 0.0 111.982 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -127.35 135.86 51.11 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.628 1.571 . . . . 0.0 111.757 -175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -129.74 -46.42 1.16 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.836 1.254 . . . . 0.0 111.966 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.5 t -80.23 -28.99 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.435 1.094 . . . . 0.0 112.201 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.1 m -88.83 126.27 35.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.283 1.033 . . . . 0.0 109.892 162.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.0 125.9 30.09 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.328 -0.858 . . . . 0.0 113.309 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -152.45 160.45 43.26 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.346 1.859 . . . . 0.0 111.606 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.8 tp -148.3 138.08 22.32 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.317 1.447 . . . . 0.0 111.404 169.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.74 136.34 42.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.318 1.447 . . . . 0.0 112.234 171.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -60.23 -29.84 69.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.894 1.278 . . . . 0.0 111.876 172.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.08 -28.94 70.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.173 1.789 . . . . 0.0 112.638 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -70.74 -26.69 63.49 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.211 -0.93 . . . . 0.0 112.65 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.4 mm -76.97 -16.18 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.518 1.127 . . . . 0.0 112.071 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.5 2.88 20.44 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.6 mtm -115.89 144.46 44.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.479 1.511 . . . . 0.0 111.808 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.7 m -138.96 153.74 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.67 1.188 . . . . 0.0 113.137 -168.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -119.27 110.56 17.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.959 1.704 . . . . 0.0 110.416 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -63.09 -31.9 73.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.194 0.998 . . . . 0.0 113.648 -176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -64.44 -42.71 95.83 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.6 tp -77.54 -39.14 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.699 -0.626 . . . . 0.0 111.569 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.15 -44.81 92.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.242 1.017 . . . . 0.0 112.213 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.94 -34.28 75.1 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.764 -0.585 . . . . 0.0 112.326 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.4 m -66.26 -48.85 69.12 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.849 0.86 . . . . 0.0 111.817 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -61.54 -33.53 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.743 -0.598 . . . . 0.0 112.455 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.81 -24.78 44.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.85 1.66 . . . . 0.0 113.759 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.5 t -92.52 -34.19 14.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.773 1.629 . . . . 0.0 113.667 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -87.76 147.86 24.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.325 1.05 . . . . 0.0 111.807 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -68.51 -47.63 66.49 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.942 -1.099 . . . . 0.0 113.779 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.9 t -140.39 129.93 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.773 1.229 . . . . 0.0 110.848 -173.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.55 137.64 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.648 1.179 . . . . 0.0 111.315 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -136.54 154.64 50.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.417 1.087 . . . . 0.0 111.758 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -134.5 143.61 47.57 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.753 0.787 . . . . 0.0 112.469 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 mt -136.79 157.45 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.495 1.518 . . . . 0.0 110.227 -155.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -76.19 106.52 7.85 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.973 153.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.26 -161.71 43.42 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.948 0.794 . . . . 0.0 114.257 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.82 156.09 41.06 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.724 1.209 . . . . 0.0 111.94 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -67.39 -21.04 47.72 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.28 1.987 . . . . 0.0 113.088 173.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.59 -24.53 21.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.136 1.374 . . . . 0.0 112.852 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.31 75.77 19.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.796 1.638 . . . . 0.0 111.334 -176.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.66 155.87 40.02 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.722 2.948 . . . . 0.0 112.362 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.3 mtt -109.62 4.04 21.67 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.316 1.446 . . . . 0.0 114.539 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 44.3 t -148.85 147.11 28.35 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.753 1.621 . . . . 0.0 110.523 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.15 94.71 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.698 -0.626 . . . . 0.0 111.548 176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -60.91 -34.66 75.02 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.278 -0.889 . . . . 0.0 112.203 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.8 m -63.48 -48.48 77.45 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 118.865 -0.588 . . . . 0.0 111.136 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -59.08 -48.97 79.67 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.025 0.83 . . . . 0.0 111.055 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -60.84 -28.64 68.98 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.417 1.087 . . . . 0.0 113.037 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 34.4 ttp -68.79 -42.62 77.11 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.6 mm -67.66 -34.57 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.227 -0.921 . . . . 0.0 110.73 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -39.53 72.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.915 1.286 . . . . 0.0 111.956 172.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.44 -42.35 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.557 1.143 . . . . 0.0 111.705 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.9 mt -66.48 -35.53 80.51 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -67.07 -33.62 75.88 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.972 -1.08 . . . . 0.0 112.495 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.79 -25.69 68.29 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.837 -1.164 . . . . 0.0 113.275 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.88 -14.48 20.66 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.426 1.09 . . . . 0.0 113.717 171.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.82 10.19 67.31 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.894 1.235 . . . . 0.0 115.355 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.32 131.38 55.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.184 0.993 . . . . 0.0 112.06 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -116.5 128.1 55.14 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.934 0.874 . . . . 0.0 113.018 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -106.36 171.98 7.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.818 2.447 . . . . 0.0 112.069 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.2 m -83.72 121.87 27.88 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.581 -1.324 . . . . 0.0 109.0 -161.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.9 m -122.79 128.03 49.91 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.243 -155.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -126.45 143.94 51.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.673 1.189 . . . . 0.0 113.386 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -92.7 113.91 26.32 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.679 1.192 . . . . 0.0 111.245 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 t -69.11 -18.44 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.757 -0.589 . . . . 0.0 112.061 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -77.7 -22.79 49.94 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.054 -1.029 . . . . 0.0 112.545 172.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.78 -37.37 17.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.893 0.769 . . . . 0.0 112.205 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -136.85 94.36 12.99 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -44.18 -20.93 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.586 1 C-N-CA 125.916 4.411 . . . . 0.0 116.891 165.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -48.62 -35.88 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 121.237 1.835 . . . . 0.0 112.867 171.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.35 -43.69 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 121.565 -0.709 . . . . 0.0 110.315 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.526 ' HA ' HG12 ' A' ' 136' ' ' VAL . 0.7 OUTLIER -62.25 -32.94 73.7 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.845 1.258 . . . . 0.0 112.542 172.63 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.421 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 40.4 m -69.57 -37.9 77.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.911 1.684 . . . . 0.0 113.686 173.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -76.17 -47.19 25.13 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 133' ' ' ARG . 8.0 p -60.54 -34.47 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 120.515 -1.365 . . . . 0.0 112.951 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 134' ' ' SER . 17.7 ptpt -62.13 -34.64 76.73 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -77.04 -43.53 34.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.664 1.986 . . . . 0.0 113.915 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.9 t -79.33 -38.59 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.108 1.363 . . . . 0.0 113.376 -166.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 m -100.39 10.98 40.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 62.11 -33.97 0.1 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 128.338 2.655 . . . . 0.0 115.376 -166.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -139.13 139.41 23.15 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.534 2.334 . . . . 0.0 108.833 169.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.99 128.37 9.11 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.075 1.85 . . . . 0.0 112.019 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.8 m -130.16 132.21 45.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.835 1.254 . . . . 0.0 110.987 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 57.0 mt -129.2 130.58 23.38 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.275 1.03 . . . . 0.0 110.52 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -80.78 152.66 82.2 Favored 'Cis proline' 0 CA--C 1.545 1.062 0 CA-C-N 120.021 1.043 . . . . 0.0 112.827 -5.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -147.81 158.56 44.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.352 1.061 . . . . 0.0 112.595 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.52 135.13 50.9 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.914 1.686 . . . . 0.0 111.987 -172.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -119.22 144.91 46.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.726 2.011 . . . . 0.0 110.128 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.6 mt -127.0 124.32 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 167.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.3 tttp 44.11 54.95 5.7 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.925 1.69 . . . . 0.0 114.328 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.69 27.83 17.55 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.08 145.86 51.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.109 1.364 . . . . 0.0 110.008 171.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -81.6 124.07 29.22 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.717 0.77 . . . . 0.0 111.332 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.9 t -99.94 -49.25 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.144 0.978 . . . . 0.0 110.104 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.05 158.75 23.88 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.674 1.429 . . . . 0.0 116.674 170.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.2 169.7 54.59 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.285 0.945 . . . . 0.0 112.157 164.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -52.12 -38.85 58.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.469 1.107 . . . . 0.0 113.969 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.49 -34.96 78.2 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.869 -1.144 . . . . 0.0 111.773 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.5 mm -72.54 -46.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.161 1.384 . . . . 0.0 110.668 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.98 -35.91 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.966 1.706 . . . . 0.0 111.032 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 90.6 m -62.04 -46.25 90.01 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.443 0.697 . . . . 0.0 111.807 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -59.57 -45.78 90.86 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.742 1.155 . . . . 0.0 110.28 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.3 mtt -61.36 -41.75 97.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.881 0.873 . . . . 0.0 111.365 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.87 -46.61 67.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.133 0.973 . . . . 0.0 111.335 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -72.64 -24.86 61.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.634 1.174 . . . . 0.0 112.597 -175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.9 t -100.44 -2.93 32.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.804 1.641 . . . . 0.0 114.041 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.44 -7.47 78.75 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 120.705 -1.247 . . . . 0.0 115.324 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -29.71 67.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.837 -1.39 . . . . 0.0 114.103 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.55 -46.42 86.03 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.077 0.853 . . . . 0.0 109.791 174.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -58.59 -42.2 87.54 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.122 0.969 . . . . 0.0 111.68 169.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.67 -37.35 86.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 117.0 -1.476 . . . . 0.0 111.825 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.8 mtm -69.82 -47.73 61.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.363 1.438 . . . . 0.0 112.88 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.27 -39.02 89.13 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.634 0.652 . . . . 0.0 112.251 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -69.36 -36.14 76.56 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.955 1.302 . . . . 0.0 111.912 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.0 -24.67 67.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.738 0.815 . . . . 0.0 112.546 168.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -92.12 6.44 46.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.929 1.292 . . . . 0.0 114.403 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.72 13.39 67.29 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.725 1.155 . . . . 0.0 114.431 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.2 mt -104.46 146.89 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.25 1.42 . . . . 0.0 108.959 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.0 m -116.02 136.13 53.32 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.861 -1.149 . . . . 0.0 112.777 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.4 p -131.34 167.98 18.33 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.18 1.792 . . . . 0.0 112.581 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 -64.53 121.93 15.58 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.439 -0.788 . . . . 0.0 110.096 171.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -135.14 139.67 44.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.286 1.434 . . . . 0.0 112.404 -167.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.701 2.001 . . . . 0.0 112.217 -170.815 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.8 p -68.57 -22.19 64.48 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.231 2.212 . . . . 0.0 115.546 -170.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.9 p -97.56 -12.23 22.79 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.19 -0.34 59.45 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.635 1.112 . . . . 0.0 114.399 -171.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.5 mm -75.98 126.05 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 118.619 1.209 . . . . 0.0 109.969 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.53 159.64 25.04 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.024 1.297 . . . . 0.0 112.785 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.4 -151.64 14.0 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.283 0.944 . . . . 0.0 112.892 -174.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -150.72 144.33 25.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.777 0.831 . . . . 0.0 112.027 168.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.03 126.83 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.266 1.826 . . . . 0.0 110.182 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.33 133.29 19.16 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.98 1.312 . . . . 0.0 112.803 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -155.06 156.14 35.36 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.192 1.797 . . . . 0.0 109.635 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.3 mt 54.37 80.99 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.204 1.802 . . . . 0.0 111.27 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -104.3 157.04 17.41 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.775 2.03 . . . . 0.0 112.691 -175.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -93.34 134.06 35.94 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.385 -0.822 . . . . 0.0 111.623 164.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.2 p -142.1 25.85 1.89 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -152.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -70.92 136.49 85.14 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 120.109 -1.62 . . . . 0.0 112.588 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.93 -25.35 19.88 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.902 2.401 . . . . 0.0 115.151 -165.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.85 11.35 39.76 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -173.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -53.72 131.12 38.72 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.567 1.147 . . . . 0.0 111.275 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -67.28 149.61 98.33 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.018 1.327 . . . . 0.0 111.696 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -57.74 149.19 70.13 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.764 2.31 . . . . 0.0 111.606 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -85.84 109.63 18.82 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.779 1.232 . . . . 0.0 108.578 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.1 mt -134.44 165.77 24.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.124 1.37 . . . . 0.0 112.22 -165.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.83 -57.97 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.841 0.857 . . . . 0.0 111.556 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 m -84.17 69.41 10.4 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.151 0.977 . . . . 0.0 110.545 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.12 172.35 15.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.75 1.62 . . . . 0.0 111.502 -172.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -94.39 175.85 6.53 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.754 1.222 . . . . 0.0 112.317 170.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.22 175.32 3.95 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.185 0.994 . . . . 0.0 112.641 157.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -149.3 166.29 29.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.883 1.273 . . . . 0.0 112.003 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.38 -40.51 68.24 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.649 1.18 . . . . 0.0 113.967 -171.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.41 -28.5 59.42 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -70.44 -35.0 73.1 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.96 -1.088 . . . . 0.0 111.955 173.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 pt -83.21 -28.25 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.44 -23.36 40.32 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.648 0.779 . . . . 0.0 112.845 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 8.3 ttt -62.89 134.42 56.19 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.816 1.247 . . . . 0.0 110.791 167.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.4 t -124.34 109.2 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.011 0.924 . . . . 0.0 110.409 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -83.43 120.64 26.15 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.854 0.862 . . . . 0.0 109.909 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -64.64 -32.04 73.53 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -161.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.92 -28.16 64.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 64.5 mt -74.48 -47.42 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.857 0.863 . . . . 0.0 109.786 173.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.97 -38.29 75.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.405 1.082 . . . . 0.0 111.968 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.34 -35.5 79.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.402 1.081 . . . . 0.0 112.969 171.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.0 m -66.2 -47.0 75.3 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.511 1.05 . . . . 0.0 111.111 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.71 -36.53 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 118.427 0.558 . . . . 0.0 111.991 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.4 -38.31 50.09 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.582 1.553 . . . . 0.0 112.896 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.7 t -81.84 -35.87 28.93 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.661 1.584 . . . . 0.0 113.122 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -83.04 142.36 31.37 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.888 -1.133 . . . . 0.0 109.968 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.416 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 34.9 m-20 -82.93 -46.0 13.48 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.879 -1.138 . . . . 0.0 112.345 -163.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 t -132.85 131.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.787 1.635 . . . . 0.0 109.764 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.2 t -132.49 132.88 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.529 1.532 . . . . 0.0 111.173 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.8 t -133.85 155.48 49.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.65 1.18 . . . . 0.0 110.839 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -131.39 142.44 50.05 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.31 0.644 . . . . 0.0 112.73 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.7 mt -136.42 159.69 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.351 1.861 . . . . 0.0 110.206 -158.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -73.06 104.03 4.01 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.509 -0.744 . . . . 0.0 109.505 158.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.24 -155.94 40.83 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.563 -0.71 . . . . 0.0 113.676 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -113.58 150.21 42.88 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.8 1.24 . . . . 0.0 112.209 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.02 -19.02 46.16 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.067 2.512 . . . . 0.0 114.711 -167.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.12 -27.34 60.82 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.606 1.162 . . . . 0.0 112.688 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.79 68.22 12.88 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.163 1.785 . . . . 0.0 111.549 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.1 143.8 73.17 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.422 2.082 . . . . 0.0 111.429 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.6 ttm -90.93 -7.51 51.91 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 41.3 t -140.8 146.28 37.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.282 1.433 . . . . 0.0 110.459 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.17 94.33 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.546 -0.721 . . . . 0.0 112.484 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -69.52 -34.1 73.78 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.436 -0.79 . . . . 0.0 111.593 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 m -62.75 -39.46 94.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.339 0.655 . . . . 0.0 112.477 168.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -67.23 -40.66 86.36 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.627 1.103 . . . . 0.0 112.828 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -64.42 -36.03 82.85 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.805 0.842 . . . . 0.0 112.509 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.8 tpt -55.94 -45.86 78.69 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.214 0.915 . . . . 0.0 112.289 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.3 mm -66.58 -34.14 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.303 0.641 . . . . 0.0 111.254 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -37.2 86.31 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.437 -0.79 . . . . 0.0 112.99 174.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.8 t -70.62 -36.11 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.897 0.879 . . . . 0.0 110.956 176.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.1 mt -66.1 -40.95 91.18 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.335 -0.853 . . . . 0.0 113.129 169.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -62.08 -31.29 71.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.09 -1.007 . . . . 0.0 111.863 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.15 -20.0 64.86 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -98.81 -9.17 24.75 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.459 1.504 . . . . 0.0 113.563 172.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.77 11.17 57.11 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.402 1.477 . . . . 0.0 114.954 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.11 132.62 55.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.333 1.066 . . . . 0.0 111.831 172.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -114.89 159.23 20.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.951 0.9 . . . . 0.0 113.356 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -133.19 172.82 12.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.856 2.062 . . . . 0.0 111.604 -161.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.4 m -87.9 119.6 28.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.469 -1.394 . . . . 0.0 108.354 -168.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.6 m -125.93 129.29 48.98 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.162 -151.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -125.88 143.72 50.96 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -91.87 122.59 34.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.395 1.478 . . . . 0.0 111.396 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.0 m -66.92 -22.22 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.0 mt -87.04 -11.3 50.74 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.211 1.404 . . . . 0.0 112.92 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.13 -36.79 15.51 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -146.29 135.27 11.2 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.95 0.9 . . . . 0.0 111.069 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.25 -31.63 93.25 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.393 2.728 . . . . 0.0 113.204 -174.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 p -44.02 -42.7 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.616 1.567 . . . . 0.0 113.789 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 t -71.11 -47.86 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.801 1.182 . . . . 0.0 111.419 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -72.42 -25.41 61.47 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 63.7 m -71.2 -48.07 53.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.316 1.046 . . . . 0.0 112.274 169.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -66.18 -44.22 84.62 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.96 -1.088 . . . . 0.0 112.623 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.82 -35.31 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.291 -0.88 . . . . 0.0 112.065 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -69.59 -36.53 76.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.274 1.03 . . . . 0.0 112.728 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -74.48 -44.21 52.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.464 1.106 . . . . 0.0 113.718 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.0 t -81.91 -41.27 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.24 1.416 . . . . 0.0 113.001 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.0 m -101.1 -9.33 21.47 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 64.13 -24.15 0.07 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 128.697 2.799 . . . . 0.0 117.439 172.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -127.3 110.6 21.3 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.189 1.795 . . . . 0.0 107.925 158.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.03 125.94 4.25 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 121.117 1.211 . . . . 0.0 111.875 -171.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.4 p -136.05 126.75 27.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.352 1.861 . . . . 0.0 109.453 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.62 146.13 57.43 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 119.226 0.921 . . . . 0.0 110.999 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.69 155.27 92.39 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 120.201 1.108 . . . . 0.0 114.292 8.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -150.01 157.29 42.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.472 1.909 . . . . 0.0 110.576 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.73 139.03 52.41 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.251 1.021 . . . . 0.0 113.665 -172.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -129.78 145.8 51.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.514 1.926 . . . . 0.0 111.101 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.6 mt -129.12 125.86 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.792 1.237 . . . . 0.0 108.685 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 90' ' ' ASP . 2.3 mmpt? 46.59 53.66 9.7 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.674 1.59 . . . . 0.0 114.422 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 58.05 24.45 11.18 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.399 1.88 . . . . 0.0 115.934 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -123.53 139.3 54.15 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.902 -1.124 . . . . 0.0 111.522 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -68.35 123.73 21.55 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.082 0.953 . . . . 0.0 111.023 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.77 -43.16 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.497 1.519 . . . . 0.0 111.807 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.62 173.67 26.33 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 117.165 1.626 . . . . 0.0 117.165 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.95 173.23 54.9 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.466 1.507 . . . . 0.0 113.769 171.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.95 -41.38 33.81 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.28 1.432 . . . . 0.0 112.895 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.86 -36.54 83.61 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.948 -1.095 . . . . 0.0 112.82 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 mm -74.27 -45.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.672 1.589 . . . . 0.0 109.62 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.5 t -58.65 -39.72 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.996 0.918 . . . . 0.0 110.835 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 30.7 m -63.52 -46.05 87.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.229 1.011 . . . . 0.0 111.369 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 29.7 tttp -60.88 -43.77 97.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.96 1.304 . . . . 0.0 111.585 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 51.9 mtt -70.6 -38.73 74.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.831 1.253 . . . . 0.0 112.698 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.09 -46.72 61.24 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.386 0.994 . . . . 0.0 112.294 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -63.55 -33.65 76.06 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.646 0.657 . . . . 0.0 111.713 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.7 m -85.14 -17.65 36.6 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.66 -4.65 85.77 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.945 1.248 . . . . 0.0 115.142 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -64.92 -28.49 69.56 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.426 1.613 . . . . 0.0 113.538 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tt -59.54 -46.55 88.56 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.915 -1.116 . . . . 0.0 109.922 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -61.9 -32.92 73.34 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.172 1.789 . . . . 0.0 112.823 172.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -64.45 -39.81 94.54 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.596 1.089 . . . . 0.0 112.101 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.1 mtm -66.16 -51.18 60.26 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.749 1.261 . . . . 0.0 111.562 172.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 53.7 tp -65.14 -42.83 93.44 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.706 2.002 . . . . 0.0 111.122 -165.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -68.65 -38.2 80.25 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.276 1.03 . . . . 0.0 112.337 171.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.89 -27.25 69.02 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.905 0.775 . . . . 0.0 112.666 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 -5.23 45.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.894 1.678 . . . . 0.0 113.714 175.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.46 16.42 64.25 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 125.203 1.383 . . . . 0.0 114.687 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.17 143.92 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.24 1.416 . . . . 0.0 110.15 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.5 m -114.15 134.34 54.96 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.244 -0.91 . . . . 0.0 113.403 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.2 p -125.73 174.07 8.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 129.007 2.923 . . . . 0.0 111.994 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -40.18 138.95 0.78 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.695 1.198 . . . . 0.0 113.172 167.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -64.4 146.36 54.6 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.663 1.185 . . . . 0.0 112.482 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.9 tp . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.38 1.472 . . . . 0.0 111.019 175.148 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -67.16 -39.95 86.57 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.3 p -124.52 -160.52 0.94 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.047 0.939 . . . . 0.0 112.872 -161.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.16 11.64 81.75 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.067 0.842 . . . . 0.0 113.99 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mm -60.23 138.98 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.24 1.416 . . . . 0.0 110.162 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.51 148.54 19.24 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.955 1.264 . . . . 0.0 112.787 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.99 -152.31 10.7 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.045 1.307 . . . . 0.0 113.653 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.0 147.51 53.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.403 1.881 . . . . 0.0 111.746 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.33 131.32 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.138 0.975 . . . . 0.0 112.305 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -68.52 136.72 53.58 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.201 -0.937 . . . . 0.0 110.572 168.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -136.0 144.47 45.35 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.157 1.383 . . . . 0.0 110.568 -168.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.8 mt -113.45 130.15 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.017 0.927 . . . . 0.0 110.381 -174.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.86 142.63 58.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.038 1.335 . . . . 0.0 112.314 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.87 143.32 57.95 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.505 -0.747 . . . . 0.0 111.837 168.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.6 p -75.84 14.87 0.59 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.247 1.819 . . . . 0.0 115.727 -171.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -71.17 153.36 94.39 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.821 1.248 . . . . 0.0 113.743 -171.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.13 173.77 13.88 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.708 3.605 . . . . 0.0 112.879 171.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -82.32 5.43 20.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -175.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -63.01 150.15 43.15 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.985 -1.072 . . . . 0.0 113.216 -170.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -70.74 153.93 94.6 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.389 1.476 . . . . 0.0 112.282 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -58.23 154.89 37.64 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.115 3.21 . . . . 0.0 113.036 173.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -125.0 143.33 50.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.987 1.315 . . . . 0.0 112.126 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.81 173.4 6.77 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.051 1.74 . . . . 0.0 111.258 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 t 68.75 -34.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 128.57 2.748 . . . . 0.0 115.322 174.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.0 p -65.82 173.15 3.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.092 2.157 . . . . 0.0 114.311 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.81 55.61 0.82 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.783 1.633 . . . . 0.0 111.141 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -142.38 168.02 20.71 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.936 1.694 . . . . 0.0 112.649 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.3 168.28 10.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.624 1.57 . . . . 0.0 113.002 166.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.35 162.16 19.18 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.606 1.162 . . . . 0.0 112.501 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -64.57 -37.95 89.32 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 120.777 -1.202 . . . . 0.0 113.361 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.57 -33.35 69.84 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.978 -1.076 . . . . 0.0 112.443 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.12 -25.43 60.85 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.641 1.177 . . . . 0.0 112.93 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.6 tp -103.75 -28.1 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.897 1.279 . . . . 0.0 114.219 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.63 -9.71 59.48 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -166.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -67.33 147.49 52.89 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.449 -0.782 . . . . 0.0 112.007 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -128.6 88.9 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.895 1.678 . . . . 0.0 107.642 172.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -70.79 103.0 2.47 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -63.96 -37.97 89.37 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -163.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -74.08 -26.11 60.19 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.006 0.821 . . . . 0.0 112.813 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.96 -42.78 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.955 1.302 . . . . 0.0 110.085 173.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -58.65 -38.29 77.79 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.652 1.181 . . . . 0.0 111.631 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.21 -29.12 64.76 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.915 0.886 . . . . 0.0 112.406 169.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.1 m -63.95 -45.41 89.27 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 120.217 -1.552 . . . . 0.0 111.311 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.6 pt -62.13 -35.3 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.747 1.158 . . . . 0.0 112.13 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -77.74 -37.75 48.49 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.044 1.738 . . . . 0.0 112.069 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 t -68.15 -31.55 71.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.853 2.461 . . . . 0.0 113.293 173.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -86.87 147.85 25.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.15 1.78 . . . . 0.0 111.727 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.87 -35.7 16.39 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.017 -1.052 . . . . 0.0 111.863 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.3 t -139.9 130.75 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.95 1.3 . . . . 0.0 112.261 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.9 t -132.83 133.32 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.059 1.344 . . . . 0.0 111.379 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 t -131.72 154.6 48.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.998 0.919 . . . . 0.0 110.596 167.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -134.2 146.23 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.404 0.621 . . . . 0.0 112.463 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.07 161.72 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.078 1.751 . . . . 0.0 109.174 -166.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.72 104.25 8.15 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.375 -0.828 . . . . 0.0 109.543 146.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.28 -162.41 18.03 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.265 0.936 . . . . 0.0 114.87 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -107.1 158.24 33.44 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.916 2.086 . . . . 0.0 110.833 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.29 -25.77 56.79 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.733 1.622 . . . . 0.0 113.666 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -76.07 -24.41 55.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.734 1.214 . . . . 0.0 113.684 169.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.12 69.05 14.14 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.07 1.348 . . . . 0.0 111.894 -174.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.99 143.71 23.24 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.856 2.37 . . . . 0.0 110.372 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 mmt -88.58 5.15 44.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 13.5 t -152.21 146.76 25.7 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.124 1.37 . . . . 0.0 110.961 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.33 77.85 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -65.3 -37.89 88.53 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.894 -1.129 . . . . 0.0 111.761 172.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 m -65.14 -39.26 92.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.872 0.869 . . . . 0.0 112.361 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.53 -45.77 92.79 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.269 1.027 . . . . 0.0 112.144 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -58.19 -35.86 72.24 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.69 1.596 . . . . 0.0 112.957 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.4 ttp -59.13 -42.45 90.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.622 0.369 . . . . 0.0 111.941 173.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 mm -71.73 -33.82 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.572 0.749 . . . . 0.0 111.848 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -58.35 -38.68 77.69 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.8 -1.188 . . . . 0.0 112.336 172.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.425 HG13 ' HG ' ' A' ' 165' ' ' LEU . 2.2 t -63.48 -39.38 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.173 0.989 . . . . 0.0 111.081 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.6 mt -65.89 -39.18 90.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.554 0.742 . . . . 0.0 112.532 173.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -67.0 -31.56 72.2 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.903 -1.123 . . . . 0.0 112.018 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.89 -19.91 64.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.848 1.259 . . . . 0.0 114.235 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.75 -9.55 28.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.889 1.276 . . . . 0.0 113.297 166.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.41 9.2 42.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.342 0.972 . . . . 0.0 113.721 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.0 mt -114.29 130.33 56.66 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 125.683 1.593 . . . . 0.0 111.72 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -115.02 133.67 55.85 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.017 0.913 . . . . 0.0 111.594 170.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -105.06 172.12 6.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.603 2.361 . . . . 0.0 110.773 -172.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.5 m -87.24 123.1 31.88 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.668 -1.27 . . . . 0.0 109.811 -161.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.5 p -108.36 134.14 51.59 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.406 1.482 . . . . 0.0 114.904 -158.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -126.71 146.78 50.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.503 1.121 . . . . 0.0 113.023 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.46 106.04 14.81 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.013 1.325 . . . . 0.0 111.328 -167.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.54 -36.04 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.586 1.555 . . . . 0.0 112.262 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 tp -80.48 -22.05 41.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.335 0.654 . . . . 0.0 111.666 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.11 -39.31 16.86 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.49 -0.757 . . . . 0.0 112.679 167.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -126.1 103.06 26.92 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 118.982 0.81 . . . . 0.0 112.52 -169.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.08 -28.77 25.92 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.713 2.942 . . . . 0.0 115.021 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -49.7 -36.86 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.792 1.237 . . . . 0.0 113.5 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.34 -52.2 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.553 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.434 ' HA ' HG12 ' A' ' 136' ' ' VAL . 16.1 ptm180 -64.48 -26.11 68.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.69 0.796 . . . . 0.0 112.955 173.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.6 m -71.46 -51.96 20.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.163 0.585 . . . . 0.0 111.763 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -73.43 -34.92 65.7 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.564 -1.335 . . . . 0.0 114.206 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 133' ' ' ARG . 11.5 p -60.28 -34.34 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.715 1.143 . . . . 0.0 112.074 172.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 34.5 tttm -69.25 -35.21 75.88 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.139 0.881 . . . . 0.0 112.731 173.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.23 -37.74 86.52 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.221 1.373 . . . . 0.0 112.541 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.61 -45.26 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.1 m -106.08 -5.37 19.49 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 62.05 -48.09 0.16 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.517 2.327 . . . . 0.0 116.186 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -135.92 92.45 16.46 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.896 1.278 . . . . 0.0 111.546 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -101.47 156.7 0.37 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.838 3.692 . . . . 0.0 114.743 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 m -117.35 128.84 55.44 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.413 1.485 . . . . 0.0 110.393 161.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.22 140.69 25.79 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.879 1.272 . . . . 0.0 108.576 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -90.59 159.62 31.11 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-N 120.733 1.298 . . . . 0.0 113.693 1.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -160.2 171.65 18.83 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.464 1.106 . . . . 0.0 113.466 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.52 141.89 51.24 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.12 1.368 . . . . 0.0 113.455 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -128.29 141.71 51.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.61 1.964 . . . . 0.0 110.665 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 84.5 mt -129.65 135.63 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 125.049 1.339 . . . . 0.0 108.471 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 47.36 40.45 10.8 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.22 1.408 . . . . 0.0 113.509 -170.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.32 25.46 7.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.002 2.121 . . . . 0.0 115.526 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.87 142.47 46.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.513 1.525 . . . . 0.0 110.007 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -70.78 126.08 28.61 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.614 0.721 . . . . 0.0 112.088 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.7 t -101.57 -53.89 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.436 1.494 . . . . 0.0 111.078 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.82 160.6 26.41 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 116.058 1.183 . . . . 0.0 116.058 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 170.36 54.91 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.035 1.302 . . . . 0.0 112.769 165.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -49.31 -46.76 47.03 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.86 1.264 . . . . 0.0 114.337 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.9 -22.67 65.07 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.101 -0.999 . . . . 0.0 112.621 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.4 mm -82.23 -47.05 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.838 1.655 . . . . 0.0 110.664 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.67 -36.57 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.852 1.661 . . . . 0.0 111.024 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 55.1 m -59.69 -44.0 93.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.907 0.883 . . . . 0.0 111.881 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -66.41 -42.45 87.8 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.105 -0.997 . . . . 0.0 111.033 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.6 mtt -61.13 -43.83 98.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.597 0.759 . . . . 0.0 110.99 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.425 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.0 tm? -65.11 -48.85 72.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.078 0.951 . . . . 0.0 111.13 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.15 -16.26 61.98 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.165 1.386 . . . . 0.0 113.477 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m -91.32 -21.01 21.26 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 173.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.83 -2.35 88.25 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 121.718 -0.614 . . . . 0.0 113.927 -164.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.0 -33.55 74.84 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.688 1.244 . . . . 0.0 111.775 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.28 -45.63 92.41 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.363 -0.836 . . . . 0.0 110.689 172.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -63.48 -37.49 87.51 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.158 1.383 . . . . 0.0 113.105 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -61.38 -43.33 99.05 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 117.611 -1.185 . . . . 0.0 112.655 170.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 74.4 mtm -68.71 -48.02 64.89 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.939 1.245 . . . . 0.0 112.309 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 pp -64.04 -35.65 81.43 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.822 -0.549 . . . . 0.0 111.709 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -69.7 -35.76 75.35 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 121.496 -0.752 . . . . 0.0 112.952 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -65.2 -30.61 71.52 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.3 1.04 . . . . 0.0 111.876 171.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.99 5.28 6.81 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.014 1.726 . . . . 0.0 112.969 170.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.91 9.25 77.93 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.502 1.525 . . . . 0.0 114.796 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.4 mt -94.66 147.22 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.219 1.008 . . . . 0.0 110.854 -168.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.3 m -112.22 130.3 55.97 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.994 1.318 . . . . 0.0 111.101 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.5 p -138.36 169.51 17.66 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.977 1.711 . . . . 0.0 113.032 -169.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.0 ttt-85 -62.03 146.28 50.68 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.862 1.265 . . . . 0.0 110.813 164.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -123.2 133.62 54.21 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.621 1.169 . . . . 0.0 111.014 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.9 tp . . . . . 0 C--O 1.253 1.255 0 C-N-CA 128.002 2.521 . . . . 0.0 114.062 -169.966 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 119.811 -0.137 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.3 p -93.68 -21.87 19.09 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.7 m -78.96 166.7 22.08 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.175 -0.953 . . . . 0.0 112.774 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.6 13.55 82.35 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.654 -1.081 . . . . 0.0 114.948 172.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.7 mt -77.74 94.65 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.333 1.567 . . . . 0.0 109.934 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -174.97 159.15 27.43 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.657 2.075 . . . . 0.0 112.155 -176.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.61 -146.39 4.96 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 121.7 -0.883 . . . . 0.0 113.348 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -96.74 145.9 25.38 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.162 1.385 . . . . 0.0 110.287 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 p -148.01 157.81 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.735 1.214 . . . . 0.0 111.634 -171.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -87.69 122.28 31.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.883 0.873 . . . . 0.0 110.096 164.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.89 143.09 48.06 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.407 1.083 . . . . 0.0 112.798 -174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.8 tt -100.92 148.21 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.569 1.148 . . . . 0.0 113.673 -170.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -118.06 147.31 43.38 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.788 1.635 . . . . 0.0 111.029 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -136.55 143.11 43.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.736 1.214 . . . . 0.0 111.52 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 p -147.59 128.33 14.29 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.215 1.806 . . . . 0.0 109.665 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -87.32 141.37 32.56 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -172.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -60.62 164.48 13.36 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.535 3.49 . . . . 0.0 114.483 174.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -80.31 14.16 2.08 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -130.04 156.68 44.09 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.078 1.351 . . . . 0.0 111.199 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -72.07 152.22 92.69 Favored Pre-proline 0 CA--C 1.549 0.923 0 O-C-N 121.918 -0.489 . . . . 0.0 112.259 168.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.76 134.77 13.77 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.761 2.974 . . . . 0.0 112.165 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -119.75 104.3 10.12 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.699 1.6 . . . . 0.0 111.608 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.9 tt -162.22 -42.04 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.222 1.809 . . . . 0.0 110.699 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 p -153.91 152.7 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.648 1.579 . . . . 0.0 111.858 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -71.97 117.12 13.18 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.367 -0.833 . . . . 0.0 111.221 169.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.72 149.88 27.95 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.526 1.53 . . . . 0.0 111.119 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -69.1 -50.18 50.46 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.701 0.8 . . . . 0.0 113.052 -170.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.72 159.08 18.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.741 1.216 . . . . 0.0 113.063 -176.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.68 162.18 19.44 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.403 1.881 . . . . 0.0 110.611 166.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.83 -32.71 74.31 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -168.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.49 -34.97 60.9 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.825 1.193 . . . . 0.0 112.971 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.6 -36.4 70.81 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.04 -1.037 . . . . 0.0 112.525 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.8 tt -73.08 -18.06 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 O-C-N 120.794 -1.191 . . . . 0.0 112.316 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.37 -11.51 59.92 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.375 1.07 . . . . 0.0 113.237 168.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.1 tpt -78.44 122.61 26.05 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.152 -0.968 . . . . 0.0 109.506 161.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.2 t -135.87 122.33 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.083 1.353 . . . . 0.0 107.85 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -68.65 113.89 6.54 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.696 0.399 . . . . 0.0 110.157 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.4 -36.16 77.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.112 0.965 . . . . 0.0 112.988 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.15 -26.37 68.28 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 50.9 mm -77.42 -45.45 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.999 1.272 . . . . 0.0 110.857 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.32 -42.25 81.48 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.615 0.766 . . . . 0.0 111.487 170.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -68.27 -34.21 75.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.512 0.725 . . . . 0.0 112.329 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -66.88 -48.55 68.42 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.999 -1.063 . . . . 0.0 111.618 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.3 pt -64.4 -36.63 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.138 0.575 . . . . 0.0 111.867 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -79.19 -34.26 43.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.323 1.449 . . . . 0.0 113.681 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -80.1 -29.65 39.06 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.853 0.861 . . . . 0.0 113.243 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -87.42 133.49 33.73 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.955 0.902 . . . . 0.0 112.047 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -67.67 -38.22 83.43 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.3 t -142.33 127.2 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.331 1.053 . . . . 0.0 111.514 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.77 130.17 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.467 1.507 . . . . 0.0 111.557 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 t -131.75 155.3 47.95 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.079 0.952 . . . . 0.0 111.532 168.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -131.62 127.9 38.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.591 1.156 . . . . 0.0 110.394 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.14 173.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.22 1.808 . . . . 0.0 111.773 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 102.15 4.52 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.333 1.053 . . . . 0.0 109.919 161.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.82 -162.12 37.11 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.41 1.005 . . . . 0.0 115.156 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.11 148.67 43.51 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.117 0.967 . . . . 0.0 110.549 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.21 -23.89 77.98 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.148 2.565 . . . . 0.0 113.996 -175.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -78.37 -26.47 46.62 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.799 1.24 . . . . 0.0 113.907 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.17 67.05 10.62 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.903 1.281 . . . . 0.0 111.881 -175.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.19 152.91 45.72 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.527 2.151 . . . . 0.0 112.841 -172.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -74.06 -8.13 55.02 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.196 -0.94 . . . . 0.0 113.34 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.7 m -152.66 146.73 25.4 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -158.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.1 64.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.247 1.419 . . . . 0.0 112.447 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -67.68 -26.66 66.3 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.315 0.962 . . . . 0.0 111.36 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.3 m -68.32 -38.38 81.51 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.274 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.31 -45.49 91.1 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.305 1.411 . . . . 0.0 111.768 167.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -56.61 -37.65 70.98 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.485 0.714 . . . . 0.0 112.342 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.8 tpt -60.79 -46.56 90.02 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.278 1.431 . . . . 0.0 112.355 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.3 mm -72.96 -33.21 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.426 -0.796 . . . . 0.0 112.459 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -57.58 -32.69 67.41 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.206 -1.558 . . . . 0.0 112.795 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.419 HG13 ' HG ' ' A' ' 165' ' ' LEU . 4.0 t -62.61 -44.07 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.177 0.991 . . . . 0.0 111.168 172.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.35 -36.28 83.53 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.031 1.332 . . . . 0.0 112.83 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -71.83 -31.23 66.32 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.358 -1.463 . . . . 0.0 113.137 172.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.91 -29.84 69.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.228 1.011 . . . . 0.0 112.642 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.35 -14.35 40.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.268 1.027 . . . . 0.0 113.412 169.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.83 11.11 57.2 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.083 1.325 . . . . 0.0 114.527 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.09 131.61 55.75 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.932 1.293 . . . . 0.0 111.326 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -113.0 145.37 40.96 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.715 1.143 . . . . 0.0 112.421 174.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -113.54 172.29 7.05 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.459 1.904 . . . . 0.0 111.721 -175.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.8 m -88.86 120.4 30.23 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -164.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.2 m -125.67 136.03 52.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.608 -148.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -124.02 159.55 29.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.827 1.251 . . . . 0.0 111.985 -173.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -112.99 118.27 34.35 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.088 1.355 . . . . 0.0 110.677 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.85 -21.78 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.427 0.691 . . . . 0.0 112.857 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.42 -9.92 53.4 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.517 1.127 . . . . 0.0 112.644 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.46 -34.35 11.53 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.332 0.969 . . . . 0.0 112.61 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -138.36 88.65 14.63 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.213 0.605 . . . . 0.0 111.005 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.86 -12.51 22.4 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.21 2.607 . . . . 0.0 114.961 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -45.91 -33.77 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.662 1.119 . . . . 0.0 112.902 167.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.43 -43.62 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.337 1.055 . . . . 0.0 111.824 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.469 ' HA ' HG12 ' A' ' 136' ' ' VAL . 11.4 ptm180 -65.68 -28.61 69.21 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.257 0.935 . . . . 0.0 111.98 177.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.4 m -74.48 -39.43 62.49 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -69.84 -39.99 76.1 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.695 1.134 . . . . 0.0 111.313 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 133' ' ' ARG . 9.9 p -67.3 -32.11 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.808 -1.182 . . . . 0.0 112.233 175.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -61.49 -33.98 74.7 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.071 -1.018 . . . . 0.0 113.024 168.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -73.31 -47.85 39.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.182 0.993 . . . . 0.0 112.72 170.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.95 -34.43 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.0 m -100.61 -2.31 33.15 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 60.84 -38.74 0.1 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 130.221 3.408 . . . . 0.0 116.635 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -136.49 91.73 15.9 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.859 2.464 . . . . 0.0 109.572 173.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.41 136.58 8.82 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.117 2.545 . . . . 0.0 113.232 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.9 m -132.65 122.55 24.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.147 0.979 . . . . 0.0 109.85 165.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 12.6 pt -95.37 156.41 37.66 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.493 1.117 . . . . 0.0 113.683 -172.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.92 158.37 97.97 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 119.037 0.692 . . . . 0.0 112.978 -5.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -131.42 160.86 33.88 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.999 1.319 . . . . 0.0 111.433 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.84 139.95 53.06 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.278 1.431 . . . . 0.0 111.991 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -132.8 143.99 49.93 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.172 1.789 . . . . 0.0 110.28 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.1 mt -126.17 117.09 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 42.89 53.03 5.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 127.215 2.206 . . . . 0.0 114.324 -169.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 57.52 26.52 12.82 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -119.29 131.19 55.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.117 1.367 . . . . 0.0 109.224 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -74.33 125.03 27.59 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.86 -42.48 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.013 1.325 . . . . 0.0 111.662 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.35 177.88 30.88 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 169.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.98 169.31 54.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.831 1.205 . . . . 0.0 113.962 168.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -45.35 -44.48 11.79 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.147 1.779 . . . . 0.0 113.145 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.62 -45.04 93.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.356 0.662 . . . . 0.0 111.656 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 mm -68.45 -46.91 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.424 1.49 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.71 -36.21 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.946 1.699 . . . . 0.0 110.672 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 29.5 m -63.39 -46.04 88.29 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 118.8 -0.619 . . . . 0.0 111.701 173.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -63.61 -41.99 98.25 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.882 1.219 . . . . 0.0 110.82 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 54.6 mtt -64.17 -39.8 94.77 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.631 1.172 . . . . 0.0 112.399 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.419 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.1 tm? -66.09 -47.17 75.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.856 0.863 . . . . 0.0 110.874 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -70.93 -26.18 63.09 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.506 1.122 . . . . 0.0 113.283 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 75.2 m -105.18 0.88 27.75 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.24 -8.09 80.62 Favored Glycine 0 N--CA 1.478 1.442 0 CA-C-N 121.094 1.77 . . . . 0.0 115.419 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.55 -29.68 69.12 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.08 1.44 . . . . 0.0 112.885 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.34 -48.26 68.03 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.651 0.78 . . . . 0.0 110.782 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -60.62 -33.59 73.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.611 1.564 . . . . 0.0 112.889 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -59.02 -41.35 87.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.952 0.796 . . . . 0.0 112.821 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.8 mtm -67.32 -47.64 69.93 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.632 1.105 . . . . 0.0 112.143 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -37.97 87.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.251 0.62 . . . . 0.0 112.49 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -75.03 -33.98 61.84 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.412 -0.805 . . . . 0.0 112.989 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.78 -24.83 67.68 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.289 0.495 . . . . 0.0 111.955 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -80.31 -0.04 34.94 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.712 1.205 . . . . 0.0 113.825 171.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.32 22.02 57.53 Favored Glycine 0 CA--C 1.524 0.622 0 O-C-N 120.521 -1.362 . . . . 0.0 114.26 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 95.9 mt -99.4 145.04 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.666 1.233 . . . . 0.0 111.395 -173.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 99.2 m -91.42 126.89 36.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.685 1.194 . . . . 0.0 111.658 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 22.0 p -120.04 166.4 13.43 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.127 1.771 . . . . 0.0 112.193 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -61.47 155.12 22.64 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.954 1.701 . . . . 0.0 112.356 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -109.49 139.42 44.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.197 0.999 . . . . 0.0 111.917 167.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 70.9 mt . . . . . 0 C--O 1.254 1.339 0 C-N-CA 125.701 1.601 . . . . 0.0 113.168 176.822 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.3 p . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.7 p -78.47 -6.7 56.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.1 p -86.07 168.95 13.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.27 1.428 . . . . 0.0 113.156 176.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.23 83.85 Favored Glycine 0 CA--C 1.535 1.337 0 N-CA-C 115.366 0.907 . . . . 0.0 115.366 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mm -63.1 137.18 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.479 1.139 . . . . 0.0 109.937 174.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.34 174.38 22.61 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.234 0.921 . . . . 0.0 114.945 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.19 152.15 29.67 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.636 1.112 . . . . 0.0 114.833 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -85.2 139.48 31.63 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -161.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.4 t -115.16 138.16 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.194 1.398 . . . . 0.0 110.482 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -58.8 151.57 21.06 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -174.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -112.79 154.93 25.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.699 2.0 . . . . 0.0 112.381 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.93 23.28 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.916 1.686 . . . . 0.0 112.993 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -108.17 136.47 47.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.365 1.466 . . . . 0.0 111.436 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -82.37 150.92 26.9 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.566 -0.709 . . . . 0.0 112.01 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.3 p -125.31 100.74 6.65 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.503 1.521 . . . . 0.0 112.261 -173.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -72.6 147.63 89.64 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.519 1.128 . . . . 0.0 112.661 173.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.86 151.02 31.01 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.36 2.706 . . . . 0.0 109.938 161.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -88.36 -5.32 58.38 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -168.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -75.06 136.85 41.16 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.17 -0.956 . . . . 0.0 110.874 169.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -107.09 151.12 40.61 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.427 1.091 . . . . 0.0 112.198 -175.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.75 154.58 43.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.452 2.768 . . . . 0.0 113.391 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -81.52 134.49 35.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.015 2.126 . . . . 0.0 111.212 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.9 mt 51.86 -174.88 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.839 1.656 . . . . 0.0 113.523 -172.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.5 133.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 120.3 -1.5 . . . . 0.0 110.372 173.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.2 m -97.48 152.03 19.4 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -172.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.59 6.83 11.03 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.823 1.649 . . . . 0.0 113.568 168.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -74.45 149.17 40.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.823 1.649 . . . . 0.0 111.815 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 36.9 tp -110.03 129.04 55.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.916 0.886 . . . . 0.0 110.693 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -148.75 173.97 12.68 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.917 1.287 . . . . 0.0 113.047 -163.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.38 -42.14 92.99 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -159.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.28 -33.63 74.7 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 120.342 1.428 . . . . 0.0 111.757 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.09 -40.29 95.91 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.032 0.933 . . . . 0.0 111.348 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.0 pt -85.1 -23.07 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.119 0.968 . . . . 0.0 113.493 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.76 -28.09 50.52 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.33 0.968 . . . . 0.0 112.399 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 78.8 mtm -80.59 115.45 20.11 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.759 0.708 . . . . 0.0 110.767 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.46 85.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.847 1.308 . . . . 0.0 108.961 171.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -78.97 103.7 9.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.468 1.507 . . . . 0.0 110.251 -169.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -65.61 -28.85 69.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.253 1.421 . . . . 0.0 113.665 -170.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.81 -32.27 73.71 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.63 0.772 . . . . 0.0 113.037 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.0 mp -76.25 -44.04 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.089 0.956 . . . . 0.0 109.661 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.32 -39.52 87.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.087 0.955 . . . . 0.0 111.83 173.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.63 -38.88 92.53 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.865 -1.147 . . . . 0.0 112.188 170.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.2 m -66.41 -43.25 86.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.74 0.816 . . . . 0.0 112.331 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 pt -60.72 -33.35 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.356 0.98 . . . . 0.0 112.928 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -78.81 -23.55 45.08 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.907 1.683 . . . . 0.0 114.542 173.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.0 t -89.22 -32.82 17.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.361 1.865 . . . . 0.0 113.061 -174.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -88.86 143.18 27.06 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.767 1.227 . . . . 0.0 111.245 169.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.26 -33.13 61.25 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.38 -0.825 . . . . 0.0 111.105 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.3 t -142.82 131.46 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.65 1.18 . . . . 0.0 111.512 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -134.36 139.12 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.097 1.359 . . . . 0.0 111.773 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 t -134.24 156.54 48.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.086 1.355 . . . . 0.0 111.299 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 147' ' ' GLN . 1.1 p90 -132.0 135.33 46.46 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.764 0.825 . . . . 0.0 110.839 173.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.65 167.64 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.585 1.954 . . . . 0.0 110.391 -168.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.11 112.55 15.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 152.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.43 -153.66 46.49 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 123.142 0.401 . . . . 0.0 113.811 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.18 160.07 65.73 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.838 1.655 . . . . 0.0 111.066 -166.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.75 -24.94 20.93 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 N-CA-C 116.515 1.698 . . . . 0.0 116.515 -156.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -98.89 -3.87 34.25 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.805 1.242 . . . . 0.0 113.402 168.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -141.62 71.97 25.19 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.531 1.532 . . . . 0.0 110.787 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.18 155.7 25.74 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.621 2.881 . . . . 0.0 112.818 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.99 7.06 18.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.36 1.464 . . . . 0.0 113.552 175.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 16.6 t -148.47 147.43 29.12 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.685 -1.26 . . . . 0.0 111.788 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.78 -41.07 77.03 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.598 -0.689 . . . . 0.0 112.011 170.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -66.66 -27.34 67.59 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.597 -0.689 . . . . 0.0 112.331 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.4 m -64.85 -47.49 77.71 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.318 -0.864 . . . . 0.0 110.936 169.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.31 -41.28 88.66 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.955 0.798 . . . . 0.0 111.298 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -61.22 -35.98 78.69 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.633 1.173 . . . . 0.0 114.06 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.7 tpt -62.13 -41.9 98.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.876 0.762 . . . . 0.0 111.246 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.6 mm -72.06 -36.91 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.26 -0.9 . . . . 0.0 112.259 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -58.23 -30.96 66.92 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.646 1.178 . . . . 0.0 112.496 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.06 -47.14 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.744 1.618 . . . . 0.0 112.141 170.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 44.9 mt -66.2 -35.49 80.59 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.144 -0.973 . . . . 0.0 113.08 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -62.4 -39.55 93.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.448 1.099 . . . . 0.0 112.011 168.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.73 -26.17 66.01 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.166 -0.959 . . . . 0.0 113.285 176.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.6 tp -86.79 -15.48 39.16 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.09 2.14 16.76 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 124.821 1.201 . . . . 0.0 115.146 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.51 135.35 54.18 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.876 1.671 . . . . 0.0 111.402 172.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -109.96 151.8 26.66 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.431 1.11 . . . . 0.0 113.286 171.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -130.2 168.9 16.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.897 2.079 . . . . 0.0 110.448 -172.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.1 m -90.33 133.73 34.78 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.868 -1.145 . . . . 0.0 111.192 -159.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.5 p -129.39 147.8 51.25 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -164.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.2 153.78 47.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.203 1.801 . . . . 0.0 111.677 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -89.96 113.96 25.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.122 0.969 . . . . 0.0 112.085 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.9 -16.78 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 121.227 -0.921 . . . . 0.0 113.265 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -73.19 -29.5 62.87 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.327 -0.858 . . . . 0.0 111.236 169.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.84 -33.78 21.23 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -130.2 102.35 17.29 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 118.744 0.702 . . . . 0.0 112.776 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -60.23 -21.66 67.38 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.221 2.614 . . . . 0.0 115.494 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 p -52.51 -31.14 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 120.05 1.296 . . . . 0.0 113.347 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.7 -47.65 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.349 -0.844 . . . . 0.0 110.592 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -67.79 -30.49 69.94 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.472 1.033 . . . . 0.0 112.831 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.5 m -58.58 -49.08 78.77 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.834 0.853 . . . . 0.0 111.993 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -74.1 -49.37 24.2 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 168.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.6 t -60.45 -41.65 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 121.083 -1.011 . . . . 0.0 113.286 -165.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -63.48 -34.87 78.72 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.233 0.54 . . . . 0.0 111.474 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.14 -50.6 11.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.271 1.829 . . . . 0.0 112.84 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.67 -30.38 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.124 0.969 . . . . 0.0 112.806 -175.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 84.4 p -90.05 -3.94 57.67 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 59.61 -34.56 0.06 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 129.839 3.256 . . . . 0.0 116.239 -171.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -145.65 110.69 4.52 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.604 1.561 . . . . 0.0 109.789 173.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -89.11 130.65 2.09 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 121.905 1.736 . . . . 0.0 114.16 -165.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 p -129.33 133.53 47.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.683 1.593 . . . . 0.0 109.97 166.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.3 pt -128.5 156.53 77.0 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 124.926 1.29 . . . . 0.0 113.678 -167.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -61.73 162.98 42.96 Favored 'Cis proline' 0 C--N 1.356 0.944 0 CA-C-N 119.967 1.024 . . . . 0.0 113.88 -5.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.426 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 18.9 tt0 -151.08 158.32 43.9 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.347 0.659 . . . . 0.0 111.729 -164.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.22 139.08 53.18 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.856 1.313 . . . . 0.0 113.724 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -120.46 140.89 50.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.787 -2.006 . . . . 0.0 109.43 169.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 53.7 mt -125.75 121.92 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 173.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.2 tptt 45.46 52.88 8.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.516 1.926 . . . . 0.0 114.073 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.72 27.46 16.72 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -121.55 136.48 54.95 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.344 1.457 . . . . 0.0 110.553 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -74.38 123.71 25.15 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.564 0.697 . . . . 0.0 111.114 174.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.6 t -103.93 -54.38 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 126.272 1.829 . . . . 0.0 111.565 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.93 166.7 23.24 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 116.967 1.547 . . . . 0.0 116.967 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.89 172.11 55.17 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.37 1.938 . . . . 0.0 113.609 170.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.2 tp -56.53 -35.82 68.53 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.472 1.109 . . . . 0.0 113.476 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.36 -33.48 75.62 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.994 0.816 . . . . 0.0 112.541 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.5 mm -77.66 -46.76 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.247 1.419 . . . . 0.0 110.475 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.69 -36.31 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.701 1.2 . . . . 0.0 110.777 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 94.6 m -59.25 -40.41 85.89 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.898 0.879 . . . . 0.0 112.108 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -65.08 -50.27 66.8 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.966 0.803 . . . . 0.0 110.157 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 47.6 mtt -61.49 -37.34 83.3 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.245 1.018 . . . . 0.0 112.333 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.36 -39.01 81.98 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.357 1.863 . . . . 0.0 112.369 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -76.95 -30.75 56.17 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 41.1 t -84.55 -26.45 28.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.024 1.33 . . . . 0.0 114.482 -172.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.31 -6.35 63.43 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-N 119.142 0.883 . . . . 0.0 114.554 -169.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.29 -32.49 72.67 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.77 1.785 . . . . 0.0 112.402 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.06 -46.15 88.83 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.203 -0.936 . . . . 0.0 110.147 174.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -62.02 -37.99 86.95 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.254 1.422 . . . . 0.0 113.199 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -67.41 -35.25 78.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.362 1.065 . . . . 0.0 112.596 175.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 60.5 mtm -70.07 -52.1 26.61 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.167 0.894 . . . . 0.0 113.143 169.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 pp -64.78 -35.88 82.51 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.251 -0.906 . . . . 0.0 112.368 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -71.8 -30.94 66.06 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.88 -36.8 82.33 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.58 0.627 . . . . 0.0 111.947 167.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.54 2.6 11.25 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.798 1.639 . . . . 0.0 113.964 175.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.54 12.57 81.61 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.121 1.343 . . . . 0.0 113.853 176.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.6 mt -93.91 149.63 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.027 1.331 . . . . 0.0 110.004 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.2 m -103.27 146.77 27.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.222 1.409 . . . . 0.0 110.947 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.7 p -141.75 167.67 21.6 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.81 1.644 . . . . 0.0 112.213 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -70.06 159.33 34.05 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.381 1.073 . . . . 0.0 112.372 168.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.0 147.9 23.22 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.79 1.236 . . . . 0.0 112.759 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 21.8 tp . . . . . 0 C--O 1.252 1.231 0 C-N-CA 129.501 3.12 . . . . 0.0 116.206 178.982 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.861 0.362 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.2 m -71.19 -19.36 62.41 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -161.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 m -124.87 20.67 8.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.014 1.326 . . . . 0.0 112.412 170.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.9 -22.3 0.92 Allowed Glycine 0 CA--C 1.54 1.636 0 C-N-CA 126.295 1.902 . . . . 0.0 116.187 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 tp -136.29 155.53 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.983 2.113 . . . . 0.0 109.521 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.46 147.04 24.25 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.841 1.21 . . . . 0.0 115.47 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.42 175.32 25.65 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.62 1.581 . . . . 0.0 115.542 -170.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -123.68 131.85 53.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.948 2.099 . . . . 0.0 109.946 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.5 p -88.54 137.58 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.537 0.735 . . . . 0.0 111.953 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -134.67 170.83 15.22 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.589 1.556 . . . . 0.0 113.424 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -154.91 153.05 30.48 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.471 1.908 . . . . 0.0 112.121 172.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.3 mt -127.78 72.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.171 1.388 . . . . 0.0 108.5 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -140.13 144.68 36.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.229 1.014 . . . . 0.0 113.003 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -91.77 133.42 35.64 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 126.371 1.868 . . . . 0.0 110.976 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.5 p -140.11 53.25 1.66 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.031 0.932 . . . . 0.0 112.599 -157.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.2 156.23 36.08 Favored Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 120.769 -1.207 . . . . 0.0 112.848 158.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.11 -179.35 3.44 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.624 2.883 . . . . 0.0 112.197 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.48 15.12 0.5 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.963 1.705 . . . . 0.0 111.634 169.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -122.5 135.21 54.6 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.059 2.144 . . . . 0.0 111.206 -168.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -109.96 140.58 22.44 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.653 0.781 . . . . 0.0 110.509 156.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.98 160.6 43.57 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.008 2.472 . . . . 0.0 110.117 159.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -64.66 135.23 55.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.928 -1.108 . . . . 0.0 111.691 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.76 147.08 36.41 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.968 1.707 . . . . 0.0 112.024 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.06 -30.4 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.773 1.629 . . . . 0.0 111.418 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 m -142.25 133.87 26.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.74 1.616 . . . . 0.0 110.749 165.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.19 146.68 53.96 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -167.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -157.78 173.6 16.56 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.349 1.06 . . . . 0.0 112.824 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.6 mt -84.4 155.79 22.12 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.606 1.162 . . . . 0.0 111.861 168.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.9 133.51 34.29 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.937 -0.477 . . . . 0.0 110.447 159.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -58.71 -34.37 71.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.903 1.281 . . . . 0.0 112.008 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.39 -28.23 62.87 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.115 1.366 . . . . 0.0 112.951 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.64 -42.35 58.7 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 119.869 -1.77 . . . . 0.0 113.024 175.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.4 tp -75.56 -17.73 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.3 -3.65 55.1 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 169.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -99.01 137.7 37.16 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.193 1.797 . . . . 0.0 111.188 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 p -94.4 130.45 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 122.041 0.924 . . . . 0.0 111.305 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -86.24 136.29 33.23 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -53.71 -43.35 68.95 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.492 0.717 . . . . 0.0 112.583 -167.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -61.95 -27.74 69.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.49 1.116 . . . . 0.0 113.726 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.89 -54.66 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 118.808 0.731 . . . . 0.0 109.483 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.66 -37.71 88.38 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.772 0.829 . . . . 0.0 111.454 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -68.96 -43.91 74.04 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.8 m -73.73 -40.19 63.73 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.394 -1.441 . . . . 0.0 112.043 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.6 pt -61.89 -35.55 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.17 0.588 . . . . 0.0 111.844 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -77.9 -32.96 52.1 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.505 1.922 . . . . 0.0 113.718 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.5 t -73.03 -15.99 61.51 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.845 1.258 . . . . 0.0 113.299 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -104.2 145.27 30.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.95 1.3 . . . . 0.0 113.969 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -83.46 -39.49 20.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.947 0.899 . . . . 0.0 111.366 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.57 137.87 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 126.731 2.012 . . . . 0.0 109.839 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.8 t -133.93 128.0 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.626 1.17 . . . . 0.0 110.566 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -136.66 156.95 47.86 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.943 1.297 . . . . 0.0 110.916 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.406 ' CE1' HG21 ' A' ' 136' ' ' VAL . 52.7 p90 -129.32 145.93 51.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.088 0.955 . . . . 0.0 111.282 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 mt -137.39 151.3 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.198 0.599 . . . . 0.0 111.406 -166.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.49 108.32 3.25 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 159.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.08 -136.36 15.59 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 118.582 0.628 . . . . 0.0 113.115 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.7 mt -123.16 158.4 58.07 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.728 2.011 . . . . 0.0 111.447 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.53 -23.47 37.12 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 121.976 1.784 . . . . 0.0 115.067 -173.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.7 -15.38 25.32 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.235 0.925 . . . . 0.0 113.221 169.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.95 68.68 70.93 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.213 1.405 . . . . 0.0 111.635 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.01 146.11 25.45 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.215 2.61 . . . . 0.0 111.414 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 96.4 mtp -97.69 4.79 49.93 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.488 1.515 . . . . 0.0 113.518 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.9 t -146.57 145.52 30.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.44 1.496 . . . . 0.0 111.078 -175.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.82 -44.12 97.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.215 0.606 . . . . 0.0 111.996 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -72.39 -24.7 61.29 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.935 -1.103 . . . . 0.0 112.567 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.0 m -68.42 -43.1 77.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.649 0.78 . . . . 0.0 111.6 167.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -61.4 -44.81 96.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.813 0.845 . . . . 0.0 111.861 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -57.8 -37.28 73.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.277 1.831 . . . . 0.0 113.036 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.9 ttp -63.58 -46.8 84.19 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.434 0.561 . . . . 0.0 111.624 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 mm -69.72 -33.01 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.346 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -57.98 -36.69 72.97 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.935 1.243 . . . . 0.0 113.026 170.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.13 -42.14 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.799 0.839 . . . . 0.0 111.1 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.35 -38.94 88.75 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.405 1.082 . . . . 0.0 112.678 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.05 -25.55 66.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.179 1.791 . . . . 0.0 112.723 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.27 73.45 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.06 -11.6 35.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.169 0.988 . . . . 0.0 113.327 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.73 20.3 70.13 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.477 1.037 . . . . 0.0 115.043 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.42 130.35 56.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.466 0.633 . . . . 0.0 109.462 156.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -115.78 131.31 56.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.472 0.709 . . . . 0.0 109.706 168.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -105.07 171.93 7.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.988 1.715 . . . . 0.0 113.021 -163.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.4 m -84.73 125.88 32.92 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.462 1.125 . . . . 0.0 108.861 -170.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.7 m -125.53 133.28 52.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.561 -154.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.04 141.98 46.24 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.097 0.951 . . . . 0.0 112.819 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -98.45 78.71 2.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.026 1.731 . . . . 0.0 112.164 -167.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.0 p -61.52 -28.3 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.263 1.425 . . . . 0.0 114.321 -172.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.0 tp -78.15 -22.69 48.39 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.664 -0.648 . . . . 0.0 111.533 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.87 -32.95 13.0 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 175.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -130.06 98.12 21.95 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.046 0.938 . . . . 0.0 112.055 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -62.19 -9.68 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.042 3.161 . . . . 0.0 116.247 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 p -48.78 -36.49 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.015 -1.053 . . . . 0.0 111.945 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.43 -47.9 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.232 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -67.57 -29.22 68.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.1 0.864 . . . . 0.0 112.243 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.2 m -70.5 -50.5 37.18 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -72.16 -39.43 68.74 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.956 0.798 . . . . 0.0 111.711 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.406 HG21 ' CE1' ' A' ' 94' ' ' PHE . 9.0 p -61.29 -35.36 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.109 0.868 . . . . 0.0 113.061 -175.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.84 -46.34 78.91 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.979 0.809 . . . . 0.0 111.568 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -64.79 -34.58 78.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.156 0.982 . . . . 0.0 113.067 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.3 t -80.3 -41.56 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.1 t -97.47 -14.27 21.25 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -168.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 67.34 -40.66 0.4 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.874 2.07 . . . . 0.0 115.079 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -130.0 104.85 16.73 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.118 1.767 . . . . 0.0 110.529 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -88.14 128.43 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.563 2.176 . . . . 0.0 112.464 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 75.1 p -131.53 146.97 52.48 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.144 2.178 . . . . 0.0 108.58 169.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.1 tt -108.46 134.93 20.07 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 119.241 0.928 . . . . 0.0 111.9 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -79.99 162.75 83.91 Favored 'Cis proline' 0 CA--C 1.551 1.35 0 CA-C-N 119.835 0.977 . . . . 0.0 111.799 -16.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -134.18 161.58 34.51 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.893 1.677 . . . . 0.0 111.288 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.59 141.82 50.87 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -130.92 141.05 50.26 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.532 1.933 . . . . 0.0 110.073 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 60.3 mt -140.54 134.05 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.731 1.213 . . . . 0.0 109.556 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt 52.96 41.75 32.11 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.687 1.595 . . . . 0.0 114.162 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.04 14.2 5.19 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.95 2.1 . . . . 0.0 115.568 -172.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -111.42 140.89 45.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.625 1.57 . . . . 0.0 110.618 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -77.84 126.25 30.57 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.257 -0.902 . . . . 0.0 112.898 175.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.3 t -101.03 -48.05 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.555 1.542 . . . . 0.0 111.835 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 162.91 170.55 27.94 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.7 169.14 54.62 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.268 1.413 . . . . 0.0 113.685 166.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -46.69 -46.89 20.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.861 1.665 . . . . 0.0 114.746 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.56 -39.06 75.84 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.543 -0.723 . . . . 0.0 111.531 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.9 mm -72.62 -47.45 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.57 1.948 . . . . 0.0 111.56 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.35 -35.76 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.903 0.881 . . . . 0.0 110.503 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.1 m -62.06 -39.31 91.96 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.744 0.818 . . . . 0.0 112.153 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -64.29 -46.69 82.53 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.184 0.902 . . . . 0.0 110.633 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 47.5 mtt -61.65 -38.76 88.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.137 0.975 . . . . 0.0 111.812 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.61 -44.16 87.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.565 1.146 . . . . 0.0 111.781 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.25 -34.38 65.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 t -105.54 3.23 29.13 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -171.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.26 -0.41 75.12 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 116.259 1.263 . . . . 0.0 116.259 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -71.65 -31.85 67.28 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.561 1.181 . . . . 0.0 113.245 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.75 -43.77 83.24 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.483 -1.385 . . . . 0.0 109.951 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -58.22 -44.59 88.24 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.128 1.771 . . . . 0.0 112.307 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -57.28 -46.16 83.37 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.248 1.019 . . . . 0.0 110.932 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 65.1 mtm -69.59 -49.87 49.93 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.9 -37.73 86.87 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.613 -0.679 . . . . 0.0 112.638 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -71.66 -30.8 66.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.188 0.995 . . . . 0.0 111.99 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.77 -31.05 72.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.432 0.693 . . . . 0.0 112.199 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -76.05 -0.18 20.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.96 1.304 . . . . 0.0 113.51 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.4 24.87 60.12 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 124.153 0.882 . . . . 0.0 113.435 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 46.2 mt -105.42 140.4 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.012 0.906 . . . . 0.0 110.893 -174.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.0 m -94.2 125.33 38.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.859 1.264 . . . . 0.0 112.037 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.1 p -118.35 173.26 6.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.096 2.559 . . . . 0.0 111.691 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -55.18 120.72 7.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.359 0.664 . . . . 0.0 111.691 164.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -112.85 121.74 45.6 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.58 1.552 . . . . 0.0 108.71 170.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 49.9 tp . . . . . 0 C--O 1.253 1.254 0 C-N-CA 124.374 1.07 . . . . 0.0 112.351 -167.705 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 119.603 -0.237 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 p -66.16 -18.23 65.22 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.375 1.47 . . . . 0.0 114.781 -174.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.7 m -128.72 146.83 50.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.363 1.465 . . . . 0.0 111.914 165.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.62 -5.87 70.3 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 117.382 1.713 . . . . 0.0 117.382 163.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.3 tt -139.27 156.99 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.367 1.583 . . . . 0.0 111.055 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.41 166.54 54.59 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 123.973 0.797 . . . . 0.0 114.673 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.08 148.21 40.77 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.448 1.023 . . . . 0.0 114.871 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -136.87 137.32 39.54 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.659 1.183 . . . . 0.0 111.454 -171.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.05 126.0 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.628 1.171 . . . . 0.0 113.402 -168.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -70.97 151.81 44.26 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -88.03 141.46 28.56 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.386 1.474 . . . . 0.0 113.219 -166.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.1 tp -59.6 135.02 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.205 1.402 . . . . 0.0 112.455 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -91.3 117.12 29.39 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.191 0.996 . . . . 0.0 110.961 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -144.17 162.41 36.39 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.798 2.039 . . . . 0.0 110.65 -171.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 m -128.44 138.09 52.15 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.976 1.31 . . . . 0.0 110.477 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -94.04 136.1 24.01 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.759 0.823 . . . . 0.0 112.162 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.8 162.07 29.96 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.925 2.417 . . . . 0.0 112.232 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.53 -9.8 59.61 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.462 1.105 . . . . 0.0 112.986 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -126.43 111.19 14.16 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.32 1.448 . . . . 0.0 108.214 170.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -106.55 153.2 40.74 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 127.116 2.167 . . . . 0.0 111.183 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.45 153.15 23.7 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.271 2.647 . . . . 0.0 114.62 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.7 ttm105 -108.92 140.49 42.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.706 2.402 . . . . 0.0 110.549 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.1 tp -145.43 -72.12 0.25 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.547 0.739 . . . . 0.0 111.904 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.4 t -106.95 -43.61 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.186 0.994 . . . . 0.0 109.681 166.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.1 m -112.54 168.61 9.51 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.486 1.514 . . . . 0.0 111.516 162.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.08 167.45 10.66 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.032 1.733 . . . . 0.0 112.024 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 52.66 61.96 2.93 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.203 1.801 . . . . 0.0 115.653 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.6 tp -139.35 139.21 37.17 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.519 1.128 . . . . 0.0 111.448 168.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.58 161.0 38.99 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.691 1.196 . . . . 0.0 113.522 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -56.01 -28.77 58.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.594 1.558 . . . . 0.0 113.432 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -59.31 -38.84 81.27 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.905 1.682 . . . . 0.0 112.789 175.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -79.06 -41.23 29.28 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 165.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.22 -30.3 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 120.501 -1.374 . . . . 0.0 112.22 -168.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.12 0.18 56.93 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 80.0 mmm -120.79 127.97 52.45 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.837 1.255 . . . . 0.0 112.364 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -85.81 146.69 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.342 0.657 . . . . 0.0 110.796 163.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -93.82 123.18 36.99 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.075 1.35 . . . . 0.0 111.153 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -61.51 -32.48 72.52 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -169.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.78 -38.88 80.34 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.155 1.343 . . . . 0.0 112.058 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.4 mt -70.45 -50.57 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.094 0.958 . . . . 0.0 109.458 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.05 -39.68 94.61 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.059 1.344 . . . . 0.0 112.526 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.23 -32.57 72.86 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.626 -0.671 . . . . 0.0 112.617 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.9 m -71.06 -48.03 55.06 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.566 1.075 . . . . 0.0 111.584 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.6 pt -62.04 -34.31 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.78 0.832 . . . . 0.0 112.054 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -78.5 -35.17 46.8 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.468 1.507 . . . . 0.0 113.534 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.5 t -72.63 -37.85 67.91 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.339 1.056 . . . . 0.0 113.015 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -87.13 133.51 33.62 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.157 0.889 . . . . 0.0 111.956 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.38 -38.31 77.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.731 -0.606 . . . . 0.0 111.717 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.5 t -143.92 131.66 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.216 1.806 . . . . 0.0 110.296 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -135.02 133.19 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.507 1.123 . . . . 0.0 112.118 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.0 t -131.41 155.13 47.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.954 1.302 . . . . 0.0 110.97 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -131.2 140.48 49.9 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.168 0.987 . . . . 0.0 111.79 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mt -140.54 155.65 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.031 1.332 . . . . 0.0 110.901 -158.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.1 102.22 1.6 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.124 0.569 . . . . 0.0 109.467 155.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.97 -143.97 23.55 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.302 -0.874 . . . . 0.0 114.7 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.1 mt -107.3 155.69 38.99 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 125.438 1.495 . . . . 0.0 111.929 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -63.9 -32.2 66.37 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.413 1.408 . . . . 0.0 112.356 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -75.2 -26.78 59.26 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.242 1.017 . . . . 0.0 113.124 172.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.81 76.51 15.48 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.31 1.444 . . . . 0.0 112.354 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.84 144.85 24.82 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.124 2.549 . . . . 0.0 111.772 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.84 10.87 28.54 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.134 1.773 . . . . 0.0 113.815 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.4 t -147.5 146.09 29.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.222 1.409 . . . . 0.0 110.233 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.52 -45.89 87.89 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.482 0.658 . . . . 0.0 111.846 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -70.73 -26.45 63.39 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.103 -0.998 . . . . 0.0 112.138 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -68.49 -38.3 80.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.255 -0.903 . . . . 0.0 112.681 166.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -65.49 -39.28 91.71 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.339 0.972 . . . . 0.0 112.285 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -59.58 -33.1 71.02 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.965 1.306 . . . . 0.0 112.873 174.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.7 tpt -61.51 -42.94 99.56 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.505 0.722 . . . . 0.0 111.74 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.12 -33.91 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.555 0.742 . . . . 0.0 111.654 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -39.79 74.58 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.741 1.216 . . . . 0.0 111.713 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.93 -43.41 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.475 1.51 . . . . 0.0 111.868 172.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.96 -37.96 89.33 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.696 -0.628 . . . . 0.0 112.102 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -69.36 -31.93 70.67 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.407 -0.808 . . . . 0.0 112.762 173.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.88 76.65 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.457 -0.777 . . . . 0.0 112.334 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.6 mt -87.01 -12.61 46.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.199 1.0 . . . . 0.0 113.298 171.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.5 15.01 63.24 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.884 1.707 . . . . 0.0 114.309 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.38 132.45 55.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.405 1.103 . . . . 0.0 113.449 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -110.82 157.36 19.9 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.249 1.02 . . . . 0.0 113.04 169.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -145.65 170.76 15.83 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.667 2.787 . . . . 0.0 110.531 -163.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.6 m -85.28 124.22 31.65 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.623 -1.298 . . . . 0.0 109.787 -168.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.9 m -130.43 132.09 45.55 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.041 1.336 . . . . 0.0 111.393 -156.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.5 143.18 48.69 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -87.65 121.1 29.66 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.693 1.197 . . . . 0.0 109.965 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.0 m -67.22 -21.2 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.049 0.94 . . . . 0.0 113.137 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.9 mt -88.34 -25.08 22.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.095 1.358 . . . . 0.0 114.446 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.11 -33.3 22.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -164.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -148.21 149.78 33.1 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.881 1.272 . . . . 0.0 110.087 -172.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.86 -6.9 19.85 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.862 2.375 . . . . 0.0 114.543 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.68 -40.37 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.704 -1.248 . . . . 0.0 113.318 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.35 -47.2 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.275 -0.891 . . . . 0.0 110.939 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -59.31 -30.19 68.16 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.27 0.941 . . . . 0.0 113.354 171.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.0 m -69.98 -44.75 68.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -77.66 -40.36 41.91 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.22 -43.87 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -159.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -69.46 -35.49 75.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.733 0.778 . . . . 0.0 110.32 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -67.39 -43.92 80.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.242 1.817 . . . . 0.0 113.343 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.54 -36.23 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.991 0.917 . . . . 0.0 113.297 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.6 p -102.37 1.13 35.09 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 -173.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 62.45 -30.84 0.08 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.589 2.355 . . . . 0.0 115.965 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -151.93 138.29 11.75 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.183 1.393 . . . . 0.0 111.349 167.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.75 128.38 19.83 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.206 1.937 . . . . 0.0 112.759 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.6 m -139.94 140.87 36.46 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.322 -1.486 . . . . 0.0 110.419 157.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.8 mt -122.83 135.62 25.96 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.443 1.097 . . . . 0.0 110.929 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -82.33 165.61 71.76 Favored 'Cis proline' 0 CA--C 1.543 0.973 0 CA-C-N 119.934 1.012 . . . . 0.0 111.837 -10.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -143.19 159.73 41.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.028 1.331 . . . . 0.0 111.96 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.1 140.15 51.69 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.515 1.126 . . . . 0.0 113.881 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -129.76 143.93 51.05 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.18 1.792 . . . . 0.0 110.514 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 55.2 mt -132.95 128.14 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.544 1.137 . . . . 0.0 108.341 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt 47.32 49.59 15.39 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.023 1.729 . . . . 0.0 115.544 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.87 19.11 9.39 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -122.59 147.1 46.81 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.502 1.921 . . . . 0.0 110.564 176.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -85.44 126.25 33.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.145 0.974 . . . . 0.0 112.88 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.1 t -100.26 -46.02 11.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 125.1 1.36 . . . . 0.0 110.602 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 158.73 179.0 33.26 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 117.261 1.665 . . . . 0.0 117.261 165.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.35 171.31 55.17 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.054 1.312 . . . . 0.0 113.751 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.6 tp -46.74 -46.31 20.27 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.793 1.237 . . . . 0.0 114.04 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -69.9 -17.87 63.36 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.8 mm -84.06 -45.64 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.967 1.307 . . . . 0.0 109.882 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.3 t -60.47 -44.19 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.752 1.621 . . . . 0.0 111.778 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.7 p -64.82 -37.96 89.37 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.679 0.672 . . . . 0.0 111.97 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -63.13 -44.1 96.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.319 1.048 . . . . 0.0 111.549 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.7 mtt -66.89 -35.97 81.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.6 1.16 . . . . 0.0 112.356 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.89 -45.96 66.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.9 1.28 . . . . 0.0 112.029 176.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -68.54 -19.94 64.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.983 1.313 . . . . 0.0 113.151 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.6 m -105.16 -8.07 18.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.511 1.524 . . . . 0.0 114.721 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.03 -1.11 76.29 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 119.587 1.085 . . . . 0.0 115.08 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -67.21 -34.07 76.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.597 1.198 . . . . 0.0 112.069 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.06 -39.49 86.19 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.798 1.285 . . . . 0.0 110.913 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -66.04 -31.33 72.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.81 2.044 . . . . 0.0 113.493 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.61 -48.82 80.18 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.63 1.104 . . . . 0.0 111.134 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -70.6 -41.21 72.62 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 pp -65.18 -37.34 87.05 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.649 0.659 . . . . 0.0 111.351 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -71.91 -34.76 69.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.52 -30.02 70.99 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 167.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -77.13 -2.68 35.56 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.44 6.82 64.01 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.751 1.643 . . . . 0.0 114.85 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.05 147.05 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.183 1.393 . . . . 0.0 111.327 -170.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 36.4 m -105.24 126.1 51.72 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.118 0.967 . . . . 0.0 110.627 170.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 17.0 p -112.08 167.97 9.97 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.8 1.64 . . . . 0.0 111.822 172.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.56 161.28 28.26 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.99 0.916 . . . . 0.0 111.238 171.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -76.08 146.35 39.43 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.288 0.566 . . . . 0.0 110.69 170.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.253 1.278 0 C-N-CA 125.186 1.394 . . . . 0.0 112.209 -174.682 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.6 p -65.51 -16.2 63.43 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -174.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 97.5 p -119.67 10.85 11.82 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.912 1.685 . . . . 0.0 113.558 171.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.92 -11.31 48.55 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.063 1.316 . . . . 0.0 115.853 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mt -125.17 125.38 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.914 1.357 . . . . 0.0 109.623 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.86 -178.66 31.15 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.193 1.377 . . . . 0.0 114.066 -175.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.65 147.53 48.05 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.11 1.338 . . . . 0.0 115.893 -167.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.12 141.5 57.4 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.159 1.384 . . . . 0.0 112.897 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.77 140.47 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.713 0.805 . . . . 0.0 112.198 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -122.08 165.57 15.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.04 1.736 . . . . 0.0 112.175 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.43 145.1 30.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.088 0.955 . . . . 0.0 112.491 166.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.5 mt -117.25 142.41 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.713 1.605 . . . . 0.0 108.536 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -116.93 151.69 36.12 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -76.53 152.65 35.95 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.542 1.537 . . . . 0.0 109.578 163.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 p -50.0 -27.67 5.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.587 2.355 . . . . 0.0 115.834 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.09 158.44 81.31 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.532 1.533 . . . . 0.0 114.108 -166.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -66.52 172.8 8.67 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.736 2.29 . . . . 0.0 110.927 160.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -104.56 -2.46 25.14 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 167.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -79.9 119.54 22.9 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.028 -1.045 . . . . 0.0 109.854 162.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -83.6 141.69 42.06 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.18 152.89 31.43 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 124.271 3.314 . . . . 0.0 114.983 -174.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.2 mtp85 -76.29 130.53 38.27 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.629 1.572 . . . . 0.0 111.515 161.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.9 mt -140.96 152.89 45.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.222 1.809 . . . . 0.0 111.076 -176.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.58 -35.79 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.362 1.065 . . . . 0.0 110.816 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.9 m -113.81 123.37 49.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.664 1.986 . . . . 0.0 109.656 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.16 103.62 15.58 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -169.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.01 155.5 18.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.701 1.2 . . . . 0.0 111.536 167.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.9 mt -71.52 141.59 50.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.139 0.975 . . . . 0.0 109.14 164.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.19 162.52 26.53 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.554 -0.716 . . . . 0.0 111.286 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -54.35 -43.45 71.3 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.291 -0.881 . . . . 0.0 111.938 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.34 -30.48 71.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.414 1.086 . . . . 0.0 113.547 175.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.52 -41.48 55.04 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 172.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.2 tt -92.78 -26.77 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -170.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.73 -5.89 54.42 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.176 -0.952 . . . . 0.0 113.008 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.2 ttt -120.09 144.27 47.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.531 1.932 . . . . 0.0 111.975 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -89.11 151.45 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.447 1.099 . . . . 0.0 113.283 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.2 106.27 16.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.324 1.449 . . . . 0.0 110.899 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -54.16 -40.24 67.29 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.033 1.333 . . . . 0.0 113.062 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.31 -36.51 74.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.649 0.779 . . . . 0.0 112.38 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.56 -46.01 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.237 1.415 . . . . 0.0 110.378 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.54 -40.63 79.28 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.574 1.15 . . . . 0.0 111.691 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.09 -29.06 65.93 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.952 0.901 . . . . 0.0 113.116 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.0 m -71.31 -48.09 52.75 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.83 1.195 . . . . 0.0 111.6 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.5 pt -59.98 -33.47 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 122.973 0.509 . . . . 0.0 111.826 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -78.2 -34.8 49.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.3 1.84 . . . . 0.0 113.542 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -68.78 -38.24 79.87 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.596 1.158 . . . . 0.0 111.719 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -86.03 133.27 33.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.494 0.718 . . . . 0.0 111.323 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.52 -26.3 45.78 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.987 -1.07 . . . . 0.0 112.507 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.5 t -142.37 131.24 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.482 1.113 . . . . 0.0 110.974 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.6 t -133.13 135.59 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.277 1.431 . . . . 0.0 111.468 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.0 t -135.45 155.2 50.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.978 1.311 . . . . 0.0 111.496 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -127.53 140.41 52.15 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.962 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.41 159.7 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.872 1.669 . . . . 0.0 110.273 -163.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -75.28 105.17 6.16 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.466 0.706 . . . . 0.0 109.299 157.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.27 -158.61 32.96 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 119.056 0.844 . . . . 0.0 113.949 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -94.35 158.73 35.29 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.428 1.491 . . . . 0.0 111.205 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.0 -31.86 76.47 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 121.897 1.731 . . . . 0.0 112.663 168.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.0 -14.53 53.84 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.027 1.331 . . . . 0.0 113.925 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.42 72.45 11.84 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.23 1.412 . . . . 0.0 112.5 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.27 141.97 18.67 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.243 1.962 . . . . 0.0 112.064 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.1 mmt -90.53 1.68 56.48 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.127 2.171 . . . . 0.0 113.645 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.4 t -152.06 146.22 25.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.096 1.358 . . . . 0.0 111.777 -171.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.4 -39.76 81.56 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.24 -0.912 . . . . 0.0 112.553 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -64.08 -29.91 71.02 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.969 -1.082 . . . . 0.0 111.746 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 m -68.27 -46.35 70.65 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.348 0.659 . . . . 0.0 112.268 169.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -58.53 -42.35 87.6 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 118.926 0.784 . . . . 0.0 112.512 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -57.35 -31.09 65.39 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.034 0.934 . . . . 0.0 113.278 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 49.9 ttm -70.38 -42.93 71.1 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.996 0.816 . . . . 0.0 112.34 171.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 mm -69.17 -30.91 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.92 -1.112 . . . . 0.0 111.359 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.43 -33.63 75.18 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.6 1.16 . . . . 0.0 112.649 167.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.415 HG13 ' HG ' ' A' ' 165' ' ' LEU . 1.4 t -73.36 -40.7 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.734 0.814 . . . . 0.0 111.468 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.8 mt -63.36 -34.86 78.63 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.897 0.879 . . . . 0.0 111.915 170.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -67.83 -34.84 77.51 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.723 -1.236 . . . . 0.0 113.014 170.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.79 79.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.991 0.814 . . . . 0.0 111.835 176.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -82.76 -14.49 54.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.01 7.68 44.95 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.463 1.03 . . . . 0.0 114.698 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.18 132.4 54.92 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.574 1.55 . . . . 0.0 111.02 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -115.91 149.85 38.05 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.292 0.951 . . . . 0.0 112.511 168.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -123.7 172.66 8.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.067 1.747 . . . . 0.0 112.676 -167.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.2 m -85.38 121.64 28.38 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.314 -0.866 . . . . 0.0 110.043 -161.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.2 m -124.76 132.14 53.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.996 -153.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -125.67 142.79 51.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.28 1.032 . . . . 0.0 112.674 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -96.04 118.54 32.84 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.788 1.235 . . . . 0.0 111.973 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.31 -22.73 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.323 1.049 . . . . 0.0 113.485 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.3 mt -87.93 -22.25 24.45 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.27 -35.09 11.37 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -124.25 108.71 29.51 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.077 0.853 . . . . 0.0 111.434 -174.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -54.19 -20.15 18.51 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.427 3.418 . . . . 0.0 116.46 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.4 p -54.32 -32.57 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.909 -1.119 . . . . 0.0 113.233 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.4 t -70.09 -53.79 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.515 -0.741 . . . . 0.0 111.7 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HA ' HG12 ' A' ' 136' ' ' VAL . 6.9 ptm180 -64.59 -25.73 68.1 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.743 0.817 . . . . 0.0 112.21 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.4 m -70.37 -50.76 35.54 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.02 0.928 . . . . 0.0 113.103 169.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -70.38 -37.44 74.53 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.74 1.154 . . . . 0.0 112.003 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 133' ' ' ARG . 7.4 p -65.89 -35.2 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 120.761 -1.212 . . . . 0.0 112.563 175.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -62.32 -38.38 89.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.241 1.016 . . . . 0.0 111.285 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -49.08 26.36 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 175.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 56.5 t -83.95 -42.93 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -169.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.8 m -100.27 -2.41 33.82 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 63.26 -32.52 0.11 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 128.765 2.826 . . . . 0.0 115.495 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -144.89 136.0 12.46 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.058 2.143 . . . . 0.0 109.961 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.3 126.78 3.76 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.852 1.701 . . . . 0.0 112.478 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.3 m -130.21 121.05 25.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.969 1.708 . . . . 0.0 107.249 166.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.4 140.4 25.8 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.849 0.86 . . . . 0.0 109.361 -172.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.53 158.21 97.35 Favored 'Cis proline' 0 CA--C 1.541 0.856 0 CA-C-N 119.383 0.815 . . . . 0.0 113.496 -10.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -128.82 152.94 47.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.774 1.63 . . . . 0.0 110.616 173.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.61 139.99 51.99 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.367 1.467 . . . . 0.0 113.108 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -131.85 142.89 49.83 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.711 2.005 . . . . 0.0 109.826 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 53.2 mt -123.91 122.57 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.3 tptt 44.09 54.36 6.0 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.852 2.061 . . . . 0.0 113.783 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.93 24.39 13.49 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -126.62 143.71 51.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.678 1.191 . . . . 0.0 110.151 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -82.81 125.62 31.51 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.586 1.184 . . . . 0.0 113.26 -169.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.17 -47.36 11.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 125.105 1.362 . . . . 0.0 110.962 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.14 176.92 28.82 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 116.62 1.408 . . . . 0.0 116.62 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.45 172.59 55.13 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.472 1.034 . . . . 0.0 113.97 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -44.85 -47.02 11.07 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.107 1.763 . . . . 0.0 113.695 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.83 -29.76 70.97 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 119.053 -0.498 . . . . 0.0 112.328 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.9 mm -82.32 -47.73 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.31 1.444 . . . . 0.0 111.177 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.6 t -62.1 -36.12 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.093 1.357 . . . . 0.0 111.089 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.1 m -59.79 -42.12 92.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.497 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -66.49 -43.91 84.07 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.801 1.182 . . . . 0.0 111.132 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 50.5 mtt -61.09 -36.73 80.44 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.142 0.577 . . . . 0.0 111.923 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.415 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.2 tm? -71.48 -47.0 58.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.159 0.984 . . . . 0.0 112.714 170.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.52 -21.49 64.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.001 0.921 . . . . 0.0 113.434 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 64.4 m -105.27 -21.5 13.23 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.975 1.71 . . . . 0.0 114.02 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.15 9.2 62.33 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.664 -1.273 . . . . 0.0 115.668 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.33 -32.14 73.63 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.627 1.713 . . . . 0.0 111.694 173.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.31 -45.18 95.51 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.83 173.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.54 -41.86 98.44 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.189 0.995 . . . . 0.0 111.815 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -56.02 -45.02 79.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.824 0.85 . . . . 0.0 110.504 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.54 -51.44 28.66 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.35 -36.62 84.72 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.316 0.507 . . . . 0.0 111.717 -175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -68.34 -38.02 81.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.898 1.279 . . . . 0.0 111.878 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.47 -29.23 69.31 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.986 0.812 . . . . 0.0 111.749 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -79.7 6.27 11.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.067 1.747 . . . . 0.0 114.306 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.8 10.91 75.01 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.194 1.378 . . . . 0.0 114.421 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.1 mt -99.13 147.42 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.887 1.275 . . . . 0.0 109.572 -171.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 5.7 m -112.93 120.22 40.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.255 1.022 . . . . 0.0 111.305 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.2 p -112.41 167.37 10.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.852 1.261 . . . . 0.0 111.779 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -56.75 144.09 34.11 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.102 0.961 . . . . 0.0 110.035 166.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -93.58 132.15 38.17 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.04 0.936 . . . . 0.0 112.107 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--O 1.251 1.15 0 C-N-CA 126.706 2.002 . . . . 0.0 111.726 175.352 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -71.21 -24.41 62.21 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -173.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.1 t -161.1 -46.16 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 167.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.02 7.65 62.9 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 116.285 1.274 . . . . 0.0 116.285 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 tt -86.84 147.14 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.882 1.341 . . . . 0.0 112.991 -167.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -171.34 177.36 44.27 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.063 0.839 . . . . 0.0 113.752 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.31 -26.47 28.06 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.02 1.295 . . . . 0.0 114.117 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.78 137.16 51.66 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.421 1.111 . . . . 0.0 110.713 165.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -141.59 165.04 18.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 125.51 1.524 . . . . 0.0 110.152 -162.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ptm85 -57.38 115.34 2.66 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.351 1.06 . . . . 0.0 111.076 168.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -161.87 127.65 3.6 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.601 1.56 . . . . 0.0 111.358 -171.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.4 tp -142.37 145.93 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.462 0.705 . . . . 0.0 112.888 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -136.97 144.08 43.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.116 1.366 . . . . 0.0 112.727 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -97.08 118.69 34.06 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.075 1.75 . . . . 0.0 109.87 164.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.5 p -80.63 42.86 0.63 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.621 1.569 . . . . 0.0 114.838 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -83.19 141.7 43.3 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.394 1.477 . . . . 0.0 112.353 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.29 166.56 12.69 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.174 2.582 . . . . 0.0 112.463 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -79.67 16.74 1.03 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -172.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -92.11 149.5 21.46 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.733 167.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -72.24 143.98 86.51 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 121.167 -0.958 . . . . 0.0 110.868 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -74.08 144.88 34.5 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.185 2.59 . . . . 0.0 112.908 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.28 111.27 16.24 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.277 1.431 . . . . 0.0 109.154 170.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.9 mt -120.08 -5.65 10.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.663 1.185 . . . . 0.0 113.995 -166.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.55 -32.31 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.742 1.155 . . . . 0.0 111.708 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.2 m -131.08 119.67 22.31 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.959 1.703 . . . . 0.0 109.866 167.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.28 152.32 29.1 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.79 -36.55 8.64 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.292 1.837 . . . . 0.0 111.526 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.2 tp -149.05 162.13 40.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.976 1.31 . . . . 0.0 111.882 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.26 123.57 30.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.195 0.998 . . . . 0.0 112.036 168.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -57.42 -35.42 70.04 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.275 1.43 . . . . 0.0 112.923 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.59 -29.99 59.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.553 1.141 . . . . 0.0 113.142 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -70.37 -34.36 72.51 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.972 -1.08 . . . . 0.0 111.784 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.89 2.85 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.642 1.177 . . . . 0.0 113.845 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.89 -10.48 13.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.152 1.381 . . . . 0.0 114.704 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -117.9 133.79 55.58 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.876 1.27 . . . . 0.0 111.472 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 m -133.2 131.91 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.544 1.137 . . . . 0.0 111.019 169.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -68.42 127.11 31.79 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.894 1.278 . . . . 0.0 109.854 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -61.63 -33.41 73.89 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -165.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.59 -34.29 77.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.257 1.023 . . . . 0.0 112.374 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.4 mm -77.54 -44.65 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.282 1.033 . . . . 0.0 110.129 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.24 -38.42 71.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.993 1.317 . . . . 0.0 111.775 172.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.69 -36.61 67.91 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.366 -0.834 . . . . 0.0 112.885 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.0 m -65.77 -44.84 84.65 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.051 -1.031 . . . . 0.0 111.31 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.1 pt -62.97 -36.85 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.768 0.827 . . . . 0.0 112.174 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -76.54 -32.46 58.24 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.226 1.41 . . . . 0.0 111.592 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.6 t -92.39 -28.34 16.95 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -170.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -86.25 147.68 25.98 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.256 -0.903 . . . . 0.0 111.427 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -72.4 -47.62 47.8 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.007 -1.058 . . . . 0.0 113.531 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.5 t -144.1 130.08 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.625 1.57 . . . . 0.0 110.196 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.76 134.89 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.588 1.155 . . . . 0.0 112.075 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -130.75 155.11 47.21 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.525 1.53 . . . . 0.0 111.29 172.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.46 143.06 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.708 0.803 . . . . 0.0 111.243 170.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mt -130.9 157.36 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.392 1.477 . . . . 0.0 109.655 -165.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -72.12 97.93 2.02 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 152.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.12 -148.38 19.15 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.518 -0.739 . . . . 0.0 114.906 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.98 157.38 63.74 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 125.999 1.72 . . . . 0.0 110.812 -174.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.1 -33.28 50.86 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 121.434 1.422 . . . . 0.0 114.637 -169.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -94.37 -0.38 54.93 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.25 68.1 15.3 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 126.258 1.823 . . . . 0.0 112.018 174.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.05 143.76 11.62 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.274 2.65 . . . . 0.0 112.261 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.3 mmt -91.15 1.42 57.1 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.977 1.311 . . . . 0.0 113.674 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.21 146.15 28.56 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.163 -0.96 . . . . 0.0 111.709 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.85 96.28 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.112 0.965 . . . . 0.0 113.154 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -63.47 -36.86 85.16 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.505 -1.372 . . . . 0.0 112.019 171.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.7 m -64.87 -36.32 83.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.564 -0.732 . . . . 0.0 112.488 173.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -62.83 -46.2 89.02 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 120.153 1.342 . . . . 0.0 111.784 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -64.72 -29.81 70.81 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.677 1.191 . . . . 0.0 113.831 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.3 tpt -57.49 -46.69 83.44 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.345 1.058 . . . . 0.0 112.356 167.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 mm -70.84 -34.42 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.396 -0.815 . . . . 0.0 111.309 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.17 -34.95 68.97 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.571 -0.705 . . . . 0.0 111.835 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.9 -41.89 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.618 1.167 . . . . 0.0 111.684 174.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 69.2 mt -65.28 -36.59 84.56 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.697 0.799 . . . . 0.0 112.882 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.94 -29.64 65.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.989 -1.069 . . . . 0.0 112.739 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.22 77.38 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.254 -0.904 . . . . 0.0 112.042 175.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.76 -11.58 33.47 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.41 1.084 . . . . 0.0 113.474 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.76 9.28 82.86 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.356 1.931 . . . . 0.0 115.989 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.18 136.8 52.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.602 1.201 . . . . 0.0 113.045 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -114.27 159.21 20.44 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 171.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -142.18 174.01 11.0 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.294 2.238 . . . . 0.0 110.943 -162.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.0 m -86.11 130.57 34.49 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.906 -1.121 . . . . 0.0 110.157 -165.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.8 p -120.6 147.47 45.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.855 1.262 . . . . 0.0 113.881 -164.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -133.42 143.51 48.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.806 1.242 . . . . 0.0 112.27 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -94.25 119.93 33.76 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.87 1.268 . . . . 0.0 110.429 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.74 -22.51 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.607 1.163 . . . . 0.0 113.434 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -81.39 -23.36 37.68 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.461 -0.775 . . . . 0.0 112.774 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.04 -33.21 19.62 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -144.29 126.91 8.48 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.428 1.091 . . . . 0.0 111.179 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.05 -18.23 45.93 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.93 2.42 . . . . 0.0 114.483 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -46.77 -35.61 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.415 1.086 . . . . 0.0 113.298 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.31 -45.86 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.201 -0.937 . . . . 0.0 111.603 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.402 ' HA ' HG12 ' A' ' 136' ' ' VAL . 23.2 ptt180 -75.25 -23.34 57.48 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.841 0.746 . . . . 0.0 112.995 177.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.2 m -70.54 -53.83 14.54 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.396 0.544 . . . . 0.0 111.844 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -72.78 -35.42 67.41 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.24 -0.913 . . . . 0.0 112.427 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 133' ' ' ARG . 11.6 p -59.15 -44.96 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.772 1.169 . . . . 0.0 112.043 174.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -71.81 -43.74 65.1 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.085 0.857 . . . . 0.0 112.396 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.25 -33.96 77.02 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.292 -0.88 . . . . 0.0 112.882 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.9 t -82.1 -46.95 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.371 0.987 . . . . 0.0 113.363 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -106.56 7.96 31.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -171.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 63.61 -26.31 0.07 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.88 2.472 . . . . 0.0 116.184 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -148.83 148.51 27.82 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.811 2.044 . . . . 0.0 112.779 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.02 150.83 16.06 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.646 2.897 . . . . 0.0 113.466 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.9 p -134.3 132.81 40.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.338 1.855 . . . . 0.0 108.706 156.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.7 mm -127.83 117.89 20.95 Favored Pre-proline 0 N--CA 1.478 0.96 0 CA-C-N 119.717 1.144 . . . . 0.0 111.754 -171.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -81.99 172.7 50.85 Favored 'Cis proline' 0 CA--C 1.543 0.943 0 CA-C-N 120.06 1.057 . . . . 0.0 112.842 -5.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -153.24 174.38 14.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.5 1.52 . . . . 0.0 112.605 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.0 140.93 47.03 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -174.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -120.48 144.17 48.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.682 1.993 . . . . 0.0 110.412 168.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.1 mt -131.53 121.49 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.522 1.129 . . . . 0.0 109.103 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 45.98 52.03 10.31 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.698 1.599 . . . . 0.0 114.211 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.258 . . 56.25 26.99 11.09 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -115.69 137.99 51.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.426 1.09 . . . . 0.0 110.111 165.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -75.91 125.53 29.27 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.218 1.009 . . . . 0.0 111.774 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -101.16 -46.42 11.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.195 1.398 . . . . 0.0 111.011 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.55 171.32 25.24 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 116.4 1.32 . . . . 0.0 116.4 169.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.02 170.29 54.74 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.014 0.816 . . . . 0.0 112.904 167.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -47.22 -37.92 11.25 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.658 1.183 . . . . 0.0 113.854 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -57.19 -43.78 82.99 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.76 0.709 . . . . 0.0 111.911 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.3 mm -76.42 -46.79 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.426 1.49 . . . . 0.0 109.931 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.18 -38.23 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.366 1.066 . . . . 0.0 110.829 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 60.7 m -64.01 -43.09 96.7 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.595 0.758 . . . . 0.0 111.655 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -67.16 -38.7 85.92 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.107 0.867 . . . . 0.0 112.125 176.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 34.7 mtt -65.65 -40.35 92.38 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.208 1.403 . . . . 0.0 112.153 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.22 -41.69 76.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.119 0.968 . . . . 0.0 111.605 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.94 -29.55 66.71 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 m -105.58 -0.8 25.42 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.09 -2.93 84.29 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.741 1.162 . . . . 0.0 115.721 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -67.38 -32.8 73.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.717 1.258 . . . . 0.0 112.07 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.81 -46.39 88.17 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.485 -0.759 . . . . 0.0 110.948 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -59.47 -42.12 91.31 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.588 1.155 . . . . 0.0 112.665 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -62.44 -39.07 92.16 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.137 0.575 . . . . 0.0 112.012 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 49.0 mtm -69.93 -53.43 17.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.609 0.763 . . . . 0.0 112.823 174.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 pp -65.64 -37.79 87.55 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.288 0.494 . . . . 0.0 111.932 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -66.8 -39.45 87.75 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.692 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -65.25 -30.54 71.43 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.744 0.702 . . . . 0.0 112.319 174.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -2.83 28.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.723 2.009 . . . . 0.0 114.183 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.23 57.4 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.418 1.009 . . . . 0.0 114.311 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.2 mt -104.17 145.57 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 118.369 1.084 . . . . 0.0 110.895 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 38.3 m -89.91 148.53 23.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.196 1.398 . . . . 0.0 111.612 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.4 p -145.86 169.27 18.9 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 120.653 -1.279 . . . . 0.0 112.903 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -76.04 156.79 33.66 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.151 0.981 . . . . 0.0 111.438 166.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -91.33 108.07 19.63 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.293 0.637 . . . . 0.0 112.446 -169.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.706 1.603 . . . . 0.0 112.575 -172.832 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.9 m . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.1 pt -61.07 -33.25 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 120.976 -1.077 . . . . 0.0 112.515 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -77.75 -22.65 49.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.587 1.555 . . . . 0.0 114.648 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 t -85.66 -28.71 24.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.049 2.14 . . . . 0.0 112.78 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -87.35 145.5 26.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.377 1.071 . . . . 0.0 111.004 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -84.12 -28.9 27.16 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.32 -0.863 . . . . 0.0 111.39 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.9 t -143.83 134.85 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.087 0.955 . . . . 0.0 112.255 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.3 t -133.01 138.32 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.893 1.277 . . . . 0.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 t -134.14 154.1 51.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.651 0.78 . . . . 0.0 111.473 170.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.57 147.58 50.28 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.487 0.661 . . . . 0.0 111.969 172.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.3 mt -137.01 159.8 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.331 -157.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -68.17 96.46 0.64 Allowed 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.345 -0.847 . . . . 0.0 108.971 156.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.49 -150.51 22.62 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 121.942 0.745 . . . . 0.0 114.383 -172.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.03 154.05 55.47 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.588 1.955 . . . . 0.0 110.029 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.63 -13.95 38.35 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.955 2.437 . . . . 0.0 114.59 -170.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -88.89 -19.92 25.23 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.716 1.206 . . . . 0.0 112.778 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.94 69.35 13.18 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.204 1.801 . . . . 0.0 111.021 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.39 148.97 74.72 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.66 2.24 . . . . 0.0 111.449 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.7 mmt -106.61 0.29 24.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.806 1.243 . . . . 0.0 113.781 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.7 t -141.84 147.0 36.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.499 1.52 . . . . 0.0 110.435 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.87 -47.01 86.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.831 0.852 . . . . 0.0 111.246 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -66.3 -33.35 75.53 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.998 -1.064 . . . . 0.0 111.548 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 m -62.26 -41.5 98.51 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.742 0.817 . . . . 0.0 113.111 170.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -62.82 -46.93 85.64 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.191 0.905 . . . . 0.0 111.466 171.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -56.97 -37.27 71.35 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.43 1.092 . . . . 0.0 111.993 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.5 tpp -59.34 -46.01 89.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.775 0.83 . . . . 0.0 112.923 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 mm -67.72 -33.13 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.981 1.264 . . . . 0.0 111.326 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.29 -32.83 73.26 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.911 0.884 . . . . 0.0 112.586 170.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.7 -37.25 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 125.628 1.571 . . . . 0.0 111.573 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.6 mt -63.77 -35.44 80.59 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.725 -1.234 . . . . 0.0 111.831 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -71.9 -31.23 66.2 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.816 -1.177 . . . . 0.0 111.998 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.26 -32.2 73.74 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.587 -1.321 . . . . 0.0 111.901 173.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.6 tp -86.07 -12.5 49.99 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.606 1.963 . . . . 0.0 112.716 171.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.82 4.23 13.49 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.854 1.693 . . . . 0.0 114.887 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.83 129.92 55.98 Favored 'General case' 0 C--N 1.335 -0.037 0 C-N-CA 124.599 1.16 . . . . 0.0 109.732 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -110.93 148.35 32.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.113 0.958 . . . . 0.0 110.645 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -120.65 172.64 7.72 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.236 1.815 . . . . 0.0 110.507 -169.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 93.0 m -86.71 122.52 30.72 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -163.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.5 p -113.27 144.63 42.4 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -159.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -137.09 147.87 46.36 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.505 1.122 . . . . 0.0 112.318 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.02 123.45 34.49 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.24 1.416 . . . . 0.0 110.464 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.6 m -67.78 -20.98 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -88.09 -24.19 23.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.938 1.295 . . . . 0.0 113.371 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.47 -35.34 17.08 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -139.11 120.07 9.78 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.357 0.663 . . . . 0.0 110.987 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.85 -13.15 36.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.853 2.369 . . . . 0.0 115.005 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.29 -36.0 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.603 0.761 . . . . 0.0 112.338 169.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.23 -51.45 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.887 0.875 . . . . 0.0 111.171 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.0 ptt-85 -69.32 -26.04 64.52 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.1 m -70.84 -49.31 47.54 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.069 0.948 . . . . 0.0 113.018 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.489 ' CE1' HG21 ' A' ' 139' ' ' VAL . 83.8 t80 -62.47 -48.55 79.12 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.736 -0.603 . . . . 0.0 111.377 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.1 p -61.0 -39.27 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 121.97 -0.456 . . . . 0.0 112.147 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -63.66 -44.77 92.82 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.226 1.41 . . . . 0.0 111.923 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -72.38 -36.51 68.74 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.489 HG21 ' CE1' ' A' ' 135' ' ' TYR 0.276 3.0 t -87.27 -31.95 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.1 p -99.02 -5.66 29.99 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 64.48 -59.27 0.22 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.825 2.45 . . . . 0.0 114.635 -167.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -121.44 106.38 37.92 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.193 1.397 . . . . 0.0 109.908 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.32 136.1 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.305 2.67 . . . . 0.0 113.693 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.5 m -134.21 112.91 11.47 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.168 1.787 . . . . 0.0 109.235 171.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.6 pt -100.59 149.27 35.99 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.68 152.49 96.46 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 119.696 0.927 . . . . 0.0 112.785 2.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -141.41 146.57 36.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.335 0.654 . . . . 0.0 111.156 -166.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.11 140.52 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.876 1.27 . . . . 0.0 113.188 -164.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -133.24 140.68 47.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.987 2.115 . . . . 0.0 109.783 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.4 mt -130.31 132.42 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.155 0.982 . . . . 0.0 108.362 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . 0.292 26.8 mtpp 46.15 51.41 11.16 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.699 2.0 . . . . 0.0 114.47 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 56.98 24.12 9.11 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.492 2.317 . . . . 0.0 115.636 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -128.91 143.75 50.98 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.879 1.672 . . . . 0.0 110.861 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -79.26 124.29 28.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.0 t -101.96 -53.37 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.236 1.815 . . . . 0.0 112.51 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 165.68 169.96 29.98 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 117.973 1.949 . . . . 0.0 117.973 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.65 170.97 55.02 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.607 1.099 . . . . 0.0 112.397 162.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.2 tp -48.48 -41.68 30.52 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.491 1.116 . . . . 0.0 113.71 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.4 -31.71 69.51 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.996 0.816 . . . . 0.0 112.304 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.72 -47.3 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.695 1.598 . . . . 0.0 110.086 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.9 t -54.43 -38.04 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.188 1.395 . . . . 0.0 110.535 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 85.9 m -58.96 -46.56 87.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.63 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -62.88 -43.71 98.06 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 120.207 1.367 . . . . 0.0 110.656 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 59.5 mtt -65.24 -42.34 93.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.787 0.835 . . . . 0.0 112.039 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -44.24 71.52 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.213 1.805 . . . . 0.0 111.594 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.74 -15.53 63.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.729 1.611 . . . . 0.0 113.533 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.1 m -106.16 -6.32 18.65 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.36 3.9 54.9 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 120.216 1.371 . . . . 0.0 114.247 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -69.32 -34.2 74.29 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.348 -1.089 . . . . 0.0 111.702 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.37 -45.68 92.67 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.146 0.978 . . . . 0.0 110.138 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -31.09 69.07 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.096 1.758 . . . . 0.0 114.539 176.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -59.62 -46.94 87.47 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.791 1.178 . . . . 0.0 111.712 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -68.87 -43.41 75.42 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.66 -35.73 80.87 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.662 -0.648 . . . . 0.0 112.193 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -68.62 -35.18 76.97 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.234 -0.916 . . . . 0.0 112.338 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.5 -26.94 68.65 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.78 0.718 . . . . 0.0 112.225 171.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -82.77 4.34 25.63 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.853 1.661 . . . . 0.0 113.586 170.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.41 16.44 71.31 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.073 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.7 mt -101.86 145.15 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 118.808 1.304 . . . . 0.0 111.068 -171.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 97.4 m -103.28 123.21 46.35 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.916 1.286 . . . . 0.0 110.941 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.7 p -108.92 166.83 10.53 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.015 1.726 . . . . 0.0 112.572 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 153.275 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 78.9 m . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 pt -58.46 -36.12 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 120.111 1.323 . . . . 0.0 111.904 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -75.08 -39.9 60.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.069 1.348 . . . . 0.0 112.952 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.3 t -72.13 -34.57 68.65 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.858 1.263 . . . . 0.0 113.954 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -85.22 143.95 28.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.209 -0.932 . . . . 0.0 111.637 -174.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -84.1 -40.46 18.25 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.199 -0.938 . . . . 0.0 111.776 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.51 129.84 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.825 1.65 . . . . 0.0 110.211 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.5 t -134.02 133.45 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.436 1.094 . . . . 0.0 111.594 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.1 t -135.41 156.26 49.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.156 1.382 . . . . 0.0 111.113 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -135.0 137.89 43.45 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.828 0.851 . . . . 0.0 110.637 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.93 160.35 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.464 1.506 . . . . 0.0 109.703 -160.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -69.72 99.15 1.29 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.3 -0.875 . . . . 0.0 108.784 158.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.38 -144.1 21.35 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 118.236 0.471 . . . . 0.0 114.114 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -124.02 158.45 60.34 Favored Pre-proline 0 N--CA 1.473 0.704 0 C-N-CA 125.714 1.605 . . . . 0.0 112.258 -171.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.62 -16.44 53.62 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.179 2.586 . . . . 0.0 114.815 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -95.18 -19.17 20.29 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.601 1.56 . . . . 0.0 113.297 168.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.65 71.64 15.46 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.627 1.571 . . . . 0.0 113.393 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.27 156.51 29.45 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.07 3.18 . . . . 0.0 113.312 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 79.2 mtp -124.24 8.31 8.51 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.332 1.453 . . . . 0.0 114.138 -170.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 22.5 t -150.63 146.78 26.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.805 1.642 . . . . 0.0 110.673 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.56 95.1 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.87 -35.1 74.42 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.55 -0.719 . . . . 0.0 111.921 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.2 m -61.85 -44.78 96.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.931 0.892 . . . . 0.0 111.579 171.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 tmpt? -64.39 -40.82 96.55 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.028 0.931 . . . . 0.0 111.755 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -63.35 -35.91 81.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.5 ttp -58.51 -38.23 77.25 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.215 0.916 . . . . 0.0 111.933 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 mm -61.69 -36.26 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.506 0.594 . . . . 0.0 111.703 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -70.2 -33.81 72.16 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.727 1.611 . . . . 0.0 113.489 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.74 -39.19 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.589 0.756 . . . . 0.0 110.522 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.1 mt -66.34 -37.99 86.61 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -61.77 -29.16 69.95 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.792 1.237 . . . . 0.0 112.198 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.88 65.99 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.217 -0.927 . . . . 0.0 113.365 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.93 -12.67 20.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.987 1.315 . . . . 0.0 113.889 170.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.86 19.35 67.45 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.278 0.942 . . . . 0.0 114.121 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.7 mt -111.72 136.54 50.84 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.289 1.835 . . . . 0.0 111.518 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -117.22 145.52 43.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.874 1.321 . . . . 0.0 113.374 165.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -119.12 173.55 6.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.914 2.086 . . . . 0.0 111.211 -169.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.3 m -84.36 119.23 24.86 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.91 -1.119 . . . . 0.0 109.394 -160.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.4 m -125.05 130.66 52.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.103 -153.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -129.01 156.57 43.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.523 1.529 . . . . 0.0 113.007 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -95.11 104.14 16.01 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.107 1.363 . . . . 0.0 112.198 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.9 p -74.57 -11.11 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.6 tp -81.14 -28.53 35.05 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.027 -1.046 . . . . 0.0 110.718 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.75 -36.92 19.85 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -117.53 105.65 47.82 Favored Pre-proline 0 N--CA 1.476 0.871 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -167.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.86 -28.76 40.26 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.544 3.496 . . . . 0.0 115.256 168.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -56.51 -43.59 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.222 0.919 . . . . 0.0 112.283 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.27 -47.62 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -48.97 -54.85 13.85 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.188 0.995 . . . . 0.0 111.554 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.4 m -61.81 -44.74 96.26 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -170.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -70.5 -46.64 63.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.207 0.527 . . . . 0.0 110.545 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.37 -41.92 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.895 0.878 . . . . 0.0 112.22 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -67.63 -42.67 81.95 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -41.56 97.75 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.134 0.974 . . . . 0.0 113.157 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.34 -36.15 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 89.6 p -102.15 -4.92 25.07 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 62.89 -46.88 0.2 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 128.914 2.886 . . . . 0.0 115.73 -173.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -142.12 101.31 5.78 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 125.57 1.548 . . . . 0.0 111.055 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -86.52 148.37 8.7 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.924 2.416 . . . . 0.0 114.098 -171.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 87.5 m -100.13 149.91 23.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.379 1.872 . . . . 0.0 109.317 164.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 81.3 mt -119.54 113.86 34.71 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.727 0.811 . . . . 0.0 109.162 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -77.03 164.25 87.66 Favored 'Cis proline' 0 CA--C 1.544 1.013 0 CA-C-N 120.103 1.073 . . . . 0.0 114.241 -7.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -146.08 172.32 13.59 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.932 1.293 . . . . 0.0 111.815 166.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.34 142.05 49.18 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -165.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -122.72 142.41 50.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.626 1.97 . . . . 0.0 111.326 173.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 74.5 mt -134.18 134.89 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.273 1.429 . . . . 0.0 108.953 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp 49.9 42.85 24.83 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.359 1.464 . . . . 0.0 112.885 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.53 18.87 2.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.918 2.087 . . . . 0.0 116.213 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.07 148.61 38.69 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.491 1.516 . . . . 0.0 111.636 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -79.93 126.57 31.19 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.196 0.998 . . . . 0.0 112.032 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.0 -39.38 6.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.918 1.287 . . . . 0.0 111.357 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.98 -179.31 21.42 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 172.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.27 171.34 52.85 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.776 1.179 . . . . 0.0 113.107 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 pp -57.39 -29.46 64.1 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -70.26 -28.82 65.54 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.029 -1.044 . . . . 0.0 111.922 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.4 mm -74.33 -45.46 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.588 1.155 . . . . 0.0 109.596 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.7 t -57.17 -46.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.049 0.94 . . . . 0.0 110.79 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.6 m -60.31 -43.87 95.95 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.844 0.858 . . . . 0.0 110.825 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -61.25 -47.35 86.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.255 1.022 . . . . 0.0 112.509 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 22.1 mmt -65.63 -39.74 91.8 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.7 1.136 . . . . 0.0 111.818 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.61 -47.46 78.54 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.228 1.411 . . . . 0.0 111.197 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.39 -22.58 60.22 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.264 1.026 . . . . 0.0 112.664 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.0 t -81.09 -20.56 41.24 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.894 1.677 . . . . 0.0 113.419 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.16 -2.5 86.89 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 121.135 -0.978 . . . . 0.0 113.911 -171.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -70.72 -32.71 70.0 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.648 -0.913 . . . . 0.0 111.729 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -44.07 97.72 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.075 -1.016 . . . . 0.0 111.004 173.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -60.31 -33.67 72.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.954 1.302 . . . . 0.0 113.51 172.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -63.2 -47.3 83.15 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.66 0.664 . . . . 0.0 111.269 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.9 mtm -68.37 -43.97 76.22 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.5 pp -65.48 -35.46 80.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.746 0.703 . . . . 0.0 112.177 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -70.5 -30.22 66.95 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.473 -0.767 . . . . 0.0 112.717 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.91 -32.78 74.27 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.419 -0.8 . . . . 0.0 111.201 171.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -1.03 27.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.993 1.717 . . . . 0.0 113.283 169.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.81 2.23 84.45 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.038 2.256 . . . . 0.0 115.462 175.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.9 mt -81.54 144.21 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 119.132 1.466 . . . . 0.0 112.671 -158.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.3 m -83.47 123.15 29.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.135 1.374 . . . . 0.0 112.181 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 5.6 p -133.44 165.69 24.28 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.138 1.775 . . . . 0.0 112.882 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 . . . . . 0 N--CA 1.478 0.927 0 C-N-CA 125.848 1.659 . . . . 0.0 113.547 171.186 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 121.023 0.439 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -65.26 -30.47 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.781 1.232 . . . . 0.0 112.081 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -37.83 73.39 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.434 1.493 . . . . 0.0 112.895 170.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.4 t -73.33 -31.07 63.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.047 0.939 . . . . 0.0 113.13 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.15 146.49 25.01 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -76.76 -40.8 47.13 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.63 -1.294 . . . . 0.0 113.83 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.7 t -145.87 135.68 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.944 1.298 . . . . 0.0 110.076 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.16 132.23 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.876 0.871 . . . . 0.0 111.599 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -133.84 155.53 49.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.115 1.366 . . . . 0.0 111.317 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -129.7 137.31 50.53 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.876 0.87 . . . . 0.0 110.787 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.18 156.3 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.063 1.345 . . . . 0.0 110.408 -161.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -70.07 102.17 1.98 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 158.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.81 -147.28 27.7 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 118.748 0.704 . . . . 0.0 113.418 -172.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -126.75 157.45 71.3 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.344 1.857 . . . . 0.0 110.925 -172.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.21 -23.57 75.52 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.026 2.484 . . . . 0.0 114.388 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -76.67 -24.24 53.24 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 171.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -148.96 68.83 9.75 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 126.06 1.744 . . . . 0.0 111.887 -175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.0 142.23 42.02 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.504 2.136 . . . . 0.0 111.744 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.5 mtt -101.28 3.87 41.18 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.544 1.538 . . . . 0.0 113.434 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.8 t -145.32 146.08 31.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.282 1.433 . . . . 0.0 111.177 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.37 -44.77 88.98 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.523 0.729 . . . . 0.0 112.265 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -61.53 -36.89 81.84 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.34 -0.85 . . . . 0.0 111.909 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 m -66.57 -37.84 85.8 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.513 0.725 . . . . 0.0 112.646 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -66.46 -44.02 83.91 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.261 1.024 . . . . 0.0 112.881 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -60.94 -35.24 76.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.228 0.611 . . . . 0.0 112.225 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.1 tpp -55.67 -44.44 77.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.182 0.593 . . . . 0.0 112.265 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.72 -32.13 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 121.257 -0.902 . . . . 0.0 111.607 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -34.33 76.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.67 1.188 . . . . 0.0 112.712 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 t -69.23 -41.86 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.907 1.683 . . . . 0.0 111.767 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.8 mt -64.64 -36.32 83.87 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.432 -0.792 . . . . 0.0 112.59 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.74 -36.96 85.06 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.717 -1.239 . . . . 0.0 111.569 171.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.74 -26.34 65.19 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.2 tp -87.8 -14.07 40.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.956 0.903 . . . . 0.0 112.702 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.75 7.38 35.02 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.282 1.896 . . . . 0.0 114.876 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.1 mt -110.99 133.44 53.39 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.641 1.176 . . . . 0.0 111.218 172.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -112.61 159.6 18.7 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.592 1.187 . . . . 0.0 111.408 160.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -136.59 175.7 9.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.835 2.054 . . . . 0.0 110.506 -157.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.0 m -86.42 122.14 29.97 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.943 -1.098 . . . . 0.0 108.622 -175.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.2 p -119.79 147.61 44.43 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.089 1.355 . . . . 0.0 112.865 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -133.77 143.37 48.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.196 0.998 . . . . 0.0 113.064 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -85.67 102.22 13.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.035 1.334 . . . . 0.0 111.818 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.6 p -71.21 -17.15 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.787 1.235 . . . . 0.0 113.683 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -83.76 -29.39 27.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.661 0.784 . . . . 0.0 111.15 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.2 -32.05 13.86 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -128.04 117.49 20.58 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 119.582 1.083 . . . . 0.0 113.509 -165.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.25 -16.82 44.63 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.814 2.343 . . . . 0.0 114.364 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 p -53.31 -42.49 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.055 1.298 . . . . 0.0 111.756 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.62 -52.55 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.779 0.832 . . . . 0.0 110.343 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -52.06 -47.14 65.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.884 0.874 . . . . 0.0 111.442 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.6 m -66.12 -44.48 84.15 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.305 0.642 . . . . 0.0 112.558 -173.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -70.98 -40.46 71.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.369 0.667 . . . . 0.0 110.58 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 t -59.65 -36.35 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.246 1.018 . . . . 0.0 111.725 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -43.4 90.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.954 0.343 . . . . 0.0 111.418 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -65.34 -47.73 75.48 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.447 1.099 . . . . 0.0 112.467 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 52.7 t -82.26 -44.21 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -172.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m -100.53 -10.06 21.42 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 68.2 -54.32 0.52 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.807 2.043 . . . . 0.0 112.949 -168.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -137.67 147.04 55.63 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.276 1.43 . . . . 0.0 112.489 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -89.63 142.47 4.14 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.348 2.698 . . . . 0.0 115.025 -171.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 m -129.91 131.91 46.19 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.876 2.07 . . . . 0.0 107.402 156.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.5 pt -128.72 135.38 27.51 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.35 156.12 99.81 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 CA-C-N 119.438 0.835 . . . . 0.0 113.053 -5.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.24 158.16 39.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.302 1.441 . . . . 0.0 111.599 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.59 141.17 49.61 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -129.36 144.17 51.13 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.19 2.196 . . . . 0.0 109.887 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.0 mt -124.63 121.99 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.916 0.886 . . . . 0.0 108.667 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.0 tttp 44.3 51.79 7.43 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.27 1.828 . . . . 0.0 113.48 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.89 14.52 6.39 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.73 138.19 39.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.708 1.603 . . . . 0.0 110.197 168.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -83.45 123.85 30.11 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 121.351 -0.843 . . . . 0.0 112.886 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -105.37 -39.95 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.865 1.666 . . . . 0.0 112.993 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 144.75 175.31 17.79 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.644 1.418 . . . . 0.0 116.644 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.04 168.79 54.85 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.182 1.372 . . . . 0.0 113.365 166.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.2 tp -45.86 -41.39 11.16 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -71.0 -27.37 63.64 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.156 0.983 . . . . 0.0 112.212 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.9 mm -79.54 -45.38 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.049 1.34 . . . . 0.0 109.923 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.0 t -62.51 -44.8 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.433 1.093 . . . . 0.0 110.56 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 65.3 m -60.15 -48.25 82.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.791 0.836 . . . . 0.0 110.857 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -55.8 -50.21 71.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.455 1.502 . . . . 0.0 111.6 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.7 mmt -70.87 -33.03 70.2 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.364 1.065 . . . . 0.0 112.762 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.74 -46.56 65.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.845 1.658 . . . . 0.0 111.167 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.24 -26.0 67.16 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.393 1.077 . . . . 0.0 112.341 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.8 t -87.92 -15.81 35.6 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.638 1.975 . . . . 0.0 114.674 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.1 -11.02 59.09 Favored Glycine 0 CA--C 1.54 1.652 0 C-N-CA 124.541 1.067 . . . . 0.0 114.493 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.97 -29.35 69.72 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.574 1.55 . . . . 0.0 112.298 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.39 -46.58 89.58 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.722 -1.236 . . . . 0.0 111.106 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -59.6 -41.31 90.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.388 1.475 . . . . 0.0 111.502 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -58.93 -44.3 91.33 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.202 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 58.7 mtm -69.04 -46.59 67.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.048 0.84 . . . . 0.0 112.001 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -41.78 84.16 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -67.81 -34.52 76.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.94 0.896 . . . . 0.0 112.59 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -59.68 -26.18 65.35 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.244 1.017 . . . . 0.0 112.341 172.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -92.03 6.99 44.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.927 1.691 . . . . 0.0 114.312 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.67 9.37 75.09 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 124.411 1.005 . . . . 0.0 114.3 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.9 mt -94.48 142.56 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.87 0.868 . . . . 0.0 109.176 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 28.5 m -114.87 124.86 52.79 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.184 0.994 . . . . 0.0 112.369 -172.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -129.86 173.91 10.23 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.918 2.087 . . . . 0.0 112.946 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.185 0 O-C-N 120.654 -1.279 . . . . 0.0 111.939 160.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 118.383 -0.817 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.8 pt -62.02 -35.1 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.955 1.252 . . . . 0.0 111.811 172.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -76.25 -24.62 54.53 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.853 1.261 . . . . 0.0 113.868 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 t -86.07 -38.24 18.03 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.302 1.441 . . . . 0.0 112.868 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -93.4 141.58 28.29 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.223 1.009 . . . . 0.0 111.937 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.64 -24.39 20.51 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.18 128.76 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.497 1.119 . . . . 0.0 110.294 168.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.01 132.8 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.058 0.943 . . . . 0.0 110.109 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 t -123.21 152.59 41.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.835 0.826 . . . . 0.0 109.903 165.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.06 143.1 49.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.791 0.805 . . . . 0.0 110.776 170.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 mt -132.92 160.09 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.837 -161.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -70.95 103.95 2.82 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 156.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.0 -143.12 23.87 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 119.246 0.93 . . . . 0.0 113.756 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.0 156.47 74.2 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.236 1.414 . . . . 0.0 111.738 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.36 -25.38 30.52 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.314 2.01 . . . . 0.0 113.937 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -90.24 -16.14 29.95 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.27 -0.894 . . . . 0.0 112.828 169.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.62 77.26 15.31 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.578 1.551 . . . . 0.0 111.628 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.95 151.9 35.88 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.262 2.641 . . . . 0.0 112.574 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 78.6 mmm -97.44 -5.22 36.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.318 1.447 . . . . 0.0 113.796 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 10.3 t -146.22 146.32 30.74 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.286 1.434 . . . . 0.0 111.334 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.6 -29.38 69.42 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -71.47 -36.84 71.32 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.633 -1.292 . . . . 0.0 111.66 169.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.3 m -63.98 -35.89 82.19 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -59.15 -47.97 83.34 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.521 1.128 . . . . 0.0 111.453 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -62.18 -28.91 69.99 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.8 tpt -52.38 -39.71 61.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.582 0.628 . . . . 0.0 111.4 171.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 mm -70.61 -35.17 60.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.66 1.184 . . . . 0.0 111.426 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -37.24 86.06 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.832 -1.167 . . . . 0.0 112.886 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 65.9 t -69.98 -37.51 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.167 0.987 . . . . 0.0 110.704 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.9 mt -65.72 -39.69 91.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.109 0.964 . . . . 0.0 113.488 170.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.55 -30.71 70.42 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.117 -0.99 . . . . 0.0 112.137 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.04 -29.47 66.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.569 0.748 . . . . 0.0 112.668 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.7 tp -81.78 -15.31 54.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.622 0.769 . . . . 0.0 112.39 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.87 11.96 58.93 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.496 1.046 . . . . 0.0 114.468 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 22.6 mt -110.58 129.4 55.81 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.551 1.176 . . . . 0.0 112.875 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -116.34 154.85 29.48 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.131 1.372 . . . . 0.0 113.519 168.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -139.59 170.27 16.21 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.576 2.35 . . . . 0.0 111.477 -161.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.0 m -88.09 131.15 34.79 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.047 -1.658 . . . . 0.0 109.655 -176.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -130.33 143.77 50.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.059 0.944 . . . . 0.0 113.528 -154.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -137.67 144.06 41.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.372 1.069 . . . . 0.0 113.315 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -83.59 120.08 25.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.774 1.23 . . . . 0.0 112.075 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.8 t -68.75 -29.82 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.25 1.02 . . . . 0.0 111.863 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.6 mt -74.98 -15.75 60.65 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.155 -0.966 . . . . 0.0 112.282 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.76 -32.57 21.77 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.421 -0.8 . . . . 0.0 112.975 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -129.67 106.48 17.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 119.451 1.023 . . . . 0.0 113.226 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -53.54 -26.94 38.69 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.085 3.19 . . . . 0.0 115.347 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.52 -35.53 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.249 -0.907 . . . . 0.0 112.54 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.79 -48.06 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.139 -0.976 . . . . 0.0 111.166 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -59.94 -28.16 67.39 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.151 0.887 . . . . 0.0 112.955 171.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.5 m -71.03 -53.92 13.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.373 0.533 . . . . 0.0 111.166 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -70.81 -34.76 72.06 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.157 -0.964 . . . . 0.0 111.915 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.15 -36.28 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 120.787 -1.196 . . . . 0.0 112.926 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -72.58 -49.37 32.79 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.484 1.038 . . . . 0.0 111.428 167.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -72.31 -30.53 64.87 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -164.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.53 -29.39 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.598 1.159 . . . . 0.0 111.396 171.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m -103.4 -5.77 22.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -169.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 62.35 -27.03 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 129.069 2.948 . . . . 0.0 116.168 -168.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -145.86 138.53 13.89 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.394 1.877 . . . . 0.0 109.521 165.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.3 149.0 11.75 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.048 2.498 . . . . 0.0 114.669 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.4 p -129.52 132.67 46.92 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.532 1.933 . . . . 0.0 108.807 160.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.0 mt -131.21 142.55 45.91 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.381 1.472 . . . . 0.0 108.383 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.58 161.18 79.14 Favored 'Cis proline' 0 C--N 1.35 0.643 0 CA-C-N 121.738 1.656 . . . . 0.0 111.924 -8.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -144.56 152.52 40.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.302 0.641 . . . . 0.0 112.287 -162.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.24 140.94 52.14 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.785 1.234 . . . . 0.0 112.362 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -130.25 140.41 50.7 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.894 2.078 . . . . 0.0 109.258 173.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 82.0 mt -129.29 133.29 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.3 1.04 . . . . 0.0 108.343 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.1 tttt 49.31 45.3 23.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.187 1.795 . . . . 0.0 113.428 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.65 12.33 5.47 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -115.85 144.2 44.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.381 1.472 . . . . 0.0 111.502 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.23 124.88 25.01 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.879 1.272 . . . . 0.0 111.976 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.49 -55.48 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.147 1.379 . . . . 0.0 110.95 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 165.67 167.21 25.93 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 117.109 1.604 . . . . 0.0 117.109 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.15 168.82 54.84 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.703 1.144 . . . . 0.0 112.499 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.7 tt -47.35 -45.72 24.98 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.058 1.343 . . . . 0.0 113.908 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.82 -35.44 78.62 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.339 -0.851 . . . . 0.0 111.407 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.67 -47.07 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.086 1.354 . . . . 0.0 110.513 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.5 -39.62 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.691 1.196 . . . . 0.0 109.992 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 41.2 m -61.5 -42.72 99.23 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.413 0.685 . . . . 0.0 112.29 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -55.2 -46.62 75.89 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.201 0.909 . . . . 0.0 110.41 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 61.1 mtt -72.92 -33.45 65.97 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.633 1.573 . . . . 0.0 113.342 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -70.52 -35.93 73.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.211 1.804 . . . . 0.0 112.629 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -80.06 -20.27 45.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.885 -1.135 . . . . 0.0 112.621 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.2 p -106.86 -16.0 14.58 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -162.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.7 82.63 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 124.756 1.17 . . . . 0.0 115.503 -170.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -70.03 -31.89 69.75 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.244 2.022 . . . . 0.0 112.55 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.86 -41.59 67.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.533 1.133 . . . . 0.0 110.596 176.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -55.84 -41.17 73.91 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.364 1.865 . . . . 0.0 110.769 173.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -56.63 -47.08 80.47 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.82 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 70.9 mtm -70.86 -46.03 63.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.461 1.028 . . . . 0.0 113.242 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -39.42 82.96 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -72.44 -32.88 66.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.597 1.159 . . . . 0.0 112.274 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.86 -27.2 64.94 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.513 0.597 . . . . 0.0 112.383 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -90.77 -4.43 56.67 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.56 22.37 47.33 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.803 1.192 . . . . 0.0 114.178 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 64.5 mt -94.51 147.84 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 119.038 1.419 . . . . 0.0 111.85 -172.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.6 m -101.11 130.89 47.24 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.323 1.449 . . . . 0.0 112.195 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 15.6 p -137.09 169.46 17.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.685 1.994 . . . . 0.0 111.502 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 174.704 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 119.295 -0.383 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 pt -60.5 -36.87 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 118.498 0.59 . . . . 0.0 111.944 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.08 -21.98 58.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.006 1.722 . . . . 0.0 113.146 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.3 t -92.84 -38.76 11.57 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.523 1.929 . . . . 0.0 112.582 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.37 139.36 31.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.44 1.096 . . . . 0.0 111.514 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -70.62 -42.21 71.23 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.179 -0.951 . . . . 0.0 113.324 -171.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.7 t -139.92 128.14 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.516 1.126 . . . . 0.0 109.511 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.0 t -133.42 130.28 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.461 1.505 . . . . 0.0 111.134 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -130.79 157.12 43.71 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.849 1.26 . . . . 0.0 110.47 170.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.56 151.58 51.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.542 0.686 . . . . 0.0 112.007 170.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 mt -133.22 169.45 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.433 1.493 . . . . 0.0 109.444 -166.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.94 112.59 23.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.835 -0.541 . . . . 0.0 111.487 144.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.46 -171.98 31.21 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.132 1.825 . . . . 0.0 114.296 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.4 mt -88.87 150.57 45.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.555 1.542 . . . . 0.0 110.546 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.25 -27.78 78.5 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.64 2.227 . . . . 0.0 114.541 -173.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.8 -21.87 56.92 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.966 -1.084 . . . . 0.0 113.036 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.61 68.2 14.63 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 125.716 1.606 . . . . 0.0 112.345 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.78 157.31 39.54 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.316 2.677 . . . . 0.0 112.427 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 mmt -96.34 10.35 38.31 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.711 1.204 . . . . 0.0 114.094 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.8 t -147.87 145.5 28.71 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.904 -1.122 . . . . 0.0 111.593 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.28 96.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -67.37 -31.91 72.48 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.449 -1.407 . . . . 0.0 112.628 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.4 m -63.84 -36.37 83.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.75 167.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.39 -40.13 89.48 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.993 1.27 . . . . 0.0 112.892 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -60.0 -35.7 75.61 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 119.67 1.123 . . . . 0.0 112.878 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.9 tpt -58.31 -46.79 85.48 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.168 0.587 . . . . 0.0 111.468 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.7 mm -71.89 -33.3 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.373 0.669 . . . . 0.0 112.06 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.35 -42.17 73.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.103 0.961 . . . . 0.0 111.147 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.425 HG13 ' HG ' ' A' ' 165' ' ' LEU . 3.8 t -62.98 -44.55 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.543 1.137 . . . . 0.0 111.586 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.22 -36.74 85.11 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.865 . . . . 0.0 112.645 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -71.37 -30.88 66.67 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.805 -1.185 . . . . 0.0 113.196 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.76 -33.8 74.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.803 0.729 . . . . 0.0 112.135 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 tp -94.38 -10.71 31.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.487 1.115 . . . . 0.0 112.811 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.06 8.89 70.51 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.956 1.741 . . . . 0.0 115.195 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 132.49 54.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.083 0.953 . . . . 0.0 111.058 173.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -114.73 153.2 30.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.121 0.963 . . . . 0.0 112.686 173.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.52 173.75 9.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.526 1.93 . . . . 0.0 111.258 -166.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.5 m -88.6 129.36 35.51 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.846 -1.159 . . . . 0.0 109.824 -167.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.7 p -114.3 141.29 47.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.098 1.759 . . . . 0.0 113.592 -163.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -128.12 161.72 28.57 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.91 1.284 . . . . 0.0 111.784 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -131.22 118.05 19.88 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.287 1.435 . . . . 0.0 112.752 -170.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.15 -21.05 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 tp -80.96 -22.1 39.82 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.321 1.048 . . . . 0.0 111.817 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.16 -40.04 16.06 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.03 -1.044 . . . . 0.0 111.905 170.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.408 ' HB3' HG12 ' A' ' 131' ' ' VAL . 59.6 m-70 -144.55 109.81 4.88 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.833 1.253 . . . . 0.0 112.319 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.95 -14.0 40.67 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.387 2.725 . . . . 0.0 114.994 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.408 HG12 ' HB3' ' A' ' 129' ' ' HIS . 7.8 p -46.9 -32.33 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 120.016 1.28 . . . . 0.0 113.032 169.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.0 t -58.01 -43.53 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.146 0.978 . . . . 0.0 111.688 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.449 ' HA ' HG12 ' A' ' 136' ' ' VAL . 23.8 ttp180 -68.83 -39.98 79.7 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.799 1.24 . . . . 0.0 111.528 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 m -65.76 -47.92 73.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -69.6 -39.69 77.11 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.162 -0.962 . . . . 0.0 112.04 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 133' ' ' ARG . 9.8 p -62.91 -35.76 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 120.2 1.364 . . . . 0.0 112.21 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -66.3 -47.66 72.88 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.075 0.95 . . . . 0.0 111.734 172.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -42.29 80.94 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.61 -34.84 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.815 1.246 . . . . 0.0 113.128 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 m -97.99 5.83 48.35 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -170.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 62.48 -40.77 0.16 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 127.797 2.439 . . . . 0.0 114.445 -162.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -135.91 134.73 20.69 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.48 1.912 . . . . 0.0 110.613 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.23 138.15 27.22 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.653 2.235 . . . . 0.0 112.192 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.0 136.6 44.21 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.505 1.522 . . . . 0.0 109.908 165.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.3 mt -127.95 131.7 23.94 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.907 173.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.92 163.16 88.24 Favored 'Cis proline' 0 CA--C 1.541 0.857 0 CA-C-N 119.929 1.01 . . . . 0.0 110.813 -12.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -150.36 172.85 14.74 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.761 0.824 . . . . 0.0 111.514 171.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.07 140.03 52.19 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -174.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -120.66 142.49 49.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 112.779 -2.009 . . . . 0.0 110.51 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.4 mt -122.24 118.32 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 tptt 45.88 48.9 12.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.146 2.178 . . . . 0.0 114.567 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 58.51 13.24 2.43 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -172.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -94.36 131.68 39.76 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.856 -1.153 . . . . 0.0 108.702 164.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -76.34 124.76 28.02 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.608 -0.682 . . . . 0.0 111.278 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.4 t -101.92 -46.82 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.735 1.214 . . . . 0.0 111.186 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.58 170.44 31.48 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.69 174.65 54.7 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.359 1.457 . . . . 0.0 114.02 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -48.62 -43.82 36.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.539 1.936 . . . . 0.0 113.331 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.27 -44.65 95.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.316 0.647 . . . . 0.0 110.321 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.84 -45.72 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.093 1.357 . . . . 0.0 111.207 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.9 t -57.52 -37.06 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.633 1.573 . . . . 0.0 110.945 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.0 m -63.09 -44.09 96.69 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.233 0.613 . . . . 0.0 111.721 172.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -63.2 -41.59 99.18 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.504 1.047 . . . . 0.0 110.796 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 38.2 mtt -63.24 -39.23 94.03 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.011 0.925 . . . . 0.0 111.946 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.425 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.2 tm? -68.58 -40.32 80.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.064 1.346 . . . . 0.0 112.195 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.32 -33.49 55.56 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.0 t -85.2 -21.26 29.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.044 1.338 . . . . 0.0 113.489 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.49 0.17 67.49 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.526 1.06 . . . . 0.0 114.788 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.03 -29.95 66.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.515 1.157 . . . . 0.0 113.633 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.62 -44.04 96.78 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.842 -1.162 . . . . 0.0 110.021 174.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -36.74 84.0 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.915 1.286 . . . . 0.0 113.039 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -59.47 -48.49 81.44 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.43 1.014 . . . . 0.0 111.194 171.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.3 mtm -69.9 -45.82 66.77 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 pp -66.33 -36.71 83.61 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.735 0.698 . . . . 0.0 112.059 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -64.01 -41.8 97.34 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.663 0.785 . . . . 0.0 111.536 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.94 -20.58 64.21 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.16 1.43 31.99 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.369 1.468 . . . . 0.0 112.485 170.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.04 17.27 74.94 Favored Glycine 0 N--CA 1.469 0.869 0 O-C-N 120.984 -1.073 . . . . 0.0 114.229 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.4 mt -103.05 146.93 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.686 1.195 . . . . 0.0 109.364 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.3 m -112.36 137.1 50.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.257 1.023 . . . . 0.0 110.651 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.1 p -132.22 168.53 17.89 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.638 1.575 . . . . 0.0 113.075 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 123.631 0.772 . . . . 0.0 111.406 169.572 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 120.779 0.323 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.8 pt -62.0 -32.47 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.421 1.088 . . . . 0.0 112.914 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -79.15 -30.64 43.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.707 2.003 . . . . 0.0 113.825 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t -80.31 -28.0 38.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.067 1.747 . . . . 0.0 113.248 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -84.85 150.12 25.22 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.905 -1.122 . . . . 0.0 111.344 167.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -76.45 -45.79 29.8 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.632 -1.292 . . . . 0.0 111.691 169.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.9 t -145.33 131.38 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.561 1.144 . . . . 0.0 111.087 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.86 131.67 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.675 1.19 . . . . 0.0 111.663 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 t -134.31 154.96 51.02 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.894 1.277 . . . . 0.0 111.733 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -132.43 139.62 48.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.923 0.889 . . . . 0.0 111.472 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 mt -132.78 157.51 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.849 2.059 . . . . 0.0 108.853 -164.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -78.17 115.21 17.73 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 147.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.99 -152.9 25.07 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.185 0.897 . . . . 0.0 113.551 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.1 mt -104.96 152.59 39.64 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 124.932 1.293 . . . . 0.0 110.596 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.08 -31.72 54.42 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 121.758 1.639 . . . . 0.0 113.453 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -81.22 -13.28 58.71 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.406 -0.809 . . . . 0.0 112.95 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.55 67.66 52.2 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.97 1.708 . . . . 0.0 112.096 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.42 142.46 59.78 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.651 2.901 . . . . 0.0 112.964 -172.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 90.7 mtp -105.65 3.78 29.48 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 37.0 t -134.6 146.52 49.68 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.831 2.053 . . . . 0.0 111.06 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.07 -46.57 85.23 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.354 -0.842 . . . . 0.0 112.018 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -67.09 -25.47 66.24 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.018 -1.051 . . . . 0.0 112.056 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.4 p -71.45 -39.05 71.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 168.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -58.69 -45.32 89.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.75 1.159 . . . . 0.0 110.203 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -62.56 -39.78 94.74 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.292 1.037 . . . . 0.0 112.438 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.5 tpt -55.86 -49.61 72.85 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.791 1.178 . . . . 0.0 111.678 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.7 mm -70.38 -32.68 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.869 -0.519 . . . . 0.0 112.339 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -59.9 -36.27 76.62 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.003 -1.061 . . . . 0.0 112.927 171.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.23 -36.36 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.732 0.813 . . . . 0.0 110.596 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.89 -37.48 87.79 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.35 -0.844 . . . . 0.0 112.885 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -65.08 -33.89 77.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.757 -1.214 . . . . 0.0 111.41 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.35 -30.96 70.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.06 0.944 . . . . 0.0 112.314 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.2 tp -82.27 -16.98 47.53 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.695 0.68 . . . . 0.0 112.626 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.64 9.49 58.9 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.611 1.101 . . . . 0.0 115.166 -174.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.5 mt -114.81 133.97 55.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.53 1.532 . . . . 0.0 113.668 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -115.63 153.43 31.29 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.755 1.264 . . . . 0.0 113.044 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -137.19 175.01 10.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.616 1.967 . . . . 0.0 111.799 -156.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.8 m -85.79 117.36 24.61 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.548 -1.345 . . . . 0.0 108.943 -168.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.2 m -127.87 133.05 49.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.141 -153.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -129.63 149.83 51.22 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -172.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -99.45 98.16 9.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.697 1.599 . . . . 0.0 111.846 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.6 -21.94 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.018 0.927 . . . . 0.0 113.229 -175.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.3 tp -73.4 -28.62 62.1 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.626 -0.671 . . . . 0.0 111.565 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.14 -32.78 11.78 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -124.12 103.97 32.74 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.745 1.157 . . . . 0.0 113.661 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -57.27 -19.75 36.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.151 3.234 . . . . 0.0 115.371 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.14 -39.31 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 120.315 1.416 . . . . 0.0 112.452 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.95 -42.53 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.186 0.994 . . . . 0.0 111.119 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 136' ' ' VAL . 2.4 ptm180 -69.99 -30.47 67.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.524 1.13 . . . . 0.0 112.148 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m -68.84 -48.98 62.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.831 0.852 . . . . 0.0 112.601 170.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -61.35 -46.67 89.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.427 0.558 . . . . 0.0 110.604 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 133' ' ' ARG . 8.0 p -66.85 -32.83 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.483 -0.76 . . . . 0.0 112.873 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -70.25 -41.62 73.27 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.826 1.194 . . . . 0.0 112.929 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -61.63 -40.42 94.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.982 0.81 . . . . 0.0 112.723 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.0 t -83.8 -50.62 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 53.9 p -113.66 -0.62 14.25 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 65.08 -49.76 0.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.112 2.165 . . . . 0.0 116.138 -172.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -132.26 116.52 15.41 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 119.909 1.231 . . . . 0.0 112.337 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.94 144.86 21.88 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.339 2.693 . . . . 0.0 112.2 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.7 m -135.2 110.7 9.13 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.437 0.695 . . . . 0.0 109.335 161.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.3 pt -91.59 163.96 26.21 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -160.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.18 154.48 98.36 Favored 'Cis proline' 0 C--N 1.352 0.747 0 CA-C-N 119.195 0.748 . . . . 0.0 111.048 -21.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -136.54 153.12 51.08 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.816 1.246 . . . . 0.0 111.273 -170.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.31 140.63 51.35 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.931 1.292 . . . . 0.0 113.536 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -131.47 143.01 50.11 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.483 1.913 . . . . 0.0 109.718 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.0 mt -125.98 115.85 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.797 0.839 . . . . 0.0 108.903 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . 0.339 17.5 ttmm 40.9 57.65 2.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.076 2.15 . . . . 0.0 114.404 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 67.45 9.22 6.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.91 138.42 37.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.551 1.14 . . . . 0.0 110.306 168.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -79.82 123.71 27.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.607 1.194 . . . . 0.0 111.716 175.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.38 -48.72 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.767 1.227 . . . . 0.0 110.584 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.61 -179.68 27.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 168.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.24 173.66 53.88 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.55 1.072 . . . . 0.0 113.442 167.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -42.75 -46.56 5.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.339 1.856 . . . . 0.0 113.765 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -70.02 -26.52 64.09 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.628 -0.67 . . . . 0.0 112.304 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 mm -79.26 -46.51 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.834 1.254 . . . . 0.0 110.316 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.12 -38.56 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.11 0.964 . . . . 0.0 110.572 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 69.3 m -60.88 -46.21 91.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.08 0.952 . . . . 0.0 111.566 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -60.17 -43.86 95.49 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.091 0.956 . . . . 0.0 111.565 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.6 mtt -69.0 -35.25 76.48 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.412 -0.805 . . . . 0.0 112.953 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -69.56 -41.3 76.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.31 1.044 . . . . 0.0 111.506 172.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -65.07 -36.58 84.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.301 1.04 . . . . 0.0 113.183 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.3 t -88.79 -9.43 51.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.427 1.491 . . . . 0.0 114.032 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.84 4.46 82.36 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.247 -1.533 . . . . 0.0 114.201 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.2 -32.36 70.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.347 1.459 . . . . 0.0 112.936 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.16 -46.28 81.51 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.054 -1.029 . . . . 0.0 109.932 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -59.05 -41.1 87.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.745 1.618 . . . . 0.0 112.728 169.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -58.09 -42.66 86.08 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.954 0.902 . . . . 0.0 111.035 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 62.4 mtm -69.6 -50.32 45.67 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -69.08 -37.38 78.42 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -65.09 -34.24 77.94 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.04 0.936 . . . . 0.0 111.44 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.72 -29.65 69.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.238 1.415 . . . . 0.0 112.493 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -89.19 6.02 42.07 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.043 2.137 . . . . 0.0 114.306 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.48 19.43 60.29 Favored Glycine 0 N--CA 1.469 0.867 0 O-C-N 121.12 -0.987 . . . . 0.0 114.44 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.02 147.68 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.33 1.052 . . . . 0.0 110.792 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 95.8 m -102.69 126.2 49.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.749 1.22 . . . . 0.0 111.572 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.8 p -127.48 168.99 14.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.888 2.075 . . . . 0.0 111.156 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 19.1 mtp-105 . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 121.906 0.86 . . . . 0.0 112.99 173.304 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 118.952 -0.547 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 pt -63.81 -34.6 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.576 0.75 . . . . 0.0 112.925 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -78.95 -39.38 34.69 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.22 1.408 . . . . 0.0 112.964 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.2 t -85.02 -11.06 56.26 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.309 1.044 . . . . 0.0 113.446 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -89.52 148.67 23.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.362 1.865 . . . . 0.0 111.449 165.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -87.28 -42.84 12.62 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.783 -1.198 . . . . 0.0 113.205 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.27 130.49 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.062 1.345 . . . . 0.0 110.265 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.4 t -131.51 130.51 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.779 1.632 . . . . 0.0 111.278 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 t -133.5 156.18 48.23 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.084 1.354 . . . . 0.0 111.186 171.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -129.62 139.77 51.35 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.42 0.688 . . . . 0.0 111.872 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.83 156.57 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.26 1.424 . . . . 0.0 109.876 -163.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.9 102.86 1.66 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.852 -0.53 . . . . 0.0 109.665 155.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.74 -160.0 33.67 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 118.887 0.767 . . . . 0.0 114.783 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.51 153.68 48.26 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.951 2.1 . . . . 0.0 112.516 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -66.75 -15.59 47.79 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.311 2.674 . . . . 0.0 114.823 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -94.84 -20.43 19.46 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.45 69.26 21.21 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.416 1.486 . . . . 0.0 110.84 -171.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.54 144.01 48.71 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.058 2.505 . . . . 0.0 111.655 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 mmt -93.36 2.41 56.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.13 1.372 . . . . 0.0 113.741 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 53.6 t -142.12 145.64 34.48 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.804 1.642 . . . . 0.0 111.488 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.77 95.63 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.878 0.871 . . . . 0.0 112.731 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.08 -24.06 62.24 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.592 -1.317 . . . . 0.0 112.354 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 m -69.77 -36.44 75.77 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.427 -0.796 . . . . 0.0 112.362 166.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -62.29 -42.02 98.99 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.605 1.162 . . . . 0.0 112.021 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -55.84 -29.83 60.46 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.068 1.347 . . . . 0.0 113.526 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.2 tpt -69.24 -43.57 73.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.986 0.915 . . . . 0.0 111.756 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.4 mm -65.46 -36.44 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.752 0.821 . . . . 0.0 111.014 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.63 -40.44 79.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.213 1.005 . . . . 0.0 112.955 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.12 -42.93 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.921 1.289 . . . . 0.0 111.659 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.1 mt -65.39 -36.77 84.99 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.739 0.815 . . . . 0.0 112.548 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -67.07 -35.47 79.9 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.374 -1.454 . . . . 0.0 112.443 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.31 -21.66 65.67 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.57 -13.27 20.49 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.64 1.576 . . . . 0.0 114.124 170.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.74 71.3 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.433 1.492 . . . . 0.0 115.479 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.8 mp -112.09 144.89 40.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.26 1.424 . . . . 0.0 111.321 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -113.75 130.17 56.48 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.617 0.767 . . . . 0.0 110.649 166.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -104.82 170.6 7.78 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.023 1.729 . . . . 0.0 111.26 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -86.34 119.83 27.04 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.5 -1.375 . . . . 0.0 109.45 -157.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.2 m -113.23 129.71 56.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.339 -158.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -115.07 155.05 27.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.994 1.317 . . . . 0.0 111.059 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -111.21 94.95 5.24 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.845 1.258 . . . . 0.0 110.48 -168.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 p -70.02 -23.2 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.236 1.015 . . . . 0.0 112.953 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.9 tp -78.35 -30.75 48.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.081 0.952 . . . . 0.0 111.424 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.53 -35.28 19.63 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -131.32 98.93 17.94 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.825 0.85 . . . . 0.0 111.945 -170.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.97 -12.23 33.56 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.394 2.729 . . . . 0.0 114.761 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.0 p -49.1 -42.04 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.717 1.207 . . . . 0.0 112.489 170.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.75 -46.27 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.802 0.841 . . . . 0.0 111.704 -177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.455 ' HA ' HG12 ' A' ' 136' ' ' VAL . 50.8 ptt85 -71.33 -23.75 61.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -70.36 -51.43 29.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.116 0.567 . . . . 0.0 112.11 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -70.96 -37.99 72.8 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.641 -0.662 . . . . 0.0 112.429 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 133' ' ' ARG . 8.9 p -65.39 -34.95 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.362 -0.836 . . . . 0.0 112.557 176.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -66.72 -43.22 84.86 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.338 -0.851 . . . . 0.0 110.991 171.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.92 -42.69 80.44 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.678 0.791 . . . . 0.0 113.037 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -80.26 -45.28 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.618 1.167 . . . . 0.0 112.988 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.5 m -106.05 -5.93 19.09 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 62.65 -25.99 0.06 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 128.075 2.55 . . . . 0.0 115.973 -172.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -136.28 92.0 16.14 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 127.2 2.2 . . . . 0.0 112.045 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -72.31 147.64 47.73 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.624 2.883 . . . . 0.0 114.317 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.4 m -125.99 137.27 53.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.616 1.566 . . . . 0.0 107.842 160.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mp -108.04 133.26 20.57 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.45 159.1 73.35 Favored 'Cis proline' 0 CA--C 1.546 1.091 0 CA-C-N 120.706 1.288 . . . . 0.0 112.012 -12.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -137.92 164.28 29.39 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.953 1.701 . . . . 0.0 110.913 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.7 139.62 52.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 122.776 1.274 . . . . 0.0 114.209 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -125.43 140.31 52.9 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 112.741 -2.027 . . . . 0.0 110.247 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 57.3 mt -128.87 121.85 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.293 1.037 . . . . 0.0 109.138 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt 45.12 51.13 9.18 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.064 1.746 . . . . 0.0 113.008 -172.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.63 10.21 1.88 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 -175.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.58 143.63 28.77 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.193 1.36 . . . . 0.0 110.516 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -86.35 123.59 31.76 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.701 0.763 . . . . 0.0 112.909 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.8 -50.92 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.459 1.504 . . . . 0.0 111.964 -171.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 175.19 163.85 28.88 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 117.238 1.655 . . . . 0.0 117.238 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.72 168.94 53.98 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 125.575 1.56 . . . . 0.0 114.124 167.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.0 tp -44.19 -42.05 6.19 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.947 1.699 . . . . 0.0 115.01 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -67.9 -38.06 82.52 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.799 -0.563 . . . . 0.0 111.338 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.4 mm -74.97 -39.12 44.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 C-N-CA 125.131 1.373 . . . . 0.0 110.26 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.05 -42.42 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 120.971 -1.081 . . . . 0.0 110.696 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.9 m -65.33 -43.87 89.59 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.703 0.801 . . . . 0.0 111.427 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -56.8 -46.25 81.7 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.72 1.208 . . . . 0.0 111.74 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.9 mtt -67.05 -35.26 79.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.752 1.621 . . . . 0.0 112.7 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.84 -46.54 68.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.389 1.076 . . . . 0.0 111.109 173.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.96 -17.39 64.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.003 1.321 . . . . 0.0 112.906 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.2 m -101.03 -16.18 17.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.218 1.407 . . . . 0.0 114.788 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.26 -4.12 73.68 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 120.21 1.368 . . . . 0.0 114.446 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -65.14 -32.03 73.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.556 1.678 . . . . 0.0 112.922 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.71 -43.3 98.0 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.114 172.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -64.35 -38.71 91.99 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.518 1.527 . . . . 0.0 112.726 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -58.43 -48.82 79.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.722 1.146 . . . . 0.0 110.92 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.9 mtm -69.59 -44.92 69.8 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 pp -66.16 -40.83 90.82 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.011 0.369 . . . . 0.0 111.435 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -71.75 -32.28 67.54 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.426 -0.796 . . . . 0.0 112.963 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.18 -26.51 68.18 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.363 0.529 . . . . 0.0 112.407 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -76.23 4.44 8.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.592 1.557 . . . . 0.0 113.875 169.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.42 0.02 89.85 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.273 1.892 . . . . 0.0 113.671 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.3 mt -84.81 144.53 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 118.782 1.291 . . . . 0.0 109.862 -169.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.9 m -108.23 139.6 42.68 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.355 1.462 . . . . 0.0 111.094 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 21.8 p -137.17 170.04 16.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.924 1.689 . . . . 0.0 112.16 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 . . . . . 0 N--CA 1.479 1.018 0 O-C-N 121.536 -0.727 . . . . 0.0 112.512 167.009 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.6 0.714 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.432 HD13 ' CE2' ' A' ' 135' ' ' TYR . 29.4 mt -55.94 -36.4 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 127.685 2.394 . . . . 0.0 110.924 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -75.83 -30.17 58.89 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 126.535 1.934 . . . . 0.0 114.729 171.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.4 t -78.94 -39.93 33.32 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.509 0.724 . . . . 0.0 112.224 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -90.16 140.93 29.18 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -170.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -66.38 -39.6 89.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.37 0.668 . . . . 0.0 112.631 -171.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.1 t -140.77 133.72 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 109.759 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.44 134.14 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.778 1.231 . . . . 0.0 110.089 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.6 t -131.86 155.39 47.92 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.083 0.953 . . . . 0.0 111.237 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -133.31 135.88 45.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.426 0.632 . . . . 0.0 111.899 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.5 mt -133.95 153.69 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 109.015 -157.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -69.49 104.58 2.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 158.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.08 -134.16 12.75 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.829 1.204 . . . . 0.0 114.337 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.1 mt -126.33 157.72 69.31 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 126.342 1.857 . . . . 0.0 111.658 -168.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.25 -21.5 31.13 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.127 1.885 . . . . 0.0 113.833 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.23 -22.22 35.97 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.477 1.111 . . . . 0.0 113.108 167.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.22 74.02 11.87 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.4 1.48 . . . . 0.0 113.046 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.37 143.65 22.26 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.948 2.432 . . . . 0.0 111.262 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 51.0 ttm -110.14 7.18 23.31 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.256 1.822 . . . . 0.0 113.081 -163.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 54.1 t -150.63 149.01 29.32 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.647 1.979 . . . . 0.0 111.041 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.75 93.99 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.32 0.964 . . . . 0.0 112.702 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -66.93 -31.45 72.05 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.83 -1.169 . . . . 0.0 111.42 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.6 m -70.39 -37.96 74.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 118.265 -0.874 . . . . 0.0 112.933 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -55.94 -47.36 77.7 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 120.199 1.363 . . . . 0.0 110.703 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -61.81 -31.9 72.16 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.9 tpt -61.41 -44.35 97.29 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.668 0.667 . . . . 0.0 111.517 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.0 mm -68.28 -37.95 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.075 0.55 . . . . 0.0 111.146 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.4 -40.56 78.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.032 0.933 . . . . 0.0 112.58 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.77 -44.3 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.272 0.629 . . . . 0.0 111.506 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.6 mt -65.9 -36.98 84.91 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.813 0.845 . . . . 0.0 112.317 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -66.01 -32.99 74.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.562 1.145 . . . . 0.0 112.917 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.95 76.6 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.715 0.806 . . . . 0.0 111.978 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.65 -14.81 44.41 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.886 0.874 . . . . 0.0 113.092 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.57 14.17 62.05 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.619 1.104 . . . . 0.0 114.26 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 58.0 mt -112.07 128.44 56.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.209 1.004 . . . . 0.0 111.315 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -115.54 144.69 43.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.854 1.262 . . . . 0.0 111.17 172.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -125.12 169.95 11.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.384 1.874 . . . . 0.0 111.809 -166.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.1 m -85.07 126.29 33.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 122.495 1.141 . . . . 0.0 109.44 -166.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.1 m -123.72 138.93 54.43 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 113.681 -1.6 . . . . 0.0 112.095 -155.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.6 139.43 53.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -84.01 112.19 19.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.343 2.257 . . . . 0.0 111.495 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.4 m -70.35 -17.85 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.1 tp -87.36 -19.97 27.39 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.607 1.163 . . . . 0.0 111.957 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.24 -29.07 13.78 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.764 1.225 . . . . 0.0 113.366 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.32 96.9 38.23 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -53.11 -26.75 34.09 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.569 3.512 . . . . 0.0 115.501 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.27 -36.04 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.112 0.965 . . . . 0.0 113.595 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 63.1 t -69.75 -51.48 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.964 0.906 . . . . 0.0 110.819 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.461 ' HA ' HG12 ' A' ' 136' ' ' VAL . 8.1 ptm180 -63.98 -26.12 68.44 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.673 175.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.9 m -71.61 -48.05 50.65 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.49 ' CZ ' HG21 ' A' ' 139' ' ' VAL . 48.7 t80 -61.02 -48.05 83.6 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 120.752 1.615 . . . . 0.0 109.807 176.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 133' ' ' ARG . 9.1 p -66.64 -35.26 74.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 121.283 -0.886 . . . . 0.0 112.837 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -59.26 -46.61 88.05 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.19 1.396 . . . . 0.0 112.102 171.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.25 -46.64 40.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.301 1.04 . . . . 0.0 112.9 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.49 HG21 ' CZ ' ' A' ' 135' ' ' TYR . 86.6 t -81.3 -36.19 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.629 1.572 . . . . 0.0 112.632 -164.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.4 m -104.97 4.22 31.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 58.19 -5.89 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.89 2.476 . . . . 0.0 117.358 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -146.27 121.43 5.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.638 1.975 . . . . 0.0 108.598 166.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.25 130.44 7.2 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.66 2.24 . . . . 0.0 111.801 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 68.5 p -128.45 136.85 51.41 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.968 1.307 . . . . 0.0 110.886 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.0 mt -130.03 140.56 39.01 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.259 1.424 . . . . 0.0 110.452 -172.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.17 156.42 78.76 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 120.939 1.371 . . . . 0.0 110.895 -8.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -138.25 160.01 40.56 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.69 135.61 52.31 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.536 1.134 . . . . 0.0 112.192 177.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -127.21 141.65 51.68 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.637 1.975 . . . . 0.0 109.155 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.6 mt -130.61 118.5 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.2 tptt 46.74 52.88 10.84 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 127.331 2.253 . . . . 0.0 115.647 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.81 28.64 18.38 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -127.89 137.29 52.26 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.093 -1.004 . . . . 0.0 110.508 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -70.35 130.39 41.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.408 0.623 . . . . 0.0 112.121 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.75 -47.58 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.063 0.945 . . . . 0.0 110.181 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.15 175.31 22.17 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.519 0.967 . . . . 0.0 115.519 171.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.64 169.99 54.65 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.258 0.933 . . . . 0.0 112.793 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.23 -43.4 10.28 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.109 1.364 . . . . 0.0 113.189 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.45 ' O ' ' HE3' ' A' ' 163' ' ' LYS . 19.7 t70 -60.24 -24.87 65.22 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.943 0.897 . . . . 0.0 113.283 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.4 mm -92.1 -47.01 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.675 1.59 . . . . 0.0 110.471 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.04 -36.55 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.361 1.864 . . . . 0.0 111.808 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -60.58 -50.92 71.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 159' ' ' ASP . 60.1 mttt -60.86 -38.62 86.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.625 0.37 . . . . 0.0 110.231 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.5 mtp -67.85 -35.5 78.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.748 0.819 . . . . 0.0 112.577 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.59 -46.24 69.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.602 1.161 . . . . 0.0 111.721 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -74.13 -16.29 61.01 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.8 m -100.78 -9.86 21.34 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.09 1.356 . . . . 0.0 114.353 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.17 -4.25 67.93 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-N 119.661 1.119 . . . . 0.0 114.453 -170.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.99 -34.12 74.3 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.866 -1.373 . . . . 0.0 113.532 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tt -61.67 -41.01 96.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.763 1.225 . . . . 0.0 111.029 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -67.31 -31.3 71.5 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.303 1.841 . . . . 0.0 113.239 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -57.02 -43.14 81.54 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.24 1.016 . . . . 0.0 111.837 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -73.6 -49.57 25.53 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 172.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.65 -39.02 90.94 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.844 -0.535 . . . . 0.0 112.128 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -69.49 -40.76 76.85 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.683 0.793 . . . . 0.0 111.393 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.82 -27.7 65.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.536 1.535 . . . . 0.0 113.455 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -75.06 -4.49 38.77 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.403 -0.81 . . . . 0.0 112.877 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.59 15.81 51.48 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 125.072 1.32 . . . . 0.0 114.498 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.0 mt -103.8 123.72 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.159 0.98 . . . . 0.0 109.976 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.3 m -85.27 133.58 34.16 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.36 0.6 . . . . 0.0 111.633 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -128.92 170.14 13.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.494 2.318 . . . . 0.0 111.957 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 . . . . . 0 N--CA 1.476 0.852 0 O-C-N 121.395 -0.815 . . . . 0.0 111.278 173.539 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.1 pt -61.2 -34.34 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.745 0.818 . . . . 0.0 111.83 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -80.85 -29.34 35.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.444 1.897 . . . . 0.0 114.486 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.1 t -74.25 -41.13 61.79 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.636 0.774 . . . . 0.0 111.209 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.82 138.29 32.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.26 1.024 . . . . 0.0 110.715 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.43 -31.89 24.39 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.252 -0.905 . . . . 0.0 112.538 -169.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.6 t -138.58 126.56 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.854 1.262 . . . . 0.0 109.546 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.0 t -130.53 131.21 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.406 1.482 . . . . 0.0 110.565 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.9 t -133.77 156.71 47.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.664 1.185 . . . . 0.0 110.457 172.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.67 142.74 49.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.146 169.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 mt -132.56 157.38 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.383 1.473 . . . . 0.0 109.403 -162.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.7 101.23 2.51 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 156.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.23 -154.82 27.93 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.174 0.897 . . . . 0.0 114.214 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.21 154.67 39.45 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 125.655 1.582 . . . . 0.0 111.969 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -65.67 -19.99 59.69 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.287 1.991 . . . . 0.0 113.605 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -93.9 -13.06 27.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.582 1.553 . . . . 0.0 113.986 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.54 73.34 11.68 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.544 1.537 . . . . 0.0 112.353 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.4 148.64 67.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.943 2.429 . . . . 0.0 111.874 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.4 mmt -104.42 -0.3 28.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.3 1.84 . . . . 0.0 113.631 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 17.1 t -146.46 144.83 29.94 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.969 1.307 . . . . 0.0 111.428 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.2 -38.66 80.45 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -72.23 -29.87 64.35 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.048 -1.033 . . . . 0.0 112.279 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 m -66.89 -34.45 77.81 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.346 167.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -67.27 -45.59 76.17 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.77 1.168 . . . . 0.0 112.781 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -57.27 -33.28 67.47 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.002 0.921 . . . . 0.0 112.915 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.0 tpt -56.07 -43.56 78.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.951 0.901 . . . . 0.0 111.865 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 mm -69.55 -33.34 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.337 1.055 . . . . 0.0 111.3 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.4 -34.91 79.41 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.36 -1.462 . . . . 0.0 112.771 172.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.81 -43.16 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.902 0.481 . . . . 0.0 110.728 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.9 mt -65.77 -37.92 87.64 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -66.65 -31.49 72.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.403 -1.436 . . . . 0.0 113.078 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.0 -25.49 68.41 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.613 -1.304 . . . . 0.0 113.374 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.04 -13.01 21.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.881 1.272 . . . . 0.0 114.154 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.6 13.0 67.92 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.568 1.08 . . . . 0.0 115.03 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.76 134.35 55.1 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.773 1.229 . . . . 0.0 112.905 174.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -113.68 157.93 21.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.772 1.229 . . . . 0.0 111.548 168.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -137.24 171.95 13.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.982 1.713 . . . . 0.0 111.418 -161.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.4 m -83.97 120.4 26.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.545 1.164 . . . . 0.0 108.842 -166.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.6 m -126.18 124.26 40.08 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.645 -155.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.25 157.98 18.3 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.305 1.042 . . . . 0.0 111.959 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -120.16 117.18 27.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.803 1.241 . . . . 0.0 111.292 -171.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.5 p -71.58 -27.7 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.3 -37.99 68.84 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.343 -0.848 . . . . 0.0 110.506 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.61 -31.62 22.51 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -141.4 107.38 6.09 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 119.466 1.03 . . . . 0.0 113.136 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -60.15 -15.49 34.48 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.648 2.898 . . . . 0.0 116.758 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 p -49.22 -32.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.552 1.524 . . . . 0.0 112.743 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.96 -44.46 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.94 0.896 . . . . 0.0 111.646 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.565 ' HA ' HG12 ' A' ' 136' ' ' VAL . 9.3 ptm85 -71.71 -27.52 63.07 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.916 0.78 . . . . 0.0 112.208 175.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m -67.05 -48.94 66.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.27 0.628 . . . . 0.0 112.259 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -38.86 71.23 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.489 1.04 . . . . 0.0 113.002 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 133' ' ' ARG . 1.9 p -66.46 -32.46 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.508 1.049 . . . . 0.0 112.188 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -62.47 -41.99 99.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.883 0.873 . . . . 0.0 112.248 170.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.56 -47.29 55.92 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.537 -0.727 . . . . 0.0 111.771 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.6 t -82.82 -40.62 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -173.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.6 m -102.57 -12.86 17.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 64.84 -47.19 0.34 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 169.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -129.0 89.75 47.75 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.085 1.754 . . . . 0.0 106.784 164.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -89.6 158.23 5.28 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.935 2.424 . . . . 0.0 113.771 -166.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.0 p -122.98 151.57 41.72 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.874 1.669 . . . . 0.0 108.918 161.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 55.0 mt -125.07 127.26 25.1 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 124.007 0.923 . . . . 0.0 109.089 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.93 161.54 65.25 Favored 'Cis proline' 0 CA--C 1.542 0.9 0 CA-C-N 119.766 0.952 . . . . 0.0 113.948 7.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -135.26 158.74 43.6 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.358 1.863 . . . . 0.0 110.836 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.81 140.54 51.97 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.141 1.376 . . . . 0.0 113.234 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -133.79 143.0 48.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.886 2.074 . . . . 0.0 109.832 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.8 mt -129.66 117.48 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.591 0.756 . . . . 0.0 109.306 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.5 tptt 43.54 47.41 6.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.359 2.263 . . . . 0.0 113.745 -170.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.95 16.88 9.59 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.15 140.11 34.86 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.734 -1.229 . . . . 0.0 109.535 162.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -80.04 125.45 29.79 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.378 -0.826 . . . . 0.0 112.418 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.5 t -102.68 -47.14 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 124.656 1.182 . . . . 0.0 111.8 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.65 176.91 32.25 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.39 168.42 53.82 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.859 1.218 . . . . 0.0 113.341 165.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -45.59 -44.69 13.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.322 1.849 . . . . 0.0 113.817 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.78 -26.55 66.16 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.718 -0.614 . . . . 0.0 112.528 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.3 mm -79.22 -46.61 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.118 1.367 . . . . 0.0 110.389 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.1 t -57.73 -35.94 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.335 1.854 . . . . 0.0 111.337 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 86.7 m -64.06 -41.61 97.3 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.696 0.798 . . . . 0.0 112.527 173.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -65.95 -44.06 86.13 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.315 0.961 . . . . 0.0 110.198 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.7 mtt -61.51 -35.7 78.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.372 1.069 . . . . 0.0 112.317 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.81 -45.52 74.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.614 1.166 . . . . 0.0 111.984 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -69.78 -33.19 72.05 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.814 0.733 . . . . 0.0 112.479 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.6 t -86.23 -30.39 22.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.81 2.42 52.47 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 120.656 -1.278 . . . . 0.0 115.463 -171.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -68.17 -35.03 77.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.107 1.454 . . . . 0.0 112.086 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -45.5 85.14 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.34 -0.85 . . . . 0.0 110.158 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.86 -38.56 82.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.46 1.504 . . . . 0.0 113.136 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -60.6 -48.41 81.92 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.959 0.503 . . . . 0.0 111.66 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.1 mtm -70.85 -44.7 65.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.44 -37.84 88.93 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.503 -0.748 . . . . 0.0 111.176 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -72.57 -32.42 66.02 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.42 -28.35 69.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.278 1.031 . . . . 0.0 111.891 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 6.16 13.73 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.303 1.841 . . . . 0.0 113.771 171.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.14 -2.78 86.38 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.744 2.116 . . . . 0.0 113.7 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.4 mt -82.15 142.72 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.617 1.209 . . . . 0.0 110.459 -165.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 m -101.12 128.82 47.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.348 1.459 . . . . 0.0 110.273 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.8 p -132.04 170.69 14.59 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.81 1.644 . . . . 0.0 112.883 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 123.961 0.904 . . . . 0.0 109.755 166.69 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.6 m . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 pt -60.25 -34.47 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.412 1.005 . . . . 0.0 112.175 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -77.91 -30.15 50.5 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.326 1.851 . . . . 0.0 113.397 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 t -87.02 -34.01 19.37 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.796 1.638 . . . . 0.0 113.162 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.22 147.93 27.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.716 2.006 . . . . 0.0 110.503 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -70.11 -43.25 71.41 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 119.943 -1.723 . . . . 0.0 112.525 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -141.1 132.9 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.974 0.91 . . . . 0.0 112.17 -171.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.56 140.93 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.156 1.382 . . . . 0.0 112.266 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 t -133.02 158.98 41.36 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.925 1.29 . . . . 0.0 111.632 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -132.43 141.09 48.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.247 0.546 . . . . 0.0 112.045 171.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 107' ' ' SER . 9.6 mt -134.48 156.9 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.622 1.969 . . . . 0.0 109.336 -163.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -66.27 101.57 0.74 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 150.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 -140.39 20.15 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 121.126 -0.984 . . . . 0.0 114.277 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.8 mt -111.58 155.9 42.25 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 125.274 1.43 . . . . 0.0 112.581 -170.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.59 -12.61 31.6 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.727 2.284 . . . . 0.0 113.094 172.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -91.53 -26.93 18.53 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.827 1.651 . . . . 0.0 112.113 170.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.39 78.01 12.37 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.204 1.802 . . . . 0.0 111.872 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.05 143.21 17.78 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.106 2.537 . . . . 0.0 112.356 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 33.9 ttm -102.6 10.57 38.66 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.561 1.544 . . . . 0.0 113.352 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 51.4 t -145.09 145.18 31.32 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.917 -1.115 . . . . 0.0 111.843 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -36.79 83.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.493 1.117 . . . . 0.0 112.845 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -69.23 -24.45 64.01 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.066 -1.022 . . . . 0.0 112.544 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.488 ' HB3' HG23 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -70.55 -34.44 72.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.921 -1.112 . . . . 0.0 113.972 163.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -61.29 -39.6 91.06 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.453 1.479 . . . . 0.0 111.32 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -60.54 -38.6 84.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.713 0.805 . . . . 0.0 112.803 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.62 -47.58 78.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.652 1.181 . . . . 0.0 112.399 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.65 -32.17 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.408 -0.808 . . . . 0.0 111.369 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.73 -34.73 67.79 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.702 -1.249 . . . . 0.0 113.207 171.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.31 -41.85 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 122.673 0.389 . . . . 0.0 110.766 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -39.43 93.88 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.107 0.963 . . . . 0.0 112.229 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.27 -34.18 76.88 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.136 -0.978 . . . . 0.0 112.358 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.06 -23.58 63.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.436 1.095 . . . . 0.0 113.78 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.2 mt -95.9 -13.18 24.13 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.024 0.929 . . . . 0.0 113.244 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.07 18.64 67.11 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.277 0.941 . . . . 0.0 113.696 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 17.9 mt -113.12 130.71 56.1 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.581 1.552 . . . . 0.0 112.697 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -116.28 147.23 41.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.828 0.851 . . . . 0.0 112.941 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -129.35 172.45 11.49 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.027 2.531 . . . . 0.0 111.167 -163.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.3 m -86.4 133.9 33.75 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.365 -0.834 . . . . 0.0 110.405 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 t -131.12 146.9 52.52 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -164.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.01 152.71 39.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.167 1.787 . . . . 0.0 112.302 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -100.42 118.11 35.98 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.374 1.07 . . . . 0.0 111.426 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.6 p -66.4 -25.22 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.312 0.645 . . . . 0.0 112.624 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 tp -73.92 -22.21 59.77 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.028 0.931 . . . . 0.0 111.786 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.84 -29.88 11.19 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -125.08 106.44 28.47 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.88 -28.31 38.58 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.401 3.4 . . . . 0.0 115.663 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.67 -35.48 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.66 0.784 . . . . 0.0 112.111 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.81 -48.97 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.506 0.723 . . . . 0.0 110.871 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.428 ' HA ' HG12 ' A' ' 136' ' ' VAL . 9.7 ptp180 -70.75 -30.97 67.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.043 0.537 . . . . 0.0 112.056 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.8 m -69.38 -47.46 64.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.633 0.651 . . . . 0.0 112.301 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.5 -40.4 77.03 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.022 -1.049 . . . . 0.0 112.293 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 133' ' ' ARG . 12.3 p -63.93 -35.81 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 120.651 -1.281 . . . . 0.0 112.539 176.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -65.87 -44.95 83.88 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.732 0.813 . . . . 0.0 111.64 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.6 -41.38 92.83 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.648 0.779 . . . . 0.0 112.956 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.35 -41.94 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.3 m -98.94 1.64 45.77 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.855 1.207 . . . . 0.0 113.91 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 67.29 -22.82 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.368 2.667 . . . . 0.0 116.448 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -145.94 132.23 9.67 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.788 1.635 . . . . 0.0 109.458 171.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.31 126.98 5.72 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.876 1.717 . . . . 0.0 113.188 -165.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.8 p -135.52 136.85 41.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.446 1.898 . . . . 0.0 111.275 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.9 mm -128.05 137.42 30.77 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 125.458 1.503 . . . . 0.0 110.745 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.64 160.57 76.48 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 121.341 1.515 . . . . 0.0 112.447 -4.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -134.88 159.63 40.81 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.968 1.307 . . . . 0.0 110.515 -172.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.33 139.46 53.28 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -124.11 140.8 52.62 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.796 2.038 . . . . 0.0 110.411 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.8 mt -130.2 123.32 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.456 1.102 . . . . 0.0 108.387 170.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm 45.54 49.92 10.63 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.886 2.075 . . . . 0.0 114.88 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.4 26.45 15.35 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -118.41 138.23 52.6 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.767 1.227 . . . . 0.0 108.689 164.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.49 125.49 30.03 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.459 -0.775 . . . . 0.0 111.093 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 t -80.55 -40.49 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.499 1.119 . . . . 0.0 110.261 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.81 175.64 34.92 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.373 1.463 . . . . 0.0 114.327 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.25 172.14 55.19 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.852 0.739 . . . . 0.0 113.885 165.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.3 tp -48.65 -42.67 35.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.069 1.347 . . . . 0.0 113.686 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -59.41 -25.32 64.22 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.832 1.253 . . . . 0.0 113.018 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 mm -91.23 -46.6 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.27 1.428 . . . . 0.0 110.122 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.73 -40.89 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.249 1.42 . . . . 0.0 111.583 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.6 p -64.78 -40.93 96.08 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -68.43 -40.87 81.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.274 0.63 . . . . 0.0 112.211 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.9 mtt -63.23 -36.09 82.49 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.329 1.052 . . . . 0.0 112.68 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.76 -42.3 77.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.468 1.107 . . . . 0.0 112.299 174.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -65.29 -39.32 92.4 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.16 0.584 . . . . 0.0 111.418 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 36.7 t -82.66 -28.08 30.89 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.262 1.825 . . . . 0.0 115.159 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.61 -2.19 67.02 Favored Glycine 0 N--CA 1.48 1.579 0 O-C-N 120.47 -1.394 . . . . 0.0 114.665 -170.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -64.07 -35.79 81.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.646 1.223 . . . . 0.0 112.263 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.66 -45.69 85.64 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.848 0.859 . . . . 0.0 110.881 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -59.33 -40.6 86.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.68 1.592 . . . . 0.0 112.748 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -65.76 -36.55 83.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 118.215 -0.897 . . . . 0.0 112.632 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 61.2 mtm -70.04 -50.44 41.29 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.73 1.15 . . . . 0.0 113.295 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -62.33 -35.02 77.8 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.259 -0.901 . . . . 0.0 111.91 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -64.35 -37.98 89.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.603 0.761 . . . . 0.0 112.846 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.18 -30.04 71.12 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.077 0.853 . . . . 0.0 111.977 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.03 5.11 17.43 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.176 1.79 . . . . 0.0 114.275 171.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.28 12.8 75.32 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.3 1.428 . . . . 0.0 114.573 173.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 60.3 mt -94.31 145.35 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 118.266 1.033 . . . . 0.0 111.276 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 29.0 m -105.13 131.29 52.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.106 1.362 . . . . 0.0 110.743 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.4 p -133.89 171.02 14.75 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.478 1.911 . . . . 0.0 112.81 -175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 . . . . . 0 N--CA 1.477 0.898 0 C-N-CA 124.158 0.983 . . . . 0.0 112.726 164.399 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.3 m . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 90.0 mt -55.56 -40.89 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.499 1.519 . . . . 0.0 110.733 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -77.62 -37.94 49.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.021 1.328 . . . . 0.0 113.255 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 t -95.57 -28.08 15.03 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.219 1.408 . . . . 0.0 114.382 -165.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -87.3 145.98 26.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.306 1.042 . . . . 0.0 111.505 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -66.67 -44.83 80.75 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.962 0.905 . . . . 0.0 112.109 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.9 t -141.7 134.45 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.771 1.229 . . . . 0.0 111.7 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.98 133.9 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.126 1.37 . . . . 0.0 111.816 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 t -133.7 156.33 48.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.619 1.568 . . . . 0.0 110.936 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -132.61 139.62 47.86 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.39 1.076 . . . . 0.0 110.399 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mt -137.1 158.39 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.851 1.66 . . . . 0.0 109.064 -165.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -77.91 106.51 9.81 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 154.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.44 -149.65 21.35 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.833 1.206 . . . . 0.0 113.096 -172.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.98 156.93 51.69 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.327 1.451 . . . . 0.0 111.114 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.97 -33.9 72.89 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 121.408 1.539 . . . . 0.0 113.378 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -82.79 -13.96 55.29 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.913 -1.117 . . . . 0.0 113.263 173.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.26 70.3 13.02 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.985 1.714 . . . . 0.0 112.839 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.11 151.93 21.14 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.24 2.627 . . . . 0.0 111.574 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 85.3 mtp -97.4 12.19 34.05 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.7 t -148.97 145.25 27.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.746 1.219 . . . . 0.0 111.245 176.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.12 -39.84 86.7 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.558 -0.714 . . . . 0.0 112.897 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -62.75 -34.56 77.48 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.086 -1.009 . . . . 0.0 111.858 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.9 m -68.45 -31.03 70.05 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.284 -0.885 . . . . 0.0 112.664 170.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -66.02 -38.56 88.73 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.083 1.31 . . . . 0.0 112.425 168.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -59.73 -31.39 69.58 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.201 1.0 . . . . 0.0 112.69 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.6 tpt -60.04 -47.15 87.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.993 0.917 . . . . 0.0 111.618 169.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mm -70.89 -33.99 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.25 -0.906 . . . . 0.0 112.81 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -58.06 -35.81 71.88 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.741 -1.225 . . . . 0.0 112.404 168.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.67 -38.7 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 122.264 -0.272 . . . . 0.0 111.281 176.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.77 -34.72 78.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.235 1.014 . . . . 0.0 113.323 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.1 -40.39 95.71 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.089 -1.007 . . . . 0.0 111.629 167.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.71 -21.7 64.39 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 tp -96.88 -15.86 21.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.929 1.292 . . . . 0.0 112.725 170.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.98 12.17 56.71 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.188 1.852 . . . . 0.0 114.932 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.5 133.06 54.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 111.76 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -111.76 150.98 29.5 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.254 1.025 . . . . 0.0 113.201 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.73 175.79 8.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.817 2.047 . . . . 0.0 112.284 -161.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.86 117.51 25.65 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.374 -0.829 . . . . 0.0 109.481 -167.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 m -126.74 129.5 48.51 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.882 0.873 . . . . 0.0 112.17 -154.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -128.29 143.01 50.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.4 77.67 9.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.91 3.284 . . . . 0.0 111.427 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.3 p -74.18 -9.74 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -167.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.07 -22.98 22.66 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.329 -0.857 . . . . 0.0 112.156 169.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.98 -32.85 21.31 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.819 0.736 . . . . 0.0 112.232 174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -134.53 107.06 10.92 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.129 0.972 . . . . 0.0 111.569 163.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 129' ' ' HIS . 37.1 Cg_endo -60.66 -16.2 41.83 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.717 2.278 . . . . 0.0 114.203 173.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.4 p -39.75 -43.38 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.616 1.966 . . . . 0.0 115.82 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 t -67.25 -43.55 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.048 -1.033 . . . . 0.0 111.248 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -64.1 -41.09 97.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.008 1.323 . . . . 0.0 111.162 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.5 m -59.02 -45.73 89.98 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.193 0.997 . . . . 0.0 111.681 -177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -75.33 -37.11 60.9 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -35.11 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 121.058 1.754 . . . . 0.0 112.091 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.53 -35.15 73.64 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.614 1.566 . . . . 0.0 112.28 170.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.88 -35.8 59.74 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.447 1.022 . . . . 0.0 113.349 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 81.1 t -80.38 -45.33 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.317 0.962 . . . . 0.0 113.214 -173.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.3 p -105.27 13.61 30.22 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.646 1.566 . . . . 0.0 115.078 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 68.57 -29.87 0.17 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 128.153 2.581 . . . . 0.0 117.143 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -149.65 130.02 6.84 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 120.632 1.56 . . . . 0.0 112.868 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -94.8 147.77 1.69 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.669 2.913 . . . . 0.0 114.413 -177.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.0 p -129.79 152.41 49.31 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.552 1.541 . . . . 0.0 110.182 162.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.1 124.24 23.77 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.994 0.918 . . . . 0.0 110.553 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.58 157.04 72.31 Favored 'Cis proline' 0 CA--C 1.543 0.944 0 CA-C-N 120.227 1.117 . . . . 0.0 113.312 -2.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -151.72 160.55 43.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.183 1.393 . . . . 0.0 111.269 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.94 141.97 51.67 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -128.7 142.48 51.0 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.1 2.16 . . . . 0.0 110.868 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.4 mt -136.88 130.59 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.123 1.369 . . . . 0.0 109.688 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt 48.19 43.87 19.01 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.867 1.667 . . . . 0.0 114.573 -172.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.21 13.25 5.71 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.061 1.744 . . . . 0.0 114.889 -172.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -112.77 141.9 46.03 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.76 1.624 . . . . 0.0 111.103 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -72.51 126.26 29.43 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.105 0.955 . . . . 0.0 112.556 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.3 t -104.49 -54.97 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.28 1.432 . . . . 0.0 112.356 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 167.09 163.29 20.68 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.48 169.0 54.16 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.991 1.758 . . . . 0.0 113.441 168.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.4 tp -46.84 -45.35 20.15 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.315 1.446 . . . . 0.0 113.803 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.2 -21.24 66.49 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.881 1.272 . . . . 0.0 112.748 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.3 mm -92.36 -44.42 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.599 1.96 . . . . 0.0 111.193 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.9 -36.0 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.046 1.738 . . . . 0.0 112.066 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -56.58 -49.81 73.77 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 170.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -61.74 -42.02 98.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.442 0.697 . . . . 0.0 110.362 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.8 mtt -66.55 -39.12 88.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.221 1.009 . . . . 0.0 112.981 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -68.36 -39.72 81.73 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.015 1.326 . . . . 0.0 112.156 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.88 -31.57 61.63 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 30.7 t -79.25 -26.97 42.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.811 1.245 . . . . 0.0 113.603 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.53 -0.64 80.74 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.082 0.849 . . . . 0.0 114.511 -168.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.04 -36.72 80.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.71 1.755 . . . . 0.0 111.781 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.1 -42.51 98.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.889 0.876 . . . . 0.0 110.906 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -69.06 -35.42 76.53 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 126.234 1.814 . . . . 0.0 112.973 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -58.05 -48.84 78.87 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.154 1.343 . . . . 0.0 110.946 171.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 70.3 mtm -67.89 -38.59 83.2 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.27 -43.64 77.35 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.341 0.973 . . . . 0.0 112.832 172.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -72.24 -26.35 61.98 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.309 -0.87 . . . . 0.0 113.305 -171.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.71 -30.12 63.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.321 1.048 . . . . 0.0 112.672 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -87.39 -2.5 58.66 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.51 16.36 55.3 Favored Glycine 0 N--CA 1.47 0.926 0 O-C-N 120.66 -1.275 . . . . 0.0 113.815 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.3 mt -86.19 147.67 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.323 1.049 . . . . 0.0 110.801 -171.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.6 m -105.04 124.44 49.54 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.091 1.356 . . . . 0.0 112.681 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 25.5 p -125.53 169.17 12.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.806 2.442 . . . . 0.0 111.441 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 N--CA 1.481 1.104 0 O-C-N 121.087 -1.008 . . . . 0.0 112.087 171.664 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.4 m . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -61.54 -33.53 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.743 -0.598 . . . . 0.0 112.455 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.81 -24.78 44.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.85 1.66 . . . . 0.0 113.759 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.5 t -92.52 -34.19 14.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.773 1.629 . . . . 0.0 113.667 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -87.76 147.86 24.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.325 1.05 . . . . 0.0 111.807 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -68.51 -47.63 66.49 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.942 -1.099 . . . . 0.0 113.779 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.9 t -140.39 129.93 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.773 1.229 . . . . 0.0 110.848 -173.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.55 137.64 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.648 1.179 . . . . 0.0 111.315 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -136.54 154.64 50.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.417 1.087 . . . . 0.0 111.758 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -134.5 143.61 47.57 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.753 0.787 . . . . 0.0 112.469 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 mt -136.79 157.45 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.495 1.518 . . . . 0.0 110.227 -155.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -76.19 106.52 7.85 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.973 153.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.26 -161.71 43.42 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.948 0.794 . . . . 0.0 114.257 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.82 156.09 41.06 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.724 1.209 . . . . 0.0 111.94 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -67.39 -21.04 47.72 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.28 1.987 . . . . 0.0 113.088 173.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.59 -24.53 21.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.136 1.374 . . . . 0.0 112.852 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.31 75.77 19.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.796 1.638 . . . . 0.0 111.334 -176.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.66 155.87 40.02 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.722 2.948 . . . . 0.0 112.362 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.3 mtt -109.62 4.04 21.67 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.316 1.446 . . . . 0.0 114.539 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 44.3 t -148.85 147.11 28.35 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.753 1.621 . . . . 0.0 110.523 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.15 94.71 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.698 -0.626 . . . . 0.0 111.548 176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -60.91 -34.66 75.02 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.278 -0.889 . . . . 0.0 112.203 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.8 m -63.48 -48.48 77.45 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 118.865 -0.588 . . . . 0.0 111.136 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -59.08 -48.97 79.67 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.025 0.83 . . . . 0.0 111.055 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -60.84 -28.64 68.98 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.417 1.087 . . . . 0.0 113.037 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 34.4 ttp -68.79 -42.62 77.11 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.6 mm -67.66 -34.57 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.227 -0.921 . . . . 0.0 110.73 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -39.53 72.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.915 1.286 . . . . 0.0 111.956 172.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.44 -42.35 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.557 1.143 . . . . 0.0 111.705 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.9 mt -66.48 -35.53 80.51 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -67.07 -33.62 75.88 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.972 -1.08 . . . . 0.0 112.495 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.79 -25.69 68.29 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.837 -1.164 . . . . 0.0 113.275 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.88 -14.48 20.66 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.426 1.09 . . . . 0.0 113.717 171.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.82 10.19 67.31 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.894 1.235 . . . . 0.0 115.355 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.32 131.38 55.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.184 0.993 . . . . 0.0 112.06 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -116.5 128.1 55.14 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.934 0.874 . . . . 0.0 113.018 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -106.36 171.98 7.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.818 2.447 . . . . 0.0 112.069 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.2 m -83.72 121.87 27.88 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.581 -1.324 . . . . 0.0 109.0 -161.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.9 m -122.79 128.03 49.91 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.243 -155.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -126.45 143.94 51.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.673 1.189 . . . . 0.0 113.386 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -92.7 113.91 26.32 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.679 1.192 . . . . 0.0 111.245 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 t -69.11 -18.44 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.757 -0.589 . . . . 0.0 112.061 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -77.7 -22.79 49.94 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.054 -1.029 . . . . 0.0 112.545 172.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.78 -37.37 17.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.893 0.769 . . . . 0.0 112.205 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -136.85 94.36 12.99 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -44.18 -20.93 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.586 1 C-N-CA 125.916 4.411 . . . . 0.0 116.891 165.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -48.62 -35.88 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 121.237 1.835 . . . . 0.0 112.867 171.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.35 -43.69 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 121.565 -0.709 . . . . 0.0 110.315 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.526 ' HA ' HG12 ' A' ' 136' ' ' VAL . 0.7 OUTLIER -62.25 -32.94 73.7 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.845 1.258 . . . . 0.0 112.542 172.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.421 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 40.4 m -69.57 -37.9 77.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.911 1.684 . . . . 0.0 113.686 173.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -76.17 -47.19 25.13 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 133' ' ' ARG . 8.0 p -60.54 -34.47 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 120.515 -1.365 . . . . 0.0 112.951 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 134' ' ' SER . 17.7 ptpt -62.13 -34.64 76.73 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -77.04 -43.53 34.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.664 1.986 . . . . 0.0 113.915 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.9 t -79.33 -38.59 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.108 1.363 . . . . 0.0 113.376 -166.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 m -100.39 10.98 40.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 62.11 -33.97 0.1 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 128.338 2.655 . . . . 0.0 115.376 -166.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -139.13 139.41 23.15 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.534 2.334 . . . . 0.0 108.833 169.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.99 128.37 9.11 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.075 1.85 . . . . 0.0 112.019 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.8 m -130.16 132.21 45.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.835 1.254 . . . . 0.0 110.987 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 57.0 mt -129.2 130.58 23.38 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.275 1.03 . . . . 0.0 110.52 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -80.78 152.66 82.2 Favored 'Cis proline' 0 CA--C 1.545 1.062 0 CA-C-N 120.021 1.043 . . . . 0.0 112.827 -5.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -147.81 158.56 44.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.352 1.061 . . . . 0.0 112.595 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.52 135.13 50.9 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.914 1.686 . . . . 0.0 111.987 -172.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -119.22 144.91 46.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.726 2.011 . . . . 0.0 110.128 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.6 mt -127.0 124.32 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 167.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.3 tttp 44.11 54.95 5.7 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.925 1.69 . . . . 0.0 114.328 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.69 27.83 17.55 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.08 145.86 51.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.109 1.364 . . . . 0.0 110.008 171.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -81.6 124.07 29.22 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.717 0.77 . . . . 0.0 111.332 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.9 t -99.94 -49.25 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.144 0.978 . . . . 0.0 110.104 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.05 158.75 23.88 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.674 1.429 . . . . 0.0 116.674 170.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.2 169.7 54.59 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.285 0.945 . . . . 0.0 112.157 164.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -52.12 -38.85 58.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.469 1.107 . . . . 0.0 113.969 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.49 -34.96 78.2 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.869 -1.144 . . . . 0.0 111.773 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.5 mm -72.54 -46.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.161 1.384 . . . . 0.0 110.668 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.98 -35.91 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.966 1.706 . . . . 0.0 111.032 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 90.6 m -62.04 -46.25 90.01 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.443 0.697 . . . . 0.0 111.807 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -59.57 -45.78 90.86 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.742 1.155 . . . . 0.0 110.28 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.3 mtt -61.36 -41.75 97.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.881 0.873 . . . . 0.0 111.365 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.87 -46.61 67.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.133 0.973 . . . . 0.0 111.335 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -72.64 -24.86 61.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.634 1.174 . . . . 0.0 112.597 -175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.9 t -100.44 -2.93 32.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.804 1.641 . . . . 0.0 114.041 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.44 -7.47 78.75 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 120.705 -1.247 . . . . 0.0 115.324 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -29.71 67.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.837 -1.39 . . . . 0.0 114.103 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.55 -46.42 86.03 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.077 0.853 . . . . 0.0 109.791 174.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -58.59 -42.2 87.54 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.122 0.969 . . . . 0.0 111.68 169.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.67 -37.35 86.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 117.0 -1.476 . . . . 0.0 111.825 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.8 mtm -69.82 -47.73 61.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.363 1.438 . . . . 0.0 112.88 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.27 -39.02 89.13 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.634 0.652 . . . . 0.0 112.251 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -69.36 -36.14 76.56 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.955 1.302 . . . . 0.0 111.912 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.0 -24.67 67.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.738 0.815 . . . . 0.0 112.546 168.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -92.12 6.44 46.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.929 1.292 . . . . 0.0 114.403 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.72 13.39 67.29 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.725 1.155 . . . . 0.0 114.431 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.2 mt -104.46 146.89 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.25 1.42 . . . . 0.0 108.959 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.0 m -116.02 136.13 53.32 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.861 -1.149 . . . . 0.0 112.777 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.4 p -131.34 167.98 18.33 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.18 1.792 . . . . 0.0 112.581 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 . . . . . 0 N--CA 1.476 0.842 0 O-C-N 121.439 -0.788 . . . . 0.0 110.096 171.009 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 119.326 -0.368 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.71 -36.53 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 118.427 0.558 . . . . 0.0 111.991 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.4 -38.31 50.09 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.582 1.553 . . . . 0.0 112.896 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.7 t -81.84 -35.87 28.93 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.661 1.584 . . . . 0.0 113.122 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -83.04 142.36 31.37 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.888 -1.133 . . . . 0.0 109.968 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.416 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 34.9 m-20 -82.93 -46.0 13.48 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.879 -1.138 . . . . 0.0 112.345 -163.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 t -132.85 131.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.787 1.635 . . . . 0.0 109.764 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.2 t -132.49 132.88 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.529 1.532 . . . . 0.0 111.173 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.8 t -133.85 155.48 49.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.65 1.18 . . . . 0.0 110.839 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -131.39 142.44 50.05 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.31 0.644 . . . . 0.0 112.73 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.7 mt -136.42 159.69 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.351 1.861 . . . . 0.0 110.206 -158.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -73.06 104.03 4.01 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.509 -0.744 . . . . 0.0 109.505 158.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.24 -155.94 40.83 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.563 -0.71 . . . . 0.0 113.676 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -113.58 150.21 42.88 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.8 1.24 . . . . 0.0 112.209 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.02 -19.02 46.16 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.067 2.512 . . . . 0.0 114.711 -167.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.12 -27.34 60.82 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.606 1.162 . . . . 0.0 112.688 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.79 68.22 12.88 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.163 1.785 . . . . 0.0 111.549 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.1 143.8 73.17 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.422 2.082 . . . . 0.0 111.429 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.6 ttm -90.93 -7.51 51.91 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 41.3 t -140.8 146.28 37.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.282 1.433 . . . . 0.0 110.459 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.17 94.33 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.546 -0.721 . . . . 0.0 112.484 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -69.52 -34.1 73.78 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.436 -0.79 . . . . 0.0 111.593 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 m -62.75 -39.46 94.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.339 0.655 . . . . 0.0 112.477 168.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -67.23 -40.66 86.36 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.627 1.103 . . . . 0.0 112.828 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -64.42 -36.03 82.85 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.805 0.842 . . . . 0.0 112.509 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.8 tpt -55.94 -45.86 78.69 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.214 0.915 . . . . 0.0 112.289 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.3 mm -66.58 -34.14 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.303 0.641 . . . . 0.0 111.254 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -37.2 86.31 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.437 -0.79 . . . . 0.0 112.99 174.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.8 t -70.62 -36.11 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.897 0.879 . . . . 0.0 110.956 176.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.1 mt -66.1 -40.95 91.18 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.335 -0.853 . . . . 0.0 113.129 169.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -62.08 -31.29 71.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.09 -1.007 . . . . 0.0 111.863 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.15 -20.0 64.86 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -98.81 -9.17 24.75 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.459 1.504 . . . . 0.0 113.563 172.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.77 11.17 57.11 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.402 1.477 . . . . 0.0 114.954 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.11 132.62 55.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.333 1.066 . . . . 0.0 111.831 172.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -114.89 159.23 20.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.951 0.9 . . . . 0.0 113.356 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -133.19 172.82 12.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.856 2.062 . . . . 0.0 111.604 -161.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.4 m -87.9 119.6 28.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.469 -1.394 . . . . 0.0 108.354 -168.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.6 m -125.93 129.29 48.98 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.162 -151.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -125.88 143.72 50.96 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -91.87 122.59 34.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.395 1.478 . . . . 0.0 111.396 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.0 m -66.92 -22.22 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.0 mt -87.04 -11.3 50.74 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.211 1.404 . . . . 0.0 112.92 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.13 -36.79 15.51 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -146.29 135.27 11.2 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.95 0.9 . . . . 0.0 111.069 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.25 -31.63 93.25 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.393 2.728 . . . . 0.0 113.204 -174.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 p -44.02 -42.7 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.616 1.567 . . . . 0.0 113.789 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 t -71.11 -47.86 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.801 1.182 . . . . 0.0 111.419 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -72.42 -25.41 61.47 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 63.7 m -71.2 -48.07 53.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.316 1.046 . . . . 0.0 112.274 169.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -66.18 -44.22 84.62 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.96 -1.088 . . . . 0.0 112.623 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.82 -35.31 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.291 -0.88 . . . . 0.0 112.065 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -69.59 -36.53 76.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.274 1.03 . . . . 0.0 112.728 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -74.48 -44.21 52.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.464 1.106 . . . . 0.0 113.718 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.0 t -81.91 -41.27 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.24 1.416 . . . . 0.0 113.001 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.0 m -101.1 -9.33 21.47 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 64.13 -24.15 0.07 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 128.697 2.799 . . . . 0.0 117.439 172.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -127.3 110.6 21.3 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.189 1.795 . . . . 0.0 107.925 158.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.03 125.94 4.25 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 121.117 1.211 . . . . 0.0 111.875 -171.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.4 p -136.05 126.75 27.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.352 1.861 . . . . 0.0 109.453 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.62 146.13 57.43 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 119.226 0.921 . . . . 0.0 110.999 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.69 155.27 92.39 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 120.201 1.108 . . . . 0.0 114.292 8.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -150.01 157.29 42.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.472 1.909 . . . . 0.0 110.576 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.73 139.03 52.41 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.251 1.021 . . . . 0.0 113.665 -172.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -129.78 145.8 51.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.514 1.926 . . . . 0.0 111.101 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.6 mt -129.12 125.86 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.792 1.237 . . . . 0.0 108.685 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 90' ' ' ASP . 2.3 mmpt? 46.59 53.66 9.7 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.674 1.59 . . . . 0.0 114.422 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 58.05 24.45 11.18 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.399 1.88 . . . . 0.0 115.934 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -123.53 139.3 54.15 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.902 -1.124 . . . . 0.0 111.522 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -68.35 123.73 21.55 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.082 0.953 . . . . 0.0 111.023 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.77 -43.16 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.497 1.519 . . . . 0.0 111.807 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.62 173.67 26.33 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 117.165 1.626 . . . . 0.0 117.165 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.95 173.23 54.9 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.466 1.507 . . . . 0.0 113.769 171.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.95 -41.38 33.81 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.28 1.432 . . . . 0.0 112.895 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.86 -36.54 83.61 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.948 -1.095 . . . . 0.0 112.82 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 mm -74.27 -45.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.672 1.589 . . . . 0.0 109.62 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.5 t -58.65 -39.72 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.996 0.918 . . . . 0.0 110.835 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 30.7 m -63.52 -46.05 87.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.229 1.011 . . . . 0.0 111.369 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 29.7 tttp -60.88 -43.77 97.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.96 1.304 . . . . 0.0 111.585 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 51.9 mtt -70.6 -38.73 74.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.831 1.253 . . . . 0.0 112.698 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.09 -46.72 61.24 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.386 0.994 . . . . 0.0 112.294 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -63.55 -33.65 76.06 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.646 0.657 . . . . 0.0 111.713 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.7 m -85.14 -17.65 36.6 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.66 -4.65 85.77 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.945 1.248 . . . . 0.0 115.142 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -64.92 -28.49 69.56 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.426 1.613 . . . . 0.0 113.538 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tt -59.54 -46.55 88.56 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.915 -1.116 . . . . 0.0 109.922 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -61.9 -32.92 73.34 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.172 1.789 . . . . 0.0 112.823 172.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -64.45 -39.81 94.54 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.596 1.089 . . . . 0.0 112.101 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.1 mtm -66.16 -51.18 60.26 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.749 1.261 . . . . 0.0 111.562 172.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 53.7 tp -65.14 -42.83 93.44 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.706 2.002 . . . . 0.0 111.122 -165.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -68.65 -38.2 80.25 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.276 1.03 . . . . 0.0 112.337 171.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.89 -27.25 69.02 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.905 0.775 . . . . 0.0 112.666 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 -5.23 45.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.894 1.678 . . . . 0.0 113.714 175.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.46 16.42 64.25 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 125.203 1.383 . . . . 0.0 114.687 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.17 143.92 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.24 1.416 . . . . 0.0 110.15 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.5 m -114.15 134.34 54.96 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.244 -0.91 . . . . 0.0 113.403 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.2 p -125.73 174.07 8.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 129.007 2.923 . . . . 0.0 111.994 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 . . . . . 0 N--CA 1.476 0.85 0 C-N-CA 124.695 1.198 . . . . 0.0 113.172 167.4 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.6 pt -62.13 -35.3 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.747 1.158 . . . . 0.0 112.13 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -77.74 -37.75 48.49 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.044 1.738 . . . . 0.0 112.069 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 t -68.15 -31.55 71.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.853 2.461 . . . . 0.0 113.293 173.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -86.87 147.85 25.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.15 1.78 . . . . 0.0 111.727 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.87 -35.7 16.39 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.017 -1.052 . . . . 0.0 111.863 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.3 t -139.9 130.75 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.95 1.3 . . . . 0.0 112.261 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.9 t -132.83 133.32 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.059 1.344 . . . . 0.0 111.379 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 t -131.72 154.6 48.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.998 0.919 . . . . 0.0 110.596 167.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -134.2 146.23 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.404 0.621 . . . . 0.0 112.463 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.07 161.72 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.078 1.751 . . . . 0.0 109.174 -166.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.72 104.25 8.15 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.375 -0.828 . . . . 0.0 109.543 146.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.28 -162.41 18.03 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.265 0.936 . . . . 0.0 114.87 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -107.1 158.24 33.44 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.916 2.086 . . . . 0.0 110.833 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.29 -25.77 56.79 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.733 1.622 . . . . 0.0 113.666 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -76.07 -24.41 55.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.734 1.214 . . . . 0.0 113.684 169.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.12 69.05 14.14 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.07 1.348 . . . . 0.0 111.894 -174.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.99 143.71 23.24 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.856 2.37 . . . . 0.0 110.372 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 mmt -88.58 5.15 44.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 13.5 t -152.21 146.76 25.7 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.124 1.37 . . . . 0.0 110.961 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.33 77.85 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -65.3 -37.89 88.53 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.894 -1.129 . . . . 0.0 111.761 172.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 m -65.14 -39.26 92.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.872 0.869 . . . . 0.0 112.361 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.53 -45.77 92.79 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.269 1.027 . . . . 0.0 112.144 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -58.19 -35.86 72.24 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.69 1.596 . . . . 0.0 112.957 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.4 ttp -59.13 -42.45 90.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.622 0.369 . . . . 0.0 111.941 173.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 mm -71.73 -33.82 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.572 0.749 . . . . 0.0 111.848 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -58.35 -38.68 77.69 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.8 -1.188 . . . . 0.0 112.336 172.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.425 HG13 ' HG ' ' A' ' 165' ' ' LEU . 2.2 t -63.48 -39.38 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.173 0.989 . . . . 0.0 111.081 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.6 mt -65.89 -39.18 90.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.554 0.742 . . . . 0.0 112.532 173.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -67.0 -31.56 72.2 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.903 -1.123 . . . . 0.0 112.018 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.89 -19.91 64.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.848 1.259 . . . . 0.0 114.235 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.75 -9.55 28.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.889 1.276 . . . . 0.0 113.297 166.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.41 9.2 42.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.342 0.972 . . . . 0.0 113.721 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.0 mt -114.29 130.33 56.66 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 125.683 1.593 . . . . 0.0 111.72 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -115.02 133.67 55.85 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.017 0.913 . . . . 0.0 111.594 170.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -105.06 172.12 6.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.603 2.361 . . . . 0.0 110.773 -172.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.5 m -87.24 123.1 31.88 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.668 -1.27 . . . . 0.0 109.811 -161.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.5 p -108.36 134.14 51.59 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.406 1.482 . . . . 0.0 114.904 -158.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -126.71 146.78 50.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.503 1.121 . . . . 0.0 113.023 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.46 106.04 14.81 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.013 1.325 . . . . 0.0 111.328 -167.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.54 -36.04 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.586 1.555 . . . . 0.0 112.262 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 tp -80.48 -22.05 41.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.335 0.654 . . . . 0.0 111.666 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.11 -39.31 16.86 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.49 -0.757 . . . . 0.0 112.679 167.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -126.1 103.06 26.92 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 118.982 0.81 . . . . 0.0 112.52 -169.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.08 -28.77 25.92 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.713 2.942 . . . . 0.0 115.021 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -49.7 -36.86 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.792 1.237 . . . . 0.0 113.5 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.34 -52.2 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.553 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.434 ' HA ' HG12 ' A' ' 136' ' ' VAL . 16.1 ptm180 -64.48 -26.11 68.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.69 0.796 . . . . 0.0 112.955 173.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.6 m -71.46 -51.96 20.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.163 0.585 . . . . 0.0 111.763 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -73.43 -34.92 65.7 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.564 -1.335 . . . . 0.0 114.206 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 133' ' ' ARG . 11.5 p -60.28 -34.34 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.715 1.143 . . . . 0.0 112.074 172.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 34.5 tttm -69.25 -35.21 75.88 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.139 0.881 . . . . 0.0 112.731 173.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.23 -37.74 86.52 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.221 1.373 . . . . 0.0 112.541 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.61 -45.26 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.1 m -106.08 -5.37 19.49 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 62.05 -48.09 0.16 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.517 2.327 . . . . 0.0 116.186 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -135.92 92.45 16.46 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.896 1.278 . . . . 0.0 111.546 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -101.47 156.7 0.37 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.838 3.692 . . . . 0.0 114.743 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 m -117.35 128.84 55.44 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.413 1.485 . . . . 0.0 110.393 161.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.22 140.69 25.79 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.879 1.272 . . . . 0.0 108.576 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -90.59 159.62 31.11 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-N 120.733 1.298 . . . . 0.0 113.693 1.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -160.2 171.65 18.83 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.464 1.106 . . . . 0.0 113.466 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.52 141.89 51.24 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.12 1.368 . . . . 0.0 113.455 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -128.29 141.71 51.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.61 1.964 . . . . 0.0 110.665 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 84.5 mt -129.65 135.63 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 125.049 1.339 . . . . 0.0 108.471 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 47.36 40.45 10.8 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.22 1.408 . . . . 0.0 113.509 -170.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.32 25.46 7.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.002 2.121 . . . . 0.0 115.526 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.87 142.47 46.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.513 1.525 . . . . 0.0 110.007 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -70.78 126.08 28.61 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.614 0.721 . . . . 0.0 112.088 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.7 t -101.57 -53.89 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.436 1.494 . . . . 0.0 111.078 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.82 160.6 26.41 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 116.058 1.183 . . . . 0.0 116.058 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 170.36 54.91 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.035 1.302 . . . . 0.0 112.769 165.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -49.31 -46.76 47.03 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.86 1.264 . . . . 0.0 114.337 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.9 -22.67 65.07 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.101 -0.999 . . . . 0.0 112.621 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.4 mm -82.23 -47.05 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.838 1.655 . . . . 0.0 110.664 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.67 -36.57 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.852 1.661 . . . . 0.0 111.024 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 55.1 m -59.69 -44.0 93.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.907 0.883 . . . . 0.0 111.881 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -66.41 -42.45 87.8 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.105 -0.997 . . . . 0.0 111.033 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.6 mtt -61.13 -43.83 98.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.597 0.759 . . . . 0.0 110.99 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.425 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.0 tm? -65.11 -48.85 72.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.078 0.951 . . . . 0.0 111.13 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.15 -16.26 61.98 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.165 1.386 . . . . 0.0 113.477 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m -91.32 -21.01 21.26 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 173.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.83 -2.35 88.25 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 121.718 -0.614 . . . . 0.0 113.927 -164.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.0 -33.55 74.84 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.688 1.244 . . . . 0.0 111.775 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.28 -45.63 92.41 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.363 -0.836 . . . . 0.0 110.689 172.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -63.48 -37.49 87.51 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.158 1.383 . . . . 0.0 113.105 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -61.38 -43.33 99.05 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 117.611 -1.185 . . . . 0.0 112.655 170.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 74.4 mtm -68.71 -48.02 64.89 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.939 1.245 . . . . 0.0 112.309 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 pp -64.04 -35.65 81.43 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.822 -0.549 . . . . 0.0 111.709 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -69.7 -35.76 75.35 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 121.496 -0.752 . . . . 0.0 112.952 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -65.2 -30.61 71.52 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.3 1.04 . . . . 0.0 111.876 171.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.99 5.28 6.81 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.014 1.726 . . . . 0.0 112.969 170.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.91 9.25 77.93 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.502 1.525 . . . . 0.0 114.796 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.4 mt -94.66 147.22 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.219 1.008 . . . . 0.0 110.854 -168.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.3 m -112.22 130.3 55.97 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.994 1.318 . . . . 0.0 111.101 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.5 p -138.36 169.51 17.66 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.977 1.711 . . . . 0.0 113.032 -169.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.0 ttt-85 . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 124.862 1.265 . . . . 0.0 110.813 164.938 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 118.851 -0.595 . . . . 0.0 111.618 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.3 pt -64.4 -36.63 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.138 0.575 . . . . 0.0 111.867 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -79.19 -34.26 43.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.323 1.449 . . . . 0.0 113.681 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -80.1 -29.65 39.06 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.853 0.861 . . . . 0.0 113.243 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -87.42 133.49 33.73 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.955 0.902 . . . . 0.0 112.047 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -67.67 -38.22 83.43 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.3 t -142.33 127.2 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.331 1.053 . . . . 0.0 111.514 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.77 130.17 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.467 1.507 . . . . 0.0 111.557 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 t -131.75 155.3 47.95 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.079 0.952 . . . . 0.0 111.532 168.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -131.62 127.9 38.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.591 1.156 . . . . 0.0 110.394 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.14 173.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.22 1.808 . . . . 0.0 111.773 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 102.15 4.52 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.333 1.053 . . . . 0.0 109.919 161.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.82 -162.12 37.11 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.41 1.005 . . . . 0.0 115.156 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.11 148.67 43.51 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.117 0.967 . . . . 0.0 110.549 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.21 -23.89 77.98 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.148 2.565 . . . . 0.0 113.996 -175.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -78.37 -26.47 46.62 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.799 1.24 . . . . 0.0 113.907 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.17 67.05 10.62 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.903 1.281 . . . . 0.0 111.881 -175.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.19 152.91 45.72 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.527 2.151 . . . . 0.0 112.841 -172.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -74.06 -8.13 55.02 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.196 -0.94 . . . . 0.0 113.34 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.7 m -152.66 146.73 25.4 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -158.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.1 64.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.247 1.419 . . . . 0.0 112.447 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -67.68 -26.66 66.3 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.315 0.962 . . . . 0.0 111.36 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.3 m -68.32 -38.38 81.51 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.274 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.31 -45.49 91.1 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.305 1.411 . . . . 0.0 111.768 167.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -56.61 -37.65 70.98 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.485 0.714 . . . . 0.0 112.342 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.8 tpt -60.79 -46.56 90.02 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.278 1.431 . . . . 0.0 112.355 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.3 mm -72.96 -33.21 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.426 -0.796 . . . . 0.0 112.459 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -57.58 -32.69 67.41 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.206 -1.558 . . . . 0.0 112.795 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.419 HG13 ' HG ' ' A' ' 165' ' ' LEU . 4.0 t -62.61 -44.07 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.177 0.991 . . . . 0.0 111.168 172.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.35 -36.28 83.53 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.031 1.332 . . . . 0.0 112.83 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -71.83 -31.23 66.32 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.358 -1.463 . . . . 0.0 113.137 172.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.91 -29.84 69.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.228 1.011 . . . . 0.0 112.642 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.35 -14.35 40.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.268 1.027 . . . . 0.0 113.412 169.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.83 11.11 57.2 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.083 1.325 . . . . 0.0 114.527 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.09 131.61 55.75 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.932 1.293 . . . . 0.0 111.326 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -113.0 145.37 40.96 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.715 1.143 . . . . 0.0 112.421 174.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -113.54 172.29 7.05 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.459 1.904 . . . . 0.0 111.721 -175.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.8 m -88.86 120.4 30.23 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -164.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.2 m -125.67 136.03 52.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.608 -148.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -124.02 159.55 29.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.827 1.251 . . . . 0.0 111.985 -173.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -112.99 118.27 34.35 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.088 1.355 . . . . 0.0 110.677 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.85 -21.78 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.427 0.691 . . . . 0.0 112.857 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.42 -9.92 53.4 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.517 1.127 . . . . 0.0 112.644 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.46 -34.35 11.53 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.332 0.969 . . . . 0.0 112.61 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -138.36 88.65 14.63 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.213 0.605 . . . . 0.0 111.005 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.86 -12.51 22.4 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.21 2.607 . . . . 0.0 114.961 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -45.91 -33.77 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.662 1.119 . . . . 0.0 112.902 167.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.43 -43.62 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.337 1.055 . . . . 0.0 111.824 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.469 ' HA ' HG12 ' A' ' 136' ' ' VAL . 11.4 ptm180 -65.68 -28.61 69.21 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.257 0.935 . . . . 0.0 111.98 177.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.4 m -74.48 -39.43 62.49 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -69.84 -39.99 76.1 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.695 1.134 . . . . 0.0 111.313 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 133' ' ' ARG . 9.9 p -67.3 -32.11 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.808 -1.182 . . . . 0.0 112.233 175.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -61.49 -33.98 74.7 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.071 -1.018 . . . . 0.0 113.024 168.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -73.31 -47.85 39.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.182 0.993 . . . . 0.0 112.72 170.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.95 -34.43 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.0 m -100.61 -2.31 33.15 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 60.84 -38.74 0.1 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 130.221 3.408 . . . . 0.0 116.635 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -136.49 91.73 15.9 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.859 2.464 . . . . 0.0 109.572 173.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.41 136.58 8.82 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.117 2.545 . . . . 0.0 113.232 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.9 m -132.65 122.55 24.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.147 0.979 . . . . 0.0 109.85 165.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 12.6 pt -95.37 156.41 37.66 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.493 1.117 . . . . 0.0 113.683 -172.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.92 158.37 97.97 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 119.037 0.692 . . . . 0.0 112.978 -5.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -131.42 160.86 33.88 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.999 1.319 . . . . 0.0 111.433 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.84 139.95 53.06 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.278 1.431 . . . . 0.0 111.991 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -132.8 143.99 49.93 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.172 1.789 . . . . 0.0 110.28 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.1 mt -126.17 117.09 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 42.89 53.03 5.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 127.215 2.206 . . . . 0.0 114.324 -169.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 57.52 26.52 12.82 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -119.29 131.19 55.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.117 1.367 . . . . 0.0 109.224 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -74.33 125.03 27.59 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.86 -42.48 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.013 1.325 . . . . 0.0 111.662 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.35 177.88 30.88 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 169.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.98 169.31 54.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.831 1.205 . . . . 0.0 113.962 168.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -45.35 -44.48 11.79 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.147 1.779 . . . . 0.0 113.145 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.62 -45.04 93.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.356 0.662 . . . . 0.0 111.656 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 mm -68.45 -46.91 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.424 1.49 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.71 -36.21 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.946 1.699 . . . . 0.0 110.672 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 29.5 m -63.39 -46.04 88.29 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 118.8 -0.619 . . . . 0.0 111.701 173.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -63.61 -41.99 98.25 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.882 1.219 . . . . 0.0 110.82 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 54.6 mtt -64.17 -39.8 94.77 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.631 1.172 . . . . 0.0 112.399 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.419 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.1 tm? -66.09 -47.17 75.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.856 0.863 . . . . 0.0 110.874 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -70.93 -26.18 63.09 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.506 1.122 . . . . 0.0 113.283 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 75.2 m -105.18 0.88 27.75 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.24 -8.09 80.62 Favored Glycine 0 N--CA 1.478 1.442 0 CA-C-N 121.094 1.77 . . . . 0.0 115.419 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.55 -29.68 69.12 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.08 1.44 . . . . 0.0 112.885 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.34 -48.26 68.03 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.651 0.78 . . . . 0.0 110.782 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -60.62 -33.59 73.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.611 1.564 . . . . 0.0 112.889 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -59.02 -41.35 87.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.952 0.796 . . . . 0.0 112.821 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.8 mtm -67.32 -47.64 69.93 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.632 1.105 . . . . 0.0 112.143 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -37.97 87.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.251 0.62 . . . . 0.0 112.49 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -75.03 -33.98 61.84 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.412 -0.805 . . . . 0.0 112.989 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.78 -24.83 67.68 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.289 0.495 . . . . 0.0 111.955 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -80.31 -0.04 34.94 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.712 1.205 . . . . 0.0 113.825 171.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.32 22.02 57.53 Favored Glycine 0 CA--C 1.524 0.622 0 O-C-N 120.521 -1.362 . . . . 0.0 114.26 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 95.9 mt -99.4 145.04 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.666 1.233 . . . . 0.0 111.395 -173.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 99.2 m -91.42 126.89 36.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.685 1.194 . . . . 0.0 111.658 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 22.0 p -120.04 166.4 13.43 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.127 1.771 . . . . 0.0 112.193 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 125.954 1.701 . . . . 0.0 112.356 173.992 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 118.896 -0.573 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 pt -60.72 -33.35 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.356 0.98 . . . . 0.0 112.928 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -78.81 -23.55 45.08 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.907 1.683 . . . . 0.0 114.542 173.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.0 t -89.22 -32.82 17.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.361 1.865 . . . . 0.0 113.061 -174.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -88.86 143.18 27.06 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.767 1.227 . . . . 0.0 111.245 169.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.26 -33.13 61.25 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.38 -0.825 . . . . 0.0 111.105 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.3 t -142.82 131.46 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.65 1.18 . . . . 0.0 111.512 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -134.36 139.12 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.097 1.359 . . . . 0.0 111.773 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 t -134.24 156.54 48.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.086 1.355 . . . . 0.0 111.299 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 147' ' ' GLN . 1.1 p90 -132.0 135.33 46.46 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.764 0.825 . . . . 0.0 110.839 173.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.65 167.64 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.585 1.954 . . . . 0.0 110.391 -168.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.11 112.55 15.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 152.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.43 -153.66 46.49 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 123.142 0.401 . . . . 0.0 113.811 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.18 160.07 65.73 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.838 1.655 . . . . 0.0 111.066 -166.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.75 -24.94 20.93 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 N-CA-C 116.515 1.698 . . . . 0.0 116.515 -156.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -98.89 -3.87 34.25 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.805 1.242 . . . . 0.0 113.402 168.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -141.62 71.97 25.19 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.531 1.532 . . . . 0.0 110.787 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.18 155.7 25.74 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.621 2.881 . . . . 0.0 112.818 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.99 7.06 18.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.36 1.464 . . . . 0.0 113.552 175.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 16.6 t -148.47 147.43 29.12 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.685 -1.26 . . . . 0.0 111.788 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.78 -41.07 77.03 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.598 -0.689 . . . . 0.0 112.011 170.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -66.66 -27.34 67.59 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.597 -0.689 . . . . 0.0 112.331 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.4 m -64.85 -47.49 77.71 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.318 -0.864 . . . . 0.0 110.936 169.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.31 -41.28 88.66 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.955 0.798 . . . . 0.0 111.298 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -61.22 -35.98 78.69 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.633 1.173 . . . . 0.0 114.06 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.7 tpt -62.13 -41.9 98.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.876 0.762 . . . . 0.0 111.246 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.6 mm -72.06 -36.91 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.26 -0.9 . . . . 0.0 112.259 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -58.23 -30.96 66.92 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.646 1.178 . . . . 0.0 112.496 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.06 -47.14 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.744 1.618 . . . . 0.0 112.141 170.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 44.9 mt -66.2 -35.49 80.59 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.144 -0.973 . . . . 0.0 113.08 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -62.4 -39.55 93.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.448 1.099 . . . . 0.0 112.011 168.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.73 -26.17 66.01 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.166 -0.959 . . . . 0.0 113.285 176.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.6 tp -86.79 -15.48 39.16 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.09 2.14 16.76 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 124.821 1.201 . . . . 0.0 115.146 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.51 135.35 54.18 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.876 1.671 . . . . 0.0 111.402 172.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -109.96 151.8 26.66 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.431 1.11 . . . . 0.0 113.286 171.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -130.2 168.9 16.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.897 2.079 . . . . 0.0 110.448 -172.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.1 m -90.33 133.73 34.78 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.868 -1.145 . . . . 0.0 111.192 -159.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.5 p -129.39 147.8 51.25 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -164.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.2 153.78 47.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.203 1.801 . . . . 0.0 111.677 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -89.96 113.96 25.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.122 0.969 . . . . 0.0 112.085 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.9 -16.78 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 121.227 -0.921 . . . . 0.0 113.265 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -73.19 -29.5 62.87 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.327 -0.858 . . . . 0.0 111.236 169.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.84 -33.78 21.23 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -130.2 102.35 17.29 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 118.744 0.702 . . . . 0.0 112.776 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -60.23 -21.66 67.38 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.221 2.614 . . . . 0.0 115.494 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 p -52.51 -31.14 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 120.05 1.296 . . . . 0.0 113.347 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.7 -47.65 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.349 -0.844 . . . . 0.0 110.592 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -67.79 -30.49 69.94 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.472 1.033 . . . . 0.0 112.831 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.5 m -58.58 -49.08 78.77 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.834 0.853 . . . . 0.0 111.993 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -74.1 -49.37 24.2 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 168.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.6 t -60.45 -41.65 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 121.083 -1.011 . . . . 0.0 113.286 -165.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -63.48 -34.87 78.72 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.233 0.54 . . . . 0.0 111.474 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.14 -50.6 11.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.271 1.829 . . . . 0.0 112.84 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.67 -30.38 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.124 0.969 . . . . 0.0 112.806 -175.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 84.4 p -90.05 -3.94 57.67 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 59.61 -34.56 0.06 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 129.839 3.256 . . . . 0.0 116.239 -171.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -145.65 110.69 4.52 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.604 1.561 . . . . 0.0 109.789 173.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -89.11 130.65 2.09 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 121.905 1.736 . . . . 0.0 114.16 -165.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 p -129.33 133.53 47.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.683 1.593 . . . . 0.0 109.97 166.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.3 pt -128.5 156.53 77.0 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 124.926 1.29 . . . . 0.0 113.678 -167.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -61.73 162.98 42.96 Favored 'Cis proline' 0 C--N 1.356 0.944 0 CA-C-N 119.967 1.024 . . . . 0.0 113.88 -5.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.426 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 18.9 tt0 -151.08 158.32 43.9 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.347 0.659 . . . . 0.0 111.729 -164.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.22 139.08 53.18 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.856 1.313 . . . . 0.0 113.724 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -120.46 140.89 50.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.787 -2.006 . . . . 0.0 109.43 169.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 53.7 mt -125.75 121.92 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 173.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.2 tptt 45.46 52.88 8.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.516 1.926 . . . . 0.0 114.073 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.72 27.46 16.72 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -121.55 136.48 54.95 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.344 1.457 . . . . 0.0 110.553 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -74.38 123.71 25.15 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.564 0.697 . . . . 0.0 111.114 174.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.6 t -103.93 -54.38 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 126.272 1.829 . . . . 0.0 111.565 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.93 166.7 23.24 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 116.967 1.547 . . . . 0.0 116.967 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.89 172.11 55.17 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.37 1.938 . . . . 0.0 113.609 170.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.2 tp -56.53 -35.82 68.53 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.472 1.109 . . . . 0.0 113.476 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.36 -33.48 75.62 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.994 0.816 . . . . 0.0 112.541 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.5 mm -77.66 -46.76 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.247 1.419 . . . . 0.0 110.475 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.69 -36.31 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.701 1.2 . . . . 0.0 110.777 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 94.6 m -59.25 -40.41 85.89 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.898 0.879 . . . . 0.0 112.108 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -65.08 -50.27 66.8 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.966 0.803 . . . . 0.0 110.157 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 47.6 mtt -61.49 -37.34 83.3 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.245 1.018 . . . . 0.0 112.333 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.36 -39.01 81.98 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.357 1.863 . . . . 0.0 112.369 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -76.95 -30.75 56.17 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 41.1 t -84.55 -26.45 28.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.024 1.33 . . . . 0.0 114.482 -172.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.31 -6.35 63.43 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-N 119.142 0.883 . . . . 0.0 114.554 -169.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.29 -32.49 72.67 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.77 1.785 . . . . 0.0 112.402 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.06 -46.15 88.83 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.203 -0.936 . . . . 0.0 110.147 174.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -62.02 -37.99 86.95 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.254 1.422 . . . . 0.0 113.199 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -67.41 -35.25 78.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.362 1.065 . . . . 0.0 112.596 175.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 60.5 mtm -70.07 -52.1 26.61 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.167 0.894 . . . . 0.0 113.143 169.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 pp -64.78 -35.88 82.51 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.251 -0.906 . . . . 0.0 112.368 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -71.8 -30.94 66.06 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.88 -36.8 82.33 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.58 0.627 . . . . 0.0 111.947 167.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.54 2.6 11.25 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.798 1.639 . . . . 0.0 113.964 175.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.54 12.57 81.61 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.121 1.343 . . . . 0.0 113.853 176.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.6 mt -93.91 149.63 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.027 1.331 . . . . 0.0 110.004 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.2 m -103.27 146.77 27.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.222 1.409 . . . . 0.0 110.947 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.7 p -141.75 167.67 21.6 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.81 1.644 . . . . 0.0 112.213 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 124.381 1.073 . . . . 0.0 112.372 168.532 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.6 pt -61.89 -35.55 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.17 0.588 . . . . 0.0 111.844 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -77.9 -32.96 52.1 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.505 1.922 . . . . 0.0 113.718 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.5 t -73.03 -15.99 61.51 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.845 1.258 . . . . 0.0 113.299 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -104.2 145.27 30.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.95 1.3 . . . . 0.0 113.969 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -83.46 -39.49 20.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.947 0.899 . . . . 0.0 111.366 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.57 137.87 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 126.731 2.012 . . . . 0.0 109.839 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.8 t -133.93 128.0 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.626 1.17 . . . . 0.0 110.566 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -136.66 156.95 47.86 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.943 1.297 . . . . 0.0 110.916 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.406 ' CE1' HG21 ' A' ' 136' ' ' VAL . 52.7 p90 -129.32 145.93 51.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.088 0.955 . . . . 0.0 111.282 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 mt -137.39 151.3 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.198 0.599 . . . . 0.0 111.406 -166.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.49 108.32 3.25 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 159.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.08 -136.36 15.59 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 118.582 0.628 . . . . 0.0 113.115 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.7 mt -123.16 158.4 58.07 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.728 2.011 . . . . 0.0 111.447 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.53 -23.47 37.12 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 121.976 1.784 . . . . 0.0 115.067 -173.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.7 -15.38 25.32 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.235 0.925 . . . . 0.0 113.221 169.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.95 68.68 70.93 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.213 1.405 . . . . 0.0 111.635 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.01 146.11 25.45 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.215 2.61 . . . . 0.0 111.414 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 96.4 mtp -97.69 4.79 49.93 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.488 1.515 . . . . 0.0 113.518 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.9 t -146.57 145.52 30.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.44 1.496 . . . . 0.0 111.078 -175.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.82 -44.12 97.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.215 0.606 . . . . 0.0 111.996 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -72.39 -24.7 61.29 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.935 -1.103 . . . . 0.0 112.567 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.0 m -68.42 -43.1 77.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.649 0.78 . . . . 0.0 111.6 167.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -61.4 -44.81 96.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.813 0.845 . . . . 0.0 111.861 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -57.8 -37.28 73.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.277 1.831 . . . . 0.0 113.036 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.9 ttp -63.58 -46.8 84.19 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.434 0.561 . . . . 0.0 111.624 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 mm -69.72 -33.01 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.346 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -57.98 -36.69 72.97 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.935 1.243 . . . . 0.0 113.026 170.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.13 -42.14 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.799 0.839 . . . . 0.0 111.1 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.35 -38.94 88.75 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.405 1.082 . . . . 0.0 112.678 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.05 -25.55 66.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.179 1.791 . . . . 0.0 112.723 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.27 73.45 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.06 -11.6 35.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.169 0.988 . . . . 0.0 113.327 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.73 20.3 70.13 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.477 1.037 . . . . 0.0 115.043 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.42 130.35 56.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.466 0.633 . . . . 0.0 109.462 156.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -115.78 131.31 56.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.472 0.709 . . . . 0.0 109.706 168.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -105.07 171.93 7.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.988 1.715 . . . . 0.0 113.021 -163.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.4 m -84.73 125.88 32.92 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.462 1.125 . . . . 0.0 108.861 -170.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.7 m -125.53 133.28 52.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.561 -154.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.04 141.98 46.24 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.097 0.951 . . . . 0.0 112.819 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -98.45 78.71 2.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.026 1.731 . . . . 0.0 112.164 -167.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.0 p -61.52 -28.3 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.263 1.425 . . . . 0.0 114.321 -172.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.0 tp -78.15 -22.69 48.39 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.664 -0.648 . . . . 0.0 111.533 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.87 -32.95 13.0 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 175.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -130.06 98.12 21.95 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.046 0.938 . . . . 0.0 112.055 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -62.19 -9.68 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.042 3.161 . . . . 0.0 116.247 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 p -48.78 -36.49 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.015 -1.053 . . . . 0.0 111.945 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.43 -47.9 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.232 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -67.57 -29.22 68.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.1 0.864 . . . . 0.0 112.243 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.2 m -70.5 -50.5 37.18 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -72.16 -39.43 68.74 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.956 0.798 . . . . 0.0 111.711 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.406 HG21 ' CE1' ' A' ' 94' ' ' PHE . 9.0 p -61.29 -35.36 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.109 0.868 . . . . 0.0 113.061 -175.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.84 -46.34 78.91 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.979 0.809 . . . . 0.0 111.568 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -64.79 -34.58 78.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.156 0.982 . . . . 0.0 113.067 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.3 t -80.3 -41.56 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.1 t -97.47 -14.27 21.25 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -168.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 67.34 -40.66 0.4 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.874 2.07 . . . . 0.0 115.079 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -130.0 104.85 16.73 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.118 1.767 . . . . 0.0 110.529 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -88.14 128.43 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.563 2.176 . . . . 0.0 112.464 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 75.1 p -131.53 146.97 52.48 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.144 2.178 . . . . 0.0 108.58 169.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.1 tt -108.46 134.93 20.07 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 119.241 0.928 . . . . 0.0 111.9 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -79.99 162.75 83.91 Favored 'Cis proline' 0 CA--C 1.551 1.35 0 CA-C-N 119.835 0.977 . . . . 0.0 111.799 -16.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -134.18 161.58 34.51 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.893 1.677 . . . . 0.0 111.288 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.59 141.82 50.87 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -130.92 141.05 50.26 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.532 1.933 . . . . 0.0 110.073 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 60.3 mt -140.54 134.05 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.731 1.213 . . . . 0.0 109.556 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt 52.96 41.75 32.11 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.687 1.595 . . . . 0.0 114.162 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.04 14.2 5.19 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.95 2.1 . . . . 0.0 115.568 -172.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -111.42 140.89 45.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.625 1.57 . . . . 0.0 110.618 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -77.84 126.25 30.57 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.257 -0.902 . . . . 0.0 112.898 175.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.3 t -101.03 -48.05 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.555 1.542 . . . . 0.0 111.835 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 162.91 170.55 27.94 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.7 169.14 54.62 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.268 1.413 . . . . 0.0 113.685 166.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -46.69 -46.89 20.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.861 1.665 . . . . 0.0 114.746 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.56 -39.06 75.84 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.543 -0.723 . . . . 0.0 111.531 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.9 mm -72.62 -47.45 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.57 1.948 . . . . 0.0 111.56 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.35 -35.76 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.903 0.881 . . . . 0.0 110.503 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.1 m -62.06 -39.31 91.96 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.744 0.818 . . . . 0.0 112.153 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -64.29 -46.69 82.53 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.184 0.902 . . . . 0.0 110.633 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 47.5 mtt -61.65 -38.76 88.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.137 0.975 . . . . 0.0 111.812 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.61 -44.16 87.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.565 1.146 . . . . 0.0 111.781 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.25 -34.38 65.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 t -105.54 3.23 29.13 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -171.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.26 -0.41 75.12 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 116.259 1.263 . . . . 0.0 116.259 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -71.65 -31.85 67.28 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.561 1.181 . . . . 0.0 113.245 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.75 -43.77 83.24 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.483 -1.385 . . . . 0.0 109.951 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -58.22 -44.59 88.24 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.128 1.771 . . . . 0.0 112.307 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -57.28 -46.16 83.37 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.248 1.019 . . . . 0.0 110.932 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 65.1 mtm -69.59 -49.87 49.93 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.9 -37.73 86.87 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.613 -0.679 . . . . 0.0 112.638 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -71.66 -30.8 66.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.188 0.995 . . . . 0.0 111.99 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.77 -31.05 72.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.432 0.693 . . . . 0.0 112.199 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -76.05 -0.18 20.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.96 1.304 . . . . 0.0 113.51 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.4 24.87 60.12 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 124.153 0.882 . . . . 0.0 113.435 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 46.2 mt -105.42 140.4 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.012 0.906 . . . . 0.0 110.893 -174.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.0 m -94.2 125.33 38.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.859 1.264 . . . . 0.0 112.037 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.1 p -118.35 173.26 6.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.096 2.559 . . . . 0.0 111.691 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 . . . . . 0 N--CA 1.472 0.672 0 C-N-CA 123.359 0.664 . . . . 0.0 111.691 164.59 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.6 pt -62.04 -34.31 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.78 0.832 . . . . 0.0 112.054 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -78.5 -35.17 46.8 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.468 1.507 . . . . 0.0 113.534 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.5 t -72.63 -37.85 67.91 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.339 1.056 . . . . 0.0 113.015 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -87.13 133.51 33.62 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.157 0.889 . . . . 0.0 111.956 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.38 -38.31 77.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.731 -0.606 . . . . 0.0 111.717 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.5 t -143.92 131.66 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.216 1.806 . . . . 0.0 110.296 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -135.02 133.19 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.507 1.123 . . . . 0.0 112.118 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.0 t -131.41 155.13 47.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.954 1.302 . . . . 0.0 110.97 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -131.2 140.48 49.9 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.168 0.987 . . . . 0.0 111.79 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mt -140.54 155.65 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.031 1.332 . . . . 0.0 110.901 -158.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.1 102.22 1.6 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.124 0.569 . . . . 0.0 109.467 155.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.97 -143.97 23.55 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.302 -0.874 . . . . 0.0 114.7 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.1 mt -107.3 155.69 38.99 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 125.438 1.495 . . . . 0.0 111.929 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -63.9 -32.2 66.37 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.413 1.408 . . . . 0.0 112.356 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -75.2 -26.78 59.26 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.242 1.017 . . . . 0.0 113.124 172.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.81 76.51 15.48 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.31 1.444 . . . . 0.0 112.354 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.84 144.85 24.82 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.124 2.549 . . . . 0.0 111.772 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.84 10.87 28.54 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.134 1.773 . . . . 0.0 113.815 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.4 t -147.5 146.09 29.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.222 1.409 . . . . 0.0 110.233 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.52 -45.89 87.89 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.482 0.658 . . . . 0.0 111.846 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -70.73 -26.45 63.39 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.103 -0.998 . . . . 0.0 112.138 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -68.49 -38.3 80.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.255 -0.903 . . . . 0.0 112.681 166.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -65.49 -39.28 91.71 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.339 0.972 . . . . 0.0 112.285 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -59.58 -33.1 71.02 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.965 1.306 . . . . 0.0 112.873 174.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.7 tpt -61.51 -42.94 99.56 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.505 0.722 . . . . 0.0 111.74 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.12 -33.91 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.555 0.742 . . . . 0.0 111.654 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -39.79 74.58 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.741 1.216 . . . . 0.0 111.713 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.93 -43.41 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.475 1.51 . . . . 0.0 111.868 172.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.96 -37.96 89.33 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.696 -0.628 . . . . 0.0 112.102 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -69.36 -31.93 70.67 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.407 -0.808 . . . . 0.0 112.762 173.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.88 76.65 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.457 -0.777 . . . . 0.0 112.334 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.6 mt -87.01 -12.61 46.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.199 1.0 . . . . 0.0 113.298 171.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.5 15.01 63.24 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.884 1.707 . . . . 0.0 114.309 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.38 132.45 55.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.405 1.103 . . . . 0.0 113.449 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -110.82 157.36 19.9 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.249 1.02 . . . . 0.0 113.04 169.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -145.65 170.76 15.83 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.667 2.787 . . . . 0.0 110.531 -163.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.6 m -85.28 124.22 31.65 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.623 -1.298 . . . . 0.0 109.787 -168.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.9 m -130.43 132.09 45.55 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.041 1.336 . . . . 0.0 111.393 -156.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.5 143.18 48.69 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -87.65 121.1 29.66 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.693 1.197 . . . . 0.0 109.965 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.0 m -67.22 -21.2 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.049 0.94 . . . . 0.0 113.137 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.9 mt -88.34 -25.08 22.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.095 1.358 . . . . 0.0 114.446 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.11 -33.3 22.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -164.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -148.21 149.78 33.1 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.881 1.272 . . . . 0.0 110.087 -172.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.86 -6.9 19.85 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.862 2.375 . . . . 0.0 114.543 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.68 -40.37 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.704 -1.248 . . . . 0.0 113.318 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.35 -47.2 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.275 -0.891 . . . . 0.0 110.939 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -59.31 -30.19 68.16 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.27 0.941 . . . . 0.0 113.354 171.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.0 m -69.98 -44.75 68.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -77.66 -40.36 41.91 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.22 -43.87 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -159.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -69.46 -35.49 75.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.733 0.778 . . . . 0.0 110.32 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -67.39 -43.92 80.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.242 1.817 . . . . 0.0 113.343 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.54 -36.23 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.991 0.917 . . . . 0.0 113.297 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.6 p -102.37 1.13 35.09 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 -173.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 62.45 -30.84 0.08 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.589 2.355 . . . . 0.0 115.965 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -151.93 138.29 11.75 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.183 1.393 . . . . 0.0 111.349 167.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.75 128.38 19.83 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.206 1.937 . . . . 0.0 112.759 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.6 m -139.94 140.87 36.46 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.322 -1.486 . . . . 0.0 110.419 157.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.8 mt -122.83 135.62 25.96 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.443 1.097 . . . . 0.0 110.929 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -82.33 165.61 71.76 Favored 'Cis proline' 0 CA--C 1.543 0.973 0 CA-C-N 119.934 1.012 . . . . 0.0 111.837 -10.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -143.19 159.73 41.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.028 1.331 . . . . 0.0 111.96 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.1 140.15 51.69 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.515 1.126 . . . . 0.0 113.881 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -129.76 143.93 51.05 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.18 1.792 . . . . 0.0 110.514 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 55.2 mt -132.95 128.14 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.544 1.137 . . . . 0.0 108.341 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt 47.32 49.59 15.39 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.023 1.729 . . . . 0.0 115.544 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.87 19.11 9.39 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -122.59 147.1 46.81 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.502 1.921 . . . . 0.0 110.564 176.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -85.44 126.25 33.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.145 0.974 . . . . 0.0 112.88 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.1 t -100.26 -46.02 11.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 125.1 1.36 . . . . 0.0 110.602 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 158.73 179.0 33.26 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 117.261 1.665 . . . . 0.0 117.261 165.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.35 171.31 55.17 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.054 1.312 . . . . 0.0 113.751 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.6 tp -46.74 -46.31 20.27 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.793 1.237 . . . . 0.0 114.04 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -69.9 -17.87 63.36 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.8 mm -84.06 -45.64 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.967 1.307 . . . . 0.0 109.882 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.3 t -60.47 -44.19 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.752 1.621 . . . . 0.0 111.778 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.7 p -64.82 -37.96 89.37 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.679 0.672 . . . . 0.0 111.97 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -63.13 -44.1 96.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.319 1.048 . . . . 0.0 111.549 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.7 mtt -66.89 -35.97 81.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.6 1.16 . . . . 0.0 112.356 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.89 -45.96 66.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.9 1.28 . . . . 0.0 112.029 176.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -68.54 -19.94 64.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.983 1.313 . . . . 0.0 113.151 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.6 m -105.16 -8.07 18.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.511 1.524 . . . . 0.0 114.721 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.03 -1.11 76.29 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 119.587 1.085 . . . . 0.0 115.08 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -67.21 -34.07 76.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.597 1.198 . . . . 0.0 112.069 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.06 -39.49 86.19 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.798 1.285 . . . . 0.0 110.913 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -66.04 -31.33 72.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.81 2.044 . . . . 0.0 113.493 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.61 -48.82 80.18 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.63 1.104 . . . . 0.0 111.134 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -70.6 -41.21 72.62 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 pp -65.18 -37.34 87.05 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.649 0.659 . . . . 0.0 111.351 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -71.91 -34.76 69.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.52 -30.02 70.99 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 167.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -77.13 -2.68 35.56 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.44 6.82 64.01 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.751 1.643 . . . . 0.0 114.85 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.05 147.05 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.183 1.393 . . . . 0.0 111.327 -170.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 36.4 m -105.24 126.1 51.72 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.118 0.967 . . . . 0.0 110.627 170.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 17.0 p -112.08 167.97 9.97 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.8 1.64 . . . . 0.0 111.822 172.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.767 0 C-N-CA 123.99 0.916 . . . . 0.0 111.238 171.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.0 m . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 119.526 -0.273 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.5 pt -59.98 -33.47 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 122.973 0.509 . . . . 0.0 111.826 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -78.2 -34.8 49.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.3 1.84 . . . . 0.0 113.542 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -68.78 -38.24 79.87 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.596 1.158 . . . . 0.0 111.719 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -86.03 133.27 33.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.494 0.718 . . . . 0.0 111.323 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.52 -26.3 45.78 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.987 -1.07 . . . . 0.0 112.507 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.5 t -142.37 131.24 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.482 1.113 . . . . 0.0 110.974 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.6 t -133.13 135.59 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.277 1.431 . . . . 0.0 111.468 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.0 t -135.45 155.2 50.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.978 1.311 . . . . 0.0 111.496 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -127.53 140.41 52.15 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.962 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.41 159.7 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.872 1.669 . . . . 0.0 110.273 -163.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -75.28 105.17 6.16 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.466 0.706 . . . . 0.0 109.299 157.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.27 -158.61 32.96 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 119.056 0.844 . . . . 0.0 113.949 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -94.35 158.73 35.29 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.428 1.491 . . . . 0.0 111.205 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.0 -31.86 76.47 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 121.897 1.731 . . . . 0.0 112.663 168.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.0 -14.53 53.84 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.027 1.331 . . . . 0.0 113.925 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.42 72.45 11.84 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.23 1.412 . . . . 0.0 112.5 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.27 141.97 18.67 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.243 1.962 . . . . 0.0 112.064 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.1 mmt -90.53 1.68 56.48 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.127 2.171 . . . . 0.0 113.645 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.4 t -152.06 146.22 25.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.096 1.358 . . . . 0.0 111.777 -171.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.4 -39.76 81.56 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.24 -0.912 . . . . 0.0 112.553 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -64.08 -29.91 71.02 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.969 -1.082 . . . . 0.0 111.746 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 m -68.27 -46.35 70.65 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.348 0.659 . . . . 0.0 112.268 169.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -58.53 -42.35 87.6 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 118.926 0.784 . . . . 0.0 112.512 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -57.35 -31.09 65.39 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.034 0.934 . . . . 0.0 113.278 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 49.9 ttm -70.38 -42.93 71.1 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.996 0.816 . . . . 0.0 112.34 171.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 mm -69.17 -30.91 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.92 -1.112 . . . . 0.0 111.359 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.43 -33.63 75.18 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.6 1.16 . . . . 0.0 112.649 167.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.415 HG13 ' HG ' ' A' ' 165' ' ' LEU . 1.4 t -73.36 -40.7 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.734 0.814 . . . . 0.0 111.468 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.8 mt -63.36 -34.86 78.63 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.897 0.879 . . . . 0.0 111.915 170.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -67.83 -34.84 77.51 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.723 -1.236 . . . . 0.0 113.014 170.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.79 79.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.991 0.814 . . . . 0.0 111.835 176.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -82.76 -14.49 54.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.01 7.68 44.95 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.463 1.03 . . . . 0.0 114.698 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.18 132.4 54.92 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.574 1.55 . . . . 0.0 111.02 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -115.91 149.85 38.05 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.292 0.951 . . . . 0.0 112.511 168.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -123.7 172.66 8.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.067 1.747 . . . . 0.0 112.676 -167.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.2 m -85.38 121.64 28.38 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.314 -0.866 . . . . 0.0 110.043 -161.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.2 m -124.76 132.14 53.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.996 -153.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -125.67 142.79 51.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.28 1.032 . . . . 0.0 112.674 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -96.04 118.54 32.84 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.788 1.235 . . . . 0.0 111.973 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.31 -22.73 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.323 1.049 . . . . 0.0 113.485 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.3 mt -87.93 -22.25 24.45 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.27 -35.09 11.37 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -124.25 108.71 29.51 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.077 0.853 . . . . 0.0 111.434 -174.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -54.19 -20.15 18.51 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.427 3.418 . . . . 0.0 116.46 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.4 p -54.32 -32.57 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.909 -1.119 . . . . 0.0 113.233 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.4 t -70.09 -53.79 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.515 -0.741 . . . . 0.0 111.7 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HA ' HG12 ' A' ' 136' ' ' VAL . 6.9 ptm180 -64.59 -25.73 68.1 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.743 0.817 . . . . 0.0 112.21 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.4 m -70.37 -50.76 35.54 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.02 0.928 . . . . 0.0 113.103 169.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -70.38 -37.44 74.53 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.74 1.154 . . . . 0.0 112.003 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 133' ' ' ARG . 7.4 p -65.89 -35.2 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 120.761 -1.212 . . . . 0.0 112.563 175.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -62.32 -38.38 89.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.241 1.016 . . . . 0.0 111.285 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -49.08 26.36 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 175.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 56.5 t -83.95 -42.93 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -169.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.8 m -100.27 -2.41 33.82 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 63.26 -32.52 0.11 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 128.765 2.826 . . . . 0.0 115.495 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -144.89 136.0 12.46 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.058 2.143 . . . . 0.0 109.961 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.3 126.78 3.76 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.852 1.701 . . . . 0.0 112.478 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.3 m -130.21 121.05 25.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.969 1.708 . . . . 0.0 107.249 166.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.4 140.4 25.8 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.849 0.86 . . . . 0.0 109.361 -172.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.53 158.21 97.35 Favored 'Cis proline' 0 CA--C 1.541 0.856 0 CA-C-N 119.383 0.815 . . . . 0.0 113.496 -10.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -128.82 152.94 47.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.774 1.63 . . . . 0.0 110.616 173.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.61 139.99 51.99 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.367 1.467 . . . . 0.0 113.108 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -131.85 142.89 49.83 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.711 2.005 . . . . 0.0 109.826 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 53.2 mt -123.91 122.57 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.3 tptt 44.09 54.36 6.0 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.852 2.061 . . . . 0.0 113.783 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.93 24.39 13.49 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -126.62 143.71 51.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.678 1.191 . . . . 0.0 110.151 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -82.81 125.62 31.51 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.586 1.184 . . . . 0.0 113.26 -169.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.17 -47.36 11.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 125.105 1.362 . . . . 0.0 110.962 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.14 176.92 28.82 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 116.62 1.408 . . . . 0.0 116.62 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.45 172.59 55.13 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.472 1.034 . . . . 0.0 113.97 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -44.85 -47.02 11.07 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.107 1.763 . . . . 0.0 113.695 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.83 -29.76 70.97 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 119.053 -0.498 . . . . 0.0 112.328 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.9 mm -82.32 -47.73 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.31 1.444 . . . . 0.0 111.177 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.6 t -62.1 -36.12 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.093 1.357 . . . . 0.0 111.089 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.1 m -59.79 -42.12 92.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.497 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -66.49 -43.91 84.07 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.801 1.182 . . . . 0.0 111.132 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 50.5 mtt -61.09 -36.73 80.44 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.142 0.577 . . . . 0.0 111.923 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.415 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.2 tm? -71.48 -47.0 58.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.159 0.984 . . . . 0.0 112.714 170.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.52 -21.49 64.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.001 0.921 . . . . 0.0 113.434 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 64.4 m -105.27 -21.5 13.23 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.975 1.71 . . . . 0.0 114.02 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.15 9.2 62.33 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.664 -1.273 . . . . 0.0 115.668 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.33 -32.14 73.63 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.627 1.713 . . . . 0.0 111.694 173.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.31 -45.18 95.51 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.83 173.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.54 -41.86 98.44 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.189 0.995 . . . . 0.0 111.815 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -56.02 -45.02 79.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.824 0.85 . . . . 0.0 110.504 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.54 -51.44 28.66 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.35 -36.62 84.72 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.316 0.507 . . . . 0.0 111.717 -175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -68.34 -38.02 81.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.898 1.279 . . . . 0.0 111.878 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.47 -29.23 69.31 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.986 0.812 . . . . 0.0 111.749 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -79.7 6.27 11.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.067 1.747 . . . . 0.0 114.306 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.8 10.91 75.01 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.194 1.378 . . . . 0.0 114.421 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.1 mt -99.13 147.42 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.887 1.275 . . . . 0.0 109.572 -171.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 5.7 m -112.93 120.22 40.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.255 1.022 . . . . 0.0 111.305 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.2 p -112.41 167.37 10.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.852 1.261 . . . . 0.0 111.779 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 . . . . . 0 N--CA 1.474 0.736 0 C-N-CA 124.102 0.961 . . . . 0.0 110.035 166.09 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.1 pt -62.97 -36.85 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.768 0.827 . . . . 0.0 112.174 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -76.54 -32.46 58.24 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.226 1.41 . . . . 0.0 111.592 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.6 t -92.39 -28.34 16.95 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -170.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -86.25 147.68 25.98 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.256 -0.903 . . . . 0.0 111.427 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -72.4 -47.62 47.8 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.007 -1.058 . . . . 0.0 113.531 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.5 t -144.1 130.08 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.625 1.57 . . . . 0.0 110.196 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.76 134.89 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.588 1.155 . . . . 0.0 112.075 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -130.75 155.11 47.21 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.525 1.53 . . . . 0.0 111.29 172.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.46 143.06 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.708 0.803 . . . . 0.0 111.243 170.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mt -130.9 157.36 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.392 1.477 . . . . 0.0 109.655 -165.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -72.12 97.93 2.02 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 152.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.12 -148.38 19.15 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.518 -0.739 . . . . 0.0 114.906 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.98 157.38 63.74 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 125.999 1.72 . . . . 0.0 110.812 -174.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.1 -33.28 50.86 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 121.434 1.422 . . . . 0.0 114.637 -169.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -94.37 -0.38 54.93 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.25 68.1 15.3 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 126.258 1.823 . . . . 0.0 112.018 174.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.05 143.76 11.62 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.274 2.65 . . . . 0.0 112.261 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.3 mmt -91.15 1.42 57.1 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.977 1.311 . . . . 0.0 113.674 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.21 146.15 28.56 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.163 -0.96 . . . . 0.0 111.709 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.85 96.28 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.112 0.965 . . . . 0.0 113.154 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -63.47 -36.86 85.16 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.505 -1.372 . . . . 0.0 112.019 171.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.7 m -64.87 -36.32 83.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.564 -0.732 . . . . 0.0 112.488 173.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -62.83 -46.2 89.02 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 120.153 1.342 . . . . 0.0 111.784 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -64.72 -29.81 70.81 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.677 1.191 . . . . 0.0 113.831 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.3 tpt -57.49 -46.69 83.44 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.345 1.058 . . . . 0.0 112.356 167.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 mm -70.84 -34.42 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.396 -0.815 . . . . 0.0 111.309 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.17 -34.95 68.97 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.571 -0.705 . . . . 0.0 111.835 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.9 -41.89 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.618 1.167 . . . . 0.0 111.684 174.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 69.2 mt -65.28 -36.59 84.56 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.697 0.799 . . . . 0.0 112.882 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.94 -29.64 65.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.989 -1.069 . . . . 0.0 112.739 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.22 77.38 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.254 -0.904 . . . . 0.0 112.042 175.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.76 -11.58 33.47 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.41 1.084 . . . . 0.0 113.474 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.76 9.28 82.86 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.356 1.931 . . . . 0.0 115.989 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.18 136.8 52.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.602 1.201 . . . . 0.0 113.045 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -114.27 159.21 20.44 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 171.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -142.18 174.01 11.0 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.294 2.238 . . . . 0.0 110.943 -162.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.0 m -86.11 130.57 34.49 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.906 -1.121 . . . . 0.0 110.157 -165.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.8 p -120.6 147.47 45.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.855 1.262 . . . . 0.0 113.881 -164.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -133.42 143.51 48.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.806 1.242 . . . . 0.0 112.27 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -94.25 119.93 33.76 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.87 1.268 . . . . 0.0 110.429 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.74 -22.51 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.607 1.163 . . . . 0.0 113.434 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -81.39 -23.36 37.68 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.461 -0.775 . . . . 0.0 112.774 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.04 -33.21 19.62 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -144.29 126.91 8.48 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.428 1.091 . . . . 0.0 111.179 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.05 -18.23 45.93 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.93 2.42 . . . . 0.0 114.483 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -46.77 -35.61 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.415 1.086 . . . . 0.0 113.298 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.31 -45.86 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.201 -0.937 . . . . 0.0 111.603 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.402 ' HA ' HG12 ' A' ' 136' ' ' VAL . 23.2 ptt180 -75.25 -23.34 57.48 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.841 0.746 . . . . 0.0 112.995 177.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.2 m -70.54 -53.83 14.54 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.396 0.544 . . . . 0.0 111.844 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -72.78 -35.42 67.41 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.24 -0.913 . . . . 0.0 112.427 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 133' ' ' ARG . 11.6 p -59.15 -44.96 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.772 1.169 . . . . 0.0 112.043 174.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -71.81 -43.74 65.1 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.085 0.857 . . . . 0.0 112.396 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.25 -33.96 77.02 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.292 -0.88 . . . . 0.0 112.882 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.9 t -82.1 -46.95 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.371 0.987 . . . . 0.0 113.363 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -106.56 7.96 31.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -171.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 63.61 -26.31 0.07 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.88 2.472 . . . . 0.0 116.184 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -148.83 148.51 27.82 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.811 2.044 . . . . 0.0 112.779 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.02 150.83 16.06 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.646 2.897 . . . . 0.0 113.466 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.9 p -134.3 132.81 40.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.338 1.855 . . . . 0.0 108.706 156.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.7 mm -127.83 117.89 20.95 Favored Pre-proline 0 N--CA 1.478 0.96 0 CA-C-N 119.717 1.144 . . . . 0.0 111.754 -171.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -81.99 172.7 50.85 Favored 'Cis proline' 0 CA--C 1.543 0.943 0 CA-C-N 120.06 1.057 . . . . 0.0 112.842 -5.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -153.24 174.38 14.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.5 1.52 . . . . 0.0 112.605 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.0 140.93 47.03 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -174.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -120.48 144.17 48.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.682 1.993 . . . . 0.0 110.412 168.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.1 mt -131.53 121.49 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.522 1.129 . . . . 0.0 109.103 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 45.98 52.03 10.31 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.698 1.599 . . . . 0.0 114.211 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.258 . . 56.25 26.99 11.09 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -115.69 137.99 51.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.426 1.09 . . . . 0.0 110.111 165.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -75.91 125.53 29.27 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.218 1.009 . . . . 0.0 111.774 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -101.16 -46.42 11.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.195 1.398 . . . . 0.0 111.011 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.55 171.32 25.24 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 116.4 1.32 . . . . 0.0 116.4 169.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.02 170.29 54.74 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.014 0.816 . . . . 0.0 112.904 167.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -47.22 -37.92 11.25 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.658 1.183 . . . . 0.0 113.854 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -57.19 -43.78 82.99 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.76 0.709 . . . . 0.0 111.911 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.3 mm -76.42 -46.79 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.426 1.49 . . . . 0.0 109.931 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.18 -38.23 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.366 1.066 . . . . 0.0 110.829 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 60.7 m -64.01 -43.09 96.7 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.595 0.758 . . . . 0.0 111.655 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -67.16 -38.7 85.92 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.107 0.867 . . . . 0.0 112.125 176.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 34.7 mtt -65.65 -40.35 92.38 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.208 1.403 . . . . 0.0 112.153 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.22 -41.69 76.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.119 0.968 . . . . 0.0 111.605 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.94 -29.55 66.71 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 m -105.58 -0.8 25.42 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.09 -2.93 84.29 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.741 1.162 . . . . 0.0 115.721 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -67.38 -32.8 73.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.717 1.258 . . . . 0.0 112.07 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.81 -46.39 88.17 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.485 -0.759 . . . . 0.0 110.948 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -59.47 -42.12 91.31 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.588 1.155 . . . . 0.0 112.665 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -62.44 -39.07 92.16 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.137 0.575 . . . . 0.0 112.012 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 49.0 mtm -69.93 -53.43 17.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.609 0.763 . . . . 0.0 112.823 174.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 pp -65.64 -37.79 87.55 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.288 0.494 . . . . 0.0 111.932 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -66.8 -39.45 87.75 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.692 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -65.25 -30.54 71.43 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.744 0.702 . . . . 0.0 112.319 174.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -2.83 28.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.723 2.009 . . . . 0.0 114.183 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.23 57.4 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.418 1.009 . . . . 0.0 114.311 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.2 mt -104.17 145.57 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 118.369 1.084 . . . . 0.0 110.895 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 38.3 m -89.91 148.53 23.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.196 1.398 . . . . 0.0 111.612 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.4 p -145.86 169.27 18.9 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 120.653 -1.279 . . . . 0.0 112.903 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 124.151 0.981 . . . . 0.0 111.438 166.368 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.188 0.042 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 68.0 p -69.31 -39.26 78.36 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.5 m 54.52 27.15 8.0 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.179 1.791 . . . . 0.0 115.126 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.92 10.77 65.36 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.696 1.141 . . . . 0.0 114.969 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.6 pt -136.18 172.72 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.485 1.914 . . . . 0.0 111.642 -170.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.94 -177.91 39.02 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 122.466 1.037 . . . . 0.0 114.613 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.49 -112.78 1.24 Allowed Glycine 0 N--CA 1.464 0.504 0 C-N-CA 125.772 1.653 . . . . 0.0 109.723 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.02 106.93 0.56 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 153.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.8 t -81.65 130.45 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.641 0.776 . . . . 0.0 108.92 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -56.14 99.52 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.11 1.364 . . . . 0.0 111.483 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -77.91 118.54 20.32 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.869 0.867 . . . . 0.0 110.969 -165.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 pt -111.97 155.76 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.33 1.052 . . . . 0.0 110.998 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -142.08 139.18 32.18 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.065 0.946 . . . . 0.0 110.298 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -83.33 116.64 22.54 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.7 m -143.87 144.27 31.67 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.039 1.736 . . . . 0.0 108.579 167.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -68.79 142.66 93.95 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-O 119.044 -0.503 . . . . 0.0 112.221 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.72 145.28 50.11 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.523 2.815 . . . . 0.0 115.319 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -107.33 -7.59 16.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.654 1.582 . . . . 0.0 112.701 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -146.21 159.49 43.25 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.954 1.702 . . . . 0.0 112.205 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -67.5 151.76 96.86 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.685 1.594 . . . . 0.0 113.257 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -75.99 150.19 33.72 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.379 2.719 . . . . 0.0 110.253 158.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -95.66 126.72 41.13 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.766 1.226 . . . . 0.0 111.763 -167.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.0 tp 53.31 -3.94 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 128.433 2.693 . . . . 0.0 117.412 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.6 t -141.17 116.6 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.825 2.05 . . . . 0.0 108.321 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 88.0 p -80.75 156.36 26.26 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.393 0.677 . . . . 0.0 112.755 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.0 149.31 46.18 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.607 1.163 . . . . 0.0 110.992 173.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.85 -27.56 13.56 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.659 1.184 . . . . 0.0 112.698 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.84 140.91 38.13 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.161 1.784 . . . . 0.0 110.059 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -116.07 152.11 34.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.452 1.101 . . . . 0.0 111.788 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.96 -37.66 85.59 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -169.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.77 -38.24 64.76 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.879 0.871 . . . . 0.0 110.983 172.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -70.47 -38.14 74.38 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.521 1.528 . . . . 0.0 112.811 -172.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.5 tp -82.66 2.44 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.244 1.018 . . . . 0.0 112.977 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.35 -29.01 7.37 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.623 1.169 . . . . 0.0 113.653 169.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 53.1 ttp -136.93 124.23 21.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.303 2.241 . . . . 0.0 110.585 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 p -69.88 150.57 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 118.357 0.526 . . . . 0.0 111.371 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -59.31 134.76 57.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.16 1.384 . . . . 0.0 110.128 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -63.23 -29.87 71.12 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -169.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -62.29 -39.08 91.79 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.61 1.164 . . . . 0.0 112.594 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 50.5 mm -75.6 -36.44 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.909 0.884 . . . . 0.0 110.847 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.33 -39.86 92.1 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.452 1.101 . . . . 0.0 111.397 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.89 -33.3 65.95 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.505 -0.747 . . . . 0.0 111.841 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.9 m -65.89 -47.31 75.26 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.17 0.988 . . . . 0.0 111.553 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.1 pt -61.07 -33.25 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 O-C-N 120.976 -1.077 . . . . 0.0 112.515 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -77.75 -22.65 49.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.587 1.555 . . . . 0.0 114.648 172.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 t -85.66 -28.71 24.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.049 2.14 . . . . 0.0 112.78 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -87.35 145.5 26.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.377 1.071 . . . . 0.0 111.004 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -84.12 -28.9 27.16 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.32 -0.863 . . . . 0.0 111.39 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.9 t -143.83 134.85 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.087 0.955 . . . . 0.0 112.255 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.3 t -133.01 138.32 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.893 1.277 . . . . 0.0 111.08 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 t -134.14 154.1 51.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.651 0.78 . . . . 0.0 111.473 170.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.57 147.58 50.28 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.487 0.661 . . . . 0.0 111.969 172.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.3 mt -137.01 159.8 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.331 -157.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -68.17 96.46 0.64 Allowed 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.345 -0.847 . . . . 0.0 108.971 156.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.49 -150.51 22.62 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 121.942 0.745 . . . . 0.0 114.383 -172.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.03 154.05 55.47 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.588 1.955 . . . . 0.0 110.029 -172.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.63 -13.95 38.35 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.955 2.437 . . . . 0.0 114.59 -170.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -88.89 -19.92 25.23 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.716 1.206 . . . . 0.0 112.778 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.94 69.35 13.18 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.204 1.801 . . . . 0.0 111.021 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.39 148.97 74.72 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.66 2.24 . . . . 0.0 111.449 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.7 mmt -106.61 0.29 24.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.806 1.243 . . . . 0.0 113.781 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 52.7 t -141.84 147.0 36.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.499 1.52 . . . . 0.0 110.435 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.87 -47.01 86.4 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.831 0.852 . . . . 0.0 111.246 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -66.3 -33.35 75.53 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.998 -1.064 . . . . 0.0 111.548 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 m -62.26 -41.5 98.51 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.742 0.817 . . . . 0.0 113.111 170.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -62.82 -46.93 85.64 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.191 0.905 . . . . 0.0 111.466 171.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -56.97 -37.27 71.35 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.43 1.092 . . . . 0.0 111.993 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.5 tpp -59.34 -46.01 89.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.775 0.83 . . . . 0.0 112.923 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 mm -67.72 -33.13 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.981 1.264 . . . . 0.0 111.326 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.29 -32.83 73.26 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.911 0.884 . . . . 0.0 112.586 170.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.7 -37.25 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 125.628 1.571 . . . . 0.0 111.573 169.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 36.6 mt -63.77 -35.44 80.59 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.725 -1.234 . . . . 0.0 111.831 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -71.9 -31.23 66.2 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.816 -1.177 . . . . 0.0 111.998 170.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.26 -32.2 73.74 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.587 -1.321 . . . . 0.0 111.901 173.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.6 tp -86.07 -12.5 49.99 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.606 1.963 . . . . 0.0 112.716 171.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.82 4.23 13.49 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.854 1.693 . . . . 0.0 114.887 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 97.0 mt -111.83 129.92 55.98 Favored 'General case' 0 C--N 1.335 -0.037 0 C-N-CA 124.599 1.16 . . . . 0.0 109.732 173.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -110.93 148.35 32.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.113 0.958 . . . . 0.0 110.645 168.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -120.65 172.64 7.72 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.236 1.815 . . . . 0.0 110.507 -169.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 93.0 m -86.71 122.52 30.72 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -163.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.5 p -113.27 144.63 42.4 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -159.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -137.09 147.87 46.36 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.505 1.122 . . . . 0.0 112.318 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -91.02 123.45 34.49 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.24 1.416 . . . . 0.0 110.464 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.6 m -67.78 -20.98 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -88.09 -24.19 23.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.938 1.295 . . . . 0.0 113.371 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.47 -35.34 17.08 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -139.11 120.07 9.78 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.357 0.663 . . . . 0.0 110.987 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.85 -13.15 36.25 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.853 2.369 . . . . 0.0 115.005 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -54.29 -36.0 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.603 0.761 . . . . 0.0 112.338 169.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.23 -51.45 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.887 0.875 . . . . 0.0 111.171 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.0 ptt-85 -69.32 -26.04 64.52 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.1 m -70.84 -49.31 47.54 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.069 0.948 . . . . 0.0 113.018 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.489 ' CE1' HG21 ' A' ' 139' ' ' VAL . 83.8 t80 -62.47 -48.55 79.12 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.736 -0.603 . . . . 0.0 111.377 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.1 p -61.0 -39.27 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 121.97 -0.456 . . . . 0.0 112.147 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -63.66 -44.77 92.82 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.226 1.41 . . . . 0.0 111.923 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -72.38 -36.51 68.74 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.489 HG21 ' CE1' ' A' ' 135' ' ' TYR 0.276 3.0 t -87.27 -31.95 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.1 p -99.02 -5.66 29.99 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 64.48 -59.27 0.22 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.825 2.45 . . . . 0.0 114.635 -167.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 30.9 m95 -121.44 106.38 37.92 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.193 1.397 . . . . 0.0 109.908 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.32 136.1 3.31 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.305 2.67 . . . . 0.0 113.693 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.5 m -134.21 112.91 11.47 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.168 1.787 . . . . 0.0 109.235 171.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.6 pt -100.59 149.27 35.99 Favored Pre-proline 0 N--CA 1.48 1.044 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.68 152.49 96.46 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 119.696 0.927 . . . . 0.0 112.785 2.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -141.41 146.57 36.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.335 0.654 . . . . 0.0 111.156 -166.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.11 140.52 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.876 1.27 . . . . 0.0 113.188 -164.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -133.24 140.68 47.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.987 2.115 . . . . 0.0 109.783 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.4 mt -130.31 132.42 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.155 0.982 . . . . 0.0 108.362 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . 0.292 26.8 mtpp 46.15 51.41 11.16 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.699 2.0 . . . . 0.0 114.47 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 56.98 24.12 9.11 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.492 2.317 . . . . 0.0 115.636 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -128.91 143.75 50.98 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.879 1.672 . . . . 0.0 110.861 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -79.26 124.29 28.24 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.0 t -101.96 -53.37 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.236 1.815 . . . . 0.0 112.51 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 165.68 169.96 29.98 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 117.973 1.949 . . . . 0.0 117.973 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.65 170.97 55.02 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.607 1.099 . . . . 0.0 112.397 162.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.2 tp -48.48 -41.68 30.52 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.491 1.116 . . . . 0.0 113.71 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.4 -31.71 69.51 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.996 0.816 . . . . 0.0 112.304 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.8 mm -87.72 -47.3 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.695 1.598 . . . . 0.0 110.086 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 72.9 t -54.43 -38.04 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.188 1.395 . . . . 0.0 110.535 173.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 85.9 m -58.96 -46.56 87.78 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.63 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -62.88 -43.71 98.06 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 120.207 1.367 . . . . 0.0 110.656 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 59.5 mtt -65.24 -42.34 93.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.787 0.835 . . . . 0.0 112.039 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -44.24 71.52 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.213 1.805 . . . . 0.0 111.594 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -68.74 -15.53 63.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.729 1.611 . . . . 0.0 113.533 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.1 m -106.16 -6.32 18.65 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.36 3.9 54.9 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 120.216 1.371 . . . . 0.0 114.247 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -69.32 -34.2 74.29 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.348 -1.089 . . . . 0.0 111.702 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.37 -45.68 92.67 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.146 0.978 . . . . 0.0 110.138 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -31.09 69.07 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.096 1.758 . . . . 0.0 114.539 176.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -59.62 -46.94 87.47 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.791 1.178 . . . . 0.0 111.712 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -68.87 -43.41 75.42 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.66 -35.73 80.87 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.662 -0.648 . . . . 0.0 112.193 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -68.62 -35.18 76.97 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.234 -0.916 . . . . 0.0 112.338 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.5 -26.94 68.65 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.78 0.718 . . . . 0.0 112.225 171.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -82.77 4.34 25.63 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.853 1.661 . . . . 0.0 113.586 170.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.41 16.44 71.31 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-O 118.575 -1.125 . . . . 0.0 114.073 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.7 mt -101.86 145.15 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 118.808 1.304 . . . . 0.0 111.068 -171.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 97.4 m -103.28 123.21 46.35 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.916 1.286 . . . . 0.0 110.941 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.7 p -108.92 166.83 10.53 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.015 1.726 . . . . 0.0 112.572 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -65.31 133.77 52.13 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 153.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -126.46 141.92 51.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.928 0.891 . . . . 0.0 111.545 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.69 1.996 . . . . 0.0 110.157 -178.692 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 p . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.9 p -94.36 -3.4 50.4 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.948 1.699 . . . . 0.0 115.568 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 83.7 p -61.13 159.54 11.72 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.999 -1.063 . . . . 0.0 112.377 167.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.64 -9.95 3.21 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-O 118.671 -1.072 . . . . 0.0 115.482 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.77 121.34 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.289 1.544 . . . . 0.0 109.315 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.05 155.2 50.48 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -173.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.46 23.61 3.72 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.968 2.223 . . . . 0.0 113.346 -169.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -66.59 134.2 51.86 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.558 1.143 . . . . 0.0 113.694 -169.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.6 m -119.45 147.68 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.888 1.675 . . . . 0.0 110.256 168.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -135.39 164.21 28.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.926 1.29 . . . . 0.0 113.467 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -131.28 110.49 11.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.661 1.584 . . . . 0.0 110.851 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.5 pt -140.83 27.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 126.029 1.732 . . . . 0.0 112.491 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -83.82 139.71 32.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.391 1.876 . . . . 0.0 110.978 -171.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 pm0 -74.45 155.82 37.61 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.279 -0.888 . . . . 0.0 113.272 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.4 p -130.98 -16.73 3.19 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -172.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -75.05 138.01 72.59 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-N 120.637 1.562 . . . . 0.0 112.663 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.63 -179.68 4.75 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.603 3.535 . . . . 0.0 113.455 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -83.54 -14.44 52.23 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.773 -1.205 . . . . 0.0 113.164 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -85.01 136.72 33.47 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.436 1.495 . . . . 0.0 111.372 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -104.17 147.16 33.89 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -159.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.16 155.25 42.17 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.772 2.981 . . . . 0.0 111.844 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -73.16 125.74 28.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.932 1.293 . . . . 0.0 110.66 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 mt -147.64 156.63 42.98 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.237 1.415 . . . . 0.0 111.884 174.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 83.5 t -68.47 -57.38 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.993 0.917 . . . . 0.0 110.705 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.8 m -141.59 129.56 21.93 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.164 0.986 . . . . 0.0 110.954 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.05 162.28 35.61 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.402 1.081 . . . . 0.0 112.158 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -156.66 -19.79 0.1 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.1 tp -141.78 139.31 32.75 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.944 1.247 . . . . 0.0 113.642 -167.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.23 129.4 16.61 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.495 1.518 . . . . 0.0 112.087 -175.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -67.23 -25.53 66.14 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.988 1.715 . . . . 0.0 113.643 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -74.0 -45.31 50.67 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.0 -1.063 . . . . 0.0 111.924 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -68.24 -26.0 65.47 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 120.718 -1.238 . . . . 0.0 113.27 -177.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.8 pt -84.93 -3.86 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 170.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.61 -22.84 12.36 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.233 1.413 . . . . 0.0 113.561 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.9 mtt -49.96 122.49 6.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.975 1.31 . . . . 0.0 110.671 168.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.9 131.08 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.478 1.111 . . . . 0.0 113.141 -175.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -111.32 128.74 56.05 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.631 1.972 . . . . 0.0 109.04 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -60.27 -29.12 68.6 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.7 0.8 . . . . 0.0 113.074 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -58.79 -27.84 65.4 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.0 mm -78.14 -43.61 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.427 -0.796 . . . . 0.0 111.029 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.68 -40.81 96.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.569 1.147 . . . . 0.0 111.614 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -61.45 -35.48 77.72 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.821 1.248 . . . . 0.0 112.623 170.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 78.9 m -73.54 -45.93 50.65 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.482 1.037 . . . . 0.0 111.91 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 pt -58.46 -36.12 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 120.111 1.323 . . . . 0.0 111.904 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -75.08 -39.9 60.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.069 1.348 . . . . 0.0 112.952 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.3 t -72.13 -34.57 68.65 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.858 1.263 . . . . 0.0 113.954 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -85.22 143.95 28.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.209 -0.932 . . . . 0.0 111.637 -174.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -84.1 -40.46 18.25 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.199 -0.938 . . . . 0.0 111.776 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.51 129.84 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.825 1.65 . . . . 0.0 110.211 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.5 t -134.02 133.45 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.436 1.094 . . . . 0.0 111.594 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.1 t -135.41 156.26 49.21 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.156 1.382 . . . . 0.0 111.113 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -135.0 137.89 43.45 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.828 0.851 . . . . 0.0 110.637 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.93 160.35 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.464 1.506 . . . . 0.0 109.703 -160.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -69.72 99.15 1.29 Allowed 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.3 -0.875 . . . . 0.0 108.784 158.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.38 -144.1 21.35 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 118.236 0.471 . . . . 0.0 114.114 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -124.02 158.45 60.34 Favored Pre-proline 0 N--CA 1.473 0.704 0 C-N-CA 125.714 1.605 . . . . 0.0 112.258 -171.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.62 -16.44 53.62 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.179 2.586 . . . . 0.0 114.815 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -95.18 -19.17 20.29 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.601 1.56 . . . . 0.0 113.297 168.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.65 71.64 15.46 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 125.627 1.571 . . . . 0.0 113.393 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.27 156.51 29.45 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.07 3.18 . . . . 0.0 113.312 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 79.2 mtp -124.24 8.31 8.51 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.332 1.453 . . . . 0.0 114.138 -170.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 22.5 t -150.63 146.78 26.73 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.805 1.642 . . . . 0.0 110.673 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.56 95.1 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.87 -35.1 74.42 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.55 -0.719 . . . . 0.0 111.921 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.2 m -61.85 -44.78 96.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.931 0.892 . . . . 0.0 111.579 171.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 tmpt? -64.39 -40.82 96.55 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.028 0.931 . . . . 0.0 111.755 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -63.35 -35.91 81.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.5 ttp -58.51 -38.23 77.25 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.215 0.916 . . . . 0.0 111.933 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.8 mm -61.69 -36.26 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.506 0.594 . . . . 0.0 111.703 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -70.2 -33.81 72.16 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.727 1.611 . . . . 0.0 113.489 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.74 -39.19 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.589 0.756 . . . . 0.0 110.522 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.1 mt -66.34 -37.99 86.61 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -61.77 -29.16 69.95 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.792 1.237 . . . . 0.0 112.198 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.88 65.99 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.217 -0.927 . . . . 0.0 113.365 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.93 -12.67 20.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.987 1.315 . . . . 0.0 113.889 170.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.86 19.35 67.45 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.278 0.942 . . . . 0.0 114.121 -175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.7 mt -111.72 136.54 50.84 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 126.289 1.835 . . . . 0.0 111.518 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -117.22 145.52 43.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.874 1.321 . . . . 0.0 113.374 165.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -119.12 173.55 6.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.914 2.086 . . . . 0.0 111.211 -169.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.3 m -84.36 119.23 24.86 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.91 -1.119 . . . . 0.0 109.394 -160.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.4 m -125.05 130.66 52.74 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.103 -153.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -129.01 156.57 43.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.523 1.529 . . . . 0.0 113.007 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -95.11 104.14 16.01 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.107 1.363 . . . . 0.0 112.198 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.9 p -74.57 -11.11 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.6 tp -81.14 -28.53 35.05 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.027 -1.046 . . . . 0.0 110.718 169.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.75 -36.92 19.85 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -117.53 105.65 47.82 Favored Pre-proline 0 N--CA 1.476 0.871 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -167.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.86 -28.76 40.26 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.544 3.496 . . . . 0.0 115.256 168.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -56.51 -43.59 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.222 0.919 . . . . 0.0 112.283 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.27 -47.62 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -48.97 -54.85 13.85 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.188 0.995 . . . . 0.0 111.554 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.4 m -61.81 -44.74 96.26 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -170.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -70.5 -46.64 63.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.207 0.527 . . . . 0.0 110.545 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.1 t -59.37 -41.92 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.895 0.878 . . . . 0.0 112.22 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -67.63 -42.67 81.95 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -41.56 97.75 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.134 0.974 . . . . 0.0 113.157 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.34 -36.15 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 89.6 p -102.15 -4.92 25.07 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 62.89 -46.88 0.2 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 128.914 2.886 . . . . 0.0 115.73 -173.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -142.12 101.31 5.78 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 125.57 1.548 . . . . 0.0 111.055 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -86.52 148.37 8.7 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.924 2.416 . . . . 0.0 114.098 -171.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 87.5 m -100.13 149.91 23.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.379 1.872 . . . . 0.0 109.317 164.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 81.3 mt -119.54 113.86 34.71 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 123.727 0.811 . . . . 0.0 109.162 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -77.03 164.25 87.66 Favored 'Cis proline' 0 CA--C 1.544 1.013 0 CA-C-N 120.103 1.073 . . . . 0.0 114.241 -7.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -146.08 172.32 13.59 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.932 1.293 . . . . 0.0 111.815 166.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.34 142.05 49.18 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -165.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -122.72 142.41 50.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.626 1.97 . . . . 0.0 111.326 173.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 74.5 mt -134.18 134.89 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.273 1.429 . . . . 0.0 108.953 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp 49.9 42.85 24.83 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.359 1.464 . . . . 0.0 112.885 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.53 18.87 2.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.918 2.087 . . . . 0.0 116.213 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.07 148.61 38.69 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.491 1.516 . . . . 0.0 111.636 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -79.93 126.57 31.19 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.196 0.998 . . . . 0.0 112.032 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.6 t -101.0 -39.38 6.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.918 1.287 . . . . 0.0 111.357 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.98 -179.31 21.42 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 172.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.27 171.34 52.85 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.776 1.179 . . . . 0.0 113.107 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 pp -57.39 -29.46 64.1 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -70.26 -28.82 65.54 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.029 -1.044 . . . . 0.0 111.922 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.4 mm -74.33 -45.46 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.588 1.155 . . . . 0.0 109.596 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 64.7 t -57.17 -46.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.049 0.94 . . . . 0.0 110.79 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.6 m -60.31 -43.87 95.95 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.844 0.858 . . . . 0.0 110.825 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -61.25 -47.35 86.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.255 1.022 . . . . 0.0 112.509 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 22.1 mmt -65.63 -39.74 91.8 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.7 1.136 . . . . 0.0 111.818 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.61 -47.46 78.54 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.228 1.411 . . . . 0.0 111.197 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.39 -22.58 60.22 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.264 1.026 . . . . 0.0 112.664 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.0 t -81.09 -20.56 41.24 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.894 1.677 . . . . 0.0 113.419 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.16 -2.5 86.89 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 121.135 -0.978 . . . . 0.0 113.911 -171.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -70.72 -32.71 70.0 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.648 -0.913 . . . . 0.0 111.729 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -44.07 97.72 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.075 -1.016 . . . . 0.0 111.004 173.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -60.31 -33.67 72.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.954 1.302 . . . . 0.0 113.51 172.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -63.2 -47.3 83.15 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.66 0.664 . . . . 0.0 111.269 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.9 mtm -68.37 -43.97 76.22 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.5 pp -65.48 -35.46 80.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.746 0.703 . . . . 0.0 112.177 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -70.5 -30.22 66.95 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.473 -0.767 . . . . 0.0 112.717 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.91 -32.78 74.27 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.419 -0.8 . . . . 0.0 111.201 171.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -1.03 27.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.993 1.717 . . . . 0.0 113.283 169.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.81 2.23 84.45 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 127.038 2.256 . . . . 0.0 115.462 175.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.9 mt -81.54 144.21 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 119.132 1.466 . . . . 0.0 112.671 -158.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.3 m -83.47 123.15 29.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.135 1.374 . . . . 0.0 112.181 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 5.6 p -133.44 165.69 24.28 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.138 1.775 . . . . 0.0 112.882 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -73.21 159.12 33.96 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.848 1.659 . . . . 0.0 113.547 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -80.36 145.04 32.25 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.124 1.77 . . . . 0.0 113.494 170.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.252 1.219 0 C-N-CA 126.55 1.94 . . . . 0.0 113.269 178.712 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.7 m -65.39 -32.81 74.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.806 0.843 . . . . 0.0 112.776 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.5 p -118.89 5.4 11.43 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.61 1.964 . . . . 0.0 114.888 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.21 11.86 83.85 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.487 1.041 . . . . 0.0 115.598 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 22.5 pt -60.07 157.85 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.112 1.765 . . . . 0.0 113.152 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.14 151.42 50.02 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.414 -0.803 . . . . 0.0 113.523 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.78 -149.66 36.77 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 123.628 0.632 . . . . 0.0 113.729 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -145.55 144.83 30.74 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.875 1.67 . . . . 0.0 111.426 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.59 151.67 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.435 1.094 . . . . 0.0 112.717 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -65.64 158.25 27.8 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.047 2.539 . . . . 0.0 114.468 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -132.79 88.86 2.56 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.366 1.466 . . . . 0.0 111.414 167.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.16 143.38 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.683 1.193 . . . . 0.0 111.669 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -150.57 128.88 12.03 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.241 1.016 . . . . 0.0 110.087 168.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -128.82 131.17 47.72 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.954 2.102 . . . . 0.0 110.223 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.7 m -80.19 53.5 1.77 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.453 1.501 . . . . 0.0 111.578 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -79.41 156.75 75.79 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.707 1.603 . . . . 0.0 113.429 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.42 133.35 14.43 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.498 2.799 . . . . 0.0 111.627 166.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -100.02 -7.07 25.48 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -81.66 146.66 29.93 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.701 1.2 . . . . 0.0 113.338 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -76.07 145.45 77.16 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.864 1.266 . . . . 0.0 112.129 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -65.31 145.29 83.2 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.287 2.658 . . . . 0.0 111.095 167.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -124.84 143.09 51.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.495 1.518 . . . . 0.0 112.336 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp 64.51 -42.52 0.29 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 129.355 3.062 . . . . 0.0 115.957 -172.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 m -148.98 147.22 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.954 1.702 . . . . 0.0 111.82 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.6 p -70.83 159.48 34.51 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.552 1.541 . . . . 0.0 113.55 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.49 -171.6 3.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.092 1.357 . . . . 0.0 113.119 -171.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.74 166.76 12.48 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.986 -1.071 . . . . 0.0 111.984 166.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.12 151.83 30.35 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.89 146.99 37.3 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.294 1.438 . . . . 0.0 111.676 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -63.68 -33.14 74.98 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -173.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.58 -33.54 68.28 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.478 1.035 . . . . 0.0 111.721 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -74.7 -25.98 59.52 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.0 pt -106.68 -14.52 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.458 1.503 . . . . 0.0 114.868 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.62 13.59 8.34 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.352 1.461 . . . . 0.0 114.204 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 49.1 tpp -119.21 148.21 43.37 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.082 2.153 . . . . 0.0 111.625 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -137.47 106.99 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.923 1.289 . . . . 0.0 108.767 159.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -78.82 156.9 28.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -59.13 -34.12 71.68 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.217 1.807 . . . . 0.0 114.933 -164.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -69.27 -29.92 67.92 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.091 1.314 . . . . 0.0 113.023 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 82' ' ' ILE . 4.6 mp -75.84 -50.74 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.794 0.837 . . . . 0.0 108.869 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.65 -39.56 73.91 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.403 1.481 . . . . 0.0 111.183 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.54 -30.74 64.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.0 m -72.54 -48.56 39.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.706 0.802 . . . . 0.0 110.312 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.7 pt -65.26 -30.47 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.781 1.232 . . . . 0.0 112.081 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -37.83 73.39 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.434 1.493 . . . . 0.0 112.895 170.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.4 t -73.33 -31.07 63.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.047 0.939 . . . . 0.0 113.13 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -97.15 146.49 25.01 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -76.76 -40.8 47.13 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.63 -1.294 . . . . 0.0 113.83 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.7 t -145.87 135.68 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.944 1.298 . . . . 0.0 110.076 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.16 132.23 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.876 0.871 . . . . 0.0 111.599 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -133.84 155.53 49.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.115 1.366 . . . . 0.0 111.317 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -129.7 137.31 50.53 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.876 0.87 . . . . 0.0 110.787 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.18 156.3 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.063 1.345 . . . . 0.0 110.408 -161.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -70.07 102.17 1.98 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 158.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.81 -147.28 27.7 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 118.748 0.704 . . . . 0.0 113.418 -172.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -126.75 157.45 71.3 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.344 1.857 . . . . 0.0 110.925 -172.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.21 -23.57 75.52 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.026 2.484 . . . . 0.0 114.388 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -76.67 -24.24 53.24 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 171.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -148.96 68.83 9.75 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 126.06 1.744 . . . . 0.0 111.887 -175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.0 142.23 42.02 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.504 2.136 . . . . 0.0 111.744 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 54.5 mtt -101.28 3.87 41.18 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.544 1.538 . . . . 0.0 113.434 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.8 t -145.32 146.08 31.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.282 1.433 . . . . 0.0 111.177 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.37 -44.77 88.98 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.523 0.729 . . . . 0.0 112.265 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -61.53 -36.89 81.84 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.34 -0.85 . . . . 0.0 111.909 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 m -66.57 -37.84 85.8 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.513 0.725 . . . . 0.0 112.646 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -66.46 -44.02 83.91 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.261 1.024 . . . . 0.0 112.881 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -60.94 -35.24 76.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.228 0.611 . . . . 0.0 112.225 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.1 tpp -55.67 -44.44 77.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.182 0.593 . . . . 0.0 112.265 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.72 -32.13 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 121.257 -0.902 . . . . 0.0 111.607 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -34.33 76.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.67 1.188 . . . . 0.0 112.712 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 t -69.23 -41.86 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.907 1.683 . . . . 0.0 111.767 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.8 mt -64.64 -36.32 83.87 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.432 -0.792 . . . . 0.0 112.59 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.74 -36.96 85.06 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.717 -1.239 . . . . 0.0 111.569 171.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.74 -26.34 65.19 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.2 tp -87.8 -14.07 40.57 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.956 0.903 . . . . 0.0 112.702 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.75 7.38 35.02 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.282 1.896 . . . . 0.0 114.876 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 71.1 mt -110.99 133.44 53.39 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.641 1.176 . . . . 0.0 111.218 172.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -112.61 159.6 18.7 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 122.592 1.187 . . . . 0.0 111.408 160.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -136.59 175.7 9.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.835 2.054 . . . . 0.0 110.506 -157.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.0 m -86.42 122.14 29.97 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.943 -1.098 . . . . 0.0 108.622 -175.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.2 p -119.79 147.61 44.43 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.089 1.355 . . . . 0.0 112.865 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -133.77 143.37 48.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.196 0.998 . . . . 0.0 113.064 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -85.67 102.22 13.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.035 1.334 . . . . 0.0 111.818 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.6 p -71.21 -17.15 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.787 1.235 . . . . 0.0 113.683 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -83.76 -29.39 27.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.661 0.784 . . . . 0.0 111.15 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.2 -32.05 13.86 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -128.04 117.49 20.58 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 119.582 1.083 . . . . 0.0 113.509 -165.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -68.25 -16.82 44.63 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.814 2.343 . . . . 0.0 114.364 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 p -53.31 -42.49 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.055 1.298 . . . . 0.0 111.756 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.62 -52.55 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.779 0.832 . . . . 0.0 110.343 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -52.06 -47.14 65.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.884 0.874 . . . . 0.0 111.442 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.6 m -66.12 -44.48 84.15 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.305 0.642 . . . . 0.0 112.558 -173.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -70.98 -40.46 71.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.369 0.667 . . . . 0.0 110.58 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 t -59.65 -36.35 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.246 1.018 . . . . 0.0 111.725 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -43.4 90.09 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.954 0.343 . . . . 0.0 111.418 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -65.34 -47.73 75.48 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.447 1.099 . . . . 0.0 112.467 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 52.7 t -82.26 -44.21 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -172.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m -100.53 -10.06 21.42 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 68.2 -54.32 0.52 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.807 2.043 . . . . 0.0 112.949 -168.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -137.67 147.04 55.63 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.276 1.43 . . . . 0.0 112.489 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -89.63 142.47 4.14 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.348 2.698 . . . . 0.0 115.025 -171.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 m -129.91 131.91 46.19 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.876 2.07 . . . . 0.0 107.402 156.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.5 pt -128.72 135.38 27.51 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.35 156.12 99.81 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 CA-C-N 119.438 0.835 . . . . 0.0 113.053 -5.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.24 158.16 39.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.302 1.441 . . . . 0.0 111.599 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -131.59 141.17 49.61 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -129.36 144.17 51.13 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.19 2.196 . . . . 0.0 109.887 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.0 mt -124.63 121.99 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.916 0.886 . . . . 0.0 108.667 173.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.0 tttp 44.3 51.79 7.43 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.27 1.828 . . . . 0.0 113.48 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.89 14.52 6.39 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.73 138.19 39.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.708 1.603 . . . . 0.0 110.197 168.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -83.45 123.85 30.11 Favored 'General case' 0 C--O 1.237 0.422 0 O-C-N 121.351 -0.843 . . . . 0.0 112.886 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -105.37 -39.95 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.865 1.666 . . . . 0.0 112.993 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 144.75 175.31 17.79 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.644 1.418 . . . . 0.0 116.644 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.04 168.79 54.85 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.182 1.372 . . . . 0.0 113.365 166.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.2 tp -45.86 -41.39 11.16 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -71.0 -27.37 63.64 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.156 0.983 . . . . 0.0 112.212 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.9 mm -79.54 -45.38 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.049 1.34 . . . . 0.0 109.923 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.0 t -62.51 -44.8 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.433 1.093 . . . . 0.0 110.56 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 65.3 m -60.15 -48.25 82.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.791 0.836 . . . . 0.0 110.857 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -55.8 -50.21 71.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.455 1.502 . . . . 0.0 111.6 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.7 mmt -70.87 -33.03 70.2 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.364 1.065 . . . . 0.0 112.762 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.74 -46.56 65.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.845 1.658 . . . . 0.0 111.167 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.24 -26.0 67.16 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.393 1.077 . . . . 0.0 112.341 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.8 t -87.92 -15.81 35.6 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.638 1.975 . . . . 0.0 114.674 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.1 -11.02 59.09 Favored Glycine 0 CA--C 1.54 1.652 0 C-N-CA 124.541 1.067 . . . . 0.0 114.493 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.97 -29.35 69.72 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.574 1.55 . . . . 0.0 112.298 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -61.39 -46.58 89.58 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 120.722 -1.236 . . . . 0.0 111.106 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -59.6 -41.31 90.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.388 1.475 . . . . 0.0 111.502 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -58.93 -44.3 91.33 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.202 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 58.7 mtm -69.04 -46.59 67.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.048 0.84 . . . . 0.0 112.001 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -41.78 84.16 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -67.81 -34.52 76.91 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.94 0.896 . . . . 0.0 112.59 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -59.68 -26.18 65.35 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.244 1.017 . . . . 0.0 112.341 172.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -92.03 6.99 44.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.927 1.691 . . . . 0.0 114.312 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.67 9.37 75.09 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 124.411 1.005 . . . . 0.0 114.3 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.9 mt -94.48 142.56 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.87 0.868 . . . . 0.0 109.176 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 28.5 m -114.87 124.86 52.79 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.184 0.994 . . . . 0.0 112.369 -172.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -129.86 173.91 10.23 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.918 2.087 . . . . 0.0 112.946 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.91 158.4 1.41 Allowed 'General case' 0 N--CA 1.483 1.185 0 O-C-N 120.654 -1.279 . . . . 0.0 111.939 160.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.25 145.79 29.83 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.25 0.62 . . . . 0.0 110.258 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 74.4 mt . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.691 1.197 . . . . 0.0 111.781 -174.451 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 p -89.1 -13.46 38.49 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 95.0 p -126.78 -12.77 5.94 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.63 -6.8 36.71 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.362 0.982 . . . . 0.0 114.431 -168.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.06 137.66 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.162 1.385 . . . . 0.0 108.883 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.92 125.73 7.46 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 121.586 -0.696 . . . . 0.0 111.658 171.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.73 -30.8 61.23 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 117.616 0.708 . . . . 0.0 112.318 170.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.93 157.68 46.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.858 1.663 . . . . 0.0 112.381 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.58 138.25 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.691 1.597 . . . . 0.0 109.504 171.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -75.91 119.54 20.02 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.535 1.134 . . . . 0.0 111.895 -174.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -144.38 88.87 1.96 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.675 1.59 . . . . 0.0 108.745 166.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.4 tt -136.44 101.04 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.137 1.375 . . . . 0.0 109.079 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -137.45 140.64 41.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.093 0.957 . . . . 0.0 111.73 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.52 156.87 45.18 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.623 1.169 . . . . 0.0 113.1 -172.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.8 m -140.48 -28.57 0.71 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -146.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -84.75 163.82 44.91 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.108 1.363 . . . . 0.0 113.433 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.7 179.09 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.634 3.556 . . . . 0.0 114.142 161.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -79.03 -5.3 53.62 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -168.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -137.16 131.49 32.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.319 1.448 . . . . 0.0 112.914 -169.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -105.82 151.78 40.04 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 126.076 1.75 . . . . 0.0 111.048 167.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.65 153.61 34.26 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 124.017 3.145 . . . . 0.0 116.398 -165.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -89.04 145.21 25.62 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.117 2.967 . . . . 0.0 112.801 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.1 tp 61.86 -22.54 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 129.343 3.057 . . . . 0.0 118.108 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.8 128.59 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.796 1.238 . . . . 0.0 110.428 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.9 p -141.95 155.58 45.47 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.129 0.972 . . . . 0.0 113.126 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.3 -22.56 10.85 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.084 1.354 . . . . 0.0 113.643 -175.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -144.56 161.53 38.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.483 1.513 . . . . 0.0 111.336 -174.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.69 111.9 23.01 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 160.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.92 141.47 58.76 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -164.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -52.34 -35.07 50.03 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.059 0.943 . . . . 0.0 112.984 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.57 -33.23 64.57 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.417 1.487 . . . . 0.0 113.309 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -73.59 -28.17 61.69 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.163 -0.96 . . . . 0.0 112.306 170.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.4 mm -80.49 -32.04 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.43 0.692 . . . . 0.0 112.014 173.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.35 -34.79 28.32 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.404 1.002 . . . . 0.0 112.756 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 39.0 tpp -74.18 143.67 45.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.663 0.665 . . . . 0.0 112.09 -174.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.2 m -125.2 141.85 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.574 1.15 . . . . 0.0 112.129 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -66.01 109.35 2.52 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 164.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -52.75 -44.9 66.79 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.274 1.43 . . . . 0.0 112.107 -171.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.44 -28.49 59.35 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.6 mm -76.54 -42.06 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.356 -0.84 . . . . 0.0 110.112 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.51 -39.22 90.19 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.483 1.113 . . . . 0.0 111.461 169.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.2 -29.38 69.03 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 120.755 -1.215 . . . . 0.0 112.094 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.5 m -73.06 -41.96 63.58 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.216 -0.927 . . . . 0.0 111.709 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.8 pt -62.02 -35.1 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.955 1.252 . . . . 0.0 111.811 172.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -76.25 -24.62 54.53 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.853 1.261 . . . . 0.0 113.868 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 t -86.07 -38.24 18.03 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.302 1.441 . . . . 0.0 112.868 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -93.4 141.58 28.29 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.223 1.009 . . . . 0.0 111.937 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.64 -24.39 20.51 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.18 128.76 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.497 1.119 . . . . 0.0 110.294 168.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.01 132.8 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.058 0.943 . . . . 0.0 110.109 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 t -123.21 152.59 41.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.835 0.826 . . . . 0.0 109.903 165.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.06 143.1 49.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.791 0.805 . . . . 0.0 110.776 170.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 mt -132.92 160.09 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.837 -161.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -70.95 103.95 2.82 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 156.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.0 -143.12 23.87 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 119.246 0.93 . . . . 0.0 113.756 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.0 156.47 74.2 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.236 1.414 . . . . 0.0 111.738 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -69.36 -25.38 30.52 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.314 2.01 . . . . 0.0 113.937 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -90.24 -16.14 29.95 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.27 -0.894 . . . . 0.0 112.828 169.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.62 77.26 15.31 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.578 1.551 . . . . 0.0 111.628 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.95 151.9 35.88 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.262 2.641 . . . . 0.0 112.574 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 78.6 mmm -97.44 -5.22 36.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.318 1.447 . . . . 0.0 113.796 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 10.3 t -146.22 146.32 30.74 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.286 1.434 . . . . 0.0 111.334 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.6 -29.38 69.42 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -71.47 -36.84 71.32 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.633 -1.292 . . . . 0.0 111.66 169.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.3 m -63.98 -35.89 82.19 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -59.15 -47.97 83.34 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.521 1.128 . . . . 0.0 111.453 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.0 mmt-85 -62.18 -28.91 69.99 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.8 tpt -52.38 -39.71 61.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.582 0.628 . . . . 0.0 111.4 171.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 mm -70.61 -35.17 60.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.66 1.184 . . . . 0.0 111.426 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -37.24 86.06 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.832 -1.167 . . . . 0.0 112.886 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 65.9 t -69.98 -37.51 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.167 0.987 . . . . 0.0 110.704 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.9 mt -65.72 -39.69 91.45 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.109 0.964 . . . . 0.0 113.488 170.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.55 -30.71 70.42 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.117 -0.99 . . . . 0.0 112.137 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.04 -29.47 66.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.569 0.748 . . . . 0.0 112.668 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.7 tp -81.78 -15.31 54.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.622 0.769 . . . . 0.0 112.39 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.87 11.96 58.93 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.496 1.046 . . . . 0.0 114.468 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 22.6 mt -110.58 129.4 55.81 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.551 1.176 . . . . 0.0 112.875 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -116.34 154.85 29.48 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.131 1.372 . . . . 0.0 113.519 168.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -139.59 170.27 16.21 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.576 2.35 . . . . 0.0 111.477 -161.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.0 m -88.09 131.15 34.79 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.047 -1.658 . . . . 0.0 109.655 -176.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -130.33 143.77 50.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.059 0.944 . . . . 0.0 113.528 -154.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -137.67 144.06 41.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.372 1.069 . . . . 0.0 113.315 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -83.59 120.08 25.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.774 1.23 . . . . 0.0 112.075 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.8 t -68.75 -29.82 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.25 1.02 . . . . 0.0 111.863 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.6 mt -74.98 -15.75 60.65 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.155 -0.966 . . . . 0.0 112.282 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.76 -32.57 21.77 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.421 -0.8 . . . . 0.0 112.975 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -129.67 106.48 17.08 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 119.451 1.023 . . . . 0.0 113.226 -168.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -53.54 -26.94 38.69 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.085 3.19 . . . . 0.0 115.347 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.52 -35.53 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.249 -0.907 . . . . 0.0 112.54 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.79 -48.06 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.139 -0.976 . . . . 0.0 111.166 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -59.94 -28.16 67.39 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 119.151 0.887 . . . . 0.0 112.955 171.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.5 m -71.03 -53.92 13.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.373 0.533 . . . . 0.0 111.166 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -70.81 -34.76 72.06 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.157 -0.964 . . . . 0.0 111.915 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.15 -36.28 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 120.787 -1.196 . . . . 0.0 112.926 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -72.58 -49.37 32.79 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.484 1.038 . . . . 0.0 111.428 167.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -72.31 -30.53 64.87 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -164.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 37.0 t -74.53 -29.39 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.598 1.159 . . . . 0.0 111.396 171.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m -103.4 -5.77 22.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -169.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 62.35 -27.03 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 129.069 2.948 . . . . 0.0 116.168 -168.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -145.86 138.53 13.89 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.394 1.877 . . . . 0.0 109.521 165.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.3 149.0 11.75 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.048 2.498 . . . . 0.0 114.669 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.4 p -129.52 132.67 46.92 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.532 1.933 . . . . 0.0 108.807 160.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.0 mt -131.21 142.55 45.91 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.381 1.472 . . . . 0.0 108.383 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.58 161.18 79.14 Favored 'Cis proline' 0 C--N 1.35 0.643 0 CA-C-N 121.738 1.656 . . . . 0.0 111.924 -8.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -144.56 152.52 40.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.302 0.641 . . . . 0.0 112.287 -162.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.24 140.94 52.14 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.785 1.234 . . . . 0.0 112.362 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -130.25 140.41 50.7 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.894 2.078 . . . . 0.0 109.258 173.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 82.0 mt -129.29 133.29 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.3 1.04 . . . . 0.0 108.343 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 67.1 tttt 49.31 45.3 23.61 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.187 1.795 . . . . 0.0 113.428 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.65 12.33 5.47 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -115.85 144.2 44.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.381 1.472 . . . . 0.0 111.502 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.23 124.88 25.01 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.879 1.272 . . . . 0.0 111.976 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.49 -55.48 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.147 1.379 . . . . 0.0 110.95 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 165.67 167.21 25.93 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 117.109 1.604 . . . . 0.0 117.109 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.15 168.82 54.84 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.703 1.144 . . . . 0.0 112.499 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.7 tt -47.35 -45.72 24.98 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.058 1.343 . . . . 0.0 113.908 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.82 -35.44 78.62 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.339 -0.851 . . . . 0.0 111.407 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.67 -47.07 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.086 1.354 . . . . 0.0 110.513 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.5 -39.62 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.691 1.196 . . . . 0.0 109.992 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 41.2 m -61.5 -42.72 99.23 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.413 0.685 . . . . 0.0 112.29 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -55.2 -46.62 75.89 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.201 0.909 . . . . 0.0 110.41 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 61.1 mtt -72.92 -33.45 65.97 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.633 1.573 . . . . 0.0 113.342 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -70.52 -35.93 73.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.211 1.804 . . . . 0.0 112.629 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -80.06 -20.27 45.63 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.885 -1.135 . . . . 0.0 112.621 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.2 p -106.86 -16.0 14.58 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -162.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.7 82.63 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 124.756 1.17 . . . . 0.0 115.503 -170.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -70.03 -31.89 69.75 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.244 2.022 . . . . 0.0 112.55 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.86 -41.59 67.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.533 1.133 . . . . 0.0 110.596 176.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -55.84 -41.17 73.91 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.364 1.865 . . . . 0.0 110.769 173.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -56.63 -47.08 80.47 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.82 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 70.9 mtm -70.86 -46.03 63.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.461 1.028 . . . . 0.0 113.242 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -39.42 82.96 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -72.44 -32.88 66.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.597 1.159 . . . . 0.0 112.274 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.86 -27.2 64.94 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.513 0.597 . . . . 0.0 112.383 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -90.77 -4.43 56.67 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.56 22.37 47.33 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.803 1.192 . . . . 0.0 114.178 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 64.5 mt -94.51 147.84 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 119.038 1.419 . . . . 0.0 111.85 -172.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.6 m -101.11 130.89 47.24 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.323 1.449 . . . . 0.0 112.195 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 15.6 p -137.09 169.46 17.74 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.685 1.994 . . . . 0.0 111.502 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -74.2 158.42 34.16 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 174.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -135.99 129.69 32.46 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.717 1.607 . . . . 0.0 113.343 165.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.413 1.485 . . . . 0.0 111.881 176.688 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 110.6 -0.148 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.7 p -78.35 -31.87 48.78 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -166.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -105.59 0.85 26.87 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.054 1.341 . . . . 0.0 114.121 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.8 7.43 74.74 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.58 1.562 . . . . 0.0 116.019 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.8 mt -91.19 141.67 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.77 2.028 . . . . 0.0 109.26 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.64 136.66 4.71 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.037 0.835 . . . . 0.0 114.684 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.62 -31.7 0.86 Allowed Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.983 1.754 . . . . 0.0 116.605 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -148.66 152.57 36.92 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.248 1.819 . . . . 0.0 110.599 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.11 152.79 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.247 1.019 . . . . 0.0 111.785 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.73 167.36 18.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.912 1.285 . . . . 0.0 111.148 173.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -149.95 166.96 28.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.832 0.853 . . . . 0.0 111.456 166.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.0 mt -85.34 116.33 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.322 1.049 . . . . 0.0 108.464 169.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -138.79 147.92 43.17 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.664 1.185 . . . . 0.0 112.619 -174.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.7 116.47 13.22 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.468 1.507 . . . . 0.0 109.252 158.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.7 p -138.97 -11.58 1.28 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -71.96 153.68 92.78 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 119.438 1.017 . . . . 0.0 112.392 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -72.29 175.1 10.45 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.01 3.14 . . . . 0.0 112.453 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -77.64 -9.84 59.19 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.746 -1.221 . . . . 0.0 113.291 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -140.38 117.0 10.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.521 1.528 . . . . 0.0 109.382 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -96.03 147.38 32.89 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -172.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.26 139.93 39.64 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.321 2.68 . . . . 0.0 111.047 167.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.9 mtm-85 -92.86 129.41 38.79 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.554 -0.716 . . . . 0.0 111.562 -171.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.0 tp -155.45 -44.09 0.08 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.167 0.987 . . . . 0.0 112.179 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.2 t -144.6 110.66 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.068 1.347 . . . . 0.0 110.414 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.4 t -82.9 75.36 9.8 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.127 -0.983 . . . . 0.0 110.672 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.69 133.17 53.3 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.819 1.248 . . . . 0.0 111.773 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.3 t0 51.94 178.91 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.033 1.733 . . . . 0.0 112.905 -163.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.9 tp -104.44 132.4 50.73 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.849 -1.157 . . . . 0.0 108.949 165.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.54 152.75 29.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -169.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -51.03 -42.46 60.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.737 1.215 . . . . 0.0 112.881 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.57 -31.5 63.65 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.016 1.726 . . . . 0.0 114.12 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -75.52 -41.69 54.5 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.162 1.385 . . . . 0.0 113.161 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.1 tp -82.64 -20.17 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.25 0.49 28.43 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.324 1.05 . . . . 0.0 113.518 170.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.4 ttt -61.69 126.92 29.07 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.129 -0.982 . . . . 0.0 112.212 -171.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.15 148.36 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.311 1.044 . . . . 0.0 112.283 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -120.42 126.86 51.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.474 1.51 . . . . 0.0 110.326 164.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -57.44 -43.55 83.97 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.62 1.168 . . . . 0.0 113.363 -163.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -72.79 -28.82 62.82 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.6 mm -72.12 -48.89 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.035 0.934 . . . . 0.0 109.618 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.53 -38.38 77.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.189 1.396 . . . . 0.0 112.304 170.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.5 -30.79 66.35 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.279 -0.888 . . . . 0.0 113.163 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 67.3 m -66.43 -47.89 71.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.193 0.997 . . . . 0.0 111.061 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 pt -60.5 -36.87 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 118.498 0.59 . . . . 0.0 111.944 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.08 -21.98 58.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.006 1.722 . . . . 0.0 113.146 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.3 t -92.84 -38.76 11.57 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.523 1.929 . . . . 0.0 112.582 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.37 139.36 31.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.44 1.096 . . . . 0.0 111.514 -176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -70.62 -42.21 71.23 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.179 -0.951 . . . . 0.0 113.324 -171.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.7 t -139.92 128.14 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.516 1.126 . . . . 0.0 109.511 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.0 t -133.42 130.28 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.461 1.505 . . . . 0.0 111.134 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -130.79 157.12 43.71 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.849 1.26 . . . . 0.0 110.47 170.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.56 151.58 51.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.542 0.686 . . . . 0.0 112.007 170.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 mt -133.22 169.45 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.433 1.493 . . . . 0.0 109.444 -166.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.94 112.59 23.51 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.835 -0.541 . . . . 0.0 111.487 144.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.46 -171.98 31.21 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.132 1.825 . . . . 0.0 114.296 -174.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.4 mt -88.87 150.57 45.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.555 1.542 . . . . 0.0 110.546 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.25 -27.78 78.5 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.64 2.227 . . . . 0.0 114.541 -173.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.8 -21.87 56.92 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.966 -1.084 . . . . 0.0 113.036 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.61 68.2 14.63 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 125.716 1.606 . . . . 0.0 112.345 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.78 157.31 39.54 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.316 2.677 . . . . 0.0 112.427 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 mmt -96.34 10.35 38.31 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.711 1.204 . . . . 0.0 114.094 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.8 t -147.87 145.5 28.71 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.904 -1.122 . . . . 0.0 111.593 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.28 96.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -67.37 -31.91 72.48 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.449 -1.407 . . . . 0.0 112.628 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.4 m -63.84 -36.37 83.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.704 -0.665 . . . . 0.0 111.75 167.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -66.39 -40.13 89.48 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.993 1.27 . . . . 0.0 112.892 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -60.0 -35.7 75.61 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 119.67 1.123 . . . . 0.0 112.878 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.9 tpt -58.31 -46.79 85.48 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.168 0.587 . . . . 0.0 111.468 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.7 mm -71.89 -33.3 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.373 0.669 . . . . 0.0 112.06 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.35 -42.17 73.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.103 0.961 . . . . 0.0 111.147 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.425 HG13 ' HG ' ' A' ' 165' ' ' LEU . 3.8 t -62.98 -44.55 99.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.543 1.137 . . . . 0.0 111.586 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.22 -36.74 85.11 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.861 0.865 . . . . 0.0 112.645 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -71.37 -30.88 66.67 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.805 -1.185 . . . . 0.0 113.196 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.76 -33.8 74.5 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.803 0.729 . . . . 0.0 112.135 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 tp -94.38 -10.71 31.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.487 1.115 . . . . 0.0 112.811 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.06 8.89 70.51 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.956 1.741 . . . . 0.0 115.195 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 132.49 54.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.083 0.953 . . . . 0.0 111.058 173.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -114.73 153.2 30.72 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.121 0.963 . . . . 0.0 112.686 173.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.52 173.75 9.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.526 1.93 . . . . 0.0 111.258 -166.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.5 m -88.6 129.36 35.51 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.846 -1.159 . . . . 0.0 109.824 -167.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.7 p -114.3 141.29 47.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.098 1.759 . . . . 0.0 113.592 -163.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -128.12 161.72 28.57 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.91 1.284 . . . . 0.0 111.784 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -131.22 118.05 19.88 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.287 1.435 . . . . 0.0 112.752 -170.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.15 -21.05 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 tp -80.96 -22.1 39.82 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.321 1.048 . . . . 0.0 111.817 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.16 -40.04 16.06 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.03 -1.044 . . . . 0.0 111.905 170.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.408 ' HB3' HG12 ' A' ' 131' ' ' VAL . 59.6 m-70 -144.55 109.81 4.88 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.833 1.253 . . . . 0.0 112.319 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.95 -14.0 40.67 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.387 2.725 . . . . 0.0 114.994 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.408 HG12 ' HB3' ' A' ' 129' ' ' HIS . 7.8 p -46.9 -32.33 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 120.016 1.28 . . . . 0.0 113.032 169.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.0 t -58.01 -43.53 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.146 0.978 . . . . 0.0 111.688 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.449 ' HA ' HG12 ' A' ' 136' ' ' VAL . 23.8 ttp180 -68.83 -39.98 79.7 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.799 1.24 . . . . 0.0 111.528 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 m -65.76 -47.92 73.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -69.6 -39.69 77.11 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.162 -0.962 . . . . 0.0 112.04 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 133' ' ' ARG . 9.8 p -62.91 -35.76 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 120.2 1.364 . . . . 0.0 112.21 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -66.3 -47.66 72.88 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.075 0.95 . . . . 0.0 111.734 172.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -42.29 80.94 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.61 -34.84 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.815 1.246 . . . . 0.0 113.128 -175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 m -97.99 5.83 48.35 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -170.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 62.48 -40.77 0.16 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 127.797 2.439 . . . . 0.0 114.445 -162.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -135.91 134.73 20.69 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.48 1.912 . . . . 0.0 110.613 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.23 138.15 27.22 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.653 2.235 . . . . 0.0 112.192 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.0 136.6 44.21 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.505 1.522 . . . . 0.0 109.908 165.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.3 mt -127.95 131.7 23.94 Favored Pre-proline 0 N--CA 1.476 0.843 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.907 173.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.92 163.16 88.24 Favored 'Cis proline' 0 CA--C 1.541 0.857 0 CA-C-N 119.929 1.01 . . . . 0.0 110.813 -12.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -150.36 172.85 14.74 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.761 0.824 . . . . 0.0 111.514 171.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.07 140.03 52.19 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -174.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -120.66 142.49 49.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 112.779 -2.009 . . . . 0.0 110.51 171.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.4 mt -122.24 118.32 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 tptt 45.88 48.9 12.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 127.146 2.178 . . . . 0.0 114.567 -173.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 58.51 13.24 2.43 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -172.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -94.36 131.68 39.76 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.856 -1.153 . . . . 0.0 108.702 164.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -76.34 124.76 28.02 Favored 'General case' 0 N--CA 1.463 0.18 0 O-C-N 121.608 -0.682 . . . . 0.0 111.278 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.4 t -101.92 -46.82 11.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.735 1.214 . . . . 0.0 111.186 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.58 170.44 31.48 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.69 174.65 54.7 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.359 1.457 . . . . 0.0 114.02 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -48.62 -43.82 36.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.539 1.936 . . . . 0.0 113.331 178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.27 -44.65 95.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.316 0.647 . . . . 0.0 110.321 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.84 -45.72 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.093 1.357 . . . . 0.0 111.207 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.9 t -57.52 -37.06 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.633 1.573 . . . . 0.0 110.945 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 53.0 m -63.09 -44.09 96.69 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.233 0.613 . . . . 0.0 111.721 172.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -63.2 -41.59 99.18 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.504 1.047 . . . . 0.0 110.796 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 38.2 mtt -63.24 -39.23 94.03 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.011 0.925 . . . . 0.0 111.946 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.425 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.2 tm? -68.58 -40.32 80.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.064 1.346 . . . . 0.0 112.195 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.32 -33.49 55.56 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.0 t -85.2 -21.26 29.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.044 1.338 . . . . 0.0 113.489 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.49 0.17 67.49 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.526 1.06 . . . . 0.0 114.788 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.03 -29.95 66.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.515 1.157 . . . . 0.0 113.633 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.62 -44.04 96.78 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.842 -1.162 . . . . 0.0 110.021 174.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -36.74 84.0 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.915 1.286 . . . . 0.0 113.039 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -59.47 -48.49 81.44 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.43 1.014 . . . . 0.0 111.194 171.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.3 mtm -69.9 -45.82 66.77 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 pp -66.33 -36.71 83.61 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.735 0.698 . . . . 0.0 112.059 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -64.01 -41.8 97.34 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.663 0.785 . . . . 0.0 111.536 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.94 -20.58 64.21 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.16 1.43 31.99 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.369 1.468 . . . . 0.0 112.485 170.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.04 17.27 74.94 Favored Glycine 0 N--CA 1.469 0.869 0 O-C-N 120.984 -1.073 . . . . 0.0 114.229 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.4 mt -103.05 146.93 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.686 1.195 . . . . 0.0 109.364 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.3 m -112.36 137.1 50.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.257 1.023 . . . . 0.0 110.651 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.1 p -132.22 168.53 17.89 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.638 1.575 . . . . 0.0 113.075 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -67.09 157.3 33.94 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.631 0.772 . . . . 0.0 111.406 169.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -90.23 105.0 17.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.469 1.107 . . . . 0.0 111.931 -170.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 58.1 tp . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.77 2.028 . . . . 0.0 112.607 -177.334 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.3 m -80.28 -32.75 38.12 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.02 0.928 . . . . 0.0 112.065 171.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.4 m 58.56 162.06 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.784 1.634 . . . . 0.0 113.367 -155.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.0 15.45 81.37 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.717 1.151 . . . . 0.0 115.197 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mt -86.22 140.72 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.243 1.417 . . . . 0.0 110.39 -172.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.37 126.76 28.51 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.292 0.949 . . . . 0.0 114.966 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.32 -147.1 43.59 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.443 1.021 . . . . 0.0 113.848 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -148.69 155.18 40.67 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.419 -1.047 . . . . 0.0 111.395 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.53 139.77 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 121.201 -0.937 . . . . 0.0 111.864 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -88.69 139.98 29.92 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.011 0.924 . . . . 0.0 111.515 171.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -87.6 151.18 23.18 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.274 1.03 . . . . 0.0 111.724 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.0 mt -112.56 144.06 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.293 1.837 . . . . 0.0 108.665 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.08 122.01 21.11 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.204 -0.935 . . . . 0.0 110.246 173.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -63.11 125.83 25.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.07 0.948 . . . . 0.0 111.916 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.0 p -131.69 137.84 48.44 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.564 1.546 . . . . 0.0 109.136 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 18.3 p80 -94.06 145.76 30.39 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -164.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 58' ' ' HIS . 32.2 Cg_exo -63.37 151.18 86.16 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.856 3.038 . . . . 0.0 113.205 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -96.21 -4.3 42.73 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -129.73 117.45 20.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.542 1.137 . . . . 0.0 111.464 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -107.23 143.19 26.65 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.543 1.937 . . . . 0.0 111.508 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -67.55 151.67 79.35 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.164 2.576 . . . . 0.0 111.649 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -68.31 128.76 37.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.147 0.979 . . . . 0.0 112.109 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -149.86 149.58 30.67 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.445 1.498 . . . . 0.0 110.565 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.1 t -111.45 -33.64 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 124.744 1.218 . . . . 0.0 111.487 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.0 m -68.78 167.73 14.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.584 1.153 . . . . 0.0 111.289 159.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -89.68 130.5 35.95 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.642 0.734 . . . . 0.0 112.147 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -151.0 150.03 30.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.116 2.166 . . . . 0.0 107.209 160.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 tp -134.75 152.44 51.76 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.606 1.094 . . . . 0.0 111.895 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.83 146.92 35.44 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.563 1.145 . . . . 0.0 113.119 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -54.25 -44.54 71.89 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.968 1.307 . . . . 0.0 113.554 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -71.51 -31.37 67.01 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.325 0.511 . . . . 0.0 112.169 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.92 -28.56 63.57 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.279 -0.888 . . . . 0.0 111.963 174.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.9 mt -72.77 -27.78 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.978 1.311 . . . . 0.0 111.321 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.9 8.74 7.61 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.907 1.283 . . . . 0.0 114.059 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 7.4 mmt -115.43 116.48 28.29 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.931 1.693 . . . . 0.0 110.481 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.4 147.88 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.186 0.995 . . . . 0.0 112.618 -172.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -92.85 128.88 38.87 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.533 1.133 . . . . 0.0 111.422 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -60.97 -29.16 69.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.872 0.869 . . . . 0.0 112.288 167.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.38 -37.68 75.75 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.056 0.942 . . . . 0.0 112.861 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 97.5 mt -75.99 -44.9 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.661 1.184 . . . . 0.0 110.119 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.41 -38.4 71.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.856 1.263 . . . . 0.0 112.15 171.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.4 -28.5 64.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.898 0.879 . . . . 0.0 113.107 172.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.7 m -70.16 -47.2 62.65 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 120.335 1.425 . . . . 0.0 110.948 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.8 pt -62.0 -32.47 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.421 1.088 . . . . 0.0 112.914 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -79.15 -30.64 43.69 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.707 2.003 . . . . 0.0 113.825 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t -80.31 -28.0 38.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.067 1.747 . . . . 0.0 113.248 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -84.85 150.12 25.22 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.905 -1.122 . . . . 0.0 111.344 167.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -76.45 -45.79 29.8 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.632 -1.292 . . . . 0.0 111.691 169.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.9 t -145.33 131.38 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.561 1.144 . . . . 0.0 111.087 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.86 131.67 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.675 1.19 . . . . 0.0 111.663 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 t -134.31 154.96 51.02 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.894 1.277 . . . . 0.0 111.733 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -132.43 139.62 48.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.923 0.889 . . . . 0.0 111.472 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 mt -132.78 157.51 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.849 2.059 . . . . 0.0 108.853 -164.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -78.17 115.21 17.73 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 147.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.99 -152.9 25.07 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.185 0.897 . . . . 0.0 113.551 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.1 mt -104.96 152.59 39.64 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 124.932 1.293 . . . . 0.0 110.596 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.08 -31.72 54.42 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 121.758 1.639 . . . . 0.0 113.453 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -81.22 -13.28 58.71 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.406 -0.809 . . . . 0.0 112.95 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.55 67.66 52.2 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.97 1.708 . . . . 0.0 112.096 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.42 142.46 59.78 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.651 2.901 . . . . 0.0 112.964 -172.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 90.7 mtp -105.65 3.78 29.48 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 37.0 t -134.6 146.52 49.68 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.831 2.053 . . . . 0.0 111.06 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.07 -46.57 85.23 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.354 -0.842 . . . . 0.0 112.018 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -67.09 -25.47 66.24 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.018 -1.051 . . . . 0.0 112.056 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.4 p -71.45 -39.05 71.22 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 168.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -58.69 -45.32 89.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.75 1.159 . . . . 0.0 110.203 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -62.56 -39.78 94.74 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.292 1.037 . . . . 0.0 112.438 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.5 tpt -55.86 -49.61 72.85 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.791 1.178 . . . . 0.0 111.678 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.7 mm -70.38 -32.68 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 121.869 -0.519 . . . . 0.0 112.339 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -59.9 -36.27 76.62 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.003 -1.061 . . . . 0.0 112.927 171.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.23 -36.36 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.732 0.813 . . . . 0.0 110.596 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.89 -37.48 87.79 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.35 -0.844 . . . . 0.0 112.885 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -65.08 -33.89 77.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.757 -1.214 . . . . 0.0 111.41 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.35 -30.96 70.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.06 0.944 . . . . 0.0 112.314 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.2 tp -82.27 -16.98 47.53 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.695 0.68 . . . . 0.0 112.626 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.64 9.49 58.9 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.611 1.101 . . . . 0.0 115.166 -174.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.5 mt -114.81 133.97 55.5 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.53 1.532 . . . . 0.0 113.668 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -115.63 153.43 31.29 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.755 1.264 . . . . 0.0 113.044 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -137.19 175.01 10.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.616 1.967 . . . . 0.0 111.799 -156.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.8 m -85.79 117.36 24.61 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.548 -1.345 . . . . 0.0 108.943 -168.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.2 m -127.87 133.05 49.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.141 -153.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -129.63 149.83 51.22 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -172.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -99.45 98.16 9.1 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.697 1.599 . . . . 0.0 111.846 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.6 -21.94 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.018 0.927 . . . . 0.0 113.229 -175.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.3 tp -73.4 -28.62 62.1 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.626 -0.671 . . . . 0.0 111.565 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.14 -32.78 11.78 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -124.12 103.97 32.74 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.745 1.157 . . . . 0.0 113.661 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -57.27 -19.75 36.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.151 3.234 . . . . 0.0 115.371 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.14 -39.31 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 120.315 1.416 . . . . 0.0 112.452 173.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.95 -42.53 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.186 0.994 . . . . 0.0 111.119 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 136' ' ' VAL . 2.4 ptm180 -69.99 -30.47 67.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.524 1.13 . . . . 0.0 112.148 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m -68.84 -48.98 62.14 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.831 0.852 . . . . 0.0 112.601 170.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -61.35 -46.67 89.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.427 0.558 . . . . 0.0 110.604 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 133' ' ' ARG . 8.0 p -66.85 -32.83 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.483 -0.76 . . . . 0.0 112.873 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -70.25 -41.62 73.27 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.826 1.194 . . . . 0.0 112.929 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -61.63 -40.42 94.78 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.982 0.81 . . . . 0.0 112.723 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.0 t -83.8 -50.62 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 53.9 p -113.66 -0.62 14.25 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 -172.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 65.08 -49.76 0.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.112 2.165 . . . . 0.0 116.138 -172.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -132.26 116.52 15.41 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 119.909 1.231 . . . . 0.0 112.337 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.94 144.86 21.88 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.339 2.693 . . . . 0.0 112.2 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.7 m -135.2 110.7 9.13 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.437 0.695 . . . . 0.0 109.335 161.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.3 pt -91.59 163.96 26.21 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -160.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.18 154.48 98.36 Favored 'Cis proline' 0 C--N 1.352 0.747 0 CA-C-N 119.195 0.748 . . . . 0.0 111.048 -21.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -136.54 153.12 51.08 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.816 1.246 . . . . 0.0 111.273 -170.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.31 140.63 51.35 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.931 1.292 . . . . 0.0 113.536 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -131.47 143.01 50.11 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.483 1.913 . . . . 0.0 109.718 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.0 mt -125.98 115.85 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.797 0.839 . . . . 0.0 108.903 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . 0.339 17.5 ttmm 40.9 57.65 2.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.076 2.15 . . . . 0.0 114.404 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 67.45 9.22 6.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.91 138.42 37.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.551 1.14 . . . . 0.0 110.306 168.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -79.82 123.71 27.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.607 1.194 . . . . 0.0 111.716 175.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.38 -48.72 10.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.767 1.227 . . . . 0.0 110.584 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.61 -179.68 27.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 168.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.24 173.66 53.88 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.55 1.072 . . . . 0.0 113.442 167.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -42.75 -46.56 5.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.339 1.856 . . . . 0.0 113.765 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -70.02 -26.52 64.09 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.628 -0.67 . . . . 0.0 112.304 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.8 mm -79.26 -46.51 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.834 1.254 . . . . 0.0 110.316 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.12 -38.56 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.11 0.964 . . . . 0.0 110.572 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 69.3 m -60.88 -46.21 91.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.08 0.952 . . . . 0.0 111.566 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -60.17 -43.86 95.49 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.091 0.956 . . . . 0.0 111.565 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.6 mtt -69.0 -35.25 76.48 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.412 -0.805 . . . . 0.0 112.953 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -69.56 -41.3 76.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.31 1.044 . . . . 0.0 111.506 172.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -65.07 -36.58 84.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.301 1.04 . . . . 0.0 113.183 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 21.3 t -88.79 -9.43 51.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.427 1.491 . . . . 0.0 114.032 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.84 4.46 82.36 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.247 -1.533 . . . . 0.0 114.201 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.2 -32.36 70.23 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.347 1.459 . . . . 0.0 112.936 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.16 -46.28 81.51 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.054 -1.029 . . . . 0.0 109.932 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -59.05 -41.1 87.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.745 1.618 . . . . 0.0 112.728 169.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -58.09 -42.66 86.08 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.954 0.902 . . . . 0.0 111.035 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 62.4 mtm -69.6 -50.32 45.67 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -69.08 -37.38 78.42 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -65.09 -34.24 77.94 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.04 0.936 . . . . 0.0 111.44 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.72 -29.65 69.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.238 1.415 . . . . 0.0 112.493 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -89.19 6.02 42.07 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.043 2.137 . . . . 0.0 114.306 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.48 19.43 60.29 Favored Glycine 0 N--CA 1.469 0.867 0 O-C-N 121.12 -0.987 . . . . 0.0 114.44 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.0 mt -104.02 147.68 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.33 1.052 . . . . 0.0 110.792 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 95.8 m -102.69 126.2 49.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.749 1.22 . . . . 0.0 111.572 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.8 p -127.48 168.99 14.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.888 2.075 . . . . 0.0 111.156 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 19.1 mtp-105 -68.33 155.59 39.46 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.906 0.86 . . . . 0.0 112.99 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -98.14 134.46 41.18 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.657 1.983 . . . . 0.0 109.463 158.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 26.1 tp . . . . . 0 C--O 1.253 1.255 0 C-N-CA 127.607 2.363 . . . . 0.0 115.141 -176.773 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.3 m -90.21 -9.14 49.21 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.864 0.866 . . . . 0.0 112.691 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.1 m -57.2 126.19 26.13 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.636 -1.29 . . . . 0.0 111.718 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.94 3.63 87.71 Favored Glycine 0 CA--C 1.54 1.64 0 N-CA-C 117.045 1.578 . . . . 0.0 117.045 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.7 mt -84.49 95.15 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.316 2.058 . . . . 0.0 110.06 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.62 158.76 20.21 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.318 1.437 . . . . 0.0 112.634 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.9 163.23 54.6 Favored Glycine 0 CA--C 1.538 1.5 0 N-CA-C 116.463 1.345 . . . . 0.0 116.463 -169.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -67.77 139.04 56.63 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.437 -1.037 . . . . 0.0 112.89 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -93.57 137.32 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.894 1.278 . . . . 0.0 109.809 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -129.69 153.12 48.46 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.309 1.044 . . . . 0.0 112.973 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -78.77 84.66 4.82 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.173 0.589 . . . . 0.0 111.352 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.3 tp -134.93 21.18 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.183 1.393 . . . . 0.0 113.92 -166.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -140.53 150.64 43.96 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.574 1.55 . . . . 0.0 111.696 167.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -109.86 147.17 33.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.377 1.871 . . . . 0.0 110.487 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.3 p -134.49 164.88 26.47 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.821 1.248 . . . . 0.0 112.017 170.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.33 159.23 51.37 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.887 1.275 . . . . 0.0 112.475 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.33 155.46 36.9 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.494 2.13 . . . . 0.0 115.282 -154.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.58 -9.5 59.63 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.201 1.8 . . . . 0.0 113.529 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -144.84 139.92 28.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.336 1.854 . . . . 0.0 109.99 -174.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -93.46 153.13 41.4 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -165.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.4 155.4 62.48 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.685 3.59 . . . . 0.0 113.543 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -122.68 110.24 15.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.124 1.77 . . . . 0.0 111.338 -176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 tp 60.46 -30.24 0.05 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 130.834 3.654 . . . . 0.0 117.631 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 m -130.29 155.45 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.41 1.884 . . . . 0.0 111.194 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.6 p -140.39 164.27 30.55 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -174.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.74 153.79 42.94 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.788 1.235 . . . . 0.0 113.004 175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -66.62 -49.94 64.64 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.327 1.051 . . . . 0.0 111.582 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.47 132.83 55.4 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.0 1.32 . . . . 0.0 110.422 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.54 162.17 18.67 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.435 1.494 . . . . 0.0 113.66 -175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -52.56 -44.78 66.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.281 1.432 . . . . 0.0 113.543 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -75.31 -37.95 60.53 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.465 1.506 . . . . 0.0 112.369 174.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.7 -29.5 67.95 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.486 1.514 . . . . 0.0 112.356 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.5 tp -89.66 -12.25 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.402 1.481 . . . . 0.0 113.159 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.14 -25.82 15.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.733 1.213 . . . . 0.0 113.617 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.7 ttp -75.12 133.46 41.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.216 1.806 . . . . 0.0 111.008 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.7 84.29 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.34 0.656 . . . . 0.0 110.29 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -72.4 114.69 10.79 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.104 0.962 . . . . 0.0 112.437 -176.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -57.8 -25.36 60.47 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.655 1.182 . . . . 0.0 113.433 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.18 -28.26 64.6 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.693 1.133 . . . . 0.0 113.037 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.2 mm -70.04 -49.09 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 120.794 1.634 . . . . 0.0 110.701 171.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.82 -39.21 93.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.372 1.469 . . . . 0.0 112.244 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.85 -29.68 61.11 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.346 -0.846 . . . . 0.0 112.559 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 92.1 m -66.31 -46.14 77.94 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.987 1.267 . . . . 0.0 110.933 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 pt -63.81 -34.6 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.576 0.75 . . . . 0.0 112.925 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -78.95 -39.38 34.69 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.22 1.408 . . . . 0.0 112.964 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.2 t -85.02 -11.06 56.26 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.309 1.044 . . . . 0.0 113.446 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -89.52 148.67 23.27 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.362 1.865 . . . . 0.0 111.449 165.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -87.28 -42.84 12.62 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.783 -1.198 . . . . 0.0 113.205 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.27 130.49 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.062 1.345 . . . . 0.0 110.265 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.4 t -131.51 130.51 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.779 1.632 . . . . 0.0 111.278 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 t -133.5 156.18 48.23 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.084 1.354 . . . . 0.0 111.186 171.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -129.62 139.77 51.35 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.42 0.688 . . . . 0.0 111.872 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.83 156.57 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.26 1.424 . . . . 0.0 109.876 -163.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.9 102.86 1.66 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.852 -0.53 . . . . 0.0 109.665 155.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.74 -160.0 33.67 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 118.887 0.767 . . . . 0.0 114.783 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.51 153.68 48.26 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 126.951 2.1 . . . . 0.0 112.516 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -66.75 -15.59 47.79 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.311 2.674 . . . . 0.0 114.823 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -94.84 -20.43 19.46 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.45 69.26 21.21 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.416 1.486 . . . . 0.0 110.84 -171.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.54 144.01 48.71 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.058 2.505 . . . . 0.0 111.655 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 mmt -93.36 2.41 56.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.13 1.372 . . . . 0.0 113.741 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 53.6 t -142.12 145.64 34.48 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.804 1.642 . . . . 0.0 111.488 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.77 95.63 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.878 0.871 . . . . 0.0 112.731 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -71.08 -24.06 62.24 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.592 -1.317 . . . . 0.0 112.354 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 m -69.77 -36.44 75.77 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.427 -0.796 . . . . 0.0 112.362 166.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -62.29 -42.02 98.99 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.605 1.162 . . . . 0.0 112.021 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -55.84 -29.83 60.46 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.068 1.347 . . . . 0.0 113.526 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.2 tpt -69.24 -43.57 73.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.986 0.915 . . . . 0.0 111.756 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.4 mm -65.46 -36.44 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.752 0.821 . . . . 0.0 111.014 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.63 -40.44 79.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.213 1.005 . . . . 0.0 112.955 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.12 -42.93 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.921 1.289 . . . . 0.0 111.659 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.1 mt -65.39 -36.77 84.99 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.739 0.815 . . . . 0.0 112.548 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -67.07 -35.47 79.9 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.374 -1.454 . . . . 0.0 112.443 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.31 -21.66 65.67 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.57 -13.27 20.49 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.64 1.576 . . . . 0.0 114.124 170.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.74 71.3 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.433 1.492 . . . . 0.0 115.479 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.8 mp -112.09 144.89 40.71 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.26 1.424 . . . . 0.0 111.321 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -113.75 130.17 56.48 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.617 0.767 . . . . 0.0 110.649 166.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -104.82 170.6 7.78 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.023 1.729 . . . . 0.0 111.26 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -86.34 119.83 27.04 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.5 -1.375 . . . . 0.0 109.45 -157.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.2 m -113.23 129.71 56.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.339 -158.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -115.07 155.05 27.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.994 1.317 . . . . 0.0 111.059 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -111.21 94.95 5.24 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.845 1.258 . . . . 0.0 110.48 -168.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 p -70.02 -23.2 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.236 1.015 . . . . 0.0 112.953 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.9 tp -78.35 -30.75 48.21 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.081 0.952 . . . . 0.0 111.424 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.53 -35.28 19.63 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -131.32 98.93 17.94 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.825 0.85 . . . . 0.0 111.945 -170.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.97 -12.23 33.56 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.394 2.729 . . . . 0.0 114.761 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.0 p -49.1 -42.04 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.717 1.207 . . . . 0.0 112.489 170.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.75 -46.27 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.802 0.841 . . . . 0.0 111.704 -177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.455 ' HA ' HG12 ' A' ' 136' ' ' VAL . 50.8 ptt85 -71.33 -23.75 61.98 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -70.36 -51.43 29.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.116 0.567 . . . . 0.0 112.11 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -70.96 -37.99 72.8 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.641 -0.662 . . . . 0.0 112.429 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 133' ' ' ARG . 8.9 p -65.39 -34.95 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 121.362 -0.836 . . . . 0.0 112.557 176.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -66.72 -43.22 84.86 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.338 -0.851 . . . . 0.0 110.991 171.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -56.92 -42.69 80.44 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.678 0.791 . . . . 0.0 113.037 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -80.26 -45.28 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.618 1.167 . . . . 0.0 112.988 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.5 m -106.05 -5.93 19.09 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 62.65 -25.99 0.06 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 128.075 2.55 . . . . 0.0 115.973 -172.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -136.28 92.0 16.14 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 127.2 2.2 . . . . 0.0 112.045 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -72.31 147.64 47.73 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.624 2.883 . . . . 0.0 114.317 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 11.4 m -125.99 137.27 53.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.616 1.566 . . . . 0.0 107.842 160.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mp -108.04 133.26 20.57 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.45 159.1 73.35 Favored 'Cis proline' 0 CA--C 1.546 1.091 0 CA-C-N 120.706 1.288 . . . . 0.0 112.012 -12.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -137.92 164.28 29.39 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.953 1.701 . . . . 0.0 110.913 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.7 139.62 52.59 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 122.776 1.274 . . . . 0.0 114.209 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -125.43 140.31 52.9 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 112.741 -2.027 . . . . 0.0 110.247 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 57.3 mt -128.87 121.85 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.293 1.037 . . . . 0.0 109.138 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt 45.12 51.13 9.18 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.064 1.746 . . . . 0.0 113.008 -172.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.63 10.21 1.88 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 -175.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.58 143.63 28.77 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.193 1.36 . . . . 0.0 110.516 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -86.35 123.59 31.76 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.701 0.763 . . . . 0.0 112.909 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.0 t -101.8 -50.92 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.459 1.504 . . . . 0.0 111.964 -171.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 175.19 163.85 28.88 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 117.238 1.655 . . . . 0.0 117.238 177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.72 168.94 53.98 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 125.575 1.56 . . . . 0.0 114.124 167.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.0 tp -44.19 -42.05 6.19 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.947 1.699 . . . . 0.0 115.01 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -67.9 -38.06 82.52 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.799 -0.563 . . . . 0.0 111.338 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 2.4 mm -74.97 -39.12 44.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 C-N-CA 125.131 1.373 . . . . 0.0 110.26 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.05 -42.42 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 120.971 -1.081 . . . . 0.0 110.696 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.9 m -65.33 -43.87 89.59 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.703 0.801 . . . . 0.0 111.427 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -56.8 -46.25 81.7 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.72 1.208 . . . . 0.0 111.74 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.9 mtt -67.05 -35.26 79.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.752 1.621 . . . . 0.0 112.7 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.84 -46.54 68.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.389 1.076 . . . . 0.0 111.109 173.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.96 -17.39 64.43 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.003 1.321 . . . . 0.0 112.906 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 20.2 m -101.03 -16.18 17.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.218 1.407 . . . . 0.0 114.788 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.26 -4.12 73.68 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 120.21 1.368 . . . . 0.0 114.446 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -65.14 -32.03 73.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.556 1.678 . . . . 0.0 112.922 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.71 -43.3 98.0 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.114 172.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -64.35 -38.71 91.99 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 125.518 1.527 . . . . 0.0 112.726 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -58.43 -48.82 79.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.722 1.146 . . . . 0.0 110.92 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.9 mtm -69.59 -44.92 69.8 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 pp -66.16 -40.83 90.82 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.011 0.369 . . . . 0.0 111.435 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -71.75 -32.28 67.54 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.426 -0.796 . . . . 0.0 112.963 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.18 -26.51 68.18 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.363 0.529 . . . . 0.0 112.407 169.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.3 mmmt -76.23 4.44 8.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.592 1.557 . . . . 0.0 113.875 169.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.42 0.02 89.85 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 126.273 1.892 . . . . 0.0 113.671 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.3 mt -84.81 144.53 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 118.782 1.291 . . . . 0.0 109.862 -169.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.9 m -108.23 139.6 42.68 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.355 1.462 . . . . 0.0 111.094 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 21.8 p -137.17 170.04 16.77 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.924 1.689 . . . . 0.0 112.16 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -47.26 155.1 0.34 Allowed 'General case' 0 N--CA 1.479 1.018 0 O-C-N 121.536 -0.727 . . . . 0.0 112.512 167.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -118.05 130.43 56.15 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.151 0.981 . . . . 0.0 108.861 154.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.9 tp . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.866 1.666 . . . . 0.0 112.025 -165.058 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 m -70.37 -7.45 42.94 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.7 m -53.14 120.38 5.85 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.911 -1.118 . . . . 0.0 111.888 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.84 -6.19 42.47 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 126.576 2.036 . . . . 0.0 117.085 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.1 mt -80.46 126.76 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 120.478 2.139 . . . . 0.0 112.68 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.69 167.11 39.42 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 125.538 1.542 . . . . 0.0 114.59 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 174.66 167.94 34.71 Favored Glycine 0 CA--C 1.536 1.382 0 O-C-N 121.635 -0.921 . . . . 0.0 115.115 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -137.44 160.9 37.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.458 1.503 . . . . 0.0 114.037 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -135.27 149.79 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.854 2.062 . . . . 0.0 111.469 -167.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.34 152.93 18.84 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 126.358 1.863 . . . . 0.0 113.466 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -117.13 151.33 37.07 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.216 1.406 . . . . 0.0 114.716 -168.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.0 mt -112.51 132.28 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 126.033 1.733 . . . . 0.0 111.088 -171.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -73.32 125.09 27.01 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.812 0.845 . . . . 0.0 113.089 177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.91 132.99 35.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.772 1.229 . . . . 0.0 109.792 169.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.6 m -136.61 -17.84 1.46 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.61 1.964 . . . . 0.0 111.593 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 53.0 t-80 -59.87 148.51 76.22 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 126.106 1.762 . . . . 0.0 112.981 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 58' ' ' HIS . 82.6 Cg_exo -63.13 -179.33 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.275 3.317 . . . . 0.0 116.924 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.99 0.14 25.53 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.164 2.186 . . . . 0.0 114.477 -176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -133.23 123.91 26.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.761 1.224 . . . . 0.0 111.264 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -73.28 145.07 85.12 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 122.891 0.476 . . . . 0.0 111.364 -175.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -59.87 154.12 52.3 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.652 2.235 . . . . 0.0 112.707 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -106.5 140.58 39.17 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.308 1.443 . . . . 0.0 109.695 171.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.9 tp -163.53 148.61 11.02 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.201 1.4 . . . . 0.0 111.822 -176.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 t -67.17 -49.46 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.912 0.885 . . . . 0.0 111.938 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.7 m -74.77 153.52 38.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.054 0.942 . . . . 0.0 111.867 173.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.39 106.79 5.35 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.796 0.838 . . . . 0.0 112.261 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -156.6 153.77 29.13 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.212 1.405 . . . . 0.0 110.109 169.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.6 mt -135.95 167.31 21.45 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.119 1.767 . . . . 0.0 110.987 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.24 176.13 2.36 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.941 1.296 . . . . 0.0 113.637 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -62.33 -26.35 68.39 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.372 -0.83 . . . . 0.0 112.044 170.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.252 0.4 OUTLIER -66.02 -25.55 67.12 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 120.339 -1.475 . . . . 0.0 114.021 -176.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -59.1 -22.83 61.45 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.746 1.618 . . . . 0.0 112.967 166.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 61.9 mt -85.17 -26.94 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.209 1.404 . . . . 0.0 110.505 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.23 14.66 13.73 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.236 1.814 . . . . 0.0 113.744 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 25.0 ttt -59.15 149.99 26.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.96 1.304 . . . . 0.0 113.113 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.7 m -45.18 148.65 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.898 1.679 . . . . 0.0 113.913 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -85.3 153.4 22.6 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.029 1.332 . . . . 0.0 111.646 -166.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -58.15 -28.51 64.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.177 1.391 . . . . 0.0 114.326 -170.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -58.01 -31.35 66.88 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.473 1.509 . . . . 0.0 113.599 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 40.0 mm -75.17 -48.28 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.682 1.193 . . . . 0.0 110.179 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.54 -37.97 82.97 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.55 1.14 . . . . 0.0 111.89 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -62.88 -30.34 71.45 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.957 1.703 . . . . 0.0 112.68 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.6 m -76.89 -48.35 18.54 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.216 1.406 . . . . 0.0 110.334 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.432 HD13 ' CE2' ' A' ' 135' ' ' TYR . 29.4 mt -55.94 -36.4 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 127.685 2.394 . . . . 0.0 110.924 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -75.83 -30.17 58.89 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 126.535 1.934 . . . . 0.0 114.729 171.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.4 t -78.94 -39.93 33.32 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.509 0.724 . . . . 0.0 112.224 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -90.16 140.93 29.18 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -170.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -66.38 -39.6 89.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.37 0.668 . . . . 0.0 112.631 -171.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.1 t -140.77 133.72 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 109.759 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.44 134.14 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.778 1.231 . . . . 0.0 110.089 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.6 t -131.86 155.39 47.92 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.083 0.953 . . . . 0.0 111.237 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -133.31 135.88 45.11 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.426 0.632 . . . . 0.0 111.899 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.5 mt -133.95 153.69 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 109.015 -157.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -69.49 104.58 2.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 158.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.08 -134.16 12.75 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.829 1.204 . . . . 0.0 114.337 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.1 mt -126.33 157.72 69.31 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 126.342 1.857 . . . . 0.0 111.658 -168.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.25 -21.5 31.13 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.127 1.885 . . . . 0.0 113.833 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.23 -22.22 35.97 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.477 1.111 . . . . 0.0 113.108 167.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.22 74.02 11.87 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.4 1.48 . . . . 0.0 113.046 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.37 143.65 22.26 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.948 2.432 . . . . 0.0 111.262 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 51.0 ttm -110.14 7.18 23.31 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.256 1.822 . . . . 0.0 113.081 -163.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 54.1 t -150.63 149.01 29.32 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.647 1.979 . . . . 0.0 111.041 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.75 93.99 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.32 0.964 . . . . 0.0 112.702 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -66.93 -31.45 72.05 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.83 -1.169 . . . . 0.0 111.42 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.6 m -70.39 -37.96 74.6 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 118.265 -0.874 . . . . 0.0 112.933 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -55.94 -47.36 77.7 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 120.199 1.363 . . . . 0.0 110.703 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -61.81 -31.9 72.16 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.9 tpt -61.41 -44.35 97.29 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.668 0.667 . . . . 0.0 111.517 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.0 mm -68.28 -37.95 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.075 0.55 . . . . 0.0 111.146 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.4 -40.56 78.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.032 0.933 . . . . 0.0 112.58 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.77 -44.3 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.272 0.629 . . . . 0.0 111.506 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.6 mt -65.9 -36.98 84.91 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.813 0.845 . . . . 0.0 112.317 177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -66.01 -32.99 74.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.562 1.145 . . . . 0.0 112.917 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.95 76.6 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.715 0.806 . . . . 0.0 111.978 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.65 -14.81 44.41 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.886 0.874 . . . . 0.0 113.092 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.57 14.17 62.05 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.619 1.104 . . . . 0.0 114.26 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 58.0 mt -112.07 128.44 56.2 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.209 1.004 . . . . 0.0 111.315 169.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -115.54 144.69 43.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.854 1.262 . . . . 0.0 111.17 172.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -125.12 169.95 11.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.384 1.874 . . . . 0.0 111.809 -166.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.1 m -85.07 126.29 33.46 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 122.495 1.141 . . . . 0.0 109.44 -166.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.1 m -123.72 138.93 54.43 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 113.681 -1.6 . . . . 0.0 112.095 -155.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -125.6 139.43 53.59 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -84.01 112.19 19.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.343 2.257 . . . . 0.0 111.495 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.4 m -70.35 -17.85 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.1 tp -87.36 -19.97 27.39 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.607 1.163 . . . . 0.0 111.957 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.24 -29.07 13.78 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.764 1.225 . . . . 0.0 113.366 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.32 96.9 38.23 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -53.11 -26.75 34.09 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.569 3.512 . . . . 0.0 115.501 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -57.27 -36.04 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.112 0.965 . . . . 0.0 113.595 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 63.1 t -69.75 -51.48 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.964 0.906 . . . . 0.0 110.819 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.461 ' HA ' HG12 ' A' ' 136' ' ' VAL . 8.1 ptm180 -63.98 -26.12 68.44 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.673 175.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.9 m -71.61 -48.05 50.65 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.49 ' CZ ' HG21 ' A' ' 139' ' ' VAL . 48.7 t80 -61.02 -48.05 83.6 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 120.752 1.615 . . . . 0.0 109.807 176.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 133' ' ' ARG . 9.1 p -66.64 -35.26 74.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 121.283 -0.886 . . . . 0.0 112.837 -175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -59.26 -46.61 88.05 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.19 1.396 . . . . 0.0 112.102 171.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.25 -46.64 40.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.301 1.04 . . . . 0.0 112.9 -177.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.49 HG21 ' CZ ' ' A' ' 135' ' ' TYR . 86.6 t -81.3 -36.19 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.629 1.572 . . . . 0.0 112.632 -164.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.4 m -104.97 4.22 31.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 58.19 -5.89 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 127.89 2.476 . . . . 0.0 117.358 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -146.27 121.43 5.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 126.638 1.975 . . . . 0.0 108.598 166.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.25 130.44 7.2 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.66 2.24 . . . . 0.0 111.801 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 68.5 p -128.45 136.85 51.41 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.968 1.307 . . . . 0.0 110.886 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.0 mt -130.03 140.56 39.01 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 125.259 1.424 . . . . 0.0 110.452 -172.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.17 156.42 78.76 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 CA-C-N 120.939 1.371 . . . . 0.0 110.895 -8.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -138.25 160.01 40.56 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.69 135.61 52.31 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.536 1.134 . . . . 0.0 112.192 177.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -127.21 141.65 51.68 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.637 1.975 . . . . 0.0 109.155 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.6 mt -130.61 118.5 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.2 tptt 46.74 52.88 10.84 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 127.331 2.253 . . . . 0.0 115.647 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.81 28.64 18.38 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -174.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -127.89 137.29 52.26 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.093 -1.004 . . . . 0.0 110.508 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -70.35 130.39 41.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.408 0.623 . . . . 0.0 112.121 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.75 -47.58 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.063 0.945 . . . . 0.0 110.181 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.15 175.31 22.17 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.519 0.967 . . . . 0.0 115.519 171.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.64 169.99 54.65 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.258 0.933 . . . . 0.0 112.793 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.23 -43.4 10.28 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.109 1.364 . . . . 0.0 113.189 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.45 ' O ' ' HE3' ' A' ' 163' ' ' LYS . 19.7 t70 -60.24 -24.87 65.22 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.943 0.897 . . . . 0.0 113.283 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.4 mm -92.1 -47.01 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.675 1.59 . . . . 0.0 110.471 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.04 -36.55 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.361 1.864 . . . . 0.0 111.808 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -60.58 -50.92 71.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 171.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 159' ' ' ASP . 60.1 mttt -60.86 -38.62 86.19 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.625 0.37 . . . . 0.0 110.231 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.5 mtp -67.85 -35.5 78.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.748 0.819 . . . . 0.0 112.577 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.59 -46.24 69.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.602 1.161 . . . . 0.0 111.721 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -74.13 -16.29 61.01 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.8 m -100.78 -9.86 21.34 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.09 1.356 . . . . 0.0 114.353 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.17 -4.25 67.93 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-N 119.661 1.119 . . . . 0.0 114.453 -170.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.99 -34.12 74.3 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.866 -1.373 . . . . 0.0 113.532 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tt -61.67 -41.01 96.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.763 1.225 . . . . 0.0 111.029 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -67.31 -31.3 71.5 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 126.303 1.841 . . . . 0.0 113.239 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -57.02 -43.14 81.54 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.24 1.016 . . . . 0.0 111.837 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -73.6 -49.57 25.53 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 172.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.65 -39.02 90.94 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.844 -0.535 . . . . 0.0 112.128 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -69.49 -40.76 76.85 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.683 0.793 . . . . 0.0 111.393 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.82 -27.7 65.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.536 1.535 . . . . 0.0 113.455 172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -75.06 -4.49 38.77 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.403 -0.81 . . . . 0.0 112.877 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.59 15.81 51.48 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 125.072 1.32 . . . . 0.0 114.498 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.0 mt -103.8 123.72 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.159 0.98 . . . . 0.0 109.976 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.3 m -85.27 133.58 34.16 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.36 0.6 . . . . 0.0 111.633 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.5 p -128.92 170.14 13.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.494 2.318 . . . . 0.0 111.957 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -81.38 154.02 26.67 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.395 -0.815 . . . . 0.0 111.278 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -81.19 139.5 35.51 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.255 1.385 0 C-N-CA 126.814 2.046 . . . . 0.0 113.119 -178.194 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.1 m -65.24 -24.05 67.22 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.299 1.408 . . . . 0.0 113.672 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.5 m -83.21 -7.57 59.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.84 22.72 78.29 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.419 1.009 . . . . 0.0 115.265 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.0 pt -100.25 153.86 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.578 1.551 . . . . 0.0 112.842 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.44 164.06 35.97 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 123.708 0.671 . . . . 0.0 114.44 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.46 -131.4 7.13 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.365 1.936 . . . . 0.0 113.488 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -109.17 106.75 16.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.112 2.165 . . . . 0.0 109.814 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.9 p -148.03 142.49 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.051 1.34 . . . . 0.0 111.011 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -142.62 150.98 41.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.153 1.381 . . . . 0.0 112.559 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -127.11 141.03 51.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.455 1.902 . . . . 0.0 110.368 173.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.0 mm -80.42 124.48 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.439 -0.788 . . . . 0.0 111.953 -175.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -155.72 127.02 7.16 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.14 1.776 . . . . 0.0 110.067 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -145.29 154.43 42.35 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.12 2.568 . . . . 0.0 111.077 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.7 p -73.5 134.46 43.87 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -93.57 146.69 32.26 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.348 1.059 . . . . 0.0 110.784 164.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.45 158.71 36.44 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.139 2.559 . . . . 0.0 111.602 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -92.18 -4.55 54.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.226 1.011 . . . . 0.0 113.328 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -142.24 153.56 44.06 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.707 1.603 . . . . 0.0 111.69 -174.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -105.98 154.16 39.68 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 126.09 1.756 . . . . 0.0 111.777 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.73 155.29 63.01 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.887 3.058 . . . . 0.0 116.162 -168.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -119.93 123.96 44.83 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.43 2.292 . . . . 0.0 110.387 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt 52.96 31.91 11.77 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.823 2.049 . . . . 0.0 114.072 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.8 t -145.21 144.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 127.122 2.169 . . . . 0.0 109.399 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.2 t -63.23 143.29 57.92 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.72 -11.52 58.55 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 170.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.0 t70 49.49 -119.85 1.33 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.783 2.033 . . . . 0.0 112.001 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.0 tp -138.02 146.41 43.03 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.595 2.358 . . . . 0.0 109.329 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.1 137.34 41.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.463 0.705 . . . . 0.0 112.516 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.31 -36.58 78.24 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.345 1.058 . . . . 0.0 111.71 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -65.52 -34.39 78.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.756 2.023 . . . . 0.0 113.806 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -73.21 -48.38 35.54 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.964 0.906 . . . . 0.0 112.728 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.8 tp -73.69 -13.13 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.136 0.974 . . . . 0.0 113.507 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.6 -22.86 50.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.602 0.761 . . . . 0.0 112.72 171.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 49.3 ttm -110.27 120.6 42.96 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.467 1.107 . . . . 0.0 111.21 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.6 m -81.91 141.56 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 158.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -94.87 111.52 23.3 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -170.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -62.79 -30.51 71.52 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -156.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.76 -32.73 72.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.272 1.396 . . . . 0.0 112.572 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.81 -44.37 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.375 1.07 . . . . 0.0 109.738 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -58.0 -36.86 73.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.04 1.336 . . . . 0.0 112.311 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -64.17 -37.14 86.41 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.762 -1.211 . . . . 0.0 112.33 170.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.2 m -75.89 -50.9 13.74 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.162 0.985 . . . . 0.0 111.694 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.1 pt -61.2 -34.34 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.745 0.818 . . . . 0.0 111.83 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -80.85 -29.34 35.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.444 1.897 . . . . 0.0 114.486 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.1 t -74.25 -41.13 61.79 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.636 0.774 . . . . 0.0 111.209 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.82 138.29 32.17 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.26 1.024 . . . . 0.0 110.715 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.43 -31.89 24.39 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.252 -0.905 . . . . 0.0 112.538 -169.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.6 t -138.58 126.56 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.854 1.262 . . . . 0.0 109.546 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.0 t -130.53 131.21 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.406 1.482 . . . . 0.0 110.565 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.9 t -133.77 156.71 47.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.664 1.185 . . . . 0.0 110.457 172.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.67 142.74 49.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.146 169.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.6 mt -132.56 157.38 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.383 1.473 . . . . 0.0 109.403 -162.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.7 101.23 2.51 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 156.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.23 -154.82 27.93 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.174 0.897 . . . . 0.0 114.214 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.21 154.67 39.45 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 125.655 1.582 . . . . 0.0 111.969 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -65.67 -19.99 59.69 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.287 1.991 . . . . 0.0 113.605 171.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -93.9 -13.06 27.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.582 1.553 . . . . 0.0 113.986 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.54 73.34 11.68 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.544 1.537 . . . . 0.0 112.353 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.4 148.64 67.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.943 2.429 . . . . 0.0 111.874 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.4 mmt -104.42 -0.3 28.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.3 1.84 . . . . 0.0 113.631 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 17.1 t -146.46 144.83 29.94 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.969 1.307 . . . . 0.0 111.428 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.2 -38.66 80.45 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -72.23 -29.87 64.35 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.048 -1.033 . . . . 0.0 112.279 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 m -66.89 -34.45 77.81 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.697 -0.668 . . . . 0.0 112.346 167.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -67.27 -45.59 76.17 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.77 1.168 . . . . 0.0 112.781 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -57.27 -33.28 67.47 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.002 0.921 . . . . 0.0 112.915 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.0 tpt -56.07 -43.56 78.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.951 0.901 . . . . 0.0 111.865 171.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 mm -69.55 -33.34 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.337 1.055 . . . . 0.0 111.3 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.4 -34.91 79.41 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.36 -1.462 . . . . 0.0 112.771 172.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.81 -43.16 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 122.902 0.481 . . . . 0.0 110.728 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.9 mt -65.77 -37.92 87.64 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -66.65 -31.49 72.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.403 -1.436 . . . . 0.0 113.078 171.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.0 -25.49 68.41 Favored 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.613 -1.304 . . . . 0.0 113.374 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.04 -13.01 21.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.881 1.272 . . . . 0.0 114.154 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.6 13.0 67.92 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.568 1.08 . . . . 0.0 115.03 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.76 134.35 55.1 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.773 1.229 . . . . 0.0 112.905 174.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -113.68 157.93 21.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.772 1.229 . . . . 0.0 111.548 168.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -137.24 171.95 13.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.982 1.713 . . . . 0.0 111.418 -161.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.4 m -83.97 120.4 26.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.545 1.164 . . . . 0.0 108.842 -166.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 74.6 m -126.18 124.26 40.08 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 113.505 -1.68 . . . . 0.0 111.645 -155.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.25 157.98 18.3 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.305 1.042 . . . . 0.0 111.959 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -120.16 117.18 27.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.803 1.241 . . . . 0.0 111.292 -171.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.5 p -71.58 -27.7 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.3 -37.99 68.84 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.343 -0.848 . . . . 0.0 110.506 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.61 -31.62 22.51 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -141.4 107.38 6.09 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 119.466 1.03 . . . . 0.0 113.136 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -60.15 -15.49 34.48 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.648 2.898 . . . . 0.0 116.758 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 p -49.22 -32.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.552 1.524 . . . . 0.0 112.743 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.96 -44.46 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.94 0.896 . . . . 0.0 111.646 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.565 ' HA ' HG12 ' A' ' 136' ' ' VAL . 9.3 ptm85 -71.71 -27.52 63.07 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.916 0.78 . . . . 0.0 112.208 175.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m -67.05 -48.94 66.78 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.27 0.628 . . . . 0.0 112.259 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -38.86 71.23 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.489 1.04 . . . . 0.0 113.002 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 133' ' ' ARG . 1.9 p -66.46 -32.46 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.508 1.049 . . . . 0.0 112.188 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -62.47 -41.99 99.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.883 0.873 . . . . 0.0 112.248 170.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.56 -47.29 55.92 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.537 -0.727 . . . . 0.0 111.771 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.6 t -82.82 -40.62 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -173.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.6 m -102.57 -12.86 17.44 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 64.84 -47.19 0.34 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 169.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -129.0 89.75 47.75 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 126.085 1.754 . . . . 0.0 106.784 164.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -89.6 158.23 5.28 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.935 2.424 . . . . 0.0 113.771 -166.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 67.0 p -122.98 151.57 41.72 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.874 1.669 . . . . 0.0 108.918 161.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 55.0 mt -125.07 127.26 25.1 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 124.007 0.923 . . . . 0.0 109.089 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.93 161.54 65.25 Favored 'Cis proline' 0 CA--C 1.542 0.9 0 CA-C-N 119.766 0.952 . . . . 0.0 113.948 7.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -135.26 158.74 43.6 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.358 1.863 . . . . 0.0 110.836 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.81 140.54 51.97 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.141 1.376 . . . . 0.0 113.234 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -133.79 143.0 48.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.886 2.074 . . . . 0.0 109.832 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.8 mt -129.66 117.48 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.591 0.756 . . . . 0.0 109.306 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.5 tptt 43.54 47.41 6.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.359 2.263 . . . . 0.0 113.745 -170.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.95 16.88 9.59 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -100.15 140.11 34.86 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 120.734 -1.229 . . . . 0.0 109.535 162.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -80.04 125.45 29.79 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.378 -0.826 . . . . 0.0 112.418 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.5 t -102.68 -47.14 10.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 124.656 1.182 . . . . 0.0 111.8 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.65 176.91 32.25 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 117.12 1.608 . . . . 0.0 117.12 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.39 168.42 53.82 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.859 1.218 . . . . 0.0 113.341 165.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -45.59 -44.69 13.19 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.322 1.849 . . . . 0.0 113.817 177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.78 -26.55 66.16 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.718 -0.614 . . . . 0.0 112.528 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.3 mm -79.22 -46.61 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.118 1.367 . . . . 0.0 110.389 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.1 t -57.73 -35.94 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.335 1.854 . . . . 0.0 111.337 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 86.7 m -64.06 -41.61 97.3 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.696 0.798 . . . . 0.0 112.527 173.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -65.95 -44.06 86.13 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.315 0.961 . . . . 0.0 110.198 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.7 mtt -61.51 -35.7 78.46 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.372 1.069 . . . . 0.0 112.317 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.81 -45.52 74.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.614 1.166 . . . . 0.0 111.984 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -69.78 -33.19 72.05 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.814 0.733 . . . . 0.0 112.479 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.6 t -86.23 -30.39 22.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.81 2.42 52.47 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 120.656 -1.278 . . . . 0.0 115.463 -171.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -68.17 -35.03 77.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.107 1.454 . . . . 0.0 112.086 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.04 -45.5 85.14 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.34 -0.85 . . . . 0.0 110.158 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.86 -38.56 82.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.46 1.504 . . . . 0.0 113.136 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -60.6 -48.41 81.92 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.959 0.503 . . . . 0.0 111.66 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.1 mtm -70.85 -44.7 65.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.44 -37.84 88.93 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.503 -0.748 . . . . 0.0 111.176 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -72.57 -32.42 66.02 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.42 -28.35 69.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.278 1.031 . . . . 0.0 111.891 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 6.16 13.73 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.303 1.841 . . . . 0.0 113.771 171.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.14 -2.78 86.38 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.744 2.116 . . . . 0.0 113.7 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.4 mt -82.15 142.72 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.617 1.209 . . . . 0.0 110.459 -165.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 m -101.12 128.82 47.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.348 1.459 . . . . 0.0 110.273 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 14.8 p -132.04 170.69 14.59 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.81 1.644 . . . . 0.0 112.883 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -65.15 129.47 39.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.961 0.904 . . . . 0.0 109.755 166.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -137.69 145.0 42.05 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--O 1.253 1.242 0 C-N-CA 126.651 1.98 . . . . 0.0 113.44 -179.308 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.9 m -82.08 -34.83 29.2 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.122 1.769 . . . . 0.0 111.879 171.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.0 m -71.89 132.69 44.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.093 0.957 . . . . 0.0 112.565 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.22 25.97 67.33 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 115.811 1.084 . . . . 0.0 115.811 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 18.4 tt -135.71 132.91 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.195 1.398 . . . . 0.0 110.523 170.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.32 160.54 49.0 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.473 1.035 . . . . 0.0 114.272 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.34 103.76 1.49 Allowed Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.866 1.698 . . . . 0.0 112.949 -175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -107.25 148.3 29.13 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.37 1.468 . . . . 0.0 112.598 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -99.53 151.29 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.371 1.068 . . . . 0.0 113.285 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -108.39 161.62 14.86 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.415 1.886 . . . . 0.0 112.926 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -114.28 148.27 37.75 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.966 1.306 . . . . 0.0 114.17 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.1 tt -152.43 145.72 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.655 1.582 . . . . 0.0 112.194 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -120.66 126.2 49.62 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 0.0 111.176 174.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.59 159.63 43.24 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.387 1.475 . . . . 0.0 113.429 -166.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.7 m -155.92 103.46 2.23 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.043 1.337 . . . . 0.0 109.763 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -74.83 141.53 75.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.13 162.69 25.79 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.052 3.168 . . . . 0.0 111.971 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -77.8 -7.21 56.29 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -67.5 122.13 17.32 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.158 0.983 . . . . 0.0 110.651 176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -73.91 144.33 82.37 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 122.936 0.495 . . . . 0.0 111.461 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.55 149.92 89.78 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.939 2.426 . . . . 0.0 112.658 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -65.34 122.91 18.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.426 1.09 . . . . 0.0 111.823 -169.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.22 157.58 25.45 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.158 0.983 . . . . 0.0 111.544 176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t 63.78 -25.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 127.835 2.454 . . . . 0.0 115.134 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 t -80.7 149.32 29.78 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.53 1.132 . . . . 0.0 113.157 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.88 58.98 5.12 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.417 1.087 . . . . 0.0 109.847 159.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.49 142.22 48.55 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.861 0.865 . . . . 0.0 111.849 -172.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tt -135.48 132.93 37.97 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.118 -0.989 . . . . 0.0 111.827 -174.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.15 149.66 38.37 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.691 1.197 . . . . 0.0 112.657 -171.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.69 -31.97 73.27 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -172.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -60.56 -28.8 68.72 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.923 -1.11 . . . . 0.0 113.044 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -56.4 -21.39 24.73 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.342 1.457 . . . . 0.0 113.596 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 97.7 mt -67.71 -26.53 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.144 0.978 . . . . 0.0 110.855 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.08 0.39 14.97 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.053 1.341 . . . . 0.0 114.459 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.3 mtt -73.26 112.89 9.74 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 166.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -146.85 133.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.713 0.805 . . . . 0.0 111.672 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -113.15 98.09 6.92 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.913 0.885 . . . . 0.0 108.669 169.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -59.63 -40.59 88.13 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.542 1.537 . . . . 0.0 113.862 -160.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -76.13 -29.59 57.89 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.9 mt -78.57 -40.81 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.855 0.862 . . . . 0.0 110.504 174.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -58.94 -39.44 81.62 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.934 0.894 . . . . 0.0 111.738 168.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.4 -33.11 74.51 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.431 1.093 . . . . 0.0 112.586 169.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.6 m -63.67 -49.94 71.2 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.185 0.902 . . . . 0.0 111.079 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.9 pt -60.25 -34.47 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 119.412 1.005 . . . . 0.0 112.175 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -77.91 -30.15 50.5 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.326 1.851 . . . . 0.0 113.397 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 t -87.02 -34.01 19.37 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.796 1.638 . . . . 0.0 113.162 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.22 147.93 27.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.716 2.006 . . . . 0.0 110.503 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -70.11 -43.25 71.41 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 119.943 -1.723 . . . . 0.0 112.525 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -141.1 132.9 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.974 0.91 . . . . 0.0 112.17 -171.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.56 140.93 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.156 1.382 . . . . 0.0 112.266 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 t -133.02 158.98 41.36 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.925 1.29 . . . . 0.0 111.632 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -132.43 141.09 48.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.247 0.546 . . . . 0.0 112.045 171.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 107' ' ' SER . 9.6 mt -134.48 156.9 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 126.622 1.969 . . . . 0.0 109.336 -163.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -66.27 101.57 0.74 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 150.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.81 -140.39 20.15 Favored Glycine 0 CA--C 1.537 1.415 0 O-C-N 121.126 -0.984 . . . . 0.0 114.277 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.8 mt -111.58 155.9 42.25 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 125.274 1.43 . . . . 0.0 112.581 -170.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.59 -12.61 31.6 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.727 2.284 . . . . 0.0 113.094 172.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -91.53 -26.93 18.53 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.827 1.651 . . . . 0.0 112.113 170.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.39 78.01 12.37 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.204 1.802 . . . . 0.0 111.872 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.05 143.21 17.78 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.106 2.537 . . . . 0.0 112.356 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 33.9 ttm -102.6 10.57 38.66 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.561 1.544 . . . . 0.0 113.352 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 51.4 t -145.09 145.18 31.32 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.917 -1.115 . . . . 0.0 111.843 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -36.79 83.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.493 1.117 . . . . 0.0 112.845 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -69.23 -24.45 64.01 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.066 -1.022 . . . . 0.0 112.544 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.488 ' HB3' HG23 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -70.55 -34.44 72.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.921 -1.112 . . . . 0.0 113.972 163.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -61.29 -39.6 91.06 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.453 1.479 . . . . 0.0 111.32 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -60.54 -38.6 84.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.713 0.805 . . . . 0.0 112.803 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.4 tpt -64.62 -47.58 78.05 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.652 1.181 . . . . 0.0 112.399 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.65 -32.17 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.408 -0.808 . . . . 0.0 111.369 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.73 -34.73 67.79 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.702 -1.249 . . . . 0.0 113.207 171.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.5 t -67.31 -41.85 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 122.673 0.389 . . . . 0.0 110.766 176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -39.43 93.88 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.107 0.963 . . . . 0.0 112.229 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.27 -34.18 76.88 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.136 -0.978 . . . . 0.0 112.358 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.06 -23.58 63.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.436 1.095 . . . . 0.0 113.78 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.2 mt -95.9 -13.18 24.13 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.024 0.929 . . . . 0.0 113.244 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.07 18.64 67.11 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.277 0.941 . . . . 0.0 113.696 -175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 17.9 mt -113.12 130.71 56.1 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.581 1.552 . . . . 0.0 112.697 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -116.28 147.23 41.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.828 0.851 . . . . 0.0 112.941 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -129.35 172.45 11.49 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.027 2.531 . . . . 0.0 111.167 -163.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.3 m -86.4 133.9 33.75 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.365 -0.834 . . . . 0.0 110.405 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 t -131.12 146.9 52.52 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -164.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.01 152.71 39.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.167 1.787 . . . . 0.0 112.302 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -100.42 118.11 35.98 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.374 1.07 . . . . 0.0 111.426 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.6 p -66.4 -25.22 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.312 0.645 . . . . 0.0 112.624 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 tp -73.92 -22.21 59.77 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.028 0.931 . . . . 0.0 111.786 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.84 -29.88 11.19 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -125.08 106.44 28.47 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -52.88 -28.31 38.58 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.401 3.4 . . . . 0.0 115.663 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.67 -35.48 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.66 0.784 . . . . 0.0 112.111 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.81 -48.97 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.506 0.723 . . . . 0.0 110.871 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.428 ' HA ' HG12 ' A' ' 136' ' ' VAL . 9.7 ptp180 -70.75 -30.97 67.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.043 0.537 . . . . 0.0 112.056 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 70.8 m -69.38 -47.46 64.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.633 0.651 . . . . 0.0 112.301 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.5 -40.4 77.03 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.022 -1.049 . . . . 0.0 112.293 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 133' ' ' ARG . 12.3 p -63.93 -35.81 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 120.651 -1.281 . . . . 0.0 112.539 176.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -65.87 -44.95 83.88 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.732 0.813 . . . . 0.0 111.64 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.6 -41.38 92.83 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.648 0.779 . . . . 0.0 112.956 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.35 -41.94 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -175.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.3 m -98.94 1.64 45.77 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.855 1.207 . . . . 0.0 113.91 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 67.29 -22.82 0.11 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.368 2.667 . . . . 0.0 116.448 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -145.94 132.23 9.67 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.788 1.635 . . . . 0.0 109.458 171.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.31 126.98 5.72 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.876 1.717 . . . . 0.0 113.188 -165.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.8 p -135.52 136.85 41.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.446 1.898 . . . . 0.0 111.275 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.9 mm -128.05 137.42 30.77 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 125.458 1.503 . . . . 0.0 110.745 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.64 160.57 76.48 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 121.341 1.515 . . . . 0.0 112.447 -4.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -134.88 159.63 40.81 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.968 1.307 . . . . 0.0 110.515 -172.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.33 139.46 53.28 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -124.11 140.8 52.62 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.796 2.038 . . . . 0.0 110.411 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.8 mt -130.2 123.32 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.456 1.102 . . . . 0.0 108.387 170.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm 45.54 49.92 10.63 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.886 2.075 . . . . 0.0 114.88 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.4 26.45 15.35 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -118.41 138.23 52.6 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.767 1.227 . . . . 0.0 108.689 164.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.49 125.49 30.03 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.459 -0.775 . . . . 0.0 111.093 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 t -80.55 -40.49 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.499 1.119 . . . . 0.0 110.261 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.81 175.64 34.92 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.373 1.463 . . . . 0.0 114.327 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.25 172.14 55.19 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.852 0.739 . . . . 0.0 113.885 165.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.3 tp -48.65 -42.67 35.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.069 1.347 . . . . 0.0 113.686 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -59.41 -25.32 64.22 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.832 1.253 . . . . 0.0 113.018 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.9 mm -91.23 -46.6 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.27 1.428 . . . . 0.0 110.122 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.9 t -57.73 -40.89 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.249 1.42 . . . . 0.0 111.583 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.6 p -64.78 -40.93 96.08 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.5 pttt -68.43 -40.87 81.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.274 0.63 . . . . 0.0 112.211 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.9 mtt -63.23 -36.09 82.49 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.329 1.052 . . . . 0.0 112.68 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.76 -42.3 77.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.468 1.107 . . . . 0.0 112.299 174.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -65.29 -39.32 92.4 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.16 0.584 . . . . 0.0 111.418 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 36.7 t -82.66 -28.08 30.89 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.262 1.825 . . . . 0.0 115.159 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.61 -2.19 67.02 Favored Glycine 0 N--CA 1.48 1.579 0 O-C-N 120.47 -1.394 . . . . 0.0 114.665 -170.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -64.07 -35.79 81.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.646 1.223 . . . . 0.0 112.263 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.66 -45.69 85.64 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.848 0.859 . . . . 0.0 110.881 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -59.33 -40.6 86.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.68 1.592 . . . . 0.0 112.748 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -65.76 -36.55 83.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 118.215 -0.897 . . . . 0.0 112.632 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 61.2 mtm -70.04 -50.44 41.29 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.73 1.15 . . . . 0.0 113.295 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 pp -62.33 -35.02 77.8 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.259 -0.901 . . . . 0.0 111.91 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -64.35 -37.98 89.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.603 0.761 . . . . 0.0 112.846 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.18 -30.04 71.12 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.077 0.853 . . . . 0.0 111.977 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.03 5.11 17.43 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.176 1.79 . . . . 0.0 114.275 171.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.28 12.8 75.32 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.3 1.428 . . . . 0.0 114.573 173.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 60.3 mt -94.31 145.35 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 118.266 1.033 . . . . 0.0 111.276 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 29.0 m -105.13 131.29 52.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.106 1.362 . . . . 0.0 110.743 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.4 p -133.89 171.02 14.75 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.478 1.911 . . . . 0.0 112.81 -175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -56.98 138.41 54.29 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.158 0.983 . . . . 0.0 112.726 164.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -137.09 147.28 45.99 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.009 1.324 . . . . 0.0 112.431 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.5 mt . . . . . 0 C--O 1.255 1.363 0 C-N-CA 128.111 2.564 . . . . 0.0 116.272 179.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m -67.08 -36.83 82.85 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 -165.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.2 t 57.46 157.33 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.249 1.42 . . . . 0.0 113.149 -157.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.28 27.26 66.33 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 120.797 -1.189 . . . . 0.0 113.008 -170.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.1 pt -69.19 162.63 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.221 1.009 . . . . 0.0 113.112 -171.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.81 171.53 34.39 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.561 1.077 . . . . 0.0 114.697 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 144.68 -45.83 0.83 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.427 1.965 . . . . 0.0 111.911 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -91.53 152.56 20.27 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.017 0.927 . . . . 0.0 111.477 159.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 m -68.87 147.52 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.058 0.543 . . . . 0.0 111.558 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -106.41 92.45 4.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.296 1.439 . . . . 0.0 110.541 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -159.34 133.81 7.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.412 1.485 . . . . 0.0 108.851 169.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.9 tp -140.66 105.9 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 122.262 1.029 . . . . 0.0 111.64 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -151.48 147.77 27.25 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.079 2.152 . . . . 0.0 109.934 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -127.6 141.52 51.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.248 1.419 . . . . 0.0 109.343 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.7 m -103.57 137.04 42.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.514 1.526 . . . . 0.0 110.379 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -82.3 148.12 58.58 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.06 156.29 55.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.362 2.708 . . . . 0.0 113.033 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -106.96 5.38 28.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.856 1.662 . . . . 0.0 113.087 -173.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -76.78 155.51 33.07 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.499 1.92 . . . . 0.0 114.256 -160.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -68.21 143.13 95.56 Favored Pre-proline 0 CA--C 1.551 1.016 0 O-C-N 121.221 -0.924 . . . . 0.0 112.104 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.14 154.02 75.7 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.042 3.162 . . . . 0.0 114.954 -169.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -85.19 140.57 30.8 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.542 1.137 . . . . 0.0 112.908 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -77.57 -36.51 51.97 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.501 1.52 . . . . 0.0 112.118 171.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.5 m -67.84 149.39 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.698 0.799 . . . . 0.0 109.942 164.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -68.06 116.23 8.45 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.506 -0.746 . . . . 0.0 111.821 -174.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.16 143.5 50.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.917 1.687 . . . . 0.0 109.95 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -157.93 35.15 0.25 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -166.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.5 tt -121.53 152.85 38.73 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.901 0.88 . . . . 0.0 111.69 -175.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -128.91 119.1 23.78 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.616 1.566 . . . . 0.0 110.976 173.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -57.09 -41.73 79.41 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.596 1.958 . . . . 0.0 114.225 -176.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.91 -36.29 76.68 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.083 1.753 . . . . 0.0 113.468 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -71.98 -24.78 61.64 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.5 mt -103.85 -28.08 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.937 1.295 . . . . 0.0 111.917 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.29 -16.44 56.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.827 1.251 . . . . 0.0 112.661 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 19.1 ttt -132.2 112.1 11.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.519 1.528 . . . . 0.0 109.18 161.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.5 t -82.98 132.05 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.426 -0.796 . . . . 0.0 111.682 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -77.67 109.54 11.74 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.635 1.174 . . . . 0.0 110.283 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -63.77 -28.17 69.69 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.538 1.135 . . . . 0.0 113.507 -166.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -59.23 -37.62 77.95 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.96 0.904 . . . . 0.0 112.83 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mp -78.21 -42.15 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.805 0.842 . . . . 0.0 110.219 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -58.83 -39.82 82.38 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.66 0.784 . . . . 0.0 112.602 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -72.41 -27.65 62.49 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.626 1.17 . . . . 0.0 112.822 170.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.3 m -72.04 -44.42 63.39 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.805 1.184 . . . . 0.0 109.063 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 90.0 mt -55.56 -40.89 61.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.499 1.519 . . . . 0.0 110.733 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -77.62 -37.94 49.08 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.021 1.328 . . . . 0.0 113.255 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 t -95.57 -28.08 15.03 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.219 1.408 . . . . 0.0 114.382 -165.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -87.3 145.98 26.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.306 1.042 . . . . 0.0 111.505 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -66.67 -44.83 80.75 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.962 0.905 . . . . 0.0 112.109 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.9 t -141.7 134.45 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.771 1.229 . . . . 0.0 111.7 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.98 133.9 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.126 1.37 . . . . 0.0 111.816 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 t -133.7 156.33 48.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.619 1.568 . . . . 0.0 110.936 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -132.61 139.62 47.86 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.39 1.076 . . . . 0.0 110.399 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 mt -137.1 158.39 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.851 1.66 . . . . 0.0 109.064 -165.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -77.91 106.51 9.81 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 154.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.44 -149.65 21.35 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.833 1.206 . . . . 0.0 113.096 -172.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.8 mt -118.98 156.93 51.69 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.327 1.451 . . . . 0.0 111.114 -169.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.97 -33.9 72.89 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 121.408 1.539 . . . . 0.0 113.378 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -82.79 -13.96 55.29 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.913 -1.117 . . . . 0.0 113.263 173.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.26 70.3 13.02 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.985 1.714 . . . . 0.0 112.839 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.11 151.93 21.14 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.24 2.627 . . . . 0.0 111.574 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 85.3 mtp -97.4 12.19 34.05 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.7 t -148.97 145.25 27.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.746 1.219 . . . . 0.0 111.245 176.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.12 -39.84 86.7 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.558 -0.714 . . . . 0.0 112.897 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -62.75 -34.56 77.48 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.086 -1.009 . . . . 0.0 111.858 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.9 m -68.45 -31.03 70.05 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.284 -0.885 . . . . 0.0 112.664 170.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -66.02 -38.56 88.73 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.083 1.31 . . . . 0.0 112.425 168.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -59.73 -31.39 69.58 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.201 1.0 . . . . 0.0 112.69 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.6 tpt -60.04 -47.15 87.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.993 0.917 . . . . 0.0 111.618 169.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mm -70.89 -33.99 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.25 -0.906 . . . . 0.0 112.81 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -58.06 -35.81 71.88 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.741 -1.225 . . . . 0.0 112.404 168.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.67 -38.7 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 122.264 -0.272 . . . . 0.0 111.281 176.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.77 -34.72 78.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.235 1.014 . . . . 0.0 113.323 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -62.1 -40.39 95.71 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.089 -1.007 . . . . 0.0 111.629 167.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.71 -21.7 64.39 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.6 tp -96.88 -15.86 21.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.929 1.292 . . . . 0.0 112.725 170.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.98 12.17 56.71 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.188 1.852 . . . . 0.0 114.932 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.5 133.06 54.77 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.058 1.343 . . . . 0.0 111.76 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -111.76 150.98 29.5 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.254 1.025 . . . . 0.0 113.201 172.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.73 175.79 8.74 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.817 2.047 . . . . 0.0 112.284 -161.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.86 117.51 25.65 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.374 -0.829 . . . . 0.0 109.481 -167.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.4 m -126.74 129.5 48.51 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.882 0.873 . . . . 0.0 112.17 -154.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -128.29 143.01 50.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.4 77.67 9.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 129.91 3.284 . . . . 0.0 111.427 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.3 p -74.18 -9.74 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -167.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.07 -22.98 22.66 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.329 -0.857 . . . . 0.0 112.156 169.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.98 -32.85 21.31 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.819 0.736 . . . . 0.0 112.232 174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -134.53 107.06 10.92 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.129 0.972 . . . . 0.0 111.569 163.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 129' ' ' HIS . 37.1 Cg_endo -60.66 -16.2 41.83 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.717 2.278 . . . . 0.0 114.203 173.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.4 p -39.75 -43.38 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.616 1.966 . . . . 0.0 115.82 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 t -67.25 -43.55 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.048 -1.033 . . . . 0.0 111.248 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -64.1 -41.09 97.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.008 1.323 . . . . 0.0 111.162 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.5 m -59.02 -45.73 89.98 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.193 0.997 . . . . 0.0 111.681 -177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -75.33 -37.11 60.9 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -35.11 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 121.058 1.754 . . . . 0.0 112.091 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.53 -35.15 73.64 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.614 1.566 . . . . 0.0 112.28 170.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.88 -35.8 59.74 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.447 1.022 . . . . 0.0 113.349 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 81.1 t -80.38 -45.33 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.317 0.962 . . . . 0.0 113.214 -173.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.3 p -105.27 13.61 30.22 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.646 1.566 . . . . 0.0 115.078 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 68.57 -29.87 0.17 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 128.153 2.581 . . . . 0.0 117.143 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -149.65 130.02 6.84 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 120.632 1.56 . . . . 0.0 112.868 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -94.8 147.77 1.69 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.669 2.913 . . . . 0.0 114.413 -177.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.0 p -129.79 152.41 49.31 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.552 1.541 . . . . 0.0 110.182 162.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.1 124.24 23.77 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.994 0.918 . . . . 0.0 110.553 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.58 157.04 72.31 Favored 'Cis proline' 0 CA--C 1.543 0.944 0 CA-C-N 120.227 1.117 . . . . 0.0 113.312 -2.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -151.72 160.55 43.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.183 1.393 . . . . 0.0 111.269 -175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.94 141.97 51.67 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -128.7 142.48 51.0 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.1 2.16 . . . . 0.0 110.868 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.4 mt -136.88 130.59 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.123 1.369 . . . . 0.0 109.688 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt 48.19 43.87 19.01 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 125.867 1.667 . . . . 0.0 114.573 -172.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.21 13.25 5.71 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.061 1.744 . . . . 0.0 114.889 -172.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -112.77 141.9 46.03 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.76 1.624 . . . . 0.0 111.103 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -72.51 126.26 29.43 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.105 0.955 . . . . 0.0 112.556 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.3 t -104.49 -54.97 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.28 1.432 . . . . 0.0 112.356 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 167.09 163.29 20.68 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.48 169.0 54.16 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.991 1.758 . . . . 0.0 113.441 168.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.4 tp -46.84 -45.35 20.15 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.315 1.446 . . . . 0.0 113.803 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.2 -21.24 66.49 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.881 1.272 . . . . 0.0 112.748 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.3 mm -92.36 -44.42 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.599 1.96 . . . . 0.0 111.193 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.0 t -59.9 -36.0 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.046 1.738 . . . . 0.0 112.066 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -56.58 -49.81 73.77 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 170.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -61.74 -42.02 98.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.442 0.697 . . . . 0.0 110.362 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.8 mtt -66.55 -39.12 88.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.221 1.009 . . . . 0.0 112.981 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -68.36 -39.72 81.73 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.015 1.326 . . . . 0.0 112.156 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.88 -31.57 61.63 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 30.7 t -79.25 -26.97 42.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.811 1.245 . . . . 0.0 113.603 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.53 -0.64 80.74 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.082 0.849 . . . . 0.0 114.511 -168.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.04 -36.72 80.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.71 1.755 . . . . 0.0 111.781 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.1 -42.51 98.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.889 0.876 . . . . 0.0 110.906 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -69.06 -35.42 76.53 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 126.234 1.814 . . . . 0.0 112.973 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -58.05 -48.84 78.87 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.154 1.343 . . . . 0.0 110.946 171.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 70.3 mtm -67.89 -38.59 83.2 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.27 -43.64 77.35 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.341 0.973 . . . . 0.0 112.832 172.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -72.24 -26.35 61.98 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.309 -0.87 . . . . 0.0 113.305 -171.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.71 -30.12 63.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.321 1.048 . . . . 0.0 112.672 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -87.39 -2.5 58.66 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.51 16.36 55.3 Favored Glycine 0 N--CA 1.47 0.926 0 O-C-N 120.66 -1.275 . . . . 0.0 113.815 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 86.3 mt -86.19 147.67 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.323 1.049 . . . . 0.0 110.801 -171.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.6 m -105.04 124.44 49.54 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.091 1.356 . . . . 0.0 112.681 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 25.5 p -125.53 169.17 12.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.806 2.442 . . . . 0.0 111.441 172.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -57.31 149.24 20.73 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.087 -1.008 . . . . 0.0 112.087 171.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.85 144.92 47.41 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.749 0.82 . . . . 0.0 112.319 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.072 1.749 . . . . 0.0 111.095 -171.421 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.4 p . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.0 p -103.15 -18.71 14.81 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -165.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.5 p -101.42 18.54 19.84 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.722 1.146 . . . . 0.0 113.931 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.88 -22.74 2.78 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.847 1.689 . . . . 0.0 115.368 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.1 tt -139.07 164.81 24.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 127.384 2.273 . . . . 0.0 109.971 170.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.56 -173.68 45.81 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 120.959 -1.088 . . . . 0.0 114.39 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.6 -155.63 28.41 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.265 1.888 . . . . 0.0 112.349 168.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -63.89 127.88 33.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.072 0.949 . . . . 0.0 111.287 176.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.84 133.1 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.705 1.202 . . . . 0.0 111.308 -169.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 mtm105 -90.32 81.49 6.05 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.119 1.368 . . . . 0.0 110.847 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -143.37 157.77 44.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.215 1.406 . . . . 0.0 111.412 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mt 56.77 38.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.835 1.254 . . . . 0.0 112.174 -173.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.25 138.83 54.27 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.824 -1.172 . . . . 0.0 113.577 -164.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -74.88 138.14 42.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.552 1.541 . . . . 0.0 111.518 -174.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 m -88.73 69.45 8.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.919 1.288 . . . . 0.0 110.642 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -59.38 155.92 33.73 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.803 -168.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.34 152.06 69.67 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.271 1.981 . . . . 0.0 111.386 165.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -98.9 3.24 47.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.604 1.161 . . . . 0.0 113.277 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -61.41 155.42 21.68 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.888 1.275 . . . . 0.0 112.552 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -73.94 147.67 86.37 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 123.451 0.7 . . . . 0.0 110.037 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -63.08 139.38 72.7 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.637 2.225 . . . . 0.0 111.982 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.0 mtm180 -127.35 135.86 51.11 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.628 1.571 . . . . 0.0 111.757 -175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 tt -129.74 -46.42 1.16 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.836 1.254 . . . . 0.0 111.966 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.5 t -80.23 -28.99 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.435 1.094 . . . . 0.0 112.201 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.1 m -88.83 126.27 35.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.283 1.033 . . . . 0.0 109.892 162.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.0 125.9 30.09 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.328 -0.858 . . . . 0.0 113.309 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -152.45 160.45 43.26 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.346 1.859 . . . . 0.0 111.606 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 55.8 tp -148.3 138.08 22.32 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.317 1.447 . . . . 0.0 111.404 169.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -102.74 136.34 42.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.318 1.447 . . . . 0.0 112.234 171.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -60.23 -29.84 69.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.894 1.278 . . . . 0.0 111.876 172.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.08 -28.94 70.13 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.173 1.789 . . . . 0.0 112.638 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -70.74 -26.69 63.49 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.211 -0.93 . . . . 0.0 112.65 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.4 mm -76.97 -16.18 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.518 1.127 . . . . 0.0 112.071 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.5 2.88 20.44 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.6 mtm -115.89 144.46 44.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.479 1.511 . . . . 0.0 111.808 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.7 m -138.96 153.74 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.67 1.188 . . . . 0.0 113.137 -168.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -119.27 110.56 17.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.959 1.704 . . . . 0.0 110.416 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -63.09 -31.9 73.15 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.194 0.998 . . . . 0.0 113.648 -176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -64.44 -42.71 95.83 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.6 tp -77.54 -39.14 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 O-C-N 121.699 -0.626 . . . . 0.0 111.569 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.15 -44.81 92.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.242 1.017 . . . . 0.0 112.213 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.94 -34.28 75.1 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.764 -0.585 . . . . 0.0 112.326 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.4 m -66.26 -48.85 69.12 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.849 0.86 . . . . 0.0 111.817 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -61.54 -33.53 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.743 -0.598 . . . . 0.0 112.455 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.81 -24.78 44.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.85 1.66 . . . . 0.0 113.759 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.5 t -92.52 -34.19 14.17 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.773 1.629 . . . . 0.0 113.667 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -87.76 147.86 24.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.325 1.05 . . . . 0.0 111.807 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.6 p30 -68.51 -47.63 66.49 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.942 -1.099 . . . . 0.0 113.779 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.9 t -140.39 129.93 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.773 1.229 . . . . 0.0 110.848 -173.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.55 137.64 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.648 1.179 . . . . 0.0 111.315 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -136.54 154.64 50.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.417 1.087 . . . . 0.0 111.758 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -134.5 143.61 47.57 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.753 0.787 . . . . 0.0 112.469 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 mt -136.79 157.45 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.495 1.518 . . . . 0.0 110.227 -155.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -76.19 106.52 7.85 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.973 153.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.26 -161.71 43.42 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 118.948 0.794 . . . . 0.0 114.257 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -92.82 156.09 41.06 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.724 1.209 . . . . 0.0 111.94 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -67.39 -21.04 47.72 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.28 1.987 . . . . 0.0 113.088 173.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.59 -24.53 21.68 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.136 1.374 . . . . 0.0 112.852 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.31 75.77 19.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.796 1.638 . . . . 0.0 111.334 -176.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.66 155.87 40.02 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.722 2.948 . . . . 0.0 112.362 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.3 mtt -109.62 4.04 21.67 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.316 1.446 . . . . 0.0 114.539 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 44.3 t -148.85 147.11 28.35 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.753 1.621 . . . . 0.0 110.523 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.83 -43.15 94.71 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.698 -0.626 . . . . 0.0 111.548 176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -60.91 -34.66 75.02 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.278 -0.889 . . . . 0.0 112.203 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.8 m -63.48 -48.48 77.45 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 118.865 -0.588 . . . . 0.0 111.136 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -59.08 -48.97 79.67 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.025 0.83 . . . . 0.0 111.055 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -60.84 -28.64 68.98 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.417 1.087 . . . . 0.0 113.037 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 34.4 ttp -68.79 -42.62 77.11 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.6 mm -67.66 -34.57 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.227 -0.921 . . . . 0.0 110.73 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -39.53 72.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.915 1.286 . . . . 0.0 111.956 172.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.44 -42.35 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.557 1.143 . . . . 0.0 111.705 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.9 mt -66.48 -35.53 80.51 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -67.07 -33.62 75.88 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.972 -1.08 . . . . 0.0 112.495 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.79 -25.69 68.29 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.837 -1.164 . . . . 0.0 113.275 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.88 -14.48 20.66 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.426 1.09 . . . . 0.0 113.717 171.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.82 10.19 67.31 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.894 1.235 . . . . 0.0 115.355 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.32 131.38 55.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.184 0.993 . . . . 0.0 112.06 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -116.5 128.1 55.14 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.934 0.874 . . . . 0.0 113.018 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -106.36 171.98 7.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.818 2.447 . . . . 0.0 112.069 -170.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.2 m -83.72 121.87 27.88 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 120.581 -1.324 . . . . 0.0 109.0 -161.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.9 m -122.79 128.03 49.91 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.243 -155.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -126.45 143.94 51.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.673 1.189 . . . . 0.0 113.386 -175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -92.7 113.91 26.32 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.679 1.192 . . . . 0.0 111.245 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 t -69.11 -18.44 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.757 -0.589 . . . . 0.0 112.061 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -77.7 -22.79 49.94 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.054 -1.029 . . . . 0.0 112.545 172.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.78 -37.37 17.89 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.893 0.769 . . . . 0.0 112.205 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -136.85 94.36 12.99 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -44.18 -20.93 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.586 1 C-N-CA 125.916 4.411 . . . . 0.0 116.891 165.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -48.62 -35.88 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 121.237 1.835 . . . . 0.0 112.867 171.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.35 -43.69 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 121.565 -0.709 . . . . 0.0 110.315 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.526 ' HA ' HG12 ' A' ' 136' ' ' VAL . 0.7 OUTLIER -62.25 -32.94 73.7 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.845 1.258 . . . . 0.0 112.542 172.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.421 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 40.4 m -69.57 -37.9 77.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.911 1.684 . . . . 0.0 113.686 173.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -76.17 -47.19 25.13 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 133' ' ' ARG . 8.0 p -60.54 -34.47 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 120.515 -1.365 . . . . 0.0 112.951 -174.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 134' ' ' SER . 17.7 ptpt -62.13 -34.64 76.73 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -77.04 -43.53 34.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.664 1.986 . . . . 0.0 113.915 171.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.9 t -79.33 -38.59 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.108 1.363 . . . . 0.0 113.376 -166.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.3 m -100.39 10.98 40.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 62.11 -33.97 0.1 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 128.338 2.655 . . . . 0.0 115.376 -166.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -139.13 139.41 23.15 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.534 2.334 . . . . 0.0 108.833 169.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.99 128.37 9.11 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.075 1.85 . . . . 0.0 112.019 -178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.8 m -130.16 132.21 45.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.835 1.254 . . . . 0.0 110.987 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 57.0 mt -129.2 130.58 23.38 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.275 1.03 . . . . 0.0 110.52 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -80.78 152.66 82.2 Favored 'Cis proline' 0 CA--C 1.545 1.062 0 CA-C-N 120.021 1.043 . . . . 0.0 112.827 -5.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -147.81 158.56 44.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.352 1.061 . . . . 0.0 112.595 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.52 135.13 50.9 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.914 1.686 . . . . 0.0 111.987 -172.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -119.22 144.91 46.47 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.726 2.011 . . . . 0.0 110.128 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.6 mt -127.0 124.32 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 167.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 51.3 tttp 44.11 54.95 5.7 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.925 1.69 . . . . 0.0 114.328 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.69 27.83 17.55 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 116.515 2.042 . . . . 0.0 116.515 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -130.08 145.86 51.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.109 1.364 . . . . 0.0 110.008 171.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -81.6 124.07 29.22 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.717 0.77 . . . . 0.0 111.332 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.9 t -99.94 -49.25 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.144 0.978 . . . . 0.0 110.104 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.05 158.75 23.88 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.674 1.429 . . . . 0.0 116.674 170.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.2 169.7 54.59 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.285 0.945 . . . . 0.0 112.157 164.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -52.12 -38.85 58.73 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.469 1.107 . . . . 0.0 113.969 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.49 -34.96 78.2 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.869 -1.144 . . . . 0.0 111.773 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.5 mm -72.54 -46.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.161 1.384 . . . . 0.0 110.668 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.98 -35.91 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.966 1.706 . . . . 0.0 111.032 176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 90.6 m -62.04 -46.25 90.01 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.443 0.697 . . . . 0.0 111.807 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -59.57 -45.78 90.86 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.742 1.155 . . . . 0.0 110.28 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.3 mtt -61.36 -41.75 97.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.881 0.873 . . . . 0.0 111.365 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.87 -46.61 67.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.133 0.973 . . . . 0.0 111.335 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -72.64 -24.86 61.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.634 1.174 . . . . 0.0 112.597 -175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.9 t -100.44 -2.93 32.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.804 1.641 . . . . 0.0 114.041 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.44 -7.47 78.75 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 120.705 -1.247 . . . . 0.0 115.324 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -29.71 67.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.837 -1.39 . . . . 0.0 114.103 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.55 -46.42 86.03 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.077 0.853 . . . . 0.0 109.791 174.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -58.59 -42.2 87.54 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.122 0.969 . . . . 0.0 111.68 169.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -62.67 -37.35 86.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 117.0 -1.476 . . . . 0.0 111.825 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 71.8 mtm -69.82 -47.73 61.68 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.363 1.438 . . . . 0.0 112.88 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.27 -39.02 89.13 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.634 0.652 . . . . 0.0 112.251 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -69.36 -36.14 76.56 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.955 1.302 . . . . 0.0 111.912 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.0 -24.67 67.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.738 0.815 . . . . 0.0 112.546 168.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -92.12 6.44 46.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.929 1.292 . . . . 0.0 114.403 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.72 13.39 67.29 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.725 1.155 . . . . 0.0 114.431 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.2 mt -104.46 146.89 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.25 1.42 . . . . 0.0 108.959 -175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.0 m -116.02 136.13 53.32 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.861 -1.149 . . . . 0.0 112.777 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.4 p -131.34 167.98 18.33 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.18 1.792 . . . . 0.0 112.581 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 -64.53 121.93 15.58 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.439 -0.788 . . . . 0.0 110.096 171.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -135.14 139.67 44.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.286 1.434 . . . . 0.0 112.404 -167.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 C--O 1.252 1.19 0 C-N-CA 126.701 2.001 . . . . 0.0 112.217 -170.815 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.8 p -68.57 -22.19 64.48 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.231 2.212 . . . . 0.0 115.546 -170.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 92.9 p -97.56 -12.23 22.79 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.19 -0.34 59.45 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.635 1.112 . . . . 0.0 114.399 -171.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.5 mm -75.98 126.05 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 118.619 1.209 . . . . 0.0 109.969 173.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.53 159.64 25.04 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.024 1.297 . . . . 0.0 112.785 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.4 -151.64 14.0 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.283 0.944 . . . . 0.0 112.892 -174.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -150.72 144.33 25.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.777 0.831 . . . . 0.0 112.027 168.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.03 126.83 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.266 1.826 . . . . 0.0 110.182 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.33 133.29 19.16 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.98 1.312 . . . . 0.0 112.803 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -155.06 156.14 35.36 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.192 1.797 . . . . 0.0 109.635 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.3 mt 54.37 80.99 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.204 1.802 . . . . 0.0 111.27 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -104.3 157.04 17.41 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.775 2.03 . . . . 0.0 112.691 -175.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -93.34 134.06 35.94 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.385 -0.822 . . . . 0.0 111.623 164.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.2 p -142.1 25.85 1.89 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -152.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -70.92 136.49 85.14 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 120.109 -1.62 . . . . 0.0 112.588 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.93 -25.35 19.88 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.902 2.401 . . . . 0.0 115.151 -165.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.85 11.35 39.76 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -173.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -53.72 131.12 38.72 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.567 1.147 . . . . 0.0 111.275 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -67.28 149.61 98.33 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.018 1.327 . . . . 0.0 111.696 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -57.74 149.19 70.13 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.764 2.31 . . . . 0.0 111.606 175.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -85.84 109.63 18.82 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.779 1.232 . . . . 0.0 108.578 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.1 mt -134.44 165.77 24.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.124 1.37 . . . . 0.0 112.22 -165.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.83 -57.97 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.841 0.857 . . . . 0.0 111.556 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 m -84.17 69.41 10.4 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.151 0.977 . . . . 0.0 110.545 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -163.12 172.35 15.0 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.75 1.62 . . . . 0.0 111.502 -172.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -94.39 175.85 6.53 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.754 1.222 . . . . 0.0 112.317 170.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.22 175.32 3.95 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.185 0.994 . . . . 0.0 112.641 157.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -149.3 166.29 29.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.883 1.273 . . . . 0.0 112.003 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.38 -40.51 68.24 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.649 1.18 . . . . 0.0 113.967 -171.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.41 -28.5 59.42 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -70.44 -35.0 73.1 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.96 -1.088 . . . . 0.0 111.955 173.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 49.9 pt -83.21 -28.25 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.44 -23.36 40.32 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.648 0.779 . . . . 0.0 112.845 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 8.3 ttt -62.89 134.42 56.19 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.816 1.247 . . . . 0.0 110.791 167.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.4 t -124.34 109.2 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.011 0.924 . . . . 0.0 110.409 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -83.43 120.64 26.15 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.854 0.862 . . . . 0.0 109.909 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -64.64 -32.04 73.53 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -161.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.92 -28.16 64.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 64.5 mt -74.48 -47.42 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.857 0.863 . . . . 0.0 109.786 173.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.97 -38.29 75.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.405 1.082 . . . . 0.0 111.968 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.34 -35.5 79.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.402 1.081 . . . . 0.0 112.969 171.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.0 m -66.2 -47.0 75.3 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.511 1.05 . . . . 0.0 111.111 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.71 -36.53 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 118.427 0.558 . . . . 0.0 111.991 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.4 -38.31 50.09 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.582 1.553 . . . . 0.0 112.896 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.7 t -81.84 -35.87 28.93 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.661 1.584 . . . . 0.0 113.122 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -83.04 142.36 31.37 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.888 -1.133 . . . . 0.0 109.968 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.416 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 34.9 m-20 -82.93 -46.0 13.48 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.879 -1.138 . . . . 0.0 112.345 -163.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 t -132.85 131.27 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.787 1.635 . . . . 0.0 109.764 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.2 t -132.49 132.88 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.529 1.532 . . . . 0.0 111.173 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.8 t -133.85 155.48 49.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.65 1.18 . . . . 0.0 110.839 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -131.39 142.44 50.05 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.31 0.644 . . . . 0.0 112.73 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.7 mt -136.42 159.69 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.351 1.861 . . . . 0.0 110.206 -158.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -73.06 104.03 4.01 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.509 -0.744 . . . . 0.0 109.505 158.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.24 -155.94 40.83 Favored Glycine 0 CA--C 1.536 1.344 0 O-C-N 121.563 -0.71 . . . . 0.0 113.676 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.1 mt -113.58 150.21 42.88 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.8 1.24 . . . . 0.0 112.209 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -68.02 -19.02 46.16 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.067 2.512 . . . . 0.0 114.711 -167.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.12 -27.34 60.82 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.606 1.162 . . . . 0.0 112.688 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.79 68.22 12.88 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.163 1.785 . . . . 0.0 111.549 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.1 143.8 73.17 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.422 2.082 . . . . 0.0 111.429 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.6 ttm -90.93 -7.51 51.91 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 41.3 t -140.8 146.28 37.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.282 1.433 . . . . 0.0 110.459 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.63 -41.17 94.33 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.546 -0.721 . . . . 0.0 112.484 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -69.52 -34.1 73.78 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.436 -0.79 . . . . 0.0 111.593 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 m -62.75 -39.46 94.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.339 0.655 . . . . 0.0 112.477 168.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -67.23 -40.66 86.36 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.627 1.103 . . . . 0.0 112.828 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -64.42 -36.03 82.85 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.805 0.842 . . . . 0.0 112.509 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.8 tpt -55.94 -45.86 78.69 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.214 0.915 . . . . 0.0 112.289 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.3 mm -66.58 -34.14 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.303 0.641 . . . . 0.0 111.254 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.23 -37.2 86.31 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.437 -0.79 . . . . 0.0 112.99 174.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.8 t -70.62 -36.11 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.897 0.879 . . . . 0.0 110.956 176.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 66.1 mt -66.1 -40.95 91.18 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.335 -0.853 . . . . 0.0 113.129 169.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -62.08 -31.29 71.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.09 -1.007 . . . . 0.0 111.863 175.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.15 -20.0 64.86 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.9 tp -98.81 -9.17 24.75 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.459 1.504 . . . . 0.0 113.563 172.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.77 11.17 57.11 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.402 1.477 . . . . 0.0 114.954 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.11 132.62 55.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.333 1.066 . . . . 0.0 111.831 172.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -114.89 159.23 20.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.951 0.9 . . . . 0.0 113.356 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -133.19 172.82 12.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.856 2.062 . . . . 0.0 111.604 -161.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.4 m -87.9 119.6 28.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.469 -1.394 . . . . 0.0 108.354 -168.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.6 m -125.93 129.29 48.98 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.162 -151.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -125.88 143.72 50.96 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -91.87 122.59 34.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.395 1.478 . . . . 0.0 111.396 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.0 m -66.92 -22.22 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.0 mt -87.04 -11.3 50.74 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.211 1.404 . . . . 0.0 112.92 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.13 -36.79 15.51 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -146.29 135.27 11.2 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.95 0.9 . . . . 0.0 111.069 -175.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.25 -31.63 93.25 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.393 2.728 . . . . 0.0 113.204 -174.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 p -44.02 -42.7 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.616 1.567 . . . . 0.0 113.789 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 t -71.11 -47.86 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.801 1.182 . . . . 0.0 111.419 -174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -72.42 -25.41 61.47 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 63.7 m -71.2 -48.07 53.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.316 1.046 . . . . 0.0 112.274 169.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -66.18 -44.22 84.62 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.96 -1.088 . . . . 0.0 112.623 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.82 -35.31 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 O-C-N 121.291 -0.88 . . . . 0.0 112.065 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -69.59 -36.53 76.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.274 1.03 . . . . 0.0 112.728 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -74.48 -44.21 52.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.464 1.106 . . . . 0.0 113.718 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.0 t -81.91 -41.27 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.24 1.416 . . . . 0.0 113.001 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.0 m -101.1 -9.33 21.47 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 64.13 -24.15 0.07 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 128.697 2.799 . . . . 0.0 117.439 172.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -127.3 110.6 21.3 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.189 1.795 . . . . 0.0 107.925 158.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.03 125.94 4.25 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 121.117 1.211 . . . . 0.0 111.875 -171.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.4 p -136.05 126.75 27.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.352 1.861 . . . . 0.0 109.453 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.62 146.13 57.43 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 119.226 0.921 . . . . 0.0 110.999 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.69 155.27 92.39 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 120.201 1.108 . . . . 0.0 114.292 8.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -150.01 157.29 42.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.472 1.909 . . . . 0.0 110.576 -173.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.73 139.03 52.41 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.251 1.021 . . . . 0.0 113.665 -172.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -129.78 145.8 51.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.514 1.926 . . . . 0.0 111.101 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.6 mt -129.12 125.86 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.792 1.237 . . . . 0.0 108.685 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.416 ' HE3' ' HA ' ' A' ' 90' ' ' ASP . 2.3 mmpt? 46.59 53.66 9.7 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 125.674 1.59 . . . . 0.0 114.422 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 58.05 24.45 11.18 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.399 1.88 . . . . 0.0 115.934 -174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -123.53 139.3 54.15 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.902 -1.124 . . . . 0.0 111.522 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -68.35 123.73 21.55 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.082 0.953 . . . . 0.0 111.023 176.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.77 -43.16 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.497 1.519 . . . . 0.0 111.807 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.62 173.67 26.33 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 117.165 1.626 . . . . 0.0 117.165 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.95 173.23 54.9 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.466 1.507 . . . . 0.0 113.769 171.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.95 -41.38 33.81 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.28 1.432 . . . . 0.0 112.895 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.86 -36.54 83.61 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.948 -1.095 . . . . 0.0 112.82 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 mm -74.27 -45.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.672 1.589 . . . . 0.0 109.62 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.5 t -58.65 -39.72 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.996 0.918 . . . . 0.0 110.835 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 30.7 m -63.52 -46.05 87.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.229 1.011 . . . . 0.0 111.369 173.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 29.7 tttp -60.88 -43.77 97.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.96 1.304 . . . . 0.0 111.585 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 51.9 mtt -70.6 -38.73 74.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.831 1.253 . . . . 0.0 112.698 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.09 -46.72 61.24 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.386 0.994 . . . . 0.0 112.294 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -63.55 -33.65 76.06 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.646 0.657 . . . . 0.0 111.713 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.7 m -85.14 -17.65 36.6 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.66 -4.65 85.77 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-N 119.945 1.248 . . . . 0.0 115.142 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -64.92 -28.49 69.56 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.426 1.613 . . . . 0.0 113.538 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tt -59.54 -46.55 88.56 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.915 -1.116 . . . . 0.0 109.922 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -61.9 -32.92 73.34 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.172 1.789 . . . . 0.0 112.823 172.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -64.45 -39.81 94.54 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.596 1.089 . . . . 0.0 112.101 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.1 mtm -66.16 -51.18 60.26 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.749 1.261 . . . . 0.0 111.562 172.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 53.7 tp -65.14 -42.83 93.44 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.706 2.002 . . . . 0.0 111.122 -165.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -68.65 -38.2 80.25 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.276 1.03 . . . . 0.0 112.337 171.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.89 -27.25 69.02 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.905 0.775 . . . . 0.0 112.666 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 -5.23 45.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.894 1.678 . . . . 0.0 113.714 175.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.46 16.42 64.25 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 125.203 1.383 . . . . 0.0 114.687 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.17 143.92 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.24 1.416 . . . . 0.0 110.15 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.5 m -114.15 134.34 54.96 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.244 -0.91 . . . . 0.0 113.403 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.2 p -125.73 174.07 8.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 129.007 2.923 . . . . 0.0 111.994 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -40.18 138.95 0.78 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.695 1.198 . . . . 0.0 113.172 167.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -64.4 146.36 54.6 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.663 1.185 . . . . 0.0 112.482 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.9 tp . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.38 1.472 . . . . 0.0 111.019 175.148 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -67.16 -39.95 86.57 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.3 p -124.52 -160.52 0.94 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.047 0.939 . . . . 0.0 112.872 -161.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.16 11.64 81.75 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.067 0.842 . . . . 0.0 113.99 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mm -60.23 138.98 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.24 1.416 . . . . 0.0 110.162 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.51 148.54 19.24 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.955 1.264 . . . . 0.0 112.787 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.99 -152.31 10.7 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.045 1.307 . . . . 0.0 113.653 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.0 147.51 53.24 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.403 1.881 . . . . 0.0 111.746 171.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.33 131.32 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.138 0.975 . . . . 0.0 112.305 -175.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -68.52 136.72 53.58 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.201 -0.937 . . . . 0.0 110.572 168.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -136.0 144.47 45.35 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.157 1.383 . . . . 0.0 110.568 -168.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.8 mt -113.45 130.15 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.017 0.927 . . . . 0.0 110.381 -174.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.86 142.63 58.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.038 1.335 . . . . 0.0 112.314 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.87 143.32 57.95 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.505 -0.747 . . . . 0.0 111.837 168.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.6 p -75.84 14.87 0.59 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.247 1.819 . . . . 0.0 115.727 -171.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -71.17 153.36 94.39 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.821 1.248 . . . . 0.0 113.743 -171.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.13 173.77 13.88 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.708 3.605 . . . . 0.0 112.879 171.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -82.32 5.43 20.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -175.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -63.01 150.15 43.15 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.985 -1.072 . . . . 0.0 113.216 -170.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -70.74 153.93 94.6 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.389 1.476 . . . . 0.0 112.282 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -58.23 154.89 37.64 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.115 3.21 . . . . 0.0 113.036 173.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -125.0 143.33 50.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.987 1.315 . . . . 0.0 112.126 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.81 173.4 6.77 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.051 1.74 . . . . 0.0 111.258 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 t 68.75 -34.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 128.57 2.748 . . . . 0.0 115.322 174.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 94.0 p -65.82 173.15 3.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.092 2.157 . . . . 0.0 114.311 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.81 55.61 0.82 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.783 1.633 . . . . 0.0 111.141 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -142.38 168.02 20.71 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.936 1.694 . . . . 0.0 112.649 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.3 168.28 10.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.624 1.57 . . . . 0.0 113.002 166.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.35 162.16 19.18 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.606 1.162 . . . . 0.0 112.501 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -64.57 -37.95 89.32 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 120.777 -1.202 . . . . 0.0 113.361 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.57 -33.35 69.84 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.978 -1.076 . . . . 0.0 112.443 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.12 -25.43 60.85 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.641 1.177 . . . . 0.0 112.93 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.6 tp -103.75 -28.1 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.897 1.279 . . . . 0.0 114.219 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.63 -9.71 59.48 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -166.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -67.33 147.49 52.89 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.449 -0.782 . . . . 0.0 112.007 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -128.6 88.9 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.895 1.678 . . . . 0.0 107.642 172.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -70.79 103.0 2.47 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -63.96 -37.97 89.37 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -163.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -74.08 -26.11 60.19 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.006 0.821 . . . . 0.0 112.813 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.96 -42.78 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.955 1.302 . . . . 0.0 110.085 173.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -58.65 -38.29 77.79 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.652 1.181 . . . . 0.0 111.631 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.21 -29.12 64.76 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.915 0.886 . . . . 0.0 112.406 169.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.1 m -63.95 -45.41 89.27 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 120.217 -1.552 . . . . 0.0 111.311 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.6 pt -62.13 -35.3 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.747 1.158 . . . . 0.0 112.13 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -77.74 -37.75 48.49 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.044 1.738 . . . . 0.0 112.069 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 t -68.15 -31.55 71.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.853 2.461 . . . . 0.0 113.293 173.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -86.87 147.85 25.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.15 1.78 . . . . 0.0 111.727 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.87 -35.7 16.39 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.017 -1.052 . . . . 0.0 111.863 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.3 t -139.9 130.75 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.95 1.3 . . . . 0.0 112.261 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.9 t -132.83 133.32 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.059 1.344 . . . . 0.0 111.379 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 t -131.72 154.6 48.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.998 0.919 . . . . 0.0 110.596 167.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -134.2 146.23 49.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.404 0.621 . . . . 0.0 112.463 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.07 161.72 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 126.078 1.751 . . . . 0.0 109.174 -166.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.72 104.25 8.15 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.375 -0.828 . . . . 0.0 109.543 146.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.28 -162.41 18.03 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.265 0.936 . . . . 0.0 114.87 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -107.1 158.24 33.44 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.916 2.086 . . . . 0.0 110.833 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.29 -25.77 56.79 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.733 1.622 . . . . 0.0 113.666 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -76.07 -24.41 55.1 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.734 1.214 . . . . 0.0 113.684 169.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.12 69.05 14.14 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.07 1.348 . . . . 0.0 111.894 -174.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.99 143.71 23.24 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.856 2.37 . . . . 0.0 110.372 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 mmt -88.58 5.15 44.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 13.5 t -152.21 146.76 25.7 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.124 1.37 . . . . 0.0 110.961 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.33 77.85 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -65.3 -37.89 88.53 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.894 -1.129 . . . . 0.0 111.761 172.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.1 m -65.14 -39.26 92.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.872 0.869 . . . . 0.0 112.361 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.53 -45.77 92.79 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.269 1.027 . . . . 0.0 112.144 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -58.19 -35.86 72.24 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.69 1.596 . . . . 0.0 112.957 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.4 ttp -59.13 -42.45 90.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.622 0.369 . . . . 0.0 111.941 173.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 mm -71.73 -33.82 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.572 0.749 . . . . 0.0 111.848 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -58.35 -38.68 77.69 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.8 -1.188 . . . . 0.0 112.336 172.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.425 HG13 ' HG ' ' A' ' 165' ' ' LEU . 2.2 t -63.48 -39.38 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.173 0.989 . . . . 0.0 111.081 175.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.6 mt -65.89 -39.18 90.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.554 0.742 . . . . 0.0 112.532 173.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -67.0 -31.56 72.2 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.903 -1.123 . . . . 0.0 112.018 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.89 -19.91 64.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.848 1.259 . . . . 0.0 114.235 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.75 -9.55 28.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.889 1.276 . . . . 0.0 113.297 166.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.41 9.2 42.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.342 0.972 . . . . 0.0 113.721 -176.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.0 mt -114.29 130.33 56.66 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 125.683 1.593 . . . . 0.0 111.72 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -115.02 133.67 55.85 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.017 0.913 . . . . 0.0 111.594 170.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -105.06 172.12 6.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.603 2.361 . . . . 0.0 110.773 -172.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.5 m -87.24 123.1 31.88 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.668 -1.27 . . . . 0.0 109.811 -161.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.5 p -108.36 134.14 51.59 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.406 1.482 . . . . 0.0 114.904 -158.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -126.71 146.78 50.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.503 1.121 . . . . 0.0 113.023 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.46 106.04 14.81 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.013 1.325 . . . . 0.0 111.328 -167.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.0 t -68.54 -36.04 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.586 1.555 . . . . 0.0 112.262 -175.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 tp -80.48 -22.05 41.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.335 0.654 . . . . 0.0 111.666 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.11 -39.31 16.86 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.49 -0.757 . . . . 0.0 112.679 167.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -126.1 103.06 26.92 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 118.982 0.81 . . . . 0.0 112.52 -169.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.08 -28.77 25.92 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.713 2.942 . . . . 0.0 115.021 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -49.7 -36.86 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.792 1.237 . . . . 0.0 113.5 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.34 -52.2 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.553 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.434 ' HA ' HG12 ' A' ' 136' ' ' VAL . 16.1 ptm180 -64.48 -26.11 68.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.69 0.796 . . . . 0.0 112.955 173.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.6 m -71.46 -51.96 20.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.163 0.585 . . . . 0.0 111.763 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -73.43 -34.92 65.7 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.564 -1.335 . . . . 0.0 114.206 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 133' ' ' ARG . 11.5 p -60.28 -34.34 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.715 1.143 . . . . 0.0 112.074 172.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 34.5 tttm -69.25 -35.21 75.88 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.139 0.881 . . . . 0.0 112.731 173.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.23 -37.74 86.52 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.221 1.373 . . . . 0.0 112.541 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 82.7 t -81.61 -45.26 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.1 m -106.08 -5.37 19.49 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 62.05 -48.09 0.16 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.517 2.327 . . . . 0.0 116.186 -169.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -135.92 92.45 16.46 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.896 1.278 . . . . 0.0 111.546 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -101.47 156.7 0.37 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.838 3.692 . . . . 0.0 114.743 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 m -117.35 128.84 55.44 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.413 1.485 . . . . 0.0 110.393 161.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.22 140.69 25.79 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.879 1.272 . . . . 0.0 108.576 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -90.59 159.62 31.11 Favored 'Cis proline' 0 CA--C 1.541 0.873 0 CA-C-N 120.733 1.298 . . . . 0.0 113.693 1.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -160.2 171.65 18.83 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.464 1.106 . . . . 0.0 113.466 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.52 141.89 51.24 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.12 1.368 . . . . 0.0 113.455 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -128.29 141.71 51.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.61 1.964 . . . . 0.0 110.665 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 84.5 mt -129.65 135.63 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 125.049 1.339 . . . . 0.0 108.471 173.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 47.36 40.45 10.8 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.22 1.408 . . . . 0.0 113.509 -170.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 55.32 25.46 7.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.002 2.121 . . . . 0.0 115.526 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.87 142.47 46.53 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.513 1.525 . . . . 0.0 110.007 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -70.78 126.08 28.61 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.614 0.721 . . . . 0.0 112.088 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.7 t -101.57 -53.89 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.436 1.494 . . . . 0.0 111.078 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.82 160.6 26.41 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 116.058 1.183 . . . . 0.0 116.058 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 170.36 54.91 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.035 1.302 . . . . 0.0 112.769 165.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -49.31 -46.76 47.03 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.86 1.264 . . . . 0.0 114.337 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.9 -22.67 65.07 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.101 -0.999 . . . . 0.0 112.621 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.4 mm -82.23 -47.05 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.838 1.655 . . . . 0.0 110.664 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.67 -36.57 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.852 1.661 . . . . 0.0 111.024 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 55.1 m -59.69 -44.0 93.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.907 0.883 . . . . 0.0 111.881 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -66.41 -42.45 87.8 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.105 -0.997 . . . . 0.0 111.033 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.6 mtt -61.13 -43.83 98.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.597 0.759 . . . . 0.0 110.99 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.425 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.0 tm? -65.11 -48.85 72.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.078 0.951 . . . . 0.0 111.13 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.15 -16.26 61.98 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.165 1.386 . . . . 0.0 113.477 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m -91.32 -21.01 21.26 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 173.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.83 -2.35 88.25 Favored Glycine 0 CA--C 1.535 1.341 0 O-C-N 121.718 -0.614 . . . . 0.0 113.927 -164.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -68.0 -33.55 74.84 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.688 1.244 . . . . 0.0 111.775 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.28 -45.63 92.41 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.363 -0.836 . . . . 0.0 110.689 172.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -63.48 -37.49 87.51 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.158 1.383 . . . . 0.0 113.105 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -61.38 -43.33 99.05 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 117.611 -1.185 . . . . 0.0 112.655 170.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 74.4 mtm -68.71 -48.02 64.89 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.939 1.245 . . . . 0.0 112.309 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.6 pp -64.04 -35.65 81.43 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.822 -0.549 . . . . 0.0 111.709 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -69.7 -35.76 75.35 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 121.496 -0.752 . . . . 0.0 112.952 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -65.2 -30.61 71.52 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.3 1.04 . . . . 0.0 111.876 171.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.99 5.28 6.81 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.014 1.726 . . . . 0.0 112.969 170.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.91 9.25 77.93 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.502 1.525 . . . . 0.0 114.796 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.4 mt -94.66 147.22 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.219 1.008 . . . . 0.0 110.854 -168.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.3 m -112.22 130.3 55.97 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.994 1.318 . . . . 0.0 111.101 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.5 p -138.36 169.51 17.66 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.977 1.711 . . . . 0.0 113.032 -169.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.0 ttt-85 -62.03 146.28 50.68 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.862 1.265 . . . . 0.0 110.813 164.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -123.2 133.62 54.21 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.621 1.169 . . . . 0.0 111.014 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.9 tp . . . . . 0 C--O 1.253 1.255 0 C-N-CA 128.002 2.521 . . . . 0.0 114.062 -169.966 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 119.811 -0.137 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.3 p -93.68 -21.87 19.09 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.7 m -78.96 166.7 22.08 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.175 -0.953 . . . . 0.0 112.774 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.6 13.55 82.35 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.654 -1.081 . . . . 0.0 114.948 172.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.7 mt -77.74 94.65 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.333 1.567 . . . . 0.0 109.934 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -174.97 159.15 27.43 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.657 2.075 . . . . 0.0 112.155 -176.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.61 -146.39 4.96 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 121.7 -0.883 . . . . 0.0 113.348 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -96.74 145.9 25.38 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.162 1.385 . . . . 0.0 110.287 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 p -148.01 157.81 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.735 1.214 . . . . 0.0 111.634 -171.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -87.69 122.28 31.17 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.883 0.873 . . . . 0.0 110.096 164.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.89 143.09 48.06 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.407 1.083 . . . . 0.0 112.798 -174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 10.8 tt -100.92 148.21 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.569 1.148 . . . . 0.0 113.673 -170.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -118.06 147.31 43.38 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.788 1.635 . . . . 0.0 111.029 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -136.55 143.11 43.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.736 1.214 . . . . 0.0 111.52 -174.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 p -147.59 128.33 14.29 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.215 1.806 . . . . 0.0 109.665 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -87.32 141.37 32.56 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -172.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -60.62 164.48 13.36 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.535 3.49 . . . . 0.0 114.483 174.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -80.31 14.16 2.08 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -130.04 156.68 44.09 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.078 1.351 . . . . 0.0 111.199 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -72.07 152.22 92.69 Favored Pre-proline 0 CA--C 1.549 0.923 0 O-C-N 121.918 -0.489 . . . . 0.0 112.259 168.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.76 134.77 13.77 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.761 2.974 . . . . 0.0 112.165 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -119.75 104.3 10.12 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.699 1.6 . . . . 0.0 111.608 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.9 tt -162.22 -42.04 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.222 1.809 . . . . 0.0 110.699 172.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 p -153.91 152.7 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.648 1.579 . . . . 0.0 111.858 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -71.97 117.12 13.18 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.367 -0.833 . . . . 0.0 111.221 169.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.72 149.88 27.95 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.526 1.53 . . . . 0.0 111.119 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -69.1 -50.18 50.46 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.701 0.8 . . . . 0.0 113.052 -170.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.72 159.08 18.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.741 1.216 . . . . 0.0 113.063 -176.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.68 162.18 19.44 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.403 1.881 . . . . 0.0 110.611 166.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -63.83 -32.71 74.31 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -168.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.49 -34.97 60.9 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.825 1.193 . . . . 0.0 112.971 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.6 -36.4 70.81 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.04 -1.037 . . . . 0.0 112.525 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.8 tt -73.08 -18.06 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 O-C-N 120.794 -1.191 . . . . 0.0 112.316 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.37 -11.51 59.92 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.375 1.07 . . . . 0.0 113.237 168.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.1 tpt -78.44 122.61 26.05 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.152 -0.968 . . . . 0.0 109.506 161.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.2 t -135.87 122.33 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.083 1.353 . . . . 0.0 107.85 170.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -68.65 113.89 6.54 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.696 0.399 . . . . 0.0 110.157 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.4 -36.16 77.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.112 0.965 . . . . 0.0 112.988 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.15 -26.37 68.28 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 50.9 mm -77.42 -45.45 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.999 1.272 . . . . 0.0 110.857 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.32 -42.25 81.48 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.615 0.766 . . . . 0.0 111.487 170.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -68.27 -34.21 75.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.512 0.725 . . . . 0.0 112.329 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.7 m -66.88 -48.55 68.42 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.999 -1.063 . . . . 0.0 111.618 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.3 pt -64.4 -36.63 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.138 0.575 . . . . 0.0 111.867 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -79.19 -34.26 43.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.323 1.449 . . . . 0.0 113.681 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -80.1 -29.65 39.06 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.853 0.861 . . . . 0.0 113.243 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -87.42 133.49 33.73 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.955 0.902 . . . . 0.0 112.047 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -67.67 -38.22 83.43 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.3 t -142.33 127.2 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.331 1.053 . . . . 0.0 111.514 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.77 130.17 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.467 1.507 . . . . 0.0 111.557 -174.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 t -131.75 155.3 47.95 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.079 0.952 . . . . 0.0 111.532 168.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -131.62 127.9 38.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.591 1.156 . . . . 0.0 110.394 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.14 173.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.22 1.808 . . . . 0.0 111.773 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 102.15 4.52 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.333 1.053 . . . . 0.0 109.919 161.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.82 -162.12 37.11 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.41 1.005 . . . . 0.0 115.156 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.11 148.67 43.51 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.117 0.967 . . . . 0.0 110.549 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.21 -23.89 77.98 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.148 2.565 . . . . 0.0 113.996 -175.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -78.37 -26.47 46.62 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.799 1.24 . . . . 0.0 113.907 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.17 67.05 10.62 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.903 1.281 . . . . 0.0 111.881 -175.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.19 152.91 45.72 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.527 2.151 . . . . 0.0 112.841 -172.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -74.06 -8.13 55.02 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.196 -0.94 . . . . 0.0 113.34 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.7 m -152.66 146.73 25.4 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -158.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.1 64.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.247 1.419 . . . . 0.0 112.447 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -67.68 -26.66 66.3 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.315 0.962 . . . . 0.0 111.36 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.3 m -68.32 -38.38 81.51 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.274 170.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.31 -45.49 91.1 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.305 1.411 . . . . 0.0 111.768 167.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -56.61 -37.65 70.98 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.485 0.714 . . . . 0.0 112.342 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.8 tpt -60.79 -46.56 90.02 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.278 1.431 . . . . 0.0 112.355 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.3 mm -72.96 -33.21 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.426 -0.796 . . . . 0.0 112.459 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -57.58 -32.69 67.41 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.206 -1.558 . . . . 0.0 112.795 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.419 HG13 ' HG ' ' A' ' 165' ' ' LEU . 4.0 t -62.61 -44.07 99.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.177 0.991 . . . . 0.0 111.168 172.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.3 mt -65.35 -36.28 83.53 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.031 1.332 . . . . 0.0 112.83 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -71.83 -31.23 66.32 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.358 -1.463 . . . . 0.0 113.137 172.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.91 -29.84 69.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.228 1.011 . . . . 0.0 112.642 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.35 -14.35 40.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.268 1.027 . . . . 0.0 113.412 169.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.83 11.11 57.2 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.083 1.325 . . . . 0.0 114.527 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.09 131.61 55.75 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.932 1.293 . . . . 0.0 111.326 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -113.0 145.37 40.96 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.715 1.143 . . . . 0.0 112.421 174.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -113.54 172.29 7.05 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.459 1.904 . . . . 0.0 111.721 -175.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.8 m -88.86 120.4 30.23 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -164.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.2 m -125.67 136.03 52.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.608 -148.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -124.02 159.55 29.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.827 1.251 . . . . 0.0 111.985 -173.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -112.99 118.27 34.35 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.088 1.355 . . . . 0.0 110.677 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 m -65.85 -21.78 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.427 0.691 . . . . 0.0 112.857 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.3 mt -87.42 -9.92 53.4 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.517 1.127 . . . . 0.0 112.644 173.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.46 -34.35 11.53 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.332 0.969 . . . . 0.0 112.61 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -138.36 88.65 14.63 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.213 0.605 . . . . 0.0 111.005 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.86 -12.51 22.4 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.21 2.607 . . . . 0.0 114.961 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -45.91 -33.77 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.662 1.119 . . . . 0.0 112.902 167.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.1 t -71.43 -43.62 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.337 1.055 . . . . 0.0 111.824 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.469 ' HA ' HG12 ' A' ' 136' ' ' VAL . 11.4 ptm180 -65.68 -28.61 69.21 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.257 0.935 . . . . 0.0 111.98 177.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.4 m -74.48 -39.43 62.49 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -69.84 -39.99 76.1 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.695 1.134 . . . . 0.0 111.313 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 133' ' ' ARG . 9.9 p -67.3 -32.11 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.808 -1.182 . . . . 0.0 112.233 175.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -61.49 -33.98 74.7 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.071 -1.018 . . . . 0.0 113.024 168.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -73.31 -47.85 39.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.182 0.993 . . . . 0.0 112.72 170.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.6 t -81.95 -34.43 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.0 m -100.61 -2.31 33.15 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 60.84 -38.74 0.1 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 130.221 3.408 . . . . 0.0 116.635 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -136.49 91.73 15.9 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.859 2.464 . . . . 0.0 109.572 173.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.41 136.58 8.82 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.117 2.545 . . . . 0.0 113.232 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.9 m -132.65 122.55 24.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.147 0.979 . . . . 0.0 109.85 165.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 12.6 pt -95.37 156.41 37.66 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.493 1.117 . . . . 0.0 113.683 -172.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.92 158.37 97.97 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 119.037 0.692 . . . . 0.0 112.978 -5.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -131.42 160.86 33.88 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.999 1.319 . . . . 0.0 111.433 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.84 139.95 53.06 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.278 1.431 . . . . 0.0 111.991 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -132.8 143.99 49.93 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.172 1.789 . . . . 0.0 110.28 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.1 mt -126.17 117.09 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.4 tttm 42.89 53.03 5.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 127.215 2.206 . . . . 0.0 114.324 -169.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 57.52 26.52 12.82 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -119.29 131.19 55.72 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.117 1.367 . . . . 0.0 109.224 169.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -74.33 125.03 27.59 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.86 -42.48 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 125.013 1.325 . . . . 0.0 111.662 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.35 177.88 30.88 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 169.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.98 169.31 54.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.831 1.205 . . . . 0.0 113.962 168.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -45.35 -44.48 11.79 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.147 1.779 . . . . 0.0 113.145 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.62 -45.04 93.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.356 0.662 . . . . 0.0 111.656 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.1 mm -68.45 -46.91 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.424 1.49 . . . . 0.0 110.968 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.71 -36.21 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.946 1.699 . . . . 0.0 110.672 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 29.5 m -63.39 -46.04 88.29 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 118.8 -0.619 . . . . 0.0 111.701 173.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -63.61 -41.99 98.25 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.882 1.219 . . . . 0.0 110.82 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 54.6 mtt -64.17 -39.8 94.77 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.631 1.172 . . . . 0.0 112.399 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.419 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.1 tm? -66.09 -47.17 75.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.856 0.863 . . . . 0.0 110.874 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -70.93 -26.18 63.09 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.506 1.122 . . . . 0.0 113.283 -174.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 75.2 m -105.18 0.88 27.75 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.24 -8.09 80.62 Favored Glycine 0 N--CA 1.478 1.442 0 CA-C-N 121.094 1.77 . . . . 0.0 115.419 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.55 -29.68 69.12 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.08 1.44 . . . . 0.0 112.885 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.34 -48.26 68.03 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.651 0.78 . . . . 0.0 110.782 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -60.62 -33.59 73.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.611 1.564 . . . . 0.0 112.889 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -59.02 -41.35 87.54 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.952 0.796 . . . . 0.0 112.821 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.8 mtm -67.32 -47.64 69.93 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.632 1.105 . . . . 0.0 112.143 176.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -37.97 87.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.251 0.62 . . . . 0.0 112.49 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -75.03 -33.98 61.84 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.412 -0.805 . . . . 0.0 112.989 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.78 -24.83 67.68 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.289 0.495 . . . . 0.0 111.955 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -80.31 -0.04 34.94 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.712 1.205 . . . . 0.0 113.825 171.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.32 22.02 57.53 Favored Glycine 0 CA--C 1.524 0.622 0 O-C-N 120.521 -1.362 . . . . 0.0 114.26 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 95.9 mt -99.4 145.04 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.666 1.233 . . . . 0.0 111.395 -173.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 99.2 m -91.42 126.89 36.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.685 1.194 . . . . 0.0 111.658 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 22.0 p -120.04 166.4 13.43 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.127 1.771 . . . . 0.0 112.193 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -61.47 155.12 22.64 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.954 1.701 . . . . 0.0 112.356 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -109.49 139.42 44.5 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.197 0.999 . . . . 0.0 111.917 167.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 70.9 mt . . . . . 0 C--O 1.254 1.339 0 C-N-CA 125.701 1.601 . . . . 0.0 113.168 176.822 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.3 p . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.7 p -78.47 -6.7 56.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.1 p -86.07 168.95 13.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.27 1.428 . . . . 0.0 113.156 176.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.66 12.23 83.85 Favored Glycine 0 CA--C 1.535 1.337 0 N-CA-C 115.366 0.907 . . . . 0.0 115.366 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mm -63.1 137.18 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.479 1.139 . . . . 0.0 109.937 174.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.34 174.38 22.61 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.234 0.921 . . . . 0.0 114.945 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.19 152.15 29.67 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.636 1.112 . . . . 0.0 114.833 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -85.2 139.48 31.63 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -161.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.4 t -115.16 138.16 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.194 1.398 . . . . 0.0 110.482 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -58.8 151.57 21.06 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -174.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -112.79 154.93 25.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.699 2.0 . . . . 0.0 112.381 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.93 23.28 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.916 1.686 . . . . 0.0 112.993 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -108.17 136.47 47.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.365 1.466 . . . . 0.0 111.436 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -82.37 150.92 26.9 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.566 -0.709 . . . . 0.0 112.01 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.3 p -125.31 100.74 6.65 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.503 1.521 . . . . 0.0 112.261 -173.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -72.6 147.63 89.64 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.519 1.128 . . . . 0.0 112.661 173.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.86 151.02 31.01 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.36 2.706 . . . . 0.0 109.938 161.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -88.36 -5.32 58.38 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -168.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -75.06 136.85 41.16 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.17 -0.956 . . . . 0.0 110.874 169.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -107.09 151.12 40.61 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.427 1.091 . . . . 0.0 112.198 -175.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.75 154.58 43.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.452 2.768 . . . . 0.0 113.391 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -81.52 134.49 35.53 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.015 2.126 . . . . 0.0 111.212 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.9 mt 51.86 -174.88 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.839 1.656 . . . . 0.0 113.523 -172.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.5 133.29 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 120.3 -1.5 . . . . 0.0 110.372 173.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.2 m -97.48 152.03 19.4 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -172.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.59 6.83 11.03 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.823 1.649 . . . . 0.0 113.568 168.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -74.45 149.17 40.51 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.823 1.649 . . . . 0.0 111.815 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 36.9 tp -110.03 129.04 55.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.916 0.886 . . . . 0.0 110.693 172.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -148.75 173.97 12.68 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.917 1.287 . . . . 0.0 113.047 -163.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.38 -42.14 92.99 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -159.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.28 -33.63 74.7 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 120.342 1.428 . . . . 0.0 111.757 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -64.09 -40.29 95.91 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.032 0.933 . . . . 0.0 111.348 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.0 pt -85.1 -23.07 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.119 0.968 . . . . 0.0 113.493 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.76 -28.09 50.52 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.33 0.968 . . . . 0.0 112.399 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 78.8 mtm -80.59 115.45 20.11 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.759 0.708 . . . . 0.0 110.767 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.46 85.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.847 1.308 . . . . 0.0 108.961 171.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -78.97 103.7 9.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.468 1.507 . . . . 0.0 110.251 -169.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -65.61 -28.85 69.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.253 1.421 . . . . 0.0 113.665 -170.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.81 -32.27 73.71 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.63 0.772 . . . . 0.0 113.037 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.0 mp -76.25 -44.04 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.089 0.956 . . . . 0.0 109.661 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.32 -39.52 87.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.087 0.955 . . . . 0.0 111.83 173.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -64.63 -38.88 92.53 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.865 -1.147 . . . . 0.0 112.188 170.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.2 m -66.41 -43.25 86.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.74 0.816 . . . . 0.0 112.331 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 pt -60.72 -33.35 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.356 0.98 . . . . 0.0 112.928 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -78.81 -23.55 45.08 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.907 1.683 . . . . 0.0 114.542 173.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.0 t -89.22 -32.82 17.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.361 1.865 . . . . 0.0 113.061 -174.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -88.86 143.18 27.06 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.767 1.227 . . . . 0.0 111.245 169.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.26 -33.13 61.25 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.38 -0.825 . . . . 0.0 111.105 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.3 t -142.82 131.46 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.65 1.18 . . . . 0.0 111.512 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -134.36 139.12 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.097 1.359 . . . . 0.0 111.773 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.0 t -134.24 156.54 48.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.086 1.355 . . . . 0.0 111.299 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 147' ' ' GLN . 1.1 p90 -132.0 135.33 46.46 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.764 0.825 . . . . 0.0 110.839 173.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.65 167.64 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.585 1.954 . . . . 0.0 110.391 -168.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.11 112.55 15.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 152.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.43 -153.66 46.49 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 123.142 0.401 . . . . 0.0 113.811 -175.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.1 mt -129.18 160.07 65.73 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.838 1.655 . . . . 0.0 111.066 -166.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.75 -24.94 20.93 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 N-CA-C 116.515 1.698 . . . . 0.0 116.515 -156.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -98.89 -3.87 34.25 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.805 1.242 . . . . 0.0 113.402 168.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -141.62 71.97 25.19 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.531 1.532 . . . . 0.0 110.787 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.18 155.7 25.74 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.621 2.881 . . . . 0.0 112.818 -174.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -112.99 7.06 18.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.36 1.464 . . . . 0.0 113.552 175.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 16.6 t -148.47 147.43 29.12 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.685 -1.26 . . . . 0.0 111.788 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.78 -41.07 77.03 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.598 -0.689 . . . . 0.0 112.011 170.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -66.66 -27.34 67.59 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.597 -0.689 . . . . 0.0 112.331 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.4 m -64.85 -47.49 77.71 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.318 -0.864 . . . . 0.0 110.936 169.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.31 -41.28 88.66 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.955 0.798 . . . . 0.0 111.298 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -61.22 -35.98 78.69 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.633 1.173 . . . . 0.0 114.06 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.7 tpt -62.13 -41.9 98.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.876 0.762 . . . . 0.0 111.246 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.6 mm -72.06 -36.91 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.26 -0.9 . . . . 0.0 112.259 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -58.23 -30.96 66.92 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.646 1.178 . . . . 0.0 112.496 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.06 -47.14 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.744 1.618 . . . . 0.0 112.141 170.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 44.9 mt -66.2 -35.49 80.59 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.144 -0.973 . . . . 0.0 113.08 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -62.4 -39.55 93.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.448 1.099 . . . . 0.0 112.011 168.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.73 -26.17 66.01 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.166 -0.959 . . . . 0.0 113.285 176.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.6 tp -86.79 -15.48 39.16 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.09 2.14 16.76 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 124.821 1.201 . . . . 0.0 115.146 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.51 135.35 54.18 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.876 1.671 . . . . 0.0 111.402 172.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -109.96 151.8 26.66 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.431 1.11 . . . . 0.0 113.286 171.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -130.2 168.9 16.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.897 2.079 . . . . 0.0 110.448 -172.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.1 m -90.33 133.73 34.78 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.868 -1.145 . . . . 0.0 111.192 -159.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.5 p -129.39 147.8 51.25 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -164.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.2 153.78 47.93 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.203 1.801 . . . . 0.0 111.677 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -89.96 113.96 25.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.122 0.969 . . . . 0.0 112.085 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.9 -16.78 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 121.227 -0.921 . . . . 0.0 113.265 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -73.19 -29.5 62.87 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.327 -0.858 . . . . 0.0 111.236 169.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.84 -33.78 21.23 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -130.2 102.35 17.29 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 118.744 0.702 . . . . 0.0 112.776 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -60.23 -21.66 67.38 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.221 2.614 . . . . 0.0 115.494 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 p -52.51 -31.14 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 120.05 1.296 . . . . 0.0 113.347 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.7 -47.65 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.349 -0.844 . . . . 0.0 110.592 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -67.79 -30.49 69.94 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.472 1.033 . . . . 0.0 112.831 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.5 m -58.58 -49.08 78.77 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.834 0.853 . . . . 0.0 111.993 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -74.1 -49.37 24.2 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 168.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.6 t -60.45 -41.65 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 121.083 -1.011 . . . . 0.0 113.286 -165.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -63.48 -34.87 78.72 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.233 0.54 . . . . 0.0 111.474 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.14 -50.6 11.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.271 1.829 . . . . 0.0 112.84 177.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.67 -30.38 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.124 0.969 . . . . 0.0 112.806 -175.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 84.4 p -90.05 -3.94 57.67 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 59.61 -34.56 0.06 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 129.839 3.256 . . . . 0.0 116.239 -171.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -145.65 110.69 4.52 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.604 1.561 . . . . 0.0 109.789 173.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -89.11 130.65 2.09 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 121.905 1.736 . . . . 0.0 114.16 -165.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.5 p -129.33 133.53 47.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.683 1.593 . . . . 0.0 109.97 166.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.3 pt -128.5 156.53 77.0 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 124.926 1.29 . . . . 0.0 113.678 -167.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -61.73 162.98 42.96 Favored 'Cis proline' 0 C--N 1.356 0.944 0 CA-C-N 119.967 1.024 . . . . 0.0 113.88 -5.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.426 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 18.9 tt0 -151.08 158.32 43.9 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.347 0.659 . . . . 0.0 111.729 -164.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.22 139.08 53.18 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.856 1.313 . . . . 0.0 113.724 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -120.46 140.89 50.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.787 -2.006 . . . . 0.0 109.43 169.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 53.7 mt -125.75 121.92 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 173.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.2 tptt 45.46 52.88 8.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.516 1.926 . . . . 0.0 114.073 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.72 27.46 16.72 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -121.55 136.48 54.95 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.344 1.457 . . . . 0.0 110.553 170.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -74.38 123.71 25.15 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.564 0.697 . . . . 0.0 111.114 174.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 31.6 t -103.93 -54.38 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 126.272 1.829 . . . . 0.0 111.565 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.93 166.7 23.24 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 116.967 1.547 . . . . 0.0 116.967 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.89 172.11 55.17 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.37 1.938 . . . . 0.0 113.609 170.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.2 tp -56.53 -35.82 68.53 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.472 1.109 . . . . 0.0 113.476 -173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.36 -33.48 75.62 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.994 0.816 . . . . 0.0 112.541 174.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 4.5 mm -77.66 -46.76 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.247 1.419 . . . . 0.0 110.475 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.69 -36.31 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.701 1.2 . . . . 0.0 110.777 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 94.6 m -59.25 -40.41 85.89 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.898 0.879 . . . . 0.0 112.108 174.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -65.08 -50.27 66.8 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.966 0.803 . . . . 0.0 110.157 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 47.6 mtt -61.49 -37.34 83.3 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.245 1.018 . . . . 0.0 112.333 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.36 -39.01 81.98 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.357 1.863 . . . . 0.0 112.369 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -76.95 -30.75 56.17 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 41.1 t -84.55 -26.45 28.0 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.024 1.33 . . . . 0.0 114.482 -172.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.31 -6.35 63.43 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-N 119.142 0.883 . . . . 0.0 114.554 -169.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.29 -32.49 72.67 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.77 1.785 . . . . 0.0 112.402 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.06 -46.15 88.83 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.203 -0.936 . . . . 0.0 110.147 174.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -62.02 -37.99 86.95 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.254 1.422 . . . . 0.0 113.199 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -67.41 -35.25 78.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.362 1.065 . . . . 0.0 112.596 175.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 60.5 mtm -70.07 -52.1 26.61 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.167 0.894 . . . . 0.0 113.143 169.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 pp -64.78 -35.88 82.51 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.251 -0.906 . . . . 0.0 112.368 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -71.8 -30.94 66.06 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.88 -36.8 82.33 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.58 0.627 . . . . 0.0 111.947 167.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.54 2.6 11.25 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.798 1.639 . . . . 0.0 113.964 175.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.54 12.57 81.61 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.121 1.343 . . . . 0.0 113.853 176.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.6 mt -93.91 149.63 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.027 1.331 . . . . 0.0 110.004 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 93.2 m -103.27 146.77 27.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.222 1.409 . . . . 0.0 110.947 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.7 p -141.75 167.67 21.6 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.81 1.644 . . . . 0.0 112.213 171.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -70.06 159.33 34.05 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.381 1.073 . . . . 0.0 112.372 168.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.0 147.9 23.22 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.79 1.236 . . . . 0.0 112.759 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 21.8 tp . . . . . 0 C--O 1.252 1.231 0 C-N-CA 129.501 3.12 . . . . 0.0 116.206 178.982 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.861 0.362 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.2 m -71.19 -19.36 62.41 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -161.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 m -124.87 20.67 8.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.014 1.326 . . . . 0.0 112.412 170.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.9 -22.3 0.92 Allowed Glycine 0 CA--C 1.54 1.636 0 C-N-CA 126.295 1.902 . . . . 0.0 116.187 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.9 tp -136.29 155.53 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.983 2.113 . . . . 0.0 109.521 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -54.46 147.04 24.25 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.841 1.21 . . . . 0.0 115.47 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.42 175.32 25.65 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.62 1.581 . . . . 0.0 115.542 -170.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -123.68 131.85 53.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.948 2.099 . . . . 0.0 109.946 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.5 p -88.54 137.58 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.537 0.735 . . . . 0.0 111.953 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -134.67 170.83 15.22 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.589 1.556 . . . . 0.0 113.424 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -154.91 153.05 30.48 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.471 1.908 . . . . 0.0 112.121 172.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.3 mt -127.78 72.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.171 1.388 . . . . 0.0 108.5 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -140.13 144.68 36.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.229 1.014 . . . . 0.0 113.003 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -91.77 133.42 35.64 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 126.371 1.868 . . . . 0.0 110.976 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.5 p -140.11 53.25 1.66 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.031 0.932 . . . . 0.0 112.599 -157.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.2 156.23 36.08 Favored Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 120.769 -1.207 . . . . 0.0 112.848 158.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.11 -179.35 3.44 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.624 2.883 . . . . 0.0 112.197 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.48 15.12 0.5 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.963 1.705 . . . . 0.0 111.634 169.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -122.5 135.21 54.6 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.059 2.144 . . . . 0.0 111.206 -168.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -109.96 140.58 22.44 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.653 0.781 . . . . 0.0 110.509 156.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -65.98 160.6 43.57 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.008 2.472 . . . . 0.0 110.117 159.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -64.66 135.23 55.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.928 -1.108 . . . . 0.0 111.691 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.76 147.08 36.41 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.968 1.707 . . . . 0.0 112.024 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.06 -30.4 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.773 1.629 . . . . 0.0 111.418 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 m -142.25 133.87 26.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.74 1.616 . . . . 0.0 110.749 165.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.19 146.68 53.96 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -167.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -157.78 173.6 16.56 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.349 1.06 . . . . 0.0 112.824 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.6 mt -84.4 155.79 22.12 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.606 1.162 . . . . 0.0 111.861 168.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.9 133.51 34.29 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.937 -0.477 . . . . 0.0 110.447 159.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -58.71 -34.37 71.24 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.903 1.281 . . . . 0.0 112.008 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.39 -28.23 62.87 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.115 1.366 . . . . 0.0 112.951 173.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.64 -42.35 58.7 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 119.869 -1.77 . . . . 0.0 113.024 175.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.4 tp -75.56 -17.73 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.3 -3.65 55.1 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 169.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -99.01 137.7 37.16 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.193 1.797 . . . . 0.0 111.188 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 p -94.4 130.45 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 122.041 0.924 . . . . 0.0 111.305 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -86.24 136.29 33.23 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -53.71 -43.35 68.95 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.492 0.717 . . . . 0.0 112.583 -167.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -61.95 -27.74 69.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.49 1.116 . . . . 0.0 113.726 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.89 -54.66 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 118.808 0.731 . . . . 0.0 109.483 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.66 -37.71 88.38 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.772 0.829 . . . . 0.0 111.454 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -68.96 -43.91 74.04 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 44.8 m -73.73 -40.19 63.73 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.394 -1.441 . . . . 0.0 112.043 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.6 pt -61.89 -35.55 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.17 0.588 . . . . 0.0 111.844 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -77.9 -32.96 52.1 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.505 1.922 . . . . 0.0 113.718 175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.5 t -73.03 -15.99 61.51 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.845 1.258 . . . . 0.0 113.299 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -104.2 145.27 30.45 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.95 1.3 . . . . 0.0 113.969 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -83.46 -39.49 20.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.947 0.899 . . . . 0.0 111.366 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.57 137.87 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 126.731 2.012 . . . . 0.0 109.839 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.8 t -133.93 128.0 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.626 1.17 . . . . 0.0 110.566 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 t -136.66 156.95 47.86 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.943 1.297 . . . . 0.0 110.916 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.406 ' CE1' HG21 ' A' ' 136' ' ' VAL . 52.7 p90 -129.32 145.93 51.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.088 0.955 . . . . 0.0 111.282 176.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 mt -137.39 151.3 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.198 0.599 . . . . 0.0 111.406 -166.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.49 108.32 3.25 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 159.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.08 -136.36 15.59 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 118.582 0.628 . . . . 0.0 113.115 -174.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.7 mt -123.16 158.4 58.07 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.728 2.011 . . . . 0.0 111.447 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.53 -23.47 37.12 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 121.976 1.784 . . . . 0.0 115.067 -173.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.7 -15.38 25.32 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.235 0.925 . . . . 0.0 113.221 169.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.95 68.68 70.93 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.213 1.405 . . . . 0.0 111.635 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.01 146.11 25.45 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.215 2.61 . . . . 0.0 111.414 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 96.4 mtp -97.69 4.79 49.93 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.488 1.515 . . . . 0.0 113.518 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.9 t -146.57 145.52 30.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.44 1.496 . . . . 0.0 111.078 -175.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.82 -44.12 97.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.215 0.606 . . . . 0.0 111.996 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -72.39 -24.7 61.29 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.935 -1.103 . . . . 0.0 112.567 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.0 m -68.42 -43.1 77.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.649 0.78 . . . . 0.0 111.6 167.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -61.4 -44.81 96.51 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.813 0.845 . . . . 0.0 111.861 174.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -57.8 -37.28 73.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.277 1.831 . . . . 0.0 113.036 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.9 ttp -63.58 -46.8 84.19 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.434 0.561 . . . . 0.0 111.624 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 mm -69.72 -33.01 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.346 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -57.98 -36.69 72.97 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.935 1.243 . . . . 0.0 113.026 170.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.13 -42.14 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.799 0.839 . . . . 0.0 111.1 177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.35 -38.94 88.75 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.405 1.082 . . . . 0.0 112.678 172.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.05 -25.55 66.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.179 1.791 . . . . 0.0 112.723 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.27 73.45 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 170.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.06 -11.6 35.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.169 0.988 . . . . 0.0 113.327 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.73 20.3 70.13 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.477 1.037 . . . . 0.0 115.043 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.42 130.35 56.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.466 0.633 . . . . 0.0 109.462 156.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -115.78 131.31 56.97 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.472 0.709 . . . . 0.0 109.706 168.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -105.07 171.93 7.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.988 1.715 . . . . 0.0 113.021 -163.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.4 m -84.73 125.88 32.92 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.462 1.125 . . . . 0.0 108.861 -170.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.7 m -125.53 133.28 52.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 113.724 -1.58 . . . . 0.0 111.561 -154.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.04 141.98 46.24 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.097 0.951 . . . . 0.0 112.819 -172.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -98.45 78.71 2.43 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.026 1.731 . . . . 0.0 112.164 -167.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.0 p -61.52 -28.3 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.263 1.425 . . . . 0.0 114.321 -172.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.0 tp -78.15 -22.69 48.39 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.664 -0.648 . . . . 0.0 111.533 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.87 -32.95 13.0 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 175.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -130.06 98.12 21.95 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.046 0.938 . . . . 0.0 112.055 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -62.19 -9.68 15.75 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.042 3.161 . . . . 0.0 116.247 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.1 p -48.78 -36.49 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 121.015 -1.053 . . . . 0.0 111.945 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.43 -47.9 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.232 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -67.57 -29.22 68.52 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.1 0.864 . . . . 0.0 112.243 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.2 m -70.5 -50.5 37.18 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -72.16 -39.43 68.74 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.956 0.798 . . . . 0.0 111.711 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.406 HG21 ' CE1' ' A' ' 94' ' ' PHE . 9.0 p -61.29 -35.36 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.109 0.868 . . . . 0.0 113.061 -175.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.84 -46.34 78.91 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.979 0.809 . . . . 0.0 111.568 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -64.79 -34.58 78.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.156 0.982 . . . . 0.0 113.067 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.3 t -80.3 -41.56 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.1 t -97.47 -14.27 21.25 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -168.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 67.34 -40.66 0.4 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.874 2.07 . . . . 0.0 115.079 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 20.6 t90 -130.0 104.85 16.73 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.118 1.767 . . . . 0.0 110.529 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -88.14 128.43 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.563 2.176 . . . . 0.0 112.464 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 75.1 p -131.53 146.97 52.48 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.144 2.178 . . . . 0.0 108.58 169.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.1 tt -108.46 134.93 20.07 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 119.241 0.928 . . . . 0.0 111.9 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -79.99 162.75 83.91 Favored 'Cis proline' 0 CA--C 1.551 1.35 0 CA-C-N 119.835 0.977 . . . . 0.0 111.799 -16.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -134.18 161.58 34.51 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.893 1.677 . . . . 0.0 111.288 177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.59 141.82 50.87 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -130.92 141.05 50.26 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.532 1.933 . . . . 0.0 110.073 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 60.3 mt -140.54 134.05 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.731 1.213 . . . . 0.0 109.556 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt 52.96 41.75 32.11 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.687 1.595 . . . . 0.0 114.162 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.04 14.2 5.19 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.95 2.1 . . . . 0.0 115.568 -172.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -111.42 140.89 45.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.625 1.57 . . . . 0.0 110.618 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -77.84 126.25 30.57 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.257 -0.902 . . . . 0.0 112.898 175.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.3 t -101.03 -48.05 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.555 1.542 . . . . 0.0 111.835 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 162.91 170.55 27.94 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 116.949 1.54 . . . . 0.0 116.949 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.7 169.14 54.62 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.268 1.413 . . . . 0.0 113.685 166.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -46.69 -46.89 20.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.861 1.665 . . . . 0.0 114.746 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.56 -39.06 75.84 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.543 -0.723 . . . . 0.0 111.531 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 8.9 mm -72.62 -47.45 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.57 1.948 . . . . 0.0 111.56 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.35 -35.76 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.903 0.881 . . . . 0.0 110.503 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.1 m -62.06 -39.31 91.96 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.744 0.818 . . . . 0.0 112.153 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -64.29 -46.69 82.53 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.184 0.902 . . . . 0.0 110.633 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 47.5 mtt -61.65 -38.76 88.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.137 0.975 . . . . 0.0 111.812 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.61 -44.16 87.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.565 1.146 . . . . 0.0 111.781 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.25 -34.38 65.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 t -105.54 3.23 29.13 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -171.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.26 -0.41 75.12 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 116.259 1.263 . . . . 0.0 116.259 169.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -71.65 -31.85 67.28 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.561 1.181 . . . . 0.0 113.245 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.75 -43.77 83.24 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.483 -1.385 . . . . 0.0 109.951 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -58.22 -44.59 88.24 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.128 1.771 . . . . 0.0 112.307 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -57.28 -46.16 83.37 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.248 1.019 . . . . 0.0 110.932 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 65.1 mtm -69.59 -49.87 49.93 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.9 -37.73 86.87 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.613 -0.679 . . . . 0.0 112.638 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -71.66 -30.8 66.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.188 0.995 . . . . 0.0 111.99 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.77 -31.05 72.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.432 0.693 . . . . 0.0 112.199 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -76.05 -0.18 20.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.96 1.304 . . . . 0.0 113.51 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.4 24.87 60.12 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 124.153 0.882 . . . . 0.0 113.435 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 46.2 mt -105.42 140.4 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.012 0.906 . . . . 0.0 110.893 -174.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.0 m -94.2 125.33 38.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.859 1.264 . . . . 0.0 112.037 176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.1 p -118.35 173.26 6.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.096 2.559 . . . . 0.0 111.691 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -55.18 120.72 7.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.359 0.664 . . . . 0.0 111.691 164.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -112.85 121.74 45.6 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.58 1.552 . . . . 0.0 108.71 170.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 49.9 tp . . . . . 0 C--O 1.253 1.254 0 C-N-CA 124.374 1.07 . . . . 0.0 112.351 -167.705 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 119.603 -0.237 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.8 p -66.16 -18.23 65.22 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.375 1.47 . . . . 0.0 114.781 -174.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.7 m -128.72 146.83 50.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.363 1.465 . . . . 0.0 111.914 165.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.62 -5.87 70.3 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 117.382 1.713 . . . . 0.0 117.382 163.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.3 tt -139.27 156.99 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.367 1.583 . . . . 0.0 111.055 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.41 166.54 54.59 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 123.973 0.797 . . . . 0.0 114.673 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.08 148.21 40.77 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.448 1.023 . . . . 0.0 114.871 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -136.87 137.32 39.54 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.659 1.183 . . . . 0.0 111.454 -171.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.05 126.0 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.628 1.171 . . . . 0.0 113.402 -168.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -70.97 151.81 44.26 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -88.03 141.46 28.56 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.386 1.474 . . . . 0.0 113.219 -166.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.1 tp -59.6 135.02 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.205 1.402 . . . . 0.0 112.455 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -91.3 117.12 29.39 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.191 0.996 . . . . 0.0 110.961 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -144.17 162.41 36.39 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.798 2.039 . . . . 0.0 110.65 -171.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.7 m -128.44 138.09 52.15 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.976 1.31 . . . . 0.0 110.477 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -94.04 136.1 24.01 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.759 0.823 . . . . 0.0 112.162 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.8 162.07 29.96 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.925 2.417 . . . . 0.0 112.232 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -81.53 -9.8 59.61 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.462 1.105 . . . . 0.0 112.986 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -126.43 111.19 14.16 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.32 1.448 . . . . 0.0 108.214 170.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -106.55 153.2 40.74 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 127.116 2.167 . . . . 0.0 111.183 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.45 153.15 23.7 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.271 2.647 . . . . 0.0 114.62 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.7 ttm105 -108.92 140.49 42.33 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.706 2.402 . . . . 0.0 110.549 171.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.1 tp -145.43 -72.12 0.25 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.547 0.739 . . . . 0.0 111.904 172.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.4 t -106.95 -43.61 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.186 0.994 . . . . 0.0 109.681 166.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.1 m -112.54 168.61 9.51 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.486 1.514 . . . . 0.0 111.516 162.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.08 167.45 10.66 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.032 1.733 . . . . 0.0 112.024 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 52.66 61.96 2.93 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.203 1.801 . . . . 0.0 115.653 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.6 tp -139.35 139.21 37.17 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.519 1.128 . . . . 0.0 111.448 168.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.58 161.0 38.99 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.691 1.196 . . . . 0.0 113.522 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -56.01 -28.77 58.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.594 1.558 . . . . 0.0 113.432 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -59.31 -38.84 81.27 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.905 1.682 . . . . 0.0 112.789 175.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -79.06 -41.23 29.28 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 165.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.22 -30.3 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 120.501 -1.374 . . . . 0.0 112.22 -168.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.12 0.18 56.93 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 80.0 mmm -120.79 127.97 52.45 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.837 1.255 . . . . 0.0 112.364 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -85.81 146.69 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.342 0.657 . . . . 0.0 110.796 163.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -93.82 123.18 36.99 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.075 1.35 . . . . 0.0 111.153 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -61.51 -32.48 72.52 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -169.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.78 -38.88 80.34 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.155 1.343 . . . . 0.0 112.058 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.4 mt -70.45 -50.57 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.094 0.958 . . . . 0.0 109.458 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.05 -39.68 94.61 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.059 1.344 . . . . 0.0 112.526 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.23 -32.57 72.86 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.626 -0.671 . . . . 0.0 112.617 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.9 m -71.06 -48.03 55.06 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.566 1.075 . . . . 0.0 111.584 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.6 pt -62.04 -34.31 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.78 0.832 . . . . 0.0 112.054 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -78.5 -35.17 46.8 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.468 1.507 . . . . 0.0 113.534 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.5 t -72.63 -37.85 67.91 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.339 1.056 . . . . 0.0 113.015 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -87.13 133.51 33.62 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.157 0.889 . . . . 0.0 111.956 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.38 -38.31 77.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.731 -0.606 . . . . 0.0 111.717 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.5 t -143.92 131.66 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.216 1.806 . . . . 0.0 110.296 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -135.02 133.19 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.507 1.123 . . . . 0.0 112.118 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.0 t -131.41 155.13 47.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.954 1.302 . . . . 0.0 110.97 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -131.2 140.48 49.9 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.168 0.987 . . . . 0.0 111.79 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mt -140.54 155.65 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.031 1.332 . . . . 0.0 110.901 -158.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.1 102.22 1.6 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.124 0.569 . . . . 0.0 109.467 155.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.97 -143.97 23.55 Favored Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.302 -0.874 . . . . 0.0 114.7 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.1 mt -107.3 155.69 38.99 Favored Pre-proline 0 N--CA 1.47 0.568 0 C-N-CA 125.438 1.495 . . . . 0.0 111.929 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -63.9 -32.2 66.37 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 121.413 1.408 . . . . 0.0 112.356 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -75.2 -26.78 59.26 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.242 1.017 . . . . 0.0 113.124 172.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.81 76.51 15.48 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.31 1.444 . . . . 0.0 112.354 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.84 144.85 24.82 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.124 2.549 . . . . 0.0 111.772 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 mmt -107.84 10.87 28.54 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.134 1.773 . . . . 0.0 113.815 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.4 t -147.5 146.09 29.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.222 1.409 . . . . 0.0 110.233 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.52 -45.89 87.89 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.482 0.658 . . . . 0.0 111.846 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -70.73 -26.45 63.39 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.103 -0.998 . . . . 0.0 112.138 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -68.49 -38.3 80.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.255 -0.903 . . . . 0.0 112.681 166.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -65.49 -39.28 91.71 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.339 0.972 . . . . 0.0 112.285 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -59.58 -33.1 71.02 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.965 1.306 . . . . 0.0 112.873 174.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.7 tpt -61.51 -42.94 99.56 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.505 0.722 . . . . 0.0 111.74 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mm -70.12 -33.91 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.555 0.742 . . . . 0.0 111.654 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -39.79 74.58 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.741 1.216 . . . . 0.0 111.713 177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.93 -43.41 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.475 1.51 . . . . 0.0 111.868 172.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.96 -37.96 89.33 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.696 -0.628 . . . . 0.0 112.102 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -69.36 -31.93 70.67 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.407 -0.808 . . . . 0.0 112.762 173.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.88 76.65 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.457 -0.777 . . . . 0.0 112.334 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 44.6 mt -87.01 -12.61 46.89 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.199 1.0 . . . . 0.0 113.298 171.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.5 15.01 63.24 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.884 1.707 . . . . 0.0 114.309 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.38 132.45 55.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.405 1.103 . . . . 0.0 113.449 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -110.82 157.36 19.9 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.249 1.02 . . . . 0.0 113.04 169.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -145.65 170.76 15.83 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.667 2.787 . . . . 0.0 110.531 -163.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.6 m -85.28 124.22 31.65 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.623 -1.298 . . . . 0.0 109.787 -168.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.9 m -130.43 132.09 45.55 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.041 1.336 . . . . 0.0 111.393 -156.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -120.5 143.18 48.69 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -87.65 121.1 29.66 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.693 1.197 . . . . 0.0 109.965 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.0 m -67.22 -21.2 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.049 0.94 . . . . 0.0 113.137 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.9 mt -88.34 -25.08 22.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.095 1.358 . . . . 0.0 114.446 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.11 -33.3 22.42 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -164.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -148.21 149.78 33.1 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.881 1.272 . . . . 0.0 110.087 -172.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.86 -6.9 19.85 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.862 2.375 . . . . 0.0 114.543 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.68 -40.37 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.704 -1.248 . . . . 0.0 113.318 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.35 -47.2 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.275 -0.891 . . . . 0.0 110.939 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -59.31 -30.19 68.16 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.27 0.941 . . . . 0.0 113.354 171.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.0 m -69.98 -44.75 68.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -77.66 -40.36 41.91 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 175.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.22 -43.87 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -159.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -69.46 -35.49 75.69 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.733 0.778 . . . . 0.0 110.32 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -67.39 -43.92 80.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.242 1.817 . . . . 0.0 113.343 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.54 -36.23 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.991 0.917 . . . . 0.0 113.297 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.6 p -102.37 1.13 35.09 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.026 1.861 . . . . 0.0 116.026 -173.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 62.45 -30.84 0.08 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.589 2.355 . . . . 0.0 115.965 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -151.93 138.29 11.75 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.183 1.393 . . . . 0.0 111.349 167.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.75 128.38 19.83 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.206 1.937 . . . . 0.0 112.759 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.6 m -139.94 140.87 36.46 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.322 -1.486 . . . . 0.0 110.419 157.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.8 mt -122.83 135.62 25.96 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.443 1.097 . . . . 0.0 110.929 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -82.33 165.61 71.76 Favored 'Cis proline' 0 CA--C 1.543 0.973 0 CA-C-N 119.934 1.012 . . . . 0.0 111.837 -10.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -143.19 159.73 41.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.028 1.331 . . . . 0.0 111.96 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.1 140.15 51.69 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.515 1.126 . . . . 0.0 113.881 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -129.76 143.93 51.05 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.18 1.792 . . . . 0.0 110.514 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 55.2 mt -132.95 128.14 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.544 1.137 . . . . 0.0 108.341 175.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt 47.32 49.59 15.39 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.023 1.729 . . . . 0.0 115.544 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.87 19.11 9.39 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -122.59 147.1 46.81 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.502 1.921 . . . . 0.0 110.564 176.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -85.44 126.25 33.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.145 0.974 . . . . 0.0 112.88 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.1 t -100.26 -46.02 11.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 125.1 1.36 . . . . 0.0 110.602 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 158.73 179.0 33.26 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 117.261 1.665 . . . . 0.0 117.261 165.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.35 171.31 55.17 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.054 1.312 . . . . 0.0 113.751 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.6 tp -46.74 -46.31 20.27 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.793 1.237 . . . . 0.0 114.04 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -69.9 -17.87 63.36 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.8 mm -84.06 -45.64 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.967 1.307 . . . . 0.0 109.882 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 44.3 t -60.47 -44.19 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.752 1.621 . . . . 0.0 111.778 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.7 p -64.82 -37.96 89.37 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.679 0.672 . . . . 0.0 111.97 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -63.13 -44.1 96.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.319 1.048 . . . . 0.0 111.549 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 52.7 mtt -66.89 -35.97 81.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.6 1.16 . . . . 0.0 112.356 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.89 -45.96 66.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.9 1.28 . . . . 0.0 112.029 176.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -68.54 -19.94 64.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.983 1.313 . . . . 0.0 113.151 178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.6 m -105.16 -8.07 18.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.511 1.524 . . . . 0.0 114.721 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.03 -1.11 76.29 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 119.587 1.085 . . . . 0.0 115.08 -175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -67.21 -34.07 76.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.597 1.198 . . . . 0.0 112.069 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.06 -39.49 86.19 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.798 1.285 . . . . 0.0 110.913 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -66.04 -31.33 72.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.81 2.044 . . . . 0.0 113.493 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.61 -48.82 80.18 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.63 1.104 . . . . 0.0 111.134 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -70.6 -41.21 72.62 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 pp -65.18 -37.34 87.05 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.649 0.659 . . . . 0.0 111.351 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -71.91 -34.76 69.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -62.52 -30.02 70.99 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 167.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -77.13 -2.68 35.56 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 92.44 6.82 64.01 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.751 1.643 . . . . 0.0 114.85 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.05 147.05 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.183 1.393 . . . . 0.0 111.327 -170.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 36.4 m -105.24 126.1 51.72 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.118 0.967 . . . . 0.0 110.627 170.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 17.0 p -112.08 167.97 9.97 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.8 1.64 . . . . 0.0 111.822 172.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.56 161.28 28.26 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.99 0.916 . . . . 0.0 111.238 171.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -76.08 146.35 39.43 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.288 0.566 . . . . 0.0 110.69 170.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.253 1.278 0 C-N-CA 125.186 1.394 . . . . 0.0 112.209 -174.682 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.6 p -65.51 -16.2 63.43 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -174.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 97.5 p -119.67 10.85 11.82 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.912 1.685 . . . . 0.0 113.558 171.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.92 -11.31 48.55 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.063 1.316 . . . . 0.0 115.853 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mt -125.17 125.38 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.914 1.357 . . . . 0.0 109.623 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.86 -178.66 31.15 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.193 1.377 . . . . 0.0 114.066 -175.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.65 147.53 48.05 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.11 1.338 . . . . 0.0 115.893 -167.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.12 141.5 57.4 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.159 1.384 . . . . 0.0 112.897 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.77 140.47 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.713 0.805 . . . . 0.0 112.198 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -122.08 165.57 15.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.04 1.736 . . . . 0.0 112.175 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.43 145.1 30.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.088 0.955 . . . . 0.0 112.491 166.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.5 mt -117.25 142.41 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.713 1.605 . . . . 0.0 108.536 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -116.93 151.69 36.12 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -76.53 152.65 35.95 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.542 1.537 . . . . 0.0 109.578 163.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.0 p -50.0 -27.67 5.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.587 2.355 . . . . 0.0 115.834 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.09 158.44 81.31 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.532 1.533 . . . . 0.0 114.108 -166.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -66.52 172.8 8.67 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.736 2.29 . . . . 0.0 110.927 160.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -104.56 -2.46 25.14 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 167.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -79.9 119.54 22.9 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.028 -1.045 . . . . 0.0 109.854 162.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -83.6 141.69 42.06 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.18 152.89 31.43 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 124.271 3.314 . . . . 0.0 114.983 -174.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.2 mtp85 -76.29 130.53 38.27 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.629 1.572 . . . . 0.0 111.515 161.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.9 mt -140.96 152.89 45.32 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.222 1.809 . . . . 0.0 111.076 -176.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.58 -35.79 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.362 1.065 . . . . 0.0 110.816 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.9 m -113.81 123.37 49.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.664 1.986 . . . . 0.0 109.656 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -87.16 103.62 15.58 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -169.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.01 155.5 18.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.701 1.2 . . . . 0.0 111.536 167.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.9 mt -71.52 141.59 50.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.139 0.975 . . . . 0.0 109.14 164.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.19 162.52 26.53 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.554 -0.716 . . . . 0.0 111.286 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -54.35 -43.45 71.3 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.291 -0.881 . . . . 0.0 111.938 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.34 -30.48 71.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.414 1.086 . . . . 0.0 113.547 175.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.52 -41.48 55.04 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 172.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.2 tt -92.78 -26.77 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -170.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.73 -5.89 54.42 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.176 -0.952 . . . . 0.0 113.008 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.2 ttt -120.09 144.27 47.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.531 1.932 . . . . 0.0 111.975 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -89.11 151.45 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.447 1.099 . . . . 0.0 113.283 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.2 106.27 16.75 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.324 1.449 . . . . 0.0 110.899 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -54.16 -40.24 67.29 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.033 1.333 . . . . 0.0 113.062 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -70.31 -36.51 74.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.649 0.779 . . . . 0.0 112.38 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.56 -46.01 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.237 1.415 . . . . 0.0 110.378 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -57.54 -40.63 79.28 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.574 1.15 . . . . 0.0 111.691 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.09 -29.06 65.93 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.952 0.901 . . . . 0.0 113.116 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.0 m -71.31 -48.09 52.75 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.83 1.195 . . . . 0.0 111.6 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.5 pt -59.98 -33.47 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 122.973 0.509 . . . . 0.0 111.826 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -78.2 -34.8 49.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.3 1.84 . . . . 0.0 113.542 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -68.78 -38.24 79.87 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.596 1.158 . . . . 0.0 111.719 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -86.03 133.27 33.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.494 0.718 . . . . 0.0 111.323 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.52 -26.3 45.78 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.987 -1.07 . . . . 0.0 112.507 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.5 t -142.37 131.24 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.482 1.113 . . . . 0.0 110.974 171.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.6 t -133.13 135.59 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.277 1.431 . . . . 0.0 111.468 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.0 t -135.45 155.2 50.92 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.978 1.311 . . . . 0.0 111.496 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -127.53 140.41 52.15 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.962 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.7 mt -133.41 159.7 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.872 1.669 . . . . 0.0 110.273 -163.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -75.28 105.17 6.16 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.466 0.706 . . . . 0.0 109.299 157.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.27 -158.61 32.96 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 119.056 0.844 . . . . 0.0 113.949 -175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -94.35 158.73 35.29 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.428 1.491 . . . . 0.0 111.205 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.0 -31.86 76.47 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 121.897 1.731 . . . . 0.0 112.663 168.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.0 -14.53 53.84 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.027 1.331 . . . . 0.0 113.925 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -147.42 72.45 11.84 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.23 1.412 . . . . 0.0 112.5 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.27 141.97 18.67 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.243 1.962 . . . . 0.0 112.064 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.1 mmt -90.53 1.68 56.48 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.127 2.171 . . . . 0.0 113.645 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.4 t -152.06 146.22 25.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.096 1.358 . . . . 0.0 111.777 -171.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.4 -39.76 81.56 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.24 -0.912 . . . . 0.0 112.553 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -64.08 -29.91 71.02 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.969 -1.082 . . . . 0.0 111.746 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.4 m -68.27 -46.35 70.65 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.348 0.659 . . . . 0.0 112.268 169.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -58.53 -42.35 87.6 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 118.926 0.784 . . . . 0.0 112.512 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -57.35 -31.09 65.39 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.034 0.934 . . . . 0.0 113.278 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 49.9 ttm -70.38 -42.93 71.1 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.996 0.816 . . . . 0.0 112.34 171.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 mm -69.17 -30.91 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 120.92 -1.112 . . . . 0.0 111.359 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.43 -33.63 75.18 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.6 1.16 . . . . 0.0 112.649 167.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.415 HG13 ' HG ' ' A' ' 165' ' ' LEU . 1.4 t -73.36 -40.7 56.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.734 0.814 . . . . 0.0 111.468 174.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.8 mt -63.36 -34.86 78.63 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.897 0.879 . . . . 0.0 111.915 170.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -67.83 -34.84 77.51 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.723 -1.236 . . . . 0.0 113.014 170.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.08 -34.79 79.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.991 0.814 . . . . 0.0 111.835 176.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -82.76 -14.49 54.38 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.01 7.68 44.95 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.463 1.03 . . . . 0.0 114.698 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 96.3 mt -112.18 132.4 54.92 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.574 1.55 . . . . 0.0 111.02 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -115.91 149.85 38.05 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.292 0.951 . . . . 0.0 112.511 168.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -123.7 172.66 8.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.067 1.747 . . . . 0.0 112.676 -167.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.2 m -85.38 121.64 28.38 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.314 -0.866 . . . . 0.0 110.043 -161.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.2 m -124.76 132.14 53.39 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.661 -1.154 . . . . 0.0 112.996 -153.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -125.67 142.79 51.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.28 1.032 . . . . 0.0 112.674 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -96.04 118.54 32.84 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.788 1.235 . . . . 0.0 111.973 -174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.6 p -68.31 -22.73 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.323 1.049 . . . . 0.0 113.485 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.3 mt -87.93 -22.25 24.45 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.27 -35.09 11.37 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -124.25 108.71 29.51 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.077 0.853 . . . . 0.0 111.434 -174.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -54.19 -20.15 18.51 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.427 3.418 . . . . 0.0 116.46 176.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.4 p -54.32 -32.57 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.909 -1.119 . . . . 0.0 113.233 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 99.4 t -70.09 -53.79 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.515 -0.741 . . . . 0.0 111.7 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.407 ' HA ' HG12 ' A' ' 136' ' ' VAL . 6.9 ptm180 -64.59 -25.73 68.1 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.743 0.817 . . . . 0.0 112.21 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.4 m -70.37 -50.76 35.54 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.02 0.928 . . . . 0.0 113.103 169.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -70.38 -37.44 74.53 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.74 1.154 . . . . 0.0 112.003 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 133' ' ' ARG . 7.4 p -65.89 -35.2 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 120.761 -1.212 . . . . 0.0 112.563 175.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -62.32 -38.38 89.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.241 1.016 . . . . 0.0 111.285 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -49.08 26.36 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 175.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 56.5 t -83.95 -42.93 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -169.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.8 m -100.27 -2.41 33.82 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 63.26 -32.52 0.11 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 128.765 2.826 . . . . 0.0 115.495 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 30.9 t90 -144.89 136.0 12.46 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 127.058 2.143 . . . . 0.0 109.961 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.3 126.78 3.76 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.852 1.701 . . . . 0.0 112.478 -172.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.3 m -130.21 121.05 25.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.969 1.708 . . . . 0.0 107.249 166.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.4 140.4 25.8 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.849 0.86 . . . . 0.0 109.361 -172.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.53 158.21 97.35 Favored 'Cis proline' 0 CA--C 1.541 0.856 0 CA-C-N 119.383 0.815 . . . . 0.0 113.496 -10.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -128.82 152.94 47.92 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.774 1.63 . . . . 0.0 110.616 173.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.61 139.99 51.99 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.367 1.467 . . . . 0.0 113.108 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -131.85 142.89 49.83 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.711 2.005 . . . . 0.0 109.826 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 53.2 mt -123.91 122.57 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.3 tptt 44.09 54.36 6.0 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.852 2.061 . . . . 0.0 113.783 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.93 24.39 13.49 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -126.62 143.71 51.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.678 1.191 . . . . 0.0 110.151 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -82.81 125.62 31.51 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.586 1.184 . . . . 0.0 113.26 -169.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.17 -47.36 11.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 125.105 1.362 . . . . 0.0 110.962 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.14 176.92 28.82 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 116.62 1.408 . . . . 0.0 116.62 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.45 172.59 55.13 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.472 1.034 . . . . 0.0 113.97 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -44.85 -47.02 11.07 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.107 1.763 . . . . 0.0 113.695 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.83 -29.76 70.97 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 119.053 -0.498 . . . . 0.0 112.328 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.9 mm -82.32 -47.73 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.31 1.444 . . . . 0.0 111.177 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.6 t -62.1 -36.12 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.093 1.357 . . . . 0.0 111.089 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.1 m -59.79 -42.12 92.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.497 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -66.49 -43.91 84.07 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.801 1.182 . . . . 0.0 111.132 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 50.5 mtt -61.09 -36.73 80.44 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.142 0.577 . . . . 0.0 111.923 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.415 ' HG ' HG13 ' A' ' 113' ' ' VAL . 3.2 tm? -71.48 -47.0 58.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.159 0.984 . . . . 0.0 112.714 170.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.52 -21.49 64.57 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.001 0.921 . . . . 0.0 113.434 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 64.4 m -105.27 -21.5 13.23 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.975 1.71 . . . . 0.0 114.02 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.15 9.2 62.33 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.664 -1.273 . . . . 0.0 115.668 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.33 -32.14 73.63 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.627 1.713 . . . . 0.0 111.694 173.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.31 -45.18 95.51 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.83 173.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.54 -41.86 98.44 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.189 0.995 . . . . 0.0 111.815 173.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -56.02 -45.02 79.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.824 0.85 . . . . 0.0 110.504 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.54 -51.44 28.66 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.35 -36.62 84.72 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.316 0.507 . . . . 0.0 111.717 -175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -68.34 -38.02 81.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.898 1.279 . . . . 0.0 111.878 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.47 -29.23 69.31 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.986 0.812 . . . . 0.0 111.749 171.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -79.7 6.27 11.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.067 1.747 . . . . 0.0 114.306 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.8 10.91 75.01 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.194 1.378 . . . . 0.0 114.421 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.1 mt -99.13 147.42 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.887 1.275 . . . . 0.0 109.572 -171.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 5.7 m -112.93 120.22 40.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.255 1.022 . . . . 0.0 111.305 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 18.2 p -112.41 167.37 10.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.852 1.261 . . . . 0.0 111.779 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.3 mmt85 -56.75 144.09 34.11 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.102 0.961 . . . . 0.0 110.035 166.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -93.58 132.15 38.17 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.04 0.936 . . . . 0.0 112.107 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--O 1.251 1.15 0 C-N-CA 126.706 2.002 . . . . 0.0 111.726 175.352 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.0 p -71.21 -24.41 62.21 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -173.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.1 t -161.1 -46.16 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 167.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.02 7.65 62.9 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 116.285 1.274 . . . . 0.0 116.285 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 tt -86.84 147.14 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.882 1.341 . . . . 0.0 112.991 -167.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -171.34 177.36 44.27 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.063 0.839 . . . . 0.0 113.752 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.31 -26.47 28.06 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.02 1.295 . . . . 0.0 114.117 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.78 137.16 51.66 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.421 1.111 . . . . 0.0 110.713 165.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.7 p -141.59 165.04 18.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 125.51 1.524 . . . . 0.0 110.152 -162.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ptm85 -57.38 115.34 2.66 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.351 1.06 . . . . 0.0 111.076 168.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -161.87 127.65 3.6 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.601 1.56 . . . . 0.0 111.358 -171.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.4 tp -142.37 145.93 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.462 0.705 . . . . 0.0 112.888 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -136.97 144.08 43.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.116 1.366 . . . . 0.0 112.727 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -97.08 118.69 34.06 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.075 1.75 . . . . 0.0 109.87 164.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.5 p -80.63 42.86 0.63 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.621 1.569 . . . . 0.0 114.838 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -83.19 141.7 43.3 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.394 1.477 . . . . 0.0 112.353 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.29 166.56 12.69 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.174 2.582 . . . . 0.0 112.463 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -79.67 16.74 1.03 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -172.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -92.11 149.5 21.46 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.191 -0.943 . . . . 0.0 109.733 167.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -72.24 143.98 86.51 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 121.167 -0.958 . . . . 0.0 110.868 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -74.08 144.88 34.5 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.185 2.59 . . . . 0.0 112.908 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.28 111.27 16.24 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.277 1.431 . . . . 0.0 109.154 170.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.9 mt -120.08 -5.65 10.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.663 1.185 . . . . 0.0 113.995 -166.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.55 -32.31 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.742 1.155 . . . . 0.0 111.708 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.2 m -131.08 119.67 22.31 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.959 1.703 . . . . 0.0 109.866 167.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.28 152.32 29.1 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -101.79 -36.55 8.64 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.292 1.837 . . . . 0.0 111.526 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.2 tp -149.05 162.13 40.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.976 1.31 . . . . 0.0 111.882 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.26 123.57 30.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.195 0.998 . . . . 0.0 112.036 168.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -57.42 -35.42 70.04 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.275 1.43 . . . . 0.0 112.923 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.59 -29.99 59.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.553 1.141 . . . . 0.0 113.142 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -70.37 -34.36 72.51 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.972 -1.08 . . . . 0.0 111.784 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.89 2.85 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.642 1.177 . . . . 0.0 113.845 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.89 -10.48 13.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.152 1.381 . . . . 0.0 114.704 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -117.9 133.79 55.58 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.876 1.27 . . . . 0.0 111.472 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.6 m -133.2 131.91 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.544 1.137 . . . . 0.0 111.019 169.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -68.42 127.11 31.79 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.894 1.278 . . . . 0.0 109.854 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -61.63 -33.41 73.89 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -165.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.59 -34.29 77.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.257 1.023 . . . . 0.0 112.374 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.4 mm -77.54 -44.65 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.282 1.033 . . . . 0.0 110.129 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.24 -38.42 71.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.993 1.317 . . . . 0.0 111.775 172.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.69 -36.61 67.91 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.366 -0.834 . . . . 0.0 112.885 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 93.0 m -65.77 -44.84 84.65 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.051 -1.031 . . . . 0.0 111.31 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.1 pt -62.97 -36.85 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.768 0.827 . . . . 0.0 112.174 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -76.54 -32.46 58.24 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.226 1.41 . . . . 0.0 111.592 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.6 t -92.39 -28.34 16.95 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -170.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -86.25 147.68 25.98 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.256 -0.903 . . . . 0.0 111.427 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -72.4 -47.62 47.8 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.007 -1.058 . . . . 0.0 113.531 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.5 t -144.1 130.08 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.625 1.57 . . . . 0.0 110.196 -175.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.76 134.89 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.588 1.155 . . . . 0.0 112.075 -176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -130.75 155.11 47.21 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.525 1.53 . . . . 0.0 111.29 172.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.46 143.06 50.52 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.708 0.803 . . . . 0.0 111.243 170.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mt -130.9 157.36 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.392 1.477 . . . . 0.0 109.655 -165.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -72.12 97.93 2.02 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 152.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.12 -148.38 19.15 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.518 -0.739 . . . . 0.0 114.906 -174.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.5 mt -123.98 157.38 63.74 Favored Pre-proline 0 N--CA 1.476 0.872 0 C-N-CA 125.999 1.72 . . . . 0.0 110.812 -174.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.1 -33.28 50.86 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 121.434 1.422 . . . . 0.0 114.637 -169.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -94.37 -0.38 54.93 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.25 68.1 15.3 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 126.258 1.823 . . . . 0.0 112.018 174.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.05 143.76 11.62 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.274 2.65 . . . . 0.0 112.261 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.3 mmt -91.15 1.42 57.1 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.977 1.311 . . . . 0.0 113.674 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.21 146.15 28.56 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.163 -0.96 . . . . 0.0 111.709 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.85 96.28 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.112 0.965 . . . . 0.0 113.154 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -63.47 -36.86 85.16 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.505 -1.372 . . . . 0.0 112.019 171.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.7 m -64.87 -36.32 83.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.564 -0.732 . . . . 0.0 112.488 173.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -62.83 -46.2 89.02 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 120.153 1.342 . . . . 0.0 111.784 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -64.72 -29.81 70.81 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.677 1.191 . . . . 0.0 113.831 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.3 tpt -57.49 -46.69 83.44 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.345 1.058 . . . . 0.0 112.356 167.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 mm -70.84 -34.42 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.396 -0.815 . . . . 0.0 111.309 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.17 -34.95 68.97 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.571 -0.705 . . . . 0.0 111.835 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.9 -41.89 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.618 1.167 . . . . 0.0 111.684 174.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 69.2 mt -65.28 -36.59 84.56 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.697 0.799 . . . . 0.0 112.882 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.94 -29.64 65.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.989 -1.069 . . . . 0.0 112.739 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.22 77.38 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.254 -0.904 . . . . 0.0 112.042 175.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.76 -11.58 33.47 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.41 1.084 . . . . 0.0 113.474 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.76 9.28 82.86 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.356 1.931 . . . . 0.0 115.989 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.18 136.8 52.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.602 1.201 . . . . 0.0 113.045 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -114.27 159.21 20.44 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 171.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -142.18 174.01 11.0 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.294 2.238 . . . . 0.0 110.943 -162.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.0 m -86.11 130.57 34.49 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 120.906 -1.121 . . . . 0.0 110.157 -165.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.8 p -120.6 147.47 45.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.855 1.262 . . . . 0.0 113.881 -164.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -133.42 143.51 48.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.806 1.242 . . . . 0.0 112.27 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -94.25 119.93 33.76 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.87 1.268 . . . . 0.0 110.429 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.74 -22.51 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.607 1.163 . . . . 0.0 113.434 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -81.39 -23.36 37.68 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.461 -0.775 . . . . 0.0 112.774 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.04 -33.21 19.62 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -144.29 126.91 8.48 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.428 1.091 . . . . 0.0 111.179 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.05 -18.23 45.93 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.93 2.42 . . . . 0.0 114.483 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -46.77 -35.61 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.415 1.086 . . . . 0.0 113.298 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.31 -45.86 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.201 -0.937 . . . . 0.0 111.603 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.402 ' HA ' HG12 ' A' ' 136' ' ' VAL . 23.2 ptt180 -75.25 -23.34 57.48 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.841 0.746 . . . . 0.0 112.995 177.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.2 m -70.54 -53.83 14.54 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.396 0.544 . . . . 0.0 111.844 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -72.78 -35.42 67.41 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.24 -0.913 . . . . 0.0 112.427 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 133' ' ' ARG . 11.6 p -59.15 -44.96 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.772 1.169 . . . . 0.0 112.043 174.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -71.81 -43.74 65.1 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.085 0.857 . . . . 0.0 112.396 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.25 -33.96 77.02 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.292 -0.88 . . . . 0.0 112.882 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.9 t -82.1 -46.95 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.371 0.987 . . . . 0.0 113.363 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -106.56 7.96 31.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -171.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 63.61 -26.31 0.07 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.88 2.472 . . . . 0.0 116.184 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -148.83 148.51 27.82 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 126.811 2.044 . . . . 0.0 112.779 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.02 150.83 16.06 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.646 2.897 . . . . 0.0 113.466 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.9 p -134.3 132.81 40.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.338 1.855 . . . . 0.0 108.706 156.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.7 mm -127.83 117.89 20.95 Favored Pre-proline 0 N--CA 1.478 0.96 0 CA-C-N 119.717 1.144 . . . . 0.0 111.754 -171.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -81.99 172.7 50.85 Favored 'Cis proline' 0 CA--C 1.543 0.943 0 CA-C-N 120.06 1.057 . . . . 0.0 112.842 -5.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -153.24 174.38 14.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.5 1.52 . . . . 0.0 112.605 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.0 140.93 47.03 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -174.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -120.48 144.17 48.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.682 1.993 . . . . 0.0 110.412 168.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.1 mt -131.53 121.49 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.522 1.129 . . . . 0.0 109.103 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 45.98 52.03 10.31 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.698 1.599 . . . . 0.0 114.211 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.258 . . 56.25 26.99 11.09 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -174.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -115.69 137.99 51.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.426 1.09 . . . . 0.0 110.111 165.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -75.91 125.53 29.27 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.218 1.009 . . . . 0.0 111.774 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -101.16 -46.42 11.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.195 1.398 . . . . 0.0 111.011 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.55 171.32 25.24 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 116.4 1.32 . . . . 0.0 116.4 169.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.02 170.29 54.74 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.014 0.816 . . . . 0.0 112.904 167.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -47.22 -37.92 11.25 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.658 1.183 . . . . 0.0 113.854 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -57.19 -43.78 82.99 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.76 0.709 . . . . 0.0 111.911 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.3 mm -76.42 -46.79 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 125.426 1.49 . . . . 0.0 109.931 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.18 -38.23 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.366 1.066 . . . . 0.0 110.829 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 60.7 m -64.01 -43.09 96.7 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.595 0.758 . . . . 0.0 111.655 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -67.16 -38.7 85.92 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.107 0.867 . . . . 0.0 112.125 176.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 34.7 mtt -65.65 -40.35 92.38 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.208 1.403 . . . . 0.0 112.153 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.22 -41.69 76.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.119 0.968 . . . . 0.0 111.605 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -69.94 -29.55 66.71 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 m -105.58 -0.8 25.42 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -172.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.09 -2.93 84.29 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.741 1.162 . . . . 0.0 115.721 175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -67.38 -32.8 73.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.717 1.258 . . . . 0.0 112.07 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.81 -46.39 88.17 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.485 -0.759 . . . . 0.0 110.948 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -59.47 -42.12 91.31 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.588 1.155 . . . . 0.0 112.665 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -62.44 -39.07 92.16 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.137 0.575 . . . . 0.0 112.012 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 49.0 mtm -69.93 -53.43 17.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.609 0.763 . . . . 0.0 112.823 174.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.4 pp -65.64 -37.79 87.55 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.288 0.494 . . . . 0.0 111.932 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -66.8 -39.45 87.75 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.692 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -65.25 -30.54 71.43 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.744 0.702 . . . . 0.0 112.319 174.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -2.83 28.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.723 2.009 . . . . 0.0 114.183 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.23 57.4 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.418 1.009 . . . . 0.0 114.311 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.2 mt -104.17 145.57 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 118.369 1.084 . . . . 0.0 110.895 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 38.3 m -89.91 148.53 23.09 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.196 1.398 . . . . 0.0 111.612 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 28.4 p -145.86 169.27 18.9 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 120.653 -1.279 . . . . 0.0 112.903 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -76.04 156.79 33.66 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.151 0.981 . . . . 0.0 111.438 166.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -91.33 108.07 19.63 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.293 0.637 . . . . 0.0 112.446 -169.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.706 1.603 . . . . 0.0 112.575 -172.832 . . . . . . . . 0 0 . 1 stop_ save_